data_1ego_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ego _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' ASP . 74.9 mtp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 107.961 -1.125 . . . . 2.96 107.961 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 42.7 tp60 -123.64 146.96 47.81 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.745 0.653 . . . . 5.9699999999999998 110.365 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -128.56 154.54 46.07 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.088 -1.045 . . . . 1.97 109.159 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -134.19 128.72 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.648 -1.241 . . . . 1.96 107.648 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mt -111.35 120.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.107 -1.071 . . . . 3.9399999999999999 108.107 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.91 74.26 1.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.882 -1.155 . . . . 1.3100000000000001 107.882 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -147.03 -173.15 17.99 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.114 -1.517 . . . . 2.2000000000000002 109.724 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 18.4 mtp-105 -123.11 154.7 38.26 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.045 -1.062 . . . . 7.0999999999999996 109.631 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -72.23 77.0 0.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.438 -0.905 . . . . 5.5300000000000002 111.296 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.35 21.5 0.17 Allowed Glycine 0 N--CA 1.502 3.045 0 C-N-CA 119.388 -1.387 . . . . 3.5600000000000001 113.101 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -121.99 80.57 42.64 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.048 -0.723 . . . . 3.1000000000000001 109.048 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -18.73 -69.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 124.194 3.262 . . . . 3.52 114.285 -143.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HB2' ' CD ' ' A' ' 60' ' ' PRO . 3.8 m-30 -34.2 -45.04 0.2 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 123.363 0.414 . . . . 5.04 112.096 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 57.7 m -52.35 -55.94 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.972 -1.013 . . . . 2.0299999999999998 109.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.25 -45.78 88.99 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 CA-C-N 114.109 -1.405 . . . . 2.1899999999999999 108.101 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.632 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 1.7 mmp_? -55.84 -51.83 66.15 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.666 -0.814 . . . . 4.7400000000000002 112.255 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.17 -50.07 65.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.089 -1.448 . . . . 1.75 107.089 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 3.0 tmtm? -53.88 -55.12 29.72 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.981 -1.009 . . . . 2.5499999999999998 109.315 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.56 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.9 m-20 -47.8 -56.86 6.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.18 0.514 . . . . 2.8999999999999999 109.617 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 75' ' ' PHE . 29.8 tp -55.35 -57.13 13.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.989 -1.005 . . . . 2.1200000000000001 111.472 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -54.39 44.64 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.903 . . . . 1.6699999999999999 109.579 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 12.5 tt0 -47.59 -47.56 28.53 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.515 -0.92 . . . . 2.2599999999999998 108.515 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -53.3 -64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.179 0.925 . . . . 5.4400000000000004 110.5 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -38.55 -47.0 1.25 Allowed 'General case' 0 N--CA 1.506 2.348 0 O-C-N 123.92 0.763 . . . . 2.2599999999999998 112.835 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -39.06 -36.0 0.26 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.335 0.865 . . . . 2.1099999999999999 113.335 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -97.66 12.6 33.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.046 1.128 . . . . 3.2599999999999998 114.046 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.591 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 19.3 mt-10 -131.9 -30.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 123.87 0.732 . . . . 3.5699999999999998 110.942 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -99.12 -24.15 14.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.954 0.724 . . . . 4.7199999999999998 112.954 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.04 -62.59 0.42 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.071 0.857 . . . . 4.7000000000000002 110.565 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 1' ' ' MET . 10.6 t70 -82.45 55.85 3.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.814 -1.55 . . . . 3.4300000000000002 106.814 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -140.83 91.94 2.46 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.225 -0.898 . . . . 1.79 109.968 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 13.6 mm-40 -110.02 128.24 55.29 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.985 -1.487 . . . . 5.0499999999999998 106.985 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -111.14 160.56 16.8 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.096 -1.041 . . . . 1.4199999999999999 110.594 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -123.97 146.64 48.36 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.372 -1.344 . . . . 3.6800000000000002 107.372 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -102.09 132.11 48.16 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.993 -1.083 . . . . 3.0099999999999998 108.378 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 135.27 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.335 -1.357 . . . . 1.6599999999999999 107.335 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 34.3 t0 -110.44 111.39 22.62 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 122.23 1.014 . . . . 1.73 109.905 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 pt -48.7 -32.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.25 -1.341 . . . . 2.8999999999999999 114.035 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 39' ' ' ARG . 2.7 mmp_? -101.46 19.32 18.09 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.699 -0.8 . . . . 10.390000000000001 111.714 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.73 -43.68 2.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.682 -1.229 . . . . 2.6699999999999999 107.682 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.52 -45.32 46.54 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.375 -1.738 . . . . 2.8799999999999999 110.429 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.59 63.49 0.34 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.746 -1.216 . . . . 1.6799999999999999 112.693 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.6 145.6 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.769 -0.772 . . . . 2.7400000000000002 109.289 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -116.93 -97.56 0.46 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.939 -0.704 . . . . 3.02 110.203 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -137.6 -50.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.78 -1.933 . . . . 8.8900000000000006 105.78 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 45' ' ' LYS . 3.8 mp0 -51.29 -50.17 59.83 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 113.679 -1.601 . . . . 5.5899999999999999 108.894 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -46.44 -64.34 0.78 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.102 0.953 . . . . 3.5899999999999999 109.329 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.1 mt -49.93 -50.94 44.65 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.21 -1.359 . . . . 3.3500000000000001 110.044 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -56.15 -36.55 68.42 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.168 -1.413 . . . . 5.2699999999999996 110.749 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.63 -39.43 57.83 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.278 0.561 . . . . 7.4900000000000002 112.064 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.625 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 1.7 ttpp -87.37 -28.79 21.98 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 114.575 1.324 . . . . 6.0199999999999996 114.575 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -118.19 -35.7 3.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.838 0.711 . . . . 3.04 112.689 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.9 -44.57 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.075 -2.81 . . . . 3.8700000000000001 106.075 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.453 ' NZ ' ' HG3' ' A' ' 57' ' ' GLU . 9.1 tttp 53.21 102.77 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 113.297 -1.451 . . . . 10.949999999999999 112.656 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -51.07 179.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.214 1.943 . . . . 6.2699999999999996 110.327 143.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.95 59.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.571 -1.252 . . . . 6.9500000000000002 110.358 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 15.6 pt-20 -103.51 178.81 4.45 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.654 -1.612 . . . . 5.6600000000000001 107.549 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -116.42 -106.32 0.39 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.356 -1.338 . . . . 7.04 109.193 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.29 154.64 78.84 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 123.964 0.79 . . . . 4.6100000000000003 109.83 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.701 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 48.6 Cg_endo -96.74 -164.95 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.507 0.741 . . . . 2.2599999999999998 110.452 -1.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -147.78 163.74 35.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.19 0.931 . . . . 3.4100000000000001 108.64 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.536 HG22 ' CD1' ' A' ' 75' ' ' PHE . 3.1 mp -121.32 151.18 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 122.302 1.048 . . . . 2.1000000000000001 111.787 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.625 ' CZ ' ' HE3' ' A' ' 51' ' ' LYS . 9.4 m-85 -133.31 130.94 39.56 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.764 -2.016 . . . . 1.5600000000000001 108.726 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.411 HG21 HG13 ' A' ' 69' ' ' ILE . 66.8 t -121.62 129.77 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.778 -1.564 . . . . 2.0499999999999998 106.778 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 5.1 m-20 51.47 25.32 2.61 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.698 1.237 . . . . 2.77 112.276 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 2.4 mm100 79.49 -6.36 1.83 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 112.216 -2.266 . . . . 8.2799999999999994 114.559 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.84 154.96 23.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.963 -1.865 . . . . 5.3399999999999999 105.963 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 17.3 t-160 -83.16 147.52 28.01 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 117.469 -1.692 . . . . 1.5700000000000001 109.492 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.411 HG13 HG21 ' A' ' 64' ' ' VAL . 16.8 mm -116.63 -35.7 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 124.294 0.996 . . . . 1.8400000000000001 109.154 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.16 -139.76 9.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.754 -1.212 . . . . 1.9399999999999999 110.301 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.15 -65.75 0.85 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.577 -1.009 . . . . 2.7999999999999998 110.577 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 66.5 t80 -157.75 -53.78 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.26 -1.376 . . . . 2.27 110.677 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -46.68 -47.62 20.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.356 -1.35 . . . . 2.5899999999999999 107.356 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.44 -59.36 4.68 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.25 -1.795 . . . . 3.27 109.602 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CD1' HG22 ' A' ' 62' ' ' ILE . 38.6 t80 -51.78 -47.64 64.1 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.442 -0.903 . . . . 0.98999999999999999 109.224 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -59.37 4.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.315 -0.954 . . . . 1.71 109.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.31 -0.859 . . . . 2.27 109.564 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -40.49 -48.89 2.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.006 0.816 . . . . 1.29 110.13 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 80' ' ' LYS . 9.9 t -60.5 -59.2 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.328 -0.99 . . . . 2.1899999999999999 108.328 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -41.27 -49.65 3.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.882 -1.054 . . . . 4.5 109.925 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.96 -55.68 7.84 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 116.41 2.004 . . . . 3.8100000000000001 116.41 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -83.54 -20.11 34.46 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 113.948 1.092 . . . . 2.0600000000000001 113.948 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.69 -37.31 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 117.997 -1.481 . . . . 2.6499999999999999 113.24 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 63.5 m-20 . . . . . 0 N--CA 1.498 1.968 0 C-N-CA 118.071 -1.452 . . . . 5.7999999999999998 112.738 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 30' ' ' ASP . 36.5 mtm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.0 -1.481 . . . . 3.1299999999999999 107.0 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -124.57 143.37 50.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.733 -0.787 . . . . 5.8099999999999996 110.008 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 61.4 m -125.19 145.11 50.12 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.08 -1.048 . . . . 1.74 113.282 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.8 136.79 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.949 -1.13 . . . . 1.54 107.949 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -118.09 122.03 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 124.226 0.954 . . . . 3.4399999999999999 109.727 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -93.66 87.21 5.41 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.618 -1.253 . . . . 1.3799999999999999 107.618 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.89 -164.29 14.51 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.529 -1.428 . . . . 1.1899999999999999 109.529 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.682 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -128.11 -158.7 0.89 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 117.98 0.89 . . . . 6.6799999999999997 109.655 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.51 ' H ' ' CG ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -101.91 61.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.66 -0.867 . . . . 3.8100000000000001 108.66 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.67 92.32 2.26 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.048 -2.021 . . . . 2.8199999999999998 108.048 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -155.27 63.63 3.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 120.311 -0.556 . . . . 2.3500000000000001 110.224 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -20.42 -55.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 124.044 3.162 . . . . 2.7000000000000002 114.001 -145.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' CYS . 4.3 m-85 -42.69 -44.94 4.52 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.246 -0.582 . . . . 4.8399999999999999 111.668 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -57.14 -46.12 82.97 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.538 -0.865 . . . . 2.3999999999999999 111.046 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.0 t -55.8 -43.17 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 115.643 -0.708 . . . . 1.8300000000000001 110.916 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.659 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -47.27 -48.98 24.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.645 -1.222 . . . . 4.6799999999999997 112.583 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.07 -45.91 68.35 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.128 -1.029 . . . . 1.72 108.864 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -58.5 -50.81 72.41 Favored 'General case' 0 C--O 1.2 -1.512 0 C-N-CA 119.277 -0.969 . . . . 3.4700000000000002 108.404 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HA ' ' HZ1' ' A' ' 18' ' ' LYS . 66.1 m-20 -49.67 -48.4 49.54 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.447 -1.301 . . . . 2.98 110.055 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.14 -65.84 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.396 -1.322 . . . . 1.8899999999999999 110.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -51.94 8.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.788 0.804 . . . . 1.8700000000000001 110.713 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.493 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 22.0 tt0 -59.05 -52.48 65.58 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.588 -1.187 . . . . 2.3100000000000001 107.906 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 tmtm? -43.7 -36.43 2.21 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 115.531 -0.759 . . . . 4.6399999999999997 110.515 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 79' ' ' VAL . 11.4 mt -78.32 -44.82 24.24 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.146 -0.934 . . . . 2.3199999999999998 110.438 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' GLU . 74.4 m -50.25 -42.31 51.78 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 118.938 -1.105 . . . . 2.1800000000000002 109.387 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 23' ' ' LYS . 3.2 p-10 -80.73 28.31 0.34 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.033 -1.467 . . . . 5.3200000000000003 111.335 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.6 mt-10 -127.68 -64.85 0.95 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.611 -1.177 . . . . 4.21 110.58 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.21 150.29 40.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.54 -0.864 . . . . 4.7999999999999998 109.655 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.34 -25.81 60.77 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.647 -0.872 . . . . 5.5800000000000001 108.647 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.5 t70 -74.54 -8.76 57.37 Favored 'General case' 0 C--O 1.202 -1.442 0 C-N-CA 119.065 -1.054 . . . . 3.3100000000000001 111.711 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -106.78 97.19 7.01 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.76 -1.976 . . . . 1.3899999999999999 111.151 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -113.75 160.13 19.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.868 -1.16 . . . . 4.5599999999999996 107.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 3' ' ' THR . 21.5 p90 -147.92 165.18 31.47 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.51 -0.876 . . . . 1.5800000000000001 108.929 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -131.05 136.53 48.53 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.225 -1.398 . . . . 4.5 107.225 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.29 140.76 29.16 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.236 -1.786 . . . . 1.71 107.659 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.78 137.38 54.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.528 -0.915 . . . . 1.9199999999999999 108.528 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -111.77 121.71 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.493 -1.299 . . . . 2.4100000000000001 107.493 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -44.81 -31.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.701 1.0 . . . . 2.4900000000000002 113.701 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 17.77 15.36 Favored 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 118.14 -1.424 . . . . 6.2300000000000004 111.972 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.86 -41.85 5.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.245 -1.761 . . . . 2.29 106.245 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -82.98 -39.66 21.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.726 -1.579 . . . . 3.4700000000000002 108.952 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 50.29 0.65 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.295 -1.522 . . . . 1.5 109.295 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.61 160.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.676 -0.762 . . . . 2.79 111.129 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.6 p -112.74 -158.14 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.606 -1.179 . . . . 3.0099999999999998 110.844 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -114.15 12.8 17.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 106.486 -1.672 . . . . 6.0 106.486 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -119.11 -50.08 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.645 -1.161 . . . . 4.9299999999999997 109.625 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -57.89 -45.4 86.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.907 -1.146 . . . . 3.8300000000000001 107.907 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -42.23 -47.88 4.8 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 115.207 -0.906 . . . . 3.0 110.468 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -46.78 -49.17 20.26 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.617 -0.882 . . . . 5.3300000000000001 108.617 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -73.86 -40.54 63.18 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.902 -1.044 . . . . 8.1500000000000004 110.98 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -47.71 70.94 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.503 -0.555 . . . . 5.6900000000000004 109.503 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.512 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -76.29 -49.68 16.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.21 -0.905 . . . . 3.1899999999999999 109.998 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.41 16.33 55.53 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.238 -1.458 . . . . 3.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 6.4 ttmt -120.26 77.42 25.45 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.602 -0.888 . . . . 6.5599999999999996 108.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -80.85 22.66 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.632 1.555 . . . . 4.9100000000000001 112.503 -127.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.24 -12.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.56 -1.2 . . . . 6.8300000000000001 111.767 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 11.6 pt-20 -86.77 174.85 8.55 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 118.748 -1.181 . . . . 6.1299999999999999 112.691 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 p -131.45 -80.07 0.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.072 -0.967 . . . . 5.6100000000000003 110.698 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 t -119.82 151.82 52.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 4.4900000000000002 109.451 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -87.64 168.53 40.48 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.814 -0.911 . . . . 2.9100000000000001 111.04 -18.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.414 ' NE2' ' HB3' ' A' ' 52' ' ' ALA . 87.2 mt-30 -131.42 117.56 19.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 105.478 -2.045 . . . . 3.48 105.478 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.543 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.0 mp -113.25 141.98 27.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.916 -1.038 . . . . 2.0899999999999999 108.894 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 4.4 m-85 -120.06 138.23 53.66 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.778 -2.01 . . . . 1.5800000000000001 108.756 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.8 t -116.79 130.07 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.064 -1.054 . . . . 1.9399999999999999 108.63 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 54.09 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 112.607 -2.088 . . . . 3.29 113.383 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 64' ' ' VAL . 72.7 mt-30 -131.22 -31.3 1.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.164 1.542 . . . . 5.4500000000000002 115.164 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 1.4 pm0 -117.56 171.95 7.67 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.003 1.112 . . . . 4.4000000000000004 114.003 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 9.3 t-80 -73.44 147.64 43.99 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 105.603 -1.999 . . . . 1.8500000000000001 105.603 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.417 HG13 ' CG2' ' A' ' 64' ' ' VAL . 46.2 mm -122.29 -29.39 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.649 -1.22 . . . . 2.7000000000000002 108.852 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.44 -171.55 34.7 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.069 -1.062 . . . . 2.27 111.337 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 73' ' ' THR . . . -105.12 -149.53 19.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.219 -2.353 . . . . 1.71 107.219 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.53 42.79 0.53 Allowed 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 117.651 -1.62 . . . . 2.9700000000000002 109.467 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 71' ' ' GLY . 11.7 p -144.62 -69.06 0.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.826 -1.079 . . . . 2.7999999999999998 109.726 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -54.09 8.88 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.873 -1.058 . . . . 2.9900000000000002 108.403 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CZ ' ' CG2' ' A' ' 79' ' ' VAL . 22.5 t80 -52.87 -56.87 12.65 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 104.959 -2.237 . . . . 1.9199999999999999 104.959 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -38.65 -52.84 1.65 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.688 -1.142 . . . . 2.77 110.232 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -63.54 -58.37 7.2 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.316 -0.954 . . . . 1.6299999999999999 110.056 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' ALA . 61.5 t90 -40.93 -51.01 3.27 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 119.243 -0.983 . . . . 1.8999999999999999 109.145 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' A' ' 24' ' ' LEU . 71.0 t -43.13 -58.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.124 -1.065 . . . . 2.4900000000000002 108.124 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.53 ' C ' ' HZ1' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -51.61 -60.9 2.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.876 -1.056 . . . . 3.79 111.655 -179.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.476 ' CD ' ' HZ3' ' A' ' 80' ' ' LYS . 8.5 mp0 -59.03 -33.1 70.37 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.239 1.94 . . . . 3.8799999999999999 116.239 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 82' ' ' ASN . 0.8 OUTLIER -98.99 -23.38 15.32 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 117.809 -1.556 . . . . 2.1699999999999999 113.066 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.446 ' O ' ' C ' ' A' ' 84' ' ' ASP . 15.3 mt -83.72 -53.59 5.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.023 -2.214 . . . . 2.04 105.023 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 83' ' ' LEU . 4.6 m-20 . . . . . 0 N--CA 1.508 2.445 0 O-C-N 124.858 1.349 . . . . 5.0999999999999996 113.552 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.509 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 44.6 tpp . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.434 -1.321 . . . . 3.2599999999999998 107.434 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 1.3 mp0 -131.97 132.92 43.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.765 0.666 . . . . 5.5800000000000001 110.317 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.422 ' OG1' ' CE1' ' A' ' 31' ' ' PHE . 38.5 m -121.64 142.79 49.78 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 119.623 -0.831 . . . . 1.8100000000000001 110.939 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.47 127.35 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 108.42 -0.956 . . . . 2.1200000000000001 108.42 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.32 109.44 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 124.84 1.337 . . . . 3.0299999999999998 108.582 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 98.3 m-85 -87.87 100.05 12.58 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.111 -1.07 . . . . 1.8700000000000001 108.111 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.8 -166.93 13.69 Favored Glycine 0 N--CA 1.501 3.015 0 N-CA-C 109.114 -1.594 . . . . 0.98999999999999999 109.114 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.697 ' CG ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 ptm180 -119.24 37.27 4.19 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.257 -1.377 . . . . 6.7800000000000002 112.088 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 50.5 m 83.47 51.71 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 116.094 1.887 . . . . 3.5299999999999998 116.094 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.77 67.34 1.49 Allowed Glycine 0 N--CA 1.505 3.246 0 C-N-CA 119.069 -1.539 . . . . 4.5 114.1 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.697 ' SG ' ' CG ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -111.42 159.07 34.41 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.339 -0.944 . . . . 2.7200000000000002 109.886 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 81.2 Cg_exo -40.31 144.24 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.438 1.426 . . . . 3.6600000000000001 110.015 157.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER 77.11 -59.46 0.48 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 107.568 -1.271 . . . . 3.8599999999999999 107.568 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 33.4 m -53.78 -47.16 71.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.4 -0.818 . . . . 1.73 110.029 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 11' ' ' CYS . 86.1 t -49.12 -41.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.856 -1.138 . . . . 2.8199999999999998 108.033 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -74.58 82.82 2.02 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.657 -1.238 . . . . 5.5199999999999996 107.657 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 173.36 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.291 -2.231 . . . . 2.46 105.471 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 5.9 tmtm? -69.17 -47.18 65.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.964 -1.495 . . . . 3.5 106.964 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -55.29 -37.39 67.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.775 -0.824 . . . . 3.4100000000000001 108.775 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.02 -58.97 3.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.301 -1.36 . . . . 2.3700000000000001 108.563 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -40.14 -54.55 2.28 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.511 -0.876 . . . . 1.79 110.918 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.508 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 3.8 mm-40 -38.77 -41.86 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.852 0.834 . . . . 3.2000000000000002 112.735 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.51 -54.63 11.42 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.013 -0.994 . . . . 5.4500000000000002 109.502 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 49.3 mt -49.99 -46.25 52.47 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.54 -1.209 . . . . 2.3399999999999999 108.15 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 m -58.02 -28.7 64.69 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.252 0.97 . . . . 2.1899999999999999 112.667 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -102.2 -17.26 16.04 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.265 -0.574 . . . . 5.1699999999999999 111.761 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CD ' HH12 ' A' ' 28' ' ' ARG . 34.1 mt-10 -87.93 -45.23 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.253 -0.579 . . . . 3.1299999999999999 110.537 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 83' ' ' LEU . 2.0 mpt_? -104.69 -17.09 14.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.867 -0.733 . . . . 6.8700000000000001 111.486 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.59 -51.32 0.62 Allowed 'General case' 0 N--CA 1.512 2.65 0 O-C-N 124.394 1.059 . . . . 5.9000000000000004 112.326 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 1' ' ' MET . 18.7 t70 -76.86 54.73 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.421 1.105 . . . . 3.4300000000000002 108.642 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 74.0 t80 -146.34 82.2 1.59 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.393 -0.821 . . . . 1.9299999999999999 109.745 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 12.8 mp0 -89.71 142.11 27.99 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.481 -1.674 . . . . 4.3399999999999999 106.481 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 18' ' ' LYS . 38.0 p90 -129.78 150.27 51.16 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.289 -0.964 . . . . 1.74 108.659 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -116.74 136.29 53.08 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.841 -0.8 . . . . 4.8200000000000003 108.841 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -95.23 114.95 26.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.091 -1.818 . . . . 2.0600000000000001 106.091 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.54 134.57 54.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 114.776 -1.102 . . . . 1.6200000000000001 109.362 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.17 132.38 55.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.504 -0.924 . . . . 2.1699999999999999 108.504 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 pt -60.87 -29.77 46.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 118.686 -1.205 . . . . 2.4700000000000002 111.825 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.15 -34.19 56.56 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.012 -1.475 . . . . 5.46 110.602 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.23 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.663 -0.815 . . . . 2.0299999999999998 111.262 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -85.08 -34.46 22.23 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.322 -0.951 . . . . 2.5499999999999998 111.225 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.89 52.85 1.07 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.677 -1.369 . . . . 1.3300000000000001 109.677 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -104.74 155.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.764 -0.718 . . . . 2.4199999999999999 110.849 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.0 p -118.62 161.58 19.83 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.167 -0.924 . . . . 2.7000000000000002 110.648 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 19.0 ttpp -55.73 -42.59 75.57 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.687 -1.597 . . . . 5.0999999999999996 106.687 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 1.2 mp0 -51.55 -56.82 11.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.237 -1.347 . . . . 3.7200000000000002 109.647 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -46.84 -51.47 16.52 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.581 -0.848 . . . . 3.6200000000000001 111.139 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.76 -52.1 61.88 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.311 -0.859 . . . . 2.25 110.457 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 40.6 tt0 -53.3 -39.29 63.89 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.839 -0.744 . . . . 4.7000000000000002 109.549 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.09 -33.81 59.52 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.388 -0.597 . . . . 5.4500000000000002 109.388 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -63.07 -36.94 85.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.468 -0.567 . . . . 4.9100000000000001 109.468 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -104.81 -88.17 0.43 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.076 -0.966 . . . . 2.6299999999999999 108.904 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 41.34 1.12 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.125 -1.512 . . . . 3.7000000000000002 113.869 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 74' ' ' ASP . 44.0 pttt -120.76 58.0 6.29 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.073 -1.051 . . . . 6.7400000000000002 109.194 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.1 38.8 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.251 3.301 . . . . 5.3399999999999999 114.043 -106.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.92 38.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.073 -1.084 . . . . 6.6200000000000001 108.073 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -104.33 154.02 20.34 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.737 -1.119 . . . . 5.9199999999999999 110.971 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -125.29 -156.23 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.566 -1.197 . . . . 5.6500000000000004 107.819 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.69 145.42 30.67 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.996 -0.742 . . . . 4.3899999999999997 108.996 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 52.8 Cg_endo -88.89 145.68 22.0 Favored 'Cis proline' 0 C--N 1.316 -1.132 0 O-C-N 123.558 1.294 . . . . 2.5299999999999998 112.36 16.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -102.51 144.12 31.35 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.445 -1.687 . . . . 4.21 106.445 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.58 140.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.843 -1.543 . . . . 2.8799999999999999 112.988 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 24.9 m-85 -136.16 135.59 39.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 110.976 -2.829 . . . . 1.4299999999999999 107.876 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 69' ' ' ILE . 61.6 t -102.6 121.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 106.828 -1.545 . . . . 1.9399999999999999 106.828 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.2 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.905 -1.043 . . . . 2.6000000000000001 111.209 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 64' ' ' VAL . 58.2 mt-30 -135.06 3.31 3.15 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.26 -0.976 . . . . 5.6600000000000001 111.666 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -105.39 155.41 19.15 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.843 0.354 . . . . 5.6600000000000001 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.526 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 8.0 t-80 -92.78 149.18 21.46 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.409 -1.33 . . . . 2.0499999999999998 107.409 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.493 HG13 HG21 ' A' ' 64' ' ' VAL . 3.2 mm -118.01 -38.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 117.513 -1.675 . . . . 1.8600000000000001 109.703 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.4 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 136.41 -26.59 3.06 Favored Glycine 0 N--CA 1.502 3.04 0 C-N-CA 118.937 -1.602 . . . . 2.3900000000000001 112.435 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.37 -173.83 20.27 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 108.231 -1.947 . . . . 2.6899999999999999 108.231 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -51.77 -59.33 4.43 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.89 -1.124 . . . . 2.5600000000000001 111.611 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.69 -45.59 49.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 112.938 0.718 . . . . 2.9300000000000002 112.938 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 1.4 m-20 -74.84 -51.71 13.25 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.793 -0.763 . . . . 2.5600000000000001 110.205 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 79' ' ' VAL . 83.4 t80 -51.21 -43.33 61.37 Favored 'General case' 0 C--O 1.194 -1.84 0 N-CA-C 107.48 -1.304 . . . . 1.23 107.48 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.79 -60.63 2.94 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.018 -0.734 . . . . 1.75 109.018 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.96 -53.94 45.83 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.909 -0.716 . . . . 1.74 111.312 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -54.93 -53.12 59.65 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.416 -0.914 . . . . 1.6299999999999999 110.126 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 80' ' ' LYS . 1.9 t -46.48 -62.52 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 124.48 1.112 . . . . 2.1800000000000002 109.006 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.534 ' N ' HG13 ' A' ' 79' ' ' VAL . 15.8 tptp -34.63 -49.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.256 -1.793 . . . . 3.75 113.3 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.04 20.05 19.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.653 1.723 . . . . 6.4199999999999999 115.653 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -132.14 -26.53 1.9 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.661 -1.615 . . . . 2.5 110.775 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 50.1 mt -100.95 45.56 0.97 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.426 -1.31 . . . . 2.75 107.804 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.933 0.873 . . . . 5.6600000000000001 110.378 177.775 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' ASP . 77.5 mtm . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.211 -0.662 . . . . 3.4100000000000001 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -109.43 102.16 11.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.727 -1.212 . . . . 5.5999999999999996 107.727 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.3 m -91.66 139.43 30.7 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.599 -1.241 . . . . 1.9399999999999999 109.27 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.52 139.03 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.045 -0.98 . . . . 1.9199999999999999 109.988 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -118.34 109.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.156 1.535 . . . . 2.75 107.86 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.486 ' CD2' HG12 ' A' ' 36' ' ' VAL . 32.5 m-85 -91.74 90.74 7.66 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.174 -1.417 . . . . 1.6100000000000001 107.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.85 -162.61 11.95 Favored Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.262 -0.971 . . . . 1.0600000000000001 110.947 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.632 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -122.77 71.59 1.04 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.095 0.95 . . . . 7.5700000000000003 111.532 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p 32.81 -77.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 116.393 1.997 . . . . 3.71 116.393 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -103.74 46.3 1.22 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 120.111 -1.042 . . . . 3.1899999999999999 113.983 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.632 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 1.1 p -116.3 114.63 40.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 108.239 -1.023 . . . . 2.3999999999999999 108.239 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.61 -54.89 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.187 1.925 . . . . 3.04 111.732 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.1 -40.43 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.279 -0.968 . . . . 3.3700000000000001 109.913 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 28.4 m -62.24 -53.6 52.93 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.141 -1.024 . . . . 1.77 110.303 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -52.62 -42.14 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 114.669 -1.15 . . . . 2.6000000000000001 111.663 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.501 HH12 ' CG ' ' A' ' 19' ' ' ASP . 10.0 mmm180 -42.5 -41.58 3.02 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 119.11 -1.036 . . . . 4.1799999999999997 111.551 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.37 86.39 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.442 -0.903 . . . . 1.9199999999999999 108.659 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' A' ' 22' ' ' GLU . 4.1 tmtm? -62.6 -38.15 89.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.626 -0.879 . . . . 2.9399999999999999 108.626 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.501 ' CG ' HH12 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -61.46 -56.94 14.65 Favored 'General case' 0 C--O 1.192 -1.955 0 N-CA-C 106.666 -1.605 . . . . 3.5299999999999998 106.666 177.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.1 tp -48.31 -56.93 6.8 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.145 -1.022 . . . . 2.3900000000000001 108.655 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -50.53 9.84 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 2.0099999999999998 108.425 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -57.41 -52.14 66.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.122 -0.631 . . . . 3.1200000000000001 110.501 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 2.4 ttpp -52.68 -17.32 1.25 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.627 -1.17 . . . . 4.5999999999999996 110.428 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.03 -53.37 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.506 -0.924 . . . . 2.7000000000000002 108.506 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -43.9 -35.39 1.97 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.593 0.59 . . . . 2.3799999999999999 112.593 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -105.62 22.3 15.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.086 1.143 . . . . 4.7199999999999998 114.086 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 19.8 mt-10 -131.86 -27.6 1.86 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.575 -0.45 . . . . 3.27 110.242 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.59 -163.98 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.809 -0.756 . . . . 4.8799999999999999 109.587 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.49 -179.98 4.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.14 -1.8 . . . . 4.6900000000000004 106.14 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 t70 43.86 30.43 0.39 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 124.923 1.389 . . . . 3.6000000000000001 112.059 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.87 85.88 2.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.243 -1.783 . . . . 1.4299999999999999 113.068 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -102.71 141.82 34.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.178 -2.156 . . . . 4.3200000000000003 105.178 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -133.1 153.62 51.34 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.627 -1.229 . . . . 1.2 109.567 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.407 ' OE1' HG22 ' A' ' 36' ' ' VAL . 1.7 tm0? -121.3 142.53 49.87 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.292 -1.373 . . . . 4.7199999999999998 107.292 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.54 118.97 33.22 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.652 -1.219 . . . . 2.3199999999999998 109.319 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.486 HG12 ' CD2' ' A' ' 6' ' ' PHE . 26.3 t -109.43 136.07 46.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.027 -0.988 . . . . 2.0600000000000001 109.152 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' A' ' 39' ' ' ARG . 17.1 t70 -118.58 44.86 2.17 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 114.842 -1.072 . . . . 1.99 108.743 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.1 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 114.364 -1.289 . . . . 2.1800000000000002 114.199 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.616 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -59.14 -51.39 70.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.75 -0.659 . . . . 7.7999999999999998 110.876 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' NH2' ' A' ' 39' ' ' ARG . . . -40.34 -51.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.381 -0.927 . . . . 2.3399999999999999 110.24 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -74.93 -43.04 56.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.426 1.079 . . . . 3.1699999999999999 110.478 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.4 30.81 1.23 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.161 -1.176 . . . . 2.3300000000000001 110.161 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -98.44 152.35 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 3.3599999999999999 108.171 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -124.4 -175.98 3.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.708 -0.678 . . . . 4.0899999999999999 112.32 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -84.3 2.15 41.56 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.983 -0.687 . . . . 5.5999999999999996 110.619 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.84 -45.91 5.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.037 -2.208 . . . . 5.0499999999999998 105.037 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.5 -56.2 21.29 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.054 -0.975 . . . . 4.1100000000000003 108.486 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -48.64 -40.25 27.13 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.713 -1.131 . . . . 2.6200000000000001 111.5 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -44.23 -53.67 6.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.925 -1.11 . . . . 7.9699999999999998 109.338 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -43.04 -49.92 6.06 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.493 -1.685 . . . . 7.4000000000000004 113.297 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 5.4 mtpp -91.06 -28.02 18.22 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.516 -1.22 . . . . 6.7300000000000004 114.162 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -73.61 -51.24 17.5 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.569 1.168 . . . . 2.2799999999999998 112.899 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.98 -32.94 2.68 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.143 -1.983 . . . . 2.3199999999999998 108.143 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HZ3' ' CG ' ' A' ' 74' ' ' ASP . 26.0 mttt -86.38 -179.07 1.27 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 114.547 -0.827 . . . . 6.7000000000000002 108.807 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 57' ' ' GLU . 27.3 Cg_exo -62.73 124.45 14.13 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.749 2.299 . . . . 5.4900000000000002 111.76 155.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.42 31.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.898 -0.592 . . . . 9.3900000000000006 111.377 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -114.19 -7.85 12.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.41 -0.959 . . . . 5.6399999999999997 108.41 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -85.04 54.09 2.97 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.243 -1.392 . . . . 7.6799999999999997 107.243 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.627 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 19.2 m -89.68 169.57 12.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.161 -1.382 . . . . 4.4199999999999999 111.799 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.627 ' C ' ' HA ' ' A' ' 59' ' ' VAL . 5.6 Cg_endo -46.16 137.67 1.8 Allowed 'Cis proline' 0 N--CA 1.489 1.219 0 C-N-CA 125.072 -0.803 . . . . 2.6600000000000001 110.518 -13.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.2 OUTLIER -94.53 116.63 29.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.091 -1.818 . . . . 3.9500000000000002 106.091 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.6 mp -108.29 139.7 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 123.035 1.397 . . . . 2.1600000000000001 111.416 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.508 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 3.8 m-85 -126.71 136.58 52.65 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 111.833 -2.44 . . . . 1.98 106.257 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' HG13 ' A' ' 69' ' ' ILE . 54.9 t -110.11 110.07 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 118.677 -1.209 . . . . 1.9199999999999999 109.84 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 t70 75.38 -72.3 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 124.29 0.994 . . . . 2.6899999999999999 112.216 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -134.03 -41.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.619 0.97 . . . . 5.29 113.619 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -94.26 160.75 14.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.552 0.945 . . . . 5.0800000000000001 113.552 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.508 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.6 t-160 -77.09 144.47 38.5 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.772 -1.936 . . . . 1.6000000000000001 105.772 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.432 HG13 ' CG2' ' A' ' 64' ' ' VAL . 20.9 mm -103.66 -25.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 117.916 -1.514 . . . . 1.8799999999999999 109.504 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.73 -34.05 2.2 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 118.522 -1.799 . . . . 2.77 113.294 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.78 -175.01 22.37 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.514 -1.434 . . . . 2.6000000000000001 109.514 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 2.6 t80 -51.29 -44.44 61.88 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.375 -0.93 . . . . 2.6299999999999999 111.625 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 p -66.81 -58.85 4.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.768 0.794 . . . . 2.1400000000000001 110.548 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 54' ' ' LYS . 5.2 m-20 -48.73 -46.44 40.87 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.634 -1.166 . . . . 2.71 109.21 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.405 ' CG ' HG22 ' A' ' 62' ' ' ILE . 48.7 t80 -60.88 -53.23 59.81 Favored 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 108.198 -1.038 . . . . 1.27 108.198 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.59 -53.39 11.55 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.71 -0.796 . . . . 1.5800000000000001 112.655 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.48 13.58 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 118.999 -1.081 . . . . 1.54 110.126 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -44.41 -48.64 9.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.22 0.95 . . . . 1.49 108.828 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 t -47.67 -59.36 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 124.154 0.909 . . . . 1.8799999999999999 108.865 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HD3' ' C ' ' A' ' 80' ' ' LYS . 7.6 tmtm? -57.33 -59.92 4.41 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.498 -1.281 . . . . 4.1299999999999999 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -52.66 -36.27 56.61 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.24 1.57 . . . . 3.8599999999999999 115.24 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -101.27 -28.67 12.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.811 -1.155 . . . . 2.1200000000000001 113.563 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.07 -26.43 26.97 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 117.862 -1.535 . . . . 1.95 112.571 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 . . . . . 0 N--CA 1.5 2.073 0 C-N-CA 118.393 -1.323 . . . . 3.3300000000000001 111.153 -179.114 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 30' ' ' ASP . 13.9 ptp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.162 -0.681 . . . . 3.4399999999999999 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 19.6 pt20 -123.82 125.53 44.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.749 0.656 . . . . 4.3799999999999999 110.721 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -94.25 132.03 39.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.488 -0.93 . . . . 1.98 108.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.87 117.94 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.59 -1.634 . . . . 1.8799999999999999 106.59 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.8 mm -108.96 125.04 66.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.568 -1.253 . . . . 2.96 108.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.13 96.02 6.94 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.962 -0.755 . . . . 1.6399999999999999 108.962 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.59 -173.67 18.09 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.559 -1.817 . . . . 1.1299999999999999 108.559 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.11 170.84 3.69 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.813 -0.81 . . . . 10.039999999999999 108.813 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -90.51 53.7 2.52 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 105.864 -1.902 . . . . 6.6500000000000004 105.864 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.83 -39.16 0.12 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.339 -1.904 . . . . 8.1999999999999993 108.339 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -90.59 151.67 44.27 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 108.578 -0.897 . . . . 5.0199999999999996 108.578 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.2 Cg_endo -91.28 178.91 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.58 2.187 . . . . 5.46 109.027 146.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER 76.6 -36.56 0.27 Allowed 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 120.454 -0.498 . . . . 4.1299999999999999 111.714 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -31.77 11.32 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 120.28 -0.568 . . . . 1.78 111.936 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.84 -53.5 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.444 -0.902 . . . . 2.0099999999999998 109.7 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -33.86 -53.15 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.295 -0.866 . . . . 5.2599999999999998 113.323 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.9 84.16 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.451 -0.9 . . . . 1.77 109.733 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 2.5 tmtm? -53.33 -47.9 68.94 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.891 -1.049 . . . . 2.54 110.251 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 1.3 p-10 -68.03 -43.14 79.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.143 -1.423 . . . . 2.8399999999999999 109.083 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.52 -58.57 6.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.273 -1.371 . . . . 1.8 109.953 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.94 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.542 -0.863 . . . . 2.02 110.725 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.61 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 24.1 tt0 -50.75 -57.8 7.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.885 -1.126 . . . . 2.6699999999999999 109.265 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.61 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -49.14 -54.07 17.94 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.901 -1.045 . . . . 5.6699999999999999 110.178 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -48.9 -44.15 39.87 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 114.107 1.151 . . . . 2.5600000000000001 114.107 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.7 p -49.73 -19.94 0.73 Allowed 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 119.351 -0.939 . . . . 2.5699999999999998 113.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 26' ' ' ASN . 1.2 m120 -99.53 -2.82 34.86 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.713 -0.395 . . . . 4.2000000000000002 111.531 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.61 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 14.9 mt-10 -114.6 -32.8 5.75 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.577 0.703 . . . . 3.3500000000000001 111.24 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 8.6 mmm-85 -95.67 -173.62 2.92 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.743 -1.183 . . . . 4.3399999999999999 113.953 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 7.1 p-10 -96.55 -71.77 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 113.45 -1.705 . . . . 5.1500000000000004 111.969 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.511 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 42.1 t0 -101.91 66.63 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.918 0.866 . . . . 4.0199999999999996 108.861 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -124.04 102.47 7.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.774 -1.103 . . . . 1.78 110.163 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 45.7 mt-30 -119.07 163.33 17.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.363 -1.718 . . . . 4.2199999999999998 106.363 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 35.3 p90 -158.83 164.07 36.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.291 -1.364 . . . . 1.3100000000000001 110.135 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -136.14 137.62 41.17 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.679 -1.146 . . . . 4.5300000000000002 108.789 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -96.78 137.21 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.164 -2.532 . . . . 1.8999999999999999 104.164 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.6 139.12 52.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.447 -0.901 . . . . 1.76 111.672 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -115.79 124.5 50.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 104.807 -2.294 . . . . 1.79 104.807 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 pt -51.02 -35.79 15.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.116 -0.947 . . . . 2.8100000000000001 111.918 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -81.75 4.02 23.53 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 113.237 0.828 . . . . 6.21 113.237 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.63 -46.27 3.06 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.987 -0.685 . . . . 2.0499999999999998 109.925 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.451 -0.899 . . . . 3.7400000000000002 109.355 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.64 48.66 1.77 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 120.035 -1.079 . . . . 3.0800000000000001 110.752 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.38 147.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.407 -0.917 . . . . 3.4500000000000002 110.471 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.1 p -117.71 170.46 8.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.712 -1.218 . . . . 4.0899999999999999 107.712 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -53.89 48.69 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.071 -1.052 . . . . 7.2300000000000004 108.978 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -35.08 -62.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.534 -1.212 . . . . 5.3799999999999999 110.559 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -46.78 -59.11 3.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.253 -0.885 . . . . 4.4100000000000001 111.976 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.1 mt -50.68 -44.87 57.92 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.834 -0.746 . . . . 2.9500000000000002 111.372 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 5.3 tm0? -42.17 -55.15 3.37 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.597 -0.841 . . . . 6.71 110.143 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -49.23 -33.96 13.83 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.022 -0.99 . . . . 7.4500000000000002 113.271 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.68 -26.37 19.61 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.981 -0.688 . . . . 4.4199999999999999 111.835 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 -45.45 53.79 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.886 -0.726 . . . . 2.8399999999999999 109.559 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.13 -52.48 0.63 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.176 -1.57 . . . . 3.6099999999999999 109.176 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.519 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 2.4 ttpm? -95.27 161.92 26.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 7.4100000000000001 108.026 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.519 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 87.5 Cg_exo -30.45 121.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 121.538 1.492 . . . . 6.4500000000000002 109.137 147.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.6 47.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.617 -0.833 . . . . 8.9000000000000004 111.812 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.408 ' C ' ' HG1' ' A' ' 58' ' ' THR . 1.8 mm-40 -83.48 53.3 2.47 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.951 1.358 . . . . 8.4900000000000002 108.697 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 57' ' ' GLU . 27.3 m -147.72 99.22 3.07 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 105.575 -2.009 . . . . 5.8200000000000003 105.575 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -113.53 147.69 38.08 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.309 -0.997 . . . . 4.3099999999999996 108.309 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.491 ' HA ' HG21 ' A' ' 59' ' ' VAL . 11.1 Cg_endo -84.2 174.35 38.49 Favored 'Cis proline' 0 C--O 1.207 -1.043 0 C-N-CA 125.403 -0.666 . . . . 2.4900000000000002 111.48 21.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.72 146.9 48.92 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.459 -0.896 . . . . 4.5700000000000003 110.57 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.429 HG22 ' CG ' ' A' ' 75' ' ' PHE . 14.8 mm -120.09 134.93 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 124.011 0.82 . . . . 3.0 108.901 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -137.38 133.16 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.634 -0.712 . . . . 2.04 111.167 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 66' ' ' GLN . 84.6 t -100.11 122.32 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 106.25 -1.759 . . . . 2.0699999999999998 106.25 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.53 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.783 0.677 . . . . 2.9700000000000002 111.582 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' VAL . 74.1 mt-30 -138.35 10.07 2.73 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.601 -0.84 . . . . 5.4299999999999997 112.239 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.77 152.66 24.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.488 -0.485 . . . . 5.2699999999999996 110.12 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -85.14 145.1 27.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.588 -1.264 . . . . 1.72 107.588 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.441 HG13 HG21 ' A' ' 64' ' ' VAL . 14.0 mm -113.5 -34.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 C-N-CA 119.255 -0.978 . . . . 1.8400000000000001 110.895 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.0 -128.94 4.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.323 -1.111 . . . . 2.1699999999999999 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.73 -59.2 0.59 Allowed Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.868 -1.158 . . . . 2.3199999999999998 112.073 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -163.63 -60.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.959 -1.096 . . . . 2.75 109.157 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 p -41.6 -48.06 3.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.973 -1.121 . . . . 2.29 107.973 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -68.75 0.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.756 -2.02 . . . . 2.96 110.353 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.442 ' CE1' ' CZ3' ' A' ' 78' ' ' TRP . 71.7 t80 -52.62 -39.23 61.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.305 -0.958 . . . . 1.3 110.762 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.499 -0.481 . . . . 1.8500000000000001 111.174 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.09 -48.71 61.91 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.894 -1.151 . . . . 2.2400000000000002 107.894 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.442 ' CZ3' ' CE1' ' A' ' 75' ' ' PHE . 60.8 t90 -41.6 -52.09 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.712 -1.131 . . . . 1.3899999999999999 108.923 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 83' ' ' LEU . 3.0 t -41.81 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.619 -1.252 . . . . 2.0899999999999999 107.619 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -53.42 15.42 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.468 0.652 . . . . 4.1699999999999999 111.235 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.69 -17.99 61.63 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.081 1.141 . . . . 4.0199999999999996 114.081 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -110.6 -32.24 6.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 118.826 -1.149 . . . . 1.9099999999999999 113.385 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 79' ' ' VAL . 19.2 mt -92.87 -19.7 21.42 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.363 -0.935 . . . . 2.2200000000000002 111.697 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.398 -0.964 . . . . 3.4500000000000002 108.398 179.839 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.898 0.38 . . . . 4.54 110.689 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.78 174.8 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.247 -1.02 . . . . 5.0599999999999996 108.247 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.41 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 57.5 m -114.88 141.18 48.27 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.741 -1.184 . . . . 1.77 113.695 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.7 t -119.63 128.27 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.14 -2.17 . . . . 1.8799999999999999 105.14 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.46 120.56 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 124.474 1.109 . . . . 2.7200000000000002 110.48 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.488 ' CD2' HG12 ' A' ' 36' ' ' VAL . 91.0 m-85 -99.42 81.3 2.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.175 -1.417 . . . . 1.26 107.175 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.42 -174.15 13.6 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.929 -1.268 . . . . 1.8700000000000001 109.929 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' SER . 7.5 mmm180 -102.91 -63.62 1.15 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.732 -0.787 . . . . 7.7800000000000002 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 75.5 m 97.45 145.9 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 125.408 1.692 . . . . 5.9500000000000002 107.78 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.18 -21.22 31.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 106.63 -2.588 . . . . 4.7000000000000002 106.63 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -113.27 150.25 42.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.996 -1.102 . . . . 4.0899999999999999 110.072 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.09 -56.48 2.53 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.702 1.601 . . . . 3.6000000000000001 112.317 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.56 -44.09 79.09 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.597 -0.841 . . . . 3.7200000000000002 112.114 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 20.1 p -54.9 -55.13 33.85 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 117.291 -1.764 . . . . 3.5699999999999998 107.999 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.97 -47.37 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 2.29 111.167 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -32.83 -50.01 0.25 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 113.555 0.946 . . . . 5.5599999999999996 113.555 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.13 95.62 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.003 -1.079 . . . . 1.97 110.517 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -61.09 -47.49 86.08 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.251 -0.648 . . . . 2.7200000000000002 109.251 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m-20 -56.86 -47.85 79.46 Favored 'General case' 0 C--O 1.199 -1.596 0 C-N-CA 118.81 -1.156 . . . . 3.4700000000000002 109.244 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.62 -57.69 11.86 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.443 -1.303 . . . . 1.8500000000000001 109.361 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -50.56 -53.51 29.79 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.145 -1.422 . . . . 1.9399999999999999 110.071 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 20.2 tt0 -55.19 -49.54 71.66 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.585 0.707 . . . . 2.7999999999999998 112.228 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.64 -51.14 71.08 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.032 -1.099 . . . . 8.3000000000000007 108.032 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.81 -52.86 37.09 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.468 -0.787 . . . . 2.9700000000000002 109.967 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 p -60.42 -14.58 19.81 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.107 -1.437 . . . . 2.54 112.358 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -117.71 17.57 14.33 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.178 0.513 . . . . 4.3200000000000003 110.194 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.54 -45.52 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.203 1.001 . . . . 3.8999999999999999 109.474 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 2.3 mmp_? -101.86 -36.68 8.57 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.193 -1.367 . . . . 4.8499999999999996 111.392 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.582 ' C ' ' H ' ' A' ' 31' ' ' PHE . 15.5 m-20 77.42 -40.74 0.35 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 124.636 1.21 . . . . 6.4000000000000004 110.389 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -72.79 17.84 0.11 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.486 -0.886 . . . . 6.5899999999999999 109.729 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 29' ' ' ASP . 47.2 t80 -125.49 120.81 31.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.11 -0.95 . . . . 2.1499999999999999 109.694 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.302 -1.37 . . . . 6.0300000000000002 107.302 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 18.3 p90 -144.68 176.12 9.66 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.63 -0.828 . . . . 2.04 112.755 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -136.14 141.64 44.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.623 -1.621 . . . . 3.7999999999999998 106.623 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -99.16 141.52 31.83 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.944 -1.503 . . . . 1.96 108.053 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -131.32 148.18 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.989 -1.115 . . . . 1.6799999999999999 107.989 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.79 123.65 50.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.922 -1.14 . . . . 1.99 107.922 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 pt -54.14 -25.32 12.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.098 -1.041 . . . . 2.9700000000000002 110.105 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.67 11.25 18.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.368 1.042 . . . . 7.8099999999999996 111.653 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.86 -51.01 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.392 -0.595 . . . . 2.5600000000000001 109.392 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.79 -32.55 63.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.547 -1.206 . . . . 3.1200000000000001 109.641 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.45 46.77 1.93 Allowed Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.82 -1.181 . . . . 1.95 111.263 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 mt -114.19 147.39 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 118.378 -1.329 . . . . 3.3100000000000001 109.065 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.5 p -105.26 -99.59 0.33 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.096 -1.042 . . . . 3.5099999999999998 110.161 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 42.6 tttp -141.03 -63.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 6.3899999999999997 106.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -45.25 -40.03 7.04 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.73 -1.123 . . . . 5.8600000000000003 109.291 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' LEU . 51.4 m-20 -56.9 -67.39 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.588 -0.893 . . . . 4.9100000000000001 108.588 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' ASP . 61.5 mt -36.75 -51.45 0.88 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.238 -0.892 . . . . 2.7200000000000002 109.931 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -52.92 -62.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.157 -1.383 . . . . 5.4500000000000002 110.59 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -58.08 -45.32 87.34 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.964 -0.694 . . . . 7.6799999999999997 111.154 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -61.61 -29.51 70.09 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.458 -0.792 . . . . 4.6299999999999999 110.563 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' A' ' 68' ' ' HIS . . . -81.8 -55.37 4.66 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.822 -0.751 . . . . 2.6299999999999999 110.574 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -16.76 11.96 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.959 -2.056 . . . . 2.54 107.959 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.409 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.05 84.34 8.82 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 108.678 -0.86 . . . . 6.0899999999999999 108.678 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -50.32 177.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.125 1.883 . . . . 5.5899999999999999 111.504 168.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t 71.34 70.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 CA-C-O 122.422 1.106 . . . . 6.5700000000000003 108.953 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.547 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 4.8 pt-20 -171.06 166.56 7.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.37 -1.741 . . . . 6.0800000000000001 109.661 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -139.86 178.72 7.05 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.719 -1.586 . . . . 5.7199999999999998 106.719 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 m -84.39 154.32 62.68 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 123.687 0.617 . . . . 4.2999999999999998 110.501 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.01 167.95 78.5 Favored 'Cis proline' 0 N--CA 1.495 1.607 0 O-C-N 122.533 0.754 . . . . 2.3100000000000001 111.842 6.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 48' ' ' LEU . 15.5 mm-40 -122.69 145.25 48.55 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 120.231 -0.588 . . . . 3.3500000000000001 109.58 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.567 HG22 ' CG ' ' A' ' 75' ' ' PHE . 10.8 mm -118.08 126.35 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 120.193 -0.603 . . . . 2.4500000000000002 111.599 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 21.1 m-85 -124.81 132.31 53.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.682 -1.97 . . . . 1.3700000000000001 105.682 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.649 HG12 ' CH2' ' A' ' 78' ' ' TRP . 45.6 t -119.22 145.39 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.86 -1.136 . . . . 2.1200000000000001 108.686 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 54.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.424 1.077 . . . . 4.4299999999999997 109.35 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' VAL . 18.7 pt20 -148.34 9.76 0.85 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.93 -0.577 . . . . 5.3700000000000001 109.971 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -116.5 169.61 9.2 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.435 0.636 . . . . 6.75 111.354 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 52' ' ' ALA . 10.9 t-80 -94.64 135.42 36.13 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.642 -2.355 . . . . 1.5900000000000001 104.642 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.7 mm -110.86 -36.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 117.901 -1.52 . . . . 2.3300000000000001 109.579 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.15 -144.74 12.29 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.239 -1.458 . . . . 1.78 111.354 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' CG1' ' A' ' 62' ' ' ILE . . . -103.77 -60.8 0.69 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-O 119.178 -0.79 . . . . 2.5699999999999998 112.942 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -150.13 -68.43 0.2 Allowed 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 117.914 -1.515 . . . . 3.4500000000000002 111.118 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 p -49.06 -51.46 31.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.078 -1.082 . . . . 3.25 108.078 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.94 -53.74 14.99 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.746 -1.57 . . . . 3.54 110.667 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.567 ' CG ' HG22 ' A' ' 62' ' ' ILE . 40.8 t80 -59.13 -51.36 70.36 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.169 -0.678 . . . . 1.02 109.169 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.2 -53.13 18.0 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.914 -0.773 . . . . 2.6600000000000001 108.914 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -63.35 1.21 Allowed 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 114.814 -1.084 . . . . 1.9299999999999999 109.051 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.649 ' CH2' HG12 ' A' ' 64' ' ' VAL . 68.5 t90 -43.06 -53.96 4.59 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.773 -0.771 . . . . 1.71 109.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.0 t -44.87 -63.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.994 -1.113 . . . . 3.0600000000000001 107.994 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -52.9 -48.03 67.52 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.996 -1.081 . . . . 4.3899999999999997 110.3 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.57 20.81 0.21 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.536 0.569 . . . . 3.9900000000000002 112.536 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -142.77 -38.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.328 -0.549 . . . . 2.29 111.37 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.6 mt -94.35 -14.41 25.37 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.039 -0.665 . . . . 2.8399999999999999 112.01 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.497 1.914 0 C-N-CA 119.62 -0.832 . . . . 3.9399999999999999 110.557 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.437 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 93.0 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.43 -0.952 . . . . 3.3399999999999999 108.43 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 3' ' ' THR . 6.5 tt0 -116.47 157.61 24.9 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.114 -1.034 . . . . 4.6100000000000003 111.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.553 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 75.8 m -145.08 127.65 16.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.261 -0.644 . . . . 2.1200000000000001 109.261 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.62 136.69 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.899 -0.778 . . . . 2.4399999999999999 108.899 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.4 mm -113.21 130.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.263 -1.014 . . . . 2.73 108.263 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.602 ' CD2' HG12 ' A' ' 36' ' ' VAL . 16.0 m-85 -108.0 97.78 7.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.025 0.828 . . . . 1.5700000000000001 109.916 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.32 -141.74 4.53 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 108.845 -1.702 . . . . 0.90000000000000002 108.845 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.714 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -116.89 176.76 4.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.213 -0.662 . . . . 6.9800000000000004 109.213 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -83.21 61.9 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.91 . . . . 3.6600000000000001 110.55 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.5 68.72 0.61 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.243 -1.456 . . . . 3.7799999999999998 110.724 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.36 113.04 35.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.548 -1.278 . . . . 2.6899999999999999 107.548 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.19 -50.29 1.61 Allowed 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 122.291 1.994 . . . . 3.6899999999999999 113.143 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -68.66 -47.75 65.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.299 -1.36 . . . . 3.5099999999999998 111.408 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -58.23 -42.73 86.95 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 118.048 -1.461 . . . . 2.8900000000000001 110.243 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.8 -26.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 115.018 -0.992 . . . . 2.1499999999999999 110.791 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 16' ' ' ARG . 4.2 tpp180 -74.02 -50.21 20.84 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.031 -1.067 . . . . 5.25 109.322 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.35 -41.53 65.89 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.492 -1.67 . . . . 2.0800000000000001 106.492 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 11.9 tmtt? -55.56 -58.98 5.52 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 113.948 -1.478 . . . . 3.29 108.255 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 79.4 m-20 -54.3 -53.47 53.4 Favored 'General case' 0 C--O 1.191 -1.998 0 C-N-CA 118.984 -1.087 . . . . 3.7000000000000002 110.098 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 tp -46.17 -60.76 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.026 -1.07 . . . . 2.0499999999999998 110.353 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.13 34.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.877 -1.129 . . . . 2.0299999999999998 111.032 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 35.2 tt0 -52.36 -56.49 14.56 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.386 -0.926 . . . . 2.7999999999999998 110.948 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 66.0 tttp -45.59 -57.17 4.38 Favored 'General case' 0 C--O 1.2 -1.54 0 CA-C-N 114.238 -1.347 . . . . 5.4400000000000004 108.32 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.32 -45.77 80.17 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.684 -1.206 . . . . 2.7000000000000002 110.03 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -50.3 -49.44 53.58 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.637 -0.71 . . . . 2.9700000000000002 111.015 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -81.15 -28.79 34.92 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.928 -0.709 . . . . 3.7400000000000002 112.185 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 62.0 mt-10 -100.93 42.01 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.21 1.005 . . . . 6.46 112.692 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.577 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -149.34 -143.71 0.14 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.104 -1.039 . . . . 6.3099999999999996 109.316 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.482 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -133.88 -48.94 0.81 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.645 -0.872 . . . . 4.1200000000000001 108.645 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 31' ' ' PHE . 51.6 t0 -98.75 -81.69 0.44 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.812 -1.086 . . . . 3.3100000000000001 110.382 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 30' ' ' ASP . 21.3 t80 1.56 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 124.349 1.03 . . . . 2.1899999999999999 113.544 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 64.9 mt-30 -94.24 112.16 23.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.895 -1.522 . . . . 3.8300000000000001 107.291 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.34 164.17 12.94 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.39 -1.324 . . . . 1.77 111.335 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.91 157.46 44.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.742 -1.947 . . . . 4.8499999999999996 105.742 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -110.43 149.45 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.545 -1.262 . . . . 1.48 109.1 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.602 HG12 ' CD2' ' A' ' 6' ' ' PHE . 1.8 t -132.75 147.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.635 -0.711 . . . . 1.8300000000000001 109.579 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -119.73 121.15 38.56 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.152 0.977 . . . . 2.04 110.323 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 pt -57.61 -30.44 36.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.087 -0.96 . . . . 2.27 111.783 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.77 9.16 14.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 117.652 -1.619 . . . . 6.6299999999999999 111.826 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.46 -43.18 3.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.898 -1.519 . . . . 1.8100000000000001 106.898 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -74.3 -36.52 63.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.355 -0.98 . . . . 3.8599999999999999 108.355 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.68 46.18 1.23 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.184 -1.566 . . . . 1.8300000000000001 109.184 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.486 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 90.2 mt -108.11 145.99 14.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.881 -0.659 . . . . 3.1699999999999999 112.625 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.4 p -117.89 -94.1 0.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.215 -1.032 . . . . 3.8999999999999999 108.215 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -135.47 -61.59 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.417 -0.956 . . . . 6.9100000000000001 108.417 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -36.37 -52.82 0.84 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.589 -1.187 . . . . 3.27 111.467 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -58.82 -56.91 16.09 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.865 -1.134 . . . . 3.1499999999999999 110.516 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 48.9 mt -49.37 -47.67 47.38 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.219 -0.992 . . . . 2.54 110.021 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -56.55 -53.73 54.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.707 -1.197 . . . . 5.0800000000000001 108.481 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -52.08 -64.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.395 1.059 . . . . 5.5499999999999998 111.284 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -58.28 -45.81 87.21 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.448 -0.796 . . . . 4.3499999999999996 112.405 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -58.04 -38.79 76.91 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 123.958 0.786 . . . . 2.3100000000000001 110.095 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.67 39.98 6.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.644 -1.783 . . . . 2.9399999999999999 108.644 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -119.44 151.62 51.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.195 -1.002 . . . . 5.7699999999999996 110.499 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.6 -25.33 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.863 1.709 . . . . 5.3799999999999999 111.671 154.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.27 108.19 23.2 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 112.416 -2.175 . . . . 7.1299999999999999 108.928 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 167.87 11.33 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.876 -1.056 . . . . 5.9900000000000002 111.861 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.2 p -156.1 174.97 14.58 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.484 -2.043 . . . . 6.6799999999999997 105.484 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.13 156.36 45.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 118.319 -1.352 . . . . 4.8300000000000001 108.573 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.08 -172.6 9.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 124.386 -1.089 . . . . 2.4300000000000002 111.291 -17.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -119.77 147.36 44.72 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 107.624 -1.25 . . . . 4.2699999999999996 107.624 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 62' ' ' ILE . 5.0 mp -122.86 143.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 122.317 1.056 . . . . 2.4900000000000002 112.53 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 39.6 m-85 -123.0 124.84 44.05 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 112.141 -2.3 . . . . 1.5 106.18 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' A' ' 65' ' ' ASP . 41.7 t -97.52 -172.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.065 -1.454 . . . . 1.98 107.52 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.613 ' H ' ' CG1' ' A' ' 64' ' ' VAL . 32.7 t70 -48.47 -35.0 12.08 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 112.954 0.724 . . . . 2.8300000000000001 112.954 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -72.66 0.6 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.522 -1.271 . . . . 9.5899999999999999 113.892 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -134.97 -167.02 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.274 0.842 . . . . 6.46 113.274 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.602 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 35.9 t-80 -70.14 140.6 52.65 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 104.79 -2.3 . . . . 2.0800000000000001 104.79 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.553 HG13 ' CG2' ' A' ' 64' ' ' VAL . 16.0 mm -107.5 -34.85 2.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 119.081 -1.048 . . . . 2.0899999999999999 110.552 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.42 -150.14 21.88 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.465 -1.35 . . . . 1.74 110.644 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.77 -169.1 33.83 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.035 -1.226 . . . . 1.74 110.035 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.36 -47.53 66.08 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.755 -1.178 . . . . 2.4500000000000002 110.733 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -62.49 -61.64 2.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.409 -0.917 . . . . 1.99 109.952 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 1.2 m-20 -42.98 -54.27 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.426 -1.261 . . . . 2.9100000000000001 109.389 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -61.23 -57.23 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.811 -1.086 . . . . 1.1100000000000001 109.423 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -42.32 -54.58 3.7 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.12 -0.632 . . . . 1.73 110.32 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -59.44 -57.64 12.08 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.035 -0.984 . . . . 2.4100000000000001 108.488 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.464 ' CH2' HG12 ' A' ' 64' ' ' VAL . 85.0 t90 -41.99 -47.14 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.079 -0.711 . . . . 1.77 109.079 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.26 -36.92 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.833 -0.621 . . . . 2.23 109.513 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.51 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -94.52 22.24 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.147 -0.478 . . . . 4.9199999999999999 112.106 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -134.79 -40.86 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.954 -0.566 . . . . 4.5599999999999996 110.13 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -92.85 -23.32 18.85 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 116.057 -0.519 . . . . 2.9100000000000001 112.309 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt -100.93 13.12 36.17 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.277 -1.369 . . . . 2.6000000000000001 110.894 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.51 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 5.2 m-20 . . . . . 0 N--CA 1.497 1.896 0 C-N-CA 119.921 -0.711 . . . . 4.6200000000000001 110.847 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 30' ' ' ASP . 29.0 ttm . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 106.52 -1.659 . . . . 3.8399999999999999 106.52 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -122.79 85.33 2.4 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.906 -0.718 . . . . 4.54 109.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.7 m -88.71 131.22 35.11 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.26 -1.015 . . . . 2.3399999999999999 108.26 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.6 138.19 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.781 -0.822 . . . . 1.97 108.781 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -114.96 119.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 124.559 1.162 . . . . 3.1899999999999999 109.326 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -92.25 85.98 5.6 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.801 -2.296 . . . . 3.46 104.801 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.15 -168.45 15.16 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.634 -1.746 . . . . 0.93999999999999995 110.593 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.581 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.61 133.14 54.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.81 -0.811 . . . . 6.7199999999999998 108.81 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.629 ' HG ' ' CG ' ' A' ' 37' ' ' ASP . 2.8 p -67.57 94.16 0.4 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.36 -0.836 . . . . 4.0 110.017 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.01 22.87 8.04 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.721 -0.951 . . . . 3.25 110.721 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -104.03 115.61 62.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 120.132 -0.627 . . . . 3.3700000000000001 110.734 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 -31.43 90.57 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.554 2.17 . . . . 3.6200000000000001 111.593 -159.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -92.72 -37.56 12.3 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.727 -1.124 . . . . 3.4399999999999999 110.9 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 63.8 m -51.83 -45.18 63.85 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.631 -1.228 . . . . 2.23 109.199 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -46.58 -41.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.656 -1.156 . . . . 2.5699999999999998 111.417 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.559 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -44.6 -37.11 3.38 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 112.157 0.429 . . . . 7.5599999999999996 112.157 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.88 98.46 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.699 -1.201 . . . . 1.6399999999999999 108.205 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.5 tmtm? -73.28 -32.98 64.97 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.17 -1.012 . . . . 3.2200000000000002 110.672 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CG ' HH21 ' A' ' 16' ' ' ARG . 5.7 m-20 -51.31 -57.49 8.73 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.015 -1.474 . . . . 3.27 108.647 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -46.13 -61.2 1.87 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.171 0.804 . . . . 2.21 113.171 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -39.17 -39.85 0.65 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.668 0.618 . . . . 2.0600000000000001 112.668 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -50.57 69.99 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.076 -1.05 . . . . 3.1099999999999999 110.051 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 5.2 tmtt? -45.13 -46.95 12.15 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.5 -1.227 . . . . 6.8300000000000001 110.256 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.2 mt -72.34 -50.03 29.89 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.208 -1.36 . . . . 2.3599999999999999 112.649 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -55.89 -26.66 48.33 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.804 -0.758 . . . . 1.95 110.803 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -93.09 24.03 3.98 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.003 -0.679 . . . . 3.5099999999999998 110.393 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.496 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 52.5 mt-10 -136.32 -49.86 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.646 0.591 . . . . 3.5899999999999999 110.971 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.2 mpt_? -108.35 124.25 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.256 -0.883 . . . . 5.5999999999999996 111.579 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.53 60.52 0.88 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 124.562 1.163 . . . . 5.9500000000000002 109.156 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t70 -165.04 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.869 -1.514 . . . . 3.1200000000000001 109.841 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 33' ' ' TYR . 14.5 t80 -66.19 102.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.596 -0.729 . . . . 1.22 109.994 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 83.6 mt-30 -91.47 -54.69 3.8 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.287 -0.565 . . . . 4.5099999999999998 111.347 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER 59.0 149.64 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 O-C-N 126.357 2.285 . . . . 2.3199999999999998 113.507 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -139.65 144.65 37.74 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 115.19 -0.914 . . . . 4.2000000000000002 110.86 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -98.8 138.19 36.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.534 -1.284 . . . . 1.54 107.534 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.53 144.52 35.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.219 -1.4 . . . . 1.72 107.219 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.629 ' CG ' ' HG ' ' A' ' 9' ' ' SER . 3.5 t70 -115.31 118.33 32.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.302 1.001 . . . . 2.2000000000000002 111.738 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.01 -19.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.839 -1.144 . . . . 2.2400000000000002 111.042 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.498 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 1.2 tmm_? -87.14 -9.8 54.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 123.289 0.368 . . . . 6.4699999999999998 111.001 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.39 -39.34 8.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.616 -1.253 . . . . 2.02 107.616 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -104.51 28.16 7.23 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.24 -1.346 . . . . 2.54 109.959 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 27.24 64.49 0.08 OUTLIER Glycine 0 N--CA 1.507 3.413 0 CA-C-N 114.648 -1.16 . . . . 1.96 113.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.56 147.97 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.579 -0.849 . . . . 2.3199999999999998 109.783 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -130.85 173.37 11.02 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.654 -0.818 . . . . 3.9500000000000002 109.217 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -50.48 -50.78 51.75 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.699 -0.8 . . . . 7.6299999999999999 110.138 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -34.2 -69.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.119 0.887 . . . . 3.4700000000000002 113.063 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.54 -46.25 80.73 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 119.981 -0.687 . . . . 3.3100000000000001 112.853 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLN . 97.8 mt -58.12 -53.2 60.9 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.457 -1.297 . . . . 2.9700000000000002 110.62 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 37.9 mt-30 -42.67 -53.04 4.67 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.153 -1.019 . . . . 4.4800000000000004 108.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -55.56 -44.86 77.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.966 1.416 . . . . 6.1699999999999999 110.873 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 11.09 21.92 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.625 -0.83 . . . . 5.5800000000000001 111.85 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.683 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -102.77 -66.1 0.95 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.819 0.674 . . . . 2.8700000000000001 112.819 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.34 18.21 34.2 Favored Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.922 -1.133 . . . . 3.52 112.81 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -121.97 24.85 0.11 Allowed Pre-proline 0 N--CA 1.502 2.168 0 CA-C-N 117.714 0.757 . . . . 6.4100000000000001 110.798 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.59 46.28 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.752 2.301 . . . . 5.9900000000000002 113.437 -105.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.3 15.95 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.982 -1.118 . . . . 6.2699999999999996 107.982 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -84.01 173.82 10.83 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.149 -1.387 . . . . 6.9299999999999997 109.542 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 t -149.22 -156.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.886 -0.726 . . . . 4.8899999999999997 109.31 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.39 131.07 56.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.04 -1.096 . . . . 3.54 108.04 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -99.11 151.76 5.76 Favored 'Cis proline' 0 N--CA 1.481 0.761 0 O-C-N 122.661 0.822 . . . . 2.3799999999999999 111.64 12.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -122.62 139.34 54.04 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.231 -0.895 . . . . 3.8199999999999998 109.037 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.548 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.5 mp -118.2 149.66 20.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.669 -1.234 . . . . 2.5 107.669 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 68' ' ' HIS . 22.6 m-85 -134.02 116.65 15.76 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 125.401 1.688 . . . . 1.26 106.726 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.501 HG21 HG13 ' A' ' 69' ' ' ILE . 84.8 t -88.2 108.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 118.067 -1.453 . . . . 1.8999999999999999 110.078 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 54.03 -79.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 123.748 0.655 . . . . 3.04 112.086 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.6 pt20 -128.38 1.9 5.68 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.041 -1.064 . . . . 5.2699999999999996 111.654 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.946 -0.391 . . . . 5.21 109.946 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.683 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 7.0 t-80 -106.66 132.75 52.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 64' ' ' VAL . 5.3 mm -111.09 -56.17 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 105.867 -1.901 . . . . 2.1899999999999999 105.867 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 88.09 0.08 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 116.261 1.265 . . . . 3.0600000000000001 116.261 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 131.18 3.78 Favored Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.282 -1.437 . . . . 3.04 114.632 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 74' ' ' ASP . 22.4 t80 -66.23 -58.09 6.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.553 -0.859 . . . . 2.0800000000000001 109.124 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 14.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.619 0.6 . . . . 2.8999999999999999 112.619 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 72' ' ' TYR . 7.9 t70 -119.37 -63.92 1.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.753 -1.943 . . . . 3.1400000000000001 105.753 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -56.41 -39.05 72.39 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.878 -1.51 . . . . 1.1200000000000001 108.426 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.302 -0.863 . . . . 1.8200000000000001 109.634 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.21 -53.43 43.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.023 -1.103 . . . . 2.7799999999999998 108.023 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -41.39 -65.45 0.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.362 -1.29 . . . . 1.8 110.862 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.8 t -42.82 -52.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.505 -0.924 . . . . 1.8200000000000001 108.505 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -46.81 -42.29 16.88 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.417 -1.72 . . . . 5.7800000000000002 109.919 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 80' ' ' LYS . 20.1 mp0 -106.81 25.18 11.59 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 120.085 -0.646 . . . . 4.7999999999999998 112.495 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -129.85 -43.02 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.379 -1.328 . . . . 2.2999999999999998 113.817 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 26.4 mt -101.54 32.26 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.118 -2.178 . . . . 2.46 105.118 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 113.026 -1.897 . . . . 6.1500000000000004 106.773 -178.147 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 33.4 tpp . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.629 -0.508 . . . . 4.0099999999999998 109.629 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -94.42 173.17 7.76 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.623 -1.231 . . . . 4.1299999999999999 108.515 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.422 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 86.6 m -130.2 145.35 51.72 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.074 -1.05 . . . . 2.1899999999999999 111.812 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.29 118.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 105.737 -1.949 . . . . 1.8100000000000001 105.737 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 30.7 mt -100.07 113.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.009 -1.108 . . . . 4.0899999999999999 108.009 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.505 ' CD2' HG13 ' A' ' 36' ' ' VAL . 45.6 m-85 -97.58 78.06 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 105.747 -1.946 . . . . 1.6200000000000001 105.747 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.74 1.91 Allowed Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.781 -1.676 . . . . 1.03 112.04 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.2 OUTLIER 179.23 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.811 -1.181 . . . . 5.8700000000000001 107.811 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 8' ' ' ARG . 13.2 m 97.29 162.92 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 O-C-N 125.335 1.647 . . . . 5.04 110.4 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' ' CG2' ' A' ' 15' ' ' VAL . . . 97.12 -12.37 65.44 Favored Glycine 0 N--CA 1.503 3.14 0 C-N-CA 120.194 -1.003 . . . . 3.8199999999999998 110.637 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.448 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -115.58 143.63 30.94 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.91 -0.645 . . . . 2.9100000000000001 110.724 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 -54.71 5.01 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.257 1.305 . . . . 4.4199999999999999 111.675 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -67.94 -2.58 7.76 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 113.802 1.038 . . . . 3.5699999999999998 113.802 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 9' ' ' SER . 29.4 p -111.66 -41.87 3.97 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.651 -1.22 . . . . 2.3300000000000001 109.09 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 17' ' ' ALA . 49.0 t -73.04 -30.98 33.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 118.824 -1.15 . . . . 2.0 108.357 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 9.3 mmm180 -71.9 23.47 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 C-N-CA 119.919 -0.712 . . . . 4.4699999999999998 110.976 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.565 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -121.49 -48.87 2.16 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.64 -1.245 . . . . 1.9099999999999999 107.64 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.9 tmtm? -57.97 -29.15 65.0 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.873 -0.731 . . . . 3.5299999999999998 110.169 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 20' ' ' LEU . 3.6 p-10 -81.06 -38.66 27.0 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.727 -0.789 . . . . 3.2799999999999998 108.926 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.478 HD21 ' CD2' ' A' ' 75' ' ' PHE . 34.2 tp -60.23 -49.06 79.11 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.686 -1.598 . . . . 1.98 106.686 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.65 71.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.008 -1.108 . . . . 2.02 108.008 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 3.2 tp10 -63.48 -56.98 11.75 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.559 -1.256 . . . . 3.3599999999999999 108.496 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -55.11 -51.88 65.01 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 118.356 -1.338 . . . . 5.46 108.145 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.426 -1.31 . . . . 2.3199999999999998 109.459 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.1 m -51.23 -43.47 61.47 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 118.72 -1.192 . . . . 1.75 108.718 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.98 42.46 1.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.874 -1.057 . . . . 4.8200000000000003 108.994 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.554 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 14.9 mm-40 -144.8 -58.7 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.957 -1.02 . . . . 3.1800000000000002 113.492 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HE ' ' HB3' ' A' ' 27' ' ' GLU . 3.5 mmt180 -101.45 -157.89 0.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.809 -1.087 . . . . 6.1799999999999997 112.476 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -102.61 -75.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.177 -0.92 . . . . 4.9000000000000004 113.411 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.62 53.57 2.73 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.627 -1.229 . . . . 3.4199999999999999 112.418 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 1' ' ' MET . 39.9 t80 -117.92 140.11 50.19 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.963 -1.095 . . . . 1.6200000000000001 109.87 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -156.64 179.95 8.77 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.12 -1.807 . . . . 3.8700000000000001 106.12 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -171.58 159.26 5.4 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.073 -1.451 . . . . 1.51 111.369 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -133.09 151.36 52.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.772 -1.566 . . . . 4.5099999999999998 106.772 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -103.67 144.9 30.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.464 -1.695 . . . . 1.79 109.678 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.505 HG13 ' CD2' ' A' ' 6' ' ' PHE . 2.4 t -132.71 148.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.453 -1.249 . . . . 1.73 108.925 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.07 113.37 20.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.627 -1.249 . . . . 2.21 107.627 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 30.9 pt -44.59 -31.03 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.391 0 CA-C-N 115.211 -0.904 . . . . 2.52 110.466 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -71.72 -60.44 2.23 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.112 -1.035 . . . . 5.7199999999999998 109.322 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.34 -43.25 1.15 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.573 0.546 . . . . 2.0 110.174 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.61 -48.37 26.89 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.283 0.989 . . . . 4.46 109.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.33 41.51 0.81 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.41 -0.9 . . . . 2.4700000000000002 111.235 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 62.7 mt -103.74 164.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.637 -0.505 . . . . 3.3700000000000001 109.637 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.2 p -113.25 -104.86 0.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.612 -0.722 . . . . 3.96 112.87 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 57' ' ' GLU . 34.7 tttp -142.82 -25.77 0.61 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.061 0.934 . . . . 8.0700000000000003 109.614 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.1 mp0 -86.98 -53.37 4.92 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 4.8099999999999996 108.311 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' LEU . 17.9 t70 -47.5 -61.87 1.71 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.704 -0.798 . . . . 3.5 111.397 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -34.36 -46.89 0.28 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.436 -0.802 . . . . 3.2200000000000002 111.073 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 53' ' ' GLY . 74.4 mt-30 -54.99 -54.56 41.38 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.119 -1.032 . . . . 6.3700000000000001 108.486 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -60.79 -36.86 80.07 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.711 -0.796 . . . . 7.6699999999999999 109.93 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -64.26 -29.43 70.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.79 -1.096 . . . . 5.0 110.12 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 68' ' ' HIS . . . -100.68 -74.81 0.6 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.68 -1.146 . . . . 2.9700000000000002 109.595 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' GLN . . . 121.94 39.78 0.55 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.73 -1.224 . . . . 3.96 111.178 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 22.3 mmtp -138.05 152.01 71.12 Favored Pre-proline 0 N--CA 1.499 2.017 0 C-N-CA 119.454 -0.898 . . . . 7.4500000000000002 110.072 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.63 49.54 3.21 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 122.391 2.061 . . . . 6.7999999999999998 111.188 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.64 94.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 115.188 -0.914 . . . . 8.0999999999999996 108.707 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.49 -0.67 11.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.853 -0.739 . . . . 8.4499999999999993 111.554 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.7 m -88.67 171.85 9.7 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.149 0.5 . . . . 6.0700000000000003 110.434 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 58' ' ' THR . 13.2 p -101.05 160.32 26.98 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 115.847 -0.615 . . . . 4.2999999999999998 110.678 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -100.12 -163.77 0.54 Allowed 'Cis proline' 0 N--CA 1.484 0.967 0 CA-C-O 121.926 0.719 . . . . 2.3599999999999999 111.344 -27.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -124.58 155.24 39.4 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.298 -1.319 . . . . 4.4000000000000004 108.608 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 5' ' ' ILE . 36.2 mm -121.97 146.05 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 123.984 0.803 . . . . 3.3399999999999999 110.251 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 12.5 m-85 -123.22 130.67 53.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.727 -1.579 . . . . 1.4099999999999999 107.257 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.441 ' CG2' HG13 ' A' ' 69' ' ' ILE . 55.3 t -109.81 138.06 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 118.221 -1.391 . . . . 1.8300000000000001 109.275 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.2 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.2 -1.818 . . . . 3.0600000000000001 111.716 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -136.47 -2.64 2.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.601 0.563 . . . . 7.0199999999999996 111.499 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.451 HE21 ' CA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -115.31 176.4 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.423 0.63 . . . . 5.9500000000000002 111.699 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -96.49 147.0 24.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.176 -1.787 . . . . 2.9500000000000002 106.176 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.441 HG13 ' CG2' ' A' ' 64' ' ' VAL . 41.7 mm -116.14 -46.5 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.703 -1.199 . . . . 1.74 110.414 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.69 -153.09 25.07 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.438 -1.363 . . . . 1.76 111.173 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.47 -170.47 47.15 Favored Glycine 0 N--CA 1.504 3.226 0 C-N-CA 119.242 -1.456 . . . . 1.78 112.149 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.9 t80 -51.93 -45.09 64.17 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.069 -0.652 . . . . 2.6099999999999999 109.836 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 p -64.34 -42.45 96.25 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.349 -0.94 . . . . 1.97 109.297 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.478 ' CG ' ' NZ ' ' A' ' 54' ' ' LYS . 21.0 m-20 -62.32 -48.79 78.3 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.198 -1.401 . . . . 2.6800000000000002 110.018 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD2' HD21 ' A' ' 20' ' ' LEU . 12.8 t80 -60.62 -51.81 67.81 Favored 'General case' 0 C--O 1.2 -1.5 0 C-N-CA 117.936 -1.506 . . . . 1.23 108.102 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.79 30.52 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.453 -0.899 . . . . 1.95 111.077 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.04 -55.3 13.07 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.696 -0.802 . . . . 1.8 109.538 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -41.41 -47.46 3.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.929 -1.137 . . . . 1.22 107.929 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 81' ' ' GLU . 40.9 t -61.14 -57.69 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 106.16 -1.793 . . . . 1.95 106.16 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.407 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 1.3 tmtm? -75.96 32.18 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.83 -0.748 . . . . 4.4900000000000002 110.427 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 79' ' ' VAL . 28.2 tt0 -132.37 -56.55 0.96 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.511 0.672 . . . . 5.4500000000000002 109.262 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -98.64 -11.54 21.97 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.857 -1.065 . . . . 2.1499999999999999 111.155 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -108.23 -34.65 6.77 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.76 -1.176 . . . . 2.3599999999999999 108.842 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.407 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 18.9 m-20 . . . . . 0 N--CA 1.497 1.897 0 C-N-CA 119.161 -1.016 . . . . 6.0599999999999996 110.541 179.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 30' ' ' ASP . 69.0 mtm . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 107.988 -1.116 . . . . 3.0499999999999998 107.988 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 20.1 mt-30 -128.04 157.43 40.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 123.633 0.583 . . . . 4.1699999999999999 110.029 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -141.6 141.71 33.46 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.819 -0.752 . . . . 1.6699999999999999 112.065 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.0 t -133.11 139.09 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 106.539 -1.652 . . . . 1.6000000000000001 106.539 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 4.6 mp -123.66 128.17 74.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.354 -0.98 . . . . 3.1400000000000001 108.354 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -97.37 61.12 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.386 -1.339 . . . . 1.4399999999999999 107.386 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.96 -158.5 23.36 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.153 -1.979 . . . . 1.3 108.153 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 21.9 ttp-105 -127.73 169.29 13.99 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.507 -1.294 . . . . 6.5300000000000002 107.507 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -52.72 -50.16 63.94 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.182 -1.044 . . . . 4.4100000000000001 108.182 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 11' ' ' CYS . . . -149.06 166.87 29.44 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.803 -1.189 . . . . 3.3599999999999999 111.366 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.4 p 167.84 42.51 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.366 0 CA-C-O 122.795 1.283 . . . . 3.7000000000000002 108.407 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -20.94 -48.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.431 2.754 . . . . 3.4399999999999999 112.765 -99.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -27.4 -40.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 124.772 1.295 . . . . 2.9500000000000002 113.907 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 85.1 m -53.59 -45.16 69.91 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.948 -0.701 . . . . 1.8600000000000001 112.322 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.34 -34.49 50.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.887 -0.597 . . . . 2.1899999999999999 111.081 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -50.96 -51.35 53.41 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.882 -1.127 . . . . 5.0300000000000002 112.043 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.2 -42.66 81.67 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.302 -0.959 . . . . 2.0499999999999998 109.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 28.8 tttm -63.22 -52.99 59.98 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.214 -1.357 . . . . 3.27 114.007 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 2.4 p30 -53.82 -34.04 58.01 Favored 'General case' 0 C--O 1.198 -1.651 0 C-N-CA 118.282 -1.367 . . . . 3.3799999999999999 111.083 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.85 -42.44 89.34 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.269 -1.372 . . . . 1.8799999999999999 109.703 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.93 19.34 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 120.448 -0.501 . . . . 2.1400000000000001 110.971 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.469 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 22.6 tt0 -59.29 -40.95 87.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.845 -1.169 . . . . 3.3100000000000001 107.845 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 4.6 ttmp? -64.0 -55.85 19.37 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 106.826 -1.546 . . . . 7.0099999999999998 106.826 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.67 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 28.9 mt -46.96 -47.31 21.85 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 119.915 -0.714 . . . . 2.0299999999999998 110.445 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -57.87 -11.42 2.32 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 124.256 0.972 . . . . 2.1200000000000001 112.541 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -114.83 -41.04 3.43 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.12 -0.491 . . . . 3.7999999999999998 111.067 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.67 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 13.0 pt-20 -74.65 -37.78 62.66 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.254 -0.885 . . . . 3.9100000000000001 111.708 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' NE ' ' O ' ' A' ' 29' ' ' ASP . 3.3 ttp180 -114.22 -168.26 1.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.388 0.613 . . . . 6.8600000000000003 111.081 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 9.0 p-10 -124.12 -168.33 1.78 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 105.521 -2.029 . . . . 3.98 105.521 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.4 t70 37.53 41.39 0.28 Allowed 'General case' 0 N--CA 1.508 2.474 0 O-C-N 123.677 0.611 . . . . 3.4300000000000002 110.543 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.38 93.07 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.441 -0.903 . . . . 1.6100000000000001 109.889 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 11.7 mm100 -105.49 117.73 34.77 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.592 -1.633 . . . . 4.4400000000000004 106.592 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -119.12 155.55 31.37 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.984 -1.007 . . . . 2.1400000000000001 112.157 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.84 150.0 50.52 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.515 -2.031 . . . . 4.4100000000000001 105.515 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 18' ' ' LYS . 26.0 t80 -112.08 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.784 -1.566 . . . . 2.2000000000000002 108.48 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 5' ' ' ILE . 2.1 t -124.66 155.28 32.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.351 -1.351 . . . . 2.1499999999999999 107.351 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 39' ' ' ARG . 1.8 t70 -127.69 42.71 3.27 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.831 0.678 . . . . 2.6600000000000001 112.831 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.489 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.83 -65.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 114.97 1.47 . . . . 3.0299999999999998 114.97 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -56.21 -51.29 68.62 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 5.29 108.521 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -42.83 2.25 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.902 -1.044 . . . . 1.8300000000000001 111.203 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.26 -47.85 17.01 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.995 -1.113 . . . . 4.4199999999999999 107.995 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.52 46.4 0.92 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.417 -1.873 . . . . 1.6000000000000001 108.417 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.8 mm -89.23 155.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 120.374 -0.53 . . . . 3.4300000000000002 111.824 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' GLU . 34.2 p -126.47 95.29 4.31 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.864 -0.607 . . . . 3.1200000000000001 111.615 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 tttm 6.12 -64.6 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 116.656 2.095 . . . . 5.21 116.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' THR . 6.6 mm-40 -47.86 -44.99 29.76 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.252 -0.979 . . . . 4.6799999999999997 110.841 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.528 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 1.2 t70 -58.5 -37.65 76.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.315 -0.857 . . . . 3.23 110.5 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.437 ' HA ' ' CG ' ' A' ' 51' ' ' LYS . 6.7 mt -65.2 -45.86 83.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.135 -1.061 . . . . 2.3599999999999999 108.135 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 13.1 mt-30 -49.99 -41.69 47.49 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.517 -1.29 . . . . 5.0700000000000003 107.517 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -66.8 -60.74 2.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.608 -0.723 . . . . 5.6600000000000001 112.496 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -60.46 -37.68 81.74 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.434 -0.906 . . . . 5.9100000000000001 113.295 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -86.55 -53.43 4.98 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.719 0.771 . . . . 2.96 110.481 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.18 -55.73 0.59 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.123 -1.591 . . . . 3.5699999999999998 109.123 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.79 74.7 37.93 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 119.602 -0.839 . . . . 6.4100000000000001 113.08 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 52' ' ' ALA . 11.9 Cg_endo -89.59 140.96 3.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.223 1.948 . . . . 9.8000000000000007 107.615 126.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.91 -15.78 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.971 -0.692 . . . . 6.3899999999999997 110.043 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -119.27 -105.21 0.39 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.845 -0.616 . . . . 6.9699999999999998 111.295 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.442 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 98.2 m -140.43 -57.09 0.53 Allowed 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.782 -0.767 . . . . 7.1600000000000001 109.542 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.1 t -112.63 151.63 44.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.662 -0.815 . . . . 5.2300000000000004 109.018 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HG2' ' N ' ' A' ' 72' ' ' TYR . 12.9 Cg_endo -97.67 173.47 10.38 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 O-C-N 122.619 0.799 . . . . 3.5899999999999999 111.592 -14.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 3.1 mp0 -130.97 119.97 22.84 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 7.1200000000000001 109.237 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.9 mp -127.39 146.71 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.511 -0.876 . . . . 2.1099999999999999 111.309 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 16.2 m-85 -126.86 133.05 50.81 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.01 -1.904 . . . . 1.3300000000000001 107.035 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.562 HG12 ' CH2' ' A' ' 78' ' ' TRP . 85.5 t -131.76 150.6 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 118.733 -1.187 . . . . 2.0899999999999999 110.097 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 8.9 t70 60.12 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.464 -1.698 . . . . 5.0099999999999998 107.978 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 65' ' ' ASP . 36.5 mt-30 -139.27 -16.27 1.07 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 124.209 0.943 . . . . 6.46 112.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . 0.412 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.2 171.99 7.13 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.756 -0.778 . . . . 4.5700000000000003 113.085 -178.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 9.4 t-80 -81.0 153.55 27.37 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.858 -1.904 . . . . 1.3600000000000001 105.858 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.2 mm -116.2 -43.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.4 -1.32 . . . . 1.8300000000000001 109.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 139.93 -131.33 5.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.466 -1.454 . . . . 1.75 109.466 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.88 -154.27 12.55 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.756 -0.937 . . . . 1.6399999999999999 110.756 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.426 ' N ' ' HG2' ' A' ' 60' ' ' PRO . 26.9 t80 -57.67 -56.33 23.37 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.1 -1.04 . . . . 2.3700000000000001 111.01 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -38.24 17.24 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.878 -0.729 . . . . 2.5299999999999998 110.537 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -72.41 -59.42 2.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.051 -0.977 . . . . 2.48 110.259 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.75 -45.8 63.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.471 -0.937 . . . . 1.8400000000000001 108.471 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -58.69 6.63 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.931 -1.031 . . . . 1.8700000000000001 109.272 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.13 -54.97 41.0 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.097 -1.041 . . . . 2.1200000000000001 110.549 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.562 ' CH2' HG12 ' A' ' 64' ' ' VAL . 75.2 t90 -45.81 -53.81 9.04 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.413 -0.915 . . . . 1.8700000000000001 109.131 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 83' ' ' LEU . 25.0 t -47.25 -58.82 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 124.453 1.096 . . . . 1.97 108.213 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -56.29 -54.18 48.41 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.015 1.117 . . . . 4.1600000000000001 114.015 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.3 -33.19 70.79 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.519 0.933 . . . . 4.7599999999999998 113.519 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.78 -26.98 13.28 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.182 1.179 . . . . 1.8799999999999999 114.182 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.407 HD11 HG11 ' A' ' 79' ' ' VAL . 11.4 mt -93.24 -22.56 18.94 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.367 -1.333 . . . . 2.5 111.52 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.495 1.776 0 C-N-CA 119.256 -0.977 . . . . 4.2800000000000002 108.694 -179.92 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 34.9 tpp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 3.8399999999999999 108.284 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.519 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 34.8 mt-30 -97.03 97.35 9.16 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.964 -0.694 . . . . 4.5 109.81 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 m -83.02 114.22 21.12 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.513 -0.875 . . . . 2.1899999999999999 109.895 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.67 140.01 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.077 -1.083 . . . . 2.1400000000000001 108.077 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 17.8 mt -120.1 105.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 124.452 1.095 . . . . 3.54 110.428 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 31.1 m-85 -84.53 93.86 8.44 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.28 -1.008 . . . . 1.3500000000000001 108.28 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.635 ' CA ' ' SG ' ' A' ' 14' ' ' CYS . . . -106.76 -163.08 22.32 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.051 -1.22 . . . . 1.3899999999999999 110.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.515 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 ttp-105 -141.43 46.68 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.284 -1.366 . . . . 7.0599999999999996 111.902 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' ' OD2' ' A' ' 37' ' ' ASP . 14.4 m 69.61 -70.73 0.14 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.809 1.04 . . . . 4.3099999999999996 113.809 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.14 66.89 0.23 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 119.946 -1.121 . . . . 4.1699999999999999 112.724 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -134.81 113.68 11.81 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.327 -1.36 . . . . 2.9199999999999999 107.327 178.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.01 -50.7 9.48 Favored 'Trans proline' 0 C--O 1.205 -1.171 0 N-CA-C 109.033 -1.18 . . . . 4.0499999999999998 109.033 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.84 -36.13 58.31 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.051 -0.977 . . . . 3.27 111.993 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' CA ' ' A' ' 7' ' ' GLY . 71.0 m -66.36 -53.21 38.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.205 -0.998 . . . . 2.2200000000000002 109.475 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.1 t -62.08 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.8 -1.091 . . . . 2.2000000000000002 110.136 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.55 ' NH2' ' N ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -61.27 -47.48 85.83 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.815 -0.629 . . . . 4.5899999999999999 110.484 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.53 -47.91 80.71 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.058 -1.46 . . . . 1.8300000000000001 107.058 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.7 tmtm? -56.96 -43.69 81.86 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 118.512 -1.275 . . . . 3.1600000000000001 109.715 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 2.0 t0 -51.98 -51.25 58.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.74 -1.208 . . . . 3.3199999999999998 107.74 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' ' NH2' ' A' ' 16' ' ' ARG . 31.4 tp -56.6 -52.09 66.17 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.929 -1.108 . . . . 2.2799999999999998 110.098 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB2' ' CG ' ' A' ' 33' ' ' TYR . . . -46.17 -51.89 13.29 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.781 -1.168 . . . . 2.3100000000000001 109.937 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -44.3 -47.48 9.51 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.113 0.959 . . . . 3.04 110.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.411 ' NZ ' ' HG2' ' A' ' 27' ' ' GLU . 8.9 tmtm? -75.0 -45.95 38.45 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.385 -1.326 . . . . 5.4100000000000001 111.865 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -49.56 -48.52 48.46 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 119.375 -0.93 . . . . 2.6600000000000001 110.531 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 m -42.99 -32.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.297 -1.774 . . . . 1.8799999999999999 109.579 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -109.92 45.43 1.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.856 -1.065 . . . . 3.4900000000000002 109.863 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.411 ' HG2' ' NZ ' ' A' ' 23' ' ' LYS . 29.6 mm-40 -137.22 -54.46 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.729 -1.123 . . . . 3.8900000000000001 110.103 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 83' ' ' LEU . 50.1 mmt-85 -101.78 175.47 5.54 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.875 -1.057 . . . . 5.7800000000000002 109.658 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.41 -51.24 17.99 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.984 -1.462 . . . . 5.0999999999999996 114.324 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -118.2 82.08 1.78 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.336 -0.946 . . . . 4.2599999999999998 111.7 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.97 113.45 14.6 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.702 -0.799 . . . . 1.4199999999999999 110.459 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.06 157.87 26.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.682 -1.97 . . . . 5.1200000000000001 105.682 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.51 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 2.9 p90 -156.39 153.48 29.0 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 117.562 -1.655 . . . . 1.3 111.29 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.9 146.68 43.61 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.183 -0.917 . . . . 4.1399999999999997 109.724 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -94.97 144.43 25.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.264 -1.384 . . . . 2.0 107.264 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.99 155.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 123.752 0.657 . . . . 2.2400000000000002 109.685 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' NH1' ' A' ' 39' ' ' ARG . 10.0 t70 -132.62 137.7 47.11 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.474 0.654 . . . . 2.52 109.306 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.7 -25.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.392 0.886 . . . . 2.5 113.392 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 29.8 mtm-85 -88.66 -14.05 38.33 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.53 -1.268 . . . . 5.7000000000000002 110.951 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.47 -40.7 61.71 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.99 -1.485 . . . . 2.5099999999999998 106.99 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.37 -41.45 12.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.489 -1.687 . . . . 3.9700000000000002 109.402 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.76 59.04 0.51 Allowed Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.653 -1.261 . . . . 1.73 111.116 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.2 mt -120.33 154.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.827 -0.749 . . . . 2.9500000000000002 110.386 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -111.07 -160.72 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.052 -1.833 . . . . 3.0099999999999998 106.052 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.464 ' HZ1' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -99.13 18.43 17.44 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 116.772 -1.971 . . . . 5.0 109.413 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -101.76 -62.94 1.19 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.724 -1.58 . . . . 4.0099999999999998 110.993 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' GLN . 1.9 t70 -56.51 -42.92 79.22 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.129 -0.628 . . . . 4.0 109.999 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -43.68 -38.57 3.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.804 -1.159 . . . . 3.1800000000000002 109.948 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.504 HE22 ' N ' ' A' ' 56' ' ' VAL . 39.1 mm-40 -53.12 -42.76 66.32 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.869 -1.132 . . . . 5.8700000000000001 109.219 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' ASP . 73.3 mm-40 -78.05 -37.04 47.62 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.812 -1.085 . . . . 7.4900000000000002 111.665 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -68.81 -37.42 79.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.595 -0.842 . . . . 5.3099999999999996 111.372 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -88.58 -47.53 8.23 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 124.128 0.893 . . . . 2.6099999999999999 111.301 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.8 15.17 56.98 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.54 -1.424 . . . . 2.8599999999999999 109.54 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HZ3' ' CG ' ' A' ' 74' ' ' ASP . 6.5 tttm -118.85 140.01 27.99 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 107.136 -1.431 . . . . 6.5800000000000001 107.136 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.49 142.62 11.82 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 120.914 1.076 . . . . 5.4000000000000004 111.662 -165.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.504 ' N ' HE22 ' A' ' 49' ' ' GLN . 40.8 t 66.75 -66.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.629 1.344 . . . . 6.3499999999999996 114.629 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.92 144.55 1.77 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.81 -0.756 . . . . 6.1200000000000001 111.363 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 45' ' ' LYS . 21.8 m -120.87 -65.12 1.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.582 -0.735 . . . . 7.9900000000000002 111.643 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.34 154.76 81.7 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 120.206 -0.598 . . . . 4.6200000000000001 110.254 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.419 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 9.5 Cg_endo -92.94 142.53 9.3 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 124.284 -1.132 . . . . 1.9399999999999999 109.775 0.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -113.62 141.05 47.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.947 -1.101 . . . . 4.3799999999999999 108.361 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.527 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.5 mp -111.08 139.07 36.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 124.019 0.825 . . . . 2.3399999999999999 108.954 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -118.32 122.49 43.0 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 103.634 -2.728 . . . . 1.6499999999999999 103.634 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 50.3 t -99.53 83.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 117.202 -1.799 . . . . 2.0499999999999998 111.627 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 28.3 t0 72.85 -60.27 0.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.326 -1.307 . . . . 3.7999999999999998 113.637 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -106.36 -56.14 2.23 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 115.337 1.606 . . . . 7.7999999999999998 115.337 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -118.86 176.2 5.39 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.318 1.229 . . . . 5.2599999999999998 114.318 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 12.3 t-80 -77.77 147.16 35.45 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.872 -1.529 . . . . 1.6299999999999999 106.872 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.54 HG13 ' CG2' ' A' ' 64' ' ' VAL . 34.4 mm -117.57 -29.36 2.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.8 -0.76 . . . . 2.1600000000000001 111.443 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 133.84 -156.32 22.25 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.085 -1.606 . . . . 2.1400000000000001 109.085 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.86 -170.74 34.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.502 -1.439 . . . . 1.5900000000000001 109.502 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -52.21 -36.38 51.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.641 -1.224 . . . . 2.1400000000000001 110.446 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 p -64.08 -61.46 2.25 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.37 -1.332 . . . . 2.4100000000000001 109.836 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.531 ' CG ' ' HZ3' ' A' ' 54' ' ' LYS . 2.7 m-20 -54.18 -50.15 67.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.635 -0.711 . . . . 2.4900000000000002 110.313 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.19 -46.75 88.66 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 119.543 -0.863 . . . . 1.3899999999999999 109.003 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.91 26.93 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.598 -0.841 . . . . 1.98 110.411 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.36 -58.7 6.24 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.186 -1.005 . . . . 1.8400000000000001 108.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.42 ' O ' ' C ' ' A' ' 79' ' ' VAL . 61.8 t90 -40.66 -57.81 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.359 -0.837 . . . . 1.3799999999999999 108.963 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 78' ' ' TRP . 2.4 t -40.7 -51.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.297 -1.372 . . . . 2.1400000000000001 107.297 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -59.39 -60.96 3.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.451 -1.249 . . . . 3.8799999999999999 110.406 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -76.81 31.21 0.13 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 113.454 0.909 . . . . 4.3399999999999999 113.454 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -145.0 -40.0 0.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.972 -0.558 . . . . 2.1299999999999999 110.704 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 28' ' ' ARG . 35.7 mt -96.05 -26.12 15.64 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.036 -1.066 . . . . 2.1400000000000001 111.325 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 . . . . . 0 N--CA 1.504 2.27 0 N-CA-C 107.136 -1.431 . . . . 4.0999999999999996 107.136 178.913 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' O ' ' A' ' 30' ' ' ASP . 25.2 ttm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.851 -1.166 . . . . 3.8100000000000001 107.851 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 54.9 mt-30 -133.33 150.22 51.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.35 -0.611 . . . . 4.9800000000000004 109.35 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 m -140.4 137.77 34.25 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 118.636 -1.226 . . . . 1.6499999999999999 112.761 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.29 133.43 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.432 -0.951 . . . . 1.49 108.432 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.64 128.73 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 124.437 1.085 . . . . 2.4900000000000002 108.265 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.561 ' CD2' HG12 ' A' ' 36' ' ' VAL . 30.6 m-85 -109.94 73.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.931 -1.137 . . . . 1.4399999999999999 107.931 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -133.71 -159.57 9.04 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 106.627 -2.589 . . . . 1.1399999999999999 106.627 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.712 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.5 ptm180 -123.88 143.53 50.3 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.025 -1.47 . . . . 6.46 109.245 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -64.78 76.95 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.35 -1.75 . . . . 4.1900000000000004 108.952 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 151.04 13.42 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.189 -1.005 . . . . 2.9199999999999999 111.889 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -119.98 124.91 27.61 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.585 -0.895 . . . . 2.3799999999999999 108.585 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -41.32 -64.21 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.063 0 C-N-CA 122.422 2.081 . . . . 3.4100000000000001 112.017 -170.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -47.01 -38.83 11.48 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.922 -0.711 . . . . 4.0499999999999998 112.553 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 m -75.1 -57.94 3.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.609 0.718 . . . . 2.1800000000000002 109.306 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.09 -41.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 114.038 -1.437 . . . . 2.1299999999999999 108.819 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 115.543 -0.753 . . . . 6.2199999999999998 109.423 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' ARG . . . -40.37 -43.26 1.73 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.454 -0.898 . . . . 2.02 108.896 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 12.6 tmtt? -60.2 -58.29 9.16 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.349 -1.352 . . . . 3.3199999999999998 107.349 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -48.48 -51.22 28.19 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.843 -0.743 . . . . 3.6200000000000001 109.648 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 75' ' ' PHE . 44.2 tp -52.2 -54.02 36.16 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.002 -0.74 . . . . 2.04 109.002 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -57.0 13.62 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.295 -0.962 . . . . 1.6399999999999999 109.509 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 13.7 tt0 -51.91 -40.28 60.48 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.156 -0.929 . . . . 3.0600000000000001 110.966 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 24.1 tptp -60.48 -60.17 4.24 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.722 -1.214 . . . . 4.04 107.722 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.645 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 53.5 mt -47.0 -52.37 14.92 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.233 -0.987 . . . . 2.0299999999999998 111.564 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -39.84 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 114.288 1.218 . . . . 2.48 114.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -118.8 -30.72 5.01 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.19 -0.604 . . . . 4.3200000000000003 111.824 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.645 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -80.71 -19.74 44.41 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.922 -0.711 . . . . 3.77 111.149 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.527 HH12 ' CB ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -111.93 -154.78 0.55 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.674 -1.148 . . . . 5.8700000000000001 108.423 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -115.81 -79.14 0.58 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 114.009 1.114 . . . . 4.0099999999999998 114.009 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 1' ' ' MET . 9.4 p-10 -93.84 60.83 2.97 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.632 -0.827 . . . . 3.46 111.003 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -116.32 99.96 7.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.914 -1.114 . . . . 1.3600000000000001 112.069 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 56.9 mm-40 -104.92 161.99 13.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.256 -1.387 . . . . 5.0599999999999996 107.256 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -159.12 166.46 31.49 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.552 -1.259 . . . . 1.73 109.253 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.01 146.48 40.91 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.746 -1.575 . . . . 4.2699999999999996 106.746 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.76 135.02 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.873 -1.531 . . . . 1.8700000000000001 107.906 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.561 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.0 t -119.51 144.15 28.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 105.859 -1.904 . . . . 1.8799999999999999 105.859 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 6.0 t70 -117.25 102.22 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.344 -0.942 . . . . 2.3700000000000001 111.295 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -49.97 -23.91 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 114.858 -1.065 . . . . 3.4100000000000001 111.17 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -87.8 -61.2 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.182 -1.407 . . . . 9.5800000000000001 108.618 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 37' ' ' ASP . . . -47.41 -43.15 23.42 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 123.789 0.681 . . . . 2.8500000000000001 112.836 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.19 -34.8 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.89 -0.724 . . . . 2.8700000000000001 112.025 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.51 50.49 1.2 Allowed Glycine 0 N--CA 1.505 3.257 0 C-N-CA 119.89 -1.148 . . . . 2.21 110.722 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.425 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 76.2 mt -109.71 143.24 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 120.161 -0.616 . . . . 2.2799999999999998 111.325 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 p -110.96 -97.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.474 -0.936 . . . . 2.9900000000000002 108.474 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HZ3' ' N ' ' A' ' 56' ' ' VAL . 29.3 tttm -134.31 -54.31 0.85 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.619 -0.882 . . . . 6.5099999999999998 108.619 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.84 -52.81 4.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.371 -1.286 . . . . 4.6600000000000001 110.97 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -54.01 -72.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 118.905 -1.118 . . . . 4.3099999999999996 108.932 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 83.4 mt -35.12 -49.62 0.48 Allowed 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 112.541 0.571 . . . . 3.2200000000000002 112.541 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -46.41 -50.84 16.14 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.828 -0.749 . . . . 6.0 109.545 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -43.34 -36.73 1.98 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.027 0.83 . . . . 6.8899999999999997 111.568 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.509 ' NZ ' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -95.68 -11.45 27.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.984 1.105 . . . . 5.9400000000000004 113.984 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.57 -47.25 2.22 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 119.325 -0.95 . . . . 3.0899999999999999 112.925 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.0 49.05 2.74 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 106.437 -2.665 . . . . 3.2599999999999998 106.437 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 56' ' ' VAL . 2.4 mmpt? -123.14 78.43 52.01 Favored Pre-proline 0 N--CA 1.505 2.325 0 N-CA-C 112.182 0.438 . . . . 6.5700000000000003 112.182 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.53 33.77 0.45 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.677 1.584 . . . . 7.9900000000000002 111.732 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.493 ' N ' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -132.27 -81.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.908 -0.775 . . . . 7.0599999999999996 108.908 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' THR . 20.1 pm0 -96.79 -165.46 1.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.369 -1.715 . . . . 5.2800000000000002 106.369 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 10.1 t 177.43 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.993 -1.083 . . . . 9.0700000000000003 112.698 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 16.3 t -117.33 138.83 25.35 Favored Pre-proline 0 N--CA 1.502 2.138 0 C-N-CA 119.488 -0.885 . . . . 4.5700000000000003 110.485 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 56.6 Cg_endo -86.86 166.78 46.51 Favored 'Cis proline' 0 N--CA 1.493 1.458 0 C-N-CA 125.105 -0.79 . . . . 3.2599999999999998 110.126 -23.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -140.76 161.92 36.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.518 -0.873 . . . . 3.8599999999999999 111.787 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.506 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.9 mp -122.94 146.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.127 -1.397 . . . . 2.5 108.243 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.509 ' CE1' ' NZ ' ' A' ' 51' ' ' LYS . 9.6 m-85 -123.8 127.18 47.72 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.027 -1.897 . . . . 2.2799999999999998 106.483 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' HG13 ' A' ' 69' ' ' ILE . 38.9 t -109.72 136.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 117.996 -1.481 . . . . 2.0 107.863 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.84 -89.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.314 1.009 . . . . 2.8500000000000001 108.383 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.3 mm-40 -141.99 3.95 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.744 0.653 . . . . 6.4100000000000001 111.151 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -107.7 152.82 23.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.087 0.47 . . . . 6.3399999999999999 111.138 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 63' ' ' PHE . 35.9 t-80 -77.77 141.29 39.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.415 -1.698 . . . . 1.98 106.415 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.489 HG13 ' CG2' ' A' ' 64' ' ' VAL . 42.2 mm -115.42 -45.97 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 C-N-CA 118.235 -1.386 . . . . 1.8500000000000001 109.253 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.66 -137.0 8.39 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.466 -1.35 . . . . 1.76 110.275 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.29 -166.94 21.22 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.754 -0.736 . . . . 1.6799999999999999 111.54 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -55.16 -66.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.994 -0.683 . . . . 3.0699999999999998 112.424 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -51.37 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.096 0.776 . . . . 2.46 113.096 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.95 -52.87 10.1 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.174 -1.01 . . . . 2.9199999999999999 111.178 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CD2' HD21 ' A' ' 20' ' ' LEU . 44.3 t80 -49.62 -38.29 31.35 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.817 -1.153 . . . . 1.0600000000000001 108.899 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.74 -65.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.149 -1.387 . . . . 2.0800000000000001 110.319 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -54.87 41.91 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.894 -1.122 . . . . 1.78 108.113 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.463 ' HH2' ' SD ' ' A' ' 1' ' ' MET . 57.2 t90 -41.15 -51.05 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.263 0.977 . . . . 1.6899999999999999 109.93 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.74 -61.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 114.803 -1.089 . . . . 2.0600000000000001 108.464 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.49 ' NZ ' ' HB3' ' A' ' 84' ' ' ASP . 5.9 tmtm? -53.58 -46.63 70.38 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.967 -0.693 . . . . 3.6899999999999999 112.673 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -56.44 -55.72 30.17 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.504 -1.225 . . . . 3.7400000000000002 113.564 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -89.06 -27.09 21.03 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 114.739 1.385 . . . . 2.0099999999999998 114.739 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.538 HD23 ' SD ' ' A' ' 1' ' ' MET . 60.4 mt -89.38 -19.24 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.157 -1.417 . . . . 2.2200000000000002 111.894 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.527 ' CB ' HH12 ' A' ' 28' ' ' ARG . 10.3 t70 . . . . . 0 N--CA 1.495 1.806 0 C-N-CA 118.487 -1.285 . . . . 4.3200000000000003 110.637 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 71.2 mtm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.123 -0.695 . . . . 3.0 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 5.8 mt-30 -126.65 123.92 38.69 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 108.265 -1.013 . . . . 4.9800000000000004 108.265 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.4 m -120.34 139.16 53.17 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.875 -1.13 . . . . 2.2799999999999998 110.026 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.25 125.42 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.803 -0.759 . . . . 1.8200000000000001 109.317 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.6 mp -106.75 117.96 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 124.882 1.364 . . . . 3.02 107.928 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 15.4 m-85 -98.23 93.46 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.828 -1.175 . . . . 1.45 107.828 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.88 -170.67 16.02 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.771 -1.204 . . . . 0.93000000000000005 110.897 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.526 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 22.0 mtp180 -126.81 27.28 6.05 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.086 -0.646 . . . . 7.25 109.292 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' ARG . 59.3 m 34.25 52.52 0.51 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 123.59 0.556 . . . . 3.6000000000000001 111.111 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.1 52.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.799 -1.32 . . . . 3.5800000000000001 109.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -151.71 72.38 8.1 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 107.623 -1.251 . . . . 3.2999999999999998 107.623 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -29.2 -59.07 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 123.202 2.601 . . . . 3.0 113.796 -139.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -39.88 -38.97 0.75 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 120.603 -0.439 . . . . 5.3799999999999999 112.0 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 92.2 m -51.05 -46.09 61.55 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.284 -0.871 . . . . 2.4199999999999999 110.426 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -55.93 -48.2 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.651 -0.82 . . . . 2.3300000000000001 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.504 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -42.98 -48.69 5.98 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.709 -0.796 . . . . 5.4299999999999997 111.063 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.99 -44.86 15.38 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.591 -0.844 . . . . 1.97 110.571 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 5.2 tmtm? -63.77 -54.44 35.2 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 108.385 -0.969 . . . . 3.75 108.385 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.504 ' CG ' HH22 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -52.56 -43.09 65.0 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.799 -0.637 . . . . 3.1299999999999999 111.699 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.66 -49.41 40.1 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.028 -0.669 . . . . 2.23 109.831 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -57.29 -42.97 82.71 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.104 -1.443 . . . . 1.78 107.104 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -55.14 -57.86 10.04 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.586 -1.264 . . . . 2.8199999999999998 107.586 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 22' ' ' GLU . 60.8 tttp -37.43 -61.77 0.57 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.32 -1.309 . . . . 4.6699999999999999 108.911 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 mt -56.45 -56.92 15.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.776 -0.77 . . . . 2.6600000000000001 112.564 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 -15.43 0.66 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 114.04 1.126 . . . . 2.1699999999999999 114.04 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -107.41 -44.5 4.3 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 119.842 -0.743 . . . . 4.1699999999999999 110.508 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.73 -19.43 48.81 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.898 -1.501 . . . . 3.6600000000000001 112.782 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.476 ' NH1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -118.69 -178.36 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.789 -0.641 . . . . 7.2000000000000002 109.954 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.08 -59.62 1.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 113.048 0.759 . . . . 3.7599999999999998 113.048 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.476 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.5 t70 -78.08 52.74 1.11 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.889 0.852 . . . . 3.29 111.786 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -145.71 92.53 2.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.287 -0.883 . . . . 1.5 111.521 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 17.7 mp0 -105.14 126.76 52.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.604 -2.369 . . . . 4.5099999999999998 104.604 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.607 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.3 p90 -127.03 157.57 39.25 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.813 -1.155 . . . . 1.48 109.549 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -131.23 140.62 49.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.495 -0.928 . . . . 4.5300000000000002 108.495 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -99.83 131.01 46.07 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.936 -1.106 . . . . 1.8999999999999999 108.045 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.2 145.47 22.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 114.689 -1.141 . . . . 1.6899999999999999 108.932 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -118.52 116.72 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.436 -1.69 . . . . 2.6600000000000001 106.436 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -51.32 -27.7 6.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.319 -1.352 . . . . 2.3399999999999999 112.416 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.6 -8.65 58.14 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.067 -1.053 . . . . 6.9900000000000002 113.071 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.21 -37.6 12.0 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.392 -0.923 . . . . 2.4300000000000002 108.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -87.03 -37.48 17.44 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.978 -0.689 . . . . 2.5600000000000001 110.826 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 52.07 0.59 Allowed Glycine 0 N--CA 1.505 3.253 0 N-CA-C 110.105 -1.198 . . . . 1.4199999999999999 110.105 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.2 137.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.899 -0.65 . . . . 2.5499999999999998 109.363 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -103.41 -101.31 0.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.145 -1.428 . . . . 2.79 107.145 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -138.97 -47.45 0.49 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.557 -2.016 . . . . 7.2199999999999998 105.557 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -46.07 -52.35 12.14 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.018 -1.104 . . . . 3.52 108.018 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 24.4 m-20 -44.93 -57.28 3.9 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.735 -1.121 . . . . 4.3499999999999996 111.611 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.1 mt -56.04 -53.66 54.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.003 -1.453 . . . . 2.1899999999999999 110.334 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -51.24 -47.04 62.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.991 -1.083 . . . . 4.2300000000000004 109.022 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -51.69 -45.13 63.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.819 -0.752 . . . . 7.1100000000000003 108.998 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.638 ' HZ1' ' CB ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -68.37 0.81 3.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.863 -1.062 . . . . 5.0 113.472 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.46 ' CB ' ' HG3' ' A' ' 55' ' ' PRO . . . -129.89 -44.76 1.18 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.942 -1.103 . . . . 2.8300000000000001 112.272 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.44 -58.82 0.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.107 -1.197 . . . . 4.7599999999999998 110.107 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 55.1 pttt -165.2 62.6 0.88 Allowed Pre-proline 0 N--CA 1.504 2.231 0 C-N-CA 119.201 -1.0 . . . . 12.279999999999999 112.844 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 10.1 Cg_endo -96.74 159.6 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.156 1.238 . . . . 7.8499999999999996 112.041 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.75 -20.81 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 115.013 -0.994 . . . . 5.5899999999999999 108.649 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -72.8 70.45 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.511 -1.222 . . . . 6.0199999999999996 108.123 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.2 t -42.43 -45.66 4.46 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.389 -0.823 . . . . 6.7800000000000002 110.465 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.76 152.45 59.37 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.891 -0.781 . . . . 3.2599999999999998 108.891 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.415 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 12.0 Cg_endo -84.26 166.8 60.23 Favored 'Cis proline' 0 N--CA 1.486 1.049 0 O-C-N 123.426 1.224 . . . . 2.3199999999999998 109.885 -17.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 82.4 mt-30 -139.76 153.99 47.3 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.074 -1.05 . . . . 3.52 111.436 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.1 mt -134.07 150.97 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.703 1.24 . . . . 2.8799999999999999 112.623 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.462 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 61.4 m-85 -135.87 126.35 26.85 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 112.62 -2.082 . . . . 1.3700000000000001 108.852 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.518 HG21 HG13 ' A' ' 69' ' ' ILE . 58.9 t -96.62 121.26 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 105.903 -1.888 . . . . 2.1200000000000001 105.903 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.16 -87.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.902 0.751 . . . . 2.6200000000000001 111.672 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.91 12.76 3.99 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.238 -0.985 . . . . 5.25 112.913 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -111.83 156.73 21.53 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.877 -0.729 . . . . 4.9199999999999999 109.699 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.462 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.7 t-160 -90.92 138.34 31.67 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.025 -1.102 . . . . 1.72 108.025 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.518 HG13 HG21 ' A' ' 64' ' ' VAL . 9.7 mm -110.71 -31.73 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.523 -1.271 . . . . 1.8200000000000001 110.547 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.96 -138.47 10.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.295 -1.431 . . . . 1.96 109.764 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . -94.29 -89.09 1.67 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.583 -1.294 . . . . 2.4100000000000001 111.476 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.12 -55.32 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.849 -1.14 . . . . 2.3199999999999998 109.49 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -43.04 -48.27 6.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.274 -1.01 . . . . 2.1400000000000001 108.274 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -64.95 0.66 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.379 -1.737 . . . . 3.2999999999999998 110.296 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -51.55 -46.15 63.29 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.246 -0.982 . . . . 1.29 109.25 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.77 -53.47 31.5 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.297 -1.001 . . . . 1.5800000000000001 108.297 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.47 -56.26 22.29 Favored 'General case' 0 C--O 1.198 -1.643 0 N-CA-C 107.933 -1.136 . . . . 1.6499999999999999 107.933 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -50.16 -34.28 21.85 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 123.43 0.456 . . . . 1.4399999999999999 110.631 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 t -71.49 -44.32 71.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.421 -0.955 . . . . 2.3999999999999999 108.421 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' NZ ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -82.25 -65.8 0.97 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.443 -1.303 . . . . 4.0999999999999996 111.602 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.21 0.77 0.38 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 117.272 2.323 . . . . 4.71 117.272 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.48 -26.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.32 -0.952 . . . . 4.0199999999999996 112.233 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.67 -21.98 28.1 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.281 -1.368 . . . . 2.7400000000000002 112.713 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 80' ' ' LYS . 30.7 p30 . . . . . 0 N--CA 1.508 2.452 0 C-N-CA 117.108 -1.837 . . . . 4.5899999999999999 112.325 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.678 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 122.951 1.358 . . . . 4.0999999999999996 109.16 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -121.02 126.5 50.06 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.829 -1.915 . . . . 7.4100000000000001 105.829 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.4 m -112.72 144.67 41.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.275 -1.37 . . . . 1.8400000000000001 113.192 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.0 117.56 52.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.941 -1.874 . . . . 2.54 105.941 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.2 mm -107.2 124.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.242 -1.392 . . . . 3.1299999999999999 107.242 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.84 96.2 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.323 -1.732 . . . . 1.4099999999999999 106.323 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -142.71 -152.6 5.71 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.639 -1.267 . . . . 0.98999999999999999 111.631 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.04 6.58 3.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.996 -0.742 . . . . 7.9800000000000004 108.996 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 t 45.24 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.569 1.176 . . . . 5.8099999999999996 112.764 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.41 -66.51 3.63 Favored Glycine 0 N--CA 1.498 2.795 0 CA-C-N 114.781 -1.1 . . . . 4.6500000000000004 111.443 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 137.93 89.28 Favored Pre-proline 0 N--CA 1.497 1.896 0 C-N-CA 119.886 -0.726 . . . . 3.3399999999999999 111.143 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.38 -61.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.283 1.989 . . . . 3.4900000000000002 111.021 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.439 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 10.3 t80 -48.89 -50.54 34.5 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.561 -0.855 . . . . 4.0099999999999998 109.431 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -53.86 -53.51 51.5 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.675 0.75 . . . . 2.5699999999999998 110.106 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -52.09 -43.21 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.513 -1.221 . . . . 1.96 111.182 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.518 HH22 ' N ' ' A' ' 20' ' ' LEU . 10.0 mmm180 -40.26 -50.96 2.76 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.714 -1.195 . . . . 4.6600000000000001 112.188 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.75 -52.66 13.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.733 -1.187 . . . . 1.51 109.193 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -58.64 -45.97 88.14 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.987 -1.461 . . . . 2.6200000000000001 110.482 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 16' ' ' ARG . 66.0 t0 -62.11 -44.38 96.77 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.41 -0.916 . . . . 3.6400000000000001 109.774 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.518 ' N ' HH22 ' A' ' 16' ' ' ARG . 11.0 tp -62.72 -58.87 5.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.617 -0.833 . . . . 1.9199999999999999 109.077 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 33' ' ' TYR . . . -52.69 -51.81 58.72 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.102 -1.039 . . . . 1.6699999999999999 109.127 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.6 tt0 -46.33 -58.93 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.964 0.79 . . . . 3.2400000000000002 109.796 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.501 ' N ' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -47.43 -60.6 2.41 Favored 'General case' 0 C--O 1.206 -1.195 0 O-C-N 125.644 1.84 . . . . 7.5700000000000003 107.76 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 56.6 mt -51.08 -51.47 52.96 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.244 -1.383 . . . . 2.3599999999999999 112.192 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 13.4 p -66.75 8.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.54 -1.264 . . . . 2.25 114.408 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 24' ' ' LEU . 31.5 m-80 -125.86 -39.71 2.1 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.693 -1.225 . . . . 5.0 107.693 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.94 -31.8 61.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.598 -1.183 . . . . 3.3999999999999999 109.046 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.0 mtp-105 -110.76 -171.04 1.75 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.318 -1.31 . . . . 5.8499999999999996 111.794 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -125.53 -48.9 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.176 -0.92 . . . . 3.6899999999999999 111.748 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.68 -21.24 61.1 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.779 -1.168 . . . . 4.8399999999999999 110.39 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 25' ' ' SER . 59.2 t80 -84.92 124.49 31.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.763 -1.175 . . . . 1.74 112.331 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -139.2 163.16 33.19 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.622 -1.626 . . . . 3.5 106.809 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 7.8 p90 -158.95 163.18 36.72 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.568 -1.253 . . . . 1.8899999999999999 110.594 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . 0.422 HE21 HG21 ' A' ' 36' ' ' VAL . 18.6 pt20 -128.73 157.25 41.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.463 -1.31 . . . . 5.3899999999999997 107.463 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -115.56 127.36 55.2 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.06 -1.456 . . . . 3.1000000000000001 107.78 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 HE21 ' A' ' 34' ' ' GLN . 1.2 t -113.45 132.05 63.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.423 -1.695 . . . . 1.97 106.423 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 9.3 t70 -108.27 110.57 22.21 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.44 -0.948 . . . . 1.8999999999999999 108.44 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -44.58 -25.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.676 0.991 . . . . 2.0299999999999998 113.676 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 6.4 mmm180 -91.93 -48.81 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.067 -1.453 . . . . 9.1300000000000008 109.584 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.44 -40.76 62.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.401 -0.963 . . . . 2.4199999999999999 108.401 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' GLY . 71.3 mm-40 -86.57 26.39 1.1 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.26 -1.336 . . . . 3.6400000000000001 110.61 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 25.04 59.43 0.06 OUTLIER Glycine 0 N--CA 1.504 3.211 0 O-C-N 123.406 0.441 . . . . 2.5800000000000001 113.73 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 44' ' ' THR . 31.7 mt -104.13 161.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.584 -0.895 . . . . 3.0699999999999998 108.584 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.42 ' N ' HG23 ' A' ' 43' ' ' ILE . 8.9 t -112.96 -168.07 1.27 Allowed 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.671 -1.233 . . . . 4.4299999999999997 107.671 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -82.3 -46.12 14.05 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.702 -1.199 . . . . 6.4100000000000001 109.887 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.625 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 7.5 mp0 -44.48 -51.82 8.45 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.901 0.858 . . . . 4.4800000000000004 110.281 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.32 -61.68 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.39 -1.277 . . . . 3.6299999999999999 111.452 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.24 -52.58 2.62 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.011 -0.995 . . . . 2.8100000000000001 113.497 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -44.68 -46.39 10.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.332 -0.947 . . . . 5.4299999999999997 111.243 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -51.27 69.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.772 0.67 . . . . 7.7300000000000004 111.244 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.605 ' NZ ' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -46.48 -37.69 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.494 -1.23 . . . . 5.7699999999999996 112.868 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.97 -30.06 11.85 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.224 0.952 . . . . 2.2200000000000002 111.574 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.56 49.88 17.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.29 -1.124 . . . . 3.3399999999999999 110.29 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -142.56 156.62 63.3 Favored Pre-proline 0 N--CA 1.501 2.114 0 C-N-CA 118.655 -1.218 . . . . 8.1999999999999993 112.003 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -81.33 39.34 0.85 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.318 2.012 . . . . 6.7000000000000002 111.175 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 p -141.01 125.86 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.529 -2.026 . . . . 5.96 105.529 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 63.54 0.91 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.254 0.835 . . . . 8.7400000000000002 113.254 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.5 p -105.08 166.62 10.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.181 -1.408 . . . . 6.25 112.558 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -113.81 152.37 45.53 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.672 -1.233 . . . . 3.75 107.672 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.93 177.04 22.42 Favored 'Cis proline' 0 N--CA 1.485 0.973 0 O-C-N 122.541 0.758 . . . . 2.4199999999999999 110.848 -12.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -131.81 142.05 49.62 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.842 -0.743 . . . . 3.6499999999999999 109.627 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.434 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.8 mp -119.65 143.18 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-O 121.822 0.82 . . . . 2.4399999999999999 111.663 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CE2' ' NZ ' ' A' ' 51' ' ' LYS . 84.3 m-85 -128.87 136.66 50.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.412 -1.722 . . . . 1.53 108.745 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.592 HG12 ' CH2' ' A' ' 78' ' ' TRP . 75.5 t -122.76 137.3 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.489 -1.284 . . . . 1.9299999999999999 109.293 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 54.42 -80.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.678 -1.601 . . . . 3.5800000000000001 111.197 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' VAL . 40.3 tt0 -138.76 -19.66 1.03 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.294 -0.866 . . . . 5.3700000000000001 112.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.65 163.82 12.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.948 1.092 . . . . 5.5999999999999996 113.948 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.461 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 29.2 t-80 -80.25 137.97 36.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.954 -1.93 . . . . 1.8700000000000001 106.532 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 78' ' ' TRP . 34.3 mm -110.15 -50.34 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.343 -1.343 . . . . 1.8700000000000001 109.718 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.1 -141.07 10.88 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.472 -1.347 . . . . 1.6000000000000001 110.81 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.7 -168.08 32.35 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.636 -1.386 . . . . 1.76 109.636 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 12.9 t80 -56.77 -23.27 41.87 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.854 -1.138 . . . . 2.1000000000000001 109.358 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -75.33 -65.76 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 2.6600000000000001 111.003 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.92 -43.06 69.44 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.54 -0.911 . . . . 2.8799999999999999 108.54 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 62' ' ' ILE . 22.7 t80 -59.71 -53.43 58.04 Favored 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 107.159 -1.423 . . . . 1.3600000000000001 107.159 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.4 11.52 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.573 -0.851 . . . . 1.48 111.043 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.4 -60.3 4.03 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.238 -0.985 . . . . 2.1899999999999999 109.997 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.592 ' CH2' HG12 ' A' ' 64' ' ' VAL . 46.2 t90 -41.62 -49.41 4.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 123.825 0.703 . . . . 1.47 109.584 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -49.49 -61.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.096 -0.956 . . . . 1.8400000000000001 110.12 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -50.96 -50.63 57.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.672 -0.811 . . . . 3.7200000000000002 111.503 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.54 -39.86 92.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.096 1.888 . . . . 3.9399999999999999 116.096 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -105.48 -17.23 14.49 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.664 1.357 . . . . 1.8500000000000001 114.664 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 31' ' ' PHE . 68.8 mt -97.55 -21.55 17.03 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.909 -1.516 . . . . 2.52 110.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.512 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 11.4 m-20 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 118.096 -1.441 . . . . 4.6799999999999997 111.373 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.617 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.01 -1.107 . . . . 3.5899999999999999 108.01 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 9.1 tt0 -105.98 157.89 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.122 -1.066 . . . . 4.71 108.122 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 2' ' ' GLN . 31.0 m -149.22 149.74 31.46 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.861 -1.149 . . . . 1.95 109.84 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.87 134.7 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 119.981 -0.688 . . . . 1.8899999999999999 111.197 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -114.93 119.61 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.97 -1.493 . . . . 2.6400000000000001 106.97 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.417 ' CD2' HG12 ' A' ' 36' ' ' VAL . 36.3 m-85 -103.0 103.71 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.46 -0.941 . . . . 1.1799999999999999 108.46 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.15 -150.18 5.43 Favored Glycine 0 N--CA 1.502 3.042 0 C-N-CA 119.399 -1.381 . . . . 1.24 110.932 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.522 HH21 ' CD1' ' A' ' 38' ' ' ILE . 18.1 mtt180 -121.85 -144.89 0.35 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.267 -0.642 . . . . 8.6999999999999993 109.267 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m -118.06 77.8 1.19 Allowed 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.973 -0.691 . . . . 3.4199999999999999 112.085 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.03 44.07 0.64 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.109 -1.52 . . . . 2.8100000000000001 111.041 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -110.0 101.61 47.91 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.438 -1.319 . . . . 2.1800000000000002 107.438 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -32.86 -34.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 123.081 2.521 . . . . 2.6000000000000001 112.899 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 1.7 t80 -75.54 -55.27 5.83 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.398 -0.819 . . . . 5.1200000000000001 109.855 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -54.16 -40.71 67.72 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.03 -1.47 . . . . 2.6200000000000001 107.03 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.47 -54.64 32.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.168 -1.378 . . . . 2.1400000000000001 107.705 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 tpm_? -46.36 -51.91 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 4.2300000000000004 110.325 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.67 87.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.115 -1.034 . . . . 1.8500000000000001 108.591 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -52.9 -47.84 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.205 -1.406 . . . . 3.5899999999999999 107.205 178.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.41 ' HA ' ' HZ1' ' A' ' 18' ' ' LYS . 36.1 m-20 -53.25 -50.81 64.03 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.901 -1.12 . . . . 2.9300000000000002 108.852 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -53.98 -58.28 7.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.037 -1.065 . . . . 2.6099999999999999 110.324 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -52.29 -52.43 52.95 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.948 -1.101 . . . . 1.6000000000000001 109.752 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 19.0 mt-10 -52.69 -49.08 66.02 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.291 0.567 . . . . 3.1499999999999999 110.094 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 28.0 ttpp -48.76 -60.65 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.277 -0.969 . . . . 5.7699999999999996 108.855 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 64.9 mt -48.19 -58.37 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.772 -0.771 . . . . 2.6899999999999999 111.515 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 m -41.25 -34.13 0.45 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.674 -0.81 . . . . 2.2400000000000002 110.896 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -88.19 -36.01 17.05 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 120.396 -0.522 . . . . 3.8100000000000001 110.513 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.587 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 6.4 pt-20 -99.74 23.48 9.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.535 0.683 . . . . 4.4000000000000004 112.017 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.424 ' HD2' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -137.02 177.11 8.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.775 -0.824 . . . . 5.2199999999999998 108.775 179.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.56 -38.78 3.67 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.536 -1.211 . . . . 4.1799999999999997 108.606 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.7 p-10 -110.34 22.0 16.02 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.821 -1.536 . . . . 4.1200000000000001 113.424 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -102.83 99.48 9.42 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 118.189 -1.404 . . . . 1.25 114.406 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 42.5 mt-30 -111.64 127.82 55.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.835 -1.543 . . . . 3.71 106.835 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.514 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 25.5 p90 -129.64 162.1 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.624 -0.83 . . . . 1.98 110.326 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -131.71 146.97 52.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.72 -0.844 . . . . 4.29 108.72 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -99.76 135.27 41.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.8 -1.556 . . . . 1.79 106.8 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -121.35 138.03 53.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.796 -0.816 . . . . 1.6699999999999999 108.796 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -111.22 109.36 19.36 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.657 -1.156 . . . . 2.3900000000000001 108.666 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CD1' HH21 ' A' ' 8' ' ' ARG . 27.0 pt -51.17 -25.81 4.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.915 -1.039 . . . . 2.0800000000000001 109.392 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -79.33 -63.53 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.02 -1.072 . . . . 5.9500000000000002 108.286 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.21 -42.3 0.67 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 123.66 0.6 . . . . 2.02 111.409 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.21 -46.81 14.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.85 -1.068 . . . . 2.6400000000000001 111.028 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.67 51.79 0.83 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.821 -1.312 . . . . 1.76 109.821 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 44' ' ' THR . 24.4 mt -100.26 172.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.977 -0.611 . . . . 2.46 109.384 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.485 ' N ' HG23 ' A' ' 43' ' ' ILE . 51.5 p -103.67 -171.01 1.86 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.601 -0.888 . . . . 3.3900000000000001 108.601 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 29.96 7.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.276 -1.379 . . . . 5.4900000000000002 107.276 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -119.31 -55.6 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 110.341 -3.118 . . . . 3.5299999999999998 104.084 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -47.96 27.65 Favored 'General case' 0 C--O 1.202 -1.396 0 CA-C-N 112.458 -2.155 . . . . 3.5800000000000001 110.46 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.6 -37.97 63.51 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.897 -1.047 . . . . 3.04 111.819 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.67 -49.71 13.95 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.928 -1.109 . . . . 5.1799999999999997 108.903 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' CD ' ' C ' ' A' ' 50' ' ' GLN . 11.2 tm0? -52.65 -43.94 65.81 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.749 -1.114 . . . . 5.7199999999999998 110.062 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -16.33 35.1 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.924 -1.035 . . . . 6.0599999999999996 111.681 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -89.75 -51.58 5.43 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.193 -1.781 . . . . 2.7000000000000002 106.193 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.79 -25.19 2.56 Favored Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.371 -1.286 . . . . 2.98 110.558 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.464 ' H ' ' C ' ' A' ' 52' ' ' ALA . 29.6 mtmm -109.43 155.78 40.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 109.008 -0.738 . . . . 10.880000000000001 109.008 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.5 74.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 123.053 2.502 . . . . 7.29 112.784 -149.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 54' ' ' LYS . 11.9 p -96.83 162.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.793 -0.817 . . . . 7.8300000000000001 108.793 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' CG ' ' H ' ' A' ' 58' ' ' THR . 1.1 pt-20 -90.34 -99.22 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.908 -1.042 . . . . 6.6799999999999997 110.552 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.415 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 13.0 t -131.03 -162.28 1.2 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.153 -0.619 . . . . 5.7400000000000002 109.819 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 60' ' ' PRO . 73.0 t -84.14 140.25 39.63 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-N 115.007 -0.997 . . . . 4.7400000000000002 109.639 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 9.7 Cg_endo -91.31 164.93 28.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 O-C-N 123.069 1.036 . . . . 2.9199999999999999 112.623 14.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -131.71 156.16 46.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.793 -1.094 . . . . 3.8799999999999999 109.816 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.55 144.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.5 -0.773 . . . . 2.2799999999999998 111.754 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 14.3 m-85 -129.03 122.65 30.46 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.624 -1.625 . . . . 1.3700000000000001 108.942 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 66' ' ' GLN . 22.3 t -91.98 122.91 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 105.358 -2.09 . . . . 1.8600000000000001 105.358 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 1.2 t70 64.05 -74.76 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 125.076 1.485 . . . . 2.9100000000000001 109.099 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -147.92 -5.5 0.46 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.921 -0.581 . . . . 5.9900000000000002 111.558 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -104.63 137.26 42.72 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.22 -0.592 . . . . 6.1900000000000004 112.554 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 50.4 t-80 -68.92 129.92 41.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.765 -1.568 . . . . 1.72 106.765 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.43 HG13 ' CG2' ' A' ' 64' ' ' VAL . 33.3 mm -106.73 -36.84 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.719 -1.193 . . . . 2.02 111.149 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.76 -132.33 4.36 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.692 -1.718 . . . . 1.8 110.843 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.62 -148.75 12.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.989 -0.844 . . . . 2.1899999999999999 110.989 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 16' ' ' ARG . 72.9 t80 -78.79 -56.98 3.99 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.053 -0.573 . . . . 2.7400000000000002 110.432 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.47 -64.99 0.64 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.141 0.793 . . . . 3.2200000000000002 113.141 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -53.98 -60.19 3.65 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.211 -0.596 . . . . 2.73 109.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -43.93 -48.44 8.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.716 -0.476 . . . . 1.8500000000000001 109.716 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.69 -59.26 5.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.01 -0.541 . . . . 2.3199999999999998 109.91 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.25 -62.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.272 -1.01 . . . . 2.6899999999999999 108.272 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -41.37 -60.21 1.34 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.194 -0.912 . . . . 1.8300000000000001 109.657 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 t -40.61 -63.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.335 -1.357 . . . . 2.25 107.335 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.64 -54.9 5.69 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 125.018 1.449 . . . . 3.9399999999999999 109.788 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -80.17 26.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.199 0.815 . . . . 5.5599999999999996 113.199 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.48 -43.5 0.32 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.13 -0.628 . . . . 2.0800000000000001 111.504 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.402 HD11 HD23 ' A' ' 24' ' ' LEU . 14.6 mt -94.44 -4.19 48.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.385 -0.926 . . . . 1.9099999999999999 111.794 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.496 1.873 0 O-C-N 124.321 1.013 . . . . 3.6000000000000001 108.592 179.182 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 83.3 mtp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 107.704 -1.221 . . . . 3.1299999999999999 107.704 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -118.9 116.99 27.63 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.857 1.348 . . . . 5.4100000000000001 107.541 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.0 m -99.74 131.91 45.42 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.5 -1.28 . . . . 1.71 108.41 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.64 128.93 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.849 -1.167 . . . . 1.8300000000000001 107.849 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.77 109.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.633 -1.618 . . . . 2.8399999999999999 106.633 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.517 ' CD2' HG12 ' A' ' 36' ' ' VAL . 26.8 m-85 -94.03 107.52 19.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.076 -1.453 . . . . 1.5700000000000001 107.076 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.83 5.6 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.354 -0.927 . . . . 1.51 110.932 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.596 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 31.9 ptt-85 -130.06 -162.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.857 -1.164 . . . . 9.1899999999999995 107.857 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 39' ' ' ARG . 33.3 p -132.49 140.09 48.22 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.178 -1.009 . . . . 4.6500000000000004 110.961 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.4 -1.91 23.64 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.247 -0.977 . . . . 3.73 111.721 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 95.72 24.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 120.022 -0.671 . . . . 2.5499999999999998 111.453 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . 0.401 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 83.3 Cg_exo -35.29 -38.63 0.2 Allowed 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 122.339 2.026 . . . . 4.6900000000000004 112.14 168.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -67.04 -45.12 78.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.701 -1.6 . . . . 4.1900000000000004 109.217 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' NH2' ' A' ' 8' ' ' ARG . 82.0 m -53.32 -41.91 66.18 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.717 -1.193 . . . . 2.0299999999999998 107.902 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 12' ' ' PRO . 58.0 t -48.33 -38.89 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.458 -0.897 . . . . 2.0499999999999998 111.14 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.8 mmp_? -50.25 -20.94 1.17 Allowed 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 112.835 0.68 . . . . 6.8600000000000003 112.835 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -43.77 22.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.76 -1.57 . . . . 2.0299999999999998 106.76 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.59 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.0 tmtt? -57.1 -46.6 82.46 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.598 -0.889 . . . . 3.6099999999999999 108.598 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.59 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 31.8 m-20 -53.3 -43.9 67.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.794 -1.162 . . . . 3.0099999999999998 111.033 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.16 -57.73 4.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.17 -1.012 . . . . 2.0699999999999998 109.529 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -43.22 37.31 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.056 -1.058 . . . . 1.96 109.156 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.629 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 19.9 tt0 -65.84 -65.21 0.7 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.366 -0.934 . . . . 2.7200000000000002 109.504 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -36.33 -50.74 0.77 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.145 0.903 . . . . 4.5499999999999998 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.554 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 95.2 mt -49.72 -40.15 39.53 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.823 -1.08 . . . . 2.0699999999999998 112.272 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.0 m -50.48 -12.59 0.1 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.576 0.548 . . . . 1.8 111.618 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 24' ' ' LEU . 44.5 m-80 -114.73 -41.8 3.34 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.853 -0.612 . . . . 3.2999999999999998 111.045 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 5.9 pt-20 -81.79 -10.59 59.3 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.156 -1.018 . . . . 3.75 113.415 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.5 mpt_? -105.76 -177.4 3.35 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.281 -0.967 . . . . 5.8700000000000001 110.914 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -63.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.486 -1.234 . . . . 6.04 112.024 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.4 t70 -118.91 -43.78 2.64 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 109.476 -0.564 . . . . 5.4699999999999998 109.476 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' SER . 16.4 t80 8.61 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.41 -1.723 . . . . 1.8400000000000001 115.113 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -112.72 158.82 19.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.689 -1.967 . . . . 3.7000000000000002 105.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.629 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 10.8 p90 -151.28 164.69 36.06 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.16 -1.416 . . . . 1.4299999999999999 110.695 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -144.27 154.86 43.51 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.374 -1.343 . . . . 5.1100000000000003 107.374 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 36' ' ' VAL . 38.7 t80 -106.76 148.28 28.64 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.117 -1.433 . . . . 1.9099999999999999 109.068 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -131.02 125.86 58.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 124.399 1.062 . . . . 1.8799999999999999 108.62 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -109.02 122.76 47.94 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.558 -1.275 . . . . 1.9399999999999999 107.558 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.1 pt -51.93 -31.35 13.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.614 -0.834 . . . . 2.6200000000000001 111.811 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.518 ' NH1' ' HB3' ' A' ' 39' ' ' ARG . 0.8 OUTLIER -84.22 -5.9 59.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.652 0.612 . . . . 5.54 112.652 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.12 -39.32 6.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.798 -0.761 . . . . 1.8400000000000001 110.194 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.76 -35.08 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.442 -0.903 . . . . 2.6699999999999999 110.148 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.41 53.85 0.71 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.151 -1.58 . . . . 1.9099999999999999 109.151 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.25 137.68 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.506 -0.924 . . . . 2.4399999999999999 108.506 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -117.46 54.06 0.9 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.69 -1.204 . . . . 4.2800000000000002 113.901 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.1 mttp 62.94 -65.01 0.1 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.365 1.246 . . . . 8.4100000000000001 114.365 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -44.25 -51.74 8.04 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.022 0.749 . . . . 4.6500000000000004 113.022 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.46 -38.23 58.86 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.758 -1.177 . . . . 4.04 109.999 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLN . 71.9 mt -71.92 -51.77 20.51 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.311 -0.956 . . . . 2.77 108.522 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -40.39 -45.21 2.14 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.178 -1.045 . . . . 6.5700000000000003 108.178 178.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -68.75 -58.02 4.81 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 126.008 2.068 . . . . 6.1799999999999997 110.455 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -43.55 -37.51 2.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.669 -0.696 . . . . 4.7199999999999998 112.327 -179.21 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.6 -8.83 18.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.044 0.84 . . . . 2.0699999999999998 111.316 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.29 49.63 55.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.102 -1.599 . . . . 2.4500000000000002 109.102 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HZ1' ' CD ' ' A' ' 57' ' ' GLU . 26.2 mmtp -122.97 154.26 64.36 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 114.401 -0.9 . . . . 5.4900000000000002 110.739 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.25 36.34 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.282 1.321 . . . . 5.4500000000000002 110.815 152.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 54' ' ' LYS . 25.1 t 57.24 151.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.432 1.083 . . . . 6.8700000000000001 112.742 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.589 ' CG ' ' H ' ' A' ' 58' ' ' THR . 6.6 pm0 -131.17 -106.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.556 -1.275 . . . . 6.2599999999999998 107.556 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.589 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 67.4 m -119.23 175.56 5.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.321 -1.363 . . . . 7.1399999999999997 107.321 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.461 HG22 HH12 ' A' ' 8' ' ' ARG . 3.2 m -112.6 164.56 15.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.64 -0.504 . . . . 5.2000000000000002 109.64 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.29 -172.5 10.93 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 124.131 -1.195 . . . . 2.6000000000000001 110.421 -11.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -103.03 131.97 49.63 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.641 -1.614 . . . . 3.7400000000000002 106.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 75' ' ' PHE . 8.7 mm -108.62 125.92 65.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.356 -0.937 . . . . 2.7799999999999998 110.832 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.21 124.16 41.84 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.421 -1.326 . . . . 1.1899999999999999 107.421 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.45 ' CG2' HG13 ' A' ' 69' ' ' ILE . 42.2 t -116.54 122.91 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.068 -1.053 . . . . 2.2799999999999998 108.863 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 50.44 32.2 6.26 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.013 1.863 . . . . 2.5299999999999998 108.803 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 82.52 -34.5 0.09 Allowed 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 110.016 -3.266 . . . . 7.71 109.757 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -47.1 112.66 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 5.8300000000000001 108.719 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -57.85 131.57 50.77 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 117.825 -1.55 . . . . 2.2000000000000002 106.876 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.45 HG13 ' CG2' ' A' ' 64' ' ' VAL . 51.0 mm -105.43 -42.97 7.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.198 -1.408 . . . . 1.71 107.198 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.54 -125.1 4.27 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.941 -1.599 . . . . 1.6799999999999999 111.109 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.22 19.8 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.626 -1.273 . . . . 2.0099999999999998 112.281 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -52.46 -44.88 65.83 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.119 -1.04 . . . . 2.9300000000000002 111.921 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -63.31 -58.82 5.88 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.306 -0.958 . . . . 1.9099999999999999 110.794 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.85 -56.47 8.64 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.096 -0.642 . . . . 4.5899999999999999 109.429 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CG ' HG22 ' A' ' 62' ' ' ILE . 66.7 t80 -55.46 -45.46 76.91 Favored 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 115.184 -0.916 . . . . 1.01 109.455 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.68 -55.1 33.31 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.716 -0.794 . . . . 2.0899999999999999 110.334 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.73 63.89 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.722 -1.214 . . . . 1.8200000000000001 107.722 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.529 ' CE2' ' ND2' ' A' ' 82' ' ' ASN . 81.6 t90 -42.75 -58.8 2.19 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 115.556 -0.747 . . . . 1.8100000000000001 110.003 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 51.3 t -46.1 -23.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.275 -0.875 . . . . 2.1699999999999999 111.579 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.458 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -105.8 -67.96 0.9 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.531 0.52 . . . . 3.3900000000000001 110.769 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.51 -22.16 19.92 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.83 1.048 . . . . 4.6900000000000004 113.83 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' ND2' ' CE2' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -112.5 -31.99 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 114.302 1.223 . . . . 4.6200000000000001 114.302 -178.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 55.0 mt -96.87 -9.41 28.63 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 117.428 -1.709 . . . . 2.3700000000000001 111.088 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 108.357 -0.979 . . . . 3.5299999999999998 108.357 178.929 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 45.3 tpp . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.706 -1.22 . . . . 3.77 107.706 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.2 100.03 11.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.606 -1.257 . . . . 4.3799999999999999 107.606 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -87.84 120.88 29.6 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.408 -0.917 . . . . 1.9299999999999999 109.237 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.44 135.17 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-N 115.876 -0.602 . . . . 1.6799999999999999 109.44 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mm -118.79 111.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.691 1.245 . . . . 2.7799999999999998 109.375 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' A' ' 36' ' ' VAL . 47.7 m-85 -93.9 98.14 10.85 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.508 -0.477 . . . . 1.6100000000000001 110.443 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.85 -163.01 11.55 Favored Glycine 0 N--CA 1.512 3.738 0 C-N-CA 120.339 -0.934 . . . . 1.0600000000000001 111.123 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.554 ' NH1' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -129.47 18.61 5.82 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 119.167 -1.013 . . . . 7.7199999999999998 112.477 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.7 m 72.55 -58.04 0.61 Allowed 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 113.772 1.027 . . . . 3.1499999999999999 113.772 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.51 35.88 3.42 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 119.106 -1.521 . . . . 3.54 110.944 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.9 88.96 45.17 Favored Pre-proline 0 N--CA 1.491 1.599 0 C-N-CA 120.453 -0.499 . . . . 2.6600000000000001 110.046 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.36 -53.48 1.34 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.711 2.274 . . . . 3.1299999999999999 112.417 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -55.83 -49.58 72.88 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.769 -1.172 . . . . 4.2400000000000002 109.292 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 37.0 m -57.59 -39.27 76.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.226 -0.99 . . . . 2.5 109.538 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' ARG . 58.6 t -60.19 -53.92 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.931 -1.108 . . . . 2.3900000000000001 110.463 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tpm_? -35.83 -51.35 0.69 Allowed 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.09 0.472 . . . . 5.29 110.716 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.89 -48.22 3.08 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.696 -0.684 . . . . 1.5600000000000001 111.245 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 7.7 tmtt? -52.25 -41.25 62.66 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.543 -0.753 . . . . 3.6600000000000001 111.949 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 17.1 m-20 -53.12 -49.8 65.78 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 118.948 -1.101 . . . . 2.6299999999999999 110.087 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.29 -55.71 4.7 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.81 -1.541 . . . . 3.3500000000000001 108.387 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB2' ' CG ' ' A' ' 33' ' ' TYR . . . -60.18 -49.43 77.67 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.177 -1.829 . . . . 1.74 109.836 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.565 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 36.8 tt0 -45.74 -53.38 9.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.784 1.302 . . . . 4.2199999999999998 109.791 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 8.5 mmmm -56.89 -64.21 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.597 -0.729 . . . . 4.5 109.783 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -44.38 -56.89 3.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.947 -1.024 . . . . 2.1299999999999999 113.249 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 p -48.16 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.044 1.498 . . . . 2.6400000000000001 115.044 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -123.36 -36.07 2.86 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.117 0.484 . . . . 4.0300000000000002 110.432 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.486 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 80.8 mt-10 -74.19 -31.16 62.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.975 -1.011 . . . . 3.6600000000000001 110.424 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -109.52 -166.38 1.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.05 -0.66 . . . . 6.1699999999999999 110.256 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.423 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.1 p30 -96.8 -77.59 0.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.593 2.071 . . . . 4.5300000000000002 116.593 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' C ' ' A' ' 31' ' ' PHE . 8.7 t70 -74.12 -59.47 2.71 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.457 0.91 . . . . 4.1299999999999999 113.457 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' A' ' 30' ' ' ASP . 57.3 t80 0.06 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.528 1.307 . . . . 2.0499999999999998 114.528 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -106.07 159.43 16.08 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.607 -1.997 . . . . 4.8799999999999999 105.607 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 40.7 p90 -160.67 154.13 22.06 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.509 -1.276 . . . . 2.0899999999999999 110.828 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.2 133.61 28.29 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.039 -0.982 . . . . 3.9500000000000002 109.85 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.65 136.57 32.89 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.834 -2.284 . . . . 2.3399999999999999 104.834 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' CE2' ' A' ' 6' ' ' PHE . 1.6 t -126.79 147.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.87 -1.159 . . . . 1.72 107.87 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 1.5 t70 -122.15 135.61 54.81 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.027 -0.669 . . . . 2.27 110.688 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.42 -23.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.508 -1.277 . . . . 3.04 110.819 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -88.95 -3.57 58.7 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.724 -0.671 . . . . 6.5999999999999996 112.637 -178.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.53 -41.83 7.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.786 -1.19 . . . . 1.99 107.786 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -83.45 -39.45 20.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.151 -1.386 . . . . 2.8300000000000001 108.859 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.14 49.48 1.14 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.452 -1.859 . . . . 1.49 108.452 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 47' ' ' ASP . 74.4 mt -112.43 157.01 13.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 120.262 -0.575 . . . . 2.54 111.07 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 46' ' ' GLU . 15.3 p -110.92 -179.17 3.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.273 -1.01 . . . . 2.6600000000000001 108.273 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -85.87 46.67 1.34 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 106.462 -1.681 . . . . 6.1600000000000001 106.462 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 44' ' ' THR . 53.2 mt-10 -122.17 -61.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.577 -1.647 . . . . 4.0700000000000003 107.274 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . 0.471 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 16.7 t70 -49.75 -46.04 50.1 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 114.851 -1.068 . . . . 3.8199999999999998 109.534 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -52.79 -4.55 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.756 1.021 . . . . 2.7599999999999998 113.756 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' ASP . 1.1 mp0 -108.39 -53.17 2.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.234 -1.395 . . . . 6.0899999999999999 107.234 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -60.37 -33.13 72.01 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.031 0.92 . . . . 7.4100000000000001 110.745 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.451 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 1.8 ttpp -92.11 14.49 15.85 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.389 -1.278 . . . . 5.0899999999999999 109.344 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.667 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -123.24 -59.82 1.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.304 1.003 . . . . 2.1200000000000001 111.988 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.85 -20.35 48.28 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.179 -1.01 . . . . 2.4700000000000002 112.823 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -131.08 161.83 59.33 Favored Pre-proline 0 N--CA 1.506 2.342 0 C-N-CA 120.749 -0.38 . . . . 6.7199999999999998 111.971 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.437 ' CD ' ' HB2' ' A' ' 54' ' ' LYS . 55.4 Cg_exo -12.98 -147.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.109 1 C-N-CA 125.316 4.011 . . . . 7.1900000000000004 116.675 -123.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.7 -51.23 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.459 -1.246 . . . . 6.8899999999999997 110.896 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -79.87 -39.01 31.49 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.626 0.602 . . . . 6.6299999999999999 112.626 -179.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.422 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 5.7 t -31.57 144.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 115.728 1.751 . . . . 7.0199999999999996 115.728 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.83 159.49 31.54 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 106.887 -1.523 . . . . 3.9900000000000002 106.887 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -79.56 -179.57 26.79 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.934 -1.277 . . . . 2.0600000000000001 109.913 -17.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.485 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 13.5 mm-40 -104.98 125.42 50.94 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.029 -1.068 . . . . 3.5600000000000001 108.29 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.474 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 13.7 mm -105.66 137.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.809 -1.552 . . . . 2.48 106.809 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.451 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 78.0 m-85 -122.15 124.33 43.63 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.879 -1.156 . . . . 1.3799999999999999 107.879 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 29.3 t -98.38 111.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.641 -1.624 . . . . 2.1400000000000001 108.339 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 59.04 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.395 1.059 . . . . 2.6000000000000001 111.701 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.5 mm-40 -133.79 -8.84 2.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.906 0.706 . . . . 6.0300000000000002 112.906 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -103.78 153.08 21.11 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.233 0.924 . . . . 6.3399999999999999 111.251 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.667 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 14.9 t-80 -87.33 133.91 33.64 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.794 -1.187 . . . . 1.6499999999999999 107.794 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.449 HG13 HG21 ' A' ' 64' ' ' VAL . 8.7 mm -116.1 -29.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.163 -0.68 . . . . 2.2200000000000002 109.163 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 29.34 108.18 0.0 OUTLIER Glycine 1 N--CA 1.518 4.107 0 N-CA-C 116.433 1.333 . . . . 2.9300000000000002 116.433 178.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.52 121.63 2.8 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.347 -1.101 . . . . 2.6200000000000001 110.347 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -59.46 -45.06 92.71 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.989 -1.084 . . . . 2.2599999999999998 108.866 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -53.97 -54.28 41.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.293 -0.867 . . . . 2.1099999999999999 110.149 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -57.97 -55.22 37.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.703 -1.135 . . . . 2.6899999999999999 110.316 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CG ' HG22 ' A' ' 62' ' ' ILE . 42.3 t80 -55.04 -45.82 75.27 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.725 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 -59.2 5.35 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.09 -0.644 . . . . 1.6399999999999999 109.534 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -56.82 -61.52 2.38 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.698 -0.801 . . . . 1.49 109.212 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.403 ' CH2' HG12 ' A' ' 64' ' ' VAL . 62.1 t90 -39.82 -51.56 2.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.251 0.97 . . . . 1.76 109.814 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 81' ' ' GLU . 4.0 t -54.74 -51.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 1.8700000000000001 108.38 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -72.45 16.24 0.15 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.634 -1.166 . . . . 5.6399999999999997 112.087 -178.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 79' ' ' VAL . 86.0 mt-10 -127.98 -60.1 1.16 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.408 0.623 . . . . 3.8199999999999998 110.57 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -83.76 -14.94 50.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.593 -1.185 . . . . 2.02 112.89 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.21 4.87 46.84 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.325 -1.75 . . . . 2.1200000000000001 108.695 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 5.7 m-20 . . . . . 0 N--CA 1.485 1.279 0 O-C-N 125.505 1.753 . . . . 3.5 107.574 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 25.6 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.161 -0.681 . . . . 3.71 109.161 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -112.19 97.87 6.94 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.508 -0.923 . . . . 6.46 108.508 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -82.13 135.27 35.32 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.503 -1.226 . . . . 2.04 109.741 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -126.38 130.18 71.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.044 -1.465 . . . . 2.0699999999999998 107.044 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -104.85 128.59 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.982 -1.488 . . . . 2.5899999999999999 106.982 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.75 94.25 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.355 -1.35 . . . . 1.8999999999999999 107.355 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.75 -164.44 11.81 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.716 -2.154 . . . . 1.0 107.716 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 ptm180 -143.16 137.61 29.18 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 117.837 -1.545 . . . . 6.3399999999999999 111.787 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.445 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 61.6 m -53.02 125.05 15.95 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.224 -1.391 . . . . 4.4500000000000002 108.424 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 -35.97 2.99 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.031 -1.557 . . . . 4.7400000000000002 110.549 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 1.5 p -71.19 161.37 78.66 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 117.845 -1.542 . . . . 3.6600000000000001 108.563 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -98.95 -57.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.504 1.469 . . . . 3.4100000000000001 112.441 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -45.86 -32.14 2.48 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.955 0.724 . . . . 3.77 112.955 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -53.53 -31.39 46.1 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 118.004 -1.478 . . . . 2.4199999999999999 110.728 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 -47.58 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.033 -0.667 . . . . 2.2200000000000002 109.263 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.539 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -37.62 -48.64 1.05 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 124.554 1.159 . . . . 4.8700000000000001 112.994 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.62 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.306 -1.358 . . . . 1.6499999999999999 109.349 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 12.8 tmtt? -62.51 -53.0 61.26 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.414 -0.812 . . . . 3.0600000000000001 111.45 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.539 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.9 OUTLIER -52.18 -48.72 64.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 118.292 -1.363 . . . . 3.29 109.657 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 -62.23 1.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.199 0.937 . . . . 1.8500000000000001 110.87 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.87 -46.04 71.18 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.711 -1.195 . . . . 1.9399999999999999 110.417 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.544 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 39.7 tt0 -48.46 -65.02 0.64 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.545 -0.752 . . . . 2.7999999999999998 110.45 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 44.2 tttm -38.91 -60.43 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.148 0.905 . . . . 4.4299999999999997 112.638 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.3 mt -35.06 -45.12 0.26 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.913 1.449 . . . . 2.52 114.913 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.6 p -49.09 -38.85 25.88 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 124.118 0.887 . . . . 3.0299999999999998 110.505 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -102.64 23.71 11.6 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.644 -0.422 . . . . 3.8900000000000001 110.236 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -130.3 -44.04 1.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.685 -0.806 . . . . 4.0700000000000003 112.174 -178.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -107.3 -24.33 11.91 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.41 -1.316 . . . . 6.21 112.089 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 35.7 t70 84.23 -27.34 0.1 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 123.932 0.77 . . . . 4.96 111.809 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.59 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 10.5 p-10 -100.86 17.08 23.09 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 120.15 -0.62 . . . . 4.7300000000000004 111.038 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . 0.406 ' CG ' ' HB3' ' A' ' 24' ' ' LEU . 72.3 t80 -112.71 119.18 37.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.842 -1.143 . . . . 1.5600000000000001 112.097 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.31 148.39 43.23 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.212 -1.403 . . . . 3.5899999999999999 107.212 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 29.9 p90 -149.17 157.69 43.58 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.001 -1.08 . . . . 1.7 110.833 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -136.3 156.97 47.89 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.072 -1.455 . . . . 4.7599999999999998 107.072 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -108.22 144.64 35.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.74 -1.584 . . . . 1.8400000000000001 109.033 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.23 129.88 65.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.353 -0.98 . . . . 1.8700000000000001 108.353 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -108.83 115.99 31.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.268 -1.753 . . . . 2.48 106.268 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.2 -7.1 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 118.372 -1.331 . . . . 2.75 111.91 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -91.81 -9.75 42.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.815 -0.809 . . . . 5.8300000000000001 108.815 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.08 -44.16 6.4 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.012 -1.477 . . . . 2.1699999999999999 107.012 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -74.22 -41.5 61.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.143 -1.428 . . . . 2.9199999999999999 107.143 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.79 55.33 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.937 -1.665 . . . . 1.3200000000000001 108.937 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.29 154.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 120.163 -0.615 . . . . 1.97 110.1 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.4 151.63 34.34 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.376 -0.829 . . . . 3.02 109.251 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 56' ' ' VAL . 19.0 mtpp -55.68 -50.56 69.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.159 -1.416 . . . . 6.6699999999999999 108.226 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -39.94 -63.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.526 1.141 . . . . 4.0999999999999996 110.403 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -55.74 8.68 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.62 0.724 . . . . 5.1100000000000003 111.3 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.87 -40.57 56.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.157 -0.929 . . . . 3.3799999999999999 110.919 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.468 ' NE2' ' HD3' ' A' ' 54' ' ' LYS . 10.9 mm100 -40.87 -40.99 1.49 Allowed 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 119.782 -0.767 . . . . 5.9900000000000002 109.963 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.008 -0.996 . . . . 5.5700000000000003 112.436 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.54 -29.8 22.4 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.385 1.254 . . . . 4.9400000000000004 114.385 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.614 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -98.73 -32.76 11.22 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.62 -0.832 . . . . 3.0600000000000001 112.273 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.15 51.24 46.02 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 120.157 -1.021 . . . . 3.9199999999999999 112.422 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HD3' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -110.04 -179.78 0.71 Allowed Pre-proline 0 N--CA 1.507 2.385 0 C-N-CA 119.407 -0.917 . . . . 9.0899999999999999 109.591 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.79 170.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.264 1.976 . . . . 7.8700000000000001 111.11 148.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.1 m -89.92 -60.58 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.179 -1.408 . . . . 8.0 110.589 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -39.53 -69.66 0.12 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 124.506 1.129 . . . . 8.1300000000000008 109.205 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -15.47 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.386 1.679 . . . . 6.3499999999999996 113.929 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -144.63 158.26 53.89 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 106.551 -1.648 . . . . 4.4900000000000002 106.551 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 59' ' ' VAL . 10.2 Cg_endo -84.34 -163.27 2.97 Favored 'Cis proline' 0 N--CA 1.483 0.868 0 N-CA-C 109.26 -1.092 . . . . 2.2999999999999998 109.26 -10.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 61' ' ' GLN . 1.2 mm100 -133.75 151.9 51.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.877 -1.529 . . . . 4.4000000000000004 109.914 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . 0.473 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 3.7 mp -119.71 145.8 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.939 -1.134 . . . . 2.3900000000000001 107.939 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -133.47 128.63 35.83 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.72 -1.582 . . . . 1.3500000000000001 107.152 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 65' ' ' ASP . 50.5 t -106.91 -166.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.402 -1.703 . . . . 2.0299999999999998 106.402 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.555 ' H ' HG13 ' A' ' 64' ' ' VAL . 2.9 m-20 -46.47 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 123.711 1.719 . . . . 3.8100000000000001 112.916 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' VAL . 81.1 mt-30 51.82 35.65 16.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 110.242 -3.163 . . . . 5.6100000000000003 113.368 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -137.53 136.44 37.65 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.0 -0.68 . . . . 5.5999999999999996 111.555 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 10.0 t-160 -79.64 141.54 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 105.377 -2.082 . . . . 1.5 105.377 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.492 HG13 HG21 ' A' ' 64' ' ' VAL . 11.2 mm -107.76 -50.59 7.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 C-N-CA 119.109 -1.036 . . . . 2.3999999999999999 110.32 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.14 -140.57 9.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.2 -1.56 . . . . 1.6699999999999999 109.2 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 62' ' ' ILE . . . -101.76 -54.62 0.92 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 120.407 -0.902 . . . . 2.6099999999999999 112.297 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 15.3 t80 -159.05 -62.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.037 -1.465 . . . . 2.8399999999999999 109.573 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -44.82 -40.43 6.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.606 1.669 . . . . 2.02 107.306 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.08 -53.97 50.49 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 111.579 -2.555 . . . . 2.6200000000000001 109.988 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -61.87 -38.55 88.72 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 117.615 -1.634 . . . . 1.25 108.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.12 -54.63 32.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.724 -1.213 . . . . 1.98 107.724 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.59 -51.37 70.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.468 -0.893 . . . . 2.1000000000000001 109.51 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CZ2' HG12 ' A' ' 64' ' ' VAL . 71.0 t90 -46.55 -48.1 19.54 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.756 -0.831 . . . . 2.4399999999999999 108.756 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.28 -51.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.653 -1.61 . . . . 2.3100000000000001 106.653 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -82.14 33.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.316 -0.954 . . . . 3.6699999999999999 110.547 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -133.29 -49.48 0.85 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.657 0.741 . . . . 7.1900000000000004 109.337 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -102.73 -15.64 16.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.31 -1.313 . . . . 2.7599999999999998 111.72 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 29.9 mt -107.45 1.96 23.92 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 117.824 -1.551 . . . . 2.6000000000000001 112.483 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 10.3 p-10 . . . . . 0 N--CA 1.503 2.217 0 C-N-CA 117.692 -1.603 . . . . 5.2400000000000002 107.487 177.622 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.071 -1.455 . . . . 2.6600000000000001 107.071 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 2.3 mp0 -110.05 105.31 14.39 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.905 -1.118 . . . . 4.7999999999999998 110.131 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 m -87.85 146.2 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.83 -1.148 . . . . 1.98 111.24 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.6 t -120.5 136.57 57.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 1.55 107.075 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -113.72 108.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.511 -0.922 . . . . 2.4900000000000002 108.511 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 61' ' ' GLN . 48.7 m-85 -94.5 103.9 15.86 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.752 -0.833 . . . . 1.21 108.752 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.21 -161.54 10.87 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 107.893 -2.083 . . . . 1.25 107.893 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.704 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.82 31.2 5.53 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.164 -1.415 . . . . 6.0300000000000002 112.869 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.613 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.1 m 67.55 174.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.13 -0.941 . . . . 3.5899999999999999 109.948 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 13.47 51.78 0.01 OUTLIER Glycine 0 N--CA 1.511 3.648 0 N-CA-C 116.0 1.16 . . . . 3.3900000000000001 116.0 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.704 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -130.7 101.85 16.81 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.682 -1.229 . . . . 2.2400000000000002 107.682 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -41.4 -47.02 5.76 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.751 1.634 . . . . 4.0199999999999996 110.644 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -57.12 -44.7 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.147 -1.021 . . . . 3.21 109.423 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.76 -51.19 69.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.735 -1.209 . . . . 1.8 107.735 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' LYS . 96.6 t -43.7 -48.81 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 114.516 -1.22 . . . . 1.9299999999999999 111.122 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.413 ' NH1' ' CD1' ' A' ' 72' ' ' TYR . 18.7 mtm180 -35.82 -39.23 0.15 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 120.057 -0.657 . . . . 8.3499999999999996 112.042 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.22 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.917 -0.771 . . . . 2.0800000000000001 108.917 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 8.5 tmtt? -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.675 -1.232 . . . . 3.79 107.675 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 60.7 m-20 -58.13 -54.65 44.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.394 -0.922 . . . . 3.1400000000000001 109.377 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.15 -59.25 4.9 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.604 -1.238 . . . . 1.8999999999999999 110.31 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -53.26 -44.56 68.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.886 -0.726 . . . . 1.8799999999999999 110.56 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.52 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 40.8 tt0 -55.7 -57.05 13.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.272 0.983 . . . . 2.9399999999999999 109.666 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.93 -54.34 47.77 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.747 -0.66 . . . . 5.3399999999999999 111.202 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 26' ' ' ASN . 79.7 mt -48.35 -57.27 6.27 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.584 -0.846 . . . . 2.7999999999999998 111.678 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -35.0 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 114.039 1.125 . . . . 1.8600000000000001 114.039 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 24' ' ' LEU . 9.2 t30 -104.1 -50.25 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.932 -0.766 . . . . 5.3399999999999999 108.932 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.37 40.52 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.837 -1.074 . . . . 4.0700000000000003 111.258 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -147.76 -150.43 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.944 -1.102 . . . . 5.7999999999999998 112.196 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 28' ' ' ARG . 4.1 m-20 -111.82 -127.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.008 -0.996 . . . . 6.7800000000000002 110.188 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.4 67.21 5.08 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.662 -1.236 . . . . 3.8500000000000001 107.662 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -112.59 114.56 27.26 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.918 -1.037 . . . . 1.23 111.565 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -120.22 158.83 26.17 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.773 -1.936 . . . . 4.29 105.773 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 16.3 p90 -160.58 152.79 20.35 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 117.804 -1.559 . . . . 1.4099999999999999 112.932 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -131.07 164.06 26.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.459 -1.246 . . . . 4.5099999999999998 108.347 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -113.14 143.2 44.77 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.767 -1.197 . . . . 2.0899999999999999 107.767 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -132.83 143.85 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.381 -0.97 . . . . 1.6799999999999999 108.381 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.95 129.66 55.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.258 0.551 . . . . 2.1600000000000001 109.805 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -58.45 -24.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.192 -1.003 . . . . 2.1099999999999999 110.933 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.58 ' NH1' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.23 -34.17 25.92 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.955 -1.098 . . . . 5.2199999999999998 109.645 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.51 -45.18 88.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.824 -0.625 . . . . 1.9399999999999999 110.193 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.34 -43.66 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.091 -1.043 . . . . 2.9300000000000002 110.075 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.76 54.66 0.72 Allowed Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.736 -1.745 . . . . 1.5900000000000001 108.736 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.5 mt -115.74 158.5 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.91 -0.645 . . . . 2.23 110.399 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.4 p -117.6 171.09 8.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.022 -0.733 . . . . 2.9100000000000001 109.022 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 7.9 tmtm? -69.37 -43.08 74.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.885 -1.526 . . . . 7.8200000000000003 108.699 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.1 mp0 -56.15 -51.07 69.32 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.072 -0.714 . . . . 3.9700000000000002 109.072 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.44 -51.56 62.25 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.92 -1.112 . . . . 3.0499999999999998 109.098 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ALA . 55.7 mt -52.97 -51.67 60.72 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.44 -1.304 . . . . 2.6200000000000001 107.682 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.1 tm0? -46.16 -48.14 17.49 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.935 0.772 . . . . 5.3499999999999996 109.894 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -59.95 -40.6 89.56 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.641 0.734 . . . . 7.75 109.034 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG3' ' HZ1' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.786 -1.097 . . . . 5.5999999999999996 111.525 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -94.19 -50.17 5.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.504 0.557 . . . . 2.1400000000000001 112.504 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.5 15.02 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.703 -1.237 . . . . 2.7200000000000002 111.545 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 19.3 ptmt -110.8 74.35 0.93 Allowed Pre-proline 0 N--CA 1.5 2.07 0 C-N-CA 120.28 -0.568 . . . . 6.9299999999999997 111.367 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.0 140.23 40.0 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.581 1.521 . . . . 4.75 111.616 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.8 t 76.18 60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.394 1.058 . . . . 6.3899999999999997 110.202 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -110.22 -176.04 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.621 -1.172 . . . . 6.6100000000000003 108.057 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.533 ' CG2' ' H ' ' A' ' 72' ' ' TYR . 12.2 t -100.93 -161.84 0.89 Allowed 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.283 -1.367 . . . . 8.75 108.357 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.3 t -105.9 162.82 18.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 121.506 0.669 . . . . 5.1900000000000004 110.325 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.56 -166.47 5.16 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 124.336 -1.11 . . . . 3.71 109.293 -29.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.32 119.0 34.02 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.878 -1.527 . . . . 3.25 106.878 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.46 134.01 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.806 -1.158 . . . . 2.9500000000000002 109.324 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 68' ' ' HIS . 2.8 m-85 -118.14 114.14 22.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 105.35 -2.093 . . . . 2.1099999999999999 105.35 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.57 HG12 ' CH2' ' A' ' 78' ' ' TRP . 53.2 t -96.86 110.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 117.188 -1.805 . . . . 1.9399999999999999 111.19 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t70 61.32 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.594 0.961 . . . . 2.5099999999999998 113.594 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' VAL . 11.8 mm-40 -130.53 -18.56 3.15 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.117 1.155 . . . . 5.21 114.117 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.46 156.7 19.16 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.741 -1.184 . . . . 5.7000000000000002 111.285 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.604 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 39.2 t-80 -87.53 141.36 28.68 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.803 -1.159 . . . . 1.8200000000000001 109.71 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 64' ' ' VAL . 8.7 mm -114.18 -54.85 4.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.005 -1.48 . . . . 1.8899999999999999 107.005 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 68' ' ' HIS . . . 58.65 123.22 0.01 OUTLIER Glycine 0 N--CA 1.501 3.003 0 O-C-N 124.493 1.121 . . . . 3.0499999999999998 113.6 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.23 141.12 10.89 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.875 -1.155 . . . . 2.79 112.57 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.533 ' H ' ' CG2' ' A' ' 58' ' ' THR . 20.2 t80 -82.97 -54.5 5.02 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.458 -0.897 . . . . 3.1800000000000002 109.211 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -67.65 1.82 2.22 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.162 -1.015 . . . . 2.7200000000000002 108.939 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 72' ' ' TYR . 15.2 t70 -100.53 -63.6 1.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.927 -1.508 . . . . 3.1000000000000001 106.927 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -55.58 -45.61 77.35 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.257 -0.883 . . . . 0.95999999999999996 108.936 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.92 -38.61 10.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.109 -0.496 . . . . 1.6699999999999999 110.39 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -81.05 -50.77 9.25 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.6 -1.259 . . . . 2.1499999999999999 107.6 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . 0.57 ' CH2' HG12 ' A' ' 64' ' ' VAL . 76.6 t90 -38.62 -53.23 1.62 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.125 0.89 . . . . 1.6399999999999999 108.712 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.6 t -44.02 -46.42 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.324 -1.307 . . . . 2.0299999999999998 110.505 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.28 -58.57 3.22 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.914 -0.714 . . . . 4.4699999999999998 111.707 -178.83 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -57.4 -24.69 56.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.122 0.786 . . . . 3.7400000000000002 113.122 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -101.02 -34.26 9.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.355 1.243 . . . . 2.1299999999999999 114.355 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.8 mt -96.04 -11.63 26.12 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.328 -1.349 . . . . 2.04 111.677 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.478 ' CG ' HH12 ' A' ' 28' ' ' ARG . 36.3 m-20 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 124.287 0.992 . . . . 3.7400000000000002 109.967 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.9 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.929 -0.767 . . . . 4.1399999999999997 108.929 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -110.11 98.18 7.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.723 -1.584 . . . . 4.9299999999999997 106.723 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 33' ' ' TYR . 86.6 m -82.17 141.3 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.383 -0.927 . . . . 1.8300000000000001 111.939 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -133.86 138.78 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.569 -0.741 . . . . 1.46 110.096 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.79 123.28 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 105.28 -2.119 . . . . 2.7400000000000002 105.28 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 36' ' ' VAL . 58.2 m-85 -104.07 78.45 1.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.048 -1.093 . . . . 1.3200000000000001 108.048 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.6 -151.06 9.49 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.514 -1.327 . . . . 1.0 110.739 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HD2' ' H ' ' A' ' 9' ' ' SER . 2.7 tmm_? -119.47 -178.32 3.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.343 -0.984 . . . . 6.3899999999999997 108.343 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.513 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.44 59.45 0.29 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.037 0.384 . . . . 3.6299999999999999 112.037 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.3 71.26 0.84 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.159 -1.496 . . . . 3.52 112.197 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -129.21 149.82 73.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.925 -0.71 . . . . 2.2200000000000002 109.687 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.48 -65.67 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.303 2.002 . . . . 4.4800000000000004 113.206 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -78.01 15.86 0.83 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 119.104 -1.038 . . . . 4.1200000000000001 112.897 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 36.1 m -107.16 -48.78 3.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.624 -1.621 . . . . 2.1200000000000001 106.624 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 17' ' ' ALA . 50.1 t -73.96 -38.3 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.947 -1.479 . . . . 2.29 108.529 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -80.09 38.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.174 0.987 . . . . 4.6799999999999997 109.391 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -142.21 -49.56 0.37 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.073 -1.825 . . . . 1.96 106.073 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HZ1' ' CD ' ' A' ' 22' ' ' GLU . 50.9 tttm -57.59 -38.88 75.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.904 -1.498 . . . . 4.1500000000000004 110.081 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -43.55 -47.42 7.34 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.376 0.608 . . . . 4.6500000000000004 110.448 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.24 -42.85 96.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.409 -0.814 . . . . 2.4300000000000002 110.156 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -63.65 -57.91 8.58 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.332 -0.947 . . . . 2.0 109.251 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . 0.665 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 47.8 mt-10 -51.44 -51.56 53.86 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.805 0.812 . . . . 3.6200000000000001 109.262 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -53.96 -59.21 4.93 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.937 -1.029 . . . . 5.1900000000000004 109.928 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 24' ' ' LEU . 7.4 mt -51.79 -53.17 42.97 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.528 -1.269 . . . . 2.7999999999999998 110.888 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -52.99 -32.12 44.63 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.061 -1.056 . . . . 2.6600000000000001 111.76 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -83.37 -37.18 23.67 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.887 -0.725 . . . . 4.2199999999999998 111.059 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -74.39 -40.06 62.31 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 122.071 0.939 . . . . 2.8999999999999999 110.336 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.543 HH21 ' CG ' ' A' ' 30' ' ' ASP . 9.1 mmm180 -99.62 179.3 4.59 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.113 -1.403 . . . . 8.3000000000000007 111.418 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ASP . . . . . 0.413 ' CG ' HH22 ' A' ' 28' ' ' ARG . 2.0 p30 -122.3 -12.79 8.2 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.772 -1.104 . . . . 4.2300000000000004 110.843 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ASP . . . . . 0.543 ' CG ' HH21 ' A' ' 28' ' ' ARG . 14.5 p30 -103.63 -46.14 4.62 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.7 1.0 . . . . 4.5199999999999996 113.7 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -48.39 110.39 0.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 113.502 0.927 . . . . 1.47 113.502 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.573 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 2.3 tm0? -103.35 156.16 17.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.493 -0.929 . . . . 6.71 108.493 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.573 ' H ' ' NE2' ' A' ' 32' ' ' GLN . 1.6 p90 -164.09 156.74 17.44 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.489 -0.884 . . . . 1.6000000000000001 111.218 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -139.23 152.44 47.32 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.606 -1.179 . . . . 4.0899999999999999 108.772 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -107.47 138.6 43.38 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.145 -1.422 . . . . 1.46 107.593 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -124.59 143.52 37.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 124.204 0.94 . . . . 1.8899999999999999 108.7 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -117.23 118.33 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.853 -1.536 . . . . 2.4700000000000002 106.853 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -53.09 -19.27 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.654 -0.818 . . . . 2.1899999999999999 110.985 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.77 -37.89 55.08 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.593 0.558 . . . . 6.79 111.445 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 -43.43 55.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.908 -0.717 . . . . 2.6299999999999999 109.298 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.27 -43.22 52.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.169 -0.923 . . . . 3.3599999999999999 109.33 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.06 60.29 1.13 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.305 -1.918 . . . . 1.4399999999999999 108.305 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -114.52 160.75 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 C-N-CA 119.458 -0.897 . . . . 4.2199999999999998 112.346 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.33 151.29 40.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.63 -1.168 . . . . 2.5800000000000001 109.772 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . 0.517 ' HE2' ' N ' ' A' ' 46' ' ' GLU . 4.1 ttpt -56.69 -46.61 81.09 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.656 -1.218 . . . . 5.5199999999999996 109.746 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . 0.517 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 23.8 mm-40 -45.06 -56.85 4.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.284 -0.566 . . . . 4.3399999999999999 110.159 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.56 -56.34 22.57 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.825 0.821 . . . . 4.3700000000000001 110.281 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 61' ' ' GLN . 21.7 mt -46.97 -46.85 21.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.112 -0.949 . . . . 2.54 110.39 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 25.8 tt0 -52.56 -50.32 63.18 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.72 -1.127 . . . . 4.2599999999999998 109.561 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -52.45 -32.17 38.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.878 0.847 . . . . 6.8300000000000001 110.301 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' LYS . . . . . 0.665 ' HZ1' ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.98 19.46 17.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.294 -1.321 . . . . 5.0499999999999998 111.139 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.593 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -113.15 -41.08 3.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.826 0.703 . . . . 2.5499999999999998 110.569 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.02 -55.4 0.51 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.45 -1.86 . . . . 2.4399999999999999 108.45 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 31.3 tttm -92.03 151.98 42.38 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.574 -1.269 . . . . 8.3399999999999999 107.574 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.438 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 30.3 Cg_exo -61.23 75.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.543 1.495 . . . . 5.3300000000000001 110.684 158.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.38 82.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.032 0.92 . . . . 7.71 108.527 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -50.3 -31.66 14.96 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.082 -1.417 . . . . 6.3600000000000003 111.57 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -94.61 169.05 10.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.682 -0.69 . . . . 5.6200000000000001 110.763 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -116.4 166.0 13.65 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.454 -1.313 . . . . 3.4500000000000002 107.454 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 76.6 Cg_endo -92.86 -151.08 0.33 Allowed 'Cis proline' 0 C--N 1.312 -1.355 0 N-CA-C 109.592 -0.965 . . . . 2.96 109.592 -17.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' HB3' ' A' ' 48' ' ' LEU . 24.9 mt-30 -123.66 154.48 39.3 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.499 -0.926 . . . . 5.29 108.499 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.04 142.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.269 -1.332 . . . . 2.4100000000000001 107.926 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.2 122.58 21.82 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.377 -1.342 . . . . 1.27 107.377 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . 0.41 HG11 ' OG1' ' A' ' 3' ' ' THR . 60.4 t -106.71 97.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 117.77 -1.572 . . . . 2.54 109.424 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 1' ' ' MET . 17.5 t0 80.49 -64.82 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.869 -1.059 . . . . 2.5099999999999998 113.011 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -140.92 -29.65 0.66 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.258 1.947 . . . . 6.5899999999999999 116.258 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -174.96 2.82 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.938 -1.105 . . . . 5.4500000000000002 111.736 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 11.9 t-160 -103.41 138.66 39.84 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.779 -1.193 . . . . 1.9399999999999999 107.779 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.2 mm -122.85 -40.73 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 124.061 0.851 . . . . 2.8399999999999999 109.872 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.02 -176.15 0.18 Allowed Glycine 0 N--CA 1.509 3.522 0 CA-C-O 122.085 0.825 . . . . 3.3500000000000001 115.153 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.02 -160.39 0.01 OUTLIER Glycine 0 N--CA 1.508 3.437 0 CA-C-N 113.857 -1.172 . . . . 2.6800000000000002 113.89 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 16' ' ' ARG . 33.4 t80 -121.51 -58.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.121 -1.066 . . . . 2.46 108.121 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 p -39.46 -47.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.246 1.022 . . . . 2.6099999999999999 110.061 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -63.04 1.2 Allowed 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 112.535 -2.12 . . . . 3.25 108.67 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.3 -49.51 9.39 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 119.231 -0.988 . . . . 1.71 109.988 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.08 -65.76 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.68 -1.145 . . . . 2.1600000000000001 111.813 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.95 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -44.95 -56.28 4.73 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.65 -1.159 . . . . 1.5700000000000001 109.502 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.93 -60.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.944 -1.132 . . . . 2.23 107.944 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -47.05 -46.75 22.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.3 1.0 . . . . 3.6400000000000001 111.095 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.11 21.05 8.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.243 1.201 . . . . 5.21 114.243 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -130.33 -32.96 1.73 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.866 -0.733 . . . . 2.1899999999999999 109.835 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.1 mt -96.21 32.62 1.91 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.349 -1.34 . . . . 2.2000000000000002 111.786 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 108.969 -0.752 . . . . 5.3200000000000003 108.969 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.548 ' N ' ' O ' ' A' ' 30' ' ' ASP . 74.9 mtp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 107.961 -1.125 . . . . 2.96 107.961 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.467 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 42.7 tp60 -123.64 146.96 47.81 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.745 0.653 . . . . 5.9699999999999998 110.365 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -128.56 154.54 46.07 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.088 -1.045 . . . . 1.97 109.159 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -134.19 128.72 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.648 -1.241 . . . . 1.96 107.648 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mt -111.35 120.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.107 -1.071 . . . . 3.9399999999999999 108.107 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.91 74.26 1.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.882 -1.155 . . . . 1.3100000000000001 107.882 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -147.03 -173.15 17.99 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.114 -1.517 . . . . 2.2000000000000002 109.724 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.489 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 18.4 mtp-105 -123.11 154.7 38.26 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.045 -1.062 . . . . 7.0999999999999996 109.631 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -72.23 77.0 0.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.438 -0.905 . . . . 5.5300000000000002 111.296 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.35 21.5 0.17 Allowed Glycine 0 N--CA 1.502 3.045 0 C-N-CA 119.388 -1.387 . . . . 3.5600000000000001 113.101 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.489 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -121.99 80.57 42.64 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.048 -0.723 . . . . 3.1000000000000001 109.048 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -18.73 -69.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 124.194 3.262 . . . . 3.52 114.285 -143.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.435 ' HB2' ' CD ' ' A' ' 60' ' ' PRO . 3.8 m-30 -34.2 -45.04 0.2 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 123.363 0.414 . . . . 5.04 112.096 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.701 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 57.7 m -52.35 -55.94 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.972 -1.013 . . . . 2.0299999999999998 109.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.25 -45.78 88.99 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 CA-C-N 114.109 -1.405 . . . . 2.1899999999999999 108.101 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.632 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 1.7 mmp_? -55.84 -51.83 66.15 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.666 -0.814 . . . . 4.7400000000000002 112.255 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.17 -50.07 65.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.089 -1.448 . . . . 1.75 107.089 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.56 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 3.0 tmtm? -53.88 -55.12 29.72 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.981 -1.009 . . . . 2.5499999999999998 109.315 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.56 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.9 m-20 -47.8 -56.86 6.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.18 0.514 . . . . 2.8999999999999999 109.617 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.452 HD22 ' CD2' ' A' ' 75' ' ' PHE . 29.8 tp -55.35 -57.13 13.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.989 -1.005 . . . . 2.1200000000000001 111.472 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -54.39 44.64 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.903 . . . . 1.6699999999999999 109.579 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 12.5 tt0 -47.59 -47.56 28.53 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.515 -0.92 . . . . 2.2599999999999998 108.515 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.591 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -53.3 -64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.179 0.925 . . . . 5.4400000000000004 110.5 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -38.55 -47.0 1.25 Allowed 'General case' 0 N--CA 1.506 2.348 0 O-C-N 123.92 0.763 . . . . 2.2599999999999998 112.835 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -39.06 -36.0 0.26 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.335 0.865 . . . . 2.1099999999999999 113.335 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -97.66 12.6 33.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.046 1.128 . . . . 3.2599999999999998 114.046 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.591 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 19.3 mt-10 -131.9 -30.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 123.87 0.732 . . . . 3.5699999999999998 110.942 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -99.12 -24.15 14.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.954 0.724 . . . . 4.7199999999999998 112.954 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.04 -62.59 0.42 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.071 0.857 . . . . 4.7000000000000002 110.565 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 1' ' ' MET . 10.6 t70 -82.45 55.85 3.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.814 -1.55 . . . . 3.4300000000000002 106.814 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -140.83 91.94 2.46 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.225 -0.898 . . . . 1.79 109.968 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.467 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 13.6 mm-40 -110.02 128.24 55.29 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.985 -1.487 . . . . 5.0499999999999998 106.985 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -111.14 160.56 16.8 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.096 -1.041 . . . . 1.4199999999999999 110.594 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -123.97 146.64 48.36 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.372 -1.344 . . . . 3.6800000000000002 107.372 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -102.09 132.11 48.16 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.993 -1.083 . . . . 3.0099999999999998 108.378 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 135.27 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.335 -1.357 . . . . 1.6599999999999999 107.335 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.4 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 34.3 t0 -110.44 111.39 22.62 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 122.23 1.014 . . . . 1.73 109.905 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 pt -48.7 -32.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.25 -1.341 . . . . 2.8999999999999999 114.035 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.483 ' HA ' ' NE ' ' A' ' 39' ' ' ARG . 2.7 mmp_? -101.46 19.32 18.09 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.699 -0.8 . . . . 10.390000000000001 111.714 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -122.73 -43.68 2.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.682 -1.229 . . . . 2.6699999999999999 107.682 179.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.52 -45.32 46.54 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.375 -1.738 . . . . 2.8799999999999999 110.429 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.59 63.49 0.34 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.746 -1.216 . . . . 1.6799999999999999 112.693 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 55.2 mt -111.6 145.6 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.769 -0.772 . . . . 2.7400000000000002 109.289 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -116.93 -97.56 0.46 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.939 -0.704 . . . . 3.02 110.203 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.461 ' HZ1' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -137.6 -50.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.78 -1.933 . . . . 8.8900000000000006 105.78 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.461 ' CD ' ' HZ1' ' A' ' 45' ' ' LYS . 3.8 mp0 -51.29 -50.17 59.83 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 113.679 -1.601 . . . . 5.5899999999999999 108.894 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.8 m-20 -46.44 -64.34 0.78 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.102 0.953 . . . . 3.5899999999999999 109.329 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 81.1 mt -49.93 -50.94 44.65 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.21 -1.359 . . . . 3.3500000000000001 110.044 -179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -56.15 -36.55 68.42 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.168 -1.413 . . . . 5.2699999999999996 110.749 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.63 -39.43 57.83 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.278 0.561 . . . . 7.4900000000000002 112.064 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.625 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 1.7 ttpp -87.37 -28.79 21.98 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 114.575 1.324 . . . . 6.0199999999999996 114.575 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.579 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -118.19 -35.7 3.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.838 0.711 . . . . 3.04 112.689 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.9 -44.57 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.075 -2.81 . . . . 3.8700000000000001 106.075 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.453 ' NZ ' ' HG3' ' A' ' 57' ' ' GLU . 9.1 tttp 53.21 102.77 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 113.297 -1.451 . . . . 10.949999999999999 112.656 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -51.07 179.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.214 1.943 . . . . 6.2699999999999996 110.327 143.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.95 59.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.571 -1.252 . . . . 6.9500000000000002 110.358 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.453 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 15.6 pt-20 -103.51 178.81 4.45 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.654 -1.612 . . . . 5.6600000000000001 107.549 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -116.42 -106.32 0.39 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.356 -1.338 . . . . 7.04 109.193 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.29 154.64 78.84 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 123.964 0.79 . . . . 4.6100000000000003 109.83 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.701 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 48.6 Cg_endo -96.74 -164.95 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.507 0.741 . . . . 2.2599999999999998 110.452 -1.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -147.78 163.74 35.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.19 0.931 . . . . 3.4100000000000001 108.64 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.536 HG22 ' CD1' ' A' ' 75' ' ' PHE . 3.1 mp -121.32 151.18 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 122.302 1.048 . . . . 2.1000000000000001 111.787 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.625 ' CZ ' ' HE3' ' A' ' 51' ' ' LYS . 9.4 m-85 -133.31 130.94 39.56 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.764 -2.016 . . . . 1.5600000000000001 108.726 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.411 HG21 HG13 ' A' ' 69' ' ' ILE . 66.8 t -121.62 129.77 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.778 -1.564 . . . . 2.0499999999999998 106.778 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.43 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 5.1 m-20 51.47 25.32 2.61 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.698 1.237 . . . . 2.77 112.276 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.43 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 2.4 mm100 79.49 -6.36 1.83 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 112.216 -2.266 . . . . 8.2799999999999994 114.559 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.84 154.96 23.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.963 -1.865 . . . . 5.3399999999999999 105.963 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.579 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 17.3 t-160 -83.16 147.52 28.01 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 117.469 -1.692 . . . . 1.5700000000000001 109.492 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.411 HG13 HG21 ' A' ' 64' ' ' VAL . 16.8 mm -116.63 -35.7 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 124.294 0.996 . . . . 1.8400000000000001 109.154 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.16 -139.76 9.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.754 -1.212 . . . . 1.9399999999999999 110.301 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.15 -65.75 0.85 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.577 -1.009 . . . . 2.7999999999999998 110.577 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.572 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 66.5 t80 -157.75 -53.78 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.26 -1.376 . . . . 2.27 110.677 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -46.68 -47.62 20.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.356 -1.35 . . . . 2.5899999999999999 107.356 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.44 -59.36 4.68 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.25 -1.795 . . . . 3.27 109.602 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.536 ' CD1' HG22 ' A' ' 62' ' ' ILE . 38.6 t80 -51.78 -47.64 64.1 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.442 -0.903 . . . . 0.98999999999999999 109.224 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -59.37 4.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.315 -0.954 . . . . 1.71 109.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.31 -0.859 . . . . 2.27 109.564 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -40.49 -48.89 2.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.006 0.816 . . . . 1.29 110.13 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 80' ' ' LYS . 9.9 t -60.5 -59.2 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.328 -0.99 . . . . 2.1899999999999999 108.328 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -41.27 -49.65 3.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.882 -1.054 . . . . 4.5 109.925 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.96 -55.68 7.84 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 116.41 2.004 . . . . 3.8100000000000001 116.41 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -83.54 -20.11 34.46 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 113.948 1.092 . . . . 2.0600000000000001 113.948 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.69 -37.31 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 117.997 -1.481 . . . . 2.6499999999999999 113.24 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 63.5 m-20 -118.96 20.31 12.79 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.071 -1.452 . . . . 5.7999999999999998 112.738 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.523 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.507 2.418 0 CA-C-O 115.991 -1.957 . . . . 6.9100000000000001 111.663 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 30' ' ' ASP . 36.5 mtm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.0 -1.481 . . . . 3.1299999999999999 107.0 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -124.57 143.37 50.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.733 -0.787 . . . . 5.8099999999999996 110.008 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 61.4 m -125.19 145.11 50.12 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.08 -1.048 . . . . 1.74 113.282 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.8 136.79 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.949 -1.13 . . . . 1.54 107.949 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -118.09 122.03 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 124.226 0.954 . . . . 3.4399999999999999 109.727 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -93.66 87.21 5.41 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.618 -1.253 . . . . 1.3799999999999999 107.618 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.89 -164.29 14.51 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.529 -1.428 . . . . 1.1899999999999999 109.529 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.682 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -128.11 -158.7 0.89 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 117.98 0.89 . . . . 6.6799999999999997 109.655 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.51 ' H ' ' CG ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -101.91 61.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.66 -0.867 . . . . 3.8100000000000001 108.66 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.67 92.32 2.26 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.048 -2.021 . . . . 2.8199999999999998 108.048 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.682 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -155.27 63.63 3.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 120.311 -0.556 . . . . 2.3500000000000001 110.224 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -20.42 -55.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 124.044 3.162 . . . . 2.7000000000000002 114.001 -145.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' CYS . 4.3 m-85 -42.69 -44.94 4.52 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.246 -0.582 . . . . 4.8399999999999999 111.668 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -57.14 -46.12 82.97 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.538 -0.865 . . . . 2.3999999999999999 111.046 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.0 t -55.8 -43.17 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 115.643 -0.708 . . . . 1.8300000000000001 110.916 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.659 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -47.27 -48.98 24.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.645 -1.222 . . . . 4.6799999999999997 112.583 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.07 -45.91 68.35 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.128 -1.029 . . . . 1.72 108.864 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.493 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 0.3 OUTLIER -58.5 -50.81 72.41 Favored 'General case' 0 C--O 1.2 -1.512 0 C-N-CA 119.277 -0.969 . . . . 3.4700000000000002 108.404 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.458 ' HA ' ' HZ1' ' A' ' 18' ' ' LYS . 66.1 m-20 -49.67 -48.4 49.54 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.447 -1.301 . . . . 2.98 110.055 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.14 -65.84 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.396 -1.322 . . . . 1.8899999999999999 110.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -51.94 8.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.788 0.804 . . . . 1.8700000000000001 110.713 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.493 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 22.0 tt0 -59.05 -52.48 65.58 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.588 -1.187 . . . . 2.3100000000000001 107.906 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.482 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 tmtm? -43.7 -36.43 2.21 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 115.531 -0.759 . . . . 4.6399999999999997 110.515 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.533 HD12 ' CG1' ' A' ' 79' ' ' VAL . 11.4 mt -78.32 -44.82 24.24 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.146 -0.934 . . . . 2.3199999999999998 110.438 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.47 ' C ' ' H ' ' A' ' 27' ' ' GLU . 74.4 m -50.25 -42.31 51.78 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 118.938 -1.105 . . . . 2.1800000000000002 109.387 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 23' ' ' LYS . 3.2 p-10 -80.73 28.31 0.34 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.033 -1.467 . . . . 5.3200000000000003 111.335 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.47 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.6 mt-10 -127.68 -64.85 0.95 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.611 -1.177 . . . . 4.21 110.58 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.492 HH22 ' C ' ' A' ' 85' ' ' ALA . 14.7 mtt180 -119.21 150.29 40.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.54 -0.864 . . . . 4.7999999999999998 109.655 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.34 -25.81 60.77 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.647 -0.872 . . . . 5.5800000000000001 108.647 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.5 t70 -74.54 -8.76 57.37 Favored 'General case' 0 C--O 1.202 -1.442 0 C-N-CA 119.065 -1.054 . . . . 3.3100000000000001 111.711 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -106.78 97.19 7.01 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.76 -1.976 . . . . 1.3899999999999999 111.151 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -113.75 160.13 19.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.868 -1.16 . . . . 4.5599999999999996 107.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 3' ' ' THR . 21.5 p90 -147.92 165.18 31.47 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.51 -0.876 . . . . 1.5800000000000001 108.929 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -131.05 136.53 48.53 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.225 -1.398 . . . . 4.5 107.225 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.29 140.76 29.16 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.236 -1.786 . . . . 1.71 107.659 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.78 137.38 54.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.528 -0.915 . . . . 1.9199999999999999 108.528 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -111.77 121.71 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.493 -1.299 . . . . 2.4100000000000001 107.493 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -44.81 -31.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.701 1.0 . . . . 2.4900000000000002 113.701 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 17.77 15.36 Favored 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 118.14 -1.424 . . . . 6.2300000000000004 111.972 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.86 -41.85 5.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.245 -1.761 . . . . 2.29 106.245 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -82.98 -39.66 21.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.726 -1.579 . . . . 3.4700000000000002 108.952 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 50.29 0.65 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.295 -1.522 . . . . 1.5 109.295 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.61 160.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.676 -0.762 . . . . 2.79 111.129 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.6 p -112.74 -158.14 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.606 -1.179 . . . . 3.0099999999999998 110.844 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 3.8 ttpp -114.15 12.8 17.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 106.486 -1.672 . . . . 6.0 106.486 178.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -119.11 -50.08 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.645 -1.161 . . . . 4.9299999999999997 109.625 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -57.89 -45.4 86.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.907 -1.146 . . . . 3.8300000000000001 107.907 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 23.0 mt -42.23 -47.88 4.8 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 115.207 -0.906 . . . . 3.0 110.468 178.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -46.78 -49.17 20.26 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.617 -0.882 . . . . 5.3300000000000001 108.617 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -73.86 -40.54 63.18 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.902 -1.044 . . . . 8.1500000000000004 110.98 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.92 -47.71 70.94 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.503 -0.555 . . . . 5.6900000000000004 109.503 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.512 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -76.29 -49.68 16.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.21 -0.905 . . . . 3.1899999999999999 109.998 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.41 16.33 55.53 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.238 -1.458 . . . . 3.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 6.4 ttmt -120.26 77.42 25.45 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.602 -0.888 . . . . 6.5599999999999996 108.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -80.85 22.66 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.632 1.555 . . . . 4.9100000000000001 112.503 -127.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.24 -12.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.56 -1.2 . . . . 6.8300000000000001 111.767 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 11.6 pt-20 -86.77 174.85 8.55 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 118.748 -1.181 . . . . 6.1299999999999999 112.691 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 p -131.45 -80.07 0.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.072 -0.967 . . . . 5.6100000000000003 110.698 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.4 t -119.82 151.82 52.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 4.4900000000000002 109.451 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -87.64 168.53 40.48 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.814 -0.911 . . . . 2.9100000000000001 111.04 -18.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.414 ' NE2' ' HB3' ' A' ' 52' ' ' ALA . 87.2 mt-30 -131.42 117.56 19.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 105.478 -2.045 . . . . 3.48 105.478 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.543 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.0 mp -113.25 141.98 27.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.916 -1.038 . . . . 2.0899999999999999 108.894 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.51 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 4.4 m-85 -120.06 138.23 53.66 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.778 -2.01 . . . . 1.5800000000000001 108.756 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 66' ' ' GLN . 74.8 t -116.79 130.07 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.064 -1.054 . . . . 1.9399999999999999 108.63 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 54.09 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 112.607 -2.088 . . . . 3.29 113.383 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 64' ' ' VAL . 72.7 mt-30 -131.22 -31.3 1.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.164 1.542 . . . . 5.4500000000000002 115.164 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 1.4 pm0 -117.56 171.95 7.67 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.003 1.112 . . . . 4.4000000000000004 114.003 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.512 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 9.3 t-80 -73.44 147.64 43.99 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 105.603 -1.999 . . . . 1.8500000000000001 105.603 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.417 HG13 ' CG2' ' A' ' 64' ' ' VAL . 46.2 mm -122.29 -29.39 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.649 -1.22 . . . . 2.7000000000000002 108.852 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.44 -171.55 34.7 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.069 -1.062 . . . . 2.27 111.337 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.452 ' C ' ' H ' ' A' ' 73' ' ' THR . . . -105.12 -149.53 19.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.219 -2.353 . . . . 1.71 107.219 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.53 42.79 0.53 Allowed 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 117.651 -1.62 . . . . 2.9700000000000002 109.467 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.452 ' H ' ' C ' ' A' ' 71' ' ' GLY . 11.7 p -144.62 -69.06 0.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.826 -1.079 . . . . 2.7999999999999998 109.726 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -54.09 8.88 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.873 -1.058 . . . . 2.9900000000000002 108.403 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CZ ' ' CG2' ' A' ' 79' ' ' VAL . 22.5 t80 -52.87 -56.87 12.65 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 104.959 -2.237 . . . . 1.9199999999999999 104.959 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.42 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -38.65 -52.84 1.65 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.688 -1.142 . . . . 2.77 110.232 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -63.54 -58.37 7.2 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.316 -0.954 . . . . 1.6299999999999999 110.056 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' ALA . 61.5 t90 -40.93 -51.01 3.27 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 119.243 -0.983 . . . . 1.8999999999999999 109.145 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.533 ' CG1' HD12 ' A' ' 24' ' ' LEU . 71.0 t -43.13 -58.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.124 -1.065 . . . . 2.4900000000000002 108.124 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.53 ' C ' ' HZ1' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -51.61 -60.9 2.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.876 -1.056 . . . . 3.79 111.655 -179.302 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.476 ' CD ' ' HZ3' ' A' ' 80' ' ' LYS . 8.5 mp0 -59.03 -33.1 70.37 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.239 1.94 . . . . 3.8799999999999999 116.239 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 82' ' ' ASN . 0.8 OUTLIER -98.99 -23.38 15.32 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 117.809 -1.556 . . . . 2.1699999999999999 113.066 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' ALA . 15.3 mt -83.72 -53.59 5.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.023 -2.214 . . . . 2.04 105.023 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 83' ' ' LEU . 4.6 m-20 18.82 -76.67 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 124.858 1.349 . . . . 5.0999999999999996 113.552 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . . . . . . 0 N--CA 1.505 2.278 0 CA-C-N 111.337 -2.665 . . . . 8.5999999999999996 112.106 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.509 ' H ' ' CG ' ' A' ' 30' ' ' ASP . 44.6 tpp . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.434 -1.321 . . . . 3.2599999999999998 107.434 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 1.3 mp0 -131.97 132.92 43.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.765 0.666 . . . . 5.5800000000000001 110.317 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.422 ' OG1' ' CE1' ' A' ' 31' ' ' PHE . 38.5 m -121.64 142.79 49.78 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 119.623 -0.831 . . . . 1.8100000000000001 110.939 178.718 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.47 127.35 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 108.42 -0.956 . . . . 2.1200000000000001 108.42 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.32 109.44 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 124.84 1.337 . . . . 3.0299999999999998 108.582 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.408 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 98.3 m-85 -87.87 100.05 12.58 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.111 -1.07 . . . . 1.8700000000000001 108.111 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.8 -166.93 13.69 Favored Glycine 0 N--CA 1.501 3.015 0 N-CA-C 109.114 -1.594 . . . . 0.98999999999999999 109.114 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.697 ' CG ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 ptm180 -119.24 37.27 4.19 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.257 -1.377 . . . . 6.7800000000000002 112.088 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.407 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 50.5 m 83.47 51.71 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 116.094 1.887 . . . . 3.5299999999999998 116.094 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.77 67.34 1.49 Allowed Glycine 0 N--CA 1.505 3.246 0 C-N-CA 119.069 -1.539 . . . . 4.5 114.1 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.697 ' SG ' ' CG ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -111.42 159.07 34.41 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.339 -0.944 . . . . 2.7200000000000002 109.886 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 81.2 Cg_exo -40.31 144.24 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.438 1.426 . . . . 3.6600000000000001 110.015 157.148 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER 77.11 -59.46 0.48 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 107.568 -1.271 . . . . 3.8599999999999999 107.568 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.4 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 33.4 m -53.78 -47.16 71.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.4 -0.818 . . . . 1.73 110.029 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.422 HG22 ' O ' ' A' ' 11' ' ' CYS . 86.1 t -49.12 -41.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.856 -1.138 . . . . 2.8199999999999998 108.033 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -74.58 82.82 2.02 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.657 -1.238 . . . . 5.5199999999999996 107.657 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 173.36 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.291 -2.231 . . . . 2.46 105.471 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.508 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 5.9 tmtm? -69.17 -47.18 65.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.964 -1.495 . . . . 3.5 106.964 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -55.29 -37.39 67.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.775 -0.824 . . . . 3.4100000000000001 108.775 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.02 -58.97 3.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.301 -1.36 . . . . 2.3700000000000001 108.563 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -40.14 -54.55 2.28 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.511 -0.876 . . . . 1.79 110.918 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.508 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 3.8 mm-40 -38.77 -41.86 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.852 0.834 . . . . 3.2000000000000002 112.735 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.429 ' NZ ' ' HB2' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.51 -54.63 11.42 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.013 -0.994 . . . . 5.4500000000000002 109.502 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.519 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 49.3 mt -49.99 -46.25 52.47 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.54 -1.209 . . . . 2.3399999999999999 108.15 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 m -58.02 -28.7 64.69 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.252 0.97 . . . . 2.1899999999999999 112.667 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -102.2 -17.26 16.04 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.265 -0.574 . . . . 5.1699999999999999 111.761 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' CD ' HH12 ' A' ' 28' ' ' ARG . 34.1 mt-10 -87.93 -45.23 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.253 -0.579 . . . . 3.1299999999999999 110.537 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 83' ' ' LEU . 2.0 mpt_? -104.69 -17.09 14.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.867 -0.733 . . . . 6.8700000000000001 111.486 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.59 -51.32 0.62 Allowed 'General case' 0 N--CA 1.512 2.65 0 O-C-N 124.394 1.059 . . . . 5.9000000000000004 112.326 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.509 ' CG ' ' H ' ' A' ' 1' ' ' MET . 18.7 t70 -76.86 54.73 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.421 1.105 . . . . 3.4300000000000002 108.642 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.519 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 74.0 t80 -146.34 82.2 1.59 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.393 -0.821 . . . . 1.9299999999999999 109.745 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 12.8 mp0 -89.71 142.11 27.99 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.481 -1.674 . . . . 4.3399999999999999 106.481 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 18' ' ' LYS . 38.0 p90 -129.78 150.27 51.16 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.289 -0.964 . . . . 1.74 108.659 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -116.74 136.29 53.08 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.841 -0.8 . . . . 4.8200000000000003 108.841 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -95.23 114.95 26.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.091 -1.818 . . . . 2.0600000000000001 106.091 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.54 134.57 54.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 114.776 -1.102 . . . . 1.6200000000000001 109.362 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.17 132.38 55.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.504 -0.924 . . . . 2.1699999999999999 108.504 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 pt -60.87 -29.77 46.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 118.686 -1.205 . . . . 2.4700000000000002 111.825 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.531 ' CZ ' ' HB2' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.15 -34.19 56.56 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.012 -1.475 . . . . 5.46 110.602 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.23 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.663 -0.815 . . . . 2.0299999999999998 111.262 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -85.08 -34.46 22.23 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.322 -0.951 . . . . 2.5499999999999998 111.225 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.89 52.85 1.07 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.677 -1.369 . . . . 1.3300000000000001 109.677 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -104.74 155.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.764 -0.718 . . . . 2.4199999999999999 110.849 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.0 p -118.62 161.58 19.83 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.167 -0.924 . . . . 2.7000000000000002 110.648 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 19.0 ttpp -55.73 -42.59 75.57 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.687 -1.597 . . . . 5.0999999999999996 106.687 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 1.2 mp0 -51.55 -56.82 11.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.237 -1.347 . . . . 3.7200000000000002 109.647 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -46.84 -51.47 16.52 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.581 -0.848 . . . . 3.6200000000000001 111.139 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.76 -52.1 61.88 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.311 -0.859 . . . . 2.25 110.457 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 40.6 tt0 -53.3 -39.29 63.89 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.839 -0.744 . . . . 4.7000000000000002 109.549 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.09 -33.81 59.52 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.388 -0.597 . . . . 5.4500000000000002 109.388 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.446 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -63.07 -36.94 85.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.468 -0.567 . . . . 4.9100000000000001 109.468 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -104.81 -88.17 0.43 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.076 -0.966 . . . . 2.6299999999999999 108.904 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 41.34 1.12 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.125 -1.512 . . . . 3.7000000000000002 113.869 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 74' ' ' ASP . 44.0 pttt -120.76 58.0 6.29 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.073 -1.051 . . . . 6.7400000000000002 109.194 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.1 38.8 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.251 3.301 . . . . 5.3399999999999999 114.043 -106.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.92 38.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.073 -1.084 . . . . 6.6200000000000001 108.073 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -104.33 154.02 20.34 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.737 -1.119 . . . . 5.9199999999999999 110.971 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -125.29 -156.23 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.566 -1.197 . . . . 5.6500000000000004 107.819 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.69 145.42 30.67 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.996 -0.742 . . . . 4.3899999999999997 108.996 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.408 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 52.8 Cg_endo -88.89 145.68 22.0 Favored 'Cis proline' 0 C--N 1.316 -1.132 0 O-C-N 123.558 1.294 . . . . 2.5299999999999998 112.36 16.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -102.51 144.12 31.35 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.445 -1.687 . . . . 4.21 106.445 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.58 140.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.843 -1.543 . . . . 2.8799999999999999 112.988 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.526 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 24.9 m-85 -136.16 135.59 39.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 110.976 -2.829 . . . . 1.4299999999999999 107.876 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.493 HG21 HG13 ' A' ' 69' ' ' ILE . 61.6 t -102.6 121.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 106.828 -1.545 . . . . 1.9399999999999999 106.828 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.2 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.905 -1.043 . . . . 2.6000000000000001 111.209 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 64' ' ' VAL . 58.2 mt-30 -135.06 3.31 3.15 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.26 -0.976 . . . . 5.6600000000000001 111.666 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -105.39 155.41 19.15 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.843 0.354 . . . . 5.6600000000000001 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.526 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 8.0 t-80 -92.78 149.18 21.46 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.409 -1.33 . . . . 2.0499999999999998 107.409 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.493 HG13 HG21 ' A' ' 64' ' ' VAL . 3.2 mm -118.01 -38.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 117.513 -1.675 . . . . 1.8600000000000001 109.703 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.4 ' HA2' ' NE2' ' A' ' 68' ' ' HIS . . . 136.41 -26.59 3.06 Favored Glycine 0 N--CA 1.502 3.04 0 C-N-CA 118.937 -1.602 . . . . 2.3900000000000001 112.435 179.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.37 -173.83 20.27 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 108.231 -1.947 . . . . 2.6899999999999999 108.231 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -51.77 -59.33 4.43 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.89 -1.124 . . . . 2.5600000000000001 111.611 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.69 -45.59 49.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 112.938 0.718 . . . . 2.9300000000000002 112.938 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 1.4 m-20 -74.84 -51.71 13.25 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.793 -0.763 . . . . 2.5600000000000001 110.205 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.429 ' CE2' HG23 ' A' ' 79' ' ' VAL . 83.4 t80 -51.21 -43.33 61.37 Favored 'General case' 0 C--O 1.194 -1.84 0 N-CA-C 107.48 -1.304 . . . . 1.23 107.48 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.79 -60.63 2.94 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.018 -0.734 . . . . 1.75 109.018 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.96 -53.94 45.83 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.909 -0.716 . . . . 1.74 111.312 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -54.93 -53.12 59.65 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.416 -0.914 . . . . 1.6299999999999999 110.126 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.534 HG13 ' N ' ' A' ' 80' ' ' LYS . 1.9 t -46.48 -62.52 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 124.48 1.112 . . . . 2.1800000000000002 109.006 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.534 ' N ' HG13 ' A' ' 79' ' ' VAL . 15.8 tptp -34.63 -49.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.256 -1.793 . . . . 3.75 113.3 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.04 20.05 19.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.653 1.723 . . . . 6.4199999999999999 115.653 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -132.14 -26.53 1.9 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.661 -1.615 . . . . 2.5 110.775 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 50.1 mt -100.95 45.56 0.97 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.426 -1.31 . . . . 2.75 107.804 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.01 39.36 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.933 0.873 . . . . 5.6600000000000001 110.378 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.837 0 C-N-CA 118.224 -1.39 . . . . 10.06 110.142 -179.599 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.512 ' N ' ' O ' ' A' ' 30' ' ' ASP . 77.5 mtm . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.211 -0.662 . . . . 3.4100000000000001 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -109.43 102.16 11.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.727 -1.212 . . . . 5.5999999999999996 107.727 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.3 m -91.66 139.43 30.7 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.599 -1.241 . . . . 1.9399999999999999 109.27 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.52 139.03 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.045 -0.98 . . . . 1.9199999999999999 109.988 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -118.34 109.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.156 1.535 . . . . 2.75 107.86 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.486 ' CD2' HG12 ' A' ' 36' ' ' VAL . 32.5 m-85 -91.74 90.74 7.66 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.174 -1.417 . . . . 1.6100000000000001 107.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.85 -162.61 11.95 Favored Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.262 -0.971 . . . . 1.0600000000000001 110.947 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.632 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -122.77 71.59 1.04 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.095 0.95 . . . . 7.5700000000000003 111.532 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p 32.81 -77.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 116.393 1.997 . . . . 3.71 116.393 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -103.74 46.3 1.22 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 120.111 -1.042 . . . . 3.1899999999999999 113.983 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.632 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 1.1 p -116.3 114.63 40.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 108.239 -1.023 . . . . 2.3999999999999999 108.239 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.61 -54.89 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.187 1.925 . . . . 3.04 111.732 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -52.1 -40.43 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.279 -0.968 . . . . 3.3700000000000001 109.913 179.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.402 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 28.4 m -62.24 -53.6 52.93 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.141 -1.024 . . . . 1.77 110.303 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -52.62 -42.14 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 114.669 -1.15 . . . . 2.6000000000000001 111.663 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.501 HH12 ' CG ' ' A' ' 19' ' ' ASP . 10.0 mmm180 -42.5 -41.58 3.02 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 119.11 -1.036 . . . . 4.1799999999999997 111.551 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.37 86.39 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.442 -0.903 . . . . 1.9199999999999999 108.659 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.472 ' NZ ' ' HB2' ' A' ' 22' ' ' GLU . 4.1 tmtm? -62.6 -38.15 89.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.626 -0.879 . . . . 2.9399999999999999 108.626 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.501 ' CG ' HH12 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -61.46 -56.94 14.65 Favored 'General case' 0 C--O 1.192 -1.955 0 N-CA-C 106.666 -1.605 . . . . 3.5299999999999998 106.666 177.578 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.1 tp -48.31 -56.93 6.8 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.145 -1.022 . . . . 2.3900000000000001 108.655 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -50.53 9.84 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 2.0099999999999998 108.425 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.472 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -57.41 -52.14 66.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.122 -0.631 . . . . 3.1200000000000001 110.501 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 2.4 ttpp -52.68 -17.32 1.25 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.627 -1.17 . . . . 4.5999999999999996 110.428 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.03 -53.37 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.506 -0.924 . . . . 2.7000000000000002 108.506 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -43.9 -35.39 1.97 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.593 0.59 . . . . 2.3799999999999999 112.593 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -105.62 22.3 15.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.086 1.143 . . . . 4.7199999999999998 114.086 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 19.8 mt-10 -131.86 -27.6 1.86 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.575 -0.45 . . . . 3.27 110.242 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.59 -163.98 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.809 -0.756 . . . . 4.8799999999999999 109.587 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.49 -179.98 4.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.14 -1.8 . . . . 4.6900000000000004 106.14 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.512 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 t70 43.86 30.43 0.39 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 124.923 1.389 . . . . 3.6000000000000001 112.059 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.87 85.88 2.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.243 -1.783 . . . . 1.4299999999999999 113.068 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -102.71 141.82 34.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.178 -2.156 . . . . 4.3200000000000003 105.178 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -133.1 153.62 51.34 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.627 -1.229 . . . . 1.2 109.567 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.407 ' OE1' HG22 ' A' ' 36' ' ' VAL . 1.7 tm0? -121.3 142.53 49.87 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.292 -1.373 . . . . 4.7199999999999998 107.292 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.54 118.97 33.22 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.652 -1.219 . . . . 2.3199999999999998 109.319 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.486 HG12 ' CD2' ' A' ' 6' ' ' PHE . 26.3 t -109.43 136.07 46.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.027 -0.988 . . . . 2.0600000000000001 109.152 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' A' ' 39' ' ' ARG . 17.1 t70 -118.58 44.86 2.17 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 114.842 -1.072 . . . . 1.99 108.743 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.488 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.1 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 114.364 -1.289 . . . . 2.1800000000000002 114.199 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.616 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -59.14 -51.39 70.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.75 -0.659 . . . . 7.7999999999999998 110.876 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' NH2' ' A' ' 39' ' ' ARG . . . -40.34 -51.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.381 -0.927 . . . . 2.3399999999999999 110.24 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -74.93 -43.04 56.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.426 1.079 . . . . 3.1699999999999999 110.478 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.4 30.81 1.23 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.161 -1.176 . . . . 2.3300000000000001 110.161 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -98.44 152.35 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 3.3599999999999999 108.171 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -124.4 -175.98 3.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.708 -0.678 . . . . 4.0899999999999999 112.32 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -84.3 2.15 41.56 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.983 -0.687 . . . . 5.5999999999999996 110.619 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.84 -45.91 5.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.037 -2.208 . . . . 5.0499999999999998 105.037 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.5 -56.2 21.29 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.054 -0.975 . . . . 4.1100000000000003 108.486 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -48.64 -40.25 27.13 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.713 -1.131 . . . . 2.6200000000000001 111.5 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -44.23 -53.67 6.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.925 -1.11 . . . . 7.9699999999999998 109.338 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -43.04 -49.92 6.06 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.493 -1.685 . . . . 7.4000000000000004 113.297 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.405 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 5.4 mtpp -91.06 -28.02 18.22 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.516 -1.22 . . . . 6.7300000000000004 114.162 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -73.61 -51.24 17.5 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.569 1.168 . . . . 2.2799999999999998 112.899 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.98 -32.94 2.68 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.143 -1.983 . . . . 2.3199999999999998 108.143 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.537 ' HZ3' ' CG ' ' A' ' 74' ' ' ASP . 26.0 mttt -86.38 -179.07 1.27 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 114.547 -0.827 . . . . 6.7000000000000002 108.807 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' C ' ' H ' ' A' ' 57' ' ' GLU . 27.3 Cg_exo -62.73 124.45 14.13 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.749 2.299 . . . . 5.4900000000000002 111.76 155.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 30.5 m -77.42 31.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.898 -0.592 . . . . 9.3900000000000006 111.377 -179.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.427 ' H ' ' C ' ' A' ' 55' ' ' PRO . 0.8 OUTLIER -114.19 -7.85 12.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.41 -0.959 . . . . 5.6399999999999997 108.41 179.214 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -85.04 54.09 2.97 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.243 -1.392 . . . . 7.6799999999999997 107.243 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.627 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 19.2 m -89.68 169.57 12.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.161 -1.382 . . . . 4.4199999999999999 111.799 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.627 ' C ' ' HA ' ' A' ' 59' ' ' VAL . 5.6 Cg_endo -46.16 137.67 1.8 Allowed 'Cis proline' 0 N--CA 1.489 1.219 0 C-N-CA 125.072 -0.803 . . . . 2.6600000000000001 110.518 -13.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.451 HE21 ' HA ' ' A' ' 61' ' ' GLN . 0.2 OUTLIER -94.53 116.63 29.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.091 -1.818 . . . . 3.9500000000000002 106.091 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.431 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.6 mp -108.29 139.7 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 123.035 1.397 . . . . 2.1600000000000001 111.416 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.508 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 3.8 m-85 -126.71 136.58 52.65 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 111.833 -2.44 . . . . 1.98 106.257 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.432 ' CG2' HG13 ' A' ' 69' ' ' ILE . 54.9 t -110.11 110.07 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 118.677 -1.209 . . . . 1.9199999999999999 109.84 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 t70 75.38 -72.3 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 124.29 0.994 . . . . 2.6899999999999999 112.216 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -134.03 -41.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.619 0.97 . . . . 5.29 113.619 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -94.26 160.75 14.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.552 0.945 . . . . 5.0800000000000001 113.552 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.508 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.6 t-160 -77.09 144.47 38.5 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.772 -1.936 . . . . 1.6000000000000001 105.772 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.432 HG13 ' CG2' ' A' ' 64' ' ' VAL . 20.9 mm -103.66 -25.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 117.916 -1.514 . . . . 1.8799999999999999 109.504 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 137.73 -34.05 2.2 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 118.522 -1.799 . . . . 2.77 113.294 178.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.78 -175.01 22.37 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.514 -1.434 . . . . 2.6000000000000001 109.514 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.412 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 2.6 t80 -51.29 -44.44 61.88 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.375 -0.93 . . . . 2.6299999999999999 111.625 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 p -66.81 -58.85 4.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.768 0.794 . . . . 2.1400000000000001 110.548 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.537 ' CG ' ' HZ3' ' A' ' 54' ' ' LYS . 5.2 m-20 -48.73 -46.44 40.87 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.634 -1.166 . . . . 2.71 109.21 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.405 ' CG ' HG22 ' A' ' 62' ' ' ILE . 48.7 t80 -60.88 -53.23 59.81 Favored 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 108.198 -1.038 . . . . 1.27 108.198 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.59 -53.39 11.55 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.71 -0.796 . . . . 1.5800000000000001 112.655 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.48 13.58 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 118.999 -1.081 . . . . 1.54 110.126 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -44.41 -48.64 9.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.22 0.95 . . . . 1.49 108.828 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 t -47.67 -59.36 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 124.154 0.909 . . . . 1.8799999999999999 108.865 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.46 ' HD3' ' C ' ' A' ' 80' ' ' LYS . 7.6 tmtm? -57.33 -59.92 4.41 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.498 -1.281 . . . . 4.1299999999999999 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -52.66 -36.27 56.61 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.24 1.57 . . . . 3.8599999999999999 115.24 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -101.27 -28.67 12.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.811 -1.155 . . . . 2.1200000000000001 113.563 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.07 -26.43 26.97 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 117.862 -1.535 . . . . 1.95 112.571 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -102.44 40.64 1.33 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.393 -1.323 . . . . 3.3300000000000001 111.153 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 116.465 -1.731 . . . . 6.5899999999999999 108.856 179.128 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.503 ' N ' ' O ' ' A' ' 30' ' ' ASP . 13.9 ptp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.162 -0.681 . . . . 3.4399999999999999 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.409 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 19.6 pt20 -123.82 125.53 44.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.749 0.656 . . . . 4.3799999999999999 110.721 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -94.25 132.03 39.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.488 -0.93 . . . . 1.98 108.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.87 117.94 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.59 -1.634 . . . . 1.8799999999999999 106.59 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.8 mm -108.96 125.04 66.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.568 -1.253 . . . . 2.96 108.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.13 96.02 6.94 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.962 -0.755 . . . . 1.6399999999999999 108.962 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.59 -173.67 18.09 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.559 -1.817 . . . . 1.1299999999999999 108.559 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.11 170.84 3.69 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.813 -0.81 . . . . 10.039999999999999 108.813 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -90.51 53.7 2.52 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 105.864 -1.902 . . . . 6.6500000000000004 105.864 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.83 -39.16 0.12 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.339 -1.904 . . . . 8.1999999999999993 108.339 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -90.59 151.67 44.27 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 108.578 -0.897 . . . . 5.0199999999999996 108.578 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.2 Cg_endo -91.28 178.91 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.58 2.187 . . . . 5.46 109.027 146.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER 76.6 -36.56 0.27 Allowed 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 120.454 -0.498 . . . . 4.1299999999999999 111.714 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -31.77 11.32 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 120.28 -0.568 . . . . 1.78 111.936 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.4 t -59.84 -53.5 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.444 -0.902 . . . . 2.0099999999999998 109.7 179.415 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -33.86 -53.15 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.295 -0.866 . . . . 5.2599999999999998 113.323 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.9 84.16 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.451 -0.9 . . . . 1.77 109.733 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.529 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 2.5 tmtm? -53.33 -47.9 68.94 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.891 -1.049 . . . . 2.54 110.251 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.529 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 1.3 p-10 -68.03 -43.14 79.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.143 -1.423 . . . . 2.8399999999999999 109.083 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.52 -58.57 6.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.273 -1.371 . . . . 1.8 109.953 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.94 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.542 -0.863 . . . . 2.02 110.725 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.61 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 24.1 tt0 -50.75 -57.8 7.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.885 -1.126 . . . . 2.6699999999999999 109.265 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.61 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -49.14 -54.07 17.94 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.901 -1.045 . . . . 5.6699999999999999 110.178 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -48.9 -44.15 39.87 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 114.107 1.151 . . . . 2.5600000000000001 114.107 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.7 p -49.73 -19.94 0.73 Allowed 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 119.351 -0.939 . . . . 2.5699999999999998 113.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.469 ' N ' HD21 ' A' ' 26' ' ' ASN . 1.2 m120 -99.53 -2.82 34.86 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.713 -0.395 . . . . 4.2000000000000002 111.531 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.61 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 14.9 mt-10 -114.6 -32.8 5.75 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.577 0.703 . . . . 3.3500000000000001 111.24 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.494 ' HE ' ' HA ' ' A' ' 28' ' ' ARG . 8.6 mmm-85 -95.67 -173.62 2.92 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.743 -1.183 . . . . 4.3399999999999999 113.953 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.511 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 7.1 p-10 -96.55 -71.77 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 113.45 -1.705 . . . . 5.1500000000000004 111.969 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.511 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 42.1 t0 -101.91 66.63 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.918 0.866 . . . . 4.0199999999999996 108.861 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -124.04 102.47 7.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.774 -1.103 . . . . 1.78 110.163 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.409 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 45.7 mt-30 -119.07 163.33 17.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.363 -1.718 . . . . 4.2199999999999998 106.363 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.61 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 35.3 p90 -158.83 164.07 36.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.291 -1.364 . . . . 1.3100000000000001 110.135 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -136.14 137.62 41.17 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.679 -1.146 . . . . 4.5300000000000002 108.789 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -96.78 137.21 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.164 -2.532 . . . . 1.8999999999999999 104.164 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.6 139.12 52.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.447 -0.901 . . . . 1.76 111.672 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -115.79 124.5 50.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 104.807 -2.294 . . . . 1.79 104.807 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 pt -51.02 -35.79 15.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.116 -0.947 . . . . 2.8100000000000001 111.918 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -81.75 4.02 23.53 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 113.237 0.828 . . . . 6.21 113.237 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.63 -46.27 3.06 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.987 -0.685 . . . . 2.0499999999999998 109.925 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.451 -0.899 . . . . 3.7400000000000002 109.355 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.64 48.66 1.77 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 120.035 -1.079 . . . . 3.0800000000000001 110.752 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.38 147.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.407 -0.917 . . . . 3.4500000000000002 110.471 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.1 p -117.71 170.46 8.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.712 -1.218 . . . . 4.0899999999999999 107.712 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -53.89 48.69 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.071 -1.052 . . . . 7.2300000000000004 108.978 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -35.08 -62.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.534 -1.212 . . . . 5.3799999999999999 110.559 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -46.78 -59.11 3.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.253 -0.885 . . . . 4.4100000000000001 111.976 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.1 mt -50.68 -44.87 57.92 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.834 -0.746 . . . . 2.9500000000000002 111.372 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 5.3 tm0? -42.17 -55.15 3.37 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.597 -0.841 . . . . 6.71 110.143 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -49.23 -33.96 13.83 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.022 -0.99 . . . . 7.4500000000000002 113.271 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.68 -26.37 19.61 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.981 -0.688 . . . . 4.4199999999999999 111.835 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 -45.45 53.79 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.886 -0.726 . . . . 2.8399999999999999 109.559 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.13 -52.48 0.63 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.176 -1.57 . . . . 3.6099999999999999 109.176 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.519 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 2.4 ttpm? -95.27 161.92 26.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 7.4100000000000001 108.026 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.519 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 87.5 Cg_exo -30.45 121.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 121.538 1.492 . . . . 6.4500000000000002 109.137 147.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.6 47.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.617 -0.833 . . . . 8.9000000000000004 111.812 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.408 ' C ' ' HG1' ' A' ' 58' ' ' THR . 1.8 mm-40 -83.48 53.3 2.47 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.951 1.358 . . . . 8.4900000000000002 108.697 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.408 ' HG1' ' C ' ' A' ' 57' ' ' GLU . 27.3 m -147.72 99.22 3.07 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 105.575 -2.009 . . . . 5.8200000000000003 105.575 179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.491 HG21 ' HA ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -113.53 147.69 38.08 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.309 -0.997 . . . . 4.3099999999999996 108.309 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.491 ' HA ' HG21 ' A' ' 59' ' ' VAL . 11.1 Cg_endo -84.2 174.35 38.49 Favored 'Cis proline' 0 C--O 1.207 -1.043 0 C-N-CA 125.403 -0.666 . . . . 2.4900000000000002 111.48 21.354 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.72 146.9 48.92 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.459 -0.896 . . . . 4.5700000000000003 110.57 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.429 HG22 ' CG ' ' A' ' 75' ' ' PHE . 14.8 mm -120.09 134.93 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 124.011 0.82 . . . . 3.0 108.901 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -137.38 133.16 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.634 -0.712 . . . . 2.04 111.167 179.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.454 ' O ' ' N ' ' A' ' 66' ' ' GLN . 84.6 t -100.11 122.32 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 106.25 -1.759 . . . . 2.0699999999999998 106.25 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.53 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.783 0.677 . . . . 2.9700000000000002 111.582 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' VAL . 74.1 mt-30 -138.35 10.07 2.73 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.601 -0.84 . . . . 5.4299999999999997 112.239 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.77 152.66 24.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.488 -0.485 . . . . 5.2699999999999996 110.12 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -85.14 145.1 27.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.588 -1.264 . . . . 1.72 107.588 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.441 HG13 HG21 ' A' ' 64' ' ' VAL . 14.0 mm -113.5 -34.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 C-N-CA 119.255 -0.978 . . . . 1.8400000000000001 110.895 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.0 -128.94 4.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.323 -1.111 . . . . 2.1699999999999999 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.73 -59.2 0.59 Allowed Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.868 -1.158 . . . . 2.3199999999999998 112.073 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -163.63 -60.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.959 -1.096 . . . . 2.75 109.157 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 p -41.6 -48.06 3.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.973 -1.121 . . . . 2.29 107.973 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -68.75 0.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.756 -2.02 . . . . 2.96 110.353 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.442 ' CE1' ' CZ3' ' A' ' 78' ' ' TRP . 71.7 t80 -52.62 -39.23 61.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.305 -0.958 . . . . 1.3 110.762 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.499 -0.481 . . . . 1.8500000000000001 111.174 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.09 -48.71 61.91 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.894 -1.151 . . . . 2.2400000000000002 107.894 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.442 ' CZ3' ' CE1' ' A' ' 75' ' ' PHE . 60.8 t90 -41.6 -52.09 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.712 -1.131 . . . . 1.3899999999999999 108.923 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.449 HG11 HD11 ' A' ' 83' ' ' LEU . 3.0 t -41.81 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.619 -1.252 . . . . 2.0899999999999999 107.619 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.78 -53.42 15.42 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.468 0.652 . . . . 4.1699999999999999 111.235 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 1.1 mp0 -62.69 -17.99 61.63 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.081 1.141 . . . . 4.0199999999999996 114.081 -179.151 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -110.6 -32.24 6.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 118.826 -1.149 . . . . 1.9099999999999999 113.385 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.449 HD11 HG11 ' A' ' 79' ' ' VAL . 19.2 mt -92.87 -19.7 21.42 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.363 -0.935 . . . . 2.2200000000000002 111.697 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 2.1 m-20 -113.19 -51.67 2.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.398 -0.964 . . . . 3.4500000000000002 108.398 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.505 2.305 0 O-C-N 126.449 2.343 . . . . 5.2300000000000004 108.834 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.898 0.38 . . . . 4.54 110.689 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.78 174.8 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.247 -1.02 . . . . 5.0599999999999996 108.247 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.41 HG23 ' CZ ' ' A' ' 75' ' ' PHE . 57.5 m -114.88 141.18 48.27 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.741 -1.184 . . . . 1.77 113.695 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.7 t -119.63 128.27 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.14 -2.17 . . . . 1.8799999999999999 105.14 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.46 120.56 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 124.474 1.109 . . . . 2.7200000000000002 110.48 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.488 ' CD2' HG12 ' A' ' 36' ' ' VAL . 91.0 m-85 -99.42 81.3 2.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.175 -1.417 . . . . 1.26 107.175 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.42 -174.15 13.6 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.929 -1.268 . . . . 1.8700000000000001 109.929 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.491 ' O ' ' HB2' ' A' ' 9' ' ' SER . 7.5 mmm180 -102.91 -63.62 1.15 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.732 -0.787 . . . . 7.7800000000000002 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.491 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 75.5 m 97.45 145.9 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 125.408 1.692 . . . . 5.9500000000000002 107.78 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.18 -21.22 31.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 106.63 -2.588 . . . . 4.7000000000000002 106.63 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -113.27 150.25 42.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.996 -1.102 . . . . 4.0899999999999999 110.072 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.09 -56.48 2.53 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.702 1.601 . . . . 3.6000000000000001 112.317 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.56 -44.09 79.09 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.597 -0.841 . . . . 3.7200000000000002 112.114 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 20.1 p -54.9 -55.13 33.85 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 117.291 -1.764 . . . . 3.5699999999999998 107.999 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.7 t -52.97 -47.37 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 2.29 111.167 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' CZ ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -32.83 -50.01 0.25 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 113.555 0.946 . . . . 5.5599999999999996 113.555 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.13 95.62 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.003 -1.079 . . . . 1.97 110.517 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -61.09 -47.49 86.08 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.251 -0.648 . . . . 2.7200000000000002 109.251 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.496 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m-20 -56.86 -47.85 79.46 Favored 'General case' 0 C--O 1.199 -1.596 0 C-N-CA 118.81 -1.156 . . . . 3.4700000000000002 109.244 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.62 -57.69 11.86 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.443 -1.303 . . . . 1.8500000000000001 109.361 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.57 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -50.56 -53.51 29.79 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.145 -1.422 . . . . 1.9399999999999999 110.071 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 20.2 tt0 -55.19 -49.54 71.66 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.585 0.707 . . . . 2.7999999999999998 112.228 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.64 -51.14 71.08 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.032 -1.099 . . . . 8.3000000000000007 108.032 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.81 -52.86 37.09 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.468 -0.787 . . . . 2.9700000000000002 109.967 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 p -60.42 -14.58 19.81 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.107 -1.437 . . . . 2.54 112.358 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -117.71 17.57 14.33 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.178 0.513 . . . . 4.3200000000000003 110.194 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.54 -45.52 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.203 1.001 . . . . 3.8999999999999999 109.474 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.426 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 2.3 mmp_? -101.86 -36.68 8.57 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.193 -1.367 . . . . 4.8499999999999996 111.392 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.582 ' C ' ' H ' ' A' ' 31' ' ' PHE . 15.5 m-20 77.42 -40.74 0.35 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 124.636 1.21 . . . . 6.4000000000000004 110.389 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -72.79 17.84 0.11 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.486 -0.886 . . . . 6.5899999999999999 109.729 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.582 ' H ' ' C ' ' A' ' 29' ' ' ASP . 47.2 t80 -125.49 120.81 31.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.11 -0.95 . . . . 2.1499999999999999 109.694 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.302 -1.37 . . . . 6.0300000000000002 107.302 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.57 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 18.3 p90 -144.68 176.12 9.66 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.63 -0.828 . . . . 2.04 112.755 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -136.14 141.64 44.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.623 -1.621 . . . . 3.7999999999999998 106.623 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -99.16 141.52 31.83 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.944 -1.503 . . . . 1.96 108.053 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.488 HG12 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -131.32 148.18 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.989 -1.115 . . . . 1.6799999999999999 107.989 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.79 123.65 50.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.922 -1.14 . . . . 1.99 107.922 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 pt -54.14 -25.32 12.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.098 -1.041 . . . . 2.9700000000000002 110.105 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.67 11.25 18.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.368 1.042 . . . . 7.8099999999999996 111.653 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.86 -51.01 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.392 -0.595 . . . . 2.5600000000000001 109.392 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.79 -32.55 63.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.547 -1.206 . . . . 3.1200000000000001 109.641 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.45 46.77 1.93 Allowed Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.82 -1.181 . . . . 1.95 111.263 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 mt -114.19 147.39 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 118.378 -1.329 . . . . 3.3100000000000001 109.065 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.5 p -105.26 -99.59 0.33 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.096 -1.042 . . . . 3.5099999999999998 110.161 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 42.6 tttp -141.03 -63.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 6.3899999999999997 106.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' CD ' ' N ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -45.25 -40.03 7.04 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.73 -1.123 . . . . 5.8600000000000003 109.291 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' LEU . 51.4 m-20 -56.9 -67.39 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.588 -0.893 . . . . 4.9100000000000001 108.588 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.419 ' C ' ' O ' ' A' ' 47' ' ' ASP . 61.5 mt -36.75 -51.45 0.88 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.238 -0.892 . . . . 2.7200000000000002 109.931 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -52.92 -62.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.157 -1.383 . . . . 5.4500000000000002 110.59 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -58.08 -45.32 87.34 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.964 -0.694 . . . . 7.6799999999999997 111.154 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -61.61 -29.51 70.09 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.458 -0.792 . . . . 4.6299999999999999 110.563 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.522 ' HB2' ' CG ' ' A' ' 68' ' ' HIS . . . -81.8 -55.37 4.66 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.822 -0.751 . . . . 2.6299999999999999 110.574 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -16.76 11.96 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.959 -2.056 . . . . 2.54 107.959 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.409 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -114.05 84.34 8.82 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 108.678 -0.86 . . . . 6.0899999999999999 108.678 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_exo -50.32 177.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.125 1.883 . . . . 5.5899999999999999 111.504 168.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 23.9 t 71.34 70.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 CA-C-O 122.422 1.106 . . . . 6.5700000000000003 108.953 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.547 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 4.8 pt-20 -171.06 166.56 7.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.37 -1.741 . . . . 6.0800000000000001 109.661 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 70.3 m -139.86 178.72 7.05 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.719 -1.586 . . . . 5.7199999999999998 106.719 179.757 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 7.1 m -84.39 154.32 62.68 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 123.687 0.617 . . . . 4.2999999999999998 110.501 -179.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.01 167.95 78.5 Favored 'Cis proline' 0 N--CA 1.495 1.607 0 O-C-N 122.533 0.754 . . . . 2.3100000000000001 111.842 6.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.4 ' HG3' ' HB3' ' A' ' 48' ' ' LEU . 15.5 mm-40 -122.69 145.25 48.55 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 120.231 -0.588 . . . . 3.3500000000000001 109.58 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.567 HG22 ' CG ' ' A' ' 75' ' ' PHE . 10.8 mm -118.08 126.35 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 120.193 -0.603 . . . . 2.4500000000000002 111.599 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.479 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 21.1 m-85 -124.81 132.31 53.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.682 -1.97 . . . . 1.3700000000000001 105.682 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.649 HG12 ' CH2' ' A' ' 78' ' ' TRP . 45.6 t -119.22 145.39 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.86 -1.136 . . . . 2.1200000000000001 108.686 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 54.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.424 1.077 . . . . 4.4299999999999997 109.35 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' VAL . 18.7 pt20 -148.34 9.76 0.85 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.93 -0.577 . . . . 5.3700000000000001 109.971 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -116.5 169.61 9.2 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.435 0.636 . . . . 6.75 111.354 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.522 ' CG ' ' HB2' ' A' ' 52' ' ' ALA . 10.9 t-80 -94.64 135.42 36.13 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.642 -2.355 . . . . 1.5900000000000001 104.642 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 5.7 mm -110.86 -36.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 117.901 -1.52 . . . . 2.3300000000000001 109.579 -178.337 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.15 -144.74 12.29 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.239 -1.458 . . . . 1.78 111.354 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' CG1' ' A' ' 62' ' ' ILE . . . -103.77 -60.8 0.69 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-O 119.178 -0.79 . . . . 2.5699999999999998 112.942 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -150.13 -68.43 0.2 Allowed 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 117.914 -1.515 . . . . 3.4500000000000002 111.118 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 p -49.06 -51.46 31.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.078 -1.082 . . . . 3.25 108.078 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.94 -53.74 14.99 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.746 -1.57 . . . . 3.54 110.667 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.567 ' CG ' HG22 ' A' ' 62' ' ' ILE . 40.8 t80 -59.13 -51.36 70.36 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.169 -0.678 . . . . 1.02 109.169 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.2 -53.13 18.0 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.914 -0.773 . . . . 2.6600000000000001 108.914 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -63.35 1.21 Allowed 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 114.814 -1.084 . . . . 1.9299999999999999 109.051 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.649 ' CH2' HG12 ' A' ' 64' ' ' VAL . 68.5 t90 -43.06 -53.96 4.59 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.773 -0.771 . . . . 1.71 109.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.0 t -44.87 -63.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.994 -1.113 . . . . 3.0600000000000001 107.994 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -52.9 -48.03 67.52 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.996 -1.081 . . . . 4.3899999999999997 110.3 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.57 20.81 0.21 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.536 0.569 . . . . 3.9900000000000002 112.536 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -142.77 -38.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.328 -0.549 . . . . 2.29 111.37 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.6 mt -94.35 -14.41 25.37 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.039 -0.665 . . . . 2.8399999999999999 112.01 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.3 -49.22 2.49 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.62 -0.832 . . . . 3.9399999999999999 110.557 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 116.895 -1.526 . . . . 6.0300000000000002 109.221 179.783 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.437 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 93.0 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.43 -0.952 . . . . 3.3399999999999999 108.43 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.553 ' HG2' ' N ' ' A' ' 3' ' ' THR . 6.5 tt0 -116.47 157.61 24.9 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.114 -1.034 . . . . 4.6100000000000003 111.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.553 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 75.8 m -145.08 127.65 16.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.261 -0.644 . . . . 2.1200000000000001 109.261 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.62 136.69 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.899 -0.778 . . . . 2.4399999999999999 108.899 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.4 mm -113.21 130.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.263 -1.014 . . . . 2.73 108.263 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.602 ' CD2' HG12 ' A' ' 36' ' ' VAL . 16.0 m-85 -108.0 97.78 7.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.025 0.828 . . . . 1.5700000000000001 109.916 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.32 -141.74 4.53 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 108.845 -1.702 . . . . 0.90000000000000002 108.845 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.714 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -116.89 176.76 4.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.213 -0.662 . . . . 6.9800000000000004 109.213 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.538 ' N ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -83.21 61.9 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.91 . . . . 3.6600000000000001 110.55 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.5 68.72 0.61 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.243 -1.456 . . . . 3.7799999999999998 110.724 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.36 113.04 35.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.548 -1.278 . . . . 2.6899999999999999 107.548 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.19 -50.29 1.61 Allowed 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 122.291 1.994 . . . . 3.6899999999999999 113.143 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -68.66 -47.75 65.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.299 -1.36 . . . . 3.5099999999999998 111.408 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -58.23 -42.73 86.95 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 118.048 -1.461 . . . . 2.8900000000000001 110.243 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.8 -26.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 115.018 -0.992 . . . . 2.1499999999999999 110.791 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 16' ' ' ARG . 4.2 tpp180 -74.02 -50.21 20.84 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.031 -1.067 . . . . 5.25 109.322 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.35 -41.53 65.89 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.492 -1.67 . . . . 2.0800000000000001 106.492 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.521 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 11.9 tmtt? -55.56 -58.98 5.52 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 113.948 -1.478 . . . . 3.29 108.255 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.521 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 79.4 m-20 -54.3 -53.47 53.4 Favored 'General case' 0 C--O 1.191 -1.998 0 C-N-CA 118.984 -1.087 . . . . 3.7000000000000002 110.098 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 tp -46.17 -60.76 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.026 -1.07 . . . . 2.0499999999999998 110.353 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.13 34.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.877 -1.129 . . . . 2.0299999999999998 111.032 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.452 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 35.2 tt0 -52.36 -56.49 14.56 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.386 -0.926 . . . . 2.7999999999999998 110.948 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 66.0 tttp -45.59 -57.17 4.38 Favored 'General case' 0 C--O 1.2 -1.54 0 CA-C-N 114.238 -1.347 . . . . 5.4400000000000004 108.32 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.32 -45.77 80.17 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.684 -1.206 . . . . 2.7000000000000002 110.03 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -50.3 -49.44 53.58 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.637 -0.71 . . . . 2.9700000000000002 111.015 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -81.15 -28.79 34.92 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.928 -0.709 . . . . 3.7400000000000002 112.185 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 62.0 mt-10 -100.93 42.01 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.21 1.005 . . . . 6.46 112.692 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.577 ' HA ' ' NE ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -149.34 -143.71 0.14 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.104 -1.039 . . . . 6.3099999999999996 109.316 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.482 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -133.88 -48.94 0.81 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.645 -0.872 . . . . 4.1200000000000001 108.645 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 31' ' ' PHE . 51.6 t0 -98.75 -81.69 0.44 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.812 -1.086 . . . . 3.3100000000000001 110.382 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 30' ' ' ASP . 21.3 t80 1.56 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 124.349 1.03 . . . . 2.1899999999999999 113.544 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.439 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 64.9 mt-30 -94.24 112.16 23.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.895 -1.522 . . . . 3.8300000000000001 107.291 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.452 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.34 164.17 12.94 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.39 -1.324 . . . . 1.77 111.335 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.91 157.46 44.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.742 -1.947 . . . . 4.8499999999999996 105.742 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -110.43 149.45 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.545 -1.262 . . . . 1.48 109.1 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.602 HG12 ' CD2' ' A' ' 6' ' ' PHE . 1.8 t -132.75 147.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.635 -0.711 . . . . 1.8300000000000001 109.579 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -119.73 121.15 38.56 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.152 0.977 . . . . 2.04 110.323 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 pt -57.61 -30.44 36.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.087 -0.96 . . . . 2.27 111.783 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.77 9.16 14.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 117.652 -1.619 . . . . 6.6299999999999999 111.826 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.46 -43.18 3.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.898 -1.519 . . . . 1.8100000000000001 106.898 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -74.3 -36.52 63.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.355 -0.98 . . . . 3.8599999999999999 108.355 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.68 46.18 1.23 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.184 -1.566 . . . . 1.8300000000000001 109.184 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.486 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 90.2 mt -108.11 145.99 14.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.881 -0.659 . . . . 3.1699999999999999 112.625 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.4 p -117.89 -94.1 0.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.215 -1.032 . . . . 3.8999999999999999 108.215 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -135.47 -61.59 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.417 -0.956 . . . . 6.9100000000000001 108.417 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -36.37 -52.82 0.84 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.589 -1.187 . . . . 3.27 111.467 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -58.82 -56.91 16.09 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.865 -1.134 . . . . 3.1499999999999999 110.516 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.486 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 48.9 mt -49.37 -47.67 47.38 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.219 -0.992 . . . . 2.54 110.021 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -56.55 -53.73 54.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.707 -1.197 . . . . 5.0800000000000001 108.481 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -52.08 -64.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.395 1.059 . . . . 5.5499999999999998 111.284 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -58.28 -45.81 87.21 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.448 -0.796 . . . . 4.3499999999999996 112.405 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.602 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -58.04 -38.79 76.91 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 123.958 0.786 . . . . 2.3100000000000001 110.095 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.67 39.98 6.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.644 -1.783 . . . . 2.9399999999999999 108.644 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -119.44 151.62 51.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.195 -1.002 . . . . 5.7699999999999996 110.499 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.6 -25.33 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.863 1.709 . . . . 5.3799999999999999 111.671 154.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.27 108.19 23.2 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 112.416 -2.175 . . . . 7.1299999999999999 108.928 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 167.87 11.33 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.876 -1.056 . . . . 5.9900000000000002 111.861 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.2 p -156.1 174.97 14.58 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.484 -2.043 . . . . 6.6799999999999997 105.484 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.13 156.36 45.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 118.319 -1.352 . . . . 4.8300000000000001 108.573 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.08 -172.6 9.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 124.386 -1.089 . . . . 2.4300000000000002 111.291 -17.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -119.77 147.36 44.72 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 107.624 -1.25 . . . . 4.2699999999999996 107.624 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.505 ' N ' HD13 ' A' ' 62' ' ' ILE . 5.0 mp -122.86 143.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 122.317 1.056 . . . . 2.4900000000000002 112.53 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.555 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 39.6 m-85 -123.0 124.84 44.05 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 112.141 -2.3 . . . . 1.5 106.18 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.613 ' CG1' ' H ' ' A' ' 65' ' ' ASP . 41.7 t -97.52 -172.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.065 -1.454 . . . . 1.98 107.52 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.613 ' H ' ' CG1' ' A' ' 64' ' ' VAL . 32.7 t70 -48.47 -35.0 12.08 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 112.954 0.724 . . . . 2.8300000000000001 112.954 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -94.2 -72.66 0.6 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.522 -1.271 . . . . 9.5899999999999999 113.892 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -134.97 -167.02 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.274 0.842 . . . . 6.46 113.274 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.602 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 35.9 t-80 -70.14 140.6 52.65 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 104.79 -2.3 . . . . 2.0800000000000001 104.79 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.553 HG13 ' CG2' ' A' ' 64' ' ' VAL . 16.0 mm -107.5 -34.85 2.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 119.081 -1.048 . . . . 2.0899999999999999 110.552 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.42 -150.14 21.88 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.465 -1.35 . . . . 1.74 110.644 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.77 -169.1 33.83 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.035 -1.226 . . . . 1.74 110.035 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.36 -47.53 66.08 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.755 -1.178 . . . . 2.4500000000000002 110.733 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -62.49 -61.64 2.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.409 -0.917 . . . . 1.99 109.952 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 74' ' ' ASP . 1.2 m-20 -42.98 -54.27 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.426 -1.261 . . . . 2.9100000000000001 109.389 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 41.7 t80 -61.23 -57.23 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.811 -1.086 . . . . 1.1100000000000001 109.423 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -42.32 -54.58 3.7 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.12 -0.632 . . . . 1.73 110.32 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -59.44 -57.64 12.08 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.035 -0.984 . . . . 2.4100000000000001 108.488 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.464 ' CH2' HG12 ' A' ' 64' ' ' VAL . 85.0 t90 -41.99 -47.14 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.079 -0.711 . . . . 1.77 109.079 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 92.6 t -62.26 -36.92 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.833 -0.621 . . . . 2.23 109.513 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.51 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -94.52 22.24 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.147 -0.478 . . . . 4.9199999999999999 112.106 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -134.79 -40.86 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.954 -0.566 . . . . 4.5599999999999996 110.13 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -92.85 -23.32 18.85 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 116.057 -0.519 . . . . 2.9100000000000001 112.309 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 39.8 mt -100.93 13.12 36.17 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.277 -1.369 . . . . 2.6000000000000001 110.894 -179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.51 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 5.2 m-20 -115.17 -63.52 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.921 -0.711 . . . . 4.6200000000000001 110.847 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.58 -1.2 . . . . 7.0700000000000003 108.109 179.12 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 30' ' ' ASP . 29.0 ttm . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 106.52 -1.659 . . . . 3.8399999999999999 106.52 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -122.79 85.33 2.4 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.906 -0.718 . . . . 4.54 109.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 27.7 m -88.71 131.22 35.11 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.26 -1.015 . . . . 2.3399999999999999 108.26 179.694 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.6 138.19 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.781 -0.822 . . . . 1.97 108.781 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -114.96 119.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 124.559 1.162 . . . . 3.1899999999999999 109.326 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -92.25 85.98 5.6 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.801 -2.296 . . . . 3.46 104.801 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.15 -168.45 15.16 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.634 -1.746 . . . . 0.93999999999999995 110.593 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.581 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.61 133.14 54.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.81 -0.811 . . . . 6.7199999999999998 108.81 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.629 ' HG ' ' CG ' ' A' ' 37' ' ' ASP . 2.8 p -67.57 94.16 0.4 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.36 -0.836 . . . . 4.0 110.017 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.01 22.87 8.04 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.721 -0.951 . . . . 3.25 110.721 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.487 ' CB ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -104.03 115.61 62.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 120.132 -0.627 . . . . 3.3700000000000001 110.734 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 -31.43 90.57 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.554 2.17 . . . . 3.6200000000000001 111.593 -159.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -92.72 -37.56 12.3 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.727 -1.124 . . . . 3.4399999999999999 110.9 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.581 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 63.8 m -51.83 -45.18 63.85 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.631 -1.228 . . . . 2.23 109.199 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -46.58 -41.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.656 -1.156 . . . . 2.5699999999999998 111.417 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.559 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -44.6 -37.11 3.38 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 112.157 0.429 . . . . 7.5599999999999996 112.157 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.88 98.46 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.699 -1.201 . . . . 1.6399999999999999 108.205 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.415 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.5 tmtm? -73.28 -32.98 64.97 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.17 -1.012 . . . . 3.2200000000000002 110.672 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.559 ' CG ' HH21 ' A' ' 16' ' ' ARG . 5.7 m-20 -51.31 -57.49 8.73 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.015 -1.474 . . . . 3.27 108.647 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -46.13 -61.2 1.87 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.171 0.804 . . . . 2.21 113.171 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.427 ' HB2' ' CD2' ' A' ' 33' ' ' TYR . . . -39.17 -39.85 0.65 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.668 0.618 . . . . 2.0600000000000001 112.668 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -50.57 69.99 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.076 -1.05 . . . . 3.1099999999999999 110.051 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.496 ' HZ1' ' CD ' ' A' ' 27' ' ' GLU . 5.2 tmtt? -45.13 -46.95 12.15 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.5 -1.227 . . . . 6.8300000000000001 110.256 179.939 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.2 mt -72.34 -50.03 29.89 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.208 -1.36 . . . . 2.3599999999999999 112.649 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -55.89 -26.66 48.33 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.804 -0.758 . . . . 1.95 110.803 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -93.09 24.03 3.98 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.003 -0.679 . . . . 3.5099999999999998 110.393 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.496 ' CD ' ' HZ1' ' A' ' 23' ' ' LYS . 52.5 mt-10 -136.32 -49.86 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.646 0.591 . . . . 3.5899999999999999 110.971 179.503 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.2 mpt_? -108.35 124.25 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.256 -0.883 . . . . 5.5999999999999996 111.579 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.53 60.52 0.88 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 124.562 1.163 . . . . 5.9500000000000002 109.156 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t70 -165.04 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.869 -1.514 . . . . 3.1200000000000001 109.841 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.451 ' CE1' ' HB3' ' A' ' 33' ' ' TYR . 14.5 t80 -66.19 102.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.596 -0.729 . . . . 1.22 109.994 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 83.6 mt-30 -91.47 -54.69 3.8 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.287 -0.565 . . . . 4.5099999999999998 111.347 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.464 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER 59.0 149.64 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 O-C-N 126.357 2.285 . . . . 2.3199999999999998 113.507 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -139.65 144.65 37.74 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 115.19 -0.914 . . . . 4.2000000000000002 110.86 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -98.8 138.19 36.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.534 -1.284 . . . . 1.54 107.534 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.53 144.52 35.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.219 -1.4 . . . . 1.72 107.219 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.629 ' CG ' ' HG ' ' A' ' 9' ' ' SER . 3.5 t70 -115.31 118.33 32.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.302 1.001 . . . . 2.2000000000000002 111.738 -178.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.01 -19.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.839 -1.144 . . . . 2.2400000000000002 111.042 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.498 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 1.2 tmm_? -87.14 -9.8 54.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 123.289 0.368 . . . . 6.4699999999999998 111.001 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.39 -39.34 8.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.616 -1.253 . . . . 2.02 107.616 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -104.51 28.16 7.23 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.24 -1.346 . . . . 2.54 109.959 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 27.24 64.49 0.08 OUTLIER Glycine 0 N--CA 1.507 3.413 0 CA-C-N 114.648 -1.16 . . . . 1.96 113.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.56 147.97 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.579 -0.849 . . . . 2.3199999999999998 109.783 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -130.85 173.37 11.02 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.654 -0.818 . . . . 3.9500000000000002 109.217 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' NZ ' ' CD ' ' A' ' 57' ' ' GLU . 0.1 OUTLIER -50.48 -50.78 51.75 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.699 -0.8 . . . . 7.6299999999999999 110.138 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -34.2 -69.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.119 0.887 . . . . 3.4700000000000002 113.063 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.54 -46.25 80.73 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 119.981 -0.687 . . . . 3.3100000000000001 112.853 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLN . 97.8 mt -58.12 -53.2 60.9 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.457 -1.297 . . . . 2.9700000000000002 110.62 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.414 ' C ' ' O ' ' A' ' 48' ' ' LEU . 37.9 mt-30 -42.67 -53.04 4.67 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.153 -1.019 . . . . 4.4800000000000004 108.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -55.56 -44.86 77.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.966 1.416 . . . . 6.1699999999999999 110.873 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.13 11.09 21.92 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.625 -0.83 . . . . 5.5800000000000001 111.85 -179.517 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.683 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -102.77 -66.1 0.95 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.819 0.674 . . . . 2.8700000000000001 112.819 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.34 18.21 34.2 Favored Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.922 -1.133 . . . . 3.52 112.81 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -121.97 24.85 0.11 Allowed Pre-proline 0 N--CA 1.502 2.168 0 CA-C-N 117.714 0.757 . . . . 6.4100000000000001 110.798 179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.59 46.28 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.752 2.301 . . . . 5.9900000000000002 113.437 -105.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.3 15.95 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.982 -1.118 . . . . 6.2699999999999996 107.982 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -84.01 173.82 10.83 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.149 -1.387 . . . . 6.9299999999999997 109.542 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 t -149.22 -156.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.886 -0.726 . . . . 4.8899999999999997 109.31 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.39 131.07 56.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.04 -1.096 . . . . 3.54 108.04 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -99.11 151.76 5.76 Favored 'Cis proline' 0 N--CA 1.481 0.761 0 O-C-N 122.661 0.822 . . . . 2.3799999999999999 111.64 12.388 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -122.62 139.34 54.04 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.231 -0.895 . . . . 3.8199999999999998 109.037 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.548 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.5 mp -118.2 149.66 20.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.669 -1.234 . . . . 2.5 107.669 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 68' ' ' HIS . 22.6 m-85 -134.02 116.65 15.76 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 125.401 1.688 . . . . 1.26 106.726 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.501 HG21 HG13 ' A' ' 69' ' ' ILE . 84.8 t -88.2 108.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 118.067 -1.453 . . . . 1.8999999999999999 110.078 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 54.03 -79.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 123.748 0.655 . . . . 3.04 112.086 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.6 pt20 -128.38 1.9 5.68 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.041 -1.064 . . . . 5.2699999999999996 111.654 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 10.0 mp0 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.946 -0.391 . . . . 5.21 109.946 179.311 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.683 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 7.0 t-80 -106.66 132.75 52.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.733 -1.21 . . . . 1.77 107.733 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.501 HG13 HG21 ' A' ' 64' ' ' VAL . 5.3 mm -111.09 -56.17 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 105.867 -1.901 . . . . 2.1899999999999999 105.867 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 68.87 88.09 0.08 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 116.261 1.265 . . . . 3.0600000000000001 116.261 177.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 131.18 3.78 Favored Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.282 -1.437 . . . . 3.04 114.632 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' C ' ' H ' ' A' ' 74' ' ' ASP . 22.4 t80 -66.23 -58.09 6.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.553 -0.859 . . . . 2.0800000000000001 109.124 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 14.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.619 0.6 . . . . 2.8999999999999999 112.619 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.54 ' H ' ' C ' ' A' ' 72' ' ' TYR . 7.9 t70 -119.37 -63.92 1.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.753 -1.943 . . . . 3.1400000000000001 105.753 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 67.0 t80 -56.41 -39.05 72.39 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.878 -1.51 . . . . 1.1200000000000001 108.426 179.22 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.302 -0.863 . . . . 1.8200000000000001 109.634 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.21 -53.43 43.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.023 -1.103 . . . . 2.7799999999999998 108.023 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 89.8 t90 -41.39 -65.45 0.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.362 -1.29 . . . . 1.8 110.862 179.546 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.8 t -42.82 -52.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.505 -0.924 . . . . 1.8200000000000001 108.505 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.448 ' HZ2' ' CD ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -46.81 -42.29 16.88 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.417 -1.72 . . . . 5.7800000000000002 109.919 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.448 ' CD ' ' HZ2' ' A' ' 80' ' ' LYS . 20.1 mp0 -106.81 25.18 11.59 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 120.085 -0.646 . . . . 4.7999999999999998 112.495 179.163 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -129.85 -43.02 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.379 -1.328 . . . . 2.2999999999999998 113.817 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 26.4 mt -101.54 32.26 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.118 -2.178 . . . . 2.46 105.118 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 5.3 m-20 55.3 30.69 15.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.026 -1.897 . . . . 6.1500000000000004 106.773 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.531 3.59 0 O-C-N 125.706 1.879 . . . . 9.1500000000000004 111.776 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.426 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 33.4 tpp . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.629 -0.508 . . . . 4.0099999999999998 109.629 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 8.5 pt20 -94.42 173.17 7.76 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.623 -1.231 . . . . 4.1299999999999999 108.515 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.422 ' OG1' ' CZ ' ' A' ' 31' ' ' PHE . 86.6 m -130.2 145.35 51.72 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.074 -1.05 . . . . 2.1899999999999999 111.812 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.29 118.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 105.737 -1.949 . . . . 1.8100000000000001 105.737 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.445 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 30.7 mt -100.07 113.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.009 -1.108 . . . . 4.0899999999999999 108.009 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.505 ' CD2' HG13 ' A' ' 36' ' ' VAL . 45.6 m-85 -97.58 78.06 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 105.747 -1.946 . . . . 1.6200000000000001 105.747 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.74 1.91 Allowed Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.781 -1.676 . . . . 1.03 112.04 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.457 ' O ' ' CB ' ' A' ' 9' ' ' SER . 0.2 OUTLIER 179.23 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.811 -1.181 . . . . 5.8700000000000001 107.811 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.457 ' CB ' ' O ' ' A' ' 8' ' ' ARG . 13.2 m 97.29 162.92 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 O-C-N 125.335 1.647 . . . . 5.04 110.4 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.415 ' H ' ' CG2' ' A' ' 15' ' ' VAL . . . 97.12 -12.37 65.44 Favored Glycine 0 N--CA 1.503 3.14 0 C-N-CA 120.194 -1.003 . . . . 3.8199999999999998 110.637 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.448 ' N ' ' SG ' ' A' ' 14' ' ' CYS . 0.5 OUTLIER -115.58 143.63 30.94 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.91 -0.645 . . . . 2.9100000000000001 110.724 -179.127 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 -54.71 5.01 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.257 1.305 . . . . 4.4199999999999999 111.675 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -67.94 -2.58 7.76 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 113.802 1.038 . . . . 3.5699999999999998 113.802 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' SG ' ' HA ' ' A' ' 9' ' ' SER . 29.4 p -111.66 -41.87 3.97 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.651 -1.22 . . . . 2.3300000000000001 109.09 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.565 ' C ' ' H ' ' A' ' 17' ' ' ALA . 49.0 t -73.04 -30.98 33.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 118.824 -1.15 . . . . 2.0 108.357 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 9.3 mmm180 -71.9 23.47 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 C-N-CA 119.919 -0.712 . . . . 4.4699999999999998 110.976 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.565 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -121.49 -48.87 2.16 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.64 -1.245 . . . . 1.9099999999999999 107.64 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.477 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.9 tmtm? -57.97 -29.15 65.0 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.873 -0.731 . . . . 3.5299999999999998 110.169 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 20' ' ' LEU . 3.6 p-10 -81.06 -38.66 27.0 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.727 -0.789 . . . . 3.2799999999999998 108.926 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.478 HD21 ' CD2' ' A' ' 75' ' ' PHE . 34.2 tp -60.23 -49.06 79.11 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.686 -1.598 . . . . 1.98 106.686 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.65 71.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.008 -1.108 . . . . 2.02 108.008 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.435 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 3.2 tp10 -63.48 -56.98 11.75 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.559 -1.256 . . . . 3.3599999999999999 108.496 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.554 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -55.11 -51.88 65.01 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 118.356 -1.338 . . . . 5.46 108.145 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.487 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.426 -1.31 . . . . 2.3199999999999998 109.459 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.1 m -51.23 -43.47 61.47 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 118.72 -1.192 . . . . 1.75 108.718 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.98 42.46 1.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.874 -1.057 . . . . 4.8200000000000003 108.994 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.554 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 14.9 mm-40 -144.8 -58.7 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.957 -1.02 . . . . 3.1800000000000002 113.492 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' HE ' ' HB3' ' A' ' 27' ' ' GLU . 3.5 mmt180 -101.45 -157.89 0.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.809 -1.087 . . . . 6.1799999999999997 112.476 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -102.61 -75.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.177 -0.92 . . . . 4.9000000000000004 113.411 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.62 53.57 2.73 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.627 -1.229 . . . . 3.4199999999999999 112.418 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 1' ' ' MET . 39.9 t80 -117.92 140.11 50.19 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.963 -1.095 . . . . 1.6200000000000001 109.87 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 43.7 mt-30 -156.64 179.95 8.77 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.12 -1.807 . . . . 3.8700000000000001 106.12 179.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -171.58 159.26 5.4 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.073 -1.451 . . . . 1.51 111.369 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -133.09 151.36 52.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.772 -1.566 . . . . 4.5099999999999998 106.772 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -103.67 144.9 30.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.464 -1.695 . . . . 1.79 109.678 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.505 HG13 ' CD2' ' A' ' 6' ' ' PHE . 2.4 t -132.71 148.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.453 -1.249 . . . . 1.73 108.925 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.07 113.37 20.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.627 -1.249 . . . . 2.21 107.627 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 30.9 pt -44.59 -31.03 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.391 0 CA-C-N 115.211 -0.904 . . . . 2.52 110.466 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 43.6 ttp180 -71.72 -60.44 2.23 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.112 -1.035 . . . . 5.7199999999999998 109.322 -179.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.34 -43.25 1.15 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.573 0.546 . . . . 2.0 110.174 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.61 -48.37 26.89 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.283 0.989 . . . . 4.46 109.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.33 41.51 0.81 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.41 -0.9 . . . . 2.4700000000000002 111.235 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.432 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 62.7 mt -103.74 164.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.637 -0.505 . . . . 3.3700000000000001 109.637 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 40.2 p -113.25 -104.86 0.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.612 -0.722 . . . . 3.96 112.87 -179.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.442 ' HE3' ' HB2' ' A' ' 57' ' ' GLU . 34.7 tttp -142.82 -25.77 0.61 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.061 0.934 . . . . 8.0700000000000003 109.614 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.512 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.1 mp0 -86.98 -53.37 4.92 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 4.8099999999999996 108.311 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' LEU . 17.9 t70 -47.5 -61.87 1.71 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.704 -0.798 . . . . 3.5 111.397 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -34.36 -46.89 0.28 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.436 -0.802 . . . . 3.2200000000000002 111.073 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 53' ' ' GLY . 74.4 mt-30 -54.99 -54.56 41.38 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.119 -1.032 . . . . 6.3700000000000001 108.486 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 2.0 mp0 -60.79 -36.86 80.07 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.711 -0.796 . . . . 7.6699999999999999 109.93 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -64.26 -29.43 70.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.79 -1.096 . . . . 5.0 110.12 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.557 ' HB2' ' CD2' ' A' ' 68' ' ' HIS . . . -100.68 -74.81 0.6 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.68 -1.146 . . . . 2.9700000000000002 109.595 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' GLN . . . 121.94 39.78 0.55 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.73 -1.224 . . . . 3.96 111.178 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 22.3 mmtp -138.05 152.01 71.12 Favored Pre-proline 0 N--CA 1.499 2.017 0 C-N-CA 119.454 -0.898 . . . . 7.4500000000000002 110.072 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.63 49.54 3.21 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 122.391 2.061 . . . . 6.7999999999999998 111.188 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.415 HG23 ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.64 94.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 115.188 -0.914 . . . . 8.0999999999999996 108.707 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.442 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.49 -0.67 11.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.853 -0.739 . . . . 8.4499999999999993 111.554 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.415 ' CG2' ' N ' ' A' ' 59' ' ' VAL . 16.7 m -88.67 171.85 9.7 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.149 0.5 . . . . 6.0700000000000003 110.434 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 ' N ' ' CG2' ' A' ' 58' ' ' THR . 13.2 p -101.05 160.32 26.98 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 115.847 -0.615 . . . . 4.2999999999999998 110.678 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -100.12 -163.77 0.54 Allowed 'Cis proline' 0 N--CA 1.484 0.967 0 CA-C-O 121.926 0.719 . . . . 2.3599999999999999 111.344 -27.18 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -124.58 155.24 39.4 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.298 -1.319 . . . . 4.4000000000000004 108.608 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.436 ' CD1' HG22 ' A' ' 5' ' ' ILE . 36.2 mm -121.97 146.05 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 123.984 0.803 . . . . 3.3399999999999999 110.251 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.567 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 12.5 m-85 -123.22 130.67 53.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.727 -1.579 . . . . 1.4099999999999999 107.257 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.441 ' CG2' HG13 ' A' ' 69' ' ' ILE . 55.3 t -109.81 138.06 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 118.221 -1.391 . . . . 1.8300000000000001 109.275 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.2 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.2 -1.818 . . . . 3.0600000000000001 111.716 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -136.47 -2.64 2.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.601 0.563 . . . . 7.0199999999999996 111.499 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.451 HE21 ' CA ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -115.31 176.4 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.423 0.63 . . . . 5.9500000000000002 111.699 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.567 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -96.49 147.0 24.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.176 -1.787 . . . . 2.9500000000000002 106.176 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.441 HG13 ' CG2' ' A' ' 64' ' ' VAL . 41.7 mm -116.14 -46.5 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.703 -1.199 . . . . 1.74 110.414 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.69 -153.09 25.07 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.438 -1.363 . . . . 1.76 111.173 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.47 -170.47 47.15 Favored Glycine 0 N--CA 1.504 3.226 0 C-N-CA 119.242 -1.456 . . . . 1.78 112.149 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.9 t80 -51.93 -45.09 64.17 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.069 -0.652 . . . . 2.6099999999999999 109.836 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 p -64.34 -42.45 96.25 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.349 -0.94 . . . . 1.97 109.297 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.478 ' CG ' ' NZ ' ' A' ' 54' ' ' LYS . 21.0 m-20 -62.32 -48.79 78.3 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.198 -1.401 . . . . 2.6800000000000002 110.018 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.478 ' CD2' HD21 ' A' ' 20' ' ' LEU . 12.8 t80 -60.62 -51.81 67.81 Favored 'General case' 0 C--O 1.2 -1.5 0 C-N-CA 117.936 -1.506 . . . . 1.23 108.102 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.79 30.52 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.453 -0.899 . . . . 1.95 111.077 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.04 -55.3 13.07 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.696 -0.802 . . . . 1.8 109.538 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -41.41 -47.46 3.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.929 -1.137 . . . . 1.22 107.929 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.46 ' C ' ' H ' ' A' ' 81' ' ' GLU . 40.9 t -61.14 -57.69 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 106.16 -1.793 . . . . 1.95 106.16 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.522 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 1.3 tmtm? -75.96 32.18 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.83 -0.748 . . . . 4.4900000000000002 110.427 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.46 ' H ' ' C ' ' A' ' 79' ' ' VAL . 28.2 tt0 -132.37 -56.55 0.96 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.511 0.672 . . . . 5.4500000000000002 109.262 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -98.64 -11.54 21.97 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.857 -1.065 . . . . 2.1499999999999999 111.155 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -108.23 -34.65 6.77 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.76 -1.176 . . . . 2.3599999999999999 108.842 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.407 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 18.9 m-20 -139.59 60.27 1.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.161 -1.016 . . . . 6.0599999999999996 110.541 179.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.522 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.51 2.548 0 CA-C-O 115.569 -2.158 . . . . 7.5300000000000002 114.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 30' ' ' ASP . 69.0 mtm . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 107.988 -1.116 . . . . 3.0499999999999998 107.988 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 20.1 mt-30 -128.04 157.43 40.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 123.633 0.583 . . . . 4.1699999999999999 110.029 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -141.6 141.71 33.46 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.819 -0.752 . . . . 1.6699999999999999 112.065 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.0 t -133.11 139.09 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 106.539 -1.652 . . . . 1.6000000000000001 106.539 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 4.6 mp -123.66 128.17 74.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.354 -0.98 . . . . 3.1400000000000001 108.354 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -97.37 61.12 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.386 -1.339 . . . . 1.4399999999999999 107.386 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -104.96 -158.5 23.36 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.153 -1.979 . . . . 1.3 108.153 -179.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 21.9 ttp-105 -127.73 169.29 13.99 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.507 -1.294 . . . . 6.5300000000000002 107.507 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -52.72 -50.16 63.94 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.182 -1.044 . . . . 4.4100000000000001 108.182 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.431 ' O ' ' HB3' ' A' ' 11' ' ' CYS . . . -149.06 166.87 29.44 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.803 -1.189 . . . . 3.3599999999999999 111.366 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.4 p 167.84 42.51 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.366 0 CA-C-O 122.795 1.283 . . . . 3.7000000000000002 108.407 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -20.94 -48.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.431 2.754 . . . . 3.4399999999999999 112.765 -99.525 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -27.4 -40.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 124.772 1.295 . . . . 2.9500000000000002 113.907 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 85.1 m -53.59 -45.16 69.91 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.948 -0.701 . . . . 1.8600000000000001 112.322 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.34 -34.49 50.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.887 -0.597 . . . . 2.1899999999999999 111.081 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.504 ' HA ' ' NE ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -50.96 -51.35 53.41 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.882 -1.127 . . . . 5.0300000000000002 112.043 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.2 -42.66 81.67 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.302 -0.959 . . . . 2.0499999999999998 109.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 28.8 tttm -63.22 -52.99 59.98 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.214 -1.357 . . . . 3.27 114.007 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.484 ' O ' ' CB ' ' A' ' 23' ' ' LYS . 2.4 p30 -53.82 -34.04 58.01 Favored 'General case' 0 C--O 1.198 -1.651 0 C-N-CA 118.282 -1.367 . . . . 3.3799999999999999 111.083 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.85 -42.44 89.34 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.269 -1.372 . . . . 1.8799999999999999 109.703 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.93 19.34 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 120.448 -0.501 . . . . 2.1400000000000001 110.971 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.469 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 22.6 tt0 -59.29 -40.95 87.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.845 -1.169 . . . . 3.3100000000000001 107.845 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.506 ' O ' ' HG2' ' A' ' 27' ' ' GLU . 4.6 ttmp? -64.0 -55.85 19.37 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 106.826 -1.546 . . . . 7.0099999999999998 106.826 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.67 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 28.9 mt -46.96 -47.31 21.85 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 119.915 -0.714 . . . . 2.0299999999999998 110.445 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -57.87 -11.42 2.32 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 124.256 0.972 . . . . 2.1200000000000001 112.541 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -114.83 -41.04 3.43 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.12 -0.491 . . . . 3.7999999999999998 111.067 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.67 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 13.0 pt-20 -74.65 -37.78 62.66 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.254 -0.885 . . . . 3.9100000000000001 111.708 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' NE ' ' O ' ' A' ' 29' ' ' ASP . 3.3 ttp180 -114.22 -168.26 1.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.388 0.613 . . . . 6.8600000000000003 111.081 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 9.0 p-10 -124.12 -168.33 1.78 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 105.521 -2.029 . . . . 3.98 105.521 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.4 t70 37.53 41.39 0.28 Allowed 'General case' 0 N--CA 1.508 2.474 0 O-C-N 123.677 0.611 . . . . 3.4300000000000002 110.543 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.38 93.07 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.441 -0.903 . . . . 1.6100000000000001 109.889 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.499 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 11.7 mm100 -105.49 117.73 34.77 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.592 -1.633 . . . . 4.4400000000000004 106.592 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.466 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -119.12 155.55 31.37 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.984 -1.007 . . . . 2.1400000000000001 112.157 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.84 150.0 50.52 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.515 -2.031 . . . . 4.4100000000000001 105.515 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.435 ' CE1' ' HB2' ' A' ' 18' ' ' LYS . 26.0 t80 -112.08 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.784 -1.566 . . . . 2.2000000000000002 108.48 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.45 ' HB ' ' O ' ' A' ' 5' ' ' ILE . 2.1 t -124.66 155.28 32.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.351 -1.351 . . . . 2.1499999999999999 107.351 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 39' ' ' ARG . 1.8 t70 -127.69 42.71 3.27 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.831 0.678 . . . . 2.6600000000000001 112.831 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.489 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.83 -65.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 114.97 1.47 . . . . 3.0299999999999998 114.97 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -56.21 -51.29 68.62 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 5.29 108.521 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -42.83 2.25 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.902 -1.044 . . . . 1.8300000000000001 111.203 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.26 -47.85 17.01 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.995 -1.113 . . . . 4.4199999999999999 107.995 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.52 46.4 0.92 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.417 -1.873 . . . . 1.6000000000000001 108.417 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.8 mm -89.23 155.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 120.374 -0.53 . . . . 3.4300000000000002 111.824 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' GLU . 34.2 p -126.47 95.29 4.31 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.864 -0.607 . . . . 3.1200000000000001 111.615 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 tttm 6.12 -64.6 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 116.656 2.095 . . . . 5.21 116.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' THR . 6.6 mm-40 -47.86 -44.99 29.76 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.252 -0.979 . . . . 4.6799999999999997 110.841 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.528 ' CG ' ' HZ2' ' A' ' 51' ' ' LYS . 1.2 t70 -58.5 -37.65 76.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.315 -0.857 . . . . 3.23 110.5 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.437 ' HA ' ' CG ' ' A' ' 51' ' ' LYS . 6.7 mt -65.2 -45.86 83.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.135 -1.061 . . . . 2.3599999999999999 108.135 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.419 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 13.1 mt-30 -49.99 -41.69 47.49 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.517 -1.29 . . . . 5.0700000000000003 107.517 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -66.8 -60.74 2.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.608 -0.723 . . . . 5.6600000000000001 112.496 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.528 ' HZ2' ' CG ' ' A' ' 47' ' ' ASP . 0.1 OUTLIER -60.46 -37.68 81.74 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.434 -0.906 . . . . 5.9100000000000001 113.295 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.534 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -86.55 -53.43 4.98 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.719 0.771 . . . . 2.96 110.481 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.18 -55.73 0.59 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.123 -1.591 . . . . 3.5699999999999998 109.123 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.79 74.7 37.93 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 119.602 -0.839 . . . . 6.4100000000000001 113.08 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.402 ' HD3' ' CB ' ' A' ' 52' ' ' ALA . 11.9 Cg_endo -89.59 140.96 3.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.223 1.948 . . . . 9.8000000000000007 107.615 126.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.91 -15.78 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.971 -0.692 . . . . 6.3899999999999997 110.043 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -119.27 -105.21 0.39 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.845 -0.616 . . . . 6.9699999999999998 111.295 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.442 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 98.2 m -140.43 -57.09 0.53 Allowed 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.782 -0.767 . . . . 7.1600000000000001 109.542 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 42.1 t -112.63 151.63 44.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.662 -0.815 . . . . 5.2300000000000004 109.018 -179.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.426 ' HG2' ' N ' ' A' ' 72' ' ' TYR . 12.9 Cg_endo -97.67 173.47 10.38 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 O-C-N 122.619 0.799 . . . . 3.5899999999999999 111.592 -14.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 3.1 mp0 -130.97 119.97 22.84 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 7.1200000000000001 109.237 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.542 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.9 mp -127.39 146.71 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.511 -0.876 . . . . 2.1099999999999999 111.309 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 16.2 m-85 -126.86 133.05 50.81 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.01 -1.904 . . . . 1.3300000000000001 107.035 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.562 HG12 ' CH2' ' A' ' 78' ' ' TRP . 85.5 t -131.76 150.6 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 118.733 -1.187 . . . . 2.0899999999999999 110.097 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.412 ' HB3' ' NE2' ' A' ' 67' ' ' GLN . 8.9 t70 60.12 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.464 -1.698 . . . . 5.0099999999999998 107.978 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.407 ' HG3' ' C ' ' A' ' 65' ' ' ASP . 36.5 mt-30 -139.27 -16.27 1.07 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 124.209 0.943 . . . . 6.46 112.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . 0.412 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.2 171.99 7.13 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.756 -0.778 . . . . 4.5700000000000003 113.085 -178.041 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.534 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 9.4 t-80 -81.0 153.55 27.37 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.858 -1.904 . . . . 1.3600000000000001 105.858 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 12.2 mm -116.2 -43.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.4 -1.32 . . . . 1.8300000000000001 109.81 -178.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.503 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 139.93 -131.33 5.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.466 -1.454 . . . . 1.75 109.466 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.435 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.88 -154.27 12.55 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.756 -0.937 . . . . 1.6399999999999999 110.756 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.426 ' N ' ' HG2' ' A' ' 60' ' ' PRO . 26.9 t80 -57.67 -56.33 23.37 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.1 -1.04 . . . . 2.3700000000000001 111.01 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -38.24 17.24 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.878 -0.729 . . . . 2.5299999999999998 110.537 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.435 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -72.41 -59.42 2.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.051 -0.977 . . . . 2.48 110.259 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.75 -45.8 63.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.471 -0.937 . . . . 1.8400000000000001 108.471 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -58.69 6.63 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.931 -1.031 . . . . 1.8700000000000001 109.272 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.13 -54.97 41.0 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.097 -1.041 . . . . 2.1200000000000001 110.549 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.562 ' CH2' HG12 ' A' ' 64' ' ' VAL . 75.2 t90 -45.81 -53.81 9.04 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.413 -0.915 . . . . 1.8700000000000001 109.131 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.407 HG11 HD11 ' A' ' 83' ' ' LEU . 25.0 t -47.25 -58.82 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 124.453 1.096 . . . . 1.97 108.213 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.602 ' HZ3' ' C ' ' A' ' 85' ' ' ALA . 2.1 tmtm? -56.29 -54.18 48.41 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.015 1.117 . . . . 4.1600000000000001 114.015 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.3 -33.19 70.79 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.519 0.933 . . . . 4.7599999999999998 113.519 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.78 -26.98 13.28 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.182 1.179 . . . . 1.8799999999999999 114.182 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.407 HD11 HG11 ' A' ' 79' ' ' VAL . 11.4 mt -93.24 -22.56 18.94 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.367 -1.333 . . . . 2.5 111.52 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 6.3 m-20 -110.98 -50.95 2.9 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.256 -0.977 . . . . 4.2800000000000002 108.694 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.602 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.502 2.161 0 O-C-N 126.377 2.298 . . . . 6.0800000000000001 107.013 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 34.9 tpp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 3.8399999999999999 108.284 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.519 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 34.8 mt-30 -97.03 97.35 9.16 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.964 -0.694 . . . . 4.5 109.81 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 m -83.02 114.22 21.12 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.513 -0.875 . . . . 2.1899999999999999 109.895 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.67 140.01 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.077 -1.083 . . . . 2.1400000000000001 108.077 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.456 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 17.8 mt -120.1 105.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 124.452 1.095 . . . . 3.54 110.428 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.411 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 31.1 m-85 -84.53 93.86 8.44 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.28 -1.008 . . . . 1.3500000000000001 108.28 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.635 ' CA ' ' SG ' ' A' ' 14' ' ' CYS . . . -106.76 -163.08 22.32 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.051 -1.22 . . . . 1.3899999999999999 110.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.515 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 ttp-105 -141.43 46.68 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.284 -1.366 . . . . 7.0599999999999996 111.902 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' ' OD2' ' A' ' 37' ' ' ASP . 14.4 m 69.61 -70.73 0.14 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.809 1.04 . . . . 4.3099999999999996 113.809 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.14 66.89 0.23 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 119.946 -1.121 . . . . 4.1699999999999999 112.724 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -134.81 113.68 11.81 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.327 -1.36 . . . . 2.9199999999999999 107.327 178.318 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.01 -50.7 9.48 Favored 'Trans proline' 0 C--O 1.205 -1.171 0 N-CA-C 109.033 -1.18 . . . . 4.0499999999999998 109.033 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -52.84 -36.13 58.31 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.051 -0.977 . . . . 3.27 111.993 179.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' CA ' ' A' ' 7' ' ' GLY . 71.0 m -66.36 -53.21 38.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.205 -0.998 . . . . 2.2200000000000002 109.475 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.1 t -62.08 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.8 -1.091 . . . . 2.2000000000000002 110.136 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.55 ' NH2' ' N ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -61.27 -47.48 85.83 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.815 -0.629 . . . . 4.5899999999999999 110.484 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.53 -47.91 80.71 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.058 -1.46 . . . . 1.8300000000000001 107.058 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.458 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.7 tmtm? -56.96 -43.69 81.86 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 118.512 -1.275 . . . . 3.1600000000000001 109.715 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 2.0 t0 -51.98 -51.25 58.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.74 -1.208 . . . . 3.3199999999999998 107.74 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' ' NH2' ' A' ' 16' ' ' ARG . 31.4 tp -56.6 -52.09 66.17 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.929 -1.108 . . . . 2.2799999999999998 110.098 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.51 ' HB2' ' CG ' ' A' ' 33' ' ' TYR . . . -46.17 -51.89 13.29 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.781 -1.168 . . . . 2.3100000000000001 109.937 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -44.3 -47.48 9.51 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.113 0.959 . . . . 3.04 110.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.411 ' NZ ' ' HG2' ' A' ' 27' ' ' GLU . 8.9 tmtm? -75.0 -45.95 38.45 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.385 -1.326 . . . . 5.4100000000000001 111.865 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 1.3 mt -49.56 -48.52 48.46 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 119.375 -0.93 . . . . 2.6600000000000001 110.531 179.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 m -42.99 -32.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.297 -1.774 . . . . 1.8799999999999999 109.579 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -109.92 45.43 1.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.856 -1.065 . . . . 3.4900000000000002 109.863 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.411 ' HG2' ' NZ ' ' A' ' 23' ' ' LYS . 29.6 mm-40 -137.22 -54.46 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.729 -1.123 . . . . 3.8900000000000001 110.103 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.408 ' NH2' ' O ' ' A' ' 83' ' ' LEU . 50.1 mmt-85 -101.78 175.47 5.54 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.875 -1.057 . . . . 5.7800000000000002 109.658 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.41 -51.24 17.99 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.984 -1.462 . . . . 5.0999999999999996 114.324 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 37.3 t70 -118.2 82.08 1.78 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.336 -0.946 . . . . 4.2599999999999998 111.7 -178.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.97 113.45 14.6 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.702 -0.799 . . . . 1.4199999999999999 110.459 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.06 157.87 26.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.682 -1.97 . . . . 5.1200000000000001 105.682 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.51 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 2.9 p90 -156.39 153.48 29.0 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 117.562 -1.655 . . . . 1.3 111.29 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.9 146.68 43.61 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.183 -0.917 . . . . 4.1399999999999997 109.724 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -94.97 144.43 25.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.264 -1.384 . . . . 2.0 107.264 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.99 155.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 123.752 0.657 . . . . 2.2400000000000002 109.685 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' NH1' ' A' ' 39' ' ' ARG . 10.0 t70 -132.62 137.7 47.11 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.474 0.654 . . . . 2.52 109.306 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 31.5 pt -53.7 -25.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.392 0.886 . . . . 2.5 113.392 -178.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 29.8 mtm-85 -88.66 -14.05 38.33 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.53 -1.268 . . . . 5.7000000000000002 110.951 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.47 -40.7 61.71 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.99 -1.485 . . . . 2.5099999999999998 106.99 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.37 -41.45 12.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.489 -1.687 . . . . 3.9700000000000002 109.402 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.76 59.04 0.51 Allowed Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.653 -1.261 . . . . 1.73 111.116 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.2 mt -120.33 154.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.827 -0.749 . . . . 2.9500000000000002 110.386 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -111.07 -160.72 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.052 -1.833 . . . . 3.0099999999999998 106.052 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.464 ' HZ1' ' HB2' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -99.13 18.43 17.44 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 116.772 -1.971 . . . . 5.0 109.413 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -101.76 -62.94 1.19 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.724 -1.58 . . . . 4.0099999999999998 110.993 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' GLN . 1.9 t70 -56.51 -42.92 79.22 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.129 -0.628 . . . . 4.0 109.999 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -43.68 -38.57 3.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.804 -1.159 . . . . 3.1800000000000002 109.948 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.504 HE22 ' N ' ' A' ' 56' ' ' VAL . 39.1 mm-40 -53.12 -42.76 66.32 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.869 -1.132 . . . . 5.8700000000000001 109.219 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' ASP . 73.3 mm-40 -78.05 -37.04 47.62 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.812 -1.085 . . . . 7.4900000000000002 111.665 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -68.81 -37.42 79.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.595 -0.842 . . . . 5.3099999999999996 111.372 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.544 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -88.58 -47.53 8.23 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 124.128 0.893 . . . . 2.6099999999999999 111.301 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.8 15.17 56.98 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.54 -1.424 . . . . 2.8599999999999999 109.54 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.531 ' HZ3' ' CG ' ' A' ' 74' ' ' ASP . 6.5 tttm -118.85 140.01 27.99 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 107.136 -1.431 . . . . 6.5800000000000001 107.136 -179.532 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.49 142.62 11.82 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 120.914 1.076 . . . . 5.4000000000000004 111.662 -165.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.504 ' N ' HE22 ' A' ' 49' ' ' GLN . 40.8 t 66.75 -66.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.629 1.344 . . . . 6.3499999999999996 114.629 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.92 144.55 1.77 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.81 -0.756 . . . . 6.1200000000000001 111.363 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 45' ' ' LYS . 21.8 m -120.87 -65.12 1.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.582 -0.735 . . . . 7.9900000000000002 111.643 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.34 154.76 81.7 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 120.206 -0.598 . . . . 4.6200000000000001 110.254 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.419 ' HB3' ' SG ' ' A' ' 14' ' ' CYS . 9.5 Cg_endo -92.94 142.53 9.3 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 124.284 -1.132 . . . . 1.9399999999999999 109.775 0.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -113.62 141.05 47.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.947 -1.101 . . . . 4.3799999999999999 108.361 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.527 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.5 mp -111.08 139.07 36.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 124.019 0.825 . . . . 2.3399999999999999 108.954 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -118.32 122.49 43.0 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 103.634 -2.728 . . . . 1.6499999999999999 103.634 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 50.3 t -99.53 83.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 117.202 -1.799 . . . . 2.0499999999999998 111.627 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.519 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 28.3 t0 72.85 -60.27 0.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.326 -1.307 . . . . 3.7999999999999998 113.637 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -106.36 -56.14 2.23 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 115.337 1.606 . . . . 7.7999999999999998 115.337 -177.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 15.2 pt20 -118.86 176.2 5.39 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.318 1.229 . . . . 5.2599999999999998 114.318 -177.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.544 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 12.3 t-80 -77.77 147.16 35.45 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.872 -1.529 . . . . 1.6299999999999999 106.872 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.54 HG13 ' CG2' ' A' ' 64' ' ' VAL . 34.4 mm -117.57 -29.36 2.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.8 -0.76 . . . . 2.1600000000000001 111.443 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.411 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 133.84 -156.32 22.25 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.085 -1.606 . . . . 2.1400000000000001 109.085 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.86 -170.74 34.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.502 -1.439 . . . . 1.5900000000000001 109.502 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -52.21 -36.38 51.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.641 -1.224 . . . . 2.1400000000000001 110.446 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 p -64.08 -61.46 2.25 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.37 -1.332 . . . . 2.4100000000000001 109.836 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.531 ' CG ' ' HZ3' ' A' ' 54' ' ' LYS . 2.7 m-20 -54.18 -50.15 67.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.635 -0.711 . . . . 2.4900000000000002 110.313 -178.958 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.19 -46.75 88.66 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 119.543 -0.863 . . . . 1.3899999999999999 109.003 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.91 26.93 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.598 -0.841 . . . . 1.98 110.411 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.36 -58.7 6.24 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.186 -1.005 . . . . 1.8400000000000001 108.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.42 ' O ' ' C ' ' A' ' 79' ' ' VAL . 61.8 t90 -40.66 -57.81 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.359 -0.837 . . . . 1.3799999999999999 108.963 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 78' ' ' TRP . 2.4 t -40.7 -51.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.297 -1.372 . . . . 2.1400000000000001 107.297 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.422 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -59.39 -60.96 3.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.451 -1.249 . . . . 3.8799999999999999 110.406 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -76.81 31.21 0.13 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 113.454 0.909 . . . . 4.3399999999999999 113.454 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -145.0 -40.0 0.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.972 -0.558 . . . . 2.1299999999999999 110.704 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.408 ' O ' ' NH2' ' A' ' 28' ' ' ARG . 35.7 mt -96.05 -26.12 15.64 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.036 -1.066 . . . . 2.1400000000000001 111.325 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -94.26 -42.21 9.05 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 107.136 -1.431 . . . . 4.0999999999999996 107.136 178.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.461 0 CA-C-O 116.472 -1.727 . . . . 5.4400000000000004 106.931 178.549 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' N ' ' O ' ' A' ' 30' ' ' ASP . 25.2 ttm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.851 -1.166 . . . . 3.8100000000000001 107.851 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.445 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 54.9 mt-30 -133.33 150.22 51.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.35 -0.611 . . . . 4.9800000000000004 109.35 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 22.6 m -140.4 137.77 34.25 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 118.636 -1.226 . . . . 1.6499999999999999 112.761 179.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.29 133.43 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.432 -0.951 . . . . 1.49 108.432 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.0 mm -111.64 128.73 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 124.437 1.085 . . . . 2.4900000000000002 108.265 179.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.561 ' CD2' HG12 ' A' ' 36' ' ' VAL . 30.6 m-85 -109.94 73.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.931 -1.137 . . . . 1.4399999999999999 107.931 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.501 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -133.71 -159.57 9.04 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 106.627 -2.589 . . . . 1.1399999999999999 106.627 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.712 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.5 ptm180 -123.88 143.53 50.3 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.025 -1.47 . . . . 6.46 109.245 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -64.78 76.95 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.35 -1.75 . . . . 4.1900000000000004 108.952 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 151.04 13.42 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.189 -1.005 . . . . 2.9199999999999999 111.889 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.712 ' SG ' ' HG2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -119.98 124.91 27.61 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.585 -0.895 . . . . 2.3799999999999999 108.585 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -41.32 -64.21 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.063 0 C-N-CA 122.422 2.081 . . . . 3.4100000000000001 112.017 -170.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -47.01 -38.83 11.48 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.922 -0.711 . . . . 4.0499999999999998 112.553 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 m -75.1 -57.94 3.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.609 0.718 . . . . 2.1800000000000002 109.306 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.09 -41.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 114.038 -1.437 . . . . 2.1299999999999999 108.819 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 115.543 -0.753 . . . . 6.2199999999999998 109.423 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' ARG . . . -40.37 -43.26 1.73 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.454 -0.898 . . . . 2.02 108.896 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 12.6 tmtt? -60.2 -58.29 9.16 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.349 -1.352 . . . . 3.3199999999999998 107.349 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -48.48 -51.22 28.19 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.843 -0.743 . . . . 3.6200000000000001 109.648 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.421 HD21 ' CD2' ' A' ' 75' ' ' PHE . 44.2 tp -52.2 -54.02 36.16 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.002 -0.74 . . . . 2.04 109.002 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -57.0 13.62 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.295 -0.962 . . . . 1.6399999999999999 109.509 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 13.7 tt0 -51.91 -40.28 60.48 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.156 -0.929 . . . . 3.0600000000000001 110.966 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.407 ' NZ ' ' OE1' ' A' ' 27' ' ' GLU . 24.1 tptp -60.48 -60.17 4.24 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.722 -1.214 . . . . 4.04 107.722 179.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.645 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 53.5 mt -47.0 -52.37 14.92 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.233 -0.987 . . . . 2.0299999999999998 111.564 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -39.84 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 114.288 1.218 . . . . 2.48 114.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -118.8 -30.72 5.01 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.19 -0.604 . . . . 4.3200000000000003 111.824 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.645 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -80.71 -19.74 44.41 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.922 -0.711 . . . . 3.77 111.149 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.527 HH12 ' CB ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -111.93 -154.78 0.55 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.674 -1.148 . . . . 5.8700000000000001 108.423 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -115.81 -79.14 0.58 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 114.009 1.114 . . . . 4.0099999999999998 114.009 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.592 ' O ' ' N ' ' A' ' 1' ' ' MET . 9.4 p-10 -93.84 60.83 2.97 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.632 -0.827 . . . . 3.46 111.003 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -116.32 99.96 7.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.914 -1.114 . . . . 1.3600000000000001 112.069 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.445 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 56.9 mm-40 -104.92 161.99 13.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.256 -1.387 . . . . 5.0599999999999996 107.256 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 40.2 p90 -159.12 166.46 31.49 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.552 -1.259 . . . . 1.73 109.253 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.01 146.48 40.91 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.746 -1.575 . . . . 4.2699999999999996 106.746 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.76 135.02 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.873 -1.531 . . . . 1.8700000000000001 107.906 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.561 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.0 t -119.51 144.15 28.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 105.859 -1.904 . . . . 1.8799999999999999 105.859 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.501 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 6.0 t70 -117.25 102.22 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.344 -0.942 . . . . 2.3700000000000001 111.295 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -49.97 -23.91 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 114.858 -1.065 . . . . 3.4100000000000001 111.17 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -87.8 -61.2 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.182 -1.407 . . . . 9.5800000000000001 108.618 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . 0.487 ' HB2' ' HB3' ' A' ' 37' ' ' ASP . . . -47.41 -43.15 23.42 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 123.789 0.681 . . . . 2.8500000000000001 112.836 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.19 -34.8 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.89 -0.724 . . . . 2.8700000000000001 112.025 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.51 50.49 1.2 Allowed Glycine 0 N--CA 1.505 3.257 0 C-N-CA 119.89 -1.148 . . . . 2.21 110.722 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.425 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 76.2 mt -109.71 143.24 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 120.161 -0.616 . . . . 2.2799999999999998 111.325 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 p -110.96 -97.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.474 -0.936 . . . . 2.9900000000000002 108.474 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.493 ' HZ3' ' N ' ' A' ' 56' ' ' VAL . 29.3 tttm -134.31 -54.31 0.85 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.619 -0.882 . . . . 6.5099999999999998 108.619 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.84 -52.81 4.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.371 -1.286 . . . . 4.6600000000000001 110.97 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -54.01 -72.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 118.905 -1.118 . . . . 4.3099999999999996 108.932 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.425 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 83.4 mt -35.12 -49.62 0.48 Allowed 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 112.541 0.571 . . . . 3.2200000000000002 112.541 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -46.41 -50.84 16.14 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.828 -0.749 . . . . 6.0 109.545 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -43.34 -36.73 1.98 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.027 0.83 . . . . 6.8899999999999997 111.568 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.509 ' NZ ' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -95.68 -11.45 27.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.984 1.105 . . . . 5.9400000000000004 113.984 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.57 -47.25 2.22 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 119.325 -0.95 . . . . 3.0899999999999999 112.925 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.0 49.05 2.74 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 106.437 -2.665 . . . . 3.2599999999999998 106.437 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' C ' ' H ' ' A' ' 56' ' ' VAL . 2.4 mmpt? -123.14 78.43 52.01 Favored Pre-proline 0 N--CA 1.505 2.325 0 N-CA-C 112.182 0.438 . . . . 6.5700000000000003 112.182 -179.03 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.53 33.77 0.45 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.677 1.584 . . . . 7.9900000000000002 111.732 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.493 ' N ' ' HZ3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -132.27 -81.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.908 -0.775 . . . . 7.0599999999999996 108.908 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.449 ' O ' ' HB ' ' A' ' 58' ' ' THR . 20.1 pm0 -96.79 -165.46 1.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.369 -1.715 . . . . 5.2800000000000002 106.369 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.449 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 10.1 t 177.43 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.993 -1.083 . . . . 9.0700000000000003 112.698 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.435 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 16.3 t -117.33 138.83 25.35 Favored Pre-proline 0 N--CA 1.502 2.138 0 C-N-CA 119.488 -0.885 . . . . 4.5700000000000003 110.485 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 56.6 Cg_endo -86.86 166.78 46.51 Favored 'Cis proline' 0 N--CA 1.493 1.458 0 C-N-CA 125.105 -0.79 . . . . 3.2599999999999998 110.126 -23.34 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -140.76 161.92 36.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.518 -0.873 . . . . 3.8599999999999999 111.787 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.506 ' N ' HD13 ' A' ' 62' ' ' ILE . 4.9 mp -122.94 146.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.127 -1.397 . . . . 2.5 108.243 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.509 ' CE1' ' NZ ' ' A' ' 51' ' ' LYS . 9.6 m-85 -123.8 127.18 47.72 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.027 -1.897 . . . . 2.2799999999999998 106.483 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.489 ' CG2' HG13 ' A' ' 69' ' ' ILE . 38.9 t -109.72 136.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 117.996 -1.481 . . . . 2.0 107.863 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.84 -89.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.314 1.009 . . . . 2.8500000000000001 108.383 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.3 mm-40 -141.99 3.95 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.744 0.653 . . . . 6.4100000000000001 111.151 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -107.7 152.82 23.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.087 0.47 . . . . 6.3399999999999999 111.138 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.451 ' HA ' ' CD1' ' A' ' 63' ' ' PHE . 35.9 t-80 -77.77 141.29 39.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.415 -1.698 . . . . 1.98 106.415 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.489 HG13 ' CG2' ' A' ' 64' ' ' VAL . 42.2 mm -115.42 -45.97 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 C-N-CA 118.235 -1.386 . . . . 1.8500000000000001 109.253 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.66 -137.0 8.39 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.466 -1.35 . . . . 1.76 110.275 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.29 -166.94 21.22 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.754 -0.736 . . . . 1.6799999999999999 111.54 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -55.16 -66.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.994 -0.683 . . . . 3.0699999999999998 112.424 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -51.37 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.096 0.776 . . . . 2.46 113.096 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.95 -52.87 10.1 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.174 -1.01 . . . . 2.9199999999999999 111.178 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.421 ' CD2' HD21 ' A' ' 20' ' ' LEU . 44.3 t80 -49.62 -38.29 31.35 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.817 -1.153 . . . . 1.0600000000000001 108.899 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -58.74 -65.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.149 -1.387 . . . . 2.0800000000000001 110.319 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -54.87 41.91 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.894 -1.122 . . . . 1.78 108.113 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.463 ' HH2' ' SD ' ' A' ' 1' ' ' MET . 57.2 t90 -41.15 -51.05 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.263 0.977 . . . . 1.6899999999999999 109.93 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 2.1 t -48.74 -61.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 114.803 -1.089 . . . . 2.0600000000000001 108.464 178.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.652 ' HZ3' ' C ' ' A' ' 85' ' ' ALA . 5.9 tmtm? -53.58 -46.63 70.38 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.967 -0.693 . . . . 3.6899999999999999 112.673 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -56.44 -55.72 30.17 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.504 -1.225 . . . . 3.7400000000000002 113.564 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -89.06 -27.09 21.03 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 114.739 1.385 . . . . 2.0099999999999998 114.739 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.538 HD23 ' SD ' ' A' ' 1' ' ' MET . 60.4 mt -89.38 -19.24 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.157 -1.417 . . . . 2.2200000000000002 111.894 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.527 ' CB ' HH12 ' A' ' 28' ' ' ARG . 10.3 t70 -121.71 -47.47 2.2 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.487 -1.285 . . . . 4.3200000000000003 110.637 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.652 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.509 2.52 0 O-C-N 125.531 1.769 . . . . 6.1699999999999999 108.453 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 71.2 mtm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.123 -0.695 . . . . 3.0 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.508 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 5.8 mt-30 -126.65 123.92 38.69 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 108.265 -1.013 . . . . 4.9800000000000004 108.265 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.4 m -120.34 139.16 53.17 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.875 -1.13 . . . . 2.2799999999999998 110.026 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.3 t -119.25 125.42 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.803 -0.759 . . . . 1.8200000000000001 109.317 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . 0.45 ' N ' HD13 ' A' ' 5' ' ' ILE . 1.6 mp -106.75 117.96 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 124.882 1.364 . . . . 3.02 107.928 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 15.4 m-85 -98.23 93.46 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.828 -1.175 . . . . 1.45 107.828 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.88 -170.67 16.02 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.771 -1.204 . . . . 0.93000000000000005 110.897 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.526 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 22.0 mtp180 -126.81 27.28 6.05 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.086 -0.646 . . . . 7.25 109.292 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' ARG . 59.3 m 34.25 52.52 0.51 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 123.59 0.556 . . . . 3.6000000000000001 111.111 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.1 52.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.799 -1.32 . . . . 3.5800000000000001 109.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.526 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -151.71 72.38 8.1 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 107.623 -1.251 . . . . 3.2999999999999998 107.623 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -29.2 -59.07 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 123.202 2.601 . . . . 3.0 113.796 -139.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -39.88 -38.97 0.75 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 120.603 -0.439 . . . . 5.3799999999999999 112.0 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.407 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 92.2 m -51.05 -46.09 61.55 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.284 -0.871 . . . . 2.4199999999999999 110.426 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -55.93 -48.2 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.651 -0.82 . . . . 2.3300000000000001 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.504 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -42.98 -48.69 5.98 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.709 -0.796 . . . . 5.4299999999999997 111.063 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.99 -44.86 15.38 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.591 -0.844 . . . . 1.97 110.571 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.54 ' HZ3' ' CD ' ' A' ' 22' ' ' GLU . 5.2 tmtm? -63.77 -54.44 35.2 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 108.385 -0.969 . . . . 3.75 108.385 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.504 ' CG ' HH22 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -52.56 -43.09 65.0 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.799 -0.637 . . . . 3.1299999999999999 111.699 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 39.2 tp -71.66 -49.41 40.1 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.028 -0.669 . . . . 2.23 109.831 -179.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.607 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -57.29 -42.97 82.71 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.104 -1.443 . . . . 1.78 107.104 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 0.6 OUTLIER -55.14 -57.86 10.04 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.586 -1.264 . . . . 2.8199999999999998 107.586 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 22' ' ' GLU . 60.8 tttp -37.43 -61.77 0.57 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.32 -1.309 . . . . 4.6699999999999999 108.911 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 mt -56.45 -56.92 15.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.776 -0.77 . . . . 2.6600000000000001 112.564 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 -15.43 0.66 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 114.04 1.126 . . . . 2.1699999999999999 114.04 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -107.41 -44.5 4.3 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 119.842 -0.743 . . . . 4.1699999999999999 110.508 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.73 -19.43 48.81 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.898 -1.501 . . . . 3.6600000000000001 112.782 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.476 ' NH1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -118.69 -178.36 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.789 -0.641 . . . . 7.2000000000000002 109.954 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.08 -59.62 1.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 113.048 0.759 . . . . 3.7599999999999998 113.048 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.476 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.5 t70 -78.08 52.74 1.11 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.889 0.852 . . . . 3.29 111.786 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -145.71 92.53 2.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.287 -0.883 . . . . 1.5 111.521 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.508 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 17.7 mp0 -105.14 126.76 52.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.604 -2.369 . . . . 4.5099999999999998 104.604 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.607 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 2.3 p90 -127.03 157.57 39.25 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.813 -1.155 . . . . 1.48 109.549 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -131.23 140.62 49.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.495 -0.928 . . . . 4.5300000000000002 108.495 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -99.83 131.01 46.07 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.936 -1.106 . . . . 1.8999999999999999 108.045 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.2 145.47 22.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 114.689 -1.141 . . . . 1.6899999999999999 108.932 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -118.52 116.72 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.436 -1.69 . . . . 2.6600000000000001 106.436 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pt -51.32 -27.7 6.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.319 -1.352 . . . . 2.3399999999999999 112.416 -178.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.6 -8.65 58.14 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.067 -1.053 . . . . 6.9900000000000002 113.071 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.21 -37.6 12.0 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.392 -0.923 . . . . 2.4300000000000002 108.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -87.03 -37.48 17.44 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.978 -0.689 . . . . 2.5600000000000001 110.826 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 52.07 0.59 Allowed Glycine 0 N--CA 1.505 3.253 0 N-CA-C 110.105 -1.198 . . . . 1.4199999999999999 110.105 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.2 137.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.899 -0.65 . . . . 2.5499999999999998 109.363 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -103.41 -101.31 0.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.145 -1.428 . . . . 2.79 107.145 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -138.97 -47.45 0.49 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.557 -2.016 . . . . 7.2199999999999998 105.557 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -46.07 -52.35 12.14 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.018 -1.104 . . . . 3.52 108.018 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.427 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 24.4 m-20 -44.93 -57.28 3.9 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.735 -1.121 . . . . 4.3499999999999996 111.611 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 77.1 mt -56.04 -53.66 54.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.003 -1.453 . . . . 2.1899999999999999 110.334 -179.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -51.24 -47.04 62.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.991 -1.083 . . . . 4.2300000000000004 109.022 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.427 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -51.69 -45.13 63.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.819 -0.752 . . . . 7.1100000000000003 108.998 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.638 ' HZ1' ' CB ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -68.37 0.81 3.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.863 -1.062 . . . . 5.0 113.472 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.46 ' CB ' ' HG3' ' A' ' 55' ' ' PRO . . . -129.89 -44.76 1.18 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.942 -1.103 . . . . 2.8300000000000001 112.272 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.44 -58.82 0.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.107 -1.197 . . . . 4.7599999999999998 110.107 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.556 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 55.1 pttt -165.2 62.6 0.88 Allowed Pre-proline 0 N--CA 1.504 2.231 0 C-N-CA 119.201 -1.0 . . . . 12.279999999999999 112.844 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.556 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 10.1 Cg_endo -96.74 159.6 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.156 1.238 . . . . 7.8499999999999996 112.041 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.75 -20.81 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 115.013 -0.994 . . . . 5.5899999999999999 108.649 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.621 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -72.8 70.45 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.511 -1.222 . . . . 6.0199999999999996 108.123 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.2 t -42.43 -45.66 4.46 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.389 -0.823 . . . . 6.7800000000000002 110.465 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 57.3 t -142.76 152.45 59.37 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.891 -0.781 . . . . 3.2599999999999998 108.891 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.415 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 12.0 Cg_endo -84.26 166.8 60.23 Favored 'Cis proline' 0 N--CA 1.486 1.049 0 O-C-N 123.426 1.224 . . . . 2.3199999999999998 109.885 -17.892 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.466 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 82.4 mt-30 -139.76 153.99 47.3 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.074 -1.05 . . . . 3.52 111.436 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.1 mt -134.07 150.97 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.703 1.24 . . . . 2.8799999999999999 112.623 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.462 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 61.4 m-85 -135.87 126.35 26.85 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 112.62 -2.082 . . . . 1.3700000000000001 108.852 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.518 HG21 HG13 ' A' ' 69' ' ' ILE . 58.9 t -96.62 121.26 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 105.903 -1.888 . . . . 2.1200000000000001 105.903 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.16 -87.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.902 0.751 . . . . 2.6200000000000001 111.672 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.91 12.76 3.99 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.238 -0.985 . . . . 5.25 112.913 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -111.83 156.73 21.53 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.877 -0.729 . . . . 4.9199999999999999 109.699 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.462 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.7 t-160 -90.92 138.34 31.67 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.025 -1.102 . . . . 1.72 108.025 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.518 HG13 HG21 ' A' ' 64' ' ' VAL . 9.7 mm -110.71 -31.73 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.523 -1.271 . . . . 1.8200000000000001 110.547 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.96 -138.47 10.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.295 -1.431 . . . . 1.96 109.764 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . -94.29 -89.09 1.67 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.583 -1.294 . . . . 2.4100000000000001 111.476 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.12 -55.32 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.849 -1.14 . . . . 2.3199999999999998 109.49 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -43.04 -48.27 6.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.274 -1.01 . . . . 2.1400000000000001 108.274 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -64.95 0.66 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.379 -1.737 . . . . 3.2999999999999998 110.296 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -51.55 -46.15 63.29 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.246 -0.982 . . . . 1.29 109.25 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.77 -53.47 31.5 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.297 -1.001 . . . . 1.5800000000000001 108.297 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -55.47 -56.26 22.29 Favored 'General case' 0 C--O 1.198 -1.643 0 N-CA-C 107.933 -1.136 . . . . 1.6499999999999999 107.933 178.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -50.16 -34.28 21.85 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 123.43 0.456 . . . . 1.4399999999999999 110.631 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 t -71.49 -44.32 71.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.421 -0.955 . . . . 2.3999999999999999 108.421 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' NZ ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -82.25 -65.8 0.97 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.443 -1.303 . . . . 4.0999999999999996 111.602 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -62.21 0.77 0.38 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 117.272 2.323 . . . . 4.71 117.272 -177.463 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.48 -26.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.32 -0.952 . . . . 4.0199999999999996 112.233 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.67 -21.98 28.1 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.281 -1.368 . . . . 2.7400000000000002 112.713 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 80' ' ' LYS . 30.7 p30 -117.3 39.79 3.19 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 117.108 -1.837 . . . . 4.5899999999999999 112.325 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.172 -1.87 . . . . 5.5199999999999996 110.05 179.601 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.678 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 122.951 1.358 . . . . 4.0999999999999996 109.16 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -121.02 126.5 50.06 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.829 -1.915 . . . . 7.4100000000000001 105.829 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 60.4 m -112.72 144.67 41.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.275 -1.37 . . . . 1.8400000000000001 113.192 -178.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.0 117.56 52.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.941 -1.874 . . . . 2.54 105.941 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.2 mm -107.2 124.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.242 -1.392 . . . . 3.1299999999999999 107.242 179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.84 96.2 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.323 -1.732 . . . . 1.4099999999999999 106.323 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.451 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -142.71 -152.6 5.71 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.639 -1.267 . . . . 0.98999999999999999 111.631 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.433 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.04 6.58 3.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.996 -0.742 . . . . 7.9800000000000004 108.996 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 t 45.24 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.569 1.176 . . . . 5.8099999999999996 112.764 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.41 -66.51 3.63 Favored Glycine 0 N--CA 1.498 2.795 0 CA-C-N 114.781 -1.1 . . . . 4.6500000000000004 111.443 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 137.93 89.28 Favored Pre-proline 0 N--CA 1.497 1.896 0 C-N-CA 119.886 -0.726 . . . . 3.3399999999999999 111.143 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.38 -61.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.283 1.989 . . . . 3.4900000000000002 111.021 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.439 ' C ' ' CD1' ' A' ' 13' ' ' TYR . 10.3 t80 -48.89 -50.54 34.5 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.561 -0.855 . . . . 4.0099999999999998 109.431 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -53.86 -53.51 51.5 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.675 0.75 . . . . 2.5699999999999998 110.106 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -52.09 -43.21 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.513 -1.221 . . . . 1.96 111.182 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.518 HH22 ' N ' ' A' ' 20' ' ' LEU . 10.0 mmm180 -40.26 -50.96 2.76 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.714 -1.195 . . . . 4.6600000000000001 112.188 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.75 -52.66 13.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.733 -1.187 . . . . 1.51 109.193 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -58.64 -45.97 88.14 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.987 -1.461 . . . . 2.6200000000000001 110.482 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.477 ' CG ' HH12 ' A' ' 16' ' ' ARG . 66.0 t0 -62.11 -44.38 96.77 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.41 -0.916 . . . . 3.6400000000000001 109.774 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.518 ' N ' HH22 ' A' ' 16' ' ' ARG . 11.0 tp -62.72 -58.87 5.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.617 -0.833 . . . . 1.9199999999999999 109.077 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.478 ' HB2' ' CG ' ' A' ' 33' ' ' TYR . . . -52.69 -51.81 58.72 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.102 -1.039 . . . . 1.6699999999999999 109.127 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.6 tt0 -46.33 -58.93 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.964 0.79 . . . . 3.2400000000000002 109.796 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.501 ' N ' ' HZ3' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -47.43 -60.6 2.41 Favored 'General case' 0 C--O 1.206 -1.195 0 O-C-N 125.644 1.84 . . . . 7.5700000000000003 107.76 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.47 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 56.6 mt -51.08 -51.47 52.96 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.244 -1.383 . . . . 2.3599999999999999 112.192 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 13.4 p -66.75 8.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.54 -1.264 . . . . 2.25 114.408 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.401 ' H ' ' C ' ' A' ' 24' ' ' LEU . 31.5 m-80 -125.86 -39.71 2.1 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.693 -1.225 . . . . 5.0 107.693 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.94 -31.8 61.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.598 -1.183 . . . . 3.3999999999999999 109.046 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.452 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.0 mtp-105 -110.76 -171.04 1.75 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.318 -1.31 . . . . 5.8499999999999996 111.794 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -125.53 -48.9 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.176 -0.92 . . . . 3.6899999999999999 111.748 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.68 -21.24 61.1 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.779 -1.168 . . . . 4.8399999999999999 110.39 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.526 ' O ' ' HA ' ' A' ' 25' ' ' SER . 59.2 t80 -84.92 124.49 31.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.763 -1.175 . . . . 1.74 112.331 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -139.2 163.16 33.19 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.622 -1.626 . . . . 3.5 106.809 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.478 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 7.8 p90 -158.95 163.18 36.72 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.568 -1.253 . . . . 1.8899999999999999 110.594 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . 0.422 HE21 HG21 ' A' ' 36' ' ' VAL . 18.6 pt20 -128.73 157.25 41.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.463 -1.31 . . . . 5.3899999999999997 107.463 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -115.56 127.36 55.2 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.06 -1.456 . . . . 3.1000000000000001 107.78 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.422 HG21 HE21 ' A' ' 34' ' ' GLN . 1.2 t -113.45 132.05 63.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.423 -1.695 . . . . 1.97 106.423 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.451 ' HA ' ' O ' ' A' ' 7' ' ' GLY . 9.3 t70 -108.27 110.57 22.21 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.44 -0.948 . . . . 1.8999999999999999 108.44 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -44.58 -25.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.676 0.991 . . . . 2.0299999999999998 113.676 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.499 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 6.4 mmm180 -91.93 -48.81 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.067 -1.453 . . . . 9.1300000000000008 109.584 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -52.44 -40.76 62.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.401 -0.963 . . . . 2.4199999999999999 108.401 179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' GLY . 71.3 mm-40 -86.57 26.39 1.1 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.26 -1.336 . . . . 3.6400000000000001 110.61 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 25.04 59.43 0.06 OUTLIER Glycine 0 N--CA 1.504 3.211 0 O-C-N 123.406 0.441 . . . . 2.5800000000000001 113.73 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.42 HG23 ' N ' ' A' ' 44' ' ' THR . 31.7 mt -104.13 161.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.584 -0.895 . . . . 3.0699999999999998 108.584 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.42 ' N ' HG23 ' A' ' 43' ' ' ILE . 8.9 t -112.96 -168.07 1.27 Allowed 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.671 -1.233 . . . . 4.4299999999999997 107.671 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -82.3 -46.12 14.05 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.702 -1.199 . . . . 6.4100000000000001 109.887 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.625 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 7.5 mp0 -44.48 -51.82 8.45 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.901 0.858 . . . . 4.4800000000000004 110.281 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.32 -61.68 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.39 -1.277 . . . . 3.6299999999999999 111.452 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.24 -52.58 2.62 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.011 -0.995 . . . . 2.8100000000000001 113.497 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -44.68 -46.39 10.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.332 -0.947 . . . . 5.4299999999999997 111.243 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -51.27 69.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.772 0.67 . . . . 7.7300000000000004 111.244 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.605 ' NZ ' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -46.48 -37.69 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.494 -1.23 . . . . 5.7699999999999996 112.868 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.97 -30.06 11.85 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.224 0.952 . . . . 2.2200000000000002 111.574 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.56 49.88 17.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.29 -1.124 . . . . 3.3399999999999999 110.29 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.0 mttm -142.56 156.62 63.3 Favored Pre-proline 0 N--CA 1.501 2.114 0 C-N-CA 118.655 -1.218 . . . . 8.1999999999999993 112.003 -179.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 8.1 Cg_endo -81.33 39.34 0.85 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.318 2.012 . . . . 6.7000000000000002 111.175 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 p -141.01 125.86 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.529 -2.026 . . . . 5.96 105.529 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 63.54 0.91 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.254 0.835 . . . . 8.7400000000000002 113.254 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.5 p -105.08 166.62 10.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.181 -1.408 . . . . 6.25 112.558 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -113.81 152.37 45.53 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.672 -1.233 . . . . 3.75 107.672 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.93 177.04 22.42 Favored 'Cis proline' 0 N--CA 1.485 0.973 0 O-C-N 122.541 0.758 . . . . 2.4199999999999999 110.848 -12.489 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -131.81 142.05 49.62 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.842 -0.743 . . . . 3.6499999999999999 109.627 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.434 ' N ' HD13 ' A' ' 62' ' ' ILE . 3.8 mp -119.65 143.18 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-O 121.822 0.82 . . . . 2.4399999999999999 111.663 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CE2' ' NZ ' ' A' ' 51' ' ' LYS . 84.3 m-85 -128.87 136.66 50.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.412 -1.722 . . . . 1.53 108.745 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.592 HG12 ' CH2' ' A' ' 78' ' ' TRP . 75.5 t -122.76 137.3 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.489 -1.284 . . . . 1.9299999999999999 109.293 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 54.42 -80.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.678 -1.601 . . . . 3.5800000000000001 111.197 -179.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' VAL . 40.3 tt0 -138.76 -19.66 1.03 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.294 -0.866 . . . . 5.3700000000000001 112.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.65 163.82 12.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.948 1.092 . . . . 5.5999999999999996 113.948 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.461 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 29.2 t-80 -80.25 137.97 36.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.954 -1.93 . . . . 1.8700000000000001 106.532 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.436 HD11 ' CD1' ' A' ' 78' ' ' TRP . 34.3 mm -110.15 -50.34 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.343 -1.343 . . . . 1.8700000000000001 109.718 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.1 -141.07 10.88 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.472 -1.347 . . . . 1.6000000000000001 110.81 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.7 -168.08 32.35 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.636 -1.386 . . . . 1.76 109.636 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.484 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 12.9 t80 -56.77 -23.27 41.87 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.854 -1.138 . . . . 2.1000000000000001 109.358 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -75.33 -65.76 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 2.6600000000000001 111.003 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.92 -43.06 69.44 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.54 -0.911 . . . . 2.8799999999999999 108.54 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.412 ' CD1' HG22 ' A' ' 62' ' ' ILE . 22.7 t80 -59.71 -53.43 58.04 Favored 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 107.159 -1.423 . . . . 1.3600000000000001 107.159 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.4 11.52 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.573 -0.851 . . . . 1.48 111.043 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.4 -60.3 4.03 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.238 -0.985 . . . . 2.1899999999999999 109.997 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.592 ' CH2' HG12 ' A' ' 64' ' ' VAL . 46.2 t90 -41.62 -49.41 4.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 123.825 0.703 . . . . 1.47 109.584 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -49.49 -61.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.096 -0.956 . . . . 1.8400000000000001 110.12 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.512 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -50.96 -50.63 57.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.672 -0.811 . . . . 3.7200000000000002 111.503 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.54 -39.86 92.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.096 1.888 . . . . 3.9399999999999999 116.096 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -105.48 -17.23 14.49 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.664 1.357 . . . . 1.8500000000000001 114.664 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.417 HD11 ' CD1' ' A' ' 31' ' ' PHE . 68.8 mt -97.55 -21.55 17.03 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.909 -1.516 . . . . 2.52 110.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.512 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 11.4 m-20 -139.16 32.07 2.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.096 -1.441 . . . . 4.6799999999999997 111.373 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.49 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 117.835 -1.079 . . . . 5.3399999999999999 110.808 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.617 ' N ' ' SD ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.01 -1.107 . . . . 3.5899999999999999 108.01 . . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.449 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 9.1 tt0 -105.98 157.89 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.122 -1.066 . . . . 4.71 108.122 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.439 ' HG1' ' C ' ' A' ' 2' ' ' GLN . 31.0 m -149.22 149.74 31.46 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.861 -1.149 . . . . 1.95 109.84 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.87 134.7 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 119.981 -0.688 . . . . 1.8899999999999999 111.197 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.3 mm -114.93 119.61 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.97 -1.493 . . . . 2.6400000000000001 106.97 178.672 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.417 ' CD2' HG12 ' A' ' 36' ' ' VAL . 36.3 m-85 -103.0 103.71 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.46 -0.941 . . . . 1.1799999999999999 108.46 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.15 -150.18 5.43 Favored Glycine 0 N--CA 1.502 3.042 0 C-N-CA 119.399 -1.381 . . . . 1.24 110.932 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.522 HH21 ' CD1' ' A' ' 38' ' ' ILE . 18.1 mtt180 -121.85 -144.89 0.35 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.267 -0.642 . . . . 8.6999999999999993 109.267 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m -118.06 77.8 1.19 Allowed 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.973 -0.691 . . . . 3.4199999999999999 112.085 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.03 44.07 0.64 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.109 -1.52 . . . . 2.8100000000000001 111.041 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -110.0 101.61 47.91 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.438 -1.319 . . . . 2.1800000000000002 107.438 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -32.86 -34.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 123.081 2.521 . . . . 2.6000000000000001 112.899 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 11' ' ' CYS . 1.7 t80 -75.54 -55.27 5.83 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.398 -0.819 . . . . 5.1200000000000001 109.855 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -54.16 -40.71 67.72 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.03 -1.47 . . . . 2.6200000000000001 107.03 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.47 -54.64 32.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.168 -1.378 . . . . 2.1400000000000001 107.705 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.473 ' HD3' ' CZ ' ' A' ' 72' ' ' TYR . 7.3 tpm_? -46.36 -51.91 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 4.2300000000000004 110.325 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -58.1 -43.67 87.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.115 -1.034 . . . . 1.8500000000000001 108.591 179.284 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.551 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 0.4 OUTLIER -52.9 -47.84 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.205 -1.406 . . . . 3.5899999999999999 107.205 178.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.41 ' HA ' ' HZ1' ' A' ' 18' ' ' LYS . 36.1 m-20 -53.25 -50.81 64.03 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.901 -1.12 . . . . 2.9300000000000002 108.852 178.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -53.98 -58.28 7.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.037 -1.065 . . . . 2.6099999999999999 110.324 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.514 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -52.29 -52.43 52.95 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.948 -1.101 . . . . 1.6000000000000001 109.752 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.551 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 19.0 mt-10 -52.69 -49.08 66.02 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.291 0.567 . . . . 3.1499999999999999 110.094 179.766 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 28.0 ttpp -48.76 -60.65 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.277 -0.969 . . . . 5.7699999999999996 108.855 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.587 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 64.9 mt -48.19 -58.37 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.772 -0.771 . . . . 2.6899999999999999 111.515 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 m -41.25 -34.13 0.45 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.674 -0.81 . . . . 2.2400000000000002 110.896 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -88.19 -36.01 17.05 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 120.396 -0.522 . . . . 3.8100000000000001 110.513 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.587 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 6.4 pt-20 -99.74 23.48 9.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.535 0.683 . . . . 4.4000000000000004 112.017 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.424 ' HD2' HD23 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -137.02 177.11 8.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.775 -0.824 . . . . 5.2199999999999998 108.775 179.003 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.56 -38.78 3.67 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.536 -1.211 . . . . 4.1799999999999997 108.606 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.593 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.7 p-10 -110.34 22.0 16.02 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.821 -1.536 . . . . 4.1200000000000001 113.424 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -102.83 99.48 9.42 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 118.189 -1.404 . . . . 1.25 114.406 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 42.5 mt-30 -111.64 127.82 55.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.835 -1.543 . . . . 3.71 106.835 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.514 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 25.5 p90 -129.64 162.1 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.624 -0.83 . . . . 1.98 110.326 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -131.71 146.97 52.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.72 -0.844 . . . . 4.29 108.72 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -99.76 135.27 41.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.8 -1.556 . . . . 1.79 106.8 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.417 HG12 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -121.35 138.03 53.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.796 -0.816 . . . . 1.6699999999999999 108.796 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -111.22 109.36 19.36 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.657 -1.156 . . . . 2.3900000000000001 108.666 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.522 ' CD1' HH21 ' A' ' 8' ' ' ARG . 27.0 pt -51.17 -25.81 4.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.915 -1.039 . . . . 2.0800000000000001 109.392 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -79.33 -63.53 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.02 -1.072 . . . . 5.9500000000000002 108.286 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.21 -42.3 0.67 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 123.66 0.6 . . . . 2.02 111.409 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.21 -46.81 14.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.85 -1.068 . . . . 2.6400000000000001 111.028 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.67 51.79 0.83 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.821 -1.312 . . . . 1.76 109.821 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.485 HG23 ' N ' ' A' ' 44' ' ' THR . 24.4 mt -100.26 172.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.977 -0.611 . . . . 2.46 109.384 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.485 ' N ' HG23 ' A' ' 43' ' ' ILE . 51.5 p -103.67 -171.01 1.86 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.601 -0.888 . . . . 3.3900000000000001 108.601 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 29.96 7.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.276 -1.379 . . . . 5.4900000000000002 107.276 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -119.31 -55.6 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 110.341 -3.118 . . . . 3.5299999999999998 104.084 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -47.96 27.65 Favored 'General case' 0 C--O 1.202 -1.396 0 CA-C-N 112.458 -2.155 . . . . 3.5800000000000001 110.46 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 59.2 mt -53.6 -37.97 63.51 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.897 -1.047 . . . . 3.04 111.819 -179.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.67 -49.71 13.95 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.928 -1.109 . . . . 5.1799999999999997 108.903 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' CD ' ' C ' ' A' ' 50' ' ' GLN . 11.2 tm0? -52.65 -43.94 65.81 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.749 -1.114 . . . . 5.7199999999999998 110.062 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -16.33 35.1 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.924 -1.035 . . . . 6.0599999999999996 111.681 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.464 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -89.75 -51.58 5.43 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.193 -1.781 . . . . 2.7000000000000002 106.193 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.79 -25.19 2.56 Favored Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.371 -1.286 . . . . 2.98 110.558 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.464 ' H ' ' C ' ' A' ' 52' ' ' ALA . 29.6 mtmm -109.43 155.78 40.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 109.008 -0.738 . . . . 10.880000000000001 109.008 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.5 74.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 123.053 2.502 . . . . 7.29 112.784 -149.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 54' ' ' LYS . 11.9 p -96.83 162.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.793 -0.817 . . . . 7.8300000000000001 108.793 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' CG ' ' H ' ' A' ' 58' ' ' THR . 1.1 pt-20 -90.34 -99.22 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.908 -1.042 . . . . 6.6799999999999997 110.552 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.415 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 13.0 t -131.03 -162.28 1.2 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.153 -0.619 . . . . 5.7400000000000002 109.819 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.526 ' CG1' ' HA ' ' A' ' 60' ' ' PRO . 73.0 t -84.14 140.25 39.63 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-N 115.007 -0.997 . . . . 4.7400000000000002 109.639 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.526 ' HA ' ' CG1' ' A' ' 59' ' ' VAL . 9.7 Cg_endo -91.31 164.93 28.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 O-C-N 123.069 1.036 . . . . 2.9199999999999999 112.623 14.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -131.71 156.16 46.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.793 -1.094 . . . . 3.8799999999999999 109.816 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 68.2 mt -125.55 144.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.5 -0.773 . . . . 2.2799999999999998 111.754 -178.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 14.3 m-85 -129.03 122.65 30.46 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.624 -1.625 . . . . 1.3700000000000001 108.942 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.448 ' O ' ' N ' ' A' ' 66' ' ' GLN . 22.3 t -91.98 122.91 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 105.358 -2.09 . . . . 1.8600000000000001 105.358 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 1.2 t70 64.05 -74.76 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 125.076 1.485 . . . . 2.9100000000000001 109.099 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.536 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -147.92 -5.5 0.46 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.921 -0.581 . . . . 5.9900000000000002 111.558 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -104.63 137.26 42.72 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.22 -0.592 . . . . 6.1900000000000004 112.554 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.417 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 50.4 t-80 -68.92 129.92 41.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.765 -1.568 . . . . 1.72 106.765 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.43 HG13 ' CG2' ' A' ' 64' ' ' VAL . 33.3 mm -106.73 -36.84 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.719 -1.193 . . . . 2.02 111.149 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.76 -132.33 4.36 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.692 -1.718 . . . . 1.8 110.843 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.62 -148.75 12.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.989 -0.844 . . . . 2.1899999999999999 110.989 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.473 ' CZ ' ' HD3' ' A' ' 16' ' ' ARG . 72.9 t80 -78.79 -56.98 3.99 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.053 -0.573 . . . . 2.7400000000000002 110.432 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.47 -64.99 0.64 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.141 0.793 . . . . 3.2200000000000002 113.141 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -53.98 -60.19 3.65 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.211 -0.596 . . . . 2.73 109.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -43.93 -48.44 8.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.716 -0.476 . . . . 1.8500000000000001 109.716 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.69 -59.26 5.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.01 -0.541 . . . . 2.3199999999999998 109.91 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.25 -62.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.272 -1.01 . . . . 2.6899999999999999 108.272 179.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -41.37 -60.21 1.34 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.194 -0.912 . . . . 1.8300000000000001 109.657 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.2 t -40.61 -63.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.335 -1.357 . . . . 2.25 107.335 178.943 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -44.64 -54.9 5.69 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 125.018 1.449 . . . . 3.9399999999999999 109.788 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 18.0 mm-40 -80.17 26.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.199 0.815 . . . . 5.5599999999999996 113.199 -178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.48 -43.5 0.32 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.13 -0.628 . . . . 2.0800000000000001 111.504 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.402 HD11 HD23 ' A' ' 24' ' ' LEU . 14.6 mt -94.44 -4.19 48.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.385 -0.926 . . . . 1.9099999999999999 111.794 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.85 -48.94 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 124.321 1.013 . . . . 3.6000000000000001 108.592 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 116.727 -1.606 . . . . 5.7199999999999998 108.713 179.201 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 83.3 mtp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 107.704 -1.221 . . . . 3.1299999999999999 107.704 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -118.9 116.99 27.63 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.857 1.348 . . . . 5.4100000000000001 107.541 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.0 m -99.74 131.91 45.42 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.5 -1.28 . . . . 1.71 108.41 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.64 128.93 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.849 -1.167 . . . . 1.8300000000000001 107.849 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.77 109.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.633 -1.618 . . . . 2.8399999999999999 106.633 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.517 ' CD2' HG12 ' A' ' 36' ' ' VAL . 26.8 m-85 -94.03 107.52 19.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.076 -1.453 . . . . 1.5700000000000001 107.076 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.83 5.6 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.354 -0.927 . . . . 1.51 110.932 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.596 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 31.9 ptt-85 -130.06 -162.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.857 -1.164 . . . . 9.1899999999999995 107.857 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 39' ' ' ARG . 33.3 p -132.49 140.09 48.22 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.178 -1.009 . . . . 4.6500000000000004 110.961 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.4 -1.91 23.64 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.247 -0.977 . . . . 3.73 111.721 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 95.72 24.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 120.022 -0.671 . . . . 2.5499999999999998 111.453 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . 0.401 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 83.3 Cg_exo -35.29 -38.63 0.2 Allowed 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 122.339 2.026 . . . . 4.6900000000000004 112.14 168.834 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -67.04 -45.12 78.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.701 -1.6 . . . . 4.1900000000000004 109.217 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' NH2' ' A' ' 8' ' ' ARG . 82.0 m -53.32 -41.91 66.18 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.717 -1.193 . . . . 2.0299999999999998 107.902 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.401 ' HB ' ' O ' ' A' ' 12' ' ' PRO . 58.0 t -48.33 -38.89 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.458 -0.897 . . . . 2.0499999999999998 111.14 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.574 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.8 mmp_? -50.25 -20.94 1.17 Allowed 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 112.835 0.68 . . . . 6.8600000000000003 112.835 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -43.77 22.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.76 -1.57 . . . . 2.0299999999999998 106.76 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.59 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.0 tmtt? -57.1 -46.6 82.46 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.598 -0.889 . . . . 3.6099999999999999 108.598 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.59 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 31.8 m-20 -53.3 -43.9 67.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.794 -1.162 . . . . 3.0099999999999998 111.033 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.16 -57.73 4.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.17 -1.012 . . . . 2.0699999999999998 109.529 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -43.22 37.31 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.056 -1.058 . . . . 1.96 109.156 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.629 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 19.9 tt0 -65.84 -65.21 0.7 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.366 -0.934 . . . . 2.7200000000000002 109.504 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -36.33 -50.74 0.77 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.145 0.903 . . . . 4.5499999999999998 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.554 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 95.2 mt -49.72 -40.15 39.53 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.823 -1.08 . . . . 2.0699999999999998 112.272 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.0 m -50.48 -12.59 0.1 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.576 0.548 . . . . 1.8 111.618 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' H ' ' C ' ' A' ' 24' ' ' LEU . 44.5 m-80 -114.73 -41.8 3.34 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.853 -0.612 . . . . 3.2999999999999998 111.045 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.554 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 5.9 pt-20 -81.79 -10.59 59.3 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.156 -1.018 . . . . 3.75 113.415 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.5 mpt_? -105.76 -177.4 3.35 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.281 -0.967 . . . . 5.8700000000000001 110.914 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -63.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.486 -1.234 . . . . 6.04 112.024 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.4 t70 -118.91 -43.78 2.64 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 109.476 -0.564 . . . . 5.4699999999999998 109.476 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.421 ' O ' ' HA ' ' A' ' 25' ' ' SER . 16.4 t80 8.61 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.41 -1.723 . . . . 1.8400000000000001 115.113 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -112.72 158.82 19.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.689 -1.967 . . . . 3.7000000000000002 105.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.629 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 10.8 p90 -151.28 164.69 36.06 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.16 -1.416 . . . . 1.4299999999999999 110.695 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -144.27 154.86 43.51 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.374 -1.343 . . . . 5.1100000000000003 107.374 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 36' ' ' VAL . 38.7 t80 -106.76 148.28 28.64 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.117 -1.433 . . . . 1.9099999999999999 109.068 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.517 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -131.02 125.86 58.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 124.399 1.062 . . . . 1.8799999999999999 108.62 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -109.02 122.76 47.94 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.558 -1.275 . . . . 1.9399999999999999 107.558 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.1 pt -51.93 -31.35 13.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.614 -0.834 . . . . 2.6200000000000001 111.811 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.518 ' NH1' ' HB3' ' A' ' 39' ' ' ARG . 0.8 OUTLIER -84.22 -5.9 59.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.652 0.612 . . . . 5.54 112.652 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.12 -39.32 6.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.798 -0.761 . . . . 1.8400000000000001 110.194 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.76 -35.08 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.442 -0.903 . . . . 2.6699999999999999 110.148 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.41 53.85 0.71 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.151 -1.58 . . . . 1.9099999999999999 109.151 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.25 137.68 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.506 -0.924 . . . . 2.4399999999999999 108.506 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -117.46 54.06 0.9 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.69 -1.204 . . . . 4.2800000000000002 113.901 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.1 mttp 62.94 -65.01 0.1 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.365 1.246 . . . . 8.4100000000000001 114.365 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -44.25 -51.74 8.04 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.022 0.749 . . . . 4.6500000000000004 113.022 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.46 -38.23 58.86 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.758 -1.177 . . . . 4.04 109.999 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLN . 71.9 mt -71.92 -51.77 20.51 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.311 -0.956 . . . . 2.77 108.522 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -40.39 -45.21 2.14 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.178 -1.045 . . . . 6.5700000000000003 108.178 178.242 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -68.75 -58.02 4.81 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 126.008 2.068 . . . . 6.1799999999999997 110.455 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -43.55 -37.51 2.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.669 -0.696 . . . . 4.7199999999999998 112.327 -179.21 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.6 -8.83 18.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.044 0.84 . . . . 2.0699999999999998 111.316 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.29 49.63 55.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.102 -1.599 . . . . 2.4500000000000002 109.102 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.52 ' HZ1' ' CD ' ' A' ' 57' ' ' GLU . 26.2 mmtp -122.97 154.26 64.36 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 114.401 -0.9 . . . . 5.4900000000000002 110.739 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.25 36.34 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.282 1.321 . . . . 5.4500000000000002 110.815 152.04 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.449 ' H ' ' C ' ' A' ' 54' ' ' LYS . 25.1 t 57.24 151.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.432 1.083 . . . . 6.8700000000000001 112.742 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.589 ' CG ' ' H ' ' A' ' 58' ' ' THR . 6.6 pm0 -131.17 -106.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.556 -1.275 . . . . 6.2599999999999998 107.556 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.589 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 67.4 m -119.23 175.56 5.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.321 -1.363 . . . . 7.1399999999999997 107.321 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.461 HG22 HH12 ' A' ' 8' ' ' ARG . 3.2 m -112.6 164.56 15.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.64 -0.504 . . . . 5.2000000000000002 109.64 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.29 -172.5 10.93 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 124.131 -1.195 . . . . 2.6000000000000001 110.421 -11.207 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -103.03 131.97 49.63 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.641 -1.614 . . . . 3.7400000000000002 106.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.577 HG22 ' CG ' ' A' ' 75' ' ' PHE . 8.7 mm -108.62 125.92 65.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.356 -0.937 . . . . 2.7799999999999998 110.832 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.21 124.16 41.84 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.421 -1.326 . . . . 1.1899999999999999 107.421 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.45 ' CG2' HG13 ' A' ' 69' ' ' ILE . 42.2 t -116.54 122.91 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.068 -1.053 . . . . 2.2799999999999998 108.863 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 50.44 32.2 6.26 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.013 1.863 . . . . 2.5299999999999998 108.803 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 82.52 -34.5 0.09 Allowed 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 110.016 -3.266 . . . . 7.71 109.757 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -47.1 112.66 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 5.8300000000000001 108.719 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -57.85 131.57 50.77 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 117.825 -1.55 . . . . 2.2000000000000002 106.876 178.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.45 HG13 ' CG2' ' A' ' 64' ' ' VAL . 51.0 mm -105.43 -42.97 7.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.198 -1.408 . . . . 1.71 107.198 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 131.54 -125.1 4.27 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.941 -1.599 . . . . 1.6799999999999999 111.109 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.22 19.8 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.626 -1.273 . . . . 2.0099999999999998 112.281 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -52.46 -44.88 65.83 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.119 -1.04 . . . . 2.9300000000000002 111.921 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -63.31 -58.82 5.88 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.306 -0.958 . . . . 1.9099999999999999 110.794 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.85 -56.47 8.64 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.096 -0.642 . . . . 4.5899999999999999 109.429 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.577 ' CG ' HG22 ' A' ' 62' ' ' ILE . 66.7 t80 -55.46 -45.46 76.91 Favored 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 115.184 -0.916 . . . . 1.01 109.455 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.68 -55.1 33.31 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.716 -0.794 . . . . 2.0899999999999999 110.334 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.73 63.89 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.722 -1.214 . . . . 1.8200000000000001 107.722 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.529 ' CE2' ' ND2' ' A' ' 82' ' ' ASN . 81.6 t90 -42.75 -58.8 2.19 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 115.556 -0.747 . . . . 1.8100000000000001 110.003 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.424 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 51.3 t -46.1 -23.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.275 -0.875 . . . . 2.1699999999999999 111.579 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.482 ' HZ3' ' C ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -105.8 -67.96 0.9 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.531 0.52 . . . . 3.3900000000000001 110.769 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.51 -22.16 19.92 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.83 1.048 . . . . 4.6900000000000004 113.83 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' ND2' ' CE2' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -112.5 -31.99 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 114.302 1.223 . . . . 4.6200000000000001 114.302 -178.239 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.424 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 55.0 mt -96.87 -9.41 28.63 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 117.428 -1.709 . . . . 2.3700000000000001 111.088 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 65.3 m-20 -120.76 -55.55 2.0 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.357 -0.979 . . . . 3.5299999999999998 108.357 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.495 1.805 0 CA-C-N 111.359 -2.655 . . . . 6.0300000000000002 106.158 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 45.3 tpp . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.706 -1.22 . . . . 3.77 107.706 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.2 100.03 11.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.606 -1.257 . . . . 4.3799999999999999 107.606 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -87.84 120.88 29.6 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.408 -0.917 . . . . 1.9299999999999999 109.237 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 46.2 t -108.44 135.17 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-N 115.876 -0.602 . . . . 1.6799999999999999 109.44 -178.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mm -118.79 111.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.691 1.245 . . . . 2.7799999999999998 109.375 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.492 ' CE2' HG12 ' A' ' 36' ' ' VAL . 47.7 m-85 -93.9 98.14 10.85 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.508 -0.477 . . . . 1.6100000000000001 110.443 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.85 -163.01 11.55 Favored Glycine 0 N--CA 1.512 3.738 0 C-N-CA 120.339 -0.934 . . . . 1.0600000000000001 111.123 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.554 ' NH1' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -129.47 18.61 5.82 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 119.167 -1.013 . . . . 7.7199999999999998 112.477 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.7 m 72.55 -58.04 0.61 Allowed 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 113.772 1.027 . . . . 3.1499999999999999 113.772 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.51 35.88 3.42 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 119.106 -1.521 . . . . 3.54 110.944 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.9 88.96 45.17 Favored Pre-proline 0 N--CA 1.491 1.599 0 C-N-CA 120.453 -0.499 . . . . 2.6600000000000001 110.046 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.36 -53.48 1.34 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.711 2.274 . . . . 3.1299999999999999 112.417 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -55.83 -49.58 72.88 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.769 -1.172 . . . . 4.2400000000000002 109.292 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.442 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 37.0 m -57.59 -39.27 76.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.226 -0.99 . . . . 2.5 109.538 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' ARG . 58.6 t -60.19 -53.92 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.931 -1.108 . . . . 2.3900000000000001 110.463 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tpm_? -35.83 -51.35 0.69 Allowed 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.09 0.472 . . . . 5.29 110.716 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.89 -48.22 3.08 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.696 -0.684 . . . . 1.5600000000000001 111.245 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.565 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 7.7 tmtt? -52.25 -41.25 62.66 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.543 -0.753 . . . . 3.6600000000000001 111.949 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.527 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 17.1 m-20 -53.12 -49.8 65.78 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 118.948 -1.101 . . . . 2.6299999999999999 110.087 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.29 -55.71 4.7 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.81 -1.541 . . . . 3.3500000000000001 108.387 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.503 ' HB2' ' CG ' ' A' ' 33' ' ' TYR . . . -60.18 -49.43 77.67 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.177 -1.829 . . . . 1.74 109.836 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.565 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 36.8 tt0 -45.74 -53.38 9.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.784 1.302 . . . . 4.2199999999999998 109.791 179.095 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.486 ' HZ2' ' CD ' ' A' ' 27' ' ' GLU . 8.5 mmmm -56.89 -64.21 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.597 -0.729 . . . . 4.5 109.783 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -44.38 -56.89 3.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.947 -1.024 . . . . 2.1299999999999999 113.249 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 p -48.16 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.044 1.498 . . . . 2.6400000000000001 115.044 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -123.36 -36.07 2.86 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.117 0.484 . . . . 4.0300000000000002 110.432 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.486 ' CD ' ' HZ2' ' A' ' 23' ' ' LYS . 80.8 mt-10 -74.19 -31.16 62.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.975 -1.011 . . . . 3.6600000000000001 110.424 179.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.423 HH21 ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -109.52 -166.38 1.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.05 -0.66 . . . . 6.1699999999999999 110.256 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.423 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.1 p30 -96.8 -77.59 0.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.593 2.071 . . . . 4.5300000000000002 116.593 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' C ' ' A' ' 31' ' ' PHE . 8.7 t70 -74.12 -59.47 2.71 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.457 0.91 . . . . 4.1299999999999999 113.457 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' A' ' 30' ' ' ASP . 57.3 t80 0.06 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.528 1.307 . . . . 2.0499999999999998 114.528 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -106.07 159.43 16.08 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.607 -1.997 . . . . 4.8799999999999999 105.607 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' CG ' ' HB2' ' A' ' 21' ' ' ALA . 40.7 p90 -160.67 154.13 22.06 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.509 -1.276 . . . . 2.0899999999999999 110.828 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.2 133.61 28.29 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.039 -0.982 . . . . 3.9500000000000002 109.85 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.65 136.57 32.89 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.834 -2.284 . . . . 2.3399999999999999 104.834 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.492 HG12 ' CE2' ' A' ' 6' ' ' PHE . 1.6 t -126.79 147.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.87 -1.159 . . . . 1.72 107.87 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 1.5 t70 -122.15 135.61 54.81 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.027 -0.669 . . . . 2.27 110.688 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.42 -23.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.508 -1.277 . . . . 3.04 110.819 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -88.95 -3.57 58.7 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.724 -0.671 . . . . 6.5999999999999996 112.637 -178.656 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.53 -41.83 7.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.786 -1.19 . . . . 1.99 107.786 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -83.45 -39.45 20.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.151 -1.386 . . . . 2.8300000000000001 108.859 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.14 49.48 1.14 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.452 -1.859 . . . . 1.49 108.452 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 47' ' ' ASP . 74.4 mt -112.43 157.01 13.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 120.262 -0.575 . . . . 2.54 111.07 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . 0.479 ' C ' ' H ' ' A' ' 46' ' ' GLU . 15.3 p -110.92 -179.17 3.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.273 -1.01 . . . . 2.6600000000000001 108.273 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -85.87 46.67 1.34 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 106.462 -1.681 . . . . 6.1600000000000001 106.462 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' H ' ' C ' ' A' ' 44' ' ' THR . 53.2 mt-10 -122.17 -61.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.577 -1.647 . . . . 4.0700000000000003 107.274 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.471 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 16.7 t70 -49.75 -46.04 50.1 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 114.851 -1.068 . . . . 3.8199999999999998 109.534 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -52.79 -4.55 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.756 1.021 . . . . 2.7599999999999998 113.756 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' ASP . 1.1 mp0 -108.39 -53.17 2.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.234 -1.395 . . . . 6.0899999999999999 107.234 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -60.37 -33.13 72.01 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.031 0.92 . . . . 7.4100000000000001 110.745 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.451 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 1.8 ttpp -92.11 14.49 15.85 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.389 -1.278 . . . . 5.0899999999999999 109.344 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.667 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -123.24 -59.82 1.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.304 1.003 . . . . 2.1200000000000001 111.988 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.85 -20.35 48.28 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.179 -1.01 . . . . 2.4700000000000002 112.823 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.538 ' NZ ' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -131.08 161.83 59.33 Favored Pre-proline 0 N--CA 1.506 2.342 0 C-N-CA 120.749 -0.38 . . . . 6.7199999999999998 111.971 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.437 ' CD ' ' HB2' ' A' ' 54' ' ' LYS . 55.4 Cg_exo -12.98 -147.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.109 1 C-N-CA 125.316 4.011 . . . . 7.1900000000000004 116.675 -123.914 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.7 -51.23 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.459 -1.246 . . . . 6.8899999999999997 110.896 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' CD ' ' H ' ' A' ' 58' ' ' THR . 0.0 OUTLIER -79.87 -39.01 31.49 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.626 0.602 . . . . 6.6299999999999999 112.626 -179.142 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.422 ' H ' ' CD ' ' A' ' 57' ' ' GLU . 5.7 t -31.57 144.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 115.728 1.751 . . . . 7.0199999999999996 115.728 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.83 159.49 31.54 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 106.887 -1.523 . . . . 3.9900000000000002 106.887 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.442 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -79.56 -179.57 26.79 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.934 -1.277 . . . . 2.0600000000000001 109.913 -17.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.485 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 13.5 mm-40 -104.98 125.42 50.94 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.029 -1.068 . . . . 3.5600000000000001 108.29 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.474 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 13.7 mm -105.66 137.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.809 -1.552 . . . . 2.48 106.809 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.451 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 78.0 m-85 -122.15 124.33 43.63 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.879 -1.156 . . . . 1.3799999999999999 107.879 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 29.3 t -98.38 111.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.641 -1.624 . . . . 2.1400000000000001 108.339 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 59.04 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.395 1.059 . . . . 2.6000000000000001 111.701 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.5 mm-40 -133.79 -8.84 2.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.906 0.706 . . . . 6.0300000000000002 112.906 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -103.78 153.08 21.11 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.233 0.924 . . . . 6.3399999999999999 111.251 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.667 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 14.9 t-80 -87.33 133.91 33.64 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.794 -1.187 . . . . 1.6499999999999999 107.794 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.449 HG13 HG21 ' A' ' 64' ' ' VAL . 8.7 mm -116.1 -29.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.163 -0.68 . . . . 2.2200000000000002 109.163 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.538 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 29.34 108.18 0.0 OUTLIER Glycine 1 N--CA 1.518 4.107 0 N-CA-C 116.433 1.333 . . . . 2.9300000000000002 116.433 178.413 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.52 121.63 2.8 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.347 -1.101 . . . . 2.6200000000000001 110.347 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -59.46 -45.06 92.71 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.989 -1.084 . . . . 2.2599999999999998 108.866 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -53.97 -54.28 41.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.293 -0.867 . . . . 2.1099999999999999 110.149 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -57.97 -55.22 37.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.703 -1.135 . . . . 2.6899999999999999 110.316 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . 0.413 ' CG ' HG22 ' A' ' 62' ' ' ILE . 42.3 t80 -55.04 -45.82 75.27 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.263 -0.975 . . . . 1.0 108.725 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 -59.2 5.35 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.09 -0.644 . . . . 1.6399999999999999 109.534 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -56.82 -61.52 2.38 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.698 -0.801 . . . . 1.49 109.212 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.403 ' CH2' HG12 ' A' ' 64' ' ' VAL . 62.1 t90 -39.82 -51.56 2.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.251 0.97 . . . . 1.76 109.814 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . 0.412 ' C ' ' H ' ' A' ' 81' ' ' GLU . 4.0 t -54.74 -51.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 1.8700000000000001 108.38 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.452 ' HZ3' ' CG ' ' A' ' 84' ' ' ASP . 0.0 OUTLIER -72.45 16.24 0.15 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.634 -1.166 . . . . 5.6399999999999997 112.087 -178.933 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 79' ' ' VAL . 86.0 mt-10 -127.98 -60.1 1.16 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.408 0.623 . . . . 3.8199999999999998 110.57 179.235 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -83.76 -14.94 50.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.593 -1.185 . . . . 2.02 112.89 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 54.4 mt -99.21 4.87 46.84 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.325 -1.75 . . . . 2.1200000000000001 108.695 179.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.452 ' CG ' ' HZ3' ' A' ' 80' ' ' LYS . 5.7 m-20 -112.47 -54.36 2.63 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 125.505 1.753 . . . . 3.5 107.574 178.768 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 116.079 -1.915 . . . . 6.5499999999999998 108.017 178.672 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 25.6 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.161 -0.681 . . . . 3.71 109.161 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -112.19 97.87 6.94 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.508 -0.923 . . . . 6.46 108.508 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -82.13 135.27 35.32 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.503 -1.226 . . . . 2.04 109.741 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -126.38 130.18 71.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.044 -1.465 . . . . 2.0699999999999998 107.044 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -104.85 128.59 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.982 -1.488 . . . . 2.5899999999999999 106.982 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.75 94.25 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.355 -1.35 . . . . 1.8999999999999999 107.355 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.75 -164.44 11.81 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.716 -2.154 . . . . 1.0 107.716 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 ptm180 -143.16 137.61 29.18 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 117.837 -1.545 . . . . 6.3399999999999999 111.787 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.445 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 61.6 m -53.02 125.05 15.95 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.224 -1.391 . . . . 4.4500000000000002 108.424 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 -35.97 2.99 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.031 -1.557 . . . . 4.7400000000000002 110.549 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 1.5 p -71.19 161.37 78.66 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 117.845 -1.542 . . . . 3.6600000000000001 108.563 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -98.95 -57.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.504 1.469 . . . . 3.4100000000000001 112.441 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -45.86 -32.14 2.48 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.955 0.724 . . . . 3.77 112.955 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -53.53 -31.39 46.1 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 118.004 -1.478 . . . . 2.4199999999999999 110.728 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 -47.58 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.033 -0.667 . . . . 2.2200000000000002 109.263 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.539 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -37.62 -48.64 1.05 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 124.554 1.159 . . . . 4.8700000000000001 112.994 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.62 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.306 -1.358 . . . . 1.6499999999999999 109.349 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.544 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 12.8 tmtt? -62.51 -53.0 61.26 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.414 -0.812 . . . . 3.0600000000000001 111.45 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.539 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.9 OUTLIER -52.18 -48.72 64.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 118.292 -1.363 . . . . 3.29 109.657 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 -62.23 1.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.199 0.937 . . . . 1.8500000000000001 110.87 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.87 -46.04 71.18 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.711 -1.195 . . . . 1.9399999999999999 110.417 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.544 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 39.7 tt0 -48.46 -65.02 0.64 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.545 -0.752 . . . . 2.7999999999999998 110.45 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 44.2 tttm -38.91 -60.43 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.148 0.905 . . . . 4.4299999999999997 112.638 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.406 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.3 mt -35.06 -45.12 0.26 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.913 1.449 . . . . 2.52 114.913 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.6 p -49.09 -38.85 25.88 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 124.118 0.887 . . . . 3.0299999999999998 110.505 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.509 ' N ' HD21 ' A' ' 26' ' ' ASN . 0.8 OUTLIER -102.64 23.71 11.6 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.644 -0.422 . . . . 3.8900000000000001 110.236 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -130.3 -44.04 1.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.685 -0.806 . . . . 4.0700000000000003 112.174 -178.895 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.59 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -107.3 -24.33 11.91 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.41 -1.316 . . . . 6.21 112.089 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.409 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 35.7 t70 84.23 -27.34 0.1 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 123.932 0.77 . . . . 4.96 111.809 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.59 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 10.5 p-10 -100.86 17.08 23.09 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 120.15 -0.62 . . . . 4.7300000000000004 111.038 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . 0.406 ' CG ' ' HB3' ' A' ' 24' ' ' LEU . 72.3 t80 -112.71 119.18 37.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.842 -1.143 . . . . 1.5600000000000001 112.097 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.31 148.39 43.23 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.212 -1.403 . . . . 3.5899999999999999 107.212 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.532 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 29.9 p90 -149.17 157.69 43.58 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.001 -1.08 . . . . 1.7 110.833 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -136.3 156.97 47.89 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.072 -1.455 . . . . 4.7599999999999998 107.072 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -108.22 144.64 35.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.74 -1.584 . . . . 1.8400000000000001 109.033 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.23 129.88 65.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.353 -0.98 . . . . 1.8700000000000001 108.353 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . 0.405 ' OD1' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -108.83 115.99 31.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.268 -1.753 . . . . 2.48 106.268 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.2 -7.1 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 118.372 -1.331 . . . . 2.75 111.91 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -91.81 -9.75 42.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.815 -0.809 . . . . 5.8300000000000001 108.815 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.08 -44.16 6.4 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.012 -1.477 . . . . 2.1699999999999999 107.012 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -74.22 -41.5 61.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.143 -1.428 . . . . 2.9199999999999999 107.143 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.79 55.33 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.937 -1.665 . . . . 1.3200000000000001 108.937 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.29 154.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 120.163 -0.615 . . . . 1.97 110.1 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.4 151.63 34.34 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.376 -0.829 . . . . 3.02 109.251 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.527 ' NZ ' ' O ' ' A' ' 56' ' ' VAL . 19.0 mtpp -55.68 -50.56 69.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.159 -1.416 . . . . 6.6699999999999999 108.226 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -39.94 -63.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.526 1.141 . . . . 4.0999999999999996 110.403 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -55.74 8.68 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.62 0.724 . . . . 5.1100000000000003 111.3 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.87 -40.57 56.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.157 -0.929 . . . . 3.3799999999999999 110.919 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.468 ' NE2' ' HD3' ' A' ' 54' ' ' LYS . 10.9 mm100 -40.87 -40.99 1.49 Allowed 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 119.782 -0.767 . . . . 5.9900000000000002 109.963 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.008 -0.996 . . . . 5.5700000000000003 112.436 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.54 -29.8 22.4 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.385 1.254 . . . . 4.9400000000000004 114.385 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.614 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -98.73 -32.76 11.22 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.62 -0.832 . . . . 3.0600000000000001 112.273 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.15 51.24 46.02 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 120.157 -1.021 . . . . 3.9199999999999999 112.422 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' HD3' ' NE2' ' A' ' 49' ' ' GLN . 0.0 OUTLIER -110.04 -179.78 0.71 Allowed Pre-proline 0 N--CA 1.507 2.385 0 C-N-CA 119.407 -0.917 . . . . 9.0899999999999999 109.591 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.79 170.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.264 1.976 . . . . 7.8700000000000001 111.11 148.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.527 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 35.1 m -89.92 -60.58 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.179 -1.408 . . . . 8.0 110.589 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.509 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.0 OUTLIER -39.53 -69.66 0.12 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 124.506 1.129 . . . . 8.1300000000000008 109.205 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -15.47 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.386 1.679 . . . . 6.3499999999999996 113.929 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.475 HG23 ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -144.63 158.26 53.89 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 106.551 -1.648 . . . . 4.4900000000000002 106.551 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.475 ' HA ' HG23 ' A' ' 59' ' ' VAL . 10.2 Cg_endo -84.34 -163.27 2.97 Favored 'Cis proline' 0 N--CA 1.483 0.868 0 N-CA-C 109.26 -1.092 . . . . 2.2999999999999998 109.26 -10.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.409 HE21 ' HA ' ' A' ' 61' ' ' GLN . 1.2 mm100 -133.75 151.9 51.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.877 -1.529 . . . . 4.4000000000000004 109.914 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . 0.473 ' CD1' ' O ' ' A' ' 71' ' ' GLY . 3.7 mp -119.71 145.8 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.939 -1.134 . . . . 2.3900000000000001 107.939 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -133.47 128.63 35.83 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.72 -1.582 . . . . 1.3500000000000001 107.152 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.555 HG13 ' H ' ' A' ' 65' ' ' ASP . 50.5 t -106.91 -166.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.402 -1.703 . . . . 2.0299999999999998 106.402 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.555 ' H ' HG13 ' A' ' 64' ' ' VAL . 2.9 m-20 -46.47 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 123.711 1.719 . . . . 3.8100000000000001 112.916 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' VAL . 81.1 mt-30 51.82 35.65 16.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 110.242 -3.163 . . . . 5.6100000000000003 113.368 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -137.53 136.44 37.65 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.0 -0.68 . . . . 5.5999999999999996 111.555 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.614 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 10.0 t-160 -79.64 141.54 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 105.377 -2.082 . . . . 1.5 105.377 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.492 HG13 HG21 ' A' ' 64' ' ' VAL . 11.2 mm -107.76 -50.59 7.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 C-N-CA 119.109 -1.036 . . . . 2.3999999999999999 110.32 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.14 -140.57 9.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.2 -1.56 . . . . 1.6699999999999999 109.2 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 62' ' ' ILE . . . -101.76 -54.62 0.92 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 120.407 -0.902 . . . . 2.6099999999999999 112.297 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.501 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 15.3 t80 -159.05 -62.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.037 -1.465 . . . . 2.8399999999999999 109.573 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -44.82 -40.43 6.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.606 1.669 . . . . 2.02 107.306 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.08 -53.97 50.49 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 111.579 -2.555 . . . . 2.6200000000000001 109.988 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -61.87 -38.55 88.72 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 117.615 -1.634 . . . . 1.25 108.353 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.12 -54.63 32.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.724 -1.213 . . . . 1.98 107.724 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.59 -51.37 70.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.468 -0.893 . . . . 2.1000000000000001 109.51 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.441 ' CZ2' HG12 ' A' ' 64' ' ' VAL . 71.0 t90 -46.55 -48.1 19.54 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.756 -0.831 . . . . 2.4399999999999999 108.756 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.28 -51.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.653 -1.61 . . . . 2.3100000000000001 106.653 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -82.14 33.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.316 -0.954 . . . . 3.6699999999999999 110.547 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -133.29 -49.48 0.85 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.657 0.741 . . . . 7.1900000000000004 109.337 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -102.73 -15.64 16.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.31 -1.313 . . . . 2.7599999999999998 111.72 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 29.9 mt -107.45 1.96 23.92 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 117.824 -1.551 . . . . 2.6000000000000001 112.483 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 10.3 p-10 -103.63 14.48 31.05 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.692 -1.603 . . . . 5.2400000000000002 107.487 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 113.174 -1.83 . . . . 7.5300000000000002 108.571 179.196 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.071 -1.455 . . . . 2.6600000000000001 107.071 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' N ' ' CD ' ' A' ' 2' ' ' GLN . 2.3 mp0 -110.05 105.31 14.39 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.905 -1.118 . . . . 4.7999999999999998 110.131 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 m -87.85 146.2 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.83 -1.148 . . . . 1.98 111.24 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.6 t -120.5 136.57 57.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 1.55 107.075 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -113.72 108.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.511 -0.922 . . . . 2.4900000000000002 108.511 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.456 ' HB2' ' HB2' ' A' ' 61' ' ' GLN . 48.7 m-85 -94.5 103.9 15.86 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.752 -0.833 . . . . 1.21 108.752 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.21 -161.54 10.87 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 107.893 -2.083 . . . . 1.25 107.893 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.704 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.82 31.2 5.53 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.164 -1.415 . . . . 6.0300000000000002 112.869 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.613 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.1 m 67.55 174.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.13 -0.941 . . . . 3.5899999999999999 109.948 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 13.47 51.78 0.01 OUTLIER Glycine 0 N--CA 1.511 3.648 0 N-CA-C 116.0 1.16 . . . . 3.3900000000000001 116.0 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.704 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -130.7 101.85 16.81 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.682 -1.229 . . . . 2.2400000000000002 107.682 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -41.4 -47.02 5.76 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.751 1.634 . . . . 4.0199999999999996 110.644 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -57.12 -44.7 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.147 -1.021 . . . . 3.21 109.423 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.76 -51.19 69.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.735 -1.209 . . . . 1.8 107.735 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' LYS . 96.6 t -43.7 -48.81 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 114.516 -1.22 . . . . 1.9299999999999999 111.122 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.413 ' NH1' ' CD1' ' A' ' 72' ' ' TYR . 18.7 mtm180 -35.82 -39.23 0.15 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 120.057 -0.657 . . . . 8.3499999999999996 112.042 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.22 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.917 -0.771 . . . . 2.0800000000000001 108.917 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.549 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 8.5 tmtt? -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.675 -1.232 . . . . 3.79 107.675 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.549 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 60.7 m-20 -58.13 -54.65 44.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.394 -0.922 . . . . 3.1400000000000001 109.377 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.15 -59.25 4.9 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.604 -1.238 . . . . 1.8999999999999999 110.31 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.416 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -53.26 -44.56 68.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.886 -0.726 . . . . 1.8799999999999999 110.56 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.52 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 40.8 tt0 -55.7 -57.05 13.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.272 0.983 . . . . 2.9399999999999999 109.666 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.93 -54.34 47.77 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.747 -0.66 . . . . 5.3399999999999999 111.202 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.458 ' O ' ' N ' ' A' ' 26' ' ' ASN . 79.7 mt -48.35 -57.27 6.27 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.584 -0.846 . . . . 2.7999999999999998 111.678 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -35.0 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 114.039 1.125 . . . . 1.8600000000000001 114.039 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 24' ' ' LEU . 9.2 t30 -104.1 -50.25 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.932 -0.766 . . . . 5.3399999999999999 108.932 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.37 40.52 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.837 -1.074 . . . . 4.0700000000000003 111.258 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.478 HH12 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -147.76 -150.43 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.944 -1.102 . . . . 5.7999999999999998 112.196 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.462 ' H ' ' CG ' ' A' ' 28' ' ' ARG . 4.1 m-20 -111.82 -127.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.008 -0.996 . . . . 6.7800000000000002 110.188 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.4 67.21 5.08 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.662 -1.236 . . . . 3.8500000000000001 107.662 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -112.59 114.56 27.26 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.918 -1.037 . . . . 1.23 111.565 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -120.22 158.83 26.17 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.773 -1.936 . . . . 4.29 105.773 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.416 ' CG ' ' HB3' ' A' ' 21' ' ' ALA . 16.3 p90 -160.58 152.79 20.35 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 117.804 -1.559 . . . . 1.4099999999999999 112.932 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -131.07 164.06 26.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.459 -1.246 . . . . 4.5099999999999998 108.347 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -113.14 143.2 44.77 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.767 -1.197 . . . . 2.0899999999999999 107.767 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.409 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -132.83 143.85 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.381 -0.97 . . . . 1.6799999999999999 108.381 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.95 129.66 55.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.258 0.551 . . . . 2.1600000000000001 109.805 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -58.45 -24.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.192 -1.003 . . . . 2.1099999999999999 110.933 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.58 ' NH1' ' HB3' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.23 -34.17 25.92 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.955 -1.098 . . . . 5.2199999999999998 109.645 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.51 -45.18 88.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.824 -0.625 . . . . 1.9399999999999999 110.193 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.2 mm-40 -86.34 -43.66 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.091 -1.043 . . . . 2.9300000000000002 110.075 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.76 54.66 0.72 Allowed Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.736 -1.745 . . . . 1.5900000000000001 108.736 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.5 mt -115.74 158.5 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.91 -0.645 . . . . 2.23 110.399 -177.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.4 p -117.6 171.09 8.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.022 -0.733 . . . . 2.9100000000000001 109.022 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 7.9 tmtm? -69.37 -43.08 74.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.885 -1.526 . . . . 7.8200000000000003 108.699 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.553 ' H ' ' CD ' ' A' ' 46' ' ' GLU . 2.1 mp0 -56.15 -51.07 69.32 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.072 -0.714 . . . . 3.9700000000000002 109.072 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.44 -51.56 62.25 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.92 -1.112 . . . . 3.0499999999999998 109.098 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ALA . 55.7 mt -52.97 -51.67 60.72 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.44 -1.304 . . . . 2.6200000000000001 107.682 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.437 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.1 tm0? -46.16 -48.14 17.49 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.935 0.772 . . . . 5.3499999999999996 109.894 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -59.95 -40.6 89.56 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.641 0.734 . . . . 7.75 109.034 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.4 ' HG3' ' HZ1' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.786 -1.097 . . . . 5.5999999999999996 111.525 -179.96 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.604 ' HB2' ' CE1' ' A' ' 68' ' ' HIS . . . -94.19 -50.17 5.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.504 0.557 . . . . 2.1400000000000001 112.504 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.5 15.02 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.703 -1.237 . . . . 2.7200000000000002 111.545 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 19.3 ptmt -110.8 74.35 0.93 Allowed Pre-proline 0 N--CA 1.5 2.07 0 C-N-CA 120.28 -0.568 . . . . 6.9299999999999997 111.367 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.0 140.23 40.0 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.581 1.521 . . . . 4.75 111.616 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.8 t 76.18 60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.394 1.058 . . . . 6.3899999999999997 110.202 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -110.22 -176.04 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.621 -1.172 . . . . 6.6100000000000003 108.057 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.533 ' CG2' ' H ' ' A' ' 72' ' ' TYR . 12.2 t -100.93 -161.84 0.89 Allowed 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.283 -1.367 . . . . 8.75 108.357 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 74.3 t -105.9 162.82 18.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 121.506 0.669 . . . . 5.1900000000000004 110.325 -178.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.56 -166.47 5.16 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 124.336 -1.11 . . . . 3.71 109.293 -29.576 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.32 119.0 34.02 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.878 -1.527 . . . . 3.25 106.878 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.46 134.01 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.806 -1.158 . . . . 2.9500000000000002 109.324 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CE1' ' HB2' ' A' ' 68' ' ' HIS . 2.8 m-85 -118.14 114.14 22.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 105.35 -2.093 . . . . 2.1099999999999999 105.35 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.57 HG12 ' CH2' ' A' ' 78' ' ' TRP . 53.2 t -96.86 110.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 117.188 -1.805 . . . . 1.9399999999999999 111.19 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t70 61.32 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.594 0.961 . . . . 2.5099999999999998 113.594 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' VAL . 11.8 mm-40 -130.53 -18.56 3.15 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.117 1.155 . . . . 5.21 114.117 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.46 156.7 19.16 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.741 -1.184 . . . . 5.7000000000000002 111.285 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.604 ' CE1' ' HB2' ' A' ' 52' ' ' ALA . 39.2 t-80 -87.53 141.36 28.68 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.803 -1.159 . . . . 1.8200000000000001 109.71 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . 0.468 HG13 HG21 ' A' ' 64' ' ' VAL . 8.7 mm -114.18 -54.85 4.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.005 -1.48 . . . . 1.8899999999999999 107.005 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . 0.509 ' HA3' ' CE1' ' A' ' 68' ' ' HIS . . . 58.65 123.22 0.01 OUTLIER Glycine 0 N--CA 1.501 3.003 0 O-C-N 124.493 1.121 . . . . 3.0499999999999998 113.6 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 104.23 141.12 10.89 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.875 -1.155 . . . . 2.79 112.57 178.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.533 ' H ' ' CG2' ' A' ' 58' ' ' THR . 20.2 t80 -82.97 -54.5 5.02 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.458 -0.897 . . . . 3.1800000000000002 109.211 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -67.65 1.82 2.22 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.162 -1.015 . . . . 2.7200000000000002 108.939 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . 0.522 ' H ' ' C ' ' A' ' 72' ' ' TYR . 15.2 t70 -100.53 -63.6 1.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.927 -1.508 . . . . 3.1000000000000001 106.927 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -55.58 -45.61 77.35 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.257 -0.883 . . . . 0.95999999999999996 108.936 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.92 -38.61 10.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.109 -0.496 . . . . 1.6699999999999999 110.39 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -81.05 -50.77 9.25 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.6 -1.259 . . . . 2.1499999999999999 107.6 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . 0.57 ' CH2' HG12 ' A' ' 64' ' ' VAL . 76.6 t90 -38.62 -53.23 1.62 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.125 0.89 . . . . 1.6399999999999999 108.712 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 75.6 t -44.02 -46.42 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.324 -1.307 . . . . 2.0299999999999998 110.505 179.602 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.556 ' HZ3' ' C ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -73.28 -58.57 3.22 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.914 -0.714 . . . . 4.4699999999999998 111.707 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -57.4 -24.69 56.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.122 0.786 . . . . 3.7400000000000002 113.122 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -101.02 -34.26 9.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.355 1.243 . . . . 2.1299999999999999 114.355 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.8 mt -96.04 -11.63 26.12 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.328 -1.349 . . . . 2.04 111.677 -178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 36.3 m-20 -122.48 -50.5 1.99 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.287 0.992 . . . . 3.7400000000000002 109.967 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.556 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.502 2.144 0 O-C-N 126.159 2.162 . . . . 6.1500000000000004 107.099 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.9 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.929 -0.767 . . . . 4.1399999999999997 108.929 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -110.11 98.18 7.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.723 -1.584 . . . . 4.9299999999999997 106.723 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.462 ' HB ' ' HB2' ' A' ' 33' ' ' TYR . 86.6 m -82.17 141.3 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.383 -0.927 . . . . 1.8300000000000001 111.939 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -133.86 138.78 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.569 -0.741 . . . . 1.46 110.096 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.79 123.28 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 105.28 -2.119 . . . . 2.7400000000000002 105.28 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PHE . . . . . 0.437 ' CD2' HG12 ' A' ' 36' ' ' VAL . 58.2 m-85 -104.07 78.45 1.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.048 -1.093 . . . . 1.3200000000000001 108.048 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.6 -151.06 9.49 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.514 -1.327 . . . . 1.0 110.739 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ARG . . . . . 0.513 ' HD2' ' H ' ' A' ' 9' ' ' SER . 2.7 tmm_? -119.47 -178.32 3.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.343 -0.984 . . . . 6.3899999999999997 108.343 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.513 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.44 59.45 0.29 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.037 0.384 . . . . 3.6299999999999999 112.037 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.3 71.26 0.84 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.159 -1.496 . . . . 3.52 112.197 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -129.21 149.82 73.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.925 -0.71 . . . . 2.2200000000000002 109.687 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.48 -65.67 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.303 2.002 . . . . 4.4800000000000004 113.206 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -78.01 15.86 0.83 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 119.104 -1.038 . . . . 4.1200000000000001 112.897 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . 0.457 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 36.1 m -107.16 -48.78 3.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.624 -1.621 . . . . 2.1200000000000001 106.624 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' VAL . . . . . 0.511 ' C ' ' H ' ' A' ' 17' ' ' ALA . 50.1 t -73.96 -38.3 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.947 -1.479 . . . . 2.29 108.529 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -80.09 38.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.174 0.987 . . . . 4.6799999999999997 109.391 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . 0.511 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -142.21 -49.56 0.37 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.073 -1.825 . . . . 1.96 106.073 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LYS . . . . . 0.665 ' HZ1' ' CD ' ' A' ' 22' ' ' GLU . 50.9 tttm -57.59 -38.88 75.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.904 -1.498 . . . . 4.1500000000000004 110.081 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -43.55 -47.42 7.34 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.376 0.608 . . . . 4.6500000000000004 110.448 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.24 -42.85 96.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.409 -0.814 . . . . 2.4300000000000002 110.156 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ALA . . . . . 0.484 ' HB3' ' CG ' ' A' ' 33' ' ' TYR . . . -63.65 -57.91 8.58 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.332 -0.947 . . . . 2.0 109.251 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . 0.665 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 47.8 mt-10 -51.44 -51.56 53.86 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.805 0.812 . . . . 3.6200000000000001 109.262 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -53.96 -59.21 4.93 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.937 -1.029 . . . . 5.1900000000000004 109.928 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LEU . . . . . 0.4 HD22 ' HA ' ' A' ' 24' ' ' LEU . 7.4 mt -51.79 -53.17 42.97 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.528 -1.269 . . . . 2.7999999999999998 110.888 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -52.99 -32.12 44.63 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.061 -1.056 . . . . 2.6600000000000001 111.76 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -83.37 -37.18 23.67 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.887 -0.725 . . . . 4.2199999999999998 111.059 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -74.39 -40.06 62.31 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 122.071 0.939 . . . . 2.8999999999999999 110.336 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.543 HH21 ' CG ' ' A' ' 30' ' ' ASP . 9.1 mmm180 -99.62 179.3 4.59 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.113 -1.403 . . . . 8.3000000000000007 111.418 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ASP . . . . . 0.413 ' CG ' HH22 ' A' ' 28' ' ' ARG . 2.0 p30 -122.3 -12.79 8.2 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.772 -1.104 . . . . 4.2300000000000004 110.843 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ASP . . . . . 0.543 ' CG ' HH21 ' A' ' 28' ' ' ARG . 14.5 p30 -103.63 -46.14 4.62 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.7 1.0 . . . . 4.5199999999999996 113.7 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -48.39 110.39 0.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 113.502 0.927 . . . . 1.47 113.502 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.573 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 2.3 tm0? -103.35 156.16 17.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.493 -0.929 . . . . 6.71 108.493 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.573 ' H ' ' NE2' ' A' ' 32' ' ' GLN . 1.6 p90 -164.09 156.74 17.44 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.489 -0.884 . . . . 1.6000000000000001 111.218 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -139.23 152.44 47.32 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.606 -1.179 . . . . 4.0899999999999999 108.772 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -107.47 138.6 43.38 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.145 -1.422 . . . . 1.46 107.593 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.437 HG12 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -124.59 143.52 37.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 124.204 0.94 . . . . 1.8899999999999999 108.7 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -117.23 118.33 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.853 -1.536 . . . . 2.4700000000000002 106.853 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -53.09 -19.27 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.654 -0.818 . . . . 2.1899999999999999 110.985 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . 0.53 ' CB ' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.77 -37.89 55.08 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.593 0.558 . . . . 6.79 111.445 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 -43.43 55.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.908 -0.717 . . . . 2.6299999999999999 109.298 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.27 -43.22 52.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.169 -0.923 . . . . 3.3599999999999999 109.33 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.06 60.29 1.13 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.305 -1.918 . . . . 1.4399999999999999 108.305 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 30.3 mm -114.52 160.75 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 C-N-CA 119.458 -0.897 . . . . 4.2199999999999998 112.346 -178.177 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.33 151.29 40.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.63 -1.168 . . . . 2.5800000000000001 109.772 179.772 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . 0.517 ' HE2' ' N ' ' A' ' 46' ' ' GLU . 4.1 ttpt -56.69 -46.61 81.09 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.656 -1.218 . . . . 5.5199999999999996 109.746 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . 0.517 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 23.8 mm-40 -45.06 -56.85 4.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.284 -0.566 . . . . 4.3399999999999999 110.159 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.56 -56.34 22.57 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.825 0.821 . . . . 4.3700000000000001 110.281 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.435 ' HB3' ' CD ' ' A' ' 61' ' ' GLN . 21.7 mt -46.97 -46.85 21.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.112 -0.949 . . . . 2.54 110.39 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLN . . . . . 0.433 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 25.8 tt0 -52.56 -50.32 63.18 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.72 -1.127 . . . . 4.2599999999999998 109.561 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -52.45 -32.17 38.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.878 0.847 . . . . 6.8300000000000001 110.301 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' LYS . . . . . 0.665 ' HZ1' ' CB ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.98 19.46 17.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.294 -1.321 . . . . 5.0499999999999998 111.139 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.593 ' HB3' ' CE1' ' A' ' 68' ' ' HIS . . . -113.15 -41.08 3.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.826 0.703 . . . . 2.5499999999999998 110.569 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.02 -55.4 0.51 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.45 -1.86 . . . . 2.4399999999999999 108.45 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.438 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 31.3 tttm -92.03 151.98 42.38 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.574 -1.269 . . . . 8.3399999999999999 107.574 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.438 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 30.3 Cg_exo -61.23 75.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.543 1.495 . . . . 5.3300000000000001 110.684 158.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -70.38 82.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.032 0.92 . . . . 7.71 108.527 178.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -50.3 -31.66 14.96 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.082 -1.417 . . . . 6.3600000000000003 111.57 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 99.9 m -94.61 169.05 10.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.682 -0.69 . . . . 5.6200000000000001 110.763 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.415 HG23 ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -116.4 166.0 13.65 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.454 -1.313 . . . . 3.4500000000000002 107.454 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.457 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 76.6 Cg_endo -92.86 -151.08 0.33 Allowed 'Cis proline' 0 C--N 1.312 -1.355 0 N-CA-C 109.592 -0.965 . . . . 2.96 109.592 -17.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.435 ' CD ' ' HB3' ' A' ' 48' ' ' LEU . 24.9 mt-30 -123.66 154.48 39.3 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.499 -0.926 . . . . 5.29 108.499 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 38.7 mt -128.04 142.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.269 -1.332 . . . . 2.4100000000000001 107.926 -179.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.2 122.58 21.82 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.377 -1.342 . . . . 1.27 107.377 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . 0.41 HG11 ' OG1' ' A' ' 3' ' ' THR . 60.4 t -106.71 97.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 117.77 -1.572 . . . . 2.54 109.424 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 1' ' ' MET . 17.5 t0 80.49 -64.82 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.869 -1.059 . . . . 2.5099999999999998 113.011 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -140.92 -29.65 0.66 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.258 1.947 . . . . 6.5899999999999999 116.258 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -100.01 -174.96 2.82 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.938 -1.105 . . . . 5.4500000000000002 111.736 -178.728 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.593 ' CE1' ' HB3' ' A' ' 52' ' ' ALA . 11.9 t-160 -103.41 138.66 39.84 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.779 -1.193 . . . . 1.9399999999999999 107.779 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ILE . . . . . . . . . . . . . 25.2 mm -122.85 -40.73 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 124.061 0.851 . . . . 2.8399999999999999 109.872 -179.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.02 -176.15 0.18 Allowed Glycine 0 N--CA 1.509 3.522 0 CA-C-O 122.085 0.825 . . . . 3.3500000000000001 115.153 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.02 -160.39 0.01 OUTLIER Glycine 0 N--CA 1.508 3.437 0 CA-C-N 113.857 -1.172 . . . . 2.6800000000000002 113.89 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 16' ' ' ARG . 33.4 t80 -121.51 -58.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.121 -1.066 . . . . 2.46 108.121 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 p -39.46 -47.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.246 1.022 . . . . 2.6099999999999999 110.061 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -63.04 1.2 Allowed 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 112.535 -2.12 . . . . 3.25 108.67 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.3 -49.51 9.39 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 119.231 -0.988 . . . . 1.71 109.988 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.08 -65.76 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.68 -1.145 . . . . 2.1600000000000001 111.813 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.95 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.875 -0.787 . . . . 2.46 108.875 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -44.95 -56.28 4.73 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.65 -1.159 . . . . 1.5700000000000001 109.502 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 3.1 t -47.93 -60.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.944 -1.132 . . . . 2.23 107.944 179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -47.05 -46.75 22.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.3 1.0 . . . . 3.6400000000000001 111.095 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.11 21.05 8.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.243 1.201 . . . . 5.21 114.243 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -130.33 -32.96 1.73 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.866 -0.733 . . . . 2.1899999999999999 109.835 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 27.1 mt -96.21 32.62 1.91 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.349 -1.34 . . . . 2.2000000000000002 111.786 -179.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ASP . . . . . 0.433 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 0.6 OUTLIER -108.63 -60.8 1.69 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.969 -0.752 . . . . 5.3200000000000003 108.969 177.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 116.584 -1.674 . . . . 8.5899999999999999 110.064 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' ASP . 74.9 mtp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 107.961 -1.125 . . . . 2.17 107.961 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 42.7 tp60 -123.64 146.96 47.81 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.745 0.653 . . . . 4.88 110.365 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -128.56 154.54 46.07 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.088 -1.045 . . . . 1.02 109.159 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -134.19 128.72 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.648 -1.241 . . . . 0.74 107.648 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mt -111.35 120.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.107 -1.071 . . . . 2.73 108.107 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.91 74.26 1.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.882 -1.155 . . . . 0.96 107.882 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -147.03 -173.15 17.99 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.114 -1.517 . . . . 2.2 109.724 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 18.4 mtp-105 -123.11 154.7 38.26 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.045 -1.062 . . . . 6.27 109.631 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -72.23 77.0 0.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.438 -0.905 . . . . 5.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.35 21.5 0.17 Allowed Glycine 0 N--CA 1.502 3.045 0 C-N-CA 119.388 -1.387 . . . . 3.01 113.101 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -121.99 80.57 42.64 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.048 -0.723 . . . . 3.1 109.048 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -18.73 -69.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 124.194 3.262 . . . . 3.18 114.285 -143.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' CD ' ' A' ' 60' ' ' PRO . 3.8 m-30 -34.2 -45.04 0.2 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 123.363 0.414 . . . . 3.71 112.096 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 57.7 m -52.35 -55.94 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.972 -1.013 . . . . 2.03 109.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.25 -45.78 88.99 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 CA-C-N 114.109 -1.405 . . . . 1.1 108.101 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.7 mmp_? -55.84 -51.83 66.15 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.666 -0.814 . . . . 3.71 112.255 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.17 -50.07 65.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.089 -1.448 . . . . 0.82 107.089 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 3.0 tmtm? -53.88 -55.12 29.72 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.981 -1.009 . . . . 1.92 109.315 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.575 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.9 m-20 -47.8 -56.86 6.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.18 0.514 . . . . 2.9 109.617 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD23 ' CD2' ' A' ' 75' ' ' PHE . 29.8 tp -55.35 -57.13 13.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.989 -1.005 . . . . 0.92 111.472 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -54.39 44.64 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.903 . . . . 0.65 109.579 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 12.5 tt0 -47.59 -47.56 28.53 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.515 -0.92 . . . . 2.26 108.515 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -53.3 -64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.179 0.925 . . . . 4.71 110.5 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -38.55 -47.0 1.25 Allowed 'General case' 0 N--CA 1.506 2.348 0 O-C-N 123.92 0.763 . . . . 1.16 112.835 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -39.06 -36.0 0.26 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.335 0.865 . . . . 1.35 113.335 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -97.66 12.6 33.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.046 1.128 . . . . 2.42 114.046 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 19.3 mt-10 -131.9 -30.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 123.87 0.732 . . . . 3.22 110.942 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -99.12 -24.15 14.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.954 0.724 . . . . 3.92 112.954 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.04 -62.59 0.42 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.071 0.857 . . . . 4.7 110.565 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 1' ' ' MET . 10.6 t70 -82.45 55.85 3.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.814 -1.55 . . . . 3.43 106.814 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -140.83 91.94 2.46 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.225 -0.898 . . . . 1.09 109.968 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 13.6 mm-40 -110.02 128.24 55.29 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.985 -1.487 . . . . 4.52 106.985 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -111.14 160.56 16.8 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.096 -1.041 . . . . 1.41 110.594 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -123.97 146.64 48.36 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.372 -1.344 . . . . 2.84 107.372 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -102.09 132.11 48.16 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.993 -1.083 . . . . 2.3 108.378 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 135.27 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.335 -1.357 . . . . 0.65 107.335 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 34.3 t0 -110.44 111.39 22.62 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 122.23 1.014 . . . . 1.73 109.905 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 pt -48.7 -32.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.25 -1.341 . . . . 2.04 114.035 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 2.7 mmp_? -101.46 19.32 18.09 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.699 -0.8 . . . . 9.02 111.714 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -122.73 -43.68 2.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.682 -1.229 . . . . 1.6 107.682 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.52 -45.32 46.54 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.375 -1.738 . . . . 2.87 110.429 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.59 63.49 0.34 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.746 -1.216 . . . . 1.68 112.693 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 47' ' ' ASP . 55.2 mt -111.6 145.6 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.769 -0.772 . . . . 1.78 109.289 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -116.93 -97.56 0.46 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.939 -0.704 . . . . 2.46 110.203 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HZ2' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -137.6 -50.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.78 -1.933 . . . . 7.8 105.78 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.572 ' CD ' ' HZ2' ' A' ' 45' ' ' LYS . 3.8 mp0 -51.29 -50.17 59.83 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 113.679 -1.601 . . . . 4.81 108.894 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 43' ' ' ILE . 23.8 m-20 -46.44 -64.34 0.78 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.102 0.953 . . . . 3.59 109.329 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 54' ' ' LYS . 81.1 mt -49.93 -50.94 44.65 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.21 -1.359 . . . . 2.25 110.044 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -56.15 -36.55 68.42 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.168 -1.413 . . . . 4.66 110.749 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.63 -39.43 57.83 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.278 0.561 . . . . 6.68 112.064 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 1.7 ttpp -87.37 -28.79 21.98 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 114.575 1.324 . . . . 4.77 114.575 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -118.19 -35.7 3.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.838 0.711 . . . . 1.89 112.689 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.9 -44.57 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.075 -2.81 . . . . 3.87 106.075 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' NZ ' ' HG3' ' A' ' 57' ' ' GLU . 9.1 tttp 53.21 102.77 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 113.297 -1.451 . . . . 9.82 112.656 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -51.07 179.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.214 1.943 . . . . 5.22 110.327 143.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.95 59.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.571 -1.252 . . . . 5.9 110.358 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 15.6 pt-20 -103.51 178.81 4.45 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.654 -1.612 . . . . 5.66 107.549 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -116.42 -106.32 0.39 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.356 -1.338 . . . . 6.1 109.193 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.29 154.64 78.84 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 123.964 0.79 . . . . 3.66 109.83 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 48.6 Cg_endo -96.74 -164.95 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.507 0.741 . . . . 2.0 110.452 -1.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -147.78 163.74 35.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.19 0.931 . . . . 2.65 108.64 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.1 mp -121.32 151.18 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 122.302 1.048 . . . . 1.01 111.787 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.642 ' CZ ' ' HE3' ' A' ' 51' ' ' LYS . 9.4 m-85 -133.31 130.94 39.56 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.764 -2.016 . . . . 1.24 108.726 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 69' ' ' ILE . 66.8 t -121.62 129.77 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.778 -1.564 . . . . 0.98 106.778 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 5.1 m-20 51.47 25.32 2.61 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.698 1.237 . . . . 2.77 112.276 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 2.4 mm100 79.49 -6.36 1.83 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 112.216 -2.266 . . . . 7.24 114.559 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.84 154.96 23.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.963 -1.865 . . . . 4.35 105.963 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 17.3 t-160 -83.16 147.52 28.01 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 117.469 -1.692 . . . . 1.26 109.492 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 64' ' ' VAL . 16.8 mm -116.63 -35.7 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 124.294 0.996 . . . . 0.92 109.154 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.16 -139.76 9.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.754 -1.212 . . . . 1.94 110.301 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.15 -65.75 0.85 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.577 -1.009 . . . . 2.8 110.577 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 66.5 t80 -157.75 -53.78 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.26 -1.376 . . . . 1.81 110.677 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -46.68 -47.62 20.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.356 -1.35 . . . . 1.55 107.356 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.44 -59.36 4.68 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.25 -1.795 . . . . 3.27 109.602 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.591 ' CD1' HG21 ' A' ' 62' ' ' ILE . 38.6 t80 -51.78 -47.64 64.1 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.442 -0.903 . . . . 0.85 109.224 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -59.37 4.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.315 -0.954 . . . . 1.04 109.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.31 -0.859 . . . . 1.04 109.564 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -40.49 -48.89 2.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.006 0.816 . . . . 1.14 110.13 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 80' ' ' LYS . 9.9 t -60.5 -59.2 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.328 -0.99 . . . . 1.23 108.328 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -41.27 -49.65 3.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.882 -1.054 . . . . 3.49 109.925 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.96 -55.68 7.84 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 116.41 2.004 . . . . 3.81 116.41 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -83.54 -20.11 34.46 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 113.948 1.092 . . . . 1.75 113.948 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.69 -37.31 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 117.997 -1.481 . . . . 2.28 113.24 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 63.5 m-20 . . . . . 0 N--CA 1.498 1.968 0 C-N-CA 118.071 -1.452 . . . . 5.8 112.738 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 30' ' ' ASP . 36.5 mtm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.0 -1.481 . . . . 2.42 107.0 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -124.57 143.37 50.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.733 -0.787 . . . . 4.65 110.008 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 61.4 m -125.19 145.11 50.12 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.08 -1.048 . . . . 0.68 113.282 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.8 136.79 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.949 -1.13 . . . . 0.58 107.949 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -118.09 122.03 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 124.226 0.954 . . . . 2.29 109.727 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -93.66 87.21 5.41 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.618 -1.253 . . . . 1.1 107.618 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.89 -164.29 14.51 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.529 -1.428 . . . . 0.97 109.529 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.692 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -128.11 -158.7 0.89 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 117.98 0.89 . . . . 5.63 109.655 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.496 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -101.91 61.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.66 -0.867 . . . . 3.81 108.66 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.67 92.32 2.26 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.048 -2.021 . . . . 2.82 108.048 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -155.27 63.63 3.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 120.311 -0.556 . . . . 2.35 110.224 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -20.42 -55.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 124.044 3.162 . . . . 2.35 114.001 -145.826 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' CYS . 4.3 m-85 -42.69 -44.94 4.52 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.246 -0.582 . . . . 4.63 111.668 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -57.14 -46.12 82.97 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.538 -0.865 . . . . 2.4 111.046 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.0 t -55.8 -43.17 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 115.643 -0.708 . . . . 0.81 110.916 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.682 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -47.27 -48.98 24.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.645 -1.222 . . . . 3.67 112.583 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.07 -45.91 68.35 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.128 -1.029 . . . . 0.67 108.864 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -58.5 -50.81 72.41 Favored 'General case' 0 C--O 1.2 -1.512 0 C-N-CA 119.277 -0.969 . . . . 2.46 108.404 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 18' ' ' LYS . 66.1 m-20 -49.67 -48.4 49.54 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.447 -1.301 . . . . 2.98 110.055 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.14 -65.84 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.396 -1.322 . . . . 0.8 110.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -51.94 8.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.788 0.804 . . . . 0.81 110.713 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.05 -52.48 65.58 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.588 -1.187 . . . . 2.31 107.906 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 tmtm? -43.7 -36.43 2.21 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 115.531 -0.759 . . . . 3.79 110.515 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 79' ' ' VAL . 11.4 mt -78.32 -44.82 24.24 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.146 -0.934 . . . . 1.38 110.438 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 27' ' ' GLU . 74.4 m -50.25 -42.31 51.78 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 118.938 -1.105 . . . . 1.37 109.387 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 23' ' ' LYS . 3.2 p-10 -80.73 28.31 0.34 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.033 -1.467 . . . . 4.75 111.335 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.6 mt-10 -127.68 -64.85 0.95 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.611 -1.177 . . . . 4.21 110.58 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.21 150.29 40.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.54 -0.864 . . . . 4.15 109.655 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.34 -25.81 60.77 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.647 -0.872 . . . . 5.58 108.647 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.5 t70 -74.54 -8.76 57.37 Favored 'General case' 0 C--O 1.202 -1.442 0 C-N-CA 119.065 -1.054 . . . . 3.31 111.711 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -106.78 97.19 7.01 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.76 -1.976 . . . . 1.14 111.151 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -113.75 160.13 19.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.868 -1.16 . . . . 3.51 107.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' THR . 21.5 p90 -147.92 165.18 31.47 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.51 -0.876 . . . . 0.99 108.929 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -131.05 136.53 48.53 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.225 -1.398 . . . . 3.59 107.225 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.29 140.76 29.16 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.236 -1.786 . . . . 1.2 107.659 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.78 137.38 54.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.528 -0.915 . . . . 0.63 108.528 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -111.77 121.71 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.493 -1.299 . . . . 2.41 107.493 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -44.81 -31.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.701 1.0 . . . . 1.53 113.701 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 17.77 15.36 Favored 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 118.14 -1.424 . . . . 5.54 111.972 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.86 -41.85 5.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.245 -1.761 . . . . 1.58 106.245 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -82.98 -39.66 21.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.726 -1.579 . . . . 3.47 108.952 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 50.29 0.65 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.295 -1.522 . . . . 1.46 109.295 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.61 160.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.676 -0.762 . . . . 1.9 111.129 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.6 p -112.74 -158.14 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.606 -1.179 . . . . 3.01 110.844 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 3.8 ttpp -114.15 12.8 17.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 106.486 -1.672 . . . . 5.43 106.486 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -119.11 -50.08 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.645 -1.161 . . . . 4.78 109.625 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -57.89 -45.4 86.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.907 -1.146 . . . . 3.83 107.907 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 48' ' ' LEU . 23.0 mt -42.23 -47.88 4.8 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 115.207 -0.906 . . . . 2.8 110.468 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 1.3 tm0? -46.78 -49.17 20.26 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.617 -0.882 . . . . 4.5 108.617 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -73.86 -40.54 63.18 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.902 -1.044 . . . . 7.16 110.98 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -53.92 -47.71 70.94 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.503 -0.555 . . . . 4.91 109.503 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -76.29 -49.68 16.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.21 -0.905 . . . . 2.59 109.998 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.41 16.33 55.53 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.238 -1.458 . . . . 3.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 6.4 ttmt -120.26 77.42 25.45 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.602 -0.888 . . . . 6.04 108.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 20.5 Cg_endo -80.85 22.66 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.632 1.555 . . . . 4.2 112.503 -127.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.24 -12.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.56 -1.2 . . . . 5.96 111.767 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 11.6 pt-20 -86.77 174.85 8.55 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 118.748 -1.181 . . . . 6.13 112.691 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 p -131.45 -80.07 0.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.072 -0.967 . . . . 4.93 110.698 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 22.4 t -119.82 151.82 52.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 3.5 109.451 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 45.4 Cg_endo -87.64 168.53 40.48 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.814 -0.911 . . . . 2.46 111.04 -18.391 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.441 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 87.2 mt-30 -131.42 117.56 19.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 105.478 -2.045 . . . . 2.77 105.478 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.0 mp -113.25 141.98 27.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.916 -1.038 . . . . 1.09 108.894 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 4.4 m-85 -120.06 138.23 53.66 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.778 -2.01 . . . . 1.31 108.756 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.443 ' CG2' HG13 ' A' ' 69' ' ' ILE . 74.8 t -116.79 130.07 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.064 -1.054 . . . . 1.22 108.63 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 54.09 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 112.607 -2.088 . . . . 3.29 113.383 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 64' ' ' VAL . 72.7 mt-30 -131.22 -31.3 1.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.164 1.542 . . . . 4.57 115.164 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.56 171.95 7.67 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.003 1.112 . . . . 3.46 114.003 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.3 t-80 -73.44 147.64 43.99 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 105.603 -1.999 . . . . 1.84 105.603 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG13 ' CG2' ' A' ' 64' ' ' VAL . 46.2 mm -122.29 -29.39 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.649 -1.22 . . . . 1.52 108.852 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.44 -171.55 34.7 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.069 -1.062 . . . . 2.13 111.337 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 73' ' ' THR . . . -105.12 -149.53 19.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.219 -2.353 . . . . 1.56 107.219 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.53 42.79 0.53 Allowed 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 117.651 -1.62 . . . . 2.97 109.467 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 71' ' ' GLY . 11.7 p -144.62 -69.06 0.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.826 -1.079 . . . . 1.82 109.726 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -54.09 8.88 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.873 -1.058 . . . . 2.99 108.403 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 62' ' ' ILE . 22.5 t80 -52.87 -56.87 12.65 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 104.959 -2.237 . . . . 1.67 104.959 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -38.65 -52.84 1.65 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.688 -1.142 . . . . 1.53 110.232 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -63.54 -58.37 7.2 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.316 -0.954 . . . . 1.14 110.056 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' ALA . 61.5 t90 -40.93 -51.01 3.27 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 119.243 -0.983 . . . . 1.47 109.145 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' A' ' 24' ' ' LEU . 71.0 t -43.13 -58.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.124 -1.065 . . . . 1.38 108.124 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -51.61 -60.9 2.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.876 -1.056 . . . . 2.76 111.655 -179.302 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 80' ' ' LYS . 8.5 mp0 -59.03 -33.1 70.37 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.239 1.94 . . . . 3.88 116.239 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -98.99 -23.38 15.32 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 117.809 -1.556 . . . . 1.77 113.066 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.52 ' CD1' HD13 ' A' ' 24' ' ' LEU . 15.3 mt -83.72 -53.59 5.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.023 -2.214 . . . . 1.35 105.023 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 83' ' ' LEU . 4.6 m-20 . . . . . 0 N--CA 1.508 2.445 0 O-C-N 124.858 1.349 . . . . 5.1 113.552 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 tpp . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.434 -1.321 . . . . 2.37 107.434 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 23.9 mp0 -131.97 132.92 43.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.765 0.666 . . . . 4.29 110.317 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m -121.64 142.79 49.78 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 119.623 -0.831 . . . . 0.74 110.939 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.47 127.35 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 108.42 -0.956 . . . . 1.02 108.42 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.32 109.44 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 124.84 1.337 . . . . 1.81 108.582 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 98.3 m-85 -87.87 100.05 12.58 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.111 -1.07 . . . . 1.35 108.111 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.8 -166.93 13.69 Favored Glycine 0 N--CA 1.501 3.015 0 N-CA-C 109.114 -1.594 . . . . 0.99 109.114 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.697 ' CG ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 ptm180 -119.24 37.27 4.19 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.257 -1.377 . . . . 5.61 112.088 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 50.5 m 83.47 51.71 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 116.094 1.887 . . . . 3.53 116.094 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.77 67.34 1.49 Allowed Glycine 0 N--CA 1.505 3.246 0 C-N-CA 119.069 -1.539 . . . . 3.78 114.1 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.697 ' SG ' ' CG ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -111.42 159.07 34.41 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.339 -0.944 . . . . 2.38 109.886 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 81.2 Cg_exo -40.31 144.24 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.438 1.426 . . . . 3.66 110.015 157.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER 77.11 -59.46 0.48 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 107.568 -1.271 . . . . 3.27 107.568 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 33.4 m -53.78 -47.16 71.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.4 -0.818 . . . . 1.73 110.029 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 11' ' ' CYS . 86.1 t -49.12 -41.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.856 -1.138 . . . . 1.61 108.033 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -74.58 82.82 2.02 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.657 -1.238 . . . . 4.41 107.657 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 173.36 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.291 -2.231 . . . . 1.01 105.471 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 33' ' ' TYR . 5.9 tmtm? -69.17 -47.18 65.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.964 -1.495 . . . . 2.72 106.964 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -55.29 -37.39 67.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.775 -0.824 . . . . 3.41 108.775 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.02 -58.97 3.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.301 -1.36 . . . . 1.18 108.563 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -40.14 -54.55 2.28 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.511 -0.876 . . . . 1.02 110.918 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 3.8 mm-40 -38.77 -41.86 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.852 0.834 . . . . 2.81 112.735 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.51 -54.63 11.42 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.013 -0.994 . . . . 4.62 109.502 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.555 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 49.3 mt -49.99 -46.25 52.47 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.54 -1.209 . . . . 1.36 108.15 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 m -58.02 -28.7 64.69 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.252 0.97 . . . . 1.35 112.667 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -102.2 -17.26 16.04 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.265 -0.574 . . . . 4.14 111.761 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 34.1 mt-10 -87.93 -45.23 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.253 -0.579 . . . . 3.13 110.537 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 83' ' ' LEU . 2.0 mpt_? -104.69 -17.09 14.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.867 -0.733 . . . . 5.55 111.486 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.59 -51.32 0.62 Allowed 'General case' 0 N--CA 1.512 2.65 0 O-C-N 124.394 1.059 . . . . 5.9 112.326 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.86 54.73 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.421 1.105 . . . . 3.43 108.642 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 74.0 t80 -146.34 82.2 1.59 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.393 -0.821 . . . . 1.28 109.745 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 12.8 mp0 -89.71 142.11 27.99 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.481 -1.674 . . . . 3.19 106.481 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 18' ' ' LYS . 38.0 p90 -129.78 150.27 51.16 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.289 -0.964 . . . . 1.26 108.659 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -116.74 136.29 53.08 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.841 -0.8 . . . . 3.79 108.841 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -95.23 114.95 26.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.091 -1.818 . . . . 1.22 106.091 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.54 134.57 54.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 114.776 -1.102 . . . . 0.6 109.362 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.17 132.38 55.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.504 -0.924 . . . . 2.17 108.504 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 pt -60.87 -29.77 46.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 118.686 -1.205 . . . . 1.35 111.825 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.15 -34.19 56.56 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.012 -1.475 . . . . 4.8 110.602 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.23 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.663 -0.815 . . . . 1.1 111.262 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -85.08 -34.46 22.23 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.322 -0.951 . . . . 2.53 111.225 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.89 52.85 1.07 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.677 -1.369 . . . . 1.33 109.677 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -104.74 155.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.764 -0.718 . . . . 1.49 110.849 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.0 p -118.62 161.58 19.83 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.167 -0.924 . . . . 2.32 110.648 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 19.0 ttpp -55.73 -42.59 75.57 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.687 -1.597 . . . . 4.53 106.687 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.2 mp0 -51.55 -56.82 11.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.237 -1.347 . . . . 3.72 109.647 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -46.84 -51.47 16.52 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.581 -0.848 . . . . 3.62 111.139 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.76 -52.1 61.88 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.311 -0.859 . . . . 1.76 110.457 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 40.6 tt0 -53.3 -39.29 63.89 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.839 -0.744 . . . . 4.2 109.549 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -76.09 -33.81 59.52 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.388 -0.597 . . . . 5.45 109.388 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -63.07 -36.94 85.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.468 -0.567 . . . . 3.92 109.468 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -104.81 -88.17 0.43 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.076 -0.966 . . . . 2.34 108.904 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 41.34 1.12 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.125 -1.512 . . . . 3.11 113.869 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 74' ' ' ASP . 44.0 pttt -120.76 58.0 6.29 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.073 -1.051 . . . . 6.17 109.194 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.1 38.8 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.251 3.301 . . . . 4.42 114.043 -106.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.92 38.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.073 -1.084 . . . . 5.56 108.073 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -104.33 154.02 20.34 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.737 -1.119 . . . . 5.92 110.971 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -125.29 -156.23 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.566 -1.197 . . . . 5.32 107.819 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.69 145.42 30.67 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.996 -0.742 . . . . 3.41 108.996 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 52.8 Cg_endo -88.89 145.68 22.0 Favored 'Cis proline' 0 C--N 1.316 -1.132 0 O-C-N 123.558 1.294 . . . . 1.96 112.36 16.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -102.51 144.12 31.35 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.445 -1.687 . . . . 3.86 106.445 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.58 140.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.843 -1.543 . . . . 1.5 112.988 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 24.9 m-85 -136.16 135.59 39.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 110.976 -2.829 . . . . 1.28 107.876 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.579 HG23 HG13 ' A' ' 69' ' ' ILE . 61.6 t -102.6 121.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 106.828 -1.545 . . . . 1.08 106.828 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.2 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.905 -1.043 . . . . 2.6 111.209 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 64' ' ' VAL . 58.2 mt-30 -135.06 3.31 3.15 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.26 -0.976 . . . . 4.92 111.666 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -105.39 155.41 19.15 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.843 0.354 . . . . 4.62 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 8.0 t-80 -92.78 149.18 21.46 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.409 -1.33 . . . . 1.77 107.409 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 64' ' ' VAL . 3.2 mm -118.01 -38.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 117.513 -1.675 . . . . 1.06 109.703 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.41 -26.59 3.06 Favored Glycine 0 N--CA 1.502 3.04 0 C-N-CA 118.937 -1.602 . . . . 2.39 112.435 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.37 -173.83 20.27 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 108.231 -1.947 . . . . 1.64 108.231 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -51.77 -59.33 4.43 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.89 -1.124 . . . . 2.0 111.611 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.69 -45.59 49.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 112.938 0.718 . . . . 2.07 112.938 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 1.4 m-20 -74.84 -51.71 13.25 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.793 -0.763 . . . . 2.56 110.205 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 79' ' ' VAL . 83.4 t80 -51.21 -43.33 61.37 Favored 'General case' 0 C--O 1.194 -1.84 0 N-CA-C 107.48 -1.304 . . . . 0.97 107.48 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.79 -60.63 2.94 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.018 -0.734 . . . . 0.9 109.018 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.96 -53.94 45.83 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.909 -0.716 . . . . 1.21 111.312 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -54.93 -53.12 59.65 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.416 -0.914 . . . . 1.43 110.126 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 80' ' ' LYS . 1.9 t -46.48 -62.52 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 124.48 1.112 . . . . 1.1 109.006 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.598 ' N ' HG12 ' A' ' 79' ' ' VAL . 15.8 tptp -34.63 -49.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.256 -1.793 . . . . 2.92 113.3 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.04 20.05 19.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.653 1.723 . . . . 6.42 115.653 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -132.14 -26.53 1.9 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.661 -1.615 . . . . 2.2 110.775 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 50.1 mt -100.95 45.56 0.97 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.426 -1.31 . . . . 2.75 107.804 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.933 0.873 . . . . 5.66 110.378 177.775 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 30' ' ' ASP . 77.5 mtm . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.211 -0.662 . . . . 2.72 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -109.43 102.16 11.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.727 -1.212 . . . . 4.5 107.727 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.3 m -91.66 139.43 30.7 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.599 -1.241 . . . . 0.78 109.27 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.52 139.03 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.045 -0.98 . . . . 0.91 109.988 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -118.34 109.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.156 1.535 . . . . 1.53 107.86 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG11 ' A' ' 36' ' ' VAL . 32.5 m-85 -91.74 90.74 7.66 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.174 -1.417 . . . . 1.28 107.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.85 -162.61 11.95 Favored Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.262 -0.971 . . . . 1.06 110.947 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.632 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -122.77 71.59 1.04 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.095 0.95 . . . . 6.25 111.532 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p 32.81 -77.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 116.393 1.997 . . . . 3.71 116.393 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -103.74 46.3 1.22 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 120.111 -1.042 . . . . 2.92 113.983 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.632 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 1.1 p -116.3 114.63 40.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 108.239 -1.023 . . . . 2.15 108.239 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.61 -54.89 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.187 1.925 . . . . 2.67 111.732 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.408 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 10.7 t80 -52.1 -40.43 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.279 -0.968 . . . . 2.54 109.913 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.42 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 28.4 m -62.24 -53.6 52.93 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.141 -1.024 . . . . 1.77 110.303 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -52.62 -42.14 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 114.669 -1.15 . . . . 1.42 111.663 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.526 HH12 ' CG ' ' A' ' 19' ' ' ASP . 10.0 mmm180 -42.5 -41.58 3.02 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 119.11 -1.036 . . . . 3.45 111.551 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.37 86.39 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.442 -0.903 . . . . 0.71 108.659 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.495 ' NZ ' ' HB2' ' A' ' 22' ' ' GLU . 4.1 tmtm? -62.6 -38.15 89.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.626 -0.879 . . . . 2.2 108.626 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CG ' HH12 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -61.46 -56.94 14.65 Favored 'General case' 0 C--O 1.192 -1.955 0 N-CA-C 106.666 -1.605 . . . . 3.53 106.666 177.578 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.1 tp -48.31 -56.93 6.8 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.145 -1.022 . . . . 1.08 108.655 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -50.53 9.84 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.71 108.425 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -57.41 -52.14 66.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.122 -0.631 . . . . 3.12 110.501 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 2.4 ttpp -52.68 -17.32 1.25 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.627 -1.17 . . . . 3.67 110.428 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.03 -53.37 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.506 -0.924 . . . . 1.48 108.506 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -43.9 -35.39 1.97 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.593 0.59 . . . . 1.53 112.593 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -105.62 22.3 15.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.086 1.143 . . . . 3.64 114.086 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 19.8 mt-10 -131.86 -27.6 1.86 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.575 -0.45 . . . . 3.27 110.242 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.59 -163.98 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.809 -0.756 . . . . 4.3 109.587 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.49 -179.98 4.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.14 -1.8 . . . . 4.69 106.14 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 t70 43.86 30.43 0.39 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 124.923 1.389 . . . . 3.6 112.059 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.87 85.88 2.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.243 -1.783 . . . . 1.01 113.068 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -102.71 141.82 34.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.178 -2.156 . . . . 3.42 105.178 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -133.1 153.62 51.34 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.627 -1.229 . . . . 1.07 109.567 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' HG23 ' A' ' 36' ' ' VAL . 1.7 tm0? -121.3 142.53 49.87 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.292 -1.373 . . . . 4.0 107.292 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.54 118.97 33.22 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.652 -1.219 . . . . 1.52 109.319 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 6' ' ' PHE . 26.3 t -109.43 136.07 46.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.027 -0.988 . . . . 1.01 109.152 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' A' ' 39' ' ' ARG . 17.1 t70 -118.58 44.86 2.17 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 114.842 -1.072 . . . . 1.99 108.743 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.1 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 114.364 -1.289 . . . . 2.0 114.199 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.616 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -59.14 -51.39 70.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.75 -0.659 . . . . 6.96 110.876 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' NH2' ' A' ' 39' ' ' ARG . . . -40.34 -51.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.381 -0.927 . . . . 1.27 110.24 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -74.93 -43.04 56.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.426 1.079 . . . . 3.17 110.478 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.4 30.81 1.23 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.161 -1.176 . . . . 2.2 110.161 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -98.44 152.35 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 2.32 108.171 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -124.4 -175.98 3.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.708 -0.678 . . . . 3.15 112.32 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -84.3 2.15 41.56 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.983 -0.687 . . . . 4.72 110.619 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.84 -45.91 5.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.037 -2.208 . . . . 5.05 105.037 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.5 -56.2 21.29 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.054 -0.975 . . . . 4.11 108.486 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -48.64 -40.25 27.13 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.713 -1.131 . . . . 2.06 111.5 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.23 -53.67 6.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.925 -1.11 . . . . 6.96 109.338 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -43.04 -49.92 6.06 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.493 -1.685 . . . . 6.89 113.297 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 5.4 mtpp -91.06 -28.02 18.22 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.516 -1.22 . . . . 5.48 114.162 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -73.61 -51.24 17.5 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.569 1.168 . . . . 1.95 112.899 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.98 -32.94 2.68 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.143 -1.983 . . . . 2.32 108.143 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 52' ' ' ALA . 26.0 mttt -86.38 -179.07 1.27 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 114.547 -0.827 . . . . 6.01 108.807 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.73 124.45 14.13 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.749 2.299 . . . . 4.81 111.76 155.534 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 56' ' ' VAL . 30.5 m -77.42 31.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.898 -0.592 . . . . 8.28 111.377 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.19 -7.85 12.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.41 -0.959 . . . . 5.64 108.41 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -85.04 54.09 2.97 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.243 -1.392 . . . . 6.46 107.243 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 19.2 m -89.68 169.57 12.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.161 -1.382 . . . . 3.41 111.799 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.671 ' C ' ' HA ' ' A' ' 59' ' ' VAL . 5.6 Cg_endo -46.16 137.67 1.8 Allowed 'Cis proline' 0 N--CA 1.489 1.219 0 C-N-CA 125.072 -0.803 . . . . 2.36 110.518 -13.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 61' ' ' GLN . 0.2 OUTLIER -94.53 116.63 29.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.091 -1.818 . . . . 3.29 106.091 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.6 mp -108.29 139.7 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 123.035 1.397 . . . . 1.12 111.416 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 3.8 m-85 -126.71 136.58 52.65 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 111.833 -2.44 . . . . 1.67 106.257 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG23 HG13 ' A' ' 69' ' ' ILE . 54.9 t -110.11 110.07 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 118.677 -1.209 . . . . 1.14 109.84 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 t70 75.38 -72.3 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 124.29 0.994 . . . . 2.69 112.216 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -134.03 -41.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.619 0.97 . . . . 4.5 113.619 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -94.26 160.75 14.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.552 0.945 . . . . 4.05 113.552 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.6 t-160 -77.09 144.47 38.5 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.772 -1.936 . . . . 1.51 105.772 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 64' ' ' VAL . 20.9 mm -103.66 -25.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 117.916 -1.514 . . . . 1.38 109.504 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.405 ' HA2' ' HD2' ' A' ' 54' ' ' LYS . . . 137.73 -34.05 2.2 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 118.522 -1.799 . . . . 2.77 113.294 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.78 -175.01 22.37 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.514 -1.434 . . . . 1.7 109.514 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 2.6 t80 -51.29 -44.44 61.88 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.375 -0.93 . . . . 2.01 111.625 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 p -66.81 -58.85 4.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.768 0.794 . . . . 1.45 110.548 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.73 -46.44 40.87 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.634 -1.166 . . . . 2.71 109.21 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 62' ' ' ILE . 48.7 t80 -60.88 -53.23 59.81 Favored 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 108.198 -1.038 . . . . 1.04 108.198 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.59 -53.39 11.55 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.71 -0.796 . . . . 0.79 112.655 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.48 13.58 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 118.999 -1.081 . . . . 0.91 110.126 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -44.41 -48.64 9.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.22 0.95 . . . . 1.32 108.828 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 t -47.67 -59.36 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 124.154 0.909 . . . . 1.02 108.865 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 7.6 tmtm? -57.33 -59.92 4.41 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.498 -1.281 . . . . 3.11 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -52.66 -36.27 56.61 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.24 1.57 . . . . 3.86 115.24 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -101.27 -28.67 12.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.811 -1.155 . . . . 1.73 113.563 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.07 -26.43 26.97 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 117.862 -1.535 . . . . 1.75 112.571 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 . . . . . 0 N--CA 1.5 2.073 0 C-N-CA 118.393 -1.323 . . . . 3.33 111.153 -179.114 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.459 ' N ' ' CG ' ' A' ' 30' ' ' ASP . 13.9 ptp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.162 -0.681 . . . . 2.91 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 19.6 pt20 -123.82 125.53 44.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.749 0.656 . . . . 3.66 110.721 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -94.25 132.03 39.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.488 -0.93 . . . . 1.12 108.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.87 117.94 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.59 -1.634 . . . . 0.91 106.59 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.8 mm -108.96 125.04 66.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.568 -1.253 . . . . 1.76 108.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.13 96.02 6.94 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.962 -0.755 . . . . 1.31 108.962 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.59 -173.67 18.09 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.559 -1.817 . . . . 0.93 108.559 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.11 170.84 3.69 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.813 -0.81 . . . . 8.79 108.813 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -90.51 53.7 2.52 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 105.864 -1.902 . . . . 6.05 105.864 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.83 -39.16 0.12 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.339 -1.904 . . . . 6.99 108.339 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -90.59 151.67 44.27 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 108.578 -0.897 . . . . 5.02 108.578 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.2 Cg_endo -91.28 178.91 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.58 2.187 . . . . 4.69 109.027 146.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER 76.6 -36.56 0.27 Allowed 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 120.454 -0.498 . . . . 3.37 111.714 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -31.77 11.32 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 120.28 -0.568 . . . . 1.78 111.936 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 59.4 t -59.84 -53.5 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.444 -0.902 . . . . 1.12 109.7 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -33.86 -53.15 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.295 -0.866 . . . . 4.2 113.323 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.9 84.16 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.451 -0.9 . . . . 0.81 109.733 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 2.5 tmtm? -53.33 -47.9 68.94 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.891 -1.049 . . . . 1.84 110.251 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.547 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 1.3 p-10 -68.03 -43.14 79.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.143 -1.423 . . . . 2.84 109.083 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.52 -58.57 6.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.273 -1.371 . . . . 0.91 109.953 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.94 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.542 -0.863 . . . . 0.89 110.725 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.623 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 24.1 tt0 -50.75 -57.8 7.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.885 -1.126 . . . . 2.67 109.265 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.61 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -49.14 -54.07 17.94 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.901 -1.045 . . . . 4.69 110.178 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -48.9 -44.15 39.87 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 114.107 1.151 . . . . 1.66 114.107 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.7 p -49.73 -19.94 0.73 Allowed 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 119.351 -0.939 . . . . 2.28 113.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -99.53 -2.82 34.86 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.713 -0.395 . . . . 3.26 111.531 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.61 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 14.9 mt-10 -114.6 -32.8 5.75 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.577 0.703 . . . . 3.35 111.24 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 8.6 mmm-85 -95.67 -173.62 2.92 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.743 -1.183 . . . . 3.74 113.953 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 7.1 p-10 -96.55 -71.77 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 113.45 -1.705 . . . . 5.15 111.969 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 42.1 t0 -101.91 66.63 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.918 0.866 . . . . 4.02 108.861 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -124.04 102.47 7.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.774 -1.103 . . . . 1.34 110.163 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 45.7 mt-30 -119.07 163.33 17.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.363 -1.718 . . . . 3.28 106.363 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 35.3 p90 -158.83 164.07 36.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.291 -1.364 . . . . 1.31 110.135 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -136.14 137.62 41.17 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.679 -1.146 . . . . 3.46 108.789 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -96.78 137.21 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.164 -2.532 . . . . 1.28 104.164 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.6 139.12 52.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.447 -0.901 . . . . 0.7 111.672 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -115.79 124.5 50.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 104.807 -2.294 . . . . 1.79 104.807 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 pt -51.02 -35.79 15.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.116 -0.947 . . . . 1.9 111.918 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -81.75 4.02 23.53 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 113.237 0.828 . . . . 5.2 113.237 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.63 -46.27 3.06 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.987 -0.685 . . . . 1.96 109.925 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.451 -0.899 . . . . 3.74 109.355 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.64 48.66 1.77 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 120.035 -1.079 . . . . 3.08 110.752 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.38 147.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.407 -0.917 . . . . 2.57 110.471 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.1 p -117.71 170.46 8.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.712 -1.218 . . . . 3.71 107.712 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -53.89 48.69 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.071 -1.052 . . . . 6.11 108.978 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -35.08 -62.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.534 -1.212 . . . . 5.38 110.559 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -46.78 -59.11 3.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.253 -0.885 . . . . 4.41 111.976 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.1 mt -50.68 -44.87 57.92 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.834 -0.746 . . . . 2.39 111.372 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 5.3 tm0? -42.17 -55.15 3.37 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.597 -0.841 . . . . 6.53 110.143 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -49.23 -33.96 13.83 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.022 -0.99 . . . . 6.6 113.271 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.68 -26.37 19.61 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.981 -0.688 . . . . 3.39 111.835 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 -45.45 53.79 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.886 -0.726 . . . . 1.69 109.559 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.13 -52.48 0.63 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.176 -1.57 . . . . 3.61 109.176 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 2.4 ttpm? -95.27 161.92 26.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 6.52 108.026 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 87.5 Cg_exo -30.45 121.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 121.538 1.492 . . . . 5.56 109.137 147.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.6 47.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.617 -0.833 . . . . 7.77 111.812 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 1.8 mm-40 -83.48 53.3 2.47 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.951 1.358 . . . . 8.49 108.697 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -147.72 99.22 3.07 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 105.575 -2.009 . . . . 5.21 105.575 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -113.53 147.69 38.08 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.309 -0.997 . . . . 3.15 108.309 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 59' ' ' VAL . 11.1 Cg_endo -84.2 174.35 38.49 Favored 'Cis proline' 0 C--O 1.207 -1.043 0 C-N-CA 125.403 -0.666 . . . . 2.12 111.48 21.354 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.72 146.9 48.92 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.459 -0.896 . . . . 3.57 110.57 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.463 HG21 ' CG ' ' A' ' 75' ' ' PHE . 14.8 mm -120.09 134.93 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 124.011 0.82 . . . . 1.74 108.901 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HA ' HG12 ' A' ' 69' ' ' ILE . 15.5 m-85 -137.38 133.16 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.167 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 69' ' ' ILE . 84.6 t -100.11 122.32 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 106.25 -1.759 . . . . 1.3 106.25 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.53 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.783 0.677 . . . . 2.97 111.582 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' VAL . 74.1 mt-30 -138.35 10.07 2.73 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.601 -0.84 . . . . 5.03 112.239 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.77 152.66 24.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.488 -0.485 . . . . 4.24 110.12 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -85.14 145.1 27.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.588 -1.264 . . . . 1.57 107.588 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 HG23 ' A' ' 64' ' ' VAL . 14.0 mm -113.5 -34.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 C-N-CA 119.255 -0.978 . . . . 1.2 110.895 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.0 -128.94 4.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.323 -1.111 . . . . 1.77 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.73 -59.2 0.59 Allowed Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.868 -1.158 . . . . 2.32 112.073 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -163.63 -60.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.959 -1.096 . . . . 1.86 109.157 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 p -41.6 -48.06 3.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.973 -1.121 . . . . 1.84 107.973 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -68.75 0.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.756 -2.02 . . . . 2.96 110.353 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CG ' HG21 ' A' ' 62' ' ' ILE . 71.7 t80 -52.62 -39.23 61.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.305 -0.958 . . . . 1.04 110.762 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.499 -0.481 . . . . 0.94 111.174 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.09 -48.71 61.91 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.894 -1.151 . . . . 1.56 107.894 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.442 ' CZ3' ' CE1' ' A' ' 75' ' ' PHE . 60.8 t90 -41.6 -52.09 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.712 -1.131 . . . . 1.2 108.923 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 83' ' ' LEU . 3.0 t -41.81 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.619 -1.252 . . . . 1.16 107.619 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -47.78 -53.42 15.42 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.468 0.652 . . . . 3.25 111.235 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 1.1 mp0 -62.69 -17.99 61.63 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.081 1.141 . . . . 4.02 114.081 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -110.6 -32.24 6.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 118.826 -1.149 . . . . 1.78 113.385 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.539 HD12 HG13 ' A' ' 79' ' ' VAL . 19.2 mt -92.87 -19.7 21.42 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.363 -0.935 . . . . 1.74 111.697 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.398 -0.964 . . . . 3.45 108.398 179.839 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.898 0.38 . . . . 4.04 110.689 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -106.78 174.8 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.247 -1.02 . . . . 4.14 108.247 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 75' ' ' PHE . 57.5 m -114.88 141.18 48.27 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.741 -1.184 . . . . 0.75 113.695 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.7 t -119.63 128.27 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.14 -2.17 . . . . 0.64 105.14 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.46 120.56 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 124.474 1.109 . . . . 1.53 110.48 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CD2' HG11 ' A' ' 36' ' ' VAL . 91.0 m-85 -99.42 81.3 2.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.175 -1.417 . . . . 0.92 107.175 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.42 -174.15 13.6 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.929 -1.268 . . . . 1.87 109.929 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 9' ' ' SER . 7.5 mmm180 -102.91 -63.62 1.15 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.732 -0.787 . . . . 6.47 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 75.5 m 97.45 145.9 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 125.408 1.692 . . . . 5.95 107.78 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.18 -21.22 31.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 106.63 -2.588 . . . . 4.7 106.63 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -113.27 150.25 42.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.996 -1.102 . . . . 3.46 110.072 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.09 -56.48 2.53 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.702 1.601 . . . . 3.03 112.317 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.56 -44.09 79.09 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.597 -0.841 . . . . 3.09 112.114 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 20.1 p -54.9 -55.13 33.85 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 117.291 -1.764 . . . . 3.57 107.999 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 18' ' ' LYS . 97.7 t -52.97 -47.37 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 1.19 111.167 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -32.83 -50.01 0.25 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 113.555 0.946 . . . . 4.46 113.555 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.13 95.62 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.003 -1.079 . . . . 0.82 110.517 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -61.09 -47.49 86.08 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.251 -0.648 . . . . 1.92 109.251 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m-20 -56.86 -47.85 79.46 Favored 'General case' 0 C--O 1.199 -1.596 0 C-N-CA 118.81 -1.156 . . . . 3.47 109.244 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.62 -57.69 11.86 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.443 -1.303 . . . . 0.87 109.361 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.582 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -50.56 -53.51 29.79 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.145 -1.422 . . . . 0.74 110.071 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 20.2 tt0 -55.19 -49.54 71.66 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.585 0.707 . . . . 2.8 112.228 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.64 -51.14 71.08 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.032 -1.099 . . . . 7.08 108.032 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.81 -52.86 37.09 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.468 -0.787 . . . . 1.7 109.967 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 p -60.42 -14.58 19.81 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.107 -1.437 . . . . 1.72 112.358 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -117.71 17.57 14.33 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.178 0.513 . . . . 3.41 110.194 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.54 -45.52 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.203 1.001 . . . . 3.9 109.474 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 2.3 mmp_? -101.86 -36.68 8.57 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.193 -1.367 . . . . 4.04 111.392 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 31' ' ' PHE . 15.5 m-20 77.42 -40.74 0.35 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 124.636 1.21 . . . . 6.4 110.389 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -72.79 17.84 0.11 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.486 -0.886 . . . . 6.59 109.729 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 29' ' ' ASP . 47.2 t80 -125.49 120.81 31.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.11 -0.95 . . . . 1.91 109.694 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.302 -1.37 . . . . 4.73 107.302 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 18.3 p90 -144.68 176.12 9.66 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.63 -0.828 . . . . 1.45 112.755 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -136.14 141.64 44.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.623 -1.621 . . . . 2.89 106.623 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -99.16 141.52 31.83 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.944 -1.503 . . . . 1.36 108.053 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -131.32 148.18 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.989 -1.115 . . . . 0.75 107.989 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.79 123.65 50.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.922 -1.14 . . . . 1.99 107.922 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 pt -54.14 -25.32 12.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.098 -1.041 . . . . 1.92 110.105 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.67 11.25 18.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.368 1.042 . . . . 6.67 111.653 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.86 -51.01 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.392 -0.595 . . . . 1.79 109.392 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.79 -32.55 63.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.547 -1.206 . . . . 2.78 109.641 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.45 46.77 1.93 Allowed Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.82 -1.181 . . . . 1.95 111.263 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 mt -114.19 147.39 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 118.378 -1.329 . . . . 1.92 109.065 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.5 p -105.26 -99.59 0.33 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.096 -1.042 . . . . 3.51 110.161 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 42.6 tttp -141.03 -63.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 5.53 106.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -45.25 -40.03 7.04 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.73 -1.123 . . . . 5.86 109.291 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' LEU . 51.4 m-20 -56.9 -67.39 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.588 -0.893 . . . . 4.91 108.588 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 61' ' ' GLN . 61.5 mt -36.75 -51.45 0.88 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.238 -0.892 . . . . 1.86 109.931 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -52.92 -62.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.157 -1.383 . . . . 5.45 110.59 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -58.08 -45.32 87.34 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.964 -0.694 . . . . 6.78 111.154 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -61.61 -29.51 70.09 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.458 -0.792 . . . . 3.56 110.563 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -81.8 -55.37 4.66 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.822 -0.751 . . . . 2.07 110.574 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -16.76 11.96 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.959 -2.056 . . . . 2.54 107.959 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -114.05 84.34 8.82 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 108.678 -0.86 . . . . 5.37 108.678 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 34.8 Cg_exo -50.32 177.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.125 1.883 . . . . 4.74 111.504 168.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 23.9 t 71.34 70.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 CA-C-O 122.422 1.106 . . . . 5.63 108.953 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.547 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 4.8 pt-20 -171.06 166.56 7.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.37 -1.741 . . . . 6.08 109.661 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 70.3 m -139.86 178.72 7.05 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.719 -1.586 . . . . 5.03 106.719 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 58' ' ' THR . 7.1 m -84.39 154.32 62.68 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 123.687 0.617 . . . . 3.37 110.501 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.01 167.95 78.5 Favored 'Cis proline' 0 N--CA 1.495 1.607 0 O-C-N 122.533 0.754 . . . . 1.95 111.842 6.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HG3' HD13 ' A' ' 48' ' ' LEU . 15.5 mm-40 -122.69 145.25 48.55 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 120.231 -0.588 . . . . 2.94 109.58 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.593 HG21 ' CG ' ' A' ' 75' ' ' PHE . 10.8 mm -118.08 126.35 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 120.193 -0.603 . . . . 1.32 111.599 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 21.1 m-85 -124.81 132.31 53.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.682 -1.97 . . . . 1.17 105.682 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.668 HG11 ' CH2' ' A' ' 78' ' ' TRP . 45.6 t -119.22 145.39 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.86 -1.136 . . . . 1.42 108.686 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 54.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.424 1.077 . . . . 4.43 109.35 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' VAL . 18.7 pt20 -148.34 9.76 0.85 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.93 -0.577 . . . . 4.64 109.971 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -116.5 169.61 9.2 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.435 0.636 . . . . 5.53 111.354 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CG ' ' HB1' ' A' ' 52' ' ' ALA . 10.9 t-80 -94.64 135.42 36.13 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 64' ' ' VAL . 5.7 mm -110.86 -36.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 117.901 -1.52 . . . . 1.07 109.579 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.15 -144.74 12.29 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.239 -1.458 . . . . 1.78 111.354 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' CG1' ' A' ' 62' ' ' ILE . . . -103.77 -60.8 0.69 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-O 119.178 -0.79 . . . . 2.57 112.942 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -150.13 -68.43 0.2 Allowed 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 117.914 -1.515 . . . . 2.11 111.118 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 p -49.06 -51.46 31.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.078 -1.082 . . . . 1.96 108.078 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.94 -53.74 14.99 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.746 -1.57 . . . . 3.54 110.667 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 62' ' ' ILE . 40.8 t80 -59.13 -51.36 70.36 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.169 -0.678 . . . . 1.02 109.169 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.2 -53.13 18.0 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.914 -0.773 . . . . 1.59 108.914 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -63.35 1.21 Allowed 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 114.814 -1.084 . . . . 1.46 109.051 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.668 ' CH2' HG11 ' A' ' 64' ' ' VAL . 68.5 t90 -43.06 -53.96 4.59 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.773 -0.771 . . . . 1.55 109.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.0 t -44.87 -63.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.994 -1.113 . . . . 1.86 107.994 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -52.9 -48.03 67.52 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.996 -1.081 . . . . 3.52 110.3 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.57 20.81 0.21 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.536 0.569 . . . . 3.99 112.536 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -142.77 -38.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.328 -0.549 . . . . 2.27 111.37 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.6 mt -94.35 -14.41 25.37 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.039 -0.665 . . . . 2.03 112.01 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.497 1.914 0 C-N-CA 119.62 -0.832 . . . . 3.94 110.557 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.43 -0.952 . . . . 2.58 108.43 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HG2' ' N ' ' A' ' 3' ' ' THR . 52.4 tt0 -116.47 157.61 24.9 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.114 -1.034 . . . . 4.44 111.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.589 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 75.8 m -145.08 127.65 16.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.261 -0.644 . . . . 0.9 109.261 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.62 136.69 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.899 -0.778 . . . . 0.96 108.899 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.4 mm -113.21 130.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 36' ' ' VAL . 16.0 m-85 -108.0 97.78 7.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.025 0.828 . . . . 1.23 109.916 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.32 -141.74 4.53 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 108.845 -1.702 . . . . 0.9 108.845 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.729 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -116.89 176.76 4.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.213 -0.662 . . . . 6.17 109.213 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -83.21 61.9 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.91 . . . . 3.56 110.55 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.5 68.72 0.61 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.243 -1.456 . . . . 3.3 110.724 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.36 113.04 35.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.548 -1.278 . . . . 2.52 107.548 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.19 -50.29 1.61 Allowed 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 122.291 1.994 . . . . 3.24 113.143 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -68.66 -47.75 65.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.299 -1.36 . . . . 2.68 111.408 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -58.23 -42.73 86.95 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 118.048 -1.461 . . . . 2.89 110.243 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.8 -26.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 115.018 -0.992 . . . . 1.35 110.791 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 4.2 tpp180 -74.02 -50.21 20.84 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.031 -1.067 . . . . 4.31 109.322 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.35 -41.53 65.89 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.492 -1.67 . . . . 0.8 106.492 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 11.9 tmtt? -55.56 -58.98 5.52 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 113.948 -1.478 . . . . 2.13 108.255 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.552 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 79.4 m-20 -54.3 -53.47 53.4 Favored 'General case' 0 C--O 1.191 -1.998 0 C-N-CA 118.984 -1.087 . . . . 3.7 110.098 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 tp -46.17 -60.76 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.026 -1.07 . . . . 0.91 110.353 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.13 34.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.877 -1.129 . . . . 0.94 111.032 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 35.2 tt0 -52.36 -56.49 14.56 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.386 -0.926 . . . . 2.8 110.948 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 66.0 tttp -45.59 -57.17 4.38 Favored 'General case' 0 C--O 1.2 -1.54 0 CA-C-N 114.238 -1.347 . . . . 4.52 108.32 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.32 -45.77 80.17 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.684 -1.206 . . . . 1.81 110.03 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -50.3 -49.44 53.58 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.637 -0.71 . . . . 2.22 111.015 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -81.15 -28.79 34.92 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.928 -0.709 . . . . 3.09 112.185 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 62.0 mt-10 -100.93 42.01 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.21 1.005 . . . . 6.46 112.692 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.626 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -149.34 -143.71 0.14 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.104 -1.039 . . . . 5.5 109.316 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -133.88 -48.94 0.81 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.645 -0.872 . . . . 4.12 108.645 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 31' ' ' PHE . 51.6 t0 -98.75 -81.69 0.44 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.812 -1.086 . . . . 3.31 110.382 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 30' ' ' ASP . 21.3 t80 1.56 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 124.349 1.03 . . . . 1.26 113.544 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 64.9 mt-30 -94.24 112.16 23.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.895 -1.522 . . . . 2.9 107.291 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.34 164.17 12.94 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.39 -1.324 . . . . 1.6 111.335 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.91 157.46 44.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.742 -1.947 . . . . 3.83 105.742 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -110.43 149.45 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.545 -1.262 . . . . 1.16 109.1 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.662 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.8 t -132.75 147.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.635 -0.711 . . . . 0.66 109.579 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -119.73 121.15 38.56 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.152 0.977 . . . . 2.04 110.323 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 pt -57.61 -30.44 36.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.087 -0.96 . . . . 1.29 111.783 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.77 9.16 14.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 117.652 -1.619 . . . . 5.62 111.826 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.46 -43.18 3.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.898 -1.519 . . . . 1.33 106.898 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -74.3 -36.52 63.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.355 -0.98 . . . . 3.86 108.355 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.68 46.18 1.23 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.184 -1.566 . . . . 1.83 109.184 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 90.2 mt -108.11 145.99 14.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.881 -0.659 . . . . 2.21 112.625 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.4 p -117.89 -94.1 0.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.215 -1.032 . . . . 3.48 108.215 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -135.47 -61.59 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.417 -0.956 . . . . 6.11 108.417 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -36.37 -52.82 0.84 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.589 -1.187 . . . . 3.27 111.467 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -58.82 -56.91 16.09 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.865 -1.134 . . . . 3.15 110.516 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 48.9 mt -49.37 -47.67 47.38 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.219 -0.992 . . . . 1.88 110.021 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -56.55 -53.73 54.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.707 -1.197 . . . . 4.18 108.481 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -52.08 -64.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.395 1.059 . . . . 4.68 111.284 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -58.28 -45.81 87.21 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.448 -0.796 . . . . 3.4 112.405 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -58.04 -38.79 76.91 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 123.958 0.786 . . . . 2.1 110.095 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.67 39.98 6.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.644 -1.783 . . . . 2.94 108.644 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -119.44 151.62 51.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.195 -1.002 . . . . 5.2 110.499 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.6 -25.33 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.863 1.709 . . . . 4.72 111.671 154.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.27 108.19 23.2 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 112.416 -2.175 . . . . 6.25 108.928 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 167.87 11.33 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.876 -1.056 . . . . 5.99 111.861 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.2 p -156.1 174.97 14.58 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.484 -2.043 . . . . 5.97 105.484 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.13 156.36 45.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 118.319 -1.352 . . . . 3.78 108.573 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.08 -172.6 9.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 124.386 -1.089 . . . . 2.12 111.291 -17.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -119.77 147.36 44.72 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 107.624 -1.25 . . . . 3.31 107.624 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 62' ' ' ILE . 5.0 mp -122.86 143.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 122.317 1.056 . . . . 1.28 112.53 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 39.6 m-85 -123.0 124.84 44.05 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 112.141 -2.3 . . . . 1.34 106.18 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.649 ' CG1' ' H ' ' A' ' 65' ' ' ASP . 41.7 t -97.52 -172.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.065 -1.454 . . . . 1.69 107.52 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.649 ' H ' ' CG1' ' A' ' 64' ' ' VAL . 32.7 t70 -48.47 -35.0 12.08 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 112.954 0.724 . . . . 2.72 112.954 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 13.4 mp0 -94.2 -72.66 0.6 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.522 -1.271 . . . . 8.49 113.892 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -134.97 -167.02 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.274 0.842 . . . . 5.25 113.274 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.627 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 35.9 t-80 -70.14 140.6 52.65 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 104.79 -2.3 . . . . 1.9 104.79 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 ' CG2' ' A' ' 64' ' ' VAL . 16.0 mm -107.5 -34.85 2.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 119.081 -1.048 . . . . 1.12 110.552 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.42 -150.14 21.88 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.465 -1.35 . . . . 1.74 110.644 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -96.77 -169.1 33.83 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.035 -1.226 . . . . 1.64 110.035 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.36 -47.53 66.08 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.755 -1.178 . . . . 1.69 110.733 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -62.49 -61.64 2.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.409 -0.917 . . . . 1.24 109.952 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -42.98 -54.27 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.426 -1.261 . . . . 2.91 109.389 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.7 t80 -61.23 -57.23 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.811 -1.086 . . . . 1.11 109.423 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -42.32 -54.58 3.7 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.12 -0.632 . . . . 1.06 110.32 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -59.44 -57.64 12.08 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.035 -0.984 . . . . 1.3 108.488 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CH2' HG11 ' A' ' 64' ' ' VAL . 85.0 t90 -41.99 -47.14 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.079 -0.711 . . . . 1.57 109.079 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HD12 ' A' ' 83' ' ' LEU . 92.6 t -62.26 -36.92 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.833 -0.621 . . . . 1.13 109.513 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -94.52 22.24 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.147 -0.478 . . . . 4.13 112.106 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -134.79 -40.86 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.954 -0.566 . . . . 4.56 110.13 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -92.85 -23.32 18.85 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 116.057 -0.519 . . . . 2.55 112.309 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 79' ' ' VAL . 39.8 mt -100.93 13.12 36.17 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.277 -1.369 . . . . 2.31 110.894 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 5.2 m-20 . . . . . 0 N--CA 1.497 1.896 0 C-N-CA 119.921 -0.711 . . . . 4.62 110.847 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 30' ' ' ASP . 29.0 ttm . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 106.52 -1.659 . . . . 2.93 106.52 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -122.79 85.33 2.4 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.906 -0.718 . . . . 3.6 109.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 64' ' ' VAL . 27.7 m -88.71 131.22 35.11 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.26 -1.015 . . . . 1.18 108.26 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.6 138.19 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.781 -0.822 . . . . 0.69 108.781 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -114.96 119.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 124.559 1.162 . . . . 1.99 109.326 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -92.25 85.98 5.6 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.801 -2.296 . . . . 2.23 104.801 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.15 -168.45 15.16 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.634 -1.746 . . . . 0.94 110.593 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.61 133.14 54.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.81 -0.811 . . . . 5.41 108.81 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.442 ' N ' HH22 ' A' ' 8' ' ' ARG . 2.8 p -67.57 94.16 0.4 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.36 -0.836 . . . . 3.67 110.017 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.01 22.87 8.04 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.721 -0.951 . . . . 2.94 110.721 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -104.03 115.61 62.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 120.132 -0.627 . . . . 2.4 110.734 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 -31.43 90.57 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.554 2.17 . . . . 2.94 111.593 -159.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -92.72 -37.56 12.3 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.727 -1.124 . . . . 2.69 110.9 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 63.8 m -51.83 -45.18 63.85 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.631 -1.228 . . . . 2.23 109.199 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -46.58 -41.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.656 -1.156 . . . . 1.35 111.417 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.587 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.6 -37.11 3.38 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 112.157 0.429 . . . . 6.61 112.157 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.88 98.46 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.699 -1.201 . . . . 0.98 108.205 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.5 tmtm? -73.28 -32.98 64.97 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.17 -1.012 . . . . 2.51 110.672 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.546 ' CG ' HH21 ' A' ' 16' ' ' ARG . 5.7 m-20 -51.31 -57.49 8.73 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.015 -1.474 . . . . 3.27 108.647 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -46.13 -61.2 1.87 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.171 0.804 . . . . 0.92 113.171 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 33' ' ' TYR . . . -39.17 -39.85 0.65 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.668 0.618 . . . . 1.11 112.668 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -50.57 69.99 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.076 -1.05 . . . . 3.11 110.051 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -45.13 -46.95 12.15 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.5 -1.227 . . . . 5.98 110.256 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.2 mt -72.34 -50.03 29.89 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.208 -1.36 . . . . 1.23 112.649 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -55.89 -26.66 48.33 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.804 -0.758 . . . . 1.5 110.803 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -93.09 24.03 3.98 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.003 -0.679 . . . . 2.68 110.393 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.32 -49.86 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.646 0.591 . . . . 3.59 110.971 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.2 mpt_? -108.35 124.25 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.256 -0.883 . . . . 4.68 111.579 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.53 60.52 0.88 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 124.562 1.163 . . . . 5.95 109.156 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t70 -165.04 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.869 -1.514 . . . . 3.12 109.841 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 33' ' ' TYR . 14.5 t80 -66.19 102.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.596 -0.729 . . . . 0.99 109.994 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 83.6 mt-30 -91.47 -54.69 3.8 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.287 -0.565 . . . . 3.74 111.347 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER 59.0 149.64 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 O-C-N 126.357 2.285 . . . . 1.31 113.507 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -139.65 144.65 37.74 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 115.19 -0.914 . . . . 3.31 110.86 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -98.8 138.19 36.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.53 144.52 35.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.219 -1.4 . . . . 0.6 107.219 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -115.31 118.33 32.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.302 1.001 . . . . 2.2 111.738 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.01 -19.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.839 -1.144 . . . . 1.22 111.042 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 1.2 tmm_? -87.14 -9.8 54.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 123.289 0.368 . . . . 5.41 111.001 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.39 -39.34 8.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.616 -1.253 . . . . 1.17 107.616 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -104.51 28.16 7.23 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.24 -1.346 . . . . 2.54 109.959 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 27.24 64.49 0.08 OUTLIER Glycine 0 N--CA 1.507 3.413 0 CA-C-N 114.648 -1.16 . . . . 1.64 113.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.56 147.97 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.579 -0.849 . . . . 1.82 109.783 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -130.85 173.37 11.02 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.654 -0.818 . . . . 2.78 109.217 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -50.48 -50.78 51.75 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.699 -0.8 . . . . 6.96 110.138 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -34.2 -69.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.119 0.887 . . . . 3.47 113.063 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.54 -46.25 80.73 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 119.981 -0.687 . . . . 3.31 112.853 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLN . 97.8 mt -58.12 -53.2 60.9 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.457 -1.297 . . . . 1.97 110.62 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HG3' ' HE2' ' A' ' 45' ' ' LYS . 37.9 mt-30 -42.67 -53.04 4.67 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.153 -1.019 . . . . 3.75 108.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -55.56 -44.86 77.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.966 1.416 . . . . 5.26 110.873 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -90.13 11.09 21.92 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.625 -0.83 . . . . 4.44 111.85 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -102.77 -66.1 0.95 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.819 0.674 . . . . 1.86 112.819 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.34 18.21 34.2 Favored Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.922 -1.133 . . . . 3.52 112.81 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 68' ' ' HIS . 50.8 mtpt -121.97 24.85 0.11 Allowed Pre-proline 0 N--CA 1.502 2.168 0 CA-C-N 117.714 0.757 . . . . 5.8 110.798 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.59 46.28 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.752 2.301 . . . . 5.13 113.437 -105.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.3 15.95 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.982 -1.118 . . . . 5.43 107.982 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -84.01 173.82 10.83 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.149 -1.387 . . . . 6.55 109.542 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 t -149.22 -156.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.886 -0.726 . . . . 4.66 109.31 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.39 131.07 56.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.04 -1.096 . . . . 2.79 108.04 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -99.11 151.76 5.76 Favored 'Cis proline' 0 N--CA 1.481 0.761 0 O-C-N 122.661 0.822 . . . . 1.95 111.64 12.388 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -122.62 139.34 54.04 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.231 -0.895 . . . . 2.94 109.037 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -118.2 149.66 20.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.669 -1.234 . . . . 1.45 107.669 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 68' ' ' HIS . 22.6 m-85 -134.02 116.65 15.76 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 125.401 1.688 . . . . 1.01 106.726 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.633 HG23 HG13 ' A' ' 69' ' ' ILE . 84.8 t -88.2 108.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 118.067 -1.453 . . . . 1.04 110.078 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 54.03 -79.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 123.748 0.655 . . . . 3.04 112.086 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.6 pt20 -128.38 1.9 5.68 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.041 -1.064 . . . . 4.83 111.654 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 66' ' ' GLN . 10.0 mp0 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.946 -0.391 . . . . 4.24 109.946 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.744 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-80 -106.66 132.75 52.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.733 -1.21 . . . . 1.52 107.733 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 64' ' ' VAL . 5.3 mm -111.09 -56.17 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 105.867 -1.901 . . . . 1.89 105.867 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' NE2' ' A' ' 68' ' ' HIS . . . 68.87 88.09 0.08 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 116.261 1.265 . . . . 2.44 116.261 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 131.18 3.78 Favored Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.282 -1.437 . . . . 1.49 114.632 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 74' ' ' ASP . 22.4 t80 -66.23 -58.09 6.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.553 -0.859 . . . . 1.25 109.124 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 14.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.619 0.6 . . . . 2.57 112.619 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 72' ' ' TYR . 7.9 t70 -119.37 -63.92 1.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' TRP . 67.0 t80 -56.41 -39.05 72.39 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.878 -1.51 . . . . 0.97 108.426 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.634 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.21 -53.43 43.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.023 -1.103 . . . . 1.4 108.023 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 89.8 t90 -41.39 -65.45 0.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.362 -1.29 . . . . 1.61 110.862 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.8 t -42.82 -52.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.505 -0.924 . . . . 1.04 108.505 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -46.81 -42.29 16.88 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.417 -1.72 . . . . 5.04 109.919 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -106.81 25.18 11.59 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 120.085 -0.646 . . . . 4.8 112.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -129.85 -43.02 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.379 -1.328 . . . . 1.94 113.817 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 26.4 mt -101.54 32.26 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.118 -2.178 . . . . 1.5 105.118 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 113.026 -1.897 . . . . 6.15 106.773 -178.147 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 33.4 tpp . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.629 -0.508 . . . . 2.6 109.629 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' H ' ' A' ' 32' ' ' GLN . 8.5 pt20 -94.42 173.17 7.76 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.623 -1.231 . . . . 3.32 108.515 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.44 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 86.6 m -130.2 145.35 51.72 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.074 -1.05 . . . . 1.28 111.812 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.29 118.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 105.737 -1.949 . . . . 0.86 105.737 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.451 HG23 ' CD1' ' A' ' 62' ' ' ILE . 30.7 mt -100.07 113.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.009 -1.108 . . . . 2.89 108.009 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CD2' HG11 ' A' ' 36' ' ' VAL . 45.6 m-85 -97.58 78.06 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 105.747 -1.946 . . . . 1.25 105.747 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.74 1.91 Allowed Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.781 -1.676 . . . . 1.03 112.04 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER 179.23 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.811 -1.181 . . . . 4.86 107.811 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 13.2 m 97.29 162.92 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 O-C-N 125.335 1.647 . . . . 5.04 110.4 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 15' ' ' VAL . . . 97.12 -12.37 65.44 Favored Glycine 0 N--CA 1.503 3.14 0 C-N-CA 120.194 -1.003 . . . . 3.52 110.637 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.58 143.63 30.94 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.91 -0.645 . . . . 2.55 110.724 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 -54.71 5.01 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.257 1.305 . . . . 3.77 111.675 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -67.94 -2.58 7.76 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 113.802 1.038 . . . . 3.15 113.802 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 9' ' ' SER . 29.4 p -111.66 -41.87 3.97 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.651 -1.22 . . . . 2.33 109.09 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 17' ' ' ALA . 49.0 t -73.04 -30.98 33.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 118.824 -1.15 . . . . 0.92 108.357 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 9.3 mmm180 -71.9 23.47 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 C-N-CA 119.919 -0.712 . . . . 3.65 110.976 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -121.49 -48.87 2.16 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.64 -1.245 . . . . 1.08 107.64 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.9 tmtm? -57.97 -29.15 65.0 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.873 -0.731 . . . . 2.56 110.169 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 20' ' ' LEU . 3.6 p-10 -81.06 -38.66 27.0 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.727 -0.789 . . . . 3.28 108.926 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 75' ' ' PHE . 34.2 tp -60.23 -49.06 79.11 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.686 -1.598 . . . . 0.76 106.686 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.65 71.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.2 tp10 -63.48 -56.98 11.75 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.559 -1.256 . . . . 3.36 108.496 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -55.11 -51.88 65.01 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 118.356 -1.338 . . . . 4.61 108.145 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.426 -1.31 . . . . 1.26 109.459 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.1 m -51.23 -43.47 61.47 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 118.72 -1.192 . . . . 1.32 108.718 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -94.98 42.46 1.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.874 -1.057 . . . . 3.69 108.994 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 14.9 mm-40 -144.8 -58.7 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.957 -1.02 . . . . 3.18 113.492 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HE ' ' HB3' ' A' ' 27' ' ' GLU . 3.5 mmt180 -101.45 -157.89 0.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.809 -1.087 . . . . 5.42 112.476 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -102.61 -75.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.177 -0.92 . . . . 4.9 113.411 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.62 53.57 2.73 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.627 -1.229 . . . . 3.42 112.418 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 1' ' ' MET . 39.9 t80 -117.92 140.11 50.19 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.963 -1.095 . . . . 1.62 109.87 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' H ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 mt-30 -156.64 179.95 8.77 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.12 -1.807 . . . . 3.09 106.12 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 3' ' ' THR . 19.7 p90 -171.58 159.26 5.4 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.073 -1.451 . . . . 1.19 111.369 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -133.09 151.36 52.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.772 -1.566 . . . . 3.57 106.772 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -103.67 144.9 30.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.464 -1.695 . . . . 1.09 109.678 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.4 t -132.71 148.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.453 -1.249 . . . . 0.57 108.925 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.07 113.37 20.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.627 -1.249 . . . . 2.21 107.627 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 30.9 pt -44.59 -31.03 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.391 0 CA-C-N 115.211 -0.904 . . . . 1.44 110.466 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 38' ' ' ILE . 43.6 ttp180 -71.72 -60.44 2.23 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.112 -1.035 . . . . 4.78 109.322 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.34 -43.25 1.15 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.573 0.546 . . . . 1.75 110.174 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.61 -48.37 26.89 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.283 0.989 . . . . 4.46 109.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.33 41.51 0.81 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.41 -0.9 . . . . 2.47 111.235 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 62.7 mt -103.74 164.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.637 -0.505 . . . . 2.29 109.637 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 43' ' ' ILE . 40.2 p -113.25 -104.86 0.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.612 -0.722 . . . . 3.96 112.87 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 57' ' ' GLU . 34.7 tttp -142.82 -25.77 0.61 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.061 0.934 . . . . 6.88 109.614 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -86.98 -53.37 4.92 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 4.1 108.311 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' LEU . 17.9 t70 -47.5 -61.87 1.71 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.704 -0.798 . . . . 3.5 111.397 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -34.36 -46.89 0.28 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.436 -0.802 . . . . 2.17 111.073 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 53' ' ' GLY . 74.4 mt-30 -54.99 -54.56 41.38 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.119 -1.032 . . . . 5.61 108.486 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -60.79 -36.86 80.07 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.711 -0.796 . . . . 7.44 109.93 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -64.26 -29.43 70.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.79 -1.096 . . . . 4.01 110.12 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.599 ' HB1' ' CD2' ' A' ' 68' ' ' HIS . . . -100.68 -74.81 0.6 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.68 -1.146 . . . . 2.06 109.595 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' GLN . . . 121.94 39.78 0.55 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.73 -1.224 . . . . 3.96 111.178 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 22.3 mmtp -138.05 152.01 71.12 Favored Pre-proline 0 N--CA 1.499 2.017 0 C-N-CA 119.454 -0.898 . . . . 6.68 110.072 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.63 49.54 3.21 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 122.391 2.061 . . . . 6.02 111.188 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.64 94.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 115.188 -0.914 . . . . 7.23 108.707 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.49 -0.67 11.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.853 -0.739 . . . . 8.45 111.554 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 59' ' ' VAL . 16.7 m -88.67 171.85 9.7 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.149 0.5 . . . . 5.37 110.434 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' N ' HG22 ' A' ' 58' ' ' THR . 13.2 p -101.05 160.32 26.98 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 115.847 -0.615 . . . . 3.51 110.678 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 73.2 Cg_endo -100.12 -163.77 0.54 Allowed 'Cis proline' 0 N--CA 1.484 0.967 0 CA-C-O 121.926 0.719 . . . . 1.93 111.344 -27.18 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -124.58 155.24 39.4 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.298 -1.319 . . . . 3.26 108.608 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' A' ' 5' ' ' ILE . 36.2 mm -121.97 146.05 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 123.984 0.803 . . . . 1.99 110.251 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 12.5 m-85 -123.22 130.67 53.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.727 -1.579 . . . . 1.2 107.257 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 69' ' ' ILE . 55.3 t -109.81 138.06 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 118.221 -1.391 . . . . 1.13 109.275 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.2 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.2 -1.818 . . . . 3.06 111.716 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -136.47 -2.64 2.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.601 0.563 . . . . 5.93 111.499 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.31 176.4 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.423 0.63 . . . . 4.94 111.699 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.599 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -96.49 147.0 24.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.176 -1.787 . . . . 2.29 106.176 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 64' ' ' VAL . 41.7 mm -116.14 -46.5 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.703 -1.199 . . . . 1.17 110.414 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.69 -153.09 25.07 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.438 -1.363 . . . . 1.76 111.173 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.47 -170.47 47.15 Favored Glycine 0 N--CA 1.504 3.226 0 C-N-CA 119.242 -1.456 . . . . 1.46 112.149 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.9 t80 -51.93 -45.09 64.17 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.069 -0.652 . . . . 2.11 109.836 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 p -64.34 -42.45 96.25 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.349 -0.94 . . . . 1.32 109.297 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.478 ' CG ' ' NZ ' ' A' ' 54' ' ' LYS . 21.0 m-20 -62.32 -48.79 78.3 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.198 -1.401 . . . . 2.68 110.018 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 20' ' ' LEU . 12.8 t80 -60.62 -51.81 67.81 Favored 'General case' 0 C--O 1.2 -1.5 0 C-N-CA 117.936 -1.506 . . . . 1.03 108.102 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.79 30.52 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.453 -0.899 . . . . 0.93 111.077 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.04 -55.3 13.07 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.696 -0.802 . . . . 1.16 109.538 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -41.41 -47.46 3.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.929 -1.137 . . . . 1.05 107.929 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 81' ' ' GLU . 40.9 t -61.14 -57.69 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 106.16 -1.793 . . . . 1.34 106.16 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -75.96 32.18 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.83 -0.748 . . . . 3.72 110.427 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 79' ' ' VAL . 28.2 tt0 -132.37 -56.55 0.96 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.511 0.672 . . . . 5.45 109.262 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -98.64 -11.54 21.97 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.857 -1.065 . . . . 2.15 111.155 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -108.23 -34.65 6.77 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.76 -1.176 . . . . 2.36 108.842 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 N--CA 1.497 1.897 0 C-N-CA 119.161 -1.016 . . . . 6.06 110.541 179.485 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 30' ' ' ASP . 69.0 mtm . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 107.988 -1.116 . . . . 2.42 107.988 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 20.1 mt-30 -128.04 157.43 40.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 123.633 0.583 . . . . 3.48 110.029 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -141.6 141.71 33.46 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.819 -0.752 . . . . 0.7 112.065 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.0 t -133.11 139.09 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 106.539 -1.652 . . . . 0.74 106.539 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 4.6 mp -123.66 128.17 74.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.354 -0.98 . . . . 1.99 108.354 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -97.37 61.12 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.386 -1.339 . . . . 1.07 107.386 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -104.96 -158.5 23.36 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.153 -1.979 . . . . 1.3 108.153 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 21.9 ttp-105 -127.73 169.29 13.99 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.507 -1.294 . . . . 5.37 107.507 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -52.72 -50.16 63.94 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.182 -1.044 . . . . 4.41 108.182 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' CYS . . . -149.06 166.87 29.44 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.803 -1.189 . . . . 3.2 111.366 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.4 p 167.84 42.51 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.366 0 CA-C-O 122.795 1.283 . . . . 3.7 108.407 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -20.94 -48.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.431 2.754 . . . . 3.05 112.765 -99.525 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -27.4 -40.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 124.772 1.295 . . . . 2.51 113.907 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 85.1 m -53.59 -45.16 69.91 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.948 -0.701 . . . . 1.86 112.322 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.34 -34.49 50.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.887 -0.597 . . . . 1.03 111.081 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -50.96 -51.35 53.41 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.882 -1.127 . . . . 4.0 112.043 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.2 -42.66 81.67 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.302 -0.959 . . . . 1.33 109.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 28.8 tttm -63.22 -52.99 59.98 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.214 -1.357 . . . . 2.7 114.007 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.4 p30 -53.82 -34.04 58.01 Favored 'General case' 0 C--O 1.198 -1.651 0 C-N-CA 118.282 -1.367 . . . . 3.38 111.083 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.85 -42.44 89.34 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.269 -1.372 . . . . 0.95 109.703 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.93 19.34 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 120.448 -0.501 . . . . 0.97 110.971 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 22.6 tt0 -59.29 -40.95 87.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.845 -1.169 . . . . 3.31 107.845 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 4.6 ttmp? -64.0 -55.85 19.37 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 106.826 -1.546 . . . . 6.15 106.826 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.686 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 28.9 mt -46.96 -47.31 21.85 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 119.915 -0.714 . . . . 1.16 110.445 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -57.87 -11.42 2.32 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 124.256 0.972 . . . . 1.71 112.541 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -114.83 -41.04 3.43 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.12 -0.491 . . . . 2.94 111.067 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.686 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 13.0 pt-20 -74.65 -37.78 62.66 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.254 -0.885 . . . . 3.8 111.708 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 3.3 ttp180 -114.22 -168.26 1.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.388 0.613 . . . . 5.95 111.081 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 9.0 p-10 -124.12 -168.33 1.78 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 105.521 -2.029 . . . . 3.98 105.521 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.4 t70 37.53 41.39 0.28 Allowed 'General case' 0 N--CA 1.508 2.474 0 O-C-N 123.677 0.611 . . . . 3.43 110.543 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.38 93.07 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.441 -0.903 . . . . 0.98 109.889 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 11.7 mm100 -105.49 117.73 34.77 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.592 -1.633 . . . . 4.07 106.592 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -119.12 155.55 31.37 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.984 -1.007 . . . . 2.14 112.157 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.84 150.0 50.52 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.515 -2.031 . . . . 3.46 105.515 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 18' ' ' LYS . 26.0 t80 -112.08 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.784 -1.566 . . . . 1.88 108.48 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 5' ' ' ILE . 2.1 t -124.66 155.28 32.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.351 -1.351 . . . . 1.26 107.351 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 39' ' ' ARG . 1.8 t70 -127.69 42.71 3.27 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.831 0.678 . . . . 2.66 112.831 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.83 -65.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 114.97 1.47 . . . . 1.76 114.97 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -56.21 -51.29 68.62 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 4.55 108.521 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -42.83 2.25 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.902 -1.044 . . . . 1.26 111.203 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.26 -47.85 17.01 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.995 -1.113 . . . . 4.42 107.995 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.52 46.4 0.92 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.417 -1.873 . . . . 1.6 108.417 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.417 HG21 ' HG ' ' A' ' 48' ' ' LEU . 11.8 mm -89.23 155.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 120.374 -0.53 . . . . 1.99 111.824 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' GLU . 34.2 p -126.47 95.29 4.31 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.864 -0.607 . . . . 3.12 111.615 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 tttm 6.12 -64.6 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 116.656 2.095 . . . . 4.49 116.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' THR . 6.6 mm-40 -47.86 -44.99 29.76 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.252 -0.979 . . . . 4.68 110.841 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.2 t70 -58.5 -37.65 76.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.315 -0.857 . . . . 3.23 110.5 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HA ' ' CG ' ' A' ' 51' ' ' LYS . 6.7 mt -65.2 -45.86 83.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.135 -1.061 . . . . 1.62 108.135 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 13.1 mt-30 -49.99 -41.69 47.49 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.517 -1.29 . . . . 4.87 107.517 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -66.8 -60.74 2.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.608 -0.723 . . . . 5.23 112.496 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.576 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -60.46 -37.68 81.74 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.434 -0.906 . . . . 4.7 113.295 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -86.55 -53.43 4.98 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.719 0.771 . . . . 1.85 110.481 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.18 -55.73 0.59 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.123 -1.591 . . . . 3.57 109.123 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.79 74.7 37.93 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 119.602 -0.839 . . . . 5.81 113.08 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 52' ' ' ALA . 11.9 Cg_endo -89.59 140.96 3.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.223 1.948 . . . . 8.38 107.615 126.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.91 -15.78 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.971 -0.692 . . . . 5.56 110.043 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -119.27 -105.21 0.39 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.845 -0.616 . . . . 6.66 111.295 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.426 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 98.2 m -140.43 -57.09 0.53 Allowed 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.782 -0.767 . . . . 6.42 109.542 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 42.1 t -112.63 151.63 44.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.662 -0.815 . . . . 4.43 109.018 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HG2' ' N ' ' A' ' 72' ' ' TYR . 12.9 Cg_endo -97.67 173.47 10.38 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 O-C-N 122.619 0.799 . . . . 3.06 111.592 -14.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 3.1 mp0 -130.97 119.97 22.84 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 5.56 109.237 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -127.39 146.71 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.511 -0.876 . . . . 1.2 111.309 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 16.2 m-85 -126.86 133.05 50.81 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.01 -1.904 . . . . 1.03 107.035 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.605 HG11 ' CH2' ' A' ' 78' ' ' TRP . 85.5 t -131.76 150.6 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 118.733 -1.187 . . . . 1.34 110.097 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 66' ' ' GLN . 8.9 t70 60.12 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.464 -1.698 . . . . 5.01 107.978 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG3' ' C ' ' A' ' 65' ' ' ASP . 33.1 mt-30 -139.27 -16.27 1.07 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 124.209 0.943 . . . . 5.53 112.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.2 171.99 7.13 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.756 -0.778 . . . . 3.59 113.085 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.4 t-80 -81.0 153.55 27.37 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.858 -1.904 . . . . 1.23 105.858 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 64' ' ' VAL . 12.2 mm -116.2 -43.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.4 -1.32 . . . . 1.01 109.81 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 139.93 -131.33 5.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.466 -1.454 . . . . 1.75 109.466 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.441 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.88 -154.27 12.55 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.756 -0.937 . . . . 1.44 110.756 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.436 ' N ' ' HG2' ' A' ' 60' ' ' PRO . 26.9 t80 -57.67 -56.33 23.37 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.1 -1.04 . . . . 1.53 111.01 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -38.24 17.24 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.878 -0.729 . . . . 1.38 110.537 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -72.41 -59.42 2.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.051 -0.977 . . . . 2.48 110.259 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.75 -45.8 63.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.471 -0.937 . . . . 1.48 108.471 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -58.69 6.63 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.931 -1.031 . . . . 0.85 109.272 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.13 -54.97 41.0 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.097 -1.041 . . . . 1.45 110.549 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.605 ' CH2' HG11 ' A' ' 64' ' ' VAL . 75.2 t90 -45.81 -53.81 9.04 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.413 -0.915 . . . . 1.65 109.131 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 83' ' ' LEU . 25.0 t -47.25 -58.82 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 124.453 1.096 . . . . 0.9 108.213 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -56.29 -54.18 48.41 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.015 1.117 . . . . 3.43 114.015 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.3 -33.19 70.79 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.519 0.933 . . . . 4.76 113.519 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.78 -26.98 13.28 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.182 1.179 . . . . 1.57 114.182 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 79' ' ' VAL . 11.4 mt -93.24 -22.56 18.94 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.367 -1.333 . . . . 1.73 111.52 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.495 1.776 0 C-N-CA 119.256 -0.977 . . . . 4.28 108.694 -179.92 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 34.9 tpp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 2.74 108.284 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.521 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 34.8 mt-30 -97.03 97.35 9.16 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.964 -0.694 . . . . 3.69 109.81 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 m -83.02 114.22 21.12 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.513 -0.875 . . . . 1.16 109.895 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.67 140.01 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.077 -1.083 . . . . 1.0 108.077 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 17.8 mt -120.1 105.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 124.452 1.095 . . . . 2.32 110.428 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 31.1 m-85 -84.53 93.86 8.44 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.28 -1.008 . . . . 1.01 108.28 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.635 ' CA ' ' SG ' ' A' ' 14' ' ' CYS . . . -106.76 -163.08 22.32 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.051 -1.22 . . . . 1.39 110.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.515 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 ttp-105 -141.43 46.68 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.284 -1.366 . . . . 5.94 111.902 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' ' OD2' ' A' ' 37' ' ' ASP . 14.4 m 69.61 -70.73 0.14 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.809 1.04 . . . . 3.79 113.809 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.14 66.89 0.23 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 119.946 -1.121 . . . . 3.77 112.724 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -134.81 113.68 11.81 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.327 -1.36 . . . . 2.4 107.327 178.318 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.01 -50.7 9.48 Favored 'Trans proline' 0 C--O 1.205 -1.171 0 N-CA-C 109.033 -1.18 . . . . 3.5 109.033 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . 3.7 m-85 -52.84 -36.13 58.31 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.051 -0.977 . . . . 2.76 111.993 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' CA ' ' A' ' 7' ' ' GLY . 71.0 m -66.36 -53.21 38.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.205 -0.998 . . . . 2.22 109.475 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.1 t -62.08 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.8 -1.091 . . . . 1.05 110.136 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.55 ' NH2' ' N ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -61.27 -47.48 85.83 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.815 -0.629 . . . . 3.83 110.484 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.53 -47.91 80.71 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 5.7 tmtm? -56.96 -43.69 81.86 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 118.512 -1.275 . . . . 2.07 109.715 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 2.0 t0 -51.98 -51.25 58.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.74 -1.208 . . . . 3.32 107.74 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' ' NH2' ' A' ' 16' ' ' ARG . 31.4 tp -56.6 -52.09 66.17 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.929 -1.108 . . . . 1.24 110.098 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -46.17 -51.89 13.29 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.781 -1.168 . . . . 1.02 109.937 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -44.3 -47.48 9.51 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.113 0.959 . . . . 3.04 110.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' NZ ' ' HG2' ' A' ' 27' ' ' GLU . 8.9 tmtm? -75.0 -45.95 38.45 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.385 -1.326 . . . . 4.64 111.865 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 83' ' ' LEU . 1.3 mt -49.56 -48.52 48.46 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 119.375 -0.93 . . . . 1.66 110.531 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 m -42.99 -32.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.297 -1.774 . . . . 1.57 109.579 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -109.92 45.43 1.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.856 -1.065 . . . . 2.66 109.863 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HG2' ' NZ ' ' A' ' 23' ' ' LYS . 29.6 mm-40 -137.22 -54.46 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.729 -1.123 . . . . 3.89 110.103 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.418 ' NE ' ' HB3' ' A' ' 83' ' ' LEU . 50.1 mmt-85 -101.78 175.47 5.54 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.875 -1.057 . . . . 4.84 109.658 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.41 -51.24 17.99 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.984 -1.462 . . . . 5.1 114.324 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 37.3 t70 -118.2 82.08 1.78 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.336 -0.946 . . . . 4.26 111.7 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.97 113.45 14.6 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.702 -0.799 . . . . 0.98 110.459 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.06 157.87 26.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.682 -1.97 . . . . 3.79 105.682 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.9 p90 -156.39 153.48 29.0 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 117.562 -1.655 . . . . 1.2 111.29 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.9 146.68 43.61 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.183 -0.917 . . . . 3.25 109.724 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -94.97 144.43 25.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.264 -1.384 . . . . 1.18 107.264 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.99 155.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 123.752 0.657 . . . . 0.87 109.685 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' NH1' ' A' ' 39' ' ' ARG . 10.0 t70 -132.62 137.7 47.11 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.474 0.654 . . . . 2.52 109.306 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.43 HD11 ' HG3' ' A' ' 8' ' ' ARG . 31.5 pt -53.7 -25.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.392 0.886 . . . . 1.66 113.392 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 29.8 mtm-85 -88.66 -14.05 38.33 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.53 -1.268 . . . . 4.88 110.951 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.47 -40.7 61.71 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.99 -1.485 . . . . 1.55 106.99 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.37 -41.45 12.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.489 -1.687 . . . . 3.44 109.402 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.76 59.04 0.51 Allowed Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.653 -1.261 . . . . 1.73 111.116 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.2 mt -120.33 154.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.827 -0.749 . . . . 1.99 110.386 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -111.07 -160.72 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.052 -1.833 . . . . 2.32 106.052 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -99.13 18.43 17.44 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 116.772 -1.971 . . . . 4.37 109.413 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -101.76 -62.94 1.19 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.724 -1.58 . . . . 4.01 110.993 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' GLN . 1.9 t70 -56.51 -42.92 79.22 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.129 -0.628 . . . . 4.0 109.999 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -43.68 -38.57 3.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.804 -1.159 . . . . 1.89 109.948 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 56' ' ' VAL . 39.1 mm-40 -53.12 -42.76 66.32 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.869 -1.132 . . . . 4.68 109.219 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' ASP . 73.3 mm-40 -78.05 -37.04 47.62 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.812 -1.085 . . . . 6.22 111.665 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -68.81 -37.42 79.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.595 -0.842 . . . . 4.38 111.372 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -88.58 -47.53 8.23 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 124.128 0.893 . . . . 2.0 111.301 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.8 15.17 56.98 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.54 -1.424 . . . . 2.86 109.54 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.85 140.01 27.99 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 107.136 -1.431 . . . . 5.92 107.136 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.49 142.62 11.82 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 120.914 1.076 . . . . 4.58 111.662 -165.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.549 ' N ' HE22 ' A' ' 49' ' ' GLN . 40.8 t 66.75 -66.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.629 1.344 . . . . 5.42 114.629 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.92 144.55 1.77 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.81 -0.756 . . . . 6.12 111.363 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 45' ' ' LYS . 21.8 m -120.87 -65.12 1.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.582 -0.735 . . . . 7.03 111.643 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.34 154.76 81.7 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 120.206 -0.598 . . . . 3.69 110.254 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 13' ' ' TYR . 9.5 Cg_endo -92.94 142.53 9.3 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 124.284 -1.132 . . . . 1.6 109.775 0.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -113.62 141.05 47.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.947 -1.101 . . . . 3.47 108.361 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.5 mp -111.08 139.07 36.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 124.019 0.825 . . . . 1.36 108.954 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -118.32 122.49 43.0 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 103.634 -2.728 . . . . 1.41 103.634 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 50.3 t -99.53 83.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 117.202 -1.799 . . . . 1.92 111.627 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 28.3 t0 72.85 -60.27 0.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.326 -1.307 . . . . 3.8 113.637 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 3.4 pt20 -106.36 -56.14 2.23 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 115.337 1.606 . . . . 6.82 115.337 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 15.2 pt20 -118.86 176.2 5.39 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.318 1.229 . . . . 4.19 114.318 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.566 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 12.3 t-80 -77.77 147.16 35.45 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.872 -1.529 . . . . 1.59 106.872 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.571 HG13 ' CG2' ' A' ' 64' ' ' VAL . 34.4 mm -117.57 -29.36 2.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.8 -0.76 . . . . 1.23 111.443 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.404 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 133.84 -156.32 22.25 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.085 -1.606 . . . . 2.14 109.085 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.86 -170.74 34.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.502 -1.439 . . . . 1.48 109.502 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -52.21 -36.38 51.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.641 -1.224 . . . . 1.41 110.446 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 p -64.08 -61.46 2.25 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.37 -1.332 . . . . 1.57 109.836 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.18 -50.15 67.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.635 -0.711 . . . . 2.49 110.313 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.19 -46.75 88.66 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 119.543 -0.863 . . . . 1.04 109.003 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.91 26.93 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.598 -0.841 . . . . 0.95 110.411 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.36 -58.7 6.24 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.186 -1.005 . . . . 1.2 108.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.42 ' O ' ' C ' ' A' ' 79' ' ' VAL . 61.8 t90 -40.66 -57.81 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.359 -0.837 . . . . 1.25 108.963 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 78' ' ' TRP . 2.4 t -40.7 -51.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.297 -1.372 . . . . 1.0 107.297 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -59.39 -60.96 3.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.451 -1.249 . . . . 2.83 110.406 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -76.81 31.21 0.13 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 113.454 0.909 . . . . 4.34 113.454 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -145.0 -40.0 0.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.972 -0.558 . . . . 1.77 110.704 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 24' ' ' LEU . 35.7 mt -96.05 -26.12 15.64 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.036 -1.066 . . . . 1.56 111.325 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.424 ' OD2' ' HA ' ' A' ' 80' ' ' LYS . 44.7 m-20 . . . . . 0 N--CA 1.504 2.27 0 N-CA-C 107.136 -1.431 . . . . 4.1 107.136 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 83' ' ' LEU . 25.2 ttm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.851 -1.166 . . . . 3.17 107.851 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 54.9 mt-30 -133.33 150.22 51.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.35 -0.611 . . . . 3.86 109.35 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 22.6 m -140.4 137.77 34.25 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 118.636 -1.226 . . . . 0.72 112.761 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.29 133.43 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.432 -0.951 . . . . 0.58 108.432 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' HB1' ' A' ' 17' ' ' ALA . 22.0 mm -111.64 128.73 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 124.437 1.085 . . . . 1.54 108.265 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 36' ' ' VAL . 30.6 m-85 -109.94 73.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.931 -1.137 . . . . 1.07 107.931 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -133.71 -159.57 9.04 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 106.627 -2.589 . . . . 1.14 106.627 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.749 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.5 ptm180 -123.88 143.53 50.3 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.025 -1.47 . . . . 5.45 109.245 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -64.78 76.95 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.35 -1.75 . . . . 4.19 108.952 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 151.04 13.42 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.189 -1.005 . . . . 2.59 111.889 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.749 ' SG ' ' HG2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -119.98 124.91 27.61 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.585 -0.895 . . . . 2.38 108.585 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -41.32 -64.21 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.063 0 C-N-CA 122.422 2.081 . . . . 2.98 112.017 -170.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -47.01 -38.83 11.48 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.922 -0.711 . . . . 3.55 112.553 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 m -75.1 -57.94 3.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.609 0.718 . . . . 2.18 109.306 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.09 -41.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 114.038 -1.437 . . . . 1.03 108.819 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 115.543 -0.753 . . . . 5.28 109.423 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' ARG . . . -40.37 -43.26 1.73 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.454 -0.898 . . . . 0.97 108.896 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 12.6 tmtt? -60.2 -58.29 9.16 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.349 -1.352 . . . . 2.21 107.349 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -48.48 -51.22 28.19 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.843 -0.743 . . . . 3.62 109.648 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 ' CD2' ' A' ' 75' ' ' PHE . 44.2 tp -52.2 -54.02 36.16 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.002 -0.74 . . . . 0.84 109.002 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -57.0 13.62 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.295 -0.962 . . . . 0.77 109.509 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 13.7 tt0 -51.91 -40.28 60.48 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.156 -0.929 . . . . 3.06 110.966 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -60.48 -60.17 4.24 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.722 -1.214 . . . . 3.54 107.722 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.654 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 53.5 mt -47.0 -52.37 14.92 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.233 -0.987 . . . . 1.07 111.564 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -39.84 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 114.288 1.218 . . . . 1.43 114.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -118.8 -30.72 5.01 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.19 -0.604 . . . . 3.28 111.824 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.654 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -80.71 -19.74 44.41 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.922 -0.711 . . . . 3.77 111.149 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.531 HH12 ' CB ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -111.93 -154.78 0.55 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.674 -1.148 . . . . 5.06 108.423 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -115.81 -79.14 0.58 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 114.009 1.114 . . . . 4.01 114.009 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 9.4 p-10 -93.84 60.83 2.97 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.632 -0.827 . . . . 3.46 111.003 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -116.32 99.96 7.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.914 -1.114 . . . . 0.9 112.069 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 56.9 mm-40 -104.92 161.99 13.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.256 -1.387 . . . . 3.68 107.256 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.443 ' HA ' ' H ' ' A' ' 3' ' ' THR . 40.2 p90 -159.12 166.46 31.49 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.552 -1.259 . . . . 1.73 109.253 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.01 146.48 40.91 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.746 -1.575 . . . . 3.35 106.746 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.76 135.02 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.873 -1.531 . . . . 1.05 107.906 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.0 t -119.51 144.15 28.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 105.859 -1.904 . . . . 0.7 105.859 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 6.0 t70 -117.25 102.22 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.344 -0.942 . . . . 2.37 111.295 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -49.97 -23.91 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 114.858 -1.065 . . . . 2.26 111.17 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -87.8 -61.2 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.182 -1.407 . . . . 8.42 108.618 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.41 -43.15 23.42 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 123.789 0.681 . . . . 2.6 112.836 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.19 -34.8 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.89 -0.724 . . . . 2.39 112.025 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.51 50.49 1.2 Allowed Glycine 0 N--CA 1.505 3.257 0 C-N-CA 119.89 -1.148 . . . . 1.97 110.722 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 76.2 mt -109.71 143.24 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 120.161 -0.616 . . . . 1.52 111.325 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 p -110.96 -97.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.474 -0.936 . . . . 2.17 108.474 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 56' ' ' VAL . 29.3 tttm -134.31 -54.31 0.85 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.619 -0.882 . . . . 5.98 108.619 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.84 -52.81 4.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.371 -1.286 . . . . 4.66 110.97 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -54.01 -72.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 118.905 -1.118 . . . . 4.31 108.932 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 83.4 mt -35.12 -49.62 0.48 Allowed 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 112.541 0.571 . . . . 3.22 112.541 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -46.41 -50.84 16.14 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.828 -0.749 . . . . 5.35 109.545 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -43.34 -36.73 1.98 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.027 0.83 . . . . 6.15 111.568 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' NZ ' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -95.68 -11.45 27.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.984 1.105 . . . . 4.86 113.984 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.57 -47.25 2.22 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 119.325 -0.95 . . . . 2.67 112.925 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.0 49.05 2.74 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 106.437 -2.665 . . . . 3.15 106.437 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -123.14 78.43 52.01 Favored Pre-proline 0 N--CA 1.505 2.325 0 N-CA-C 112.182 0.438 . . . . 5.95 112.182 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.53 33.77 0.45 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.677 1.584 . . . . 7.25 111.732 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -132.27 -81.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.908 -0.775 . . . . 6.22 108.908 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 58' ' ' THR . 20.1 pm0 -96.79 -165.46 1.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.369 -1.715 . . . . 5.28 106.369 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 10.1 t 177.43 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.993 -1.083 . . . . 8.39 112.698 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 16.3 t -117.33 138.83 25.35 Favored Pre-proline 0 N--CA 1.502 2.138 0 C-N-CA 119.488 -0.885 . . . . 3.77 110.485 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 56.6 Cg_endo -86.86 166.78 46.51 Favored 'Cis proline' 0 N--CA 1.493 1.458 0 C-N-CA 125.105 -0.79 . . . . 2.85 110.126 -23.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -140.76 161.92 36.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.518 -0.873 . . . . 3.08 111.787 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -122.94 146.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.127 -1.397 . . . . 1.37 108.243 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 51' ' ' LYS . 9.6 m-85 -123.8 127.18 47.72 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.027 -1.897 . . . . 1.75 106.483 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' HG13 ' A' ' 69' ' ' ILE . 38.9 t -109.72 136.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 117.996 -1.481 . . . . 0.98 107.863 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.84 -89.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.314 1.009 . . . . 2.85 108.383 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.3 mm-40 -141.99 3.95 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.744 0.653 . . . . 5.39 111.151 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -107.7 152.82 23.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.087 0.47 . . . . 5.14 111.138 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' HA ' ' CD1' ' A' ' 63' ' ' PHE . 35.9 t-80 -77.77 141.29 39.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.415 -1.698 . . . . 1.79 106.415 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.513 HG13 ' CG2' ' A' ' 64' ' ' VAL . 42.2 mm -115.42 -45.97 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 C-N-CA 118.235 -1.386 . . . . 1.13 109.253 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.66 -137.0 8.39 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.466 -1.35 . . . . 1.76 110.275 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.29 -166.94 21.22 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.754 -0.736 . . . . 1.57 111.54 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -55.16 -66.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.994 -0.683 . . . . 2.11 112.424 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -51.37 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.096 0.776 . . . . 1.84 113.096 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.95 -52.87 10.1 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.174 -1.01 . . . . 2.92 111.178 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CD2' HD23 ' A' ' 20' ' ' LEU . 44.3 t80 -49.62 -38.29 31.35 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.817 -1.153 . . . . 0.88 108.899 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -58.74 -65.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.149 -1.387 . . . . 0.93 110.319 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -54.87 41.91 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.894 -1.122 . . . . 1.15 108.113 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.468 ' HH2' ' SD ' ' A' ' 1' ' ' MET . 57.2 t90 -41.15 -51.05 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.263 0.977 . . . . 1.49 109.93 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 80' ' ' LYS . 2.1 t -48.74 -61.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 114.803 -1.089 . . . . 1.02 108.464 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.503 ' NZ ' ' HB3' ' A' ' 84' ' ' ASP . 5.9 tmtm? -53.58 -46.63 70.38 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.967 -0.693 . . . . 2.86 112.673 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -56.44 -55.72 30.17 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.504 -1.225 . . . . 3.74 113.564 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -89.06 -27.09 21.03 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 114.739 1.385 . . . . 2.01 114.739 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 1' ' ' MET . 60.4 mt -89.38 -19.24 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.157 -1.417 . . . . 1.58 111.894 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.531 ' CB ' HH12 ' A' ' 28' ' ' ARG . 10.3 t70 . . . . . 0 N--CA 1.495 1.806 0 C-N-CA 118.487 -1.285 . . . . 4.32 110.637 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 71.2 mtm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.123 -0.695 . . . . 1.99 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 5.8 mt-30 -126.65 123.92 38.69 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 108.265 -1.013 . . . . 4.14 108.265 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.4 m -120.34 139.16 53.17 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.875 -1.13 . . . . 0.96 110.026 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.3 t -119.25 125.42 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.803 -0.759 . . . . 0.62 109.317 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -106.75 117.96 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 124.882 1.364 . . . . 2.07 107.928 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 15.4 m-85 -98.23 93.46 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.828 -1.175 . . . . 1.11 107.828 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.88 -170.67 16.02 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.771 -1.204 . . . . 0.93 110.897 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 22.0 mtp180 -126.81 27.28 6.05 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.086 -0.646 . . . . 6.35 109.292 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' ARG . 59.3 m 34.25 52.52 0.51 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 123.59 0.556 . . . . 3.6 111.111 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.1 52.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.799 -1.32 . . . . 3.58 109.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -151.71 72.38 8.1 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 107.623 -1.251 . . . . 3.3 107.623 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -29.2 -59.07 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 123.202 2.601 . . . . 2.72 113.796 -139.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -39.88 -38.97 0.75 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 120.603 -0.439 . . . . 4.79 112.0 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 92.2 m -51.05 -46.09 61.55 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.284 -0.871 . . . . 2.42 110.426 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -55.93 -48.2 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.651 -0.82 . . . . 1.16 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.497 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -42.98 -48.69 5.98 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.709 -0.796 . . . . 4.51 111.063 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.99 -44.86 15.38 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.591 -0.844 . . . . 0.9 110.571 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.2 tmtm? -63.77 -54.44 35.2 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 108.385 -0.969 . . . . 2.79 108.385 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.497 ' CG ' HH22 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -52.56 -43.09 65.0 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.799 -0.637 . . . . 3.13 111.699 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 39.2 tp -71.66 -49.41 40.1 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.028 -0.669 . . . . 0.97 109.831 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -57.29 -42.97 82.71 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.104 -1.443 . . . . 0.61 107.104 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.14 -57.86 10.04 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.586 -1.264 . . . . 2.82 107.586 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 22' ' ' GLU . 60.8 tttp -37.43 -61.77 0.57 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.32 -1.309 . . . . 3.78 108.911 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 mt -56.45 -56.92 15.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.776 -0.77 . . . . 1.72 112.564 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 -15.43 0.66 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 114.04 1.126 . . . . 1.55 114.04 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.41 -44.5 4.3 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 119.842 -0.743 . . . . 3.08 110.508 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.73 -19.43 48.81 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.898 -1.501 . . . . 3.66 112.782 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NH1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -118.69 -178.36 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.789 -0.641 . . . . 6.48 109.954 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.08 -59.62 1.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 113.048 0.759 . . . . 3.76 113.048 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.5 t70 -78.08 52.74 1.11 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.889 0.852 . . . . 3.29 111.786 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -145.71 92.53 2.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.287 -0.883 . . . . 0.96 111.521 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 17.7 mp0 -105.14 126.76 52.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.604 -2.369 . . . . 3.31 104.604 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.68 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.3 p90 -127.03 157.57 39.25 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.813 -1.155 . . . . 1.48 109.549 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -131.23 140.62 49.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.495 -0.928 . . . . 3.79 108.495 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -99.83 131.01 46.07 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.936 -1.106 . . . . 1.26 108.045 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.2 145.47 22.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 114.689 -1.141 . . . . 0.71 108.932 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -118.52 116.72 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.436 -1.69 . . . . 2.66 106.436 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' A' ' 8' ' ' ARG . 2.7 pt -51.32 -27.7 6.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.319 -1.352 . . . . 1.32 112.416 -178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.6 -8.65 58.14 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.067 -1.053 . . . . 6.22 113.071 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.21 -37.6 12.0 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.392 -0.923 . . . . 1.47 108.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -87.03 -37.48 17.44 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.978 -0.689 . . . . 2.56 110.826 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 52.07 0.59 Allowed Glycine 0 N--CA 1.505 3.253 0 N-CA-C 110.105 -1.198 . . . . 1.42 110.105 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.2 137.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.899 -0.65 . . . . 1.6 109.363 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -103.41 -101.31 0.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.145 -1.428 . . . . 2.67 107.145 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -138.97 -47.45 0.49 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.557 -2.016 . . . . 6.44 105.557 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -46.07 -52.35 12.14 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.018 -1.104 . . . . 3.52 108.018 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 24.4 m-20 -44.93 -57.28 3.9 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.735 -1.121 . . . . 4.35 111.611 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 77.1 mt -56.04 -53.66 54.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.003 -1.453 . . . . 1.86 110.334 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -51.24 -47.04 62.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.991 -1.083 . . . . 3.86 109.022 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 12.9 tm0? -51.69 -45.13 63.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.819 -0.752 . . . . 6.03 108.998 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -68.37 0.81 3.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.863 -1.062 . . . . 4.03 113.472 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' PRO . . . -129.89 -44.76 1.18 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.942 -1.103 . . . . 2.83 112.272 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.44 -58.82 0.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.107 -1.197 . . . . 4.76 110.107 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.574 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 55.1 pttt -165.2 62.6 0.88 Allowed Pre-proline 0 N--CA 1.504 2.231 0 C-N-CA 119.201 -1.0 . . . . 11.28 112.844 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 10.1 Cg_endo -96.74 159.6 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.156 1.238 . . . . 6.44 112.041 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.75 -20.81 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 115.013 -0.994 . . . . 4.78 108.649 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.714 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -72.8 70.45 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.511 -1.222 . . . . 5.55 108.123 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.2 t -42.43 -45.66 4.46 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.389 -0.823 . . . . 6.6 110.465 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 60' ' ' PRO . 57.3 t -142.76 152.45 59.37 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.891 -0.781 . . . . 2.63 108.891 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 12.0 Cg_endo -84.26 166.8 60.23 Favored 'Cis proline' 0 N--CA 1.486 1.049 0 O-C-N 123.426 1.224 . . . . 1.98 109.885 -17.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 82.4 mt-30 -139.76 153.99 47.3 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.074 -1.05 . . . . 2.74 111.436 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.1 mt -134.07 150.97 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.703 1.24 . . . . 1.74 112.623 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.49 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 61.4 m-85 -135.87 126.35 26.85 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 112.62 -2.082 . . . . 1.18 108.852 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 69' ' ' ILE . 58.9 t -96.62 121.26 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 105.903 -1.888 . . . . 1.19 105.903 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.16 -87.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.902 0.751 . . . . 2.62 111.672 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.91 12.76 3.99 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.238 -0.985 . . . . 4.47 112.913 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -111.83 156.73 21.53 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.877 -0.729 . . . . 3.91 109.699 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.49 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 22.3 t60 -90.92 138.34 31.67 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.025 -1.102 . . . . 1.54 108.025 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.586 HG13 HG23 ' A' ' 64' ' ' VAL . 9.7 mm -110.71 -31.73 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.523 -1.271 . . . . 0.9 110.547 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.96 -138.47 10.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.295 -1.431 . . . . 1.96 109.764 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . -94.29 -89.09 1.67 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.583 -1.294 . . . . 2.41 111.476 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.12 -55.32 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.849 -1.14 . . . . 1.72 109.49 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -43.04 -48.27 6.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.274 -1.01 . . . . 1.33 108.274 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -64.95 0.66 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.379 -1.737 . . . . 3.3 110.296 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -51.55 -46.15 63.29 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.246 -0.982 . . . . 1.11 109.25 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.77 -53.47 31.5 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.297 -1.001 . . . . 0.84 108.297 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' GLU . . . -55.47 -56.26 22.29 Favored 'General case' 0 C--O 1.198 -1.643 0 N-CA-C 107.933 -1.136 . . . . 0.98 107.933 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -50.16 -34.28 21.85 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 123.43 0.456 . . . . 1.3 110.631 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 t -71.49 -44.32 71.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.421 -0.955 . . . . 1.8 108.421 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' NZ ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -82.25 -65.8 0.97 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.443 -1.303 . . . . 3.07 111.602 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' ALA . 41.9 mt-10 -62.21 0.77 0.38 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 117.272 2.323 . . . . 4.71 117.272 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.48 -26.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.32 -0.952 . . . . 2.67 112.233 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.67 -21.98 28.1 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.281 -1.368 . . . . 1.95 112.713 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 80' ' ' LYS . 30.7 p30 . . . . . 0 N--CA 1.508 2.452 0 C-N-CA 117.108 -1.837 . . . . 4.59 112.325 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 122.951 1.358 . . . . 2.82 109.16 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -121.02 126.5 50.06 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.829 -1.915 . . . . 5.97 105.829 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 64' ' ' VAL . 60.4 m -112.72 144.67 41.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.275 -1.37 . . . . 0.95 113.192 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.0 117.56 52.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.941 -1.874 . . . . 1.08 105.941 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 62' ' ' ILE . 16.2 mm -107.2 124.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.242 -1.392 . . . . 1.9 107.242 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.84 96.2 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.323 -1.732 . . . . 1.05 106.323 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -142.71 -152.6 5.71 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.639 -1.267 . . . . 0.9 111.631 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.04 6.58 3.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.996 -0.742 . . . . 6.74 108.996 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 t 45.24 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.569 1.176 . . . . 5.75 112.764 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.41 -66.51 3.63 Favored Glycine 0 N--CA 1.498 2.795 0 CA-C-N 114.781 -1.1 . . . . 4.65 111.443 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 137.93 89.28 Favored Pre-proline 0 N--CA 1.497 1.896 0 C-N-CA 119.886 -0.726 . . . . 2.75 111.143 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.38 -61.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.283 1.989 . . . . 3.16 111.021 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 10.3 t80 -48.89 -50.54 34.5 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.561 -0.855 . . . . 4.0 109.431 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -53.86 -53.51 51.5 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.675 0.75 . . . . 2.57 110.106 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -52.09 -43.21 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.513 -1.221 . . . . 0.96 111.182 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.526 HH22 ' N ' ' A' ' 20' ' ' LEU . 10.0 mmm180 -40.26 -50.96 2.76 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.714 -1.195 . . . . 3.84 112.188 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.75 -52.66 13.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.733 -1.187 . . . . 0.69 109.193 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -58.64 -45.97 88.14 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.987 -1.461 . . . . 1.93 110.482 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 66.0 t0 -62.11 -44.38 96.77 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.41 -0.916 . . . . 3.64 109.774 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' N ' HH22 ' A' ' 16' ' ' ARG . 11.0 tp -62.72 -58.87 5.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.617 -0.833 . . . . 0.91 109.077 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.69 -51.81 58.72 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.102 -1.039 . . . . 0.63 109.127 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.6 tt0 -46.33 -58.93 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.964 0.79 . . . . 3.24 109.796 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HZ2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -47.43 -60.6 2.41 Favored 'General case' 0 C--O 1.206 -1.195 0 O-C-N 125.644 1.84 . . . . 6.34 107.76 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 56.6 mt -51.08 -51.47 52.96 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.244 -1.383 . . . . 1.39 112.192 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 13.4 p -66.75 8.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.54 -1.264 . . . . 1.86 114.408 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.86 -39.71 2.1 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.693 -1.225 . . . . 4.04 107.693 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.94 -31.8 61.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.598 -1.183 . . . . 3.4 109.046 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.0 mtp-105 -110.76 -171.04 1.75 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.318 -1.31 . . . . 4.63 111.794 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -125.53 -48.9 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.176 -0.92 . . . . 3.69 111.748 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.68 -21.24 61.1 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.779 -1.168 . . . . 4.84 110.39 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 25' ' ' SER . 59.2 t80 -84.92 124.49 31.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.763 -1.175 . . . . 1.13 112.331 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 38.0 mt-30 -139.2 163.16 33.19 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.622 -1.626 . . . . 2.68 106.809 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 7.8 p90 -158.95 163.18 36.72 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.568 -1.253 . . . . 1.65 110.594 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -128.73 157.25 41.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.463 -1.31 . . . . 4.71 107.463 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -115.56 127.36 55.2 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.06 -1.456 . . . . 1.7 107.78 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.45 132.05 63.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.423 -1.695 . . . . 0.82 106.423 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.3 t70 -108.27 110.57 22.21 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.44 -0.948 . . . . 1.9 108.44 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -44.58 -25.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.676 0.991 . . . . 1.13 113.676 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.523 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 6.4 mmm180 -91.93 -48.81 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.067 -1.453 . . . . 7.95 109.584 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -52.44 -40.76 62.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.401 -0.963 . . . . 1.48 108.401 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' GLY . 71.3 mm-40 -86.57 26.39 1.1 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.26 -1.336 . . . . 3.64 110.61 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 25.04 59.43 0.06 OUTLIER Glycine 0 N--CA 1.504 3.211 0 O-C-N 123.406 0.441 . . . . 2.39 113.73 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 44' ' ' THR . 31.7 mt -104.13 161.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.584 -0.895 . . . . 2.18 108.584 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 43' ' ' ILE . 8.9 t -112.96 -168.07 1.27 Allowed 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.671 -1.233 . . . . 3.01 107.671 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -82.3 -46.12 14.05 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.702 -1.199 . . . . 5.6 109.887 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.726 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.5 mp0 -44.48 -51.82 8.45 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.901 0.858 . . . . 4.48 110.281 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.32 -61.68 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.39 -1.277 . . . . 3.63 111.452 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.24 -52.58 2.62 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.011 -0.995 . . . . 1.88 113.497 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -44.68 -46.39 10.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.332 -0.947 . . . . 4.81 111.243 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -51.27 69.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.772 0.67 . . . . 6.69 111.244 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.605 ' NZ ' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -46.48 -37.69 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.494 -1.23 . . . . 4.48 112.868 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.97 -30.06 11.85 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.224 0.952 . . . . 2.0 111.574 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.56 49.88 17.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.29 -1.124 . . . . 3.34 110.29 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 37.0 mttm -142.56 156.62 63.3 Favored Pre-proline 0 N--CA 1.501 2.114 0 C-N-CA 118.655 -1.218 . . . . 7.51 112.003 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 8.1 Cg_endo -81.33 39.34 0.85 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.318 2.012 . . . . 5.89 111.175 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 p -141.01 125.86 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.529 -2.026 . . . . 5.14 105.529 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 63.54 0.91 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.254 0.835 . . . . 8.74 113.254 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.5 p -105.08 166.62 10.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.181 -1.408 . . . . 5.2 112.558 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -113.81 152.37 45.53 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.672 -1.233 . . . . 3.2 107.672 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.93 177.04 22.42 Favored 'Cis proline' 0 N--CA 1.485 0.973 0 O-C-N 122.541 0.758 . . . . 2.0 110.848 -12.489 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -131.81 142.05 49.62 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.842 -0.743 . . . . 2.99 109.627 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.8 mp -119.65 143.18 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-O 121.822 0.82 . . . . 1.47 111.663 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CE2' ' NZ ' ' A' ' 51' ' ' LYS . 84.3 m-85 -128.87 136.66 50.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.412 -1.722 . . . . 1.22 108.745 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.691 HG11 ' CH2' ' A' ' 78' ' ' TRP . 75.5 t -122.76 137.3 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.489 -1.284 . . . . 1.25 109.293 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 56.4 m-20 54.42 -80.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.678 -1.601 . . . . 3.58 111.197 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' VAL . 40.3 tt0 -138.76 -19.66 1.03 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.294 -0.866 . . . . 4.68 112.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.65 163.82 12.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.948 1.092 . . . . 4.57 113.948 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.484 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 74.1 t60 -80.25 137.97 36.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.954 -1.93 . . . . 1.56 106.532 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.525 HG13 HG23 ' A' ' 64' ' ' VAL . 34.3 mm -110.15 -50.34 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.343 -1.343 . . . . 0.97 109.718 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.1 -141.07 10.88 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.472 -1.347 . . . . 1.6 110.81 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.7 -168.08 32.35 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.636 -1.386 . . . . 1.49 109.636 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 12.9 t80 -56.77 -23.27 41.87 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.854 -1.138 . . . . 1.32 109.358 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -75.33 -65.76 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 1.43 111.003 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.92 -43.06 69.44 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.54 -0.911 . . . . 2.88 108.54 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 62' ' ' ILE . 22.7 t80 -59.71 -53.43 58.04 Favored 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 107.159 -1.423 . . . . 1.13 107.159 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.4 11.52 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.573 -0.851 . . . . 0.77 111.043 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.4 -60.3 4.03 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.238 -0.985 . . . . 0.96 109.997 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.691 ' CH2' HG11 ' A' ' 64' ' ' VAL . 46.2 t90 -41.62 -49.41 4.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 123.825 0.703 . . . . 1.25 109.584 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -49.49 -61.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.096 -0.956 . . . . 1.12 110.12 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -50.96 -50.63 57.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.672 -0.811 . . . . 3.11 111.503 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.54 -39.86 92.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.096 1.888 . . . . 3.94 116.096 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -105.48 -17.23 14.49 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.664 1.357 . . . . 1.65 114.664 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 31' ' ' PHE . 68.8 mt -97.55 -21.55 17.03 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.909 -1.516 . . . . 2.06 110.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.498 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 11.4 m-20 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 118.096 -1.441 . . . . 4.68 111.373 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.01 -1.107 . . . . 2.91 108.01 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 9.1 tt0 -105.98 157.89 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.122 -1.066 . . . . 3.82 108.122 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.43 ' HA ' ' H ' ' A' ' 65' ' ' ASP . 31.0 m -149.22 149.74 31.46 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.861 -1.149 . . . . 0.91 109.84 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.87 134.7 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 119.981 -0.688 . . . . 0.62 111.197 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 62' ' ' ILE . 25.3 mm -114.93 119.61 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.97 -1.493 . . . . 1.72 106.97 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.493 ' CD2' HG11 ' A' ' 36' ' ' VAL . 36.3 m-85 -103.0 103.71 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.46 -0.941 . . . . 0.87 108.46 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.15 -150.18 5.43 Favored Glycine 0 N--CA 1.502 3.042 0 C-N-CA 119.399 -1.381 . . . . 1.24 110.932 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 38' ' ' ILE . 18.1 mtt180 -121.85 -144.89 0.35 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.267 -0.642 . . . . 7.34 109.267 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m -118.06 77.8 1.19 Allowed 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.973 -0.691 . . . . 3.42 112.085 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.03 44.07 0.64 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.109 -1.52 . . . . 2.48 111.041 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -110.0 101.61 47.91 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.438 -1.319 . . . . 2.13 107.438 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -32.86 -34.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 123.081 2.521 . . . . 2.24 112.899 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 1.7 t80 -75.54 -55.27 5.83 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.398 -0.819 . . . . 4.62 109.855 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -54.16 -40.71 67.72 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.03 -1.47 . . . . 2.51 107.03 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.47 -54.64 32.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.168 -1.378 . . . . 1.01 107.705 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 7.3 tpm_? -46.36 -51.91 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 3.28 110.325 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -58.1 -43.67 87.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.115 -1.034 . . . . 0.7 108.591 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.9 -47.84 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.205 -1.406 . . . . 2.76 107.205 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.25 -50.81 64.03 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.901 -1.12 . . . . 2.93 108.852 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -53.98 -58.28 7.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.037 -1.065 . . . . 1.34 110.324 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.29 -52.43 52.95 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.948 -1.101 . . . . 0.69 109.752 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.69 -49.08 66.02 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.291 0.567 . . . . 2.91 110.094 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 28.0 ttpp -48.76 -60.65 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.277 -0.969 . . . . 5.07 108.855 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.603 HD22 ' HD2' ' A' ' 28' ' ' ARG . 64.9 mt -48.19 -58.37 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.772 -0.771 . . . . 1.42 111.515 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 m -41.25 -34.13 0.45 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.674 -0.81 . . . . 1.38 110.896 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -88.19 -36.01 17.05 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 120.396 -0.522 . . . . 3.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 6.4 pt-20 -99.74 23.48 9.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.535 0.683 . . . . 4.4 112.017 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HD2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -137.02 177.11 8.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.775 -0.824 . . . . 4.53 108.775 179.003 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.56 -38.78 3.67 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.536 -1.211 . . . . 4.18 108.606 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.7 p-10 -110.34 22.0 16.02 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.821 -1.536 . . . . 4.12 113.424 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -102.83 99.48 9.42 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 118.189 -1.404 . . . . 0.92 114.406 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 42.5 mt-30 -111.64 127.82 55.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.835 -1.543 . . . . 2.8 106.835 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 25.5 p90 -129.64 162.1 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.624 -0.83 . . . . 1.05 110.326 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.71 146.97 52.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.72 -0.844 . . . . 3.38 108.72 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -99.76 135.27 41.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.8 -1.556 . . . . 1.15 106.8 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.493 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -121.35 138.03 53.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.796 -0.816 . . . . 0.71 108.796 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -111.22 109.36 19.36 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.657 -1.156 . . . . 2.39 108.666 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CD1' HH21 ' A' ' 8' ' ' ARG . 27.0 pt -51.17 -25.81 4.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.915 -1.039 . . . . 1.26 109.392 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -79.33 -63.53 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.02 -1.072 . . . . 5.18 108.286 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.21 -42.3 0.67 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 123.66 0.6 . . . . 1.47 111.409 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.21 -46.81 14.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.85 -1.068 . . . . 2.4 111.028 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.67 51.79 0.83 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.821 -1.312 . . . . 1.76 109.821 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 44' ' ' THR . 24.4 mt -100.26 172.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.977 -0.611 . . . . 1.85 109.384 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.518 ' N ' HG22 ' A' ' 43' ' ' ILE . 51.5 p -103.67 -171.01 1.86 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.601 -0.888 . . . . 2.46 108.601 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 29.96 7.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.276 -1.379 . . . . 4.84 107.276 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -119.31 -55.6 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 110.341 -3.118 . . . . 3.53 104.084 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -47.96 27.65 Favored 'General case' 0 C--O 1.202 -1.396 0 CA-C-N 112.458 -2.155 . . . . 3.58 110.46 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 59' ' ' VAL . 59.2 mt -53.6 -37.97 63.51 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.897 -1.047 . . . . 1.98 111.819 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.67 -49.71 13.95 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.928 -1.109 . . . . 4.47 108.903 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' C ' ' CD ' ' A' ' 50' ' ' GLN . 11.2 tm0? -52.65 -43.94 65.81 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.749 -1.114 . . . . 4.73 110.062 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -16.33 35.1 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.924 -1.035 . . . . 4.95 111.681 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -89.75 -51.58 5.43 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.193 -1.781 . . . . 2.05 106.193 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.79 -25.19 2.56 Favored Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.371 -1.286 . . . . 2.98 110.558 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' VAL . 29.6 mtmm -109.43 155.78 40.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 109.008 -0.738 . . . . 9.97 109.008 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.5 74.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 123.053 2.502 . . . . 6.38 112.784 -149.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 54' ' ' LYS . 11.9 p -96.83 162.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.793 -0.817 . . . . 6.8 108.793 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.1 pt-20 -90.34 -99.22 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.908 -1.042 . . . . 6.68 110.552 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -131.03 -162.28 1.2 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.153 -0.619 . . . . 5.27 109.819 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 60' ' ' PRO . 73.0 t -84.14 140.25 39.63 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-N 115.007 -0.997 . . . . 4.05 109.639 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 59' ' ' VAL . 9.7 Cg_endo -91.31 164.93 28.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 O-C-N 123.069 1.036 . . . . 2.49 112.623 14.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -131.71 156.16 46.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.793 -1.094 . . . . 3.11 109.816 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 5' ' ' ILE . 68.2 mt -125.55 144.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.5 -0.773 . . . . 1.2 111.754 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 14.3 m-85 -129.03 122.65 30.46 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.624 -1.625 . . . . 1.1 108.942 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 69' ' ' ILE . 22.3 t -91.98 122.91 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 105.358 -2.09 . . . . 1.08 105.358 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.549 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 1.2 t70 64.05 -74.76 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 125.076 1.485 . . . . 2.91 109.099 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.549 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -147.92 -5.5 0.46 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.921 -0.581 . . . . 4.78 111.558 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -104.63 137.26 42.72 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.22 -0.592 . . . . 5.29 112.554 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 50.4 t-80 -68.92 129.92 41.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.765 -1.568 . . . . 1.6 106.765 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 64' ' ' VAL . 33.3 mm -106.73 -36.84 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.719 -1.193 . . . . 1.29 111.149 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.76 -132.33 4.36 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.692 -1.718 . . . . 1.63 110.843 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.62 -148.75 12.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.989 -0.844 . . . . 1.85 110.989 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 16' ' ' ARG . 72.9 t80 -78.79 -56.98 3.99 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.053 -0.573 . . . . 1.94 110.432 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.47 -64.99 0.64 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.141 0.793 . . . . 2.1 113.141 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -53.98 -60.19 3.65 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.211 -0.596 . . . . 2.73 109.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -43.93 -48.44 8.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.716 -0.476 . . . . 1.31 109.716 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.69 -59.26 5.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.01 -0.541 . . . . 1.42 109.91 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -53.25 -62.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.272 -1.01 . . . . 1.55 108.272 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -41.37 -60.21 1.34 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.194 -0.912 . . . . 1.6 109.657 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG1' HD21 ' A' ' 24' ' ' LEU . 3.2 t -40.61 -63.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.335 -1.357 . . . . 1.22 107.335 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -44.64 -54.9 5.69 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 125.018 1.449 . . . . 2.72 109.788 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' ALA . 18.0 mm-40 -80.17 26.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.199 0.815 . . . . 5.56 113.199 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -142.48 -43.5 0.32 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.13 -0.628 . . . . 1.73 111.504 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' HD3' ' A' ' 28' ' ' ARG . 14.6 mt -94.44 -4.19 48.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.385 -0.926 . . . . 1.77 111.794 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.496 1.873 0 O-C-N 124.321 1.013 . . . . 3.6 108.592 179.182 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 83.3 mtp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 107.704 -1.221 . . . . 2.03 107.704 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -118.9 116.99 27.63 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.857 1.348 . . . . 5.0 107.541 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.0 m -99.74 131.91 45.42 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.5 -1.28 . . . . 0.67 108.41 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.64 128.93 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.849 -1.167 . . . . 0.54 107.849 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.77 109.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.633 -1.618 . . . . 1.66 106.633 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.581 ' CD2' HG11 ' A' ' 36' ' ' VAL . 26.8 m-85 -94.03 107.52 19.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.076 -1.453 . . . . 1.18 107.076 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.83 5.6 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.354 -0.927 . . . . 1.51 110.932 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.596 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 31.9 ptt-85 -130.06 -162.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.857 -1.164 . . . . 7.82 107.857 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 39' ' ' ARG . 33.3 p -132.49 140.09 48.22 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.178 -1.009 . . . . 3.96 110.961 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.4 -1.91 23.64 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.247 -0.977 . . . . 3.11 111.721 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 95.72 24.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 120.022 -0.671 . . . . 2.16 111.453 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 83.3 Cg_exo -35.29 -38.63 0.2 Allowed 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 122.339 2.026 . . . . 4.02 112.14 168.834 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -67.04 -45.12 78.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.701 -1.6 . . . . 3.8 109.217 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' NH2' ' A' ' 8' ' ' ARG . 82.0 m -53.32 -41.91 66.18 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.717 -1.193 . . . . 2.03 107.902 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' PRO . 58.0 t -48.33 -38.89 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.458 -0.897 . . . . 1.02 111.14 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.8 mmp_? -50.25 -20.94 1.17 Allowed 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 112.835 0.68 . . . . 5.79 112.835 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -43.77 22.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.76 -1.57 . . . . 0.83 106.76 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.0 tmtt? -57.1 -46.6 82.46 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.598 -0.889 . . . . 2.69 108.598 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.611 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 31.8 m-20 -53.3 -43.9 67.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.794 -1.162 . . . . 3.01 111.033 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.16 -57.73 4.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.17 -1.012 . . . . 0.81 109.529 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -43.22 37.31 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.056 -1.058 . . . . 1.13 109.156 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 19.9 tt0 -65.84 -65.21 0.7 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.366 -0.934 . . . . 2.72 109.504 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -36.33 -50.74 0.77 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.145 0.903 . . . . 3.6 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.551 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 95.2 mt -49.72 -40.15 39.53 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.823 -1.08 . . . . 1.26 112.272 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.0 m -50.48 -12.59 0.1 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.576 0.548 . . . . 1.25 111.618 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 24' ' ' LEU . 44.5 m-80 -114.73 -41.8 3.34 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.853 -0.612 . . . . 2.49 111.045 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 5.9 pt-20 -81.79 -10.59 59.3 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.156 -1.018 . . . . 3.69 113.415 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.5 mpt_? -105.76 -177.4 3.35 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.281 -0.967 . . . . 5.2 110.914 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -63.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.486 -1.234 . . . . 6.04 112.024 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.4 t70 -118.91 -43.78 2.64 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 109.476 -0.564 . . . . 5.47 109.476 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 25' ' ' SER . 16.4 t80 8.61 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.41 -1.723 . . . . 0.76 115.113 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -112.72 158.82 19.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.689 -1.967 . . . . 3.27 105.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.657 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 10.8 p90 -151.28 164.69 36.06 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.16 -1.416 . . . . 1.02 110.695 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -144.27 154.86 43.51 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.374 -1.343 . . . . 4.0 107.374 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 36' ' ' VAL . 38.7 t80 -106.76 148.28 28.64 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.117 -1.433 . . . . 1.7 109.068 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -131.02 125.86 58.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 124.399 1.062 . . . . 1.13 108.62 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -109.02 122.76 47.94 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.558 -1.275 . . . . 1.94 107.558 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.1 pt -51.93 -31.35 13.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.614 -0.834 . . . . 1.48 111.811 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.8 OUTLIER -84.22 -5.9 59.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.652 0.612 . . . . 4.82 112.652 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.12 -39.32 6.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.798 -0.761 . . . . 1.3 110.194 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.76 -35.08 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.442 -0.903 . . . . 2.67 110.148 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.41 53.85 0.71 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.151 -1.58 . . . . 1.91 109.151 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.25 137.68 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.506 -0.924 . . . . 1.8 108.506 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -117.46 54.06 0.9 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.69 -1.204 . . . . 4.28 113.901 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.1 mttp 62.94 -65.01 0.1 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.365 1.246 . . . . 7.52 114.365 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -44.25 -51.74 8.04 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.022 0.749 . . . . 4.65 113.022 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.46 -38.23 58.86 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.758 -1.177 . . . . 4.04 109.999 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLN . 71.9 mt -71.92 -51.77 20.51 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.311 -0.956 . . . . 1.73 108.522 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LEU . 12.3 tm0? -40.39 -45.21 2.14 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.178 -1.045 . . . . 5.49 108.178 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -68.75 -58.02 4.81 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 126.008 2.068 . . . . 5.79 110.455 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -43.55 -37.51 2.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.669 -0.696 . . . . 3.67 112.327 -179.21 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.6 -8.83 18.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.044 0.84 . . . . 1.96 111.316 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.29 49.63 55.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.102 -1.599 . . . . 2.4 109.102 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 26.2 mmtp -122.97 154.26 64.36 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 114.401 -0.9 . . . . 4.99 110.739 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.25 36.34 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.282 1.321 . . . . 4.76 110.815 152.04 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 54' ' ' LYS . 25.1 t 57.24 151.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.432 1.083 . . . . 6.07 112.742 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.551 ' CG ' ' H ' ' A' ' 58' ' ' THR . 6.6 pm0 -131.17 -106.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.556 -1.275 . . . . 6.26 107.556 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 67.4 m -119.23 175.56 5.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.321 -1.363 . . . . 6.36 107.321 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.534 HG21 HH12 ' A' ' 8' ' ' ARG . 3.2 m -112.6 164.56 15.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.64 -0.504 . . . . 4.13 109.64 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.29 -172.5 10.93 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 124.131 -1.195 . . . . 2.3 110.421 -11.207 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -103.03 131.97 49.63 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.641 -1.614 . . . . 3.55 106.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.594 HG21 ' CG ' ' A' ' 75' ' ' PHE . 8.7 mm -108.62 125.92 65.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.356 -0.937 . . . . 1.48 110.832 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.21 124.16 41.84 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.421 -1.326 . . . . 1.03 107.421 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.474 ' CG2' HG13 ' A' ' 69' ' ' ILE . 42.2 t -116.54 122.91 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.068 -1.053 . . . . 1.0 108.863 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 50.44 32.2 6.26 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.013 1.863 . . . . 2.53 108.803 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 82.52 -34.5 0.09 Allowed 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 110.016 -3.266 . . . . 6.99 109.757 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -47.1 112.66 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 4.91 108.719 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HA2' ' A' ' 70' ' ' GLY . 21.6 t-80 -57.85 131.57 50.77 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 117.825 -1.55 . . . . 1.81 106.876 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 ' CG2' ' A' ' 64' ' ' VAL . 51.0 mm -105.43 -42.97 7.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.198 -1.408 . . . . 1.13 107.198 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 131.54 -125.1 4.27 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.941 -1.599 . . . . 1.59 111.109 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.22 19.8 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.626 -1.273 . . . . 1.94 112.281 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -52.46 -44.88 65.83 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.119 -1.04 . . . . 1.67 111.921 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -63.31 -58.82 5.88 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.306 -0.958 . . . . 1.57 110.794 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.85 -56.47 8.64 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.096 -0.642 . . . . 4.59 109.429 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 62' ' ' ILE . 66.7 t80 -55.46 -45.46 76.91 Favored 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 115.184 -0.916 . . . . 0.8 109.455 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.68 -55.1 33.31 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.716 -0.794 . . . . 0.78 110.334 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.73 63.89 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.722 -1.214 . . . . 1.09 107.722 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.448 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 81.6 t90 -42.75 -58.8 2.19 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 115.556 -0.747 . . . . 1.59 110.003 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 51.3 t -46.1 -23.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.275 -0.875 . . . . 1.89 111.579 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 -67.96 0.9 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.531 0.52 . . . . 2.55 110.769 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.51 -22.16 19.92 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.83 1.048 . . . . 4.69 113.83 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.5 -31.99 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 114.302 1.223 . . . . 3.11 114.302 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 55.0 mt -96.87 -9.41 28.63 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 117.428 -1.709 . . . . 1.36 111.088 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 108.357 -0.979 . . . . 3.53 108.357 178.929 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 45.3 tpp . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.706 -1.22 . . . . 2.7 107.706 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.2 100.03 11.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.606 -1.257 . . . . 3.76 107.606 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -87.84 120.88 29.6 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.408 -0.917 . . . . 0.86 109.237 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 46.2 t -108.44 135.17 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-N 115.876 -0.602 . . . . 0.73 109.44 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mm -118.79 111.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.691 1.245 . . . . 1.55 109.375 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 36' ' ' VAL . 47.7 m-85 -93.9 98.14 10.85 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.508 -0.477 . . . . 1.29 110.443 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.85 -163.01 11.55 Favored Glycine 0 N--CA 1.512 3.738 0 C-N-CA 120.339 -0.934 . . . . 1.06 111.123 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.579 ' HG2' ' NH1' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -129.47 18.61 5.82 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 119.167 -1.013 . . . . 6.55 112.477 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.7 m 72.55 -58.04 0.61 Allowed 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 113.772 1.027 . . . . 3.05 113.772 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.51 35.88 3.42 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 119.106 -1.521 . . . . 2.84 110.944 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.9 88.96 45.17 Favored Pre-proline 0 N--CA 1.491 1.599 0 C-N-CA 120.453 -0.499 . . . . 2.63 110.046 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.36 -53.48 1.34 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.711 2.274 . . . . 2.6 112.417 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -55.83 -49.58 72.88 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.769 -1.172 . . . . 3.73 109.292 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 37.0 m -57.59 -39.27 76.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.226 -0.99 . . . . 2.5 109.538 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' ARG . 58.6 t -60.19 -53.92 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.931 -1.108 . . . . 1.26 110.463 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tpm_? -35.83 -51.35 0.69 Allowed 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.09 0.472 . . . . 4.43 110.716 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.89 -48.22 3.08 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.696 -0.684 . . . . 0.92 111.245 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.7 tmtt? -52.25 -41.25 62.66 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.543 -0.753 . . . . 3.02 111.949 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.546 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 17.1 m-20 -53.12 -49.8 65.78 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 118.948 -1.101 . . . . 2.63 110.087 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.29 -55.71 4.7 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.81 -1.541 . . . . 1.74 108.387 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -60.18 -49.43 77.67 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.177 -1.829 . . . . 0.91 109.836 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -45.74 -53.38 9.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.784 1.302 . . . . 4.22 109.791 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 8.5 mmmm -56.89 -64.21 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.597 -0.729 . . . . 3.56 109.783 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -44.38 -56.89 3.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.947 -1.024 . . . . 1.22 113.249 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 p -48.16 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.044 1.498 . . . . 2.01 115.044 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -123.36 -36.07 2.86 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.117 0.484 . . . . 3.03 110.432 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -74.19 -31.16 62.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.975 -1.011 . . . . 3.66 110.424 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.415 HH21 ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -109.52 -166.38 1.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.05 -0.66 . . . . 5.47 110.256 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.1 p30 -96.8 -77.59 0.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.593 2.071 . . . . 4.53 116.593 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' C ' ' A' ' 31' ' ' PHE . 8.7 t70 -74.12 -59.47 2.71 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.457 0.91 . . . . 4.13 113.457 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' A' ' 30' ' ' ASP . 57.3 t80 0.06 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.528 1.307 . . . . 0.93 114.528 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -106.07 159.43 16.08 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.607 -1.997 . . . . 3.92 105.607 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.512 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 40.7 p90 -160.67 154.13 22.06 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.509 -1.276 . . . . 1.66 110.828 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.2 133.61 28.29 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.039 -0.982 . . . . 3.01 109.85 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.65 136.57 32.89 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.834 -2.284 . . . . 1.58 104.834 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 6' ' ' PHE . 1.6 t -126.79 147.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.87 -1.159 . . . . 0.59 107.87 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 1.5 t70 -122.15 135.61 54.81 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.027 -0.669 . . . . 2.27 110.688 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.42 -23.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.508 -1.277 . . . . 1.94 110.819 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -88.95 -3.57 58.7 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.724 -0.671 . . . . 5.86 112.637 -178.656 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.53 -41.83 7.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.786 -1.19 . . . . 1.44 107.786 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -83.45 -39.45 20.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.151 -1.386 . . . . 2.83 108.859 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.14 49.48 1.14 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.452 -1.859 . . . . 1.49 108.452 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 47' ' ' ASP . 74.4 mt -112.43 157.01 13.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 120.262 -0.575 . . . . 1.41 111.07 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 46' ' ' GLU . 15.3 p -110.92 -179.17 3.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.273 -1.01 . . . . 2.17 108.273 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -85.87 46.67 1.34 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 106.462 -1.681 . . . . 5.46 106.462 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' THR . 53.2 mt-10 -122.17 -61.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.577 -1.647 . . . . 4.07 107.274 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 16.7 t70 -49.75 -46.04 50.1 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 114.851 -1.068 . . . . 3.82 109.534 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -52.79 -4.55 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.756 1.021 . . . . 2.76 113.756 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' ASP . 1.1 mp0 -108.39 -53.17 2.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.234 -1.395 . . . . 5.42 107.234 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -60.37 -33.13 72.01 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.031 0.92 . . . . 6.18 110.745 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 1.8 ttpp -92.11 14.49 15.85 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.389 -1.278 . . . . 3.84 109.344 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -123.24 -59.82 1.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.304 1.003 . . . . 1.56 111.988 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.85 -20.35 48.28 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.179 -1.01 . . . . 2.47 112.823 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -131.08 161.83 59.33 Favored Pre-proline 0 N--CA 1.506 2.342 0 C-N-CA 120.749 -0.38 . . . . 5.98 111.971 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 54' ' ' LYS . 55.4 Cg_exo -12.98 -147.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.109 1 C-N-CA 125.316 4.011 . . . . 6.11 116.675 -123.914 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.7 -51.23 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.459 -1.246 . . . . 6.23 110.896 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -39.01 31.49 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.626 0.602 . . . . 6.05 112.626 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -31.57 144.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 115.728 1.751 . . . . 6.08 115.728 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.83 159.49 31.54 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 106.887 -1.523 . . . . 2.82 106.887 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -79.56 -179.57 26.79 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.934 -1.277 . . . . 1.78 109.913 -17.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.519 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 13.5 mm-40 -104.98 125.42 50.94 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.029 -1.068 . . . . 3.22 108.29 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.503 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 13.7 mm -105.66 137.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.809 -1.552 . . . . 1.31 106.809 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 78.0 m-85 -122.15 124.33 43.63 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.879 -1.156 . . . . 1.11 107.879 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 29.3 t -98.38 111.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.641 -1.624 . . . . 1.15 108.339 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 59.04 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.395 1.059 . . . . 2.6 111.701 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.5 mm-40 -133.79 -8.84 2.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.906 0.706 . . . . 4.93 112.906 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -103.78 153.08 21.11 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.233 0.924 . . . . 5.24 111.251 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.731 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.9 t-80 -87.33 133.91 33.64 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.794 -1.187 . . . . 1.4 107.794 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -116.1 -29.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.163 -0.68 . . . . 1.52 109.163 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 29.34 108.18 0.0 OUTLIER Glycine 1 N--CA 1.518 4.107 0 N-CA-C 116.433 1.333 . . . . 2.59 116.433 178.413 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.52 121.63 2.8 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.347 -1.101 . . . . 1.77 110.347 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -59.46 -45.06 92.71 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.989 -1.084 . . . . 1.54 108.866 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -53.97 -54.28 41.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.293 -0.867 . . . . 1.21 110.149 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -57.97 -55.22 37.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.703 -1.135 . . . . 2.69 110.316 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.433 ' CG ' HG21 ' A' ' 62' ' ' ILE . 42.3 t80 -55.04 -45.82 75.27 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.263 -0.975 . . . . 0.81 108.725 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 -59.2 5.35 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.09 -0.644 . . . . 0.79 109.534 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -56.82 -61.52 2.38 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.698 -0.801 . . . . 0.88 109.212 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.419 ' CH2' HG11 ' A' ' 64' ' ' VAL . 62.1 t90 -39.82 -51.56 2.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.251 0.97 . . . . 1.54 109.814 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG13 HD12 ' A' ' 83' ' ' LEU . 4.0 t -54.74 -51.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.91 108.38 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.45 16.24 0.15 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.634 -1.166 . . . . 4.86 112.087 -178.933 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -127.98 -60.1 1.16 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.408 0.623 . . . . 3.82 110.57 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -83.76 -14.94 50.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.593 -1.185 . . . . 2.02 112.89 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.415 HD12 HG13 ' A' ' 79' ' ' VAL . 54.4 mt -99.21 4.87 46.84 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.325 -1.75 . . . . 1.39 108.695 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.485 1.279 0 O-C-N 125.505 1.753 . . . . 3.5 107.574 178.768 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 25.6 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.161 -0.681 . . . . 2.7 109.161 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -112.19 97.87 6.94 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.508 -0.923 . . . . 5.3 108.508 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -82.13 135.27 35.32 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.503 -1.226 . . . . 0.78 109.741 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -126.38 130.18 71.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.044 -1.465 . . . . 0.75 107.044 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -104.85 128.59 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.982 -1.488 . . . . 1.51 106.982 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.75 94.25 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.355 -1.35 . . . . 1.3 107.355 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.75 -164.44 11.81 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.716 -2.154 . . . . 1.0 107.716 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 ptm180 -143.16 137.61 29.18 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 117.837 -1.545 . . . . 5.45 111.787 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.445 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 61.6 m -53.02 125.05 15.95 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.224 -1.391 . . . . 4.45 108.424 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 -35.97 2.99 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.031 -1.557 . . . . 3.87 110.549 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 1.5 p -71.19 161.37 78.66 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 117.845 -1.542 . . . . 3.66 108.563 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -98.95 -57.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.504 1.469 . . . . 2.71 112.441 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -45.86 -32.14 2.48 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.955 0.724 . . . . 3.55 112.955 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -53.53 -31.39 46.1 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 118.004 -1.478 . . . . 2.42 110.728 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 -47.58 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.033 -0.667 . . . . 1.08 109.263 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.549 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -37.62 -48.64 1.05 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 124.554 1.159 . . . . 4.09 112.994 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.62 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.306 -1.358 . . . . 0.73 109.349 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 12.8 tmtt? -62.51 -53.0 61.26 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.414 -0.812 . . . . 2.21 111.45 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.549 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.9 OUTLIER -52.18 -48.72 64.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 118.292 -1.363 . . . . 3.29 109.657 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 -62.23 1.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.199 0.937 . . . . 0.73 110.87 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.87 -46.04 71.18 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.711 -1.195 . . . . 0.84 110.417 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 39.7 tt0 -48.46 -65.02 0.64 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.545 -0.752 . . . . 2.8 110.45 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 44.2 tttm -38.91 -60.43 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.148 0.905 . . . . 3.78 112.638 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.3 mt -35.06 -45.12 0.26 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.913 1.449 . . . . 1.42 114.913 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.6 p -49.09 -38.85 25.88 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 124.118 0.887 . . . . 3.03 110.505 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -102.64 23.71 11.6 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.644 -0.422 . . . . 3.0 110.236 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -130.3 -44.04 1.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.685 -0.806 . . . . 3.29 112.174 -178.895 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.607 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -107.3 -24.33 11.91 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.41 -1.316 . . . . 5.62 112.089 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 35.7 t70 84.23 -27.34 0.1 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 123.932 0.77 . . . . 4.96 111.809 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 10.5 p-10 -100.86 17.08 23.09 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 120.15 -0.62 . . . . 4.73 111.038 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CG ' ' HB3' ' A' ' 24' ' ' LEU . 72.3 t80 -112.71 119.18 37.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.842 -1.143 . . . . 1.13 112.097 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.31 148.39 43.23 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.212 -1.403 . . . . 2.8 107.212 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 29.9 p90 -149.17 157.69 43.58 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.001 -1.08 . . . . 1.32 110.833 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -136.3 156.97 47.89 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.072 -1.455 . . . . 3.75 107.072 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -108.22 144.64 35.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.74 -1.584 . . . . 1.26 109.033 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.23 129.88 65.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.353 -0.98 . . . . 0.66 108.353 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -108.83 115.99 31.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.268 -1.753 . . . . 2.48 106.268 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.2 -7.1 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 118.372 -1.331 . . . . 1.73 111.91 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -91.81 -9.75 42.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.815 -0.809 . . . . 4.94 108.815 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.08 -44.16 6.4 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.012 -1.477 . . . . 1.21 107.012 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -74.22 -41.5 61.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.143 -1.428 . . . . 2.92 107.143 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.79 55.33 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.937 -1.665 . . . . 1.32 108.937 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.29 154.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 120.163 -0.615 . . . . 1.33 110.1 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.4 151.63 34.34 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.376 -0.829 . . . . 2.33 109.251 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 56' ' ' VAL . 19.0 mtpp -55.68 -50.56 69.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.159 -1.416 . . . . 5.55 108.226 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -39.94 -63.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.526 1.141 . . . . 4.1 110.403 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -55.74 8.68 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.62 0.724 . . . . 5.11 111.3 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.87 -40.57 56.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.157 -0.929 . . . . 2.26 110.919 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 54' ' ' LYS . 10.9 mm100 -40.87 -40.99 1.49 Allowed 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 119.782 -0.767 . . . . 5.31 109.963 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.008 -0.996 . . . . 4.89 112.436 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.54 -29.8 22.4 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.385 1.254 . . . . 3.99 114.385 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -98.73 -32.76 11.22 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.62 -0.832 . . . . 3.06 112.273 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.15 51.24 46.02 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 120.157 -1.021 . . . . 3.92 112.422 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.04 -179.78 0.71 Allowed Pre-proline 0 N--CA 1.507 2.385 0 C-N-CA 119.407 -0.917 . . . . 8.24 109.591 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.79 170.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.264 1.976 . . . . 6.97 111.11 148.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 57' ' ' GLU . 35.1 m -89.92 -60.58 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.179 -1.408 . . . . 7.13 110.589 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -39.53 -69.66 0.12 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 124.506 1.129 . . . . 7.3 109.205 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -15.47 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.386 1.679 . . . . 5.54 113.929 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -144.63 158.26 53.89 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 106.551 -1.648 . . . . 3.37 106.551 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.2 Cg_endo -84.34 -163.27 2.97 Favored 'Cis proline' 0 N--CA 1.483 0.868 0 N-CA-C 109.26 -1.092 . . . . 1.84 109.26 -10.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HA ' HE21 ' A' ' 61' ' ' GLN . 1.2 mm100 -133.75 151.9 51.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.877 -1.529 . . . . 3.61 109.914 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.7 mp -119.71 145.8 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.939 -1.134 . . . . 1.13 107.939 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -133.47 128.63 35.83 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.72 -1.582 . . . . 1.12 107.152 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 65' ' ' ASP . 50.5 t -106.91 -166.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.402 -1.703 . . . . 2.03 106.402 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.841 ' H ' HG12 ' A' ' 64' ' ' VAL . 2.9 m-20 -46.47 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 123.711 1.719 . . . . 3.81 112.916 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' VAL . 81.1 mt-30 51.82 35.65 16.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 110.242 -3.163 . . . . 4.95 113.368 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -137.53 136.44 37.65 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.0 -0.68 . . . . 4.86 111.555 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.661 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -79.64 141.54 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 105.377 -2.082 . . . . 1.36 105.377 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 64' ' ' VAL . 11.2 mm -107.76 -50.59 7.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 C-N-CA 119.109 -1.036 . . . . 1.36 110.32 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.14 -140.57 9.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.2 -1.56 . . . . 1.66 109.2 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 62' ' ' ILE . . . -101.76 -54.62 0.92 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 120.407 -0.902 . . . . 2.61 112.297 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 15.3 t80 -159.05 -62.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.037 -1.465 . . . . 1.7 109.573 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -44.82 -40.43 6.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.606 1.669 . . . . 1.37 107.306 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.08 -53.97 50.49 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 111.579 -2.555 . . . . 2.62 109.988 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' HG21 ' A' ' 69' ' ' ILE . 19.0 t80 -61.87 -38.55 88.72 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 117.615 -1.634 . . . . 1.01 108.353 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.12 -54.63 32.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.724 -1.213 . . . . 1.03 107.724 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.59 -51.37 70.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.468 -0.893 . . . . 1.42 109.51 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 71.0 t90 -46.55 -48.1 19.54 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.756 -0.831 . . . . 2.14 108.756 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.28 -51.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -82.14 33.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.316 -0.954 . . . . 3.03 110.547 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -133.29 -49.48 0.85 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.657 0.741 . . . . 7.19 109.337 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -102.73 -15.64 16.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.31 -1.313 . . . . 2.55 111.72 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 29.9 mt -107.45 1.96 23.92 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 117.824 -1.551 . . . . 1.56 112.483 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 10.3 p-10 . . . . . 0 N--CA 1.503 2.217 0 C-N-CA 117.692 -1.603 . . . . 5.24 107.487 177.622 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.071 -1.455 . . . . 2.13 107.071 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.3 mp0 -110.05 105.31 14.39 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.905 -1.118 . . . . 4.09 110.131 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 m -87.85 146.2 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.83 -1.148 . . . . 0.84 111.24 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.6 t -120.5 136.57 57.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 0.72 107.075 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -113.72 108.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.511 -0.922 . . . . 1.4 108.511 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 61' ' ' GLN . 48.7 m-85 -94.5 103.9 15.86 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.752 -0.833 . . . . 0.89 108.752 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.21 -161.54 10.87 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 107.893 -2.083 . . . . 1.25 107.893 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.718 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.82 31.2 5.53 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.164 -1.415 . . . . 4.97 112.869 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.613 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.1 m 67.55 174.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.13 -0.941 . . . . 3.52 109.948 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 13.47 51.78 0.01 OUTLIER Glycine 0 N--CA 1.511 3.648 0 N-CA-C 116.0 1.16 . . . . 2.75 116.0 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.718 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -130.7 101.85 16.81 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.682 -1.229 . . . . 2.16 107.682 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -41.4 -47.02 5.76 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.751 1.634 . . . . 3.4 110.644 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB ' ' A' ' 59' ' ' VAL . 6.1 t80 -57.12 -44.7 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.147 -1.021 . . . . 2.61 109.423 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.76 -51.19 69.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.735 -1.209 . . . . 1.8 107.735 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' LYS . 96.6 t -43.7 -48.81 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 114.516 -1.22 . . . . 1.03 111.122 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' C ' ' HE2' ' A' ' 72' ' ' TYR . 18.7 mtm180 -35.82 -39.23 0.15 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 120.057 -0.657 . . . . 7.42 112.042 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.22 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.917 -0.771 . . . . 0.89 108.917 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 8.5 tmtt? -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.675 -1.232 . . . . 2.74 107.675 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASP . . . . . 0.567 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 60.7 m-20 -58.13 -54.65 44.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.394 -0.922 . . . . 3.14 109.377 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.15 -59.25 4.9 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.604 -1.238 . . . . 0.77 110.31 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -53.26 -44.56 68.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.886 -0.726 . . . . 0.67 110.56 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.8 tt0 -55.7 -57.05 13.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.272 0.983 . . . . 2.94 109.666 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.93 -54.34 47.77 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.747 -0.66 . . . . 4.22 111.202 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 28' ' ' ARG . 79.7 mt -48.35 -57.27 6.27 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.584 -0.846 . . . . 1.61 111.678 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -35.0 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 114.039 1.125 . . . . 1.38 114.039 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 24' ' ' LEU . 7.0 t-20 -104.1 -50.25 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.932 -0.766 . . . . 4.1 108.932 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.37 40.52 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.837 -1.074 . . . . 4.07 111.258 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.486 HH12 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -147.76 -150.43 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.944 -1.102 . . . . 5.03 112.196 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 4.1 m-20 -111.82 -127.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.008 -0.996 . . . . 6.78 110.188 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.4 67.21 5.08 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.662 -1.236 . . . . 3.85 107.662 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -112.59 114.56 27.26 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.918 -1.037 . . . . 0.9 111.565 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -120.22 158.83 26.17 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.773 -1.936 . . . . 3.39 105.773 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 16.3 p90 -160.58 152.79 20.35 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 117.804 -1.559 . . . . 1.2 112.932 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -131.07 164.06 26.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.459 -1.246 . . . . 4.09 108.347 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -113.14 143.2 44.77 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.767 -1.197 . . . . 1.18 107.767 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -132.83 143.85 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.381 -0.97 . . . . 0.66 108.381 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.95 129.66 55.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.258 0.551 . . . . 2.16 109.805 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -58.45 -24.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.192 -1.003 . . . . 1.33 110.933 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.611 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.23 -34.17 25.92 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.955 -1.098 . . . . 4.44 109.645 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.51 -45.18 88.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.824 -0.625 . . . . 1.19 110.193 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 43' ' ' ILE . 8.2 mm-40 -86.34 -43.66 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.091 -1.043 . . . . 2.93 110.075 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.76 54.66 0.72 Allowed Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.736 -1.745 . . . . 1.56 108.736 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 41' ' ' GLU . 6.5 mt -115.74 158.5 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.91 -0.645 . . . . 1.51 110.399 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.4 p -117.6 171.09 8.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.022 -0.733 . . . . 2.63 109.022 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 7.9 tmtm? -69.37 -43.08 74.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.885 -1.526 . . . . 7.01 108.699 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -56.15 -51.07 69.32 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.072 -0.714 . . . . 3.83 109.072 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.44 -51.56 62.25 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.92 -1.112 . . . . 3.05 109.098 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ALA . 55.7 mt -52.97 -51.67 60.72 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.44 -1.304 . . . . 1.59 107.682 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.1 tm0? -46.16 -48.14 17.49 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.935 0.772 . . . . 4.56 109.894 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -59.95 -40.6 89.56 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.641 0.734 . . . . 6.38 109.034 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.786 -1.097 . . . . 4.41 111.525 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -94.19 -50.17 5.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.504 0.557 . . . . 1.88 112.504 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.5 15.02 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.703 -1.237 . . . . 2.72 111.545 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 19.3 ptmt -110.8 74.35 0.93 Allowed Pre-proline 0 N--CA 1.5 2.07 0 C-N-CA 120.28 -0.568 . . . . 6.39 111.367 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.0 140.23 40.0 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.581 1.521 . . . . 4.15 111.616 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.8 t 76.18 60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.394 1.058 . . . . 5.6 110.202 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -110.22 -176.04 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.621 -1.172 . . . . 5.93 108.057 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.548 ' CG2' ' H ' ' A' ' 72' ' ' TYR . 12.2 t -100.93 -161.84 0.89 Allowed 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.283 -1.367 . . . . 7.97 108.357 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' A' ' 13' ' ' TYR . 74.3 t -105.9 162.82 18.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 121.506 0.669 . . . . 4.63 110.325 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.56 -166.47 5.16 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 124.336 -1.11 . . . . 3.19 109.293 -29.576 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.32 119.0 34.02 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.878 -1.527 . . . . 2.93 106.878 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.46 134.01 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.806 -1.158 . . . . 1.52 109.324 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 68' ' ' HIS . 2.8 m-85 -118.14 114.14 22.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 105.35 -2.093 . . . . 1.76 105.35 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.603 HG23 HG13 ' A' ' 69' ' ' ILE . 53.2 t -96.86 110.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 117.188 -1.805 . . . . 1.31 111.19 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t70 61.32 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.594 0.961 . . . . 2.51 113.594 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' VAL . 11.8 mm-40 -130.53 -18.56 3.15 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.117 1.155 . . . . 4.46 114.117 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.46 156.7 19.16 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.741 -1.184 . . . . 4.83 111.285 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 80.0 t60 -87.53 141.36 28.68 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.803 -1.159 . . . . 1.76 109.71 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -114.18 -54.85 4.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.005 -1.48 . . . . 1.51 107.005 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 58.65 123.22 0.01 OUTLIER Glycine 0 N--CA 1.501 3.003 0 O-C-N 124.493 1.121 . . . . 2.4 113.6 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' A' ' 58' ' ' THR . . . 104.23 141.12 10.89 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.875 -1.155 . . . . 1.54 112.57 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' H ' ' CG2' ' A' ' 58' ' ' THR . 20.2 t80 -82.97 -54.5 5.02 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.458 -0.897 . . . . 1.89 109.211 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -67.65 1.82 2.22 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.162 -1.015 . . . . 1.8 108.939 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 72' ' ' TYR . 15.2 t70 -100.53 -63.6 1.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.927 -1.508 . . . . 3.1 106.927 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -55.58 -45.61 77.35 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.257 -0.883 . . . . 0.78 108.936 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.92 -38.61 10.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.109 -0.496 . . . . 0.88 110.39 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -81.05 -50.77 9.25 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.6 -1.259 . . . . 0.97 107.6 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' TRP . . . . . 0.602 ' CH2' HG11 ' A' ' 64' ' ' VAL . 76.6 t90 -38.62 -53.23 1.62 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.125 0.89 . . . . 1.35 108.712 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 83' ' ' LEU . 75.6 t -44.02 -46.42 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.324 -1.307 . . . . 1.13 110.505 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HZ3' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -73.28 -58.57 3.22 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.914 -0.714 . . . . 3.61 111.707 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -57.4 -24.69 56.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.122 0.786 . . . . 3.74 113.122 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -101.02 -34.26 9.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.355 1.243 . . . . 1.95 114.355 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 79' ' ' VAL . 36.8 mt -96.04 -11.63 26.12 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.328 -1.349 . . . . 1.77 111.677 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ASP . . . . . 0.486 ' CG ' HH12 ' A' ' 28' ' ' ARG . 36.3 m-20 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 124.287 0.992 . . . . 3.74 109.967 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.9 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.929 -0.767 . . . . 2.95 108.929 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.514 ' HG3' HE21 ' A' ' 32' ' ' GLN . 5.0 mp0 -110.11 98.18 7.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.723 -1.584 . . . . 3.94 106.723 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 33' ' ' TYR . 86.6 m -82.17 141.3 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.383 -0.927 . . . . 0.79 111.939 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -133.86 138.78 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.569 -0.741 . . . . 0.63 110.096 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.79 123.28 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 105.28 -2.119 . . . . 1.54 105.28 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' CD2' HG11 ' A' ' 36' ' ' VAL . 58.2 m-85 -104.07 78.45 1.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.048 -1.093 . . . . 1.17 108.048 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.6 -151.06 9.49 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.514 -1.327 . . . . 1.0 110.739 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ARG . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' SER . 2.7 tmm_? -119.47 -178.32 3.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.343 -0.984 . . . . 5.35 108.343 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.647 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.44 59.45 0.29 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.037 0.384 . . . . 3.6 112.037 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.3 71.26 0.84 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.159 -1.496 . . . . 2.89 112.197 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -129.21 149.82 73.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.925 -0.71 . . . . 2.14 109.687 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.48 -65.67 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.303 2.002 . . . . 3.89 113.206 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -78.01 15.86 0.83 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 119.104 -1.038 . . . . 3.69 112.897 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 36.1 m -107.16 -48.78 3.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.624 -1.621 . . . . 2.12 106.624 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 17' ' ' ALA . 50.1 t -73.96 -38.3 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.947 -1.479 . . . . 1.08 108.529 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -80.09 38.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.174 0.987 . . . . 3.77 109.391 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -142.21 -49.56 0.37 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.073 -1.825 . . . . 1.33 106.073 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' LYS . . . . . 0.697 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 50.9 tttm -57.59 -38.88 75.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.904 -1.498 . . . . 3.46 110.081 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -43.55 -47.42 7.34 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.376 0.608 . . . . 4.65 110.448 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.24 -42.85 96.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.409 -0.814 . . . . 1.51 110.156 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -63.65 -57.91 8.58 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.332 -0.947 . . . . 0.73 109.251 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.697 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 47.8 mt-10 -51.44 -51.56 53.86 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.805 0.812 . . . . 3.53 109.262 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -53.96 -59.21 4.93 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.937 -1.029 . . . . 4.24 109.928 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 24' ' ' LEU . 7.4 mt -51.79 -53.17 42.97 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.528 -1.269 . . . . 1.93 110.888 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -52.99 -32.12 44.63 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.061 -1.056 . . . . 1.61 111.76 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -83.37 -37.18 23.67 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.887 -0.725 . . . . 3.3 111.059 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -74.39 -40.06 62.31 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 122.071 0.939 . . . . 2.9 110.336 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.607 HH21 ' CG ' ' A' ' 30' ' ' ASP . 9.1 mmm180 -99.62 179.3 4.59 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.113 -1.403 . . . . 6.92 111.418 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' CZ ' ' A' ' 28' ' ' ARG . 2.0 p30 -122.3 -12.79 8.2 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.772 -1.104 . . . . 3.79 110.843 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' HH21 ' A' ' 28' ' ' ARG . 14.5 p30 -103.63 -46.14 4.62 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.7 1.0 . . . . 4.52 113.7 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -48.39 110.39 0.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 113.502 0.927 . . . . 0.83 113.502 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.514 HE21 ' HG3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -103.35 156.16 17.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.493 -0.929 . . . . 5.29 108.493 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 1.6 p90 -164.09 156.74 17.44 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.489 -0.884 . . . . 1.24 111.218 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -139.23 152.44 47.32 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.606 -1.179 . . . . 3.12 108.772 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 53.3 t80 -107.47 138.6 43.38 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.145 -1.422 . . . . 1.05 107.593 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -124.59 143.52 37.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 124.204 0.94 . . . . 0.66 108.7 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -117.23 118.33 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.853 -1.536 . . . . 2.47 106.853 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -53.09 -19.27 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.654 -0.818 . . . . 1.28 110.985 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.77 -37.89 55.08 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.593 0.558 . . . . 5.65 111.445 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 -43.43 55.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.908 -0.717 . . . . 1.32 109.298 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.27 -43.22 52.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.169 -0.923 . . . . 3.36 109.33 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.06 60.29 1.13 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.305 -1.918 . . . . 1.41 108.305 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 44' ' ' THR . 30.3 mm -114.52 160.75 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 C-N-CA 119.458 -0.897 . . . . 2.83 112.346 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -121.33 151.29 40.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.63 -1.168 . . . . 2.51 109.772 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 46' ' ' GLU . 4.1 ttpt -56.69 -46.61 81.09 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.656 -1.218 . . . . 4.82 109.746 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 23.8 mm-40 -45.06 -56.85 4.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.284 -0.566 . . . . 4.34 110.159 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.56 -56.34 22.57 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.825 0.821 . . . . 4.37 110.281 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' HB3' ' CD ' ' A' ' 61' ' ' GLN . 21.7 mt -46.97 -46.85 21.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.112 -0.949 . . . . 1.62 110.39 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 25.8 tt0 -52.56 -50.32 63.18 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.72 -1.127 . . . . 3.62 109.561 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -52.45 -32.17 38.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.878 0.847 . . . . 5.62 110.301 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' LYS . . . . . 0.771 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.98 19.46 17.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.294 -1.321 . . . . 4.03 111.139 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -113.15 -41.08 3.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.826 0.703 . . . . 1.83 110.569 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.02 -55.4 0.51 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.45 -1.86 . . . . 2.44 108.45 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 55' ' ' PRO . 31.3 tttm -92.03 151.98 42.38 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.574 -1.269 . . . . 7.37 107.574 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 30.3 Cg_exo -61.23 75.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.543 1.495 . . . . 4.65 110.684 158.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.38 82.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.032 0.92 . . . . 6.48 108.527 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -50.3 -31.66 14.96 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.082 -1.417 . . . . 5.5 111.57 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 59' ' ' VAL . 99.9 m -94.61 169.05 10.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.682 -0.69 . . . . 5.16 110.763 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -116.4 166.0 13.65 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.454 -1.313 . . . . 2.78 107.454 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 76.6 Cg_endo -92.86 -151.08 0.33 Allowed 'Cis proline' 0 C--N 1.312 -1.355 0 N-CA-C 109.592 -0.965 . . . . 2.61 109.592 -17.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.457 ' CD ' ' HB3' ' A' ' 48' ' ' LEU . 24.9 mt-30 -123.66 154.48 39.3 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.499 -0.926 . . . . 4.3 108.499 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ILE . . . . . 0.485 HD11 ' HB1' ' A' ' 17' ' ' ALA . 38.7 mt -128.04 142.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.269 -1.332 . . . . 1.2 107.926 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.2 122.58 21.82 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.377 -1.342 . . . . 0.97 107.377 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 3' ' ' THR . 60.4 t -106.71 97.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 117.77 -1.572 . . . . 1.71 109.424 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 1' ' ' MET . 17.5 t0 80.49 -64.82 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.869 -1.059 . . . . 2.51 113.011 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -140.92 -29.65 0.66 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.258 1.947 . . . . 5.78 116.258 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -100.01 -174.96 2.82 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.938 -1.105 . . . . 5.31 111.736 -178.728 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.9 t-160 -103.41 138.66 39.84 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.779 -1.193 . . . . 1.57 107.779 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ILE . . . . . 0.454 HG13 HG23 ' A' ' 64' ' ' VAL . 25.2 mm -122.85 -40.73 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 124.061 0.851 . . . . 2.1 109.872 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.02 -176.15 0.18 Allowed Glycine 0 N--CA 1.509 3.522 0 CA-C-O 122.085 0.825 . . . . 2.86 115.153 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.02 -160.39 0.01 OUTLIER Glycine 0 N--CA 1.508 3.437 0 CA-C-N 113.857 -1.172 . . . . 1.86 113.89 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 16' ' ' ARG . 33.4 t80 -121.51 -58.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.121 -1.066 . . . . 1.92 108.121 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 p -39.46 -47.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.246 1.022 . . . . 1.8 110.061 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -63.04 1.2 Allowed 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 112.535 -2.12 . . . . 3.25 108.67 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.3 -49.51 9.39 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 119.231 -0.988 . . . . 1.23 109.988 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.08 -65.76 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.68 -1.145 . . . . 1.2 111.813 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.95 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.875 -0.787 . . . . 1.3 108.875 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -44.95 -56.28 4.73 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.65 -1.159 . . . . 1.46 109.502 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 83' ' ' LEU . 3.1 t -47.93 -60.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.944 -1.132 . . . . 1.33 107.944 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -47.05 -46.75 22.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.3 1.0 . . . . 3.16 111.095 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.11 21.05 8.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.243 1.201 . . . . 5.21 114.243 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -130.33 -32.96 1.73 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.866 -0.733 . . . . 2.15 109.835 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 HG13 ' A' ' 79' ' ' VAL . 27.1 mt -96.21 32.62 1.91 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.349 -1.34 . . . . 2.01 111.786 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 108.969 -0.752 . . . . 5.32 108.969 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' ASP . 74.9 mtp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 107.961 -1.125 . . . . 2.17 107.961 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 42.7 tp60 -123.64 146.96 47.81 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.745 0.653 . . . . 4.88 110.365 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -128.56 154.54 46.07 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.088 -1.045 . . . . 1.02 109.159 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -134.19 128.72 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.648 -1.241 . . . . 0.74 107.648 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mt -111.35 120.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.107 -1.071 . . . . 2.73 108.107 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.91 74.26 1.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.882 -1.155 . . . . 0.96 107.882 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -147.03 -173.15 17.99 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.114 -1.517 . . . . 2.2 109.724 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 18.4 mtp-105 -123.11 154.7 38.26 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.045 -1.062 . . . . 6.27 109.631 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -72.23 77.0 0.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.438 -0.905 . . . . 5.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.35 21.5 0.17 Allowed Glycine 0 N--CA 1.502 3.045 0 C-N-CA 119.388 -1.387 . . . . 3.01 113.101 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -121.99 80.57 42.64 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.048 -0.723 . . . . 3.1 109.048 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -18.73 -69.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 124.194 3.262 . . . . 3.18 114.285 -143.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' CD ' ' A' ' 60' ' ' PRO . 3.8 m-30 -34.2 -45.04 0.2 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 123.363 0.414 . . . . 3.71 112.096 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 57.7 m -52.35 -55.94 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.972 -1.013 . . . . 2.03 109.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.25 -45.78 88.99 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 CA-C-N 114.109 -1.405 . . . . 1.1 108.101 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.7 mmp_? -55.84 -51.83 66.15 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.666 -0.814 . . . . 3.71 112.255 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.17 -50.07 65.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.089 -1.448 . . . . 0.82 107.089 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 3.0 tmtm? -53.88 -55.12 29.72 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.981 -1.009 . . . . 1.92 109.315 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.575 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.9 m-20 -47.8 -56.86 6.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.18 0.514 . . . . 2.9 109.617 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD23 ' CD2' ' A' ' 75' ' ' PHE . 29.8 tp -55.35 -57.13 13.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.989 -1.005 . . . . 0.92 111.472 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -54.39 44.64 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.903 . . . . 0.65 109.579 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 12.5 tt0 -47.59 -47.56 28.53 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.515 -0.92 . . . . 2.26 108.515 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -53.3 -64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.179 0.925 . . . . 4.71 110.5 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -38.55 -47.0 1.25 Allowed 'General case' 0 N--CA 1.506 2.348 0 O-C-N 123.92 0.763 . . . . 1.16 112.835 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -39.06 -36.0 0.26 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.335 0.865 . . . . 1.35 113.335 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -97.66 12.6 33.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.046 1.128 . . . . 2.42 114.046 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 19.3 mt-10 -131.9 -30.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 123.87 0.732 . . . . 3.22 110.942 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -99.12 -24.15 14.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.954 0.724 . . . . 3.92 112.954 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.04 -62.59 0.42 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.071 0.857 . . . . 4.7 110.565 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 1' ' ' MET . 10.6 t70 -82.45 55.85 3.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.814 -1.55 . . . . 3.43 106.814 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -140.83 91.94 2.46 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.225 -0.898 . . . . 1.09 109.968 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 13.6 mm-40 -110.02 128.24 55.29 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.985 -1.487 . . . . 4.52 106.985 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -111.14 160.56 16.8 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.096 -1.041 . . . . 1.41 110.594 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -123.97 146.64 48.36 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.372 -1.344 . . . . 2.84 107.372 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -102.09 132.11 48.16 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.993 -1.083 . . . . 2.3 108.378 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 135.27 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.335 -1.357 . . . . 0.65 107.335 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 34.3 t0 -110.44 111.39 22.62 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 122.23 1.014 . . . . 1.73 109.905 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 pt -48.7 -32.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.25 -1.341 . . . . 2.04 114.035 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 2.7 mmp_? -101.46 19.32 18.09 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.699 -0.8 . . . . 9.02 111.714 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -122.73 -43.68 2.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.682 -1.229 . . . . 1.6 107.682 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.52 -45.32 46.54 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.375 -1.738 . . . . 2.87 110.429 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.59 63.49 0.34 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.746 -1.216 . . . . 1.68 112.693 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 47' ' ' ASP . 55.2 mt -111.6 145.6 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.769 -0.772 . . . . 1.78 109.289 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -116.93 -97.56 0.46 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.939 -0.704 . . . . 2.46 110.203 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HZ2' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -137.6 -50.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.78 -1.933 . . . . 7.8 105.78 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.572 ' CD ' ' HZ2' ' A' ' 45' ' ' LYS . 3.8 mp0 -51.29 -50.17 59.83 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 113.679 -1.601 . . . . 4.81 108.894 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 43' ' ' ILE . 23.8 m-20 -46.44 -64.34 0.78 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.102 0.953 . . . . 3.59 109.329 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 54' ' ' LYS . 81.1 mt -49.93 -50.94 44.65 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.21 -1.359 . . . . 2.25 110.044 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -56.15 -36.55 68.42 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.168 -1.413 . . . . 4.66 110.749 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.63 -39.43 57.83 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.278 0.561 . . . . 6.68 112.064 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 1.7 ttpp -87.37 -28.79 21.98 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 114.575 1.324 . . . . 4.77 114.575 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -118.19 -35.7 3.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.838 0.711 . . . . 1.89 112.689 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.9 -44.57 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.075 -2.81 . . . . 3.87 106.075 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' NZ ' ' HG3' ' A' ' 57' ' ' GLU . 9.1 tttp 53.21 102.77 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 113.297 -1.451 . . . . 9.82 112.656 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -51.07 179.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.214 1.943 . . . . 5.22 110.327 143.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.95 59.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.571 -1.252 . . . . 5.9 110.358 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 15.6 pt-20 -103.51 178.81 4.45 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.654 -1.612 . . . . 5.66 107.549 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -116.42 -106.32 0.39 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.356 -1.338 . . . . 6.1 109.193 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.29 154.64 78.84 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 123.964 0.79 . . . . 3.66 109.83 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 48.6 Cg_endo -96.74 -164.95 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.507 0.741 . . . . 2.0 110.452 -1.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -147.78 163.74 35.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.19 0.931 . . . . 2.65 108.64 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.1 mp -121.32 151.18 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 122.302 1.048 . . . . 1.01 111.787 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.642 ' CZ ' ' HE3' ' A' ' 51' ' ' LYS . 9.4 m-85 -133.31 130.94 39.56 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.764 -2.016 . . . . 1.24 108.726 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 69' ' ' ILE . 66.8 t -121.62 129.77 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.778 -1.564 . . . . 0.98 106.778 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 5.1 m-20 51.47 25.32 2.61 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.698 1.237 . . . . 2.77 112.276 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 2.4 mm100 79.49 -6.36 1.83 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 112.216 -2.266 . . . . 7.24 114.559 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.84 154.96 23.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.963 -1.865 . . . . 4.35 105.963 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 17.3 t-160 -83.16 147.52 28.01 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 117.469 -1.692 . . . . 1.26 109.492 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 64' ' ' VAL . 16.8 mm -116.63 -35.7 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 124.294 0.996 . . . . 0.92 109.154 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.16 -139.76 9.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.754 -1.212 . . . . 1.94 110.301 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.15 -65.75 0.85 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.577 -1.009 . . . . 2.8 110.577 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 66.5 t80 -157.75 -53.78 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.26 -1.376 . . . . 1.81 110.677 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -46.68 -47.62 20.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.356 -1.35 . . . . 1.55 107.356 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.44 -59.36 4.68 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.25 -1.795 . . . . 3.27 109.602 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.591 ' CD1' HG21 ' A' ' 62' ' ' ILE . 38.6 t80 -51.78 -47.64 64.1 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.442 -0.903 . . . . 0.85 109.224 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -59.37 4.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.315 -0.954 . . . . 1.04 109.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.31 -0.859 . . . . 1.04 109.564 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -40.49 -48.89 2.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.006 0.816 . . . . 1.14 110.13 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 80' ' ' LYS . 9.9 t -60.5 -59.2 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.328 -0.99 . . . . 1.23 108.328 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -41.27 -49.65 3.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.882 -1.054 . . . . 3.49 109.925 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.96 -55.68 7.84 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 116.41 2.004 . . . . 3.81 116.41 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -83.54 -20.11 34.46 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 113.948 1.092 . . . . 1.75 113.948 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.69 -37.31 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 117.997 -1.481 . . . . 2.28 113.24 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 63.5 m-20 -118.96 20.31 12.79 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.071 -1.452 . . . . 5.8 112.738 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.507 2.418 0 CA-C-O 115.991 -1.957 . . . . 6.91 111.663 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 30' ' ' ASP . 36.5 mtm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.0 -1.481 . . . . 2.42 107.0 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -124.57 143.37 50.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.733 -0.787 . . . . 4.65 110.008 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 61.4 m -125.19 145.11 50.12 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.08 -1.048 . . . . 0.68 113.282 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.8 136.79 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.949 -1.13 . . . . 0.58 107.949 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -118.09 122.03 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 124.226 0.954 . . . . 2.29 109.727 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -93.66 87.21 5.41 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.618 -1.253 . . . . 1.1 107.618 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.89 -164.29 14.51 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.529 -1.428 . . . . 0.97 109.529 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.692 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -128.11 -158.7 0.89 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 117.98 0.89 . . . . 5.63 109.655 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.496 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -101.91 61.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.66 -0.867 . . . . 3.81 108.66 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.67 92.32 2.26 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.048 -2.021 . . . . 2.82 108.048 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -155.27 63.63 3.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 120.311 -0.556 . . . . 2.35 110.224 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -20.42 -55.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 124.044 3.162 . . . . 2.35 114.001 -145.826 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' CYS . 4.3 m-85 -42.69 -44.94 4.52 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.246 -0.582 . . . . 4.63 111.668 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -57.14 -46.12 82.97 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.538 -0.865 . . . . 2.4 111.046 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.0 t -55.8 -43.17 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 115.643 -0.708 . . . . 0.81 110.916 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.682 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -47.27 -48.98 24.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.645 -1.222 . . . . 3.67 112.583 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.07 -45.91 68.35 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.128 -1.029 . . . . 0.67 108.864 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -58.5 -50.81 72.41 Favored 'General case' 0 C--O 1.2 -1.512 0 C-N-CA 119.277 -0.969 . . . . 2.46 108.404 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 18' ' ' LYS . 66.1 m-20 -49.67 -48.4 49.54 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.447 -1.301 . . . . 2.98 110.055 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.14 -65.84 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.396 -1.322 . . . . 0.8 110.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -51.94 8.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.788 0.804 . . . . 0.81 110.713 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.05 -52.48 65.58 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.588 -1.187 . . . . 2.31 107.906 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 tmtm? -43.7 -36.43 2.21 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 115.531 -0.759 . . . . 3.79 110.515 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 79' ' ' VAL . 11.4 mt -78.32 -44.82 24.24 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.146 -0.934 . . . . 1.38 110.438 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 27' ' ' GLU . 74.4 m -50.25 -42.31 51.78 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 118.938 -1.105 . . . . 1.37 109.387 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 23' ' ' LYS . 3.2 p-10 -80.73 28.31 0.34 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.033 -1.467 . . . . 4.75 111.335 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.6 mt-10 -127.68 -64.85 0.95 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.611 -1.177 . . . . 4.21 110.58 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.488 HH22 ' C ' ' A' ' 85' ' ' ALA . 14.7 mtt180 -119.21 150.29 40.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.54 -0.864 . . . . 4.15 109.655 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.34 -25.81 60.77 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.647 -0.872 . . . . 5.58 108.647 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.5 t70 -74.54 -8.76 57.37 Favored 'General case' 0 C--O 1.202 -1.442 0 C-N-CA 119.065 -1.054 . . . . 3.31 111.711 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -106.78 97.19 7.01 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.76 -1.976 . . . . 1.14 111.151 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -113.75 160.13 19.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.868 -1.16 . . . . 3.51 107.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' THR . 21.5 p90 -147.92 165.18 31.47 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.51 -0.876 . . . . 0.99 108.929 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -131.05 136.53 48.53 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.225 -1.398 . . . . 3.59 107.225 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.29 140.76 29.16 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.236 -1.786 . . . . 1.2 107.659 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.78 137.38 54.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.528 -0.915 . . . . 0.63 108.528 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -111.77 121.71 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.493 -1.299 . . . . 2.41 107.493 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -44.81 -31.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.701 1.0 . . . . 1.53 113.701 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 17.77 15.36 Favored 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 118.14 -1.424 . . . . 5.54 111.972 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.86 -41.85 5.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.245 -1.761 . . . . 1.58 106.245 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -82.98 -39.66 21.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.726 -1.579 . . . . 3.47 108.952 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 50.29 0.65 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.295 -1.522 . . . . 1.46 109.295 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.61 160.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.676 -0.762 . . . . 1.9 111.129 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.6 p -112.74 -158.14 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.606 -1.179 . . . . 3.01 110.844 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 3.8 ttpp -114.15 12.8 17.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 106.486 -1.672 . . . . 5.43 106.486 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -119.11 -50.08 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.645 -1.161 . . . . 4.78 109.625 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -57.89 -45.4 86.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.907 -1.146 . . . . 3.83 107.907 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 48' ' ' LEU . 23.0 mt -42.23 -47.88 4.8 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 115.207 -0.906 . . . . 2.8 110.468 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 1.3 tm0? -46.78 -49.17 20.26 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.617 -0.882 . . . . 4.5 108.617 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -73.86 -40.54 63.18 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.902 -1.044 . . . . 7.16 110.98 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -53.92 -47.71 70.94 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.503 -0.555 . . . . 4.91 109.503 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -76.29 -49.68 16.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.21 -0.905 . . . . 2.59 109.998 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.41 16.33 55.53 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.238 -1.458 . . . . 3.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 6.4 ttmt -120.26 77.42 25.45 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.602 -0.888 . . . . 6.04 108.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 20.5 Cg_endo -80.85 22.66 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.632 1.555 . . . . 4.2 112.503 -127.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.24 -12.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.56 -1.2 . . . . 5.96 111.767 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 11.6 pt-20 -86.77 174.85 8.55 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 118.748 -1.181 . . . . 6.13 112.691 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 p -131.45 -80.07 0.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.072 -0.967 . . . . 4.93 110.698 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 22.4 t -119.82 151.82 52.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 3.5 109.451 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 45.4 Cg_endo -87.64 168.53 40.48 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.814 -0.911 . . . . 2.46 111.04 -18.391 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.441 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 87.2 mt-30 -131.42 117.56 19.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 105.478 -2.045 . . . . 2.77 105.478 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.0 mp -113.25 141.98 27.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.916 -1.038 . . . . 1.09 108.894 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 4.4 m-85 -120.06 138.23 53.66 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.778 -2.01 . . . . 1.31 108.756 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.443 ' CG2' HG13 ' A' ' 69' ' ' ILE . 74.8 t -116.79 130.07 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.064 -1.054 . . . . 1.22 108.63 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 54.09 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 112.607 -2.088 . . . . 3.29 113.383 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 64' ' ' VAL . 72.7 mt-30 -131.22 -31.3 1.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.164 1.542 . . . . 4.57 115.164 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -117.56 171.95 7.67 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.003 1.112 . . . . 3.46 114.003 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.3 t-80 -73.44 147.64 43.99 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 105.603 -1.999 . . . . 1.84 105.603 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG13 ' CG2' ' A' ' 64' ' ' VAL . 46.2 mm -122.29 -29.39 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.649 -1.22 . . . . 1.52 108.852 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.44 -171.55 34.7 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.069 -1.062 . . . . 2.13 111.337 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 73' ' ' THR . . . -105.12 -149.53 19.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.219 -2.353 . . . . 1.56 107.219 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.53 42.79 0.53 Allowed 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 117.651 -1.62 . . . . 2.97 109.467 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 71' ' ' GLY . 11.7 p -144.62 -69.06 0.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.826 -1.079 . . . . 1.82 109.726 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -54.09 8.88 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.873 -1.058 . . . . 2.99 108.403 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 62' ' ' ILE . 22.5 t80 -52.87 -56.87 12.65 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 104.959 -2.237 . . . . 1.67 104.959 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -38.65 -52.84 1.65 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.688 -1.142 . . . . 1.53 110.232 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -63.54 -58.37 7.2 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.316 -0.954 . . . . 1.14 110.056 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' ALA . 61.5 t90 -40.93 -51.01 3.27 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 119.243 -0.983 . . . . 1.47 109.145 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' A' ' 24' ' ' LEU . 71.0 t -43.13 -58.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.124 -1.065 . . . . 1.38 108.124 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -51.61 -60.9 2.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.876 -1.056 . . . . 2.76 111.655 -179.302 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 80' ' ' LYS . 8.5 mp0 -59.03 -33.1 70.37 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.239 1.94 . . . . 3.88 116.239 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -98.99 -23.38 15.32 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 117.809 -1.556 . . . . 1.77 113.066 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' ALA . 15.3 mt -83.72 -53.59 5.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.023 -2.214 . . . . 1.35 105.023 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 83' ' ' LEU . 4.6 m-20 18.82 -76.67 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 124.858 1.349 . . . . 5.1 113.552 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . . . . . . 0 N--CA 1.505 2.278 0 CA-C-N 111.337 -2.665 . . . . 8.6 112.106 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 tpp . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.434 -1.321 . . . . 2.37 107.434 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 23.9 mp0 -131.97 132.92 43.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.765 0.666 . . . . 4.29 110.317 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m -121.64 142.79 49.78 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 119.623 -0.831 . . . . 0.74 110.939 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.47 127.35 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 108.42 -0.956 . . . . 1.02 108.42 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.32 109.44 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 124.84 1.337 . . . . 1.81 108.582 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 98.3 m-85 -87.87 100.05 12.58 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.111 -1.07 . . . . 1.35 108.111 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.8 -166.93 13.69 Favored Glycine 0 N--CA 1.501 3.015 0 N-CA-C 109.114 -1.594 . . . . 0.99 109.114 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.697 ' CG ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 ptm180 -119.24 37.27 4.19 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.257 -1.377 . . . . 5.61 112.088 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 50.5 m 83.47 51.71 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 116.094 1.887 . . . . 3.53 116.094 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.77 67.34 1.49 Allowed Glycine 0 N--CA 1.505 3.246 0 C-N-CA 119.069 -1.539 . . . . 3.78 114.1 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.697 ' SG ' ' CG ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -111.42 159.07 34.41 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.339 -0.944 . . . . 2.38 109.886 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 81.2 Cg_exo -40.31 144.24 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.438 1.426 . . . . 3.66 110.015 157.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER 77.11 -59.46 0.48 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 107.568 -1.271 . . . . 3.27 107.568 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 33.4 m -53.78 -47.16 71.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.4 -0.818 . . . . 1.73 110.029 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 11' ' ' CYS . 86.1 t -49.12 -41.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.856 -1.138 . . . . 1.61 108.033 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -74.58 82.82 2.02 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.657 -1.238 . . . . 4.41 107.657 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 173.36 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.291 -2.231 . . . . 1.01 105.471 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 33' ' ' TYR . 5.9 tmtm? -69.17 -47.18 65.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.964 -1.495 . . . . 2.72 106.964 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -55.29 -37.39 67.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.775 -0.824 . . . . 3.41 108.775 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.02 -58.97 3.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.301 -1.36 . . . . 1.18 108.563 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -40.14 -54.55 2.28 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.511 -0.876 . . . . 1.02 110.918 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 3.8 mm-40 -38.77 -41.86 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.852 0.834 . . . . 2.81 112.735 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.51 -54.63 11.42 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.013 -0.994 . . . . 4.62 109.502 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.555 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 49.3 mt -49.99 -46.25 52.47 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.54 -1.209 . . . . 1.36 108.15 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 m -58.02 -28.7 64.69 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.252 0.97 . . . . 1.35 112.667 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -102.2 -17.26 16.04 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.265 -0.574 . . . . 4.14 111.761 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 34.1 mt-10 -87.93 -45.23 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.253 -0.579 . . . . 3.13 110.537 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 83' ' ' LEU . 2.0 mpt_? -104.69 -17.09 14.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.867 -0.733 . . . . 5.55 111.486 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.59 -51.32 0.62 Allowed 'General case' 0 N--CA 1.512 2.65 0 O-C-N 124.394 1.059 . . . . 5.9 112.326 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.86 54.73 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.421 1.105 . . . . 3.43 108.642 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 74.0 t80 -146.34 82.2 1.59 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.393 -0.821 . . . . 1.28 109.745 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 12.8 mp0 -89.71 142.11 27.99 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.481 -1.674 . . . . 3.19 106.481 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 18' ' ' LYS . 38.0 p90 -129.78 150.27 51.16 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.289 -0.964 . . . . 1.26 108.659 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -116.74 136.29 53.08 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.841 -0.8 . . . . 3.79 108.841 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -95.23 114.95 26.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.091 -1.818 . . . . 1.22 106.091 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.54 134.57 54.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 114.776 -1.102 . . . . 0.6 109.362 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.17 132.38 55.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.504 -0.924 . . . . 2.17 108.504 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 pt -60.87 -29.77 46.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 118.686 -1.205 . . . . 1.35 111.825 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.15 -34.19 56.56 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.012 -1.475 . . . . 4.8 110.602 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.23 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.663 -0.815 . . . . 1.1 111.262 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -85.08 -34.46 22.23 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.322 -0.951 . . . . 2.53 111.225 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.89 52.85 1.07 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.677 -1.369 . . . . 1.33 109.677 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -104.74 155.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.764 -0.718 . . . . 1.49 110.849 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.0 p -118.62 161.58 19.83 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.167 -0.924 . . . . 2.32 110.648 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 19.0 ttpp -55.73 -42.59 75.57 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.687 -1.597 . . . . 4.53 106.687 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.2 mp0 -51.55 -56.82 11.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.237 -1.347 . . . . 3.72 109.647 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -46.84 -51.47 16.52 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.581 -0.848 . . . . 3.62 111.139 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.76 -52.1 61.88 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.311 -0.859 . . . . 1.76 110.457 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 40.6 tt0 -53.3 -39.29 63.89 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.839 -0.744 . . . . 4.2 109.549 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 70.7 mt-30 -76.09 -33.81 59.52 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.388 -0.597 . . . . 5.45 109.388 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -63.07 -36.94 85.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.468 -0.567 . . . . 3.92 109.468 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -104.81 -88.17 0.43 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.076 -0.966 . . . . 2.34 108.904 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 41.34 1.12 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.125 -1.512 . . . . 3.11 113.869 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 74' ' ' ASP . 44.0 pttt -120.76 58.0 6.29 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.073 -1.051 . . . . 6.17 109.194 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.1 38.8 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.251 3.301 . . . . 4.42 114.043 -106.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.92 38.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.073 -1.084 . . . . 5.56 108.073 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -104.33 154.02 20.34 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.737 -1.119 . . . . 5.92 110.971 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -125.29 -156.23 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.566 -1.197 . . . . 5.32 107.819 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.69 145.42 30.67 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.996 -0.742 . . . . 3.41 108.996 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 52.8 Cg_endo -88.89 145.68 22.0 Favored 'Cis proline' 0 C--N 1.316 -1.132 0 O-C-N 123.558 1.294 . . . . 1.96 112.36 16.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -102.51 144.12 31.35 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.445 -1.687 . . . . 3.86 106.445 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.58 140.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.843 -1.543 . . . . 1.5 112.988 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 24.9 m-85 -136.16 135.59 39.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 110.976 -2.829 . . . . 1.28 107.876 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.579 HG23 HG13 ' A' ' 69' ' ' ILE . 61.6 t -102.6 121.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 106.828 -1.545 . . . . 1.08 106.828 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.2 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.905 -1.043 . . . . 2.6 111.209 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 64' ' ' VAL . 58.2 mt-30 -135.06 3.31 3.15 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.26 -0.976 . . . . 4.92 111.666 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -105.39 155.41 19.15 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.843 0.354 . . . . 4.62 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 8.0 t-80 -92.78 149.18 21.46 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.409 -1.33 . . . . 1.77 107.409 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 64' ' ' VAL . 3.2 mm -118.01 -38.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 117.513 -1.675 . . . . 1.06 109.703 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.41 -26.59 3.06 Favored Glycine 0 N--CA 1.502 3.04 0 C-N-CA 118.937 -1.602 . . . . 2.39 112.435 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.37 -173.83 20.27 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 108.231 -1.947 . . . . 1.64 108.231 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -51.77 -59.33 4.43 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.89 -1.124 . . . . 2.0 111.611 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.69 -45.59 49.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 112.938 0.718 . . . . 2.07 112.938 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 1.4 m-20 -74.84 -51.71 13.25 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.793 -0.763 . . . . 2.56 110.205 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 79' ' ' VAL . 83.4 t80 -51.21 -43.33 61.37 Favored 'General case' 0 C--O 1.194 -1.84 0 N-CA-C 107.48 -1.304 . . . . 0.97 107.48 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.79 -60.63 2.94 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.018 -0.734 . . . . 0.9 109.018 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.96 -53.94 45.83 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.909 -0.716 . . . . 1.21 111.312 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -54.93 -53.12 59.65 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.416 -0.914 . . . . 1.43 110.126 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 80' ' ' LYS . 1.9 t -46.48 -62.52 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 124.48 1.112 . . . . 1.1 109.006 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.598 ' N ' HG12 ' A' ' 79' ' ' VAL . 15.8 tptp -34.63 -49.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.256 -1.793 . . . . 2.92 113.3 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.04 20.05 19.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.653 1.723 . . . . 6.42 115.653 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -132.14 -26.53 1.9 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.661 -1.615 . . . . 2.2 110.775 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 50.1 mt -100.95 45.56 0.97 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.426 -1.31 . . . . 2.75 107.804 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.01 39.36 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.933 0.873 . . . . 5.66 110.378 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.837 0 C-N-CA 118.224 -1.39 . . . . 9.04 110.142 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 30' ' ' ASP . 77.5 mtm . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.211 -0.662 . . . . 2.72 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -109.43 102.16 11.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.727 -1.212 . . . . 4.5 107.727 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.3 m -91.66 139.43 30.7 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.599 -1.241 . . . . 0.78 109.27 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.52 139.03 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.045 -0.98 . . . . 0.91 109.988 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -118.34 109.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.156 1.535 . . . . 1.53 107.86 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG11 ' A' ' 36' ' ' VAL . 32.5 m-85 -91.74 90.74 7.66 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.174 -1.417 . . . . 1.28 107.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.85 -162.61 11.95 Favored Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.262 -0.971 . . . . 1.06 110.947 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.632 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -122.77 71.59 1.04 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.095 0.95 . . . . 6.25 111.532 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p 32.81 -77.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 116.393 1.997 . . . . 3.71 116.393 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -103.74 46.3 1.22 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 120.111 -1.042 . . . . 2.92 113.983 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.632 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 1.1 p -116.3 114.63 40.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 108.239 -1.023 . . . . 2.15 108.239 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.61 -54.89 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.187 1.925 . . . . 2.67 111.732 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.408 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 10.7 t80 -52.1 -40.43 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.279 -0.968 . . . . 2.54 109.913 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.42 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 28.4 m -62.24 -53.6 52.93 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.141 -1.024 . . . . 1.77 110.303 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -52.62 -42.14 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 114.669 -1.15 . . . . 1.42 111.663 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.526 HH12 ' CG ' ' A' ' 19' ' ' ASP . 10.0 mmm180 -42.5 -41.58 3.02 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 119.11 -1.036 . . . . 3.45 111.551 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.37 86.39 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.442 -0.903 . . . . 0.71 108.659 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.495 ' NZ ' ' HB2' ' A' ' 22' ' ' GLU . 4.1 tmtm? -62.6 -38.15 89.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.626 -0.879 . . . . 2.2 108.626 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CG ' HH12 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -61.46 -56.94 14.65 Favored 'General case' 0 C--O 1.192 -1.955 0 N-CA-C 106.666 -1.605 . . . . 3.53 106.666 177.578 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.1 tp -48.31 -56.93 6.8 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.145 -1.022 . . . . 1.08 108.655 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -50.53 9.84 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.71 108.425 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -57.41 -52.14 66.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.122 -0.631 . . . . 3.12 110.501 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 2.4 ttpp -52.68 -17.32 1.25 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.627 -1.17 . . . . 3.67 110.428 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.03 -53.37 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.506 -0.924 . . . . 1.48 108.506 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -43.9 -35.39 1.97 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.593 0.59 . . . . 1.53 112.593 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -105.62 22.3 15.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.086 1.143 . . . . 3.64 114.086 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 19.8 mt-10 -131.86 -27.6 1.86 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.575 -0.45 . . . . 3.27 110.242 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.59 -163.98 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.809 -0.756 . . . . 4.3 109.587 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.49 -179.98 4.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.14 -1.8 . . . . 4.69 106.14 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 t70 43.86 30.43 0.39 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 124.923 1.389 . . . . 3.6 112.059 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.87 85.88 2.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.243 -1.783 . . . . 1.01 113.068 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -102.71 141.82 34.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.178 -2.156 . . . . 3.42 105.178 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -133.1 153.62 51.34 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.627 -1.229 . . . . 1.07 109.567 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' HG23 ' A' ' 36' ' ' VAL . 1.7 tm0? -121.3 142.53 49.87 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.292 -1.373 . . . . 4.0 107.292 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.54 118.97 33.22 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.652 -1.219 . . . . 1.52 109.319 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 6' ' ' PHE . 26.3 t -109.43 136.07 46.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.027 -0.988 . . . . 1.01 109.152 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' A' ' 39' ' ' ARG . 17.1 t70 -118.58 44.86 2.17 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 114.842 -1.072 . . . . 1.99 108.743 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.1 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 114.364 -1.289 . . . . 2.0 114.199 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.616 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -59.14 -51.39 70.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.75 -0.659 . . . . 6.96 110.876 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' NH2' ' A' ' 39' ' ' ARG . . . -40.34 -51.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.381 -0.927 . . . . 1.27 110.24 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -74.93 -43.04 56.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.426 1.079 . . . . 3.17 110.478 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.4 30.81 1.23 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.161 -1.176 . . . . 2.2 110.161 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -98.44 152.35 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 2.32 108.171 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -124.4 -175.98 3.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.708 -0.678 . . . . 3.15 112.32 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -84.3 2.15 41.56 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.983 -0.687 . . . . 4.72 110.619 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.84 -45.91 5.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.037 -2.208 . . . . 5.05 105.037 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.5 -56.2 21.29 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.054 -0.975 . . . . 4.11 108.486 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -48.64 -40.25 27.13 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.713 -1.131 . . . . 2.06 111.5 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.23 -53.67 6.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.925 -1.11 . . . . 6.96 109.338 179.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -43.04 -49.92 6.06 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.493 -1.685 . . . . 6.89 113.297 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 5.4 mtpp -91.06 -28.02 18.22 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.516 -1.22 . . . . 5.48 114.162 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -73.61 -51.24 17.5 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.569 1.168 . . . . 1.95 112.899 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.98 -32.94 2.68 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.143 -1.983 . . . . 2.32 108.143 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 52' ' ' ALA . 26.0 mttt -86.38 -179.07 1.27 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 114.547 -0.827 . . . . 6.01 108.807 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.73 124.45 14.13 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.749 2.299 . . . . 4.81 111.76 155.534 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 56' ' ' VAL . 30.5 m -77.42 31.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.898 -0.592 . . . . 8.28 111.377 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.19 -7.85 12.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.41 -0.959 . . . . 5.64 108.41 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -85.04 54.09 2.97 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.243 -1.392 . . . . 6.46 107.243 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 19.2 m -89.68 169.57 12.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.161 -1.382 . . . . 3.41 111.799 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.671 ' C ' ' HA ' ' A' ' 59' ' ' VAL . 5.6 Cg_endo -46.16 137.67 1.8 Allowed 'Cis proline' 0 N--CA 1.489 1.219 0 C-N-CA 125.072 -0.803 . . . . 2.36 110.518 -13.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 61' ' ' GLN . 0.2 OUTLIER -94.53 116.63 29.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.091 -1.818 . . . . 3.29 106.091 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.6 mp -108.29 139.7 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 123.035 1.397 . . . . 1.12 111.416 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 3.8 m-85 -126.71 136.58 52.65 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 111.833 -2.44 . . . . 1.67 106.257 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG23 HG13 ' A' ' 69' ' ' ILE . 54.9 t -110.11 110.07 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 118.677 -1.209 . . . . 1.14 109.84 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 t70 75.38 -72.3 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 124.29 0.994 . . . . 2.69 112.216 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -134.03 -41.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.619 0.97 . . . . 4.5 113.619 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -94.26 160.75 14.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.552 0.945 . . . . 4.05 113.552 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.6 t-160 -77.09 144.47 38.5 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.772 -1.936 . . . . 1.51 105.772 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 64' ' ' VAL . 20.9 mm -103.66 -25.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 117.916 -1.514 . . . . 1.38 109.504 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.405 ' HA2' ' HD2' ' A' ' 54' ' ' LYS . . . 137.73 -34.05 2.2 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 118.522 -1.799 . . . . 2.77 113.294 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.78 -175.01 22.37 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.514 -1.434 . . . . 1.7 109.514 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 2.6 t80 -51.29 -44.44 61.88 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.375 -0.93 . . . . 2.01 111.625 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 p -66.81 -58.85 4.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.768 0.794 . . . . 1.45 110.548 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.73 -46.44 40.87 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.634 -1.166 . . . . 2.71 109.21 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 62' ' ' ILE . 48.7 t80 -60.88 -53.23 59.81 Favored 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 108.198 -1.038 . . . . 1.04 108.198 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.59 -53.39 11.55 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.71 -0.796 . . . . 0.79 112.655 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.48 13.58 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 118.999 -1.081 . . . . 0.91 110.126 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -44.41 -48.64 9.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.22 0.95 . . . . 1.32 108.828 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 t -47.67 -59.36 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 124.154 0.909 . . . . 1.02 108.865 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 7.6 tmtm? -57.33 -59.92 4.41 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.498 -1.281 . . . . 3.11 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -52.66 -36.27 56.61 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.24 1.57 . . . . 3.86 115.24 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -101.27 -28.67 12.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.811 -1.155 . . . . 1.73 113.563 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.07 -26.43 26.97 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 117.862 -1.535 . . . . 1.75 112.571 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -102.44 40.64 1.33 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.393 -1.323 . . . . 3.33 111.153 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 116.465 -1.731 . . . . 6.59 108.856 179.128 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.459 ' N ' ' CG ' ' A' ' 30' ' ' ASP . 13.9 ptp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.162 -0.681 . . . . 2.91 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 19.6 pt20 -123.82 125.53 44.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.749 0.656 . . . . 3.66 110.721 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -94.25 132.03 39.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.488 -0.93 . . . . 1.12 108.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.87 117.94 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.59 -1.634 . . . . 0.91 106.59 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.8 mm -108.96 125.04 66.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.568 -1.253 . . . . 1.76 108.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.13 96.02 6.94 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.962 -0.755 . . . . 1.31 108.962 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.59 -173.67 18.09 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.559 -1.817 . . . . 0.93 108.559 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.11 170.84 3.69 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.813 -0.81 . . . . 8.79 108.813 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -90.51 53.7 2.52 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 105.864 -1.902 . . . . 6.05 105.864 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.83 -39.16 0.12 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.339 -1.904 . . . . 6.99 108.339 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -90.59 151.67 44.27 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 108.578 -0.897 . . . . 5.02 108.578 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.2 Cg_endo -91.28 178.91 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.58 2.187 . . . . 4.69 109.027 146.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER 76.6 -36.56 0.27 Allowed 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 120.454 -0.498 . . . . 3.37 111.714 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -31.77 11.32 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 120.28 -0.568 . . . . 1.78 111.936 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 59.4 t -59.84 -53.5 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.444 -0.902 . . . . 1.12 109.7 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -33.86 -53.15 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.295 -0.866 . . . . 4.2 113.323 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.9 84.16 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.451 -0.9 . . . . 0.81 109.733 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 2.5 tmtm? -53.33 -47.9 68.94 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.891 -1.049 . . . . 1.84 110.251 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 1.3 p-10 -68.03 -43.14 79.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.143 -1.423 . . . . 2.84 109.083 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.52 -58.57 6.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.273 -1.371 . . . . 0.91 109.953 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.94 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.542 -0.863 . . . . 0.89 110.725 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.623 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 24.1 tt0 -50.75 -57.8 7.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.885 -1.126 . . . . 2.67 109.265 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.61 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -49.14 -54.07 17.94 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.901 -1.045 . . . . 4.69 110.178 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -48.9 -44.15 39.87 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 114.107 1.151 . . . . 1.66 114.107 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.7 p -49.73 -19.94 0.73 Allowed 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 119.351 -0.939 . . . . 2.28 113.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.9 m-20 -99.53 -2.82 34.86 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.713 -0.395 . . . . 3.26 111.531 -179.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.61 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 14.9 mt-10 -114.6 -32.8 5.75 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.577 0.703 . . . . 3.35 111.24 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 8.6 mmm-85 -95.67 -173.62 2.92 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.743 -1.183 . . . . 3.74 113.953 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 7.1 p-10 -96.55 -71.77 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 113.45 -1.705 . . . . 5.15 111.969 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 42.1 t0 -101.91 66.63 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.918 0.866 . . . . 4.02 108.861 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -124.04 102.47 7.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.774 -1.103 . . . . 1.34 110.163 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 45.7 mt-30 -119.07 163.33 17.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.363 -1.718 . . . . 3.28 106.363 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 35.3 p90 -158.83 164.07 36.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.291 -1.364 . . . . 1.31 110.135 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -136.14 137.62 41.17 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.679 -1.146 . . . . 3.46 108.789 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -96.78 137.21 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.164 -2.532 . . . . 1.28 104.164 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.6 139.12 52.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.447 -0.901 . . . . 0.7 111.672 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -115.79 124.5 50.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 104.807 -2.294 . . . . 1.79 104.807 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 pt -51.02 -35.79 15.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.116 -0.947 . . . . 1.9 111.918 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -81.75 4.02 23.53 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 113.237 0.828 . . . . 5.2 113.237 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.63 -46.27 3.06 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.987 -0.685 . . . . 1.96 109.925 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.451 -0.899 . . . . 3.74 109.355 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.64 48.66 1.77 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 120.035 -1.079 . . . . 3.08 110.752 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.38 147.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.407 -0.917 . . . . 2.57 110.471 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.1 p -117.71 170.46 8.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.712 -1.218 . . . . 3.71 107.712 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -53.89 48.69 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.071 -1.052 . . . . 6.11 108.978 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -35.08 -62.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.534 -1.212 . . . . 5.38 110.559 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -46.78 -59.11 3.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.253 -0.885 . . . . 4.41 111.976 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.1 mt -50.68 -44.87 57.92 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.834 -0.746 . . . . 2.39 111.372 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 5.3 tm0? -42.17 -55.15 3.37 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.597 -0.841 . . . . 6.53 110.143 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -49.23 -33.96 13.83 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.022 -0.99 . . . . 6.6 113.271 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.68 -26.37 19.61 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.981 -0.688 . . . . 3.39 111.835 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 -45.45 53.79 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.886 -0.726 . . . . 1.69 109.559 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.13 -52.48 0.63 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.176 -1.57 . . . . 3.61 109.176 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 2.4 ttpm? -95.27 161.92 26.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 6.52 108.026 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 87.5 Cg_exo -30.45 121.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 121.538 1.492 . . . . 5.56 109.137 147.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.6 47.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.617 -0.833 . . . . 7.77 111.812 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 1.8 mm-40 -83.48 53.3 2.47 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.951 1.358 . . . . 8.49 108.697 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -147.72 99.22 3.07 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 105.575 -2.009 . . . . 5.21 105.575 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -113.53 147.69 38.08 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.309 -0.997 . . . . 3.15 108.309 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 59' ' ' VAL . 11.1 Cg_endo -84.2 174.35 38.49 Favored 'Cis proline' 0 C--O 1.207 -1.043 0 C-N-CA 125.403 -0.666 . . . . 2.12 111.48 21.354 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.72 146.9 48.92 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.459 -0.896 . . . . 3.57 110.57 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.463 HG21 ' CG ' ' A' ' 75' ' ' PHE . 14.8 mm -120.09 134.93 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 124.011 0.82 . . . . 1.74 108.901 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HA ' HG12 ' A' ' 69' ' ' ILE . 15.5 m-85 -137.38 133.16 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.167 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 69' ' ' ILE . 84.6 t -100.11 122.32 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 106.25 -1.759 . . . . 1.3 106.25 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.53 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.783 0.677 . . . . 2.97 111.582 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' VAL . 74.1 mt-30 -138.35 10.07 2.73 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.601 -0.84 . . . . 5.03 112.239 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.77 152.66 24.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.488 -0.485 . . . . 4.24 110.12 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -85.14 145.1 27.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.588 -1.264 . . . . 1.57 107.588 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 HG23 ' A' ' 64' ' ' VAL . 14.0 mm -113.5 -34.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 C-N-CA 119.255 -0.978 . . . . 1.2 110.895 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.0 -128.94 4.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.323 -1.111 . . . . 1.77 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.73 -59.2 0.59 Allowed Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.868 -1.158 . . . . 2.32 112.073 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -163.63 -60.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.959 -1.096 . . . . 1.86 109.157 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 p -41.6 -48.06 3.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.973 -1.121 . . . . 1.84 107.973 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -68.75 0.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.756 -2.02 . . . . 2.96 110.353 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CG ' HG21 ' A' ' 62' ' ' ILE . 71.7 t80 -52.62 -39.23 61.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.305 -0.958 . . . . 1.04 110.762 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.499 -0.481 . . . . 0.94 111.174 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.09 -48.71 61.91 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.894 -1.151 . . . . 1.56 107.894 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.442 ' CZ3' ' CE1' ' A' ' 75' ' ' PHE . 60.8 t90 -41.6 -52.09 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.712 -1.131 . . . . 1.2 108.923 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 83' ' ' LEU . 3.0 t -41.81 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.619 -1.252 . . . . 1.16 107.619 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -47.78 -53.42 15.42 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.468 0.652 . . . . 3.25 111.235 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 1.1 mp0 -62.69 -17.99 61.63 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.081 1.141 . . . . 4.02 114.081 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -110.6 -32.24 6.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 118.826 -1.149 . . . . 1.78 113.385 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.539 HD12 HG13 ' A' ' 79' ' ' VAL . 19.2 mt -92.87 -19.7 21.42 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.363 -0.935 . . . . 1.74 111.697 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 2.1 m-20 -113.19 -51.67 2.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.398 -0.964 . . . . 3.45 108.398 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.505 2.305 0 O-C-N 126.449 2.343 . . . . 5.23 108.834 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.898 0.38 . . . . 4.04 110.689 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 64.3 mt-30 -106.78 174.8 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.247 -1.02 . . . . 4.14 108.247 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 75' ' ' PHE . 57.5 m -114.88 141.18 48.27 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.741 -1.184 . . . . 0.75 113.695 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.7 t -119.63 128.27 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.14 -2.17 . . . . 0.64 105.14 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.46 120.56 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 124.474 1.109 . . . . 1.53 110.48 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CD2' HG11 ' A' ' 36' ' ' VAL . 91.0 m-85 -99.42 81.3 2.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.175 -1.417 . . . . 0.92 107.175 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.42 -174.15 13.6 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.929 -1.268 . . . . 1.87 109.929 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 9' ' ' SER . 7.5 mmm180 -102.91 -63.62 1.15 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.732 -0.787 . . . . 6.47 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 75.5 m 97.45 145.9 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 125.408 1.692 . . . . 5.95 107.78 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.18 -21.22 31.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 106.63 -2.588 . . . . 4.7 106.63 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -113.27 150.25 42.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.996 -1.102 . . . . 3.46 110.072 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.09 -56.48 2.53 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.702 1.601 . . . . 3.03 112.317 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.56 -44.09 79.09 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.597 -0.841 . . . . 3.09 112.114 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 20.1 p -54.9 -55.13 33.85 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 117.291 -1.764 . . . . 3.57 107.999 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 18' ' ' LYS . 97.7 t -52.97 -47.37 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 1.19 111.167 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -32.83 -50.01 0.25 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 113.555 0.946 . . . . 4.46 113.555 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.13 95.62 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.003 -1.079 . . . . 0.82 110.517 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -61.09 -47.49 86.08 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.251 -0.648 . . . . 1.92 109.251 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m-20 -56.86 -47.85 79.46 Favored 'General case' 0 C--O 1.199 -1.596 0 C-N-CA 118.81 -1.156 . . . . 3.47 109.244 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.62 -57.69 11.86 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.443 -1.303 . . . . 0.87 109.361 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.582 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -50.56 -53.51 29.79 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.145 -1.422 . . . . 0.74 110.071 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 20.2 tt0 -55.19 -49.54 71.66 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.585 0.707 . . . . 2.8 112.228 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.64 -51.14 71.08 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.032 -1.099 . . . . 7.08 108.032 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.81 -52.86 37.09 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.468 -0.787 . . . . 1.7 109.967 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 p -60.42 -14.58 19.81 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.107 -1.437 . . . . 1.72 112.358 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -117.71 17.57 14.33 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.178 0.513 . . . . 3.41 110.194 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.54 -45.52 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.203 1.001 . . . . 3.9 109.474 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 2.3 mmp_? -101.86 -36.68 8.57 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.193 -1.367 . . . . 4.04 111.392 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 31' ' ' PHE . 15.5 m-20 77.42 -40.74 0.35 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 124.636 1.21 . . . . 6.4 110.389 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -72.79 17.84 0.11 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.486 -0.886 . . . . 6.59 109.729 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 29' ' ' ASP . 47.2 t80 -125.49 120.81 31.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.11 -0.95 . . . . 1.91 109.694 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.302 -1.37 . . . . 4.73 107.302 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 18.3 p90 -144.68 176.12 9.66 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.63 -0.828 . . . . 1.45 112.755 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -136.14 141.64 44.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.623 -1.621 . . . . 2.89 106.623 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -99.16 141.52 31.83 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.944 -1.503 . . . . 1.36 108.053 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -131.32 148.18 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.989 -1.115 . . . . 0.75 107.989 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.79 123.65 50.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.922 -1.14 . . . . 1.99 107.922 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 pt -54.14 -25.32 12.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.098 -1.041 . . . . 1.92 110.105 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.67 11.25 18.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.368 1.042 . . . . 6.67 111.653 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.86 -51.01 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.392 -0.595 . . . . 1.79 109.392 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.79 -32.55 63.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.547 -1.206 . . . . 2.78 109.641 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.45 46.77 1.93 Allowed Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.82 -1.181 . . . . 1.95 111.263 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 mt -114.19 147.39 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 118.378 -1.329 . . . . 1.92 109.065 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.5 p -105.26 -99.59 0.33 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.096 -1.042 . . . . 3.51 110.161 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 42.6 tttp -141.03 -63.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 5.53 106.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -45.25 -40.03 7.04 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.73 -1.123 . . . . 5.86 109.291 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' LEU . 51.4 m-20 -56.9 -67.39 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.588 -0.893 . . . . 4.91 108.588 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 61' ' ' GLN . 61.5 mt -36.75 -51.45 0.88 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.238 -0.892 . . . . 1.86 109.931 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -52.92 -62.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.157 -1.383 . . . . 5.45 110.59 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -58.08 -45.32 87.34 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.964 -0.694 . . . . 6.78 111.154 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -61.61 -29.51 70.09 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.458 -0.792 . . . . 3.56 110.563 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -81.8 -55.37 4.66 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.822 -0.751 . . . . 2.07 110.574 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -16.76 11.96 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.959 -2.056 . . . . 2.54 107.959 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -114.05 84.34 8.82 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 108.678 -0.86 . . . . 5.37 108.678 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 34.8 Cg_exo -50.32 177.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.125 1.883 . . . . 4.74 111.504 168.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 23.9 t 71.34 70.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 CA-C-O 122.422 1.106 . . . . 5.63 108.953 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.547 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 4.8 pt-20 -171.06 166.56 7.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.37 -1.741 . . . . 6.08 109.661 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 70.3 m -139.86 178.72 7.05 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.719 -1.586 . . . . 5.03 106.719 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 58' ' ' THR . 7.1 m -84.39 154.32 62.68 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 123.687 0.617 . . . . 3.37 110.501 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.01 167.95 78.5 Favored 'Cis proline' 0 N--CA 1.495 1.607 0 O-C-N 122.533 0.754 . . . . 1.95 111.842 6.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HG3' HD13 ' A' ' 48' ' ' LEU . 15.5 mm-40 -122.69 145.25 48.55 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 120.231 -0.588 . . . . 2.94 109.58 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.593 HG21 ' CG ' ' A' ' 75' ' ' PHE . 10.8 mm -118.08 126.35 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 120.193 -0.603 . . . . 1.32 111.599 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 21.1 m-85 -124.81 132.31 53.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.682 -1.97 . . . . 1.17 105.682 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.668 HG11 ' CH2' ' A' ' 78' ' ' TRP . 45.6 t -119.22 145.39 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.86 -1.136 . . . . 1.42 108.686 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 54.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.424 1.077 . . . . 4.43 109.35 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' VAL . 18.7 pt20 -148.34 9.76 0.85 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.93 -0.577 . . . . 4.64 109.971 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -116.5 169.61 9.2 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.435 0.636 . . . . 5.53 111.354 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CG ' ' HB1' ' A' ' 52' ' ' ALA . 10.9 t-80 -94.64 135.42 36.13 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 64' ' ' VAL . 5.7 mm -110.86 -36.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 117.901 -1.52 . . . . 1.07 109.579 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.15 -144.74 12.29 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.239 -1.458 . . . . 1.78 111.354 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' CG1' ' A' ' 62' ' ' ILE . . . -103.77 -60.8 0.69 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-O 119.178 -0.79 . . . . 2.57 112.942 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -150.13 -68.43 0.2 Allowed 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 117.914 -1.515 . . . . 2.11 111.118 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 p -49.06 -51.46 31.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.078 -1.082 . . . . 1.96 108.078 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.94 -53.74 14.99 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.746 -1.57 . . . . 3.54 110.667 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 62' ' ' ILE . 40.8 t80 -59.13 -51.36 70.36 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.169 -0.678 . . . . 1.02 109.169 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.2 -53.13 18.0 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.914 -0.773 . . . . 1.59 108.914 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -63.35 1.21 Allowed 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 114.814 -1.084 . . . . 1.46 109.051 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.668 ' CH2' HG11 ' A' ' 64' ' ' VAL . 68.5 t90 -43.06 -53.96 4.59 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.773 -0.771 . . . . 1.55 109.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.0 t -44.87 -63.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.994 -1.113 . . . . 1.86 107.994 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -52.9 -48.03 67.52 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.996 -1.081 . . . . 3.52 110.3 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.57 20.81 0.21 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.536 0.569 . . . . 3.99 112.536 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -142.77 -38.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.328 -0.549 . . . . 2.27 111.37 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.6 mt -94.35 -14.41 25.37 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.039 -0.665 . . . . 2.03 112.01 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.3 -49.22 2.49 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.62 -0.832 . . . . 3.94 110.557 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 116.895 -1.526 . . . . 6.03 109.221 179.783 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.43 -0.952 . . . . 2.58 108.43 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HG2' ' N ' ' A' ' 3' ' ' THR . 52.4 tt0 -116.47 157.61 24.9 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.114 -1.034 . . . . 4.44 111.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.589 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 75.8 m -145.08 127.65 16.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.261 -0.644 . . . . 0.9 109.261 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.62 136.69 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.899 -0.778 . . . . 0.96 108.899 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.4 mm -113.21 130.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 36' ' ' VAL . 16.0 m-85 -108.0 97.78 7.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.025 0.828 . . . . 1.23 109.916 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.32 -141.74 4.53 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 108.845 -1.702 . . . . 0.9 108.845 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.729 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -116.89 176.76 4.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.213 -0.662 . . . . 6.17 109.213 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -83.21 61.9 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.91 . . . . 3.56 110.55 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.5 68.72 0.61 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.243 -1.456 . . . . 3.3 110.724 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.36 113.04 35.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.548 -1.278 . . . . 2.52 107.548 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.19 -50.29 1.61 Allowed 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 122.291 1.994 . . . . 3.24 113.143 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -68.66 -47.75 65.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.299 -1.36 . . . . 2.68 111.408 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -58.23 -42.73 86.95 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 118.048 -1.461 . . . . 2.89 110.243 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.8 -26.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 115.018 -0.992 . . . . 1.35 110.791 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 4.2 tpp180 -74.02 -50.21 20.84 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.031 -1.067 . . . . 4.31 109.322 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.35 -41.53 65.89 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.492 -1.67 . . . . 0.8 106.492 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 11.9 tmtt? -55.56 -58.98 5.52 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 113.948 -1.478 . . . . 2.13 108.255 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.552 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 79.4 m-20 -54.3 -53.47 53.4 Favored 'General case' 0 C--O 1.191 -1.998 0 C-N-CA 118.984 -1.087 . . . . 3.7 110.098 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 tp -46.17 -60.76 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.026 -1.07 . . . . 0.91 110.353 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.13 34.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.877 -1.129 . . . . 0.94 111.032 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 35.2 tt0 -52.36 -56.49 14.56 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.386 -0.926 . . . . 2.8 110.948 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 66.0 tttp -45.59 -57.17 4.38 Favored 'General case' 0 C--O 1.2 -1.54 0 CA-C-N 114.238 -1.347 . . . . 4.52 108.32 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.32 -45.77 80.17 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.684 -1.206 . . . . 1.81 110.03 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -50.3 -49.44 53.58 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.637 -0.71 . . . . 2.22 111.015 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -81.15 -28.79 34.92 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.928 -0.709 . . . . 3.09 112.185 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 62.0 mt-10 -100.93 42.01 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.21 1.005 . . . . 6.46 112.692 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.626 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -149.34 -143.71 0.14 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.104 -1.039 . . . . 5.5 109.316 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -133.88 -48.94 0.81 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.645 -0.872 . . . . 4.12 108.645 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 31' ' ' PHE . 51.6 t0 -98.75 -81.69 0.44 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.812 -1.086 . . . . 3.31 110.382 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 30' ' ' ASP . 21.3 t80 1.56 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 124.349 1.03 . . . . 1.26 113.544 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 64.9 mt-30 -94.24 112.16 23.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.895 -1.522 . . . . 2.9 107.291 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.34 164.17 12.94 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.39 -1.324 . . . . 1.6 111.335 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.91 157.46 44.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.742 -1.947 . . . . 3.83 105.742 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -110.43 149.45 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.545 -1.262 . . . . 1.16 109.1 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.662 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.8 t -132.75 147.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.635 -0.711 . . . . 0.66 109.579 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -119.73 121.15 38.56 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.152 0.977 . . . . 2.04 110.323 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 pt -57.61 -30.44 36.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.087 -0.96 . . . . 1.29 111.783 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.77 9.16 14.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 117.652 -1.619 . . . . 5.62 111.826 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.46 -43.18 3.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.898 -1.519 . . . . 1.33 106.898 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -74.3 -36.52 63.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.355 -0.98 . . . . 3.86 108.355 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.68 46.18 1.23 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.184 -1.566 . . . . 1.83 109.184 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 90.2 mt -108.11 145.99 14.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.881 -0.659 . . . . 2.21 112.625 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.4 p -117.89 -94.1 0.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.215 -1.032 . . . . 3.48 108.215 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -135.47 -61.59 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.417 -0.956 . . . . 6.11 108.417 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -36.37 -52.82 0.84 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.589 -1.187 . . . . 3.27 111.467 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -58.82 -56.91 16.09 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.865 -1.134 . . . . 3.15 110.516 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 48.9 mt -49.37 -47.67 47.38 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.219 -0.992 . . . . 1.88 110.021 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -56.55 -53.73 54.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.707 -1.197 . . . . 4.18 108.481 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -52.08 -64.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.395 1.059 . . . . 4.68 111.284 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -58.28 -45.81 87.21 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.448 -0.796 . . . . 3.4 112.405 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -58.04 -38.79 76.91 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 123.958 0.786 . . . . 2.1 110.095 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.67 39.98 6.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.644 -1.783 . . . . 2.94 108.644 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -119.44 151.62 51.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.195 -1.002 . . . . 5.2 110.499 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.6 -25.33 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.863 1.709 . . . . 4.72 111.671 154.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.27 108.19 23.2 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 112.416 -2.175 . . . . 6.25 108.928 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 167.87 11.33 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.876 -1.056 . . . . 5.99 111.861 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.2 p -156.1 174.97 14.58 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.484 -2.043 . . . . 5.97 105.484 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.13 156.36 45.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 118.319 -1.352 . . . . 3.78 108.573 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.08 -172.6 9.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 124.386 -1.089 . . . . 2.12 111.291 -17.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -119.77 147.36 44.72 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 107.624 -1.25 . . . . 3.31 107.624 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 62' ' ' ILE . 5.0 mp -122.86 143.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 122.317 1.056 . . . . 1.28 112.53 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 39.6 m-85 -123.0 124.84 44.05 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 112.141 -2.3 . . . . 1.34 106.18 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.649 ' CG1' ' H ' ' A' ' 65' ' ' ASP . 41.7 t -97.52 -172.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.065 -1.454 . . . . 1.69 107.52 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.649 ' H ' ' CG1' ' A' ' 64' ' ' VAL . 32.7 t70 -48.47 -35.0 12.08 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 112.954 0.724 . . . . 2.72 112.954 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.464 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 13.4 mp0 -94.2 -72.66 0.6 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.522 -1.271 . . . . 8.49 113.892 -178.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -134.97 -167.02 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.274 0.842 . . . . 5.25 113.274 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.627 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 35.9 t-80 -70.14 140.6 52.65 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 104.79 -2.3 . . . . 1.9 104.79 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 ' CG2' ' A' ' 64' ' ' VAL . 16.0 mm -107.5 -34.85 2.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 119.081 -1.048 . . . . 1.12 110.552 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.42 -150.14 21.88 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.465 -1.35 . . . . 1.74 110.644 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -96.77 -169.1 33.83 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.035 -1.226 . . . . 1.64 110.035 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.36 -47.53 66.08 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.755 -1.178 . . . . 1.69 110.733 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -62.49 -61.64 2.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.409 -0.917 . . . . 1.24 109.952 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -42.98 -54.27 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.426 -1.261 . . . . 2.91 109.389 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.7 t80 -61.23 -57.23 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.811 -1.086 . . . . 1.11 109.423 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -42.32 -54.58 3.7 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.12 -0.632 . . . . 1.06 110.32 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -59.44 -57.64 12.08 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.035 -0.984 . . . . 1.3 108.488 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CH2' HG11 ' A' ' 64' ' ' VAL . 85.0 t90 -41.99 -47.14 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.079 -0.711 . . . . 1.57 109.079 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HD12 ' A' ' 83' ' ' LEU . 92.6 t -62.26 -36.92 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.833 -0.621 . . . . 1.13 109.513 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -94.52 22.24 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.147 -0.478 . . . . 4.13 112.106 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -134.79 -40.86 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.954 -0.566 . . . . 4.56 110.13 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -92.85 -23.32 18.85 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 116.057 -0.519 . . . . 2.55 112.309 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 79' ' ' VAL . 39.8 mt -100.93 13.12 36.17 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.277 -1.369 . . . . 2.31 110.894 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 5.2 m-20 -115.17 -63.52 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.921 -0.711 . . . . 4.62 110.847 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.58 -1.2 . . . . 7.07 108.109 179.12 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 30' ' ' ASP . 29.0 ttm . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 106.52 -1.659 . . . . 2.93 106.52 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -122.79 85.33 2.4 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.906 -0.718 . . . . 3.6 109.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 64' ' ' VAL . 27.7 m -88.71 131.22 35.11 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.26 -1.015 . . . . 1.18 108.26 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.6 138.19 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.781 -0.822 . . . . 0.69 108.781 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -114.96 119.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 124.559 1.162 . . . . 1.99 109.326 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -92.25 85.98 5.6 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.801 -2.296 . . . . 2.23 104.801 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.15 -168.45 15.16 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.634 -1.746 . . . . 0.94 110.593 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.61 133.14 54.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.81 -0.811 . . . . 5.41 108.81 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.442 ' N ' HH22 ' A' ' 8' ' ' ARG . 2.8 p -67.57 94.16 0.4 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.36 -0.836 . . . . 3.67 110.017 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.01 22.87 8.04 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.721 -0.951 . . . . 2.94 110.721 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -104.03 115.61 62.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 120.132 -0.627 . . . . 2.4 110.734 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 -31.43 90.57 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.554 2.17 . . . . 2.94 111.593 -159.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -92.72 -37.56 12.3 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.727 -1.124 . . . . 2.69 110.9 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 63.8 m -51.83 -45.18 63.85 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.631 -1.228 . . . . 2.23 109.199 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -46.58 -41.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.656 -1.156 . . . . 1.35 111.417 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.587 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.6 -37.11 3.38 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 112.157 0.429 . . . . 6.61 112.157 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.88 98.46 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.699 -1.201 . . . . 0.98 108.205 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.5 tmtm? -73.28 -32.98 64.97 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.17 -1.012 . . . . 2.51 110.672 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.546 ' CG ' HH21 ' A' ' 16' ' ' ARG . 5.7 m-20 -51.31 -57.49 8.73 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.015 -1.474 . . . . 3.27 108.647 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -46.13 -61.2 1.87 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.171 0.804 . . . . 0.92 113.171 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 33' ' ' TYR . . . -39.17 -39.85 0.65 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.668 0.618 . . . . 1.11 112.668 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -50.57 69.99 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.076 -1.05 . . . . 3.11 110.051 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -45.13 -46.95 12.15 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.5 -1.227 . . . . 5.98 110.256 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.2 mt -72.34 -50.03 29.89 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.208 -1.36 . . . . 1.23 112.649 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -55.89 -26.66 48.33 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.804 -0.758 . . . . 1.5 110.803 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -93.09 24.03 3.98 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.003 -0.679 . . . . 2.68 110.393 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.32 -49.86 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.646 0.591 . . . . 3.59 110.971 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.2 mpt_? -108.35 124.25 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.256 -0.883 . . . . 4.68 111.579 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.53 60.52 0.88 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 124.562 1.163 . . . . 5.95 109.156 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t70 -165.04 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.869 -1.514 . . . . 3.12 109.841 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 33' ' ' TYR . 14.5 t80 -66.19 102.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.596 -0.729 . . . . 0.99 109.994 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 83.6 mt-30 -91.47 -54.69 3.8 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.287 -0.565 . . . . 3.74 111.347 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER 59.0 149.64 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 O-C-N 126.357 2.285 . . . . 1.31 113.507 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -139.65 144.65 37.74 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 115.19 -0.914 . . . . 3.31 110.86 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -98.8 138.19 36.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.53 144.52 35.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.219 -1.4 . . . . 0.6 107.219 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -115.31 118.33 32.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.302 1.001 . . . . 2.2 111.738 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.01 -19.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.839 -1.144 . . . . 1.22 111.042 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 1.2 tmm_? -87.14 -9.8 54.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 123.289 0.368 . . . . 5.41 111.001 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.39 -39.34 8.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.616 -1.253 . . . . 1.17 107.616 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -104.51 28.16 7.23 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.24 -1.346 . . . . 2.54 109.959 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 27.24 64.49 0.08 OUTLIER Glycine 0 N--CA 1.507 3.413 0 CA-C-N 114.648 -1.16 . . . . 1.64 113.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.56 147.97 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.579 -0.849 . . . . 1.82 109.783 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -130.85 173.37 11.02 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.654 -0.818 . . . . 2.78 109.217 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -50.48 -50.78 51.75 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.699 -0.8 . . . . 6.96 110.138 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -34.2 -69.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.119 0.887 . . . . 3.47 113.063 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.54 -46.25 80.73 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 119.981 -0.687 . . . . 3.31 112.853 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLN . 97.8 mt -58.12 -53.2 60.9 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.457 -1.297 . . . . 1.97 110.62 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HG3' ' HE2' ' A' ' 45' ' ' LYS . 37.9 mt-30 -42.67 -53.04 4.67 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.153 -1.019 . . . . 3.75 108.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -55.56 -44.86 77.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.966 1.416 . . . . 5.26 110.873 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -90.13 11.09 21.92 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.625 -0.83 . . . . 4.44 111.85 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -102.77 -66.1 0.95 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.819 0.674 . . . . 1.86 112.819 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.34 18.21 34.2 Favored Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.922 -1.133 . . . . 3.52 112.81 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 68' ' ' HIS . 50.8 mtpt -121.97 24.85 0.11 Allowed Pre-proline 0 N--CA 1.502 2.168 0 CA-C-N 117.714 0.757 . . . . 5.8 110.798 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.59 46.28 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.752 2.301 . . . . 5.13 113.437 -105.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.3 15.95 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.982 -1.118 . . . . 5.43 107.982 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -84.01 173.82 10.83 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.149 -1.387 . . . . 6.55 109.542 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 t -149.22 -156.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.886 -0.726 . . . . 4.66 109.31 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.39 131.07 56.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.04 -1.096 . . . . 2.79 108.04 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -99.11 151.76 5.76 Favored 'Cis proline' 0 N--CA 1.481 0.761 0 O-C-N 122.661 0.822 . . . . 1.95 111.64 12.388 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -122.62 139.34 54.04 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.231 -0.895 . . . . 2.94 109.037 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -118.2 149.66 20.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.669 -1.234 . . . . 1.45 107.669 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 68' ' ' HIS . 22.6 m-85 -134.02 116.65 15.76 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 125.401 1.688 . . . . 1.01 106.726 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.633 HG23 HG13 ' A' ' 69' ' ' ILE . 84.8 t -88.2 108.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 118.067 -1.453 . . . . 1.04 110.078 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 54.03 -79.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 123.748 0.655 . . . . 3.04 112.086 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.6 pt20 -128.38 1.9 5.68 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.041 -1.064 . . . . 4.83 111.654 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 66' ' ' GLN . 10.0 mp0 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.946 -0.391 . . . . 4.24 109.946 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.744 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-80 -106.66 132.75 52.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.733 -1.21 . . . . 1.52 107.733 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 64' ' ' VAL . 5.3 mm -111.09 -56.17 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 105.867 -1.901 . . . . 1.89 105.867 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' NE2' ' A' ' 68' ' ' HIS . . . 68.87 88.09 0.08 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 116.261 1.265 . . . . 2.44 116.261 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 131.18 3.78 Favored Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.282 -1.437 . . . . 1.49 114.632 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 74' ' ' ASP . 22.4 t80 -66.23 -58.09 6.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.553 -0.859 . . . . 1.25 109.124 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 14.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.619 0.6 . . . . 2.57 112.619 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 72' ' ' TYR . 7.9 t70 -119.37 -63.92 1.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' TRP . 67.0 t80 -56.41 -39.05 72.39 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.878 -1.51 . . . . 0.97 108.426 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.634 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.21 -53.43 43.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.023 -1.103 . . . . 1.4 108.023 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 89.8 t90 -41.39 -65.45 0.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.362 -1.29 . . . . 1.61 110.862 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.8 t -42.82 -52.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.505 -0.924 . . . . 1.04 108.505 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -46.81 -42.29 16.88 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.417 -1.72 . . . . 5.04 109.919 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -106.81 25.18 11.59 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 120.085 -0.646 . . . . 4.8 112.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -129.85 -43.02 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.379 -1.328 . . . . 1.94 113.817 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 26.4 mt -101.54 32.26 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.118 -2.178 . . . . 1.5 105.118 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 5.3 m-20 55.3 30.69 15.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.026 -1.897 . . . . 6.15 106.773 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.531 3.59 0 O-C-N 125.706 1.879 . . . . 8.66 111.776 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 33.4 tpp . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.629 -0.508 . . . . 2.6 109.629 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' H ' ' A' ' 32' ' ' GLN . 8.5 pt20 -94.42 173.17 7.76 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.623 -1.231 . . . . 3.32 108.515 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.44 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 86.6 m -130.2 145.35 51.72 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.074 -1.05 . . . . 1.28 111.812 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.29 118.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 105.737 -1.949 . . . . 0.86 105.737 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.451 HG23 ' CD1' ' A' ' 62' ' ' ILE . 30.7 mt -100.07 113.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.009 -1.108 . . . . 2.89 108.009 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CD2' HG11 ' A' ' 36' ' ' VAL . 45.6 m-85 -97.58 78.06 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 105.747 -1.946 . . . . 1.25 105.747 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.74 1.91 Allowed Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.781 -1.676 . . . . 1.03 112.04 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER 179.23 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.811 -1.181 . . . . 4.86 107.811 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 13.2 m 97.29 162.92 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 O-C-N 125.335 1.647 . . . . 5.04 110.4 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 15' ' ' VAL . . . 97.12 -12.37 65.44 Favored Glycine 0 N--CA 1.503 3.14 0 C-N-CA 120.194 -1.003 . . . . 3.52 110.637 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.58 143.63 30.94 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.91 -0.645 . . . . 2.55 110.724 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 -54.71 5.01 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.257 1.305 . . . . 3.77 111.675 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -67.94 -2.58 7.76 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 113.802 1.038 . . . . 3.15 113.802 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 9' ' ' SER . 29.4 p -111.66 -41.87 3.97 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.651 -1.22 . . . . 2.33 109.09 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 17' ' ' ALA . 49.0 t -73.04 -30.98 33.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 118.824 -1.15 . . . . 0.92 108.357 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 9.3 mmm180 -71.9 23.47 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 C-N-CA 119.919 -0.712 . . . . 3.65 110.976 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -121.49 -48.87 2.16 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.64 -1.245 . . . . 1.08 107.64 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.9 tmtm? -57.97 -29.15 65.0 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.873 -0.731 . . . . 2.56 110.169 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 20' ' ' LEU . 3.6 p-10 -81.06 -38.66 27.0 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.727 -0.789 . . . . 3.28 108.926 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 75' ' ' PHE . 34.2 tp -60.23 -49.06 79.11 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.686 -1.598 . . . . 0.76 106.686 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.65 71.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.2 tp10 -63.48 -56.98 11.75 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.559 -1.256 . . . . 3.36 108.496 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -55.11 -51.88 65.01 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 118.356 -1.338 . . . . 4.61 108.145 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.426 -1.31 . . . . 1.26 109.459 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.1 m -51.23 -43.47 61.47 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 118.72 -1.192 . . . . 1.32 108.718 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.5 t30 -94.98 42.46 1.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.874 -1.057 . . . . 3.69 108.994 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 14.9 mm-40 -144.8 -58.7 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.957 -1.02 . . . . 3.18 113.492 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HE ' ' HB3' ' A' ' 27' ' ' GLU . 3.5 mmt180 -101.45 -157.89 0.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.809 -1.087 . . . . 5.42 112.476 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -102.61 -75.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.177 -0.92 . . . . 4.9 113.411 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.62 53.57 2.73 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.627 -1.229 . . . . 3.42 112.418 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 1' ' ' MET . 39.9 t80 -117.92 140.11 50.19 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.963 -1.095 . . . . 1.62 109.87 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' H ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 mt-30 -156.64 179.95 8.77 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.12 -1.807 . . . . 3.09 106.12 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 3' ' ' THR . 19.7 p90 -171.58 159.26 5.4 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.073 -1.451 . . . . 1.19 111.369 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -133.09 151.36 52.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.772 -1.566 . . . . 3.57 106.772 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -103.67 144.9 30.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.464 -1.695 . . . . 1.09 109.678 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.4 t -132.71 148.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.453 -1.249 . . . . 0.57 108.925 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.07 113.37 20.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.627 -1.249 . . . . 2.21 107.627 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 30.9 pt -44.59 -31.03 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.391 0 CA-C-N 115.211 -0.904 . . . . 1.44 110.466 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 38' ' ' ILE . 43.6 ttp180 -71.72 -60.44 2.23 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.112 -1.035 . . . . 4.78 109.322 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.34 -43.25 1.15 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.573 0.546 . . . . 1.75 110.174 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.61 -48.37 26.89 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.283 0.989 . . . . 4.46 109.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.33 41.51 0.81 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.41 -0.9 . . . . 2.47 111.235 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 62.7 mt -103.74 164.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.637 -0.505 . . . . 2.29 109.637 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 43' ' ' ILE . 40.2 p -113.25 -104.86 0.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.612 -0.722 . . . . 3.96 112.87 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 57' ' ' GLU . 34.7 tttp -142.82 -25.77 0.61 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.061 0.934 . . . . 6.88 109.614 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -86.98 -53.37 4.92 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 4.1 108.311 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' LEU . 17.9 t70 -47.5 -61.87 1.71 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.704 -0.798 . . . . 3.5 111.397 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -34.36 -46.89 0.28 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.436 -0.802 . . . . 2.17 111.073 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 53' ' ' GLY . 74.4 mt-30 -54.99 -54.56 41.38 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.119 -1.032 . . . . 5.61 108.486 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.4 mp0 -60.79 -36.86 80.07 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.711 -0.796 . . . . 7.44 109.93 178.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -64.26 -29.43 70.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.79 -1.096 . . . . 4.01 110.12 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.599 ' HB1' ' CD2' ' A' ' 68' ' ' HIS . . . -100.68 -74.81 0.6 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.68 -1.146 . . . . 2.06 109.595 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' GLN . . . 121.94 39.78 0.55 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.73 -1.224 . . . . 3.96 111.178 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 22.3 mmtp -138.05 152.01 71.12 Favored Pre-proline 0 N--CA 1.499 2.017 0 C-N-CA 119.454 -0.898 . . . . 6.68 110.072 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.63 49.54 3.21 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 122.391 2.061 . . . . 6.02 111.188 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.64 94.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 115.188 -0.914 . . . . 7.23 108.707 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.49 -0.67 11.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.853 -0.739 . . . . 8.45 111.554 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 59' ' ' VAL . 16.7 m -88.67 171.85 9.7 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.149 0.5 . . . . 5.37 110.434 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' N ' HG22 ' A' ' 58' ' ' THR . 13.2 p -101.05 160.32 26.98 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 115.847 -0.615 . . . . 3.51 110.678 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 73.2 Cg_endo -100.12 -163.77 0.54 Allowed 'Cis proline' 0 N--CA 1.484 0.967 0 CA-C-O 121.926 0.719 . . . . 1.93 111.344 -27.18 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -124.58 155.24 39.4 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.298 -1.319 . . . . 3.26 108.608 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' A' ' 5' ' ' ILE . 36.2 mm -121.97 146.05 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 123.984 0.803 . . . . 1.99 110.251 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 12.5 m-85 -123.22 130.67 53.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.727 -1.579 . . . . 1.2 107.257 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 69' ' ' ILE . 55.3 t -109.81 138.06 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 118.221 -1.391 . . . . 1.13 109.275 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.2 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.2 -1.818 . . . . 3.06 111.716 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -136.47 -2.64 2.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.601 0.563 . . . . 5.93 111.499 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.31 176.4 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.423 0.63 . . . . 4.94 111.699 -178.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.599 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -96.49 147.0 24.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.176 -1.787 . . . . 2.29 106.176 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 64' ' ' VAL . 41.7 mm -116.14 -46.5 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.703 -1.199 . . . . 1.17 110.414 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.69 -153.09 25.07 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.438 -1.363 . . . . 1.76 111.173 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.47 -170.47 47.15 Favored Glycine 0 N--CA 1.504 3.226 0 C-N-CA 119.242 -1.456 . . . . 1.46 112.149 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.9 t80 -51.93 -45.09 64.17 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.069 -0.652 . . . . 2.11 109.836 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 p -64.34 -42.45 96.25 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.349 -0.94 . . . . 1.32 109.297 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.478 ' CG ' ' NZ ' ' A' ' 54' ' ' LYS . 21.0 m-20 -62.32 -48.79 78.3 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.198 -1.401 . . . . 2.68 110.018 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 20' ' ' LEU . 12.8 t80 -60.62 -51.81 67.81 Favored 'General case' 0 C--O 1.2 -1.5 0 C-N-CA 117.936 -1.506 . . . . 1.03 108.102 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.79 30.52 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.453 -0.899 . . . . 0.93 111.077 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.04 -55.3 13.07 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.696 -0.802 . . . . 1.16 109.538 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -41.41 -47.46 3.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.929 -1.137 . . . . 1.05 107.929 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 81' ' ' GLU . 40.9 t -61.14 -57.69 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 106.16 -1.793 . . . . 1.34 106.16 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.522 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 1.3 tmtm? -75.96 32.18 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.83 -0.748 . . . . 3.72 110.427 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 79' ' ' VAL . 28.2 tt0 -132.37 -56.55 0.96 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.511 0.672 . . . . 5.45 109.262 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -98.64 -11.54 21.97 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.857 -1.065 . . . . 2.15 111.155 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -108.23 -34.65 6.77 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.76 -1.176 . . . . 2.36 108.842 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -139.59 60.27 1.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.161 -1.016 . . . . 6.06 110.541 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.522 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.51 2.548 0 CA-C-O 115.569 -2.158 . . . . 7.53 114.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 30' ' ' ASP . 69.0 mtm . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 107.988 -1.116 . . . . 2.42 107.988 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 20.1 mt-30 -128.04 157.43 40.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 123.633 0.583 . . . . 3.48 110.029 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -141.6 141.71 33.46 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.819 -0.752 . . . . 0.7 112.065 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.0 t -133.11 139.09 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 106.539 -1.652 . . . . 0.74 106.539 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 4.6 mp -123.66 128.17 74.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.354 -0.98 . . . . 1.99 108.354 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -97.37 61.12 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.386 -1.339 . . . . 1.07 107.386 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -104.96 -158.5 23.36 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.153 -1.979 . . . . 1.3 108.153 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 21.9 ttp-105 -127.73 169.29 13.99 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.507 -1.294 . . . . 5.37 107.507 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -52.72 -50.16 63.94 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.182 -1.044 . . . . 4.41 108.182 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' CYS . . . -149.06 166.87 29.44 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.803 -1.189 . . . . 3.2 111.366 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.4 p 167.84 42.51 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.366 0 CA-C-O 122.795 1.283 . . . . 3.7 108.407 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -20.94 -48.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.431 2.754 . . . . 3.05 112.765 -99.525 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -27.4 -40.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 124.772 1.295 . . . . 2.51 113.907 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 85.1 m -53.59 -45.16 69.91 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.948 -0.701 . . . . 1.86 112.322 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.34 -34.49 50.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.887 -0.597 . . . . 1.03 111.081 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -50.96 -51.35 53.41 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.882 -1.127 . . . . 4.0 112.043 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.2 -42.66 81.67 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.302 -0.959 . . . . 1.33 109.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 28.8 tttm -63.22 -52.99 59.98 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.214 -1.357 . . . . 2.7 114.007 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.4 p30 -53.82 -34.04 58.01 Favored 'General case' 0 C--O 1.198 -1.651 0 C-N-CA 118.282 -1.367 . . . . 3.38 111.083 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.85 -42.44 89.34 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.269 -1.372 . . . . 0.95 109.703 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.93 19.34 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 120.448 -0.501 . . . . 0.97 110.971 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 22.6 tt0 -59.29 -40.95 87.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.845 -1.169 . . . . 3.31 107.845 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 4.6 ttmp? -64.0 -55.85 19.37 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 106.826 -1.546 . . . . 6.15 106.826 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.686 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 28.9 mt -46.96 -47.31 21.85 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 119.915 -0.714 . . . . 1.16 110.445 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -57.87 -11.42 2.32 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 124.256 0.972 . . . . 1.71 112.541 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -114.83 -41.04 3.43 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.12 -0.491 . . . . 2.94 111.067 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.686 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 13.0 pt-20 -74.65 -37.78 62.66 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.254 -0.885 . . . . 3.8 111.708 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 3.3 ttp180 -114.22 -168.26 1.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.388 0.613 . . . . 5.95 111.081 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 9.0 p-10 -124.12 -168.33 1.78 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 105.521 -2.029 . . . . 3.98 105.521 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.4 t70 37.53 41.39 0.28 Allowed 'General case' 0 N--CA 1.508 2.474 0 O-C-N 123.677 0.611 . . . . 3.43 110.543 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.38 93.07 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.441 -0.903 . . . . 0.98 109.889 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 11.7 mm100 -105.49 117.73 34.77 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.592 -1.633 . . . . 4.07 106.592 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -119.12 155.55 31.37 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.984 -1.007 . . . . 2.14 112.157 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.84 150.0 50.52 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.515 -2.031 . . . . 3.46 105.515 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 18' ' ' LYS . 26.0 t80 -112.08 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.784 -1.566 . . . . 1.88 108.48 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 5' ' ' ILE . 2.1 t -124.66 155.28 32.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.351 -1.351 . . . . 1.26 107.351 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 39' ' ' ARG . 1.8 t70 -127.69 42.71 3.27 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.831 0.678 . . . . 2.66 112.831 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.83 -65.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 114.97 1.47 . . . . 1.76 114.97 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -56.21 -51.29 68.62 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 4.55 108.521 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -42.83 2.25 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.902 -1.044 . . . . 1.26 111.203 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.26 -47.85 17.01 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.995 -1.113 . . . . 4.42 107.995 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.52 46.4 0.92 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.417 -1.873 . . . . 1.6 108.417 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.417 HG21 ' HG ' ' A' ' 48' ' ' LEU . 11.8 mm -89.23 155.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 120.374 -0.53 . . . . 1.99 111.824 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' GLU . 34.2 p -126.47 95.29 4.31 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.864 -0.607 . . . . 3.12 111.615 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 tttm 6.12 -64.6 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 116.656 2.095 . . . . 4.49 116.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' THR . 6.6 mm-40 -47.86 -44.99 29.76 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.252 -0.979 . . . . 4.68 110.841 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.2 t70 -58.5 -37.65 76.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.315 -0.857 . . . . 3.23 110.5 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HA ' ' CG ' ' A' ' 51' ' ' LYS . 6.7 mt -65.2 -45.86 83.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.135 -1.061 . . . . 1.62 108.135 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 13.1 mt-30 -49.99 -41.69 47.49 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.517 -1.29 . . . . 4.87 107.517 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 94.6 mt-30 -66.8 -60.74 2.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.608 -0.723 . . . . 5.23 112.496 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.576 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -60.46 -37.68 81.74 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.434 -0.906 . . . . 4.7 113.295 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -86.55 -53.43 4.98 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.719 0.771 . . . . 1.85 110.481 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.18 -55.73 0.59 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.123 -1.591 . . . . 3.57 109.123 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.79 74.7 37.93 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 119.602 -0.839 . . . . 5.81 113.08 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 52' ' ' ALA . 11.9 Cg_endo -89.59 140.96 3.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.223 1.948 . . . . 8.38 107.615 126.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.91 -15.78 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.971 -0.692 . . . . 5.56 110.043 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -119.27 -105.21 0.39 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.845 -0.616 . . . . 6.66 111.295 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.426 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 98.2 m -140.43 -57.09 0.53 Allowed 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.782 -0.767 . . . . 6.42 109.542 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 42.1 t -112.63 151.63 44.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.662 -0.815 . . . . 4.43 109.018 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HG2' ' N ' ' A' ' 72' ' ' TYR . 12.9 Cg_endo -97.67 173.47 10.38 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 O-C-N 122.619 0.799 . . . . 3.06 111.592 -14.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 3.1 mp0 -130.97 119.97 22.84 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 5.56 109.237 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -127.39 146.71 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.511 -0.876 . . . . 1.2 111.309 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 16.2 m-85 -126.86 133.05 50.81 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.01 -1.904 . . . . 1.03 107.035 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.605 HG11 ' CH2' ' A' ' 78' ' ' TRP . 85.5 t -131.76 150.6 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 118.733 -1.187 . . . . 1.34 110.097 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 66' ' ' GLN . 8.9 t70 60.12 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.464 -1.698 . . . . 5.01 107.978 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG3' ' C ' ' A' ' 65' ' ' ASP . 33.1 mt-30 -139.27 -16.27 1.07 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 124.209 0.943 . . . . 5.53 112.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -110.2 171.99 7.13 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.756 -0.778 . . . . 3.59 113.085 -178.041 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.4 t-80 -81.0 153.55 27.37 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.858 -1.904 . . . . 1.23 105.858 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 64' ' ' VAL . 12.2 mm -116.2 -43.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.4 -1.32 . . . . 1.01 109.81 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 139.93 -131.33 5.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.466 -1.454 . . . . 1.75 109.466 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.441 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.88 -154.27 12.55 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.756 -0.937 . . . . 1.44 110.756 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' N ' ' HG2' ' A' ' 60' ' ' PRO . 26.9 t80 -57.67 -56.33 23.37 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.1 -1.04 . . . . 1.53 111.01 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -38.24 17.24 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.878 -0.729 . . . . 1.38 110.537 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -72.41 -59.42 2.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.051 -0.977 . . . . 2.48 110.259 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.75 -45.8 63.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.471 -0.937 . . . . 1.48 108.471 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -58.69 6.63 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.931 -1.031 . . . . 0.85 109.272 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.13 -54.97 41.0 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.097 -1.041 . . . . 1.45 110.549 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.605 ' CH2' HG11 ' A' ' 64' ' ' VAL . 75.2 t90 -45.81 -53.81 9.04 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.413 -0.915 . . . . 1.65 109.131 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 83' ' ' LEU . 25.0 t -47.25 -58.82 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 124.453 1.096 . . . . 0.9 108.213 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 2.1 tmtm? -56.29 -54.18 48.41 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.015 1.117 . . . . 3.43 114.015 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.3 -33.19 70.79 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.519 0.933 . . . . 4.76 113.519 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.78 -26.98 13.28 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.182 1.179 . . . . 1.57 114.182 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 79' ' ' VAL . 11.4 mt -93.24 -22.56 18.94 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.367 -1.333 . . . . 1.73 111.52 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 6.3 m-20 -110.98 -50.95 2.9 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.256 -0.977 . . . . 4.28 108.694 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.161 0 O-C-N 126.377 2.298 . . . . 6.08 107.013 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 34.9 tpp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 2.74 108.284 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.521 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 34.8 mt-30 -97.03 97.35 9.16 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.964 -0.694 . . . . 3.69 109.81 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 m -83.02 114.22 21.12 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.513 -0.875 . . . . 1.16 109.895 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.67 140.01 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.077 -1.083 . . . . 1.0 108.077 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 17.8 mt -120.1 105.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 124.452 1.095 . . . . 2.32 110.428 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 31.1 m-85 -84.53 93.86 8.44 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.28 -1.008 . . . . 1.01 108.28 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.635 ' CA ' ' SG ' ' A' ' 14' ' ' CYS . . . -106.76 -163.08 22.32 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.051 -1.22 . . . . 1.39 110.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.515 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 ttp-105 -141.43 46.68 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.284 -1.366 . . . . 5.94 111.902 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' ' OD2' ' A' ' 37' ' ' ASP . 14.4 m 69.61 -70.73 0.14 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.809 1.04 . . . . 3.79 113.809 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.14 66.89 0.23 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 119.946 -1.121 . . . . 3.77 112.724 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -134.81 113.68 11.81 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.327 -1.36 . . . . 2.4 107.327 178.318 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.01 -50.7 9.48 Favored 'Trans proline' 0 C--O 1.205 -1.171 0 N-CA-C 109.033 -1.18 . . . . 3.5 109.033 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . 3.7 m-85 -52.84 -36.13 58.31 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.051 -0.977 . . . . 2.76 111.993 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' CA ' ' A' ' 7' ' ' GLY . 71.0 m -66.36 -53.21 38.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.205 -0.998 . . . . 2.22 109.475 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.1 t -62.08 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.8 -1.091 . . . . 1.05 110.136 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.55 ' NH2' ' N ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -61.27 -47.48 85.83 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.815 -0.629 . . . . 3.83 110.484 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.53 -47.91 80.71 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 5.7 tmtm? -56.96 -43.69 81.86 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 118.512 -1.275 . . . . 2.07 109.715 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 2.0 t0 -51.98 -51.25 58.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.74 -1.208 . . . . 3.32 107.74 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' ' NH2' ' A' ' 16' ' ' ARG . 31.4 tp -56.6 -52.09 66.17 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.929 -1.108 . . . . 1.24 110.098 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -46.17 -51.89 13.29 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.781 -1.168 . . . . 1.02 109.937 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -44.3 -47.48 9.51 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.113 0.959 . . . . 3.04 110.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' NZ ' ' HG2' ' A' ' 27' ' ' GLU . 8.9 tmtm? -75.0 -45.95 38.45 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.385 -1.326 . . . . 4.64 111.865 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 83' ' ' LEU . 1.3 mt -49.56 -48.52 48.46 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 119.375 -0.93 . . . . 1.66 110.531 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 m -42.99 -32.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.297 -1.774 . . . . 1.57 109.579 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -109.92 45.43 1.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.856 -1.065 . . . . 2.66 109.863 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HG2' ' NZ ' ' A' ' 23' ' ' LYS . 29.6 mm-40 -137.22 -54.46 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.729 -1.123 . . . . 3.89 110.103 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.418 ' NE ' ' HB3' ' A' ' 83' ' ' LEU . 50.1 mmt-85 -101.78 175.47 5.54 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.875 -1.057 . . . . 4.84 109.658 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.41 -51.24 17.99 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.984 -1.462 . . . . 5.1 114.324 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 37.3 t70 -118.2 82.08 1.78 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.336 -0.946 . . . . 4.26 111.7 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.97 113.45 14.6 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.702 -0.799 . . . . 0.98 110.459 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.06 157.87 26.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.682 -1.97 . . . . 3.79 105.682 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.9 p90 -156.39 153.48 29.0 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 117.562 -1.655 . . . . 1.2 111.29 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.9 146.68 43.61 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.183 -0.917 . . . . 3.25 109.724 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -94.97 144.43 25.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.264 -1.384 . . . . 1.18 107.264 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.99 155.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 123.752 0.657 . . . . 0.87 109.685 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' NH1' ' A' ' 39' ' ' ARG . 10.0 t70 -132.62 137.7 47.11 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.474 0.654 . . . . 2.52 109.306 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.43 HD11 ' HG3' ' A' ' 8' ' ' ARG . 31.5 pt -53.7 -25.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.392 0.886 . . . . 1.66 113.392 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 29.8 mtm-85 -88.66 -14.05 38.33 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.53 -1.268 . . . . 4.88 110.951 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.47 -40.7 61.71 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.99 -1.485 . . . . 1.55 106.99 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.37 -41.45 12.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.489 -1.687 . . . . 3.44 109.402 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.76 59.04 0.51 Allowed Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.653 -1.261 . . . . 1.73 111.116 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.2 mt -120.33 154.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.827 -0.749 . . . . 1.99 110.386 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -111.07 -160.72 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.052 -1.833 . . . . 2.32 106.052 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -99.13 18.43 17.44 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 116.772 -1.971 . . . . 4.37 109.413 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -101.76 -62.94 1.19 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.724 -1.58 . . . . 4.01 110.993 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' GLN . 1.9 t70 -56.51 -42.92 79.22 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.129 -0.628 . . . . 4.0 109.999 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -43.68 -38.57 3.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.804 -1.159 . . . . 1.89 109.948 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 56' ' ' VAL . 39.1 mm-40 -53.12 -42.76 66.32 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.869 -1.132 . . . . 4.68 109.219 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' ASP . 73.3 mm-40 -78.05 -37.04 47.62 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.812 -1.085 . . . . 6.22 111.665 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -68.81 -37.42 79.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.595 -0.842 . . . . 4.38 111.372 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -88.58 -47.53 8.23 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 124.128 0.893 . . . . 2.0 111.301 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.8 15.17 56.98 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.54 -1.424 . . . . 2.86 109.54 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.85 140.01 27.99 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 107.136 -1.431 . . . . 5.92 107.136 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.49 142.62 11.82 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 120.914 1.076 . . . . 4.58 111.662 -165.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.549 ' N ' HE22 ' A' ' 49' ' ' GLN . 40.8 t 66.75 -66.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.629 1.344 . . . . 5.42 114.629 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.92 144.55 1.77 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.81 -0.756 . . . . 6.12 111.363 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 45' ' ' LYS . 21.8 m -120.87 -65.12 1.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.582 -0.735 . . . . 7.03 111.643 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.34 154.76 81.7 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 120.206 -0.598 . . . . 3.69 110.254 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 13' ' ' TYR . 9.5 Cg_endo -92.94 142.53 9.3 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 124.284 -1.132 . . . . 1.6 109.775 0.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -113.62 141.05 47.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.947 -1.101 . . . . 3.47 108.361 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.5 mp -111.08 139.07 36.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 124.019 0.825 . . . . 1.36 108.954 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -118.32 122.49 43.0 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 103.634 -2.728 . . . . 1.41 103.634 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 50.3 t -99.53 83.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 117.202 -1.799 . . . . 1.92 111.627 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 28.3 t0 72.85 -60.27 0.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.326 -1.307 . . . . 3.8 113.637 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 3.4 pt20 -106.36 -56.14 2.23 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 115.337 1.606 . . . . 6.82 115.337 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 15.2 pt20 -118.86 176.2 5.39 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.318 1.229 . . . . 4.19 114.318 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.566 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 12.3 t-80 -77.77 147.16 35.45 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.872 -1.529 . . . . 1.59 106.872 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.571 HG13 ' CG2' ' A' ' 64' ' ' VAL . 34.4 mm -117.57 -29.36 2.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.8 -0.76 . . . . 1.23 111.443 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.404 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 133.84 -156.32 22.25 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.085 -1.606 . . . . 2.14 109.085 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.86 -170.74 34.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.502 -1.439 . . . . 1.48 109.502 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -52.21 -36.38 51.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.641 -1.224 . . . . 1.41 110.446 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 p -64.08 -61.46 2.25 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.37 -1.332 . . . . 1.57 109.836 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.18 -50.15 67.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.635 -0.711 . . . . 2.49 110.313 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.19 -46.75 88.66 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 119.543 -0.863 . . . . 1.04 109.003 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.91 26.93 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.598 -0.841 . . . . 0.95 110.411 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.36 -58.7 6.24 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.186 -1.005 . . . . 1.2 108.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.42 ' O ' ' C ' ' A' ' 79' ' ' VAL . 61.8 t90 -40.66 -57.81 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.359 -0.837 . . . . 1.25 108.963 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 78' ' ' TRP . 2.4 t -40.7 -51.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.297 -1.372 . . . . 1.0 107.297 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -59.39 -60.96 3.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.451 -1.249 . . . . 2.83 110.406 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -76.81 31.21 0.13 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 113.454 0.909 . . . . 4.34 113.454 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.9 m120 -145.0 -40.0 0.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.972 -0.558 . . . . 1.77 110.704 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 24' ' ' LEU . 35.7 mt -96.05 -26.12 15.64 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.036 -1.066 . . . . 1.56 111.325 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.424 ' OD2' ' HA ' ' A' ' 80' ' ' LYS . 44.7 m-20 -94.26 -42.21 9.05 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 107.136 -1.431 . . . . 4.1 107.136 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.461 0 CA-C-O 116.472 -1.727 . . . . 5.44 106.931 178.549 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 83' ' ' LEU . 25.2 ttm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.851 -1.166 . . . . 3.17 107.851 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 54.9 mt-30 -133.33 150.22 51.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.35 -0.611 . . . . 3.86 109.35 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 22.6 m -140.4 137.77 34.25 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 118.636 -1.226 . . . . 0.72 112.761 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.29 133.43 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.432 -0.951 . . . . 0.58 108.432 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' HB1' ' A' ' 17' ' ' ALA . 22.0 mm -111.64 128.73 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 124.437 1.085 . . . . 1.54 108.265 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 36' ' ' VAL . 30.6 m-85 -109.94 73.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.931 -1.137 . . . . 1.07 107.931 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -133.71 -159.57 9.04 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 106.627 -2.589 . . . . 1.14 106.627 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.749 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.5 ptm180 -123.88 143.53 50.3 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.025 -1.47 . . . . 5.45 109.245 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -64.78 76.95 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.35 -1.75 . . . . 4.19 108.952 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 151.04 13.42 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.189 -1.005 . . . . 2.59 111.889 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.749 ' SG ' ' HG2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -119.98 124.91 27.61 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.585 -0.895 . . . . 2.38 108.585 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -41.32 -64.21 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.063 0 C-N-CA 122.422 2.081 . . . . 2.98 112.017 -170.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -47.01 -38.83 11.48 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.922 -0.711 . . . . 3.55 112.553 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 m -75.1 -57.94 3.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.609 0.718 . . . . 2.18 109.306 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.09 -41.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 114.038 -1.437 . . . . 1.03 108.819 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 115.543 -0.753 . . . . 5.28 109.423 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' ARG . . . -40.37 -43.26 1.73 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.454 -0.898 . . . . 0.97 108.896 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 12.6 tmtt? -60.2 -58.29 9.16 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.349 -1.352 . . . . 2.21 107.349 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -48.48 -51.22 28.19 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.843 -0.743 . . . . 3.62 109.648 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 ' CD2' ' A' ' 75' ' ' PHE . 44.2 tp -52.2 -54.02 36.16 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.002 -0.74 . . . . 0.84 109.002 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -57.0 13.62 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.295 -0.962 . . . . 0.77 109.509 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 13.7 tt0 -51.91 -40.28 60.48 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.156 -0.929 . . . . 3.06 110.966 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -60.48 -60.17 4.24 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.722 -1.214 . . . . 3.54 107.722 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.654 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 53.5 mt -47.0 -52.37 14.92 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.233 -0.987 . . . . 1.07 111.564 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -39.84 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 114.288 1.218 . . . . 1.43 114.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -118.8 -30.72 5.01 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.19 -0.604 . . . . 3.28 111.824 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -80.71 -19.74 44.41 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.922 -0.711 . . . . 3.77 111.149 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.531 HH12 ' CB ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -111.93 -154.78 0.55 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.674 -1.148 . . . . 5.06 108.423 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -115.81 -79.14 0.58 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 114.009 1.114 . . . . 4.01 114.009 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 9.4 p-10 -93.84 60.83 2.97 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.632 -0.827 . . . . 3.46 111.003 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -116.32 99.96 7.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.914 -1.114 . . . . 0.9 112.069 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 56.9 mm-40 -104.92 161.99 13.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.256 -1.387 . . . . 3.68 107.256 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' HA ' ' H ' ' A' ' 3' ' ' THR . 40.2 p90 -159.12 166.46 31.49 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.552 -1.259 . . . . 1.73 109.253 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.01 146.48 40.91 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.746 -1.575 . . . . 3.35 106.746 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.76 135.02 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.873 -1.531 . . . . 1.05 107.906 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.0 t -119.51 144.15 28.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 105.859 -1.904 . . . . 0.7 105.859 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 6.0 t70 -117.25 102.22 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.344 -0.942 . . . . 2.37 111.295 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -49.97 -23.91 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 114.858 -1.065 . . . . 2.26 111.17 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -87.8 -61.2 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.182 -1.407 . . . . 8.42 108.618 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.41 -43.15 23.42 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 123.789 0.681 . . . . 2.6 112.836 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.19 -34.8 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.89 -0.724 . . . . 2.39 112.025 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.51 50.49 1.2 Allowed Glycine 0 N--CA 1.505 3.257 0 C-N-CA 119.89 -1.148 . . . . 1.97 110.722 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 76.2 mt -109.71 143.24 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 120.161 -0.616 . . . . 1.52 111.325 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 p -110.96 -97.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.474 -0.936 . . . . 2.17 108.474 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 56' ' ' VAL . 29.3 tttm -134.31 -54.31 0.85 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.619 -0.882 . . . . 5.98 108.619 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.84 -52.81 4.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.371 -1.286 . . . . 4.66 110.97 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -54.01 -72.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 118.905 -1.118 . . . . 4.31 108.932 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 83.4 mt -35.12 -49.62 0.48 Allowed 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 112.541 0.571 . . . . 3.22 112.541 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -46.41 -50.84 16.14 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.828 -0.749 . . . . 5.35 109.545 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -43.34 -36.73 1.98 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.027 0.83 . . . . 6.15 111.568 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' NZ ' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -95.68 -11.45 27.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.984 1.105 . . . . 4.86 113.984 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.57 -47.25 2.22 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 119.325 -0.95 . . . . 2.67 112.925 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.0 49.05 2.74 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 106.437 -2.665 . . . . 3.15 106.437 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -123.14 78.43 52.01 Favored Pre-proline 0 N--CA 1.505 2.325 0 N-CA-C 112.182 0.438 . . . . 5.95 112.182 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.53 33.77 0.45 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.677 1.584 . . . . 7.25 111.732 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -132.27 -81.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.908 -0.775 . . . . 6.22 108.908 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 58' ' ' THR . 20.1 pm0 -96.79 -165.46 1.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.369 -1.715 . . . . 5.28 106.369 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 10.1 t 177.43 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.993 -1.083 . . . . 8.39 112.698 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 16.3 t -117.33 138.83 25.35 Favored Pre-proline 0 N--CA 1.502 2.138 0 C-N-CA 119.488 -0.885 . . . . 3.77 110.485 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 56.6 Cg_endo -86.86 166.78 46.51 Favored 'Cis proline' 0 N--CA 1.493 1.458 0 C-N-CA 125.105 -0.79 . . . . 2.85 110.126 -23.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 29.8 mt-30 -140.76 161.92 36.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.518 -0.873 . . . . 3.08 111.787 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -122.94 146.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.127 -1.397 . . . . 1.37 108.243 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 51' ' ' LYS . 9.6 m-85 -123.8 127.18 47.72 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.027 -1.897 . . . . 1.75 106.483 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' HG13 ' A' ' 69' ' ' ILE . 38.9 t -109.72 136.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 117.996 -1.481 . . . . 0.98 107.863 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.84 -89.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.314 1.009 . . . . 2.85 108.383 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.3 mm-40 -141.99 3.95 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.744 0.653 . . . . 5.39 111.151 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -107.7 152.82 23.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.087 0.47 . . . . 5.14 111.138 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' HA ' ' CD1' ' A' ' 63' ' ' PHE . 35.9 t-80 -77.77 141.29 39.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.415 -1.698 . . . . 1.79 106.415 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.513 HG13 ' CG2' ' A' ' 64' ' ' VAL . 42.2 mm -115.42 -45.97 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 C-N-CA 118.235 -1.386 . . . . 1.13 109.253 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.66 -137.0 8.39 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.466 -1.35 . . . . 1.76 110.275 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.29 -166.94 21.22 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.754 -0.736 . . . . 1.57 111.54 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -55.16 -66.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.994 -0.683 . . . . 2.11 112.424 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -51.37 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.096 0.776 . . . . 1.84 113.096 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.95 -52.87 10.1 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.174 -1.01 . . . . 2.92 111.178 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CD2' HD23 ' A' ' 20' ' ' LEU . 44.3 t80 -49.62 -38.29 31.35 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.817 -1.153 . . . . 0.88 108.899 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -58.74 -65.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.149 -1.387 . . . . 0.93 110.319 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -54.87 41.91 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.894 -1.122 . . . . 1.15 108.113 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.468 ' HH2' ' SD ' ' A' ' 1' ' ' MET . 57.2 t90 -41.15 -51.05 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.263 0.977 . . . . 1.49 109.93 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 80' ' ' LYS . 2.1 t -48.74 -61.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 114.803 -1.089 . . . . 1.02 108.464 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.52 ' HZ3' ' HB3' ' A' ' 84' ' ' ASP . 5.9 tmtm? -53.58 -46.63 70.38 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.967 -0.693 . . . . 2.86 112.673 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -56.44 -55.72 30.17 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.504 -1.225 . . . . 3.74 113.564 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -89.06 -27.09 21.03 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 114.739 1.385 . . . . 2.01 114.739 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 1' ' ' MET . 60.4 mt -89.38 -19.24 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.157 -1.417 . . . . 1.58 111.894 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.531 ' CB ' HH12 ' A' ' 28' ' ' ARG . 10.3 t70 -121.71 -47.47 2.2 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.487 -1.285 . . . . 4.32 110.637 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.495 ' C ' ' HZ1' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.509 2.52 0 O-C-N 125.531 1.769 . . . . 6.17 108.453 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 71.2 mtm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.123 -0.695 . . . . 1.99 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 5.8 mt-30 -126.65 123.92 38.69 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 108.265 -1.013 . . . . 4.14 108.265 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.4 m -120.34 139.16 53.17 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.875 -1.13 . . . . 0.96 110.026 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.3 t -119.25 125.42 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.803 -0.759 . . . . 0.62 109.317 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -106.75 117.96 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 124.882 1.364 . . . . 2.07 107.928 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 15.4 m-85 -98.23 93.46 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.828 -1.175 . . . . 1.11 107.828 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.88 -170.67 16.02 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.771 -1.204 . . . . 0.93 110.897 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 22.0 mtp180 -126.81 27.28 6.05 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.086 -0.646 . . . . 6.35 109.292 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' ARG . 59.3 m 34.25 52.52 0.51 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 123.59 0.556 . . . . 3.6 111.111 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.1 52.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.799 -1.32 . . . . 3.58 109.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -151.71 72.38 8.1 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 107.623 -1.251 . . . . 3.3 107.623 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -29.2 -59.07 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 123.202 2.601 . . . . 2.72 113.796 -139.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -39.88 -38.97 0.75 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 120.603 -0.439 . . . . 4.79 112.0 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 92.2 m -51.05 -46.09 61.55 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.284 -0.871 . . . . 2.42 110.426 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -55.93 -48.2 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.651 -0.82 . . . . 1.16 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.497 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -42.98 -48.69 5.98 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.709 -0.796 . . . . 4.51 111.063 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.99 -44.86 15.38 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.591 -0.844 . . . . 0.9 110.571 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.2 tmtm? -63.77 -54.44 35.2 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 108.385 -0.969 . . . . 2.79 108.385 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.497 ' CG ' HH22 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -52.56 -43.09 65.0 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.799 -0.637 . . . . 3.13 111.699 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 39.2 tp -71.66 -49.41 40.1 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.028 -0.669 . . . . 0.97 109.831 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -57.29 -42.97 82.71 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.104 -1.443 . . . . 0.61 107.104 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.14 -57.86 10.04 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.586 -1.264 . . . . 2.82 107.586 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 22' ' ' GLU . 60.8 tttp -37.43 -61.77 0.57 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.32 -1.309 . . . . 3.78 108.911 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 mt -56.45 -56.92 15.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.776 -0.77 . . . . 1.72 112.564 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 -15.43 0.66 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 114.04 1.126 . . . . 1.55 114.04 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.9 t-20 -107.41 -44.5 4.3 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 119.842 -0.743 . . . . 3.08 110.508 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.73 -19.43 48.81 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.898 -1.501 . . . . 3.66 112.782 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NH1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -118.69 -178.36 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.789 -0.641 . . . . 6.48 109.954 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.08 -59.62 1.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 113.048 0.759 . . . . 3.76 113.048 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.5 t70 -78.08 52.74 1.11 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.889 0.852 . . . . 3.29 111.786 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -145.71 92.53 2.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.287 -0.883 . . . . 0.96 111.521 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 17.7 mp0 -105.14 126.76 52.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.604 -2.369 . . . . 3.31 104.604 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.68 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.3 p90 -127.03 157.57 39.25 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.813 -1.155 . . . . 1.48 109.549 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -131.23 140.62 49.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.495 -0.928 . . . . 3.79 108.495 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -99.83 131.01 46.07 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.936 -1.106 . . . . 1.26 108.045 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.2 145.47 22.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 114.689 -1.141 . . . . 0.71 108.932 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -118.52 116.72 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.436 -1.69 . . . . 2.66 106.436 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' A' ' 8' ' ' ARG . 2.7 pt -51.32 -27.7 6.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.319 -1.352 . . . . 1.32 112.416 -178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.6 -8.65 58.14 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.067 -1.053 . . . . 6.22 113.071 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.21 -37.6 12.0 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.392 -0.923 . . . . 1.47 108.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -87.03 -37.48 17.44 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.978 -0.689 . . . . 2.56 110.826 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 52.07 0.59 Allowed Glycine 0 N--CA 1.505 3.253 0 N-CA-C 110.105 -1.198 . . . . 1.42 110.105 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.2 137.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.899 -0.65 . . . . 1.6 109.363 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -103.41 -101.31 0.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.145 -1.428 . . . . 2.67 107.145 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -138.97 -47.45 0.49 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.557 -2.016 . . . . 6.44 105.557 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -46.07 -52.35 12.14 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.018 -1.104 . . . . 3.52 108.018 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 24.4 m-20 -44.93 -57.28 3.9 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.735 -1.121 . . . . 4.35 111.611 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 77.1 mt -56.04 -53.66 54.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.003 -1.453 . . . . 1.86 110.334 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -51.24 -47.04 62.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.991 -1.083 . . . . 3.86 109.022 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 12.9 tm0? -51.69 -45.13 63.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.819 -0.752 . . . . 6.03 108.998 178.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -68.37 0.81 3.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.863 -1.062 . . . . 4.03 113.472 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' PRO . . . -129.89 -44.76 1.18 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.942 -1.103 . . . . 2.83 112.272 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.44 -58.82 0.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.107 -1.197 . . . . 4.76 110.107 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 55.1 pttt -165.2 62.6 0.88 Allowed Pre-proline 0 N--CA 1.504 2.231 0 C-N-CA 119.201 -1.0 . . . . 11.28 112.844 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 10.1 Cg_endo -96.74 159.6 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.156 1.238 . . . . 6.44 112.041 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.75 -20.81 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 115.013 -0.994 . . . . 4.78 108.649 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.714 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -72.8 70.45 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.511 -1.222 . . . . 5.55 108.123 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.2 t -42.43 -45.66 4.46 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.389 -0.823 . . . . 6.6 110.465 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 60' ' ' PRO . 57.3 t -142.76 152.45 59.37 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.891 -0.781 . . . . 2.63 108.891 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 12.0 Cg_endo -84.26 166.8 60.23 Favored 'Cis proline' 0 N--CA 1.486 1.049 0 O-C-N 123.426 1.224 . . . . 1.98 109.885 -17.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 82.4 mt-30 -139.76 153.99 47.3 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.074 -1.05 . . . . 2.74 111.436 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.1 mt -134.07 150.97 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.703 1.24 . . . . 1.74 112.623 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.49 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 61.4 m-85 -135.87 126.35 26.85 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 112.62 -2.082 . . . . 1.18 108.852 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 69' ' ' ILE . 58.9 t -96.62 121.26 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 105.903 -1.888 . . . . 1.19 105.903 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.16 -87.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.902 0.751 . . . . 2.62 111.672 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.91 12.76 3.99 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.238 -0.985 . . . . 4.47 112.913 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 43.5 tt0 -111.83 156.73 21.53 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.877 -0.729 . . . . 3.91 109.699 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.49 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 22.3 t60 -90.92 138.34 31.67 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.025 -1.102 . . . . 1.54 108.025 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.586 HG13 HG23 ' A' ' 64' ' ' VAL . 9.7 mm -110.71 -31.73 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.523 -1.271 . . . . 0.9 110.547 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.96 -138.47 10.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.295 -1.431 . . . . 1.96 109.764 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . -94.29 -89.09 1.67 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.583 -1.294 . . . . 2.41 111.476 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.12 -55.32 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.849 -1.14 . . . . 1.72 109.49 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -43.04 -48.27 6.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.274 -1.01 . . . . 1.33 108.274 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -64.95 0.66 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.379 -1.737 . . . . 3.3 110.296 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -51.55 -46.15 63.29 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.246 -0.982 . . . . 1.11 109.25 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.77 -53.47 31.5 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.297 -1.001 . . . . 0.84 108.297 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' GLU . . . -55.47 -56.26 22.29 Favored 'General case' 0 C--O 1.198 -1.643 0 N-CA-C 107.933 -1.136 . . . . 0.98 107.933 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -50.16 -34.28 21.85 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 123.43 0.456 . . . . 1.3 110.631 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 t -71.49 -44.32 71.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.421 -0.955 . . . . 1.8 108.421 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' NZ ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -82.25 -65.8 0.97 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.443 -1.303 . . . . 3.07 111.602 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' ALA . 41.9 mt-10 -62.21 0.77 0.38 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 117.272 2.323 . . . . 4.71 117.272 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.48 -26.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.32 -0.952 . . . . 2.67 112.233 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.67 -21.98 28.1 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.281 -1.368 . . . . 1.95 112.713 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 80' ' ' LYS . 30.7 p30 -117.3 39.79 3.19 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 117.108 -1.837 . . . . 4.59 112.325 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.172 -1.87 . . . . 5.52 110.05 179.601 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 122.951 1.358 . . . . 2.82 109.16 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -121.02 126.5 50.06 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.829 -1.915 . . . . 5.97 105.829 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 64' ' ' VAL . 60.4 m -112.72 144.67 41.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.275 -1.37 . . . . 0.95 113.192 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.0 117.56 52.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.941 -1.874 . . . . 1.08 105.941 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 62' ' ' ILE . 16.2 mm -107.2 124.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.242 -1.392 . . . . 1.9 107.242 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.84 96.2 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.323 -1.732 . . . . 1.05 106.323 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -142.71 -152.6 5.71 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.639 -1.267 . . . . 0.9 111.631 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.04 6.58 3.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.996 -0.742 . . . . 6.74 108.996 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 t 45.24 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.569 1.176 . . . . 5.75 112.764 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.41 -66.51 3.63 Favored Glycine 0 N--CA 1.498 2.795 0 CA-C-N 114.781 -1.1 . . . . 4.65 111.443 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 137.93 89.28 Favored Pre-proline 0 N--CA 1.497 1.896 0 C-N-CA 119.886 -0.726 . . . . 2.75 111.143 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.38 -61.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.283 1.989 . . . . 3.16 111.021 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 10.3 t80 -48.89 -50.54 34.5 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.561 -0.855 . . . . 4.0 109.431 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -53.86 -53.51 51.5 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.675 0.75 . . . . 2.57 110.106 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -52.09 -43.21 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.513 -1.221 . . . . 0.96 111.182 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.526 HH22 ' N ' ' A' ' 20' ' ' LEU . 10.0 mmm180 -40.26 -50.96 2.76 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.714 -1.195 . . . . 3.84 112.188 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.75 -52.66 13.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.733 -1.187 . . . . 0.69 109.193 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -58.64 -45.97 88.14 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.987 -1.461 . . . . 1.93 110.482 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 66.0 t0 -62.11 -44.38 96.77 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.41 -0.916 . . . . 3.64 109.774 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' N ' HH22 ' A' ' 16' ' ' ARG . 11.0 tp -62.72 -58.87 5.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.617 -0.833 . . . . 0.91 109.077 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.69 -51.81 58.72 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.102 -1.039 . . . . 0.63 109.127 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.6 tt0 -46.33 -58.93 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.964 0.79 . . . . 3.24 109.796 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HZ2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -47.43 -60.6 2.41 Favored 'General case' 0 C--O 1.206 -1.195 0 O-C-N 125.644 1.84 . . . . 6.34 107.76 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 56.6 mt -51.08 -51.47 52.96 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.244 -1.383 . . . . 1.39 112.192 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 13.4 p -66.75 8.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.54 -1.264 . . . . 1.86 114.408 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.86 -39.71 2.1 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.693 -1.225 . . . . 4.04 107.693 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.94 -31.8 61.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.598 -1.183 . . . . 3.4 109.046 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.0 mtp-105 -110.76 -171.04 1.75 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.318 -1.31 . . . . 4.63 111.794 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -125.53 -48.9 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.176 -0.92 . . . . 3.69 111.748 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.68 -21.24 61.1 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.779 -1.168 . . . . 4.84 110.39 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 25' ' ' SER . 59.2 t80 -84.92 124.49 31.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.763 -1.175 . . . . 1.13 112.331 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 38.0 mt-30 -139.2 163.16 33.19 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.622 -1.626 . . . . 2.68 106.809 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 7.8 p90 -158.95 163.18 36.72 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.568 -1.253 . . . . 1.65 110.594 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 pt20 -128.73 157.25 41.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.463 -1.31 . . . . 4.71 107.463 177.868 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -115.56 127.36 55.2 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.06 -1.456 . . . . 1.7 107.78 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.2 t -113.45 132.05 63.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.423 -1.695 . . . . 0.82 106.423 179.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.3 t70 -108.27 110.57 22.21 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.44 -0.948 . . . . 1.9 108.44 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -44.58 -25.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.676 0.991 . . . . 1.13 113.676 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.523 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 6.4 mmm180 -91.93 -48.81 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.067 -1.453 . . . . 7.95 109.584 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -52.44 -40.76 62.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.401 -0.963 . . . . 1.48 108.401 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' GLY . 71.3 mm-40 -86.57 26.39 1.1 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.26 -1.336 . . . . 3.64 110.61 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 25.04 59.43 0.06 OUTLIER Glycine 0 N--CA 1.504 3.211 0 O-C-N 123.406 0.441 . . . . 2.39 113.73 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 44' ' ' THR . 31.7 mt -104.13 161.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.584 -0.895 . . . . 2.18 108.584 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 43' ' ' ILE . 8.9 t -112.96 -168.07 1.27 Allowed 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.671 -1.233 . . . . 3.01 107.671 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -82.3 -46.12 14.05 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.702 -1.199 . . . . 5.6 109.887 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.726 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.5 mp0 -44.48 -51.82 8.45 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.901 0.858 . . . . 4.48 110.281 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.32 -61.68 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.39 -1.277 . . . . 3.63 111.452 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.24 -52.58 2.62 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.011 -0.995 . . . . 1.88 113.497 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -44.68 -46.39 10.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.332 -0.947 . . . . 4.81 111.243 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -51.27 69.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.772 0.67 . . . . 6.69 111.244 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.605 ' NZ ' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -46.48 -37.69 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.494 -1.23 . . . . 4.48 112.868 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.97 -30.06 11.85 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.224 0.952 . . . . 2.0 111.574 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.56 49.88 17.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.29 -1.124 . . . . 3.34 110.29 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 37.0 mttm -142.56 156.62 63.3 Favored Pre-proline 0 N--CA 1.501 2.114 0 C-N-CA 118.655 -1.218 . . . . 7.51 112.003 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 8.1 Cg_endo -81.33 39.34 0.85 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.318 2.012 . . . . 5.89 111.175 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 p -141.01 125.86 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.529 -2.026 . . . . 5.14 105.529 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 63.54 0.91 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.254 0.835 . . . . 8.74 113.254 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.5 p -105.08 166.62 10.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.181 -1.408 . . . . 5.2 112.558 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -113.81 152.37 45.53 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.672 -1.233 . . . . 3.2 107.672 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.93 177.04 22.42 Favored 'Cis proline' 0 N--CA 1.485 0.973 0 O-C-N 122.541 0.758 . . . . 2.0 110.848 -12.489 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -131.81 142.05 49.62 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.842 -0.743 . . . . 2.99 109.627 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.8 mp -119.65 143.18 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-O 121.822 0.82 . . . . 1.47 111.663 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CE2' ' NZ ' ' A' ' 51' ' ' LYS . 84.3 m-85 -128.87 136.66 50.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.412 -1.722 . . . . 1.22 108.745 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.691 HG11 ' CH2' ' A' ' 78' ' ' TRP . 75.5 t -122.76 137.3 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.489 -1.284 . . . . 1.25 109.293 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 56.4 m-20 54.42 -80.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.678 -1.601 . . . . 3.58 111.197 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' VAL . 40.3 tt0 -138.76 -19.66 1.03 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.294 -0.866 . . . . 4.68 112.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.65 163.82 12.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.948 1.092 . . . . 4.57 113.948 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.484 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 74.1 t60 -80.25 137.97 36.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.954 -1.93 . . . . 1.56 106.532 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.525 HG13 HG23 ' A' ' 64' ' ' VAL . 34.3 mm -110.15 -50.34 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.343 -1.343 . . . . 0.97 109.718 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.1 -141.07 10.88 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.472 -1.347 . . . . 1.6 110.81 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.7 -168.08 32.35 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.636 -1.386 . . . . 1.49 109.636 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 12.9 t80 -56.77 -23.27 41.87 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.854 -1.138 . . . . 1.32 109.358 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -75.33 -65.76 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 1.43 111.003 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.92 -43.06 69.44 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.54 -0.911 . . . . 2.88 108.54 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 62' ' ' ILE . 22.7 t80 -59.71 -53.43 58.04 Favored 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 107.159 -1.423 . . . . 1.13 107.159 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.4 11.52 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.573 -0.851 . . . . 0.77 111.043 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.4 -60.3 4.03 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.238 -0.985 . . . . 0.96 109.997 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.691 ' CH2' HG11 ' A' ' 64' ' ' VAL . 46.2 t90 -41.62 -49.41 4.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 123.825 0.703 . . . . 1.25 109.584 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -49.49 -61.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.096 -0.956 . . . . 1.12 110.12 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HZ2' ' C ' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -50.96 -50.63 57.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.672 -0.811 . . . . 3.11 111.503 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.54 -39.86 92.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.096 1.888 . . . . 3.94 116.096 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -105.48 -17.23 14.49 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.664 1.357 . . . . 1.65 114.664 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 31' ' ' PHE . 68.8 mt -97.55 -21.55 17.03 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.909 -1.516 . . . . 2.06 110.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.498 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 11.4 m-20 -139.16 32.07 2.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.096 -1.441 . . . . 4.68 111.373 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' C ' ' HZ2' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 117.835 -1.079 . . . . 5.34 110.808 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.01 -1.107 . . . . 2.91 108.01 . . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 9.1 tt0 -105.98 157.89 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.122 -1.066 . . . . 3.82 108.122 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.43 ' HA ' ' H ' ' A' ' 65' ' ' ASP . 31.0 m -149.22 149.74 31.46 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.861 -1.149 . . . . 0.91 109.84 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.87 134.7 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 119.981 -0.688 . . . . 0.62 111.197 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 62' ' ' ILE . 25.3 mm -114.93 119.61 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.97 -1.493 . . . . 1.72 106.97 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.493 ' CD2' HG11 ' A' ' 36' ' ' VAL . 36.3 m-85 -103.0 103.71 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.46 -0.941 . . . . 0.87 108.46 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.15 -150.18 5.43 Favored Glycine 0 N--CA 1.502 3.042 0 C-N-CA 119.399 -1.381 . . . . 1.24 110.932 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 38' ' ' ILE . 18.1 mtt180 -121.85 -144.89 0.35 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.267 -0.642 . . . . 7.34 109.267 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m -118.06 77.8 1.19 Allowed 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.973 -0.691 . . . . 3.42 112.085 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.03 44.07 0.64 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.109 -1.52 . . . . 2.48 111.041 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -110.0 101.61 47.91 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.438 -1.319 . . . . 2.13 107.438 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -32.86 -34.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 123.081 2.521 . . . . 2.24 112.899 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 1.7 t80 -75.54 -55.27 5.83 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.398 -0.819 . . . . 4.62 109.855 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -54.16 -40.71 67.72 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.03 -1.47 . . . . 2.51 107.03 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.47 -54.64 32.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.168 -1.378 . . . . 1.01 107.705 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 7.3 tpm_? -46.36 -51.91 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 3.28 110.325 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -58.1 -43.67 87.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.115 -1.034 . . . . 0.7 108.591 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.9 -47.84 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.205 -1.406 . . . . 2.76 107.205 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.25 -50.81 64.03 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.901 -1.12 . . . . 2.93 108.852 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -53.98 -58.28 7.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.037 -1.065 . . . . 1.34 110.324 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.29 -52.43 52.95 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.948 -1.101 . . . . 0.69 109.752 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.69 -49.08 66.02 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.291 0.567 . . . . 2.91 110.094 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 28.0 ttpp -48.76 -60.65 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.277 -0.969 . . . . 5.07 108.855 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD22 ' HD2' ' A' ' 28' ' ' ARG . 64.9 mt -48.19 -58.37 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.772 -0.771 . . . . 1.42 111.515 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 m -41.25 -34.13 0.45 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.674 -0.81 . . . . 1.38 110.896 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -88.19 -36.01 17.05 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 120.396 -0.522 . . . . 3.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 6.4 pt-20 -99.74 23.48 9.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.535 0.683 . . . . 4.4 112.017 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HD2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -137.02 177.11 8.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.775 -0.824 . . . . 4.53 108.775 179.003 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.56 -38.78 3.67 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.536 -1.211 . . . . 4.18 108.606 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.7 p-10 -110.34 22.0 16.02 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.821 -1.536 . . . . 4.12 113.424 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -102.83 99.48 9.42 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 118.189 -1.404 . . . . 0.92 114.406 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 42.5 mt-30 -111.64 127.82 55.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.835 -1.543 . . . . 2.8 106.835 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 25.5 p90 -129.64 162.1 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.624 -0.83 . . . . 1.05 110.326 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 53.9 tt0 -131.71 146.97 52.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.72 -0.844 . . . . 3.38 108.72 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -99.76 135.27 41.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.8 -1.556 . . . . 1.15 106.8 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.493 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -121.35 138.03 53.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.796 -0.816 . . . . 0.71 108.796 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -111.22 109.36 19.36 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.657 -1.156 . . . . 2.39 108.666 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CD1' HH21 ' A' ' 8' ' ' ARG . 27.0 pt -51.17 -25.81 4.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.915 -1.039 . . . . 1.26 109.392 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -79.33 -63.53 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.02 -1.072 . . . . 5.18 108.286 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.21 -42.3 0.67 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 123.66 0.6 . . . . 1.47 111.409 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.21 -46.81 14.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.85 -1.068 . . . . 2.4 111.028 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.67 51.79 0.83 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.821 -1.312 . . . . 1.76 109.821 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 44' ' ' THR . 24.4 mt -100.26 172.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.977 -0.611 . . . . 1.85 109.384 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.518 ' N ' HG22 ' A' ' 43' ' ' ILE . 51.5 p -103.67 -171.01 1.86 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.601 -0.888 . . . . 2.46 108.601 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 29.96 7.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.276 -1.379 . . . . 4.84 107.276 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -119.31 -55.6 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 110.341 -3.118 . . . . 3.53 104.084 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -47.96 27.65 Favored 'General case' 0 C--O 1.202 -1.396 0 CA-C-N 112.458 -2.155 . . . . 3.58 110.46 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 59' ' ' VAL . 59.2 mt -53.6 -37.97 63.51 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.897 -1.047 . . . . 1.98 111.819 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.67 -49.71 13.95 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.928 -1.109 . . . . 4.47 108.903 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' C ' ' CD ' ' A' ' 50' ' ' GLN . 11.2 tm0? -52.65 -43.94 65.81 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.749 -1.114 . . . . 4.73 110.062 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -16.33 35.1 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.924 -1.035 . . . . 4.95 111.681 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -89.75 -51.58 5.43 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.193 -1.781 . . . . 2.05 106.193 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.79 -25.19 2.56 Favored Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.371 -1.286 . . . . 2.98 110.558 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' VAL . 29.6 mtmm -109.43 155.78 40.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 109.008 -0.738 . . . . 9.97 109.008 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.5 74.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 123.053 2.502 . . . . 6.38 112.784 -149.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 54' ' ' LYS . 11.9 p -96.83 162.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.793 -0.817 . . . . 6.8 108.793 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.1 pt-20 -90.34 -99.22 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.908 -1.042 . . . . 6.68 110.552 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -131.03 -162.28 1.2 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.153 -0.619 . . . . 5.27 109.819 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 60' ' ' PRO . 73.0 t -84.14 140.25 39.63 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-N 115.007 -0.997 . . . . 4.05 109.639 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 59' ' ' VAL . 9.7 Cg_endo -91.31 164.93 28.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 O-C-N 123.069 1.036 . . . . 2.49 112.623 14.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -131.71 156.16 46.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.793 -1.094 . . . . 3.11 109.816 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 5' ' ' ILE . 68.2 mt -125.55 144.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.5 -0.773 . . . . 1.2 111.754 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 14.3 m-85 -129.03 122.65 30.46 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.624 -1.625 . . . . 1.1 108.942 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 69' ' ' ILE . 22.3 t -91.98 122.91 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 105.358 -2.09 . . . . 1.08 105.358 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.549 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 1.2 t70 64.05 -74.76 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 125.076 1.485 . . . . 2.91 109.099 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.549 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -147.92 -5.5 0.46 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.921 -0.581 . . . . 4.78 111.558 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -104.63 137.26 42.72 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.22 -0.592 . . . . 5.29 112.554 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 50.4 t-80 -68.92 129.92 41.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.765 -1.568 . . . . 1.6 106.765 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 64' ' ' VAL . 33.3 mm -106.73 -36.84 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.719 -1.193 . . . . 1.29 111.149 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.76 -132.33 4.36 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.692 -1.718 . . . . 1.63 110.843 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.62 -148.75 12.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.989 -0.844 . . . . 1.85 110.989 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 16' ' ' ARG . 72.9 t80 -78.79 -56.98 3.99 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.053 -0.573 . . . . 1.94 110.432 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.47 -64.99 0.64 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.141 0.793 . . . . 2.1 113.141 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -53.98 -60.19 3.65 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.211 -0.596 . . . . 2.73 109.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -43.93 -48.44 8.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.716 -0.476 . . . . 1.31 109.716 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.69 -59.26 5.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.01 -0.541 . . . . 1.42 109.91 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -53.25 -62.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.272 -1.01 . . . . 1.55 108.272 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -41.37 -60.21 1.34 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.194 -0.912 . . . . 1.6 109.657 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG1' HD21 ' A' ' 24' ' ' LEU . 3.2 t -40.61 -63.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.335 -1.357 . . . . 1.22 107.335 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -44.64 -54.9 5.69 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 125.018 1.449 . . . . 2.72 109.788 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' ALA . 18.0 mm-40 -80.17 26.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.199 0.815 . . . . 5.56 113.199 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -142.48 -43.5 0.32 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.13 -0.628 . . . . 1.73 111.504 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' HD3' ' A' ' 28' ' ' ARG . 14.6 mt -94.44 -4.19 48.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.385 -0.926 . . . . 1.77 111.794 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.85 -48.94 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 124.321 1.013 . . . . 3.6 108.592 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 116.727 -1.606 . . . . 5.72 108.713 179.201 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 83.3 mtp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 107.704 -1.221 . . . . 2.03 107.704 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -118.9 116.99 27.63 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.857 1.348 . . . . 5.0 107.541 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.0 m -99.74 131.91 45.42 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.5 -1.28 . . . . 0.67 108.41 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.64 128.93 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.849 -1.167 . . . . 0.54 107.849 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.77 109.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.633 -1.618 . . . . 1.66 106.633 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.581 ' CD2' HG11 ' A' ' 36' ' ' VAL . 26.8 m-85 -94.03 107.52 19.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.076 -1.453 . . . . 1.18 107.076 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.83 5.6 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.354 -0.927 . . . . 1.51 110.932 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.596 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 31.9 ptt-85 -130.06 -162.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.857 -1.164 . . . . 7.82 107.857 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 39' ' ' ARG . 33.3 p -132.49 140.09 48.22 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.178 -1.009 . . . . 3.96 110.961 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.4 -1.91 23.64 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.247 -0.977 . . . . 3.11 111.721 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 95.72 24.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 120.022 -0.671 . . . . 2.16 111.453 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 83.3 Cg_exo -35.29 -38.63 0.2 Allowed 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 122.339 2.026 . . . . 4.02 112.14 168.834 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -67.04 -45.12 78.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.701 -1.6 . . . . 3.8 109.217 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' NH2' ' A' ' 8' ' ' ARG . 82.0 m -53.32 -41.91 66.18 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.717 -1.193 . . . . 2.03 107.902 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' PRO . 58.0 t -48.33 -38.89 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.458 -0.897 . . . . 1.02 111.14 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.8 mmp_? -50.25 -20.94 1.17 Allowed 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 112.835 0.68 . . . . 5.79 112.835 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -43.77 22.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.76 -1.57 . . . . 0.83 106.76 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.0 tmtt? -57.1 -46.6 82.46 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.598 -0.889 . . . . 2.69 108.598 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.611 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 31.8 m-20 -53.3 -43.9 67.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.794 -1.162 . . . . 3.01 111.033 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.16 -57.73 4.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.17 -1.012 . . . . 0.81 109.529 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -43.22 37.31 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.056 -1.058 . . . . 1.13 109.156 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 19.9 tt0 -65.84 -65.21 0.7 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.366 -0.934 . . . . 2.72 109.504 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -36.33 -50.74 0.77 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.145 0.903 . . . . 3.6 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.551 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 95.2 mt -49.72 -40.15 39.53 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.823 -1.08 . . . . 1.26 112.272 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.0 m -50.48 -12.59 0.1 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.576 0.548 . . . . 1.25 111.618 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 24' ' ' LEU . 44.5 m-80 -114.73 -41.8 3.34 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.853 -0.612 . . . . 2.49 111.045 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 5.9 pt-20 -81.79 -10.59 59.3 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.156 -1.018 . . . . 3.69 113.415 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.5 mpt_? -105.76 -177.4 3.35 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.281 -0.967 . . . . 5.2 110.914 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -63.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.486 -1.234 . . . . 6.04 112.024 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.4 t70 -118.91 -43.78 2.64 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 109.476 -0.564 . . . . 5.47 109.476 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 25' ' ' SER . 16.4 t80 8.61 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.41 -1.723 . . . . 0.76 115.113 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -112.72 158.82 19.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.689 -1.967 . . . . 3.27 105.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.657 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 10.8 p90 -151.28 164.69 36.06 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.16 -1.416 . . . . 1.02 110.695 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -144.27 154.86 43.51 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.374 -1.343 . . . . 4.0 107.374 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 36' ' ' VAL . 38.7 t80 -106.76 148.28 28.64 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.117 -1.433 . . . . 1.7 109.068 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -131.02 125.86 58.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 124.399 1.062 . . . . 1.13 108.62 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -109.02 122.76 47.94 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.558 -1.275 . . . . 1.94 107.558 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.1 pt -51.93 -31.35 13.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.614 -0.834 . . . . 1.48 111.811 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.8 OUTLIER -84.22 -5.9 59.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.652 0.612 . . . . 4.82 112.652 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.12 -39.32 6.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.798 -0.761 . . . . 1.3 110.194 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.76 -35.08 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.442 -0.903 . . . . 2.67 110.148 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.41 53.85 0.71 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.151 -1.58 . . . . 1.91 109.151 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.25 137.68 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.506 -0.924 . . . . 1.8 108.506 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -117.46 54.06 0.9 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.69 -1.204 . . . . 4.28 113.901 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.1 mttp 62.94 -65.01 0.1 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.365 1.246 . . . . 7.52 114.365 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -44.25 -51.74 8.04 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.022 0.749 . . . . 4.65 113.022 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.46 -38.23 58.86 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.758 -1.177 . . . . 4.04 109.999 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLN . 71.9 mt -71.92 -51.77 20.51 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.311 -0.956 . . . . 1.73 108.522 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.405 ' C ' ' O ' ' A' ' 48' ' ' LEU . 12.3 tm0? -40.39 -45.21 2.14 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.178 -1.045 . . . . 5.49 108.178 178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -68.75 -58.02 4.81 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 126.008 2.068 . . . . 5.79 110.455 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -43.55 -37.51 2.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.669 -0.696 . . . . 3.67 112.327 -179.21 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.6 -8.83 18.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.044 0.84 . . . . 1.96 111.316 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.29 49.63 55.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.102 -1.599 . . . . 2.4 109.102 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 26.2 mmtp -122.97 154.26 64.36 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 114.401 -0.9 . . . . 4.99 110.739 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.25 36.34 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.282 1.321 . . . . 4.76 110.815 152.04 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 54' ' ' LYS . 25.1 t 57.24 151.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.432 1.083 . . . . 6.07 112.742 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.551 ' CG ' ' H ' ' A' ' 58' ' ' THR . 6.6 pm0 -131.17 -106.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.556 -1.275 . . . . 6.26 107.556 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 67.4 m -119.23 175.56 5.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.321 -1.363 . . . . 6.36 107.321 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.534 HG21 HH12 ' A' ' 8' ' ' ARG . 3.2 m -112.6 164.56 15.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.64 -0.504 . . . . 4.13 109.64 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.29 -172.5 10.93 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 124.131 -1.195 . . . . 2.3 110.421 -11.207 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -103.03 131.97 49.63 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.641 -1.614 . . . . 3.55 106.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.594 HG21 ' CG ' ' A' ' 75' ' ' PHE . 8.7 mm -108.62 125.92 65.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.356 -0.937 . . . . 1.48 110.832 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.21 124.16 41.84 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.421 -1.326 . . . . 1.03 107.421 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.474 ' CG2' HG13 ' A' ' 69' ' ' ILE . 42.2 t -116.54 122.91 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.068 -1.053 . . . . 1.0 108.863 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 50.44 32.2 6.26 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.013 1.863 . . . . 2.53 108.803 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 82.52 -34.5 0.09 Allowed 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 110.016 -3.266 . . . . 6.99 109.757 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -47.1 112.66 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 4.91 108.719 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HA2' ' A' ' 70' ' ' GLY . 21.6 t-80 -57.85 131.57 50.77 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 117.825 -1.55 . . . . 1.81 106.876 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 ' CG2' ' A' ' 64' ' ' VAL . 51.0 mm -105.43 -42.97 7.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.198 -1.408 . . . . 1.13 107.198 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 131.54 -125.1 4.27 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.941 -1.599 . . . . 1.59 111.109 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.22 19.8 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.626 -1.273 . . . . 1.94 112.281 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -52.46 -44.88 65.83 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.119 -1.04 . . . . 1.67 111.921 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -63.31 -58.82 5.88 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.306 -0.958 . . . . 1.57 110.794 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.85 -56.47 8.64 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.096 -0.642 . . . . 4.59 109.429 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 62' ' ' ILE . 66.7 t80 -55.46 -45.46 76.91 Favored 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 115.184 -0.916 . . . . 0.8 109.455 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.68 -55.1 33.31 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.716 -0.794 . . . . 0.78 110.334 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.73 63.89 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.722 -1.214 . . . . 1.09 107.722 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.448 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 81.6 t90 -42.75 -58.8 2.19 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 115.556 -0.747 . . . . 1.59 110.003 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 51.3 t -46.1 -23.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.275 -0.875 . . . . 1.89 111.579 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -105.8 -67.96 0.9 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.531 0.52 . . . . 2.55 110.769 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.51 -22.16 19.92 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.83 1.048 . . . . 4.69 113.83 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -112.5 -31.99 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 114.302 1.223 . . . . 3.11 114.302 -178.239 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 55.0 mt -96.87 -9.41 28.63 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 117.428 -1.709 . . . . 1.36 111.088 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 65.3 m-20 -120.76 -55.55 2.0 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.357 -0.979 . . . . 3.53 108.357 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.495 1.805 0 CA-C-N 111.359 -2.655 . . . . 6.03 106.158 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 45.3 tpp . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.706 -1.22 . . . . 2.7 107.706 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.2 100.03 11.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.606 -1.257 . . . . 3.76 107.606 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -87.84 120.88 29.6 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.408 -0.917 . . . . 0.86 109.237 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 46.2 t -108.44 135.17 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-N 115.876 -0.602 . . . . 0.73 109.44 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mm -118.79 111.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.691 1.245 . . . . 1.55 109.375 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 36' ' ' VAL . 47.7 m-85 -93.9 98.14 10.85 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.508 -0.477 . . . . 1.29 110.443 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.85 -163.01 11.55 Favored Glycine 0 N--CA 1.512 3.738 0 C-N-CA 120.339 -0.934 . . . . 1.06 111.123 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.579 ' HG2' ' NH1' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -129.47 18.61 5.82 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 119.167 -1.013 . . . . 6.55 112.477 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.7 m 72.55 -58.04 0.61 Allowed 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 113.772 1.027 . . . . 3.05 113.772 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.51 35.88 3.42 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 119.106 -1.521 . . . . 2.84 110.944 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.9 88.96 45.17 Favored Pre-proline 0 N--CA 1.491 1.599 0 C-N-CA 120.453 -0.499 . . . . 2.63 110.046 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.36 -53.48 1.34 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.711 2.274 . . . . 2.6 112.417 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -55.83 -49.58 72.88 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.769 -1.172 . . . . 3.73 109.292 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 37.0 m -57.59 -39.27 76.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.226 -0.99 . . . . 2.5 109.538 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' ARG . 58.6 t -60.19 -53.92 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.931 -1.108 . . . . 1.26 110.463 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tpm_? -35.83 -51.35 0.69 Allowed 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.09 0.472 . . . . 4.43 110.716 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.89 -48.22 3.08 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.696 -0.684 . . . . 0.92 111.245 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.7 tmtt? -52.25 -41.25 62.66 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.543 -0.753 . . . . 3.02 111.949 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.546 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 17.1 m-20 -53.12 -49.8 65.78 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 118.948 -1.101 . . . . 2.63 110.087 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.29 -55.71 4.7 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.81 -1.541 . . . . 1.74 108.387 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -60.18 -49.43 77.67 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.177 -1.829 . . . . 0.91 109.836 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -45.74 -53.38 9.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.784 1.302 . . . . 4.22 109.791 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 8.5 mmmm -56.89 -64.21 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.597 -0.729 . . . . 3.56 109.783 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -44.38 -56.89 3.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.947 -1.024 . . . . 1.22 113.249 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 p -48.16 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.044 1.498 . . . . 2.01 115.044 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -123.36 -36.07 2.86 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.117 0.484 . . . . 3.03 110.432 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -74.19 -31.16 62.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.975 -1.011 . . . . 3.66 110.424 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.415 HH21 ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -109.52 -166.38 1.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.05 -0.66 . . . . 5.47 110.256 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.1 p30 -96.8 -77.59 0.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.593 2.071 . . . . 4.53 116.593 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' C ' ' A' ' 31' ' ' PHE . 8.7 t70 -74.12 -59.47 2.71 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.457 0.91 . . . . 4.13 113.457 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' A' ' 30' ' ' ASP . 57.3 t80 0.06 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.528 1.307 . . . . 0.93 114.528 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -106.07 159.43 16.08 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.607 -1.997 . . . . 3.92 105.607 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.512 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 40.7 p90 -160.67 154.13 22.06 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.509 -1.276 . . . . 1.66 110.828 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.2 133.61 28.29 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.039 -0.982 . . . . 3.01 109.85 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.65 136.57 32.89 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.834 -2.284 . . . . 1.58 104.834 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 6' ' ' PHE . 1.6 t -126.79 147.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.87 -1.159 . . . . 0.59 107.87 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 1.5 t70 -122.15 135.61 54.81 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.027 -0.669 . . . . 2.27 110.688 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.42 -23.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.508 -1.277 . . . . 1.94 110.819 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -88.95 -3.57 58.7 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.724 -0.671 . . . . 5.86 112.637 -178.656 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.53 -41.83 7.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.786 -1.19 . . . . 1.44 107.786 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -83.45 -39.45 20.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.151 -1.386 . . . . 2.83 108.859 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.14 49.48 1.14 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.452 -1.859 . . . . 1.49 108.452 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 47' ' ' ASP . 74.4 mt -112.43 157.01 13.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 120.262 -0.575 . . . . 1.41 111.07 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 46' ' ' GLU . 15.3 p -110.92 -179.17 3.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.273 -1.01 . . . . 2.17 108.273 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -85.87 46.67 1.34 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 106.462 -1.681 . . . . 5.46 106.462 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' THR . 53.2 mt-10 -122.17 -61.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.577 -1.647 . . . . 4.07 107.274 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 16.7 t70 -49.75 -46.04 50.1 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 114.851 -1.068 . . . . 3.82 109.534 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -52.79 -4.55 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.756 1.021 . . . . 2.76 113.756 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' ASP . 1.1 mp0 -108.39 -53.17 2.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.234 -1.395 . . . . 5.42 107.234 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -60.37 -33.13 72.01 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.031 0.92 . . . . 6.18 110.745 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 1.8 ttpp -92.11 14.49 15.85 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.389 -1.278 . . . . 3.84 109.344 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -123.24 -59.82 1.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.304 1.003 . . . . 1.56 111.988 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.85 -20.35 48.28 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.179 -1.01 . . . . 2.47 112.823 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -131.08 161.83 59.33 Favored Pre-proline 0 N--CA 1.506 2.342 0 C-N-CA 120.749 -0.38 . . . . 5.98 111.971 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 54' ' ' LYS . 55.4 Cg_exo -12.98 -147.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.109 1 C-N-CA 125.316 4.011 . . . . 6.11 116.675 -123.914 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.7 -51.23 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.459 -1.246 . . . . 6.23 110.896 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -39.01 31.49 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.626 0.602 . . . . 6.05 112.626 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -31.57 144.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 115.728 1.751 . . . . 6.08 115.728 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.83 159.49 31.54 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 106.887 -1.523 . . . . 2.82 106.887 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -79.56 -179.57 26.79 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.934 -1.277 . . . . 1.78 109.913 -17.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.519 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 13.5 mm-40 -104.98 125.42 50.94 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.029 -1.068 . . . . 3.22 108.29 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.503 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 13.7 mm -105.66 137.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.809 -1.552 . . . . 1.31 106.809 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 78.0 m-85 -122.15 124.33 43.63 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.879 -1.156 . . . . 1.11 107.879 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 29.3 t -98.38 111.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.641 -1.624 . . . . 1.15 108.339 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 59.04 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.395 1.059 . . . . 2.6 111.701 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.5 mm-40 -133.79 -8.84 2.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.906 0.706 . . . . 4.93 112.906 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -103.78 153.08 21.11 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.233 0.924 . . . . 5.24 111.251 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.731 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.9 t-80 -87.33 133.91 33.64 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.794 -1.187 . . . . 1.4 107.794 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -116.1 -29.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.163 -0.68 . . . . 1.52 109.163 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 29.34 108.18 0.0 OUTLIER Glycine 1 N--CA 1.518 4.107 0 N-CA-C 116.433 1.333 . . . . 2.59 116.433 178.413 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.52 121.63 2.8 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.347 -1.101 . . . . 1.77 110.347 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -59.46 -45.06 92.71 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.989 -1.084 . . . . 1.54 108.866 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -53.97 -54.28 41.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.293 -0.867 . . . . 1.21 110.149 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -57.97 -55.22 37.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.703 -1.135 . . . . 2.69 110.316 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' CG ' HG21 ' A' ' 62' ' ' ILE . 42.3 t80 -55.04 -45.82 75.27 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.263 -0.975 . . . . 0.81 108.725 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 -59.2 5.35 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.09 -0.644 . . . . 0.79 109.534 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -56.82 -61.52 2.38 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.698 -0.801 . . . . 0.88 109.212 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.419 ' CH2' HG11 ' A' ' 64' ' ' VAL . 62.1 t90 -39.82 -51.56 2.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.251 0.97 . . . . 1.54 109.814 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG13 HD12 ' A' ' 83' ' ' LEU . 4.0 t -54.74 -51.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.91 108.38 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.45 16.24 0.15 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.634 -1.166 . . . . 4.86 112.087 -178.933 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -127.98 -60.1 1.16 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.408 0.623 . . . . 3.82 110.57 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -83.76 -14.94 50.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.593 -1.185 . . . . 2.02 112.89 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.415 HD12 HG13 ' A' ' 79' ' ' VAL . 54.4 mt -99.21 4.87 46.84 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.325 -1.75 . . . . 1.39 108.695 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -112.47 -54.36 2.63 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 125.505 1.753 . . . . 3.5 107.574 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 116.079 -1.915 . . . . 6.55 108.017 178.672 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 25.6 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.161 -0.681 . . . . 2.7 109.161 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 9.3 tp-100 -112.19 97.87 6.94 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.508 -0.923 . . . . 5.3 108.508 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -82.13 135.27 35.32 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.503 -1.226 . . . . 0.78 109.741 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -126.38 130.18 71.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.044 -1.465 . . . . 0.75 107.044 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -104.85 128.59 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.982 -1.488 . . . . 1.51 106.982 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.75 94.25 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.355 -1.35 . . . . 1.3 107.355 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.75 -164.44 11.81 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.716 -2.154 . . . . 1.0 107.716 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 ptm180 -143.16 137.61 29.18 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 117.837 -1.545 . . . . 5.45 111.787 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.445 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 61.6 m -53.02 125.05 15.95 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.224 -1.391 . . . . 4.45 108.424 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 -35.97 2.99 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.031 -1.557 . . . . 3.87 110.549 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 1.5 p -71.19 161.37 78.66 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 117.845 -1.542 . . . . 3.66 108.563 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -98.95 -57.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.504 1.469 . . . . 2.71 112.441 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -45.86 -32.14 2.48 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.955 0.724 . . . . 3.55 112.955 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -53.53 -31.39 46.1 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 118.004 -1.478 . . . . 2.42 110.728 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 -47.58 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.033 -0.667 . . . . 1.08 109.263 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.549 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -37.62 -48.64 1.05 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 124.554 1.159 . . . . 4.09 112.994 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.62 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.306 -1.358 . . . . 0.73 109.349 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 12.8 tmtt? -62.51 -53.0 61.26 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.414 -0.812 . . . . 2.21 111.45 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.549 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.9 OUTLIER -52.18 -48.72 64.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 118.292 -1.363 . . . . 3.29 109.657 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 -62.23 1.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.199 0.937 . . . . 0.73 110.87 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.87 -46.04 71.18 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.711 -1.195 . . . . 0.84 110.417 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 39.7 tt0 -48.46 -65.02 0.64 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.545 -0.752 . . . . 2.8 110.45 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 44.2 tttm -38.91 -60.43 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.148 0.905 . . . . 3.78 112.638 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.3 mt -35.06 -45.12 0.26 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.913 1.449 . . . . 1.42 114.913 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.6 p -49.09 -38.85 25.88 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 124.118 0.887 . . . . 3.03 110.505 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.5 m-20 -102.64 23.71 11.6 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.644 -0.422 . . . . 3.0 110.236 -179.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -130.3 -44.04 1.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.685 -0.806 . . . . 3.29 112.174 -178.895 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.607 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -107.3 -24.33 11.91 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.41 -1.316 . . . . 5.62 112.089 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 35.7 t70 84.23 -27.34 0.1 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 123.932 0.77 . . . . 4.96 111.809 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 10.5 p-10 -100.86 17.08 23.09 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 120.15 -0.62 . . . . 4.73 111.038 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CG ' ' HB3' ' A' ' 24' ' ' LEU . 72.3 t80 -112.71 119.18 37.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.842 -1.143 . . . . 1.13 112.097 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.31 148.39 43.23 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.212 -1.403 . . . . 2.8 107.212 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 29.9 p90 -149.17 157.69 43.58 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.001 -1.08 . . . . 1.32 110.833 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -136.3 156.97 47.89 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.072 -1.455 . . . . 3.75 107.072 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -108.22 144.64 35.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.74 -1.584 . . . . 1.26 109.033 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.23 129.88 65.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.353 -0.98 . . . . 0.66 108.353 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -108.83 115.99 31.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.268 -1.753 . . . . 2.48 106.268 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.2 -7.1 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 118.372 -1.331 . . . . 1.73 111.91 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -91.81 -9.75 42.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.815 -0.809 . . . . 4.94 108.815 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.08 -44.16 6.4 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.012 -1.477 . . . . 1.21 107.012 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -74.22 -41.5 61.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.143 -1.428 . . . . 2.92 107.143 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.79 55.33 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.937 -1.665 . . . . 1.32 108.937 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.29 154.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 120.163 -0.615 . . . . 1.33 110.1 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.4 151.63 34.34 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.376 -0.829 . . . . 2.33 109.251 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 56' ' ' VAL . 19.0 mtpp -55.68 -50.56 69.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.159 -1.416 . . . . 5.55 108.226 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -39.94 -63.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.526 1.141 . . . . 4.1 110.403 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -55.74 8.68 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.62 0.724 . . . . 5.11 111.3 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.87 -40.57 56.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.157 -0.929 . . . . 2.26 110.919 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 54' ' ' LYS . 10.9 mm100 -40.87 -40.99 1.49 Allowed 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 119.782 -0.767 . . . . 5.31 109.963 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.008 -0.996 . . . . 4.89 112.436 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.54 -29.8 22.4 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.385 1.254 . . . . 3.99 114.385 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -98.73 -32.76 11.22 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.62 -0.832 . . . . 3.06 112.273 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.15 51.24 46.02 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 120.157 -1.021 . . . . 3.92 112.422 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.04 -179.78 0.71 Allowed Pre-proline 0 N--CA 1.507 2.385 0 C-N-CA 119.407 -0.917 . . . . 8.24 109.591 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.79 170.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.264 1.976 . . . . 6.97 111.11 148.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 57' ' ' GLU . 35.1 m -89.92 -60.58 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.179 -1.408 . . . . 7.13 110.589 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -39.53 -69.66 0.12 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 124.506 1.129 . . . . 7.3 109.205 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -15.47 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.386 1.679 . . . . 5.54 113.929 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -144.63 158.26 53.89 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 106.551 -1.648 . . . . 3.37 106.551 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.2 Cg_endo -84.34 -163.27 2.97 Favored 'Cis proline' 0 N--CA 1.483 0.868 0 N-CA-C 109.26 -1.092 . . . . 1.84 109.26 -10.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HA ' HE21 ' A' ' 61' ' ' GLN . 1.2 mm100 -133.75 151.9 51.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.877 -1.529 . . . . 3.61 109.914 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.7 mp -119.71 145.8 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.939 -1.134 . . . . 1.13 107.939 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -133.47 128.63 35.83 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.72 -1.582 . . . . 1.12 107.152 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 65' ' ' ASP . 50.5 t -106.91 -166.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.402 -1.703 . . . . 2.03 106.402 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.841 ' H ' HG12 ' A' ' 64' ' ' VAL . 2.9 m-20 -46.47 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 123.711 1.719 . . . . 3.81 112.916 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' VAL . 81.1 mt-30 51.82 35.65 16.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 110.242 -3.163 . . . . 4.95 113.368 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -137.53 136.44 37.65 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.0 -0.68 . . . . 4.86 111.555 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.661 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -79.64 141.54 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 105.377 -2.082 . . . . 1.36 105.377 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 64' ' ' VAL . 11.2 mm -107.76 -50.59 7.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 C-N-CA 119.109 -1.036 . . . . 1.36 110.32 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.14 -140.57 9.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.2 -1.56 . . . . 1.66 109.2 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 62' ' ' ILE . . . -101.76 -54.62 0.92 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 120.407 -0.902 . . . . 2.61 112.297 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 15.3 t80 -159.05 -62.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.037 -1.465 . . . . 1.7 109.573 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -44.82 -40.43 6.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.606 1.669 . . . . 1.37 107.306 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.08 -53.97 50.49 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 111.579 -2.555 . . . . 2.62 109.988 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' HG21 ' A' ' 69' ' ' ILE . 19.0 t80 -61.87 -38.55 88.72 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 117.615 -1.634 . . . . 1.01 108.353 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.12 -54.63 32.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.724 -1.213 . . . . 1.03 107.724 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.59 -51.37 70.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.468 -0.893 . . . . 1.42 109.51 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 71.0 t90 -46.55 -48.1 19.54 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.756 -0.831 . . . . 2.14 108.756 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.28 -51.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -82.14 33.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.316 -0.954 . . . . 3.03 110.547 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -133.29 -49.48 0.85 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.657 0.741 . . . . 7.19 109.337 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -102.73 -15.64 16.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.31 -1.313 . . . . 2.55 111.72 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 29.9 mt -107.45 1.96 23.92 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 117.824 -1.551 . . . . 1.56 112.483 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 10.3 p-10 -103.63 14.48 31.05 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.692 -1.603 . . . . 5.24 107.487 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 113.174 -1.83 . . . . 7.53 108.571 179.196 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.071 -1.455 . . . . 2.13 107.071 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.3 mp0 -110.05 105.31 14.39 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.905 -1.118 . . . . 4.09 110.131 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 m -87.85 146.2 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.83 -1.148 . . . . 0.84 111.24 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.6 t -120.5 136.57 57.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 0.72 107.075 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -113.72 108.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.511 -0.922 . . . . 1.4 108.511 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 61' ' ' GLN . 48.7 m-85 -94.5 103.9 15.86 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.752 -0.833 . . . . 0.89 108.752 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.21 -161.54 10.87 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 107.893 -2.083 . . . . 1.25 107.893 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.718 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.82 31.2 5.53 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.164 -1.415 . . . . 4.97 112.869 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.613 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.1 m 67.55 174.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.13 -0.941 . . . . 3.52 109.948 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 13.47 51.78 0.01 OUTLIER Glycine 0 N--CA 1.511 3.648 0 N-CA-C 116.0 1.16 . . . . 2.75 116.0 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.718 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -130.7 101.85 16.81 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.682 -1.229 . . . . 2.16 107.682 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -41.4 -47.02 5.76 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.751 1.634 . . . . 3.4 110.644 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB ' ' A' ' 59' ' ' VAL . 6.1 t80 -57.12 -44.7 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.147 -1.021 . . . . 2.61 109.423 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.76 -51.19 69.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.735 -1.209 . . . . 1.8 107.735 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' LYS . 96.6 t -43.7 -48.81 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 114.516 -1.22 . . . . 1.03 111.122 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' C ' ' HE2' ' A' ' 72' ' ' TYR . 18.7 mtm180 -35.82 -39.23 0.15 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 120.057 -0.657 . . . . 7.42 112.042 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.22 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.917 -0.771 . . . . 0.89 108.917 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 8.5 tmtt? -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.675 -1.232 . . . . 2.74 107.675 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.567 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 60.7 m-20 -58.13 -54.65 44.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.394 -0.922 . . . . 3.14 109.377 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.15 -59.25 4.9 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.604 -1.238 . . . . 0.77 110.31 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -53.26 -44.56 68.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.886 -0.726 . . . . 0.67 110.56 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.8 tt0 -55.7 -57.05 13.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.272 0.983 . . . . 2.94 109.666 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.93 -54.34 47.77 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.747 -0.66 . . . . 4.22 111.202 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 28' ' ' ARG . 79.7 mt -48.35 -57.27 6.27 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.584 -0.846 . . . . 1.61 111.678 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -35.0 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 114.039 1.125 . . . . 1.38 114.039 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 24' ' ' LEU . 7.0 t-20 -104.1 -50.25 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.932 -0.766 . . . . 4.1 108.932 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.37 40.52 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.837 -1.074 . . . . 4.07 111.258 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.486 HH12 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -147.76 -150.43 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.944 -1.102 . . . . 5.03 112.196 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 4.1 m-20 -111.82 -127.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.008 -0.996 . . . . 6.78 110.188 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.4 67.21 5.08 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.662 -1.236 . . . . 3.85 107.662 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -112.59 114.56 27.26 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.918 -1.037 . . . . 0.9 111.565 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -120.22 158.83 26.17 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.773 -1.936 . . . . 3.39 105.773 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 16.3 p90 -160.58 152.79 20.35 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 117.804 -1.559 . . . . 1.2 112.932 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -131.07 164.06 26.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.459 -1.246 . . . . 4.09 108.347 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -113.14 143.2 44.77 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.767 -1.197 . . . . 1.18 107.767 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -132.83 143.85 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.381 -0.97 . . . . 0.66 108.381 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.95 129.66 55.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.258 0.551 . . . . 2.16 109.805 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -58.45 -24.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.192 -1.003 . . . . 1.33 110.933 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.611 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.23 -34.17 25.92 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.955 -1.098 . . . . 4.44 109.645 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.51 -45.18 88.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.824 -0.625 . . . . 1.19 110.193 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 43' ' ' ILE . 8.2 mm-40 -86.34 -43.66 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.091 -1.043 . . . . 2.93 110.075 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.76 54.66 0.72 Allowed Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.736 -1.745 . . . . 1.56 108.736 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 41' ' ' GLU . 6.5 mt -115.74 158.5 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.91 -0.645 . . . . 1.51 110.399 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.4 p -117.6 171.09 8.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.022 -0.733 . . . . 2.63 109.022 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 7.9 tmtm? -69.37 -43.08 74.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.885 -1.526 . . . . 7.01 108.699 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -56.15 -51.07 69.32 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.072 -0.714 . . . . 3.83 109.072 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.44 -51.56 62.25 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.92 -1.112 . . . . 3.05 109.098 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ALA . 55.7 mt -52.97 -51.67 60.72 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.44 -1.304 . . . . 1.59 107.682 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.1 tm0? -46.16 -48.14 17.49 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.935 0.772 . . . . 4.56 109.894 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -59.95 -40.6 89.56 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.641 0.734 . . . . 6.38 109.034 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.786 -1.097 . . . . 4.41 111.525 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.515 ' N ' ' O ' ' A' ' 48' ' ' LEU . . . -94.19 -50.17 5.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.504 0.557 . . . . 1.88 112.504 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.5 15.02 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.703 -1.237 . . . . 2.72 111.545 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 19.3 ptmt -110.8 74.35 0.93 Allowed Pre-proline 0 N--CA 1.5 2.07 0 C-N-CA 120.28 -0.568 . . . . 6.39 111.367 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.0 140.23 40.0 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.581 1.521 . . . . 4.15 111.616 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.8 t 76.18 60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.394 1.058 . . . . 5.6 110.202 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -110.22 -176.04 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.621 -1.172 . . . . 5.93 108.057 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.548 ' CG2' ' H ' ' A' ' 72' ' ' TYR . 12.2 t -100.93 -161.84 0.89 Allowed 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.283 -1.367 . . . . 7.97 108.357 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' A' ' 13' ' ' TYR . 74.3 t -105.9 162.82 18.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 121.506 0.669 . . . . 4.63 110.325 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.56 -166.47 5.16 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 124.336 -1.11 . . . . 3.19 109.293 -29.576 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.32 119.0 34.02 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.878 -1.527 . . . . 2.93 106.878 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.46 134.01 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.806 -1.158 . . . . 1.52 109.324 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 68' ' ' HIS . 2.8 m-85 -118.14 114.14 22.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 105.35 -2.093 . . . . 1.76 105.35 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.603 HG23 HG13 ' A' ' 69' ' ' ILE . 53.2 t -96.86 110.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 117.188 -1.805 . . . . 1.31 111.19 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t70 61.32 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.594 0.961 . . . . 2.51 113.594 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' VAL . 11.8 mm-40 -130.53 -18.56 3.15 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.117 1.155 . . . . 4.46 114.117 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -108.46 156.7 19.16 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.741 -1.184 . . . . 4.83 111.285 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.456 ' HB2' ' CE1' ' A' ' 63' ' ' PHE . 80.0 t60 -87.53 141.36 28.68 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.803 -1.159 . . . . 1.76 109.71 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -114.18 -54.85 4.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.005 -1.48 . . . . 1.51 107.005 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLY . . . . . 0.47 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 58.65 123.22 0.01 OUTLIER Glycine 0 N--CA 1.501 3.003 0 O-C-N 124.493 1.121 . . . . 2.4 113.6 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' A' ' 58' ' ' THR . . . 104.23 141.12 10.89 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.875 -1.155 . . . . 1.54 112.57 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' H ' ' CG2' ' A' ' 58' ' ' THR . 20.2 t80 -82.97 -54.5 5.02 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.458 -0.897 . . . . 1.89 109.211 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -67.65 1.82 2.22 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.162 -1.015 . . . . 1.8 108.939 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 72' ' ' TYR . 15.2 t70 -100.53 -63.6 1.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.927 -1.508 . . . . 3.1 106.927 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -55.58 -45.61 77.35 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.257 -0.883 . . . . 0.78 108.936 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.92 -38.61 10.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.109 -0.496 . . . . 0.88 110.39 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -81.05 -50.77 9.25 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.6 -1.259 . . . . 0.97 107.6 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' TRP . . . . . 0.602 ' CH2' HG11 ' A' ' 64' ' ' VAL . 76.6 t90 -38.62 -53.23 1.62 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.125 0.89 . . . . 1.35 108.712 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 83' ' ' LEU . 75.6 t -44.02 -46.42 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.324 -1.307 . . . . 1.13 110.505 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HZ1' ' C ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -73.28 -58.57 3.22 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.914 -0.714 . . . . 3.61 111.707 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -57.4 -24.69 56.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.122 0.786 . . . . 3.74 113.122 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -101.02 -34.26 9.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.355 1.243 . . . . 1.95 114.355 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 79' ' ' VAL . 36.8 mt -96.04 -11.63 26.12 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.328 -1.349 . . . . 1.77 111.677 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 36.3 m-20 -122.48 -50.5 1.99 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.287 0.992 . . . . 3.74 109.967 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' C ' ' HZ1' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.502 2.144 0 O-C-N 126.159 2.162 . . . . 6.15 107.099 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.9 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.929 -0.767 . . . . 2.95 108.929 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.514 ' HG3' HE21 ' A' ' 32' ' ' GLN . 5.0 mp0 -110.11 98.18 7.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.723 -1.584 . . . . 3.94 106.723 179.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 33' ' ' TYR . 86.6 m -82.17 141.3 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.383 -0.927 . . . . 0.79 111.939 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -133.86 138.78 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.569 -0.741 . . . . 0.63 110.096 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.79 123.28 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 105.28 -2.119 . . . . 1.54 105.28 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' CD2' HG11 ' A' ' 36' ' ' VAL . 58.2 m-85 -104.07 78.45 1.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.048 -1.093 . . . . 1.17 108.048 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.6 -151.06 9.49 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.514 -1.327 . . . . 1.0 110.739 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ARG . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' SER . 2.7 tmm_? -119.47 -178.32 3.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.343 -0.984 . . . . 5.35 108.343 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.647 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.44 59.45 0.29 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.037 0.384 . . . . 3.6 112.037 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.3 71.26 0.84 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.159 -1.496 . . . . 2.89 112.197 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -129.21 149.82 73.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.925 -0.71 . . . . 2.14 109.687 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.48 -65.67 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.303 2.002 . . . . 3.89 113.206 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -78.01 15.86 0.83 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 119.104 -1.038 . . . . 3.69 112.897 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 36.1 m -107.16 -48.78 3.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.624 -1.621 . . . . 2.12 106.624 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 17' ' ' ALA . 50.1 t -73.96 -38.3 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.947 -1.479 . . . . 1.08 108.529 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -80.09 38.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.174 0.987 . . . . 3.77 109.391 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -142.21 -49.56 0.37 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.073 -1.825 . . . . 1.33 106.073 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LYS . . . . . 0.697 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 50.9 tttm -57.59 -38.88 75.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.904 -1.498 . . . . 3.46 110.081 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -43.55 -47.42 7.34 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.376 0.608 . . . . 4.65 110.448 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.24 -42.85 96.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.409 -0.814 . . . . 1.51 110.156 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -63.65 -57.91 8.58 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.332 -0.947 . . . . 0.73 109.251 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.697 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 47.8 mt-10 -51.44 -51.56 53.86 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.805 0.812 . . . . 3.53 109.262 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -53.96 -59.21 4.93 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.937 -1.029 . . . . 4.24 109.928 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 24' ' ' LEU . 7.4 mt -51.79 -53.17 42.97 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.528 -1.269 . . . . 1.93 110.888 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -52.99 -32.12 44.63 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.061 -1.056 . . . . 1.61 111.76 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -83.37 -37.18 23.67 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.887 -0.725 . . . . 3.3 111.059 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -74.39 -40.06 62.31 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 122.071 0.939 . . . . 2.9 110.336 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.607 HH21 ' CG ' ' A' ' 30' ' ' ASP . 9.1 mmm180 -99.62 179.3 4.59 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.113 -1.403 . . . . 6.92 111.418 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' CZ ' ' A' ' 28' ' ' ARG . 2.0 p30 -122.3 -12.79 8.2 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.772 -1.104 . . . . 3.79 110.843 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' HH21 ' A' ' 28' ' ' ARG . 14.5 p30 -103.63 -46.14 4.62 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.7 1.0 . . . . 4.52 113.7 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -48.39 110.39 0.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 113.502 0.927 . . . . 0.83 113.502 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.514 HE21 ' HG3' ' A' ' 2' ' ' GLN . 0.2 OUTLIER -103.35 156.16 17.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.493 -0.929 . . . . 5.29 108.493 179.114 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.545 ' HB2' ' HB ' ' A' ' 3' ' ' THR . 1.6 p90 -164.09 156.74 17.44 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.489 -0.884 . . . . 1.24 111.218 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 61.2 tt0 -139.23 152.44 47.32 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.606 -1.179 . . . . 3.12 108.772 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 53.3 t80 -107.47 138.6 43.38 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.145 -1.422 . . . . 1.05 107.593 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -124.59 143.52 37.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 124.204 0.94 . . . . 0.66 108.7 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -117.23 118.33 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.853 -1.536 . . . . 2.47 106.853 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -53.09 -19.27 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.654 -0.818 . . . . 1.28 110.985 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.77 -37.89 55.08 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.593 0.558 . . . . 5.65 111.445 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 -43.43 55.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.908 -0.717 . . . . 1.32 109.298 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.27 -43.22 52.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.169 -0.923 . . . . 3.36 109.33 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.06 60.29 1.13 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.305 -1.918 . . . . 1.41 108.305 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 44' ' ' THR . 30.3 mm -114.52 160.75 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 C-N-CA 119.458 -0.897 . . . . 2.83 112.346 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -121.33 151.29 40.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.63 -1.168 . . . . 2.51 109.772 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 46' ' ' GLU . 4.1 ttpt -56.69 -46.61 81.09 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.656 -1.218 . . . . 4.82 109.746 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 23.8 mm-40 -45.06 -56.85 4.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.284 -0.566 . . . . 4.34 110.159 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.56 -56.34 22.57 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.825 0.821 . . . . 4.37 110.281 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' HB3' ' CD ' ' A' ' 61' ' ' GLN . 21.7 mt -46.97 -46.85 21.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.112 -0.949 . . . . 1.62 110.39 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 25.8 tt0 -52.56 -50.32 63.18 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.72 -1.127 . . . . 3.62 109.561 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -52.45 -32.17 38.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.878 0.847 . . . . 5.62 110.301 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' LYS . . . . . 0.771 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.98 19.46 17.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.294 -1.321 . . . . 4.03 111.139 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -113.15 -41.08 3.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.826 0.703 . . . . 1.83 110.569 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.02 -55.4 0.51 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.45 -1.86 . . . . 2.44 108.45 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 55' ' ' PRO . 31.3 tttm -92.03 151.98 42.38 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.574 -1.269 . . . . 7.37 107.574 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 30.3 Cg_exo -61.23 75.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.543 1.495 . . . . 4.65 110.684 158.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.38 82.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.032 0.92 . . . . 6.48 108.527 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -50.3 -31.66 14.96 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.082 -1.417 . . . . 5.5 111.57 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 59' ' ' VAL . 99.9 m -94.61 169.05 10.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.682 -0.69 . . . . 5.16 110.763 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -116.4 166.0 13.65 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.454 -1.313 . . . . 2.78 107.454 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 76.6 Cg_endo -92.86 -151.08 0.33 Allowed 'Cis proline' 0 C--N 1.312 -1.355 0 N-CA-C 109.592 -0.965 . . . . 2.61 109.592 -17.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.457 ' CD ' ' HB3' ' A' ' 48' ' ' LEU . 24.9 mt-30 -123.66 154.48 39.3 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.499 -0.926 . . . . 4.3 108.499 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ILE . . . . . 0.485 HD11 ' HB1' ' A' ' 17' ' ' ALA . 38.7 mt -128.04 142.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.269 -1.332 . . . . 1.2 107.926 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.2 122.58 21.82 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.377 -1.342 . . . . 0.97 107.377 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 3' ' ' THR . 60.4 t -106.71 97.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 117.77 -1.572 . . . . 1.71 109.424 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 1' ' ' MET . 17.5 t0 80.49 -64.82 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.869 -1.059 . . . . 2.51 113.011 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -140.92 -29.65 0.66 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.258 1.947 . . . . 5.78 116.258 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -100.01 -174.96 2.82 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.938 -1.105 . . . . 5.31 111.736 -178.728 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.9 t-160 -103.41 138.66 39.84 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.779 -1.193 . . . . 1.57 107.779 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ILE . . . . . 0.454 HG13 HG23 ' A' ' 64' ' ' VAL . 25.2 mm -122.85 -40.73 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 124.061 0.851 . . . . 2.1 109.872 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.02 -176.15 0.18 Allowed Glycine 0 N--CA 1.509 3.522 0 CA-C-O 122.085 0.825 . . . . 2.86 115.153 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.02 -160.39 0.01 OUTLIER Glycine 0 N--CA 1.508 3.437 0 CA-C-N 113.857 -1.172 . . . . 1.86 113.89 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 16' ' ' ARG . 33.4 t80 -121.51 -58.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.121 -1.066 . . . . 1.92 108.121 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 p -39.46 -47.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.246 1.022 . . . . 1.8 110.061 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -63.04 1.2 Allowed 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 112.535 -2.12 . . . . 3.25 108.67 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.3 -49.51 9.39 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 119.231 -0.988 . . . . 1.23 109.988 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.08 -65.76 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.68 -1.145 . . . . 1.2 111.813 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.95 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.875 -0.787 . . . . 1.3 108.875 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -44.95 -56.28 4.73 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.65 -1.159 . . . . 1.46 109.502 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 83' ' ' LEU . 3.1 t -47.93 -60.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.944 -1.132 . . . . 1.33 107.944 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -47.05 -46.75 22.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.3 1.0 . . . . 3.16 111.095 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.11 21.05 8.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.243 1.201 . . . . 5.21 114.243 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -130.33 -32.96 1.73 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.866 -0.733 . . . . 2.15 109.835 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 HG13 ' A' ' 79' ' ' VAL . 27.1 mt -96.21 32.62 1.91 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.349 -1.34 . . . . 2.01 111.786 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.63 -60.8 1.69 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.969 -0.752 . . . . 5.32 108.969 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 116.584 -1.674 . . . . 8.59 110.064 179.974 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' ASP . 74.9 mtp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 107.961 -1.125 . . . . 2.17 107.961 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 42.7 tp60 -123.64 146.96 47.81 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.745 0.653 . . . . 4.88 110.365 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -128.56 154.54 46.07 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.088 -1.045 . . . . 1.02 109.159 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -134.19 128.72 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.648 -1.241 . . . . 0.74 107.648 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mt -111.35 120.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.107 -1.071 . . . . 2.73 108.107 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.91 74.26 1.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.882 -1.155 . . . . 0.96 107.882 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -147.03 -173.15 17.99 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.114 -1.517 . . . . 2.2 109.724 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 18.4 mtp-105 -123.11 154.7 38.26 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.045 -1.062 . . . . 6.27 109.631 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -72.23 77.0 0.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.438 -0.905 . . . . 5.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.35 21.5 0.17 Allowed Glycine 0 N--CA 1.502 3.045 0 C-N-CA 119.388 -1.387 . . . . 3.01 113.101 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -121.99 80.57 42.64 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.048 -0.723 . . . . 3.1 109.048 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -18.73 -69.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 124.194 3.262 . . . . 3.18 114.285 -143.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' CD ' ' A' ' 60' ' ' PRO . 3.8 m-30 -34.2 -45.04 0.2 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 123.363 0.414 . . . . 3.71 112.096 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 57.7 m -52.35 -55.94 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.972 -1.013 . . . . 2.03 109.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.25 -45.78 88.99 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 CA-C-N 114.109 -1.405 . . . . 1.1 108.101 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.7 mmp_? -55.84 -51.83 66.15 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.666 -0.814 . . . . 3.71 112.255 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.17 -50.07 65.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.089 -1.448 . . . . 0.82 107.089 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 3.0 tmtm? -53.88 -55.12 29.72 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.981 -1.009 . . . . 1.92 109.315 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.575 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.9 m-20 -47.8 -56.86 6.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.18 0.514 . . . . 2.9 109.617 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.462 HD23 ' CD2' ' A' ' 75' ' ' PHE . 29.8 tp -55.35 -57.13 13.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.989 -1.005 . . . . 0.92 111.472 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -54.39 44.64 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.903 . . . . 0.65 109.579 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.484 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 12.5 tt0 -47.59 -47.56 28.53 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.515 -0.92 . . . . 2.26 108.515 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -53.3 -64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.179 0.925 . . . . 4.71 110.5 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -38.55 -47.0 1.25 Allowed 'General case' 0 N--CA 1.506 2.348 0 O-C-N 123.92 0.763 . . . . 1.16 112.835 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -39.06 -36.0 0.26 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.335 0.865 . . . . 1.35 113.335 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -97.66 12.6 33.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.046 1.128 . . . . 2.42 114.046 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 19.3 mt-10 -131.9 -30.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 123.87 0.732 . . . . 3.22 110.942 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -99.12 -24.15 14.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.954 0.724 . . . . 3.92 112.954 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.04 -62.59 0.42 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.071 0.857 . . . . 4.7 110.565 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 1' ' ' MET . 10.6 t70 -82.45 55.85 3.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.814 -1.55 . . . . 3.43 106.814 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -140.83 91.94 2.46 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.225 -0.898 . . . . 1.09 109.968 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 13.6 mm-40 -110.02 128.24 55.29 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.985 -1.487 . . . . 4.52 106.985 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -111.14 160.56 16.8 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.096 -1.041 . . . . 1.41 110.594 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -123.97 146.64 48.36 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.372 -1.344 . . . . 2.84 107.372 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -102.09 132.11 48.16 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.993 -1.083 . . . . 2.3 108.378 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 135.27 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.335 -1.357 . . . . 0.65 107.335 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 34.3 t0 -110.44 111.39 22.62 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 122.23 1.014 . . . . 1.73 109.905 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 pt -48.7 -32.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.25 -1.341 . . . . 2.04 114.035 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 2.7 mmp_? -101.46 19.32 18.09 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.699 -0.8 . . . . 9.02 111.714 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -122.73 -43.68 2.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.682 -1.229 . . . . 1.6 107.682 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.52 -45.32 46.54 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.375 -1.738 . . . . 2.87 110.429 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.59 63.49 0.34 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.746 -1.216 . . . . 1.68 112.693 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 47' ' ' ASP . 55.2 mt -111.6 145.6 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.769 -0.772 . . . . 1.78 109.289 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -116.93 -97.56 0.46 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.939 -0.704 . . . . 2.46 110.203 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HZ2' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -137.6 -50.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.78 -1.933 . . . . 7.8 105.78 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.572 ' CD ' ' HZ2' ' A' ' 45' ' ' LYS . 3.8 mp0 -51.29 -50.17 59.83 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 113.679 -1.601 . . . . 4.81 108.894 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 43' ' ' ILE . 23.8 m-20 -46.44 -64.34 0.78 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.102 0.953 . . . . 3.59 109.329 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 54' ' ' LYS . 81.1 mt -49.93 -50.94 44.65 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.21 -1.359 . . . . 2.25 110.044 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -56.15 -36.55 68.42 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.168 -1.413 . . . . 4.66 110.749 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.63 -39.43 57.83 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.278 0.561 . . . . 6.68 112.064 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 1.7 ttpp -87.37 -28.79 21.98 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 114.575 1.324 . . . . 4.77 114.575 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -118.19 -35.7 3.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.838 0.711 . . . . 1.89 112.689 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.9 -44.57 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.075 -2.81 . . . . 3.87 106.075 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.499 ' NZ ' ' HG3' ' A' ' 57' ' ' GLU . 9.1 tttp 53.21 102.77 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 113.297 -1.451 . . . . 9.82 112.656 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -51.07 179.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.214 1.943 . . . . 5.22 110.327 143.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.95 59.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.571 -1.252 . . . . 5.9 110.358 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 15.6 pt-20 -103.51 178.81 4.45 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.654 -1.612 . . . . 5.66 107.549 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -116.42 -106.32 0.39 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.356 -1.338 . . . . 6.1 109.193 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.29 154.64 78.84 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 123.964 0.79 . . . . 3.66 109.83 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 48.6 Cg_endo -96.74 -164.95 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.507 0.741 . . . . 2.0 110.452 -1.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -147.78 163.74 35.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.19 0.931 . . . . 2.65 108.64 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.1 mp -121.32 151.18 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 122.302 1.048 . . . . 1.01 111.787 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.642 ' CZ ' ' HE3' ' A' ' 51' ' ' LYS . 9.4 m-85 -133.31 130.94 39.56 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.764 -2.016 . . . . 1.24 108.726 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 69' ' ' ILE . 66.8 t -121.62 129.77 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.778 -1.564 . . . . 0.98 106.778 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 5.1 m-20 51.47 25.32 2.61 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.698 1.237 . . . . 2.77 112.276 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 2.4 mm100 79.49 -6.36 1.83 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 112.216 -2.266 . . . . 7.24 114.559 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.84 154.96 23.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.963 -1.865 . . . . 4.35 105.963 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 17.3 t-160 -83.16 147.52 28.01 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 117.469 -1.692 . . . . 1.26 109.492 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 64' ' ' VAL . 16.8 mm -116.63 -35.7 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 124.294 0.996 . . . . 0.92 109.154 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.16 -139.76 9.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.754 -1.212 . . . . 1.94 110.301 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.15 -65.75 0.85 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.577 -1.009 . . . . 2.8 110.577 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 66.5 t80 -157.75 -53.78 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.26 -1.376 . . . . 1.81 110.677 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -46.68 -47.62 20.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.356 -1.35 . . . . 1.55 107.356 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.44 -59.36 4.68 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.25 -1.795 . . . . 3.27 109.602 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.591 ' CD1' HG21 ' A' ' 62' ' ' ILE . 38.6 t80 -51.78 -47.64 64.1 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.442 -0.903 . . . . 0.85 109.224 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -59.37 4.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.315 -0.954 . . . . 1.04 109.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.31 -0.859 . . . . 1.04 109.564 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -40.49 -48.89 2.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.006 0.816 . . . . 1.14 110.13 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 80' ' ' LYS . 9.9 t -60.5 -59.2 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.328 -0.99 . . . . 1.23 108.328 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -41.27 -49.65 3.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.882 -1.054 . . . . 3.49 109.925 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.96 -55.68 7.84 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 116.41 2.004 . . . . 3.81 116.41 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -83.54 -20.11 34.46 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 113.948 1.092 . . . . 1.75 113.948 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.69 -37.31 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 117.997 -1.481 . . . . 2.28 113.24 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 63.5 m-20 . . . . . 0 N--CA 1.498 1.968 0 C-N-CA 118.071 -1.452 . . . . 5.8 112.738 -177.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 30' ' ' ASP . 36.5 mtm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.0 -1.481 . . . . 2.42 107.0 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -124.57 143.37 50.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.733 -0.787 . . . . 4.65 110.008 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 61.4 m -125.19 145.11 50.12 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.08 -1.048 . . . . 0.68 113.282 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.8 136.79 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.949 -1.13 . . . . 0.58 107.949 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -118.09 122.03 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 124.226 0.954 . . . . 2.29 109.727 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -93.66 87.21 5.41 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.618 -1.253 . . . . 1.1 107.618 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.89 -164.29 14.51 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.529 -1.428 . . . . 0.97 109.529 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.692 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -128.11 -158.7 0.89 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 117.98 0.89 . . . . 5.63 109.655 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.496 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -101.91 61.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.66 -0.867 . . . . 3.81 108.66 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.67 92.32 2.26 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.048 -2.021 . . . . 2.82 108.048 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -155.27 63.63 3.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 120.311 -0.556 . . . . 2.35 110.224 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -20.42 -55.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 124.044 3.162 . . . . 2.35 114.001 -145.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' CYS . 4.3 m-85 -42.69 -44.94 4.52 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.246 -0.582 . . . . 4.63 111.668 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -57.14 -46.12 82.97 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.538 -0.865 . . . . 2.4 111.046 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.0 t -55.8 -43.17 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 115.643 -0.708 . . . . 0.81 110.916 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.682 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -47.27 -48.98 24.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.645 -1.222 . . . . 3.67 112.583 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.07 -45.91 68.35 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.128 -1.029 . . . . 0.67 108.864 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -58.5 -50.81 72.41 Favored 'General case' 0 C--O 1.2 -1.512 0 C-N-CA 119.277 -0.969 . . . . 2.46 108.404 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 18' ' ' LYS . 66.1 m-20 -49.67 -48.4 49.54 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.447 -1.301 . . . . 2.98 110.055 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.14 -65.84 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.396 -1.322 . . . . 0.8 110.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -51.94 8.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.788 0.804 . . . . 0.81 110.713 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.05 -52.48 65.58 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.588 -1.187 . . . . 2.31 107.906 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 tmtm? -43.7 -36.43 2.21 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 115.531 -0.759 . . . . 3.79 110.515 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 79' ' ' VAL . 11.4 mt -78.32 -44.82 24.24 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.146 -0.934 . . . . 1.38 110.438 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 27' ' ' GLU . 74.4 m -50.25 -42.31 51.78 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 118.938 -1.105 . . . . 1.37 109.387 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 23' ' ' LYS . 3.2 p-10 -80.73 28.31 0.34 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.033 -1.467 . . . . 4.75 111.335 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.6 mt-10 -127.68 -64.85 0.95 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.611 -1.177 . . . . 4.21 110.58 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 14.7 mtt180 -119.21 150.29 40.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.54 -0.864 . . . . 4.15 109.655 -178.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.34 -25.81 60.77 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.647 -0.872 . . . . 5.58 108.647 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.5 t70 -74.54 -8.76 57.37 Favored 'General case' 0 C--O 1.202 -1.442 0 C-N-CA 119.065 -1.054 . . . . 3.31 111.711 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -106.78 97.19 7.01 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.76 -1.976 . . . . 1.14 111.151 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -113.75 160.13 19.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.868 -1.16 . . . . 3.51 107.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' THR . 21.5 p90 -147.92 165.18 31.47 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.51 -0.876 . . . . 0.99 108.929 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -131.05 136.53 48.53 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.225 -1.398 . . . . 3.59 107.225 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.29 140.76 29.16 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.236 -1.786 . . . . 1.2 107.659 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.78 137.38 54.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.528 -0.915 . . . . 0.63 108.528 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -111.77 121.71 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.493 -1.299 . . . . 2.41 107.493 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -44.81 -31.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.701 1.0 . . . . 1.53 113.701 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 17.77 15.36 Favored 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 118.14 -1.424 . . . . 5.54 111.972 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.86 -41.85 5.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.245 -1.761 . . . . 1.58 106.245 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -82.98 -39.66 21.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.726 -1.579 . . . . 3.47 108.952 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 50.29 0.65 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.295 -1.522 . . . . 1.46 109.295 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.61 160.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.676 -0.762 . . . . 1.9 111.129 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.6 p -112.74 -158.14 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.606 -1.179 . . . . 3.01 110.844 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 3.8 ttpp -114.15 12.8 17.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 106.486 -1.672 . . . . 5.43 106.486 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -119.11 -50.08 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.645 -1.161 . . . . 4.78 109.625 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -57.89 -45.4 86.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.907 -1.146 . . . . 3.83 107.907 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 48' ' ' LEU . 23.0 mt -42.23 -47.88 4.8 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 115.207 -0.906 . . . . 2.8 110.468 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 1.3 tm0? -46.78 -49.17 20.26 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.617 -0.882 . . . . 4.5 108.617 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -73.86 -40.54 63.18 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.902 -1.044 . . . . 7.16 110.98 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -53.92 -47.71 70.94 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.503 -0.555 . . . . 4.91 109.503 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -76.29 -49.68 16.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.21 -0.905 . . . . 2.59 109.998 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.41 16.33 55.53 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.238 -1.458 . . . . 3.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.415 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 6.4 ttmt -120.26 77.42 25.45 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.602 -0.888 . . . . 6.04 108.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 20.5 Cg_endo -80.85 22.66 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.632 1.555 . . . . 4.2 112.503 -127.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.24 -12.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.56 -1.2 . . . . 5.96 111.767 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 11.6 pt-20 -86.77 174.85 8.55 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 118.748 -1.181 . . . . 6.13 112.691 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 p -131.45 -80.07 0.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.072 -0.967 . . . . 4.93 110.698 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 22.4 t -119.82 151.82 52.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 3.5 109.451 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 45.4 Cg_endo -87.64 168.53 40.48 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.814 -0.911 . . . . 2.46 111.04 -18.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.441 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 87.2 mt-30 -131.42 117.56 19.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 105.478 -2.045 . . . . 2.77 105.478 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.0 mp -113.25 141.98 27.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.916 -1.038 . . . . 1.09 108.894 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 4.4 m-85 -120.06 138.23 53.66 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.778 -2.01 . . . . 1.31 108.756 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.443 ' CG2' HG13 ' A' ' 69' ' ' ILE . 74.8 t -116.79 130.07 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.064 -1.054 . . . . 1.22 108.63 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 54.09 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 112.607 -2.088 . . . . 3.29 113.383 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 64' ' ' VAL . 72.7 mt-30 -131.22 -31.3 1.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.164 1.542 . . . . 4.57 115.164 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.476 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 1.4 pm0 -117.56 171.95 7.67 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.003 1.112 . . . . 3.46 114.003 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.3 t-80 -73.44 147.64 43.99 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 105.603 -1.999 . . . . 1.84 105.603 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.443 HG13 ' CG2' ' A' ' 64' ' ' VAL . 46.2 mm -122.29 -29.39 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.649 -1.22 . . . . 1.52 108.852 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.44 -171.55 34.7 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.069 -1.062 . . . . 2.13 111.337 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 73' ' ' THR . . . -105.12 -149.53 19.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.219 -2.353 . . . . 1.56 107.219 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.53 42.79 0.53 Allowed 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 117.651 -1.62 . . . . 2.97 109.467 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 71' ' ' GLY . 11.7 p -144.62 -69.06 0.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.826 -1.079 . . . . 1.82 109.726 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -54.09 8.88 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.873 -1.058 . . . . 2.99 108.403 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 62' ' ' ILE . 22.5 t80 -52.87 -56.87 12.65 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 104.959 -2.237 . . . . 1.67 104.959 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -38.65 -52.84 1.65 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.688 -1.142 . . . . 1.53 110.232 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -63.54 -58.37 7.2 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.316 -0.954 . . . . 1.14 110.056 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' ALA . 61.5 t90 -40.93 -51.01 3.27 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 119.243 -0.983 . . . . 1.47 109.145 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' A' ' 24' ' ' LEU . 71.0 t -43.13 -58.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.124 -1.065 . . . . 1.38 108.124 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -51.61 -60.9 2.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.876 -1.056 . . . . 2.76 111.655 -179.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 80' ' ' LYS . 8.5 mp0 -59.03 -33.1 70.37 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.239 1.94 . . . . 3.88 116.239 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -98.99 -23.38 15.32 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 117.809 -1.556 . . . . 1.77 113.066 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.52 ' CD1' HD13 ' A' ' 24' ' ' LEU . 15.3 mt -83.72 -53.59 5.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.023 -2.214 . . . . 1.35 105.023 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 83' ' ' LEU . 4.6 m-20 . . . . . 0 N--CA 1.508 2.445 0 O-C-N 124.858 1.349 . . . . 5.1 113.552 176.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 tpp . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.434 -1.321 . . . . 2.37 107.434 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 1.3 mp0 -131.97 132.92 43.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.765 0.666 . . . . 4.29 110.317 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m -121.64 142.79 49.78 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 119.623 -0.831 . . . . 0.74 110.939 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.47 127.35 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 108.42 -0.956 . . . . 1.02 108.42 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.32 109.44 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 124.84 1.337 . . . . 1.81 108.582 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 98.3 m-85 -87.87 100.05 12.58 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.111 -1.07 . . . . 1.35 108.111 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.8 -166.93 13.69 Favored Glycine 0 N--CA 1.501 3.015 0 N-CA-C 109.114 -1.594 . . . . 0.99 109.114 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.697 ' CG ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 ptm180 -119.24 37.27 4.19 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.257 -1.377 . . . . 5.61 112.088 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 50.5 m 83.47 51.71 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 116.094 1.887 . . . . 3.53 116.094 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.77 67.34 1.49 Allowed Glycine 0 N--CA 1.505 3.246 0 C-N-CA 119.069 -1.539 . . . . 3.78 114.1 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.697 ' SG ' ' CG ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -111.42 159.07 34.41 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.339 -0.944 . . . . 2.38 109.886 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 81.2 Cg_exo -40.31 144.24 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.438 1.426 . . . . 3.66 110.015 157.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER 77.11 -59.46 0.48 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 107.568 -1.271 . . . . 3.27 107.568 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 33.4 m -53.78 -47.16 71.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.4 -0.818 . . . . 1.73 110.029 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 11' ' ' CYS . 86.1 t -49.12 -41.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.856 -1.138 . . . . 1.61 108.033 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -74.58 82.82 2.02 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.657 -1.238 . . . . 4.41 107.657 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 173.36 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.291 -2.231 . . . . 1.01 105.471 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 33' ' ' TYR . 5.9 tmtm? -69.17 -47.18 65.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.964 -1.495 . . . . 2.72 106.964 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -55.29 -37.39 67.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.775 -0.824 . . . . 3.41 108.775 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.02 -58.97 3.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.301 -1.36 . . . . 1.18 108.563 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -40.14 -54.55 2.28 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.511 -0.876 . . . . 1.02 110.918 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 3.8 mm-40 -38.77 -41.86 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.852 0.834 . . . . 2.81 112.735 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.51 -54.63 11.42 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.013 -0.994 . . . . 4.62 109.502 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.555 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 49.3 mt -49.99 -46.25 52.47 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.54 -1.209 . . . . 1.36 108.15 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 m -58.02 -28.7 64.69 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.252 0.97 . . . . 1.35 112.667 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -102.2 -17.26 16.04 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.265 -0.574 . . . . 4.14 111.761 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 34.1 mt-10 -87.93 -45.23 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.253 -0.579 . . . . 3.13 110.537 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 83' ' ' LEU . 2.0 mpt_? -104.69 -17.09 14.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.867 -0.733 . . . . 5.55 111.486 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.59 -51.32 0.62 Allowed 'General case' 0 N--CA 1.512 2.65 0 O-C-N 124.394 1.059 . . . . 5.9 112.326 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.86 54.73 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.421 1.105 . . . . 3.43 108.642 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 74.0 t80 -146.34 82.2 1.59 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.393 -0.821 . . . . 1.28 109.745 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 12.8 mp0 -89.71 142.11 27.99 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.481 -1.674 . . . . 3.19 106.481 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 18' ' ' LYS . 38.0 p90 -129.78 150.27 51.16 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.289 -0.964 . . . . 1.26 108.659 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -116.74 136.29 53.08 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.841 -0.8 . . . . 3.79 108.841 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -95.23 114.95 26.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.091 -1.818 . . . . 1.22 106.091 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.54 134.57 54.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 114.776 -1.102 . . . . 0.6 109.362 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.17 132.38 55.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.504 -0.924 . . . . 2.17 108.504 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 pt -60.87 -29.77 46.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 118.686 -1.205 . . . . 1.35 111.825 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.15 -34.19 56.56 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.012 -1.475 . . . . 4.8 110.602 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.23 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.663 -0.815 . . . . 1.1 111.262 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -85.08 -34.46 22.23 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.322 -0.951 . . . . 2.53 111.225 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.89 52.85 1.07 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.677 -1.369 . . . . 1.33 109.677 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -104.74 155.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.764 -0.718 . . . . 1.49 110.849 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.0 p -118.62 161.58 19.83 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.167 -0.924 . . . . 2.32 110.648 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.47 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 19.0 ttpp -55.73 -42.59 75.57 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.687 -1.597 . . . . 4.53 106.687 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.508 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.2 mp0 -51.55 -56.82 11.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.237 -1.347 . . . . 3.72 109.647 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -46.84 -51.47 16.52 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.581 -0.848 . . . . 3.62 111.139 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.76 -52.1 61.88 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.311 -0.859 . . . . 1.76 110.457 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.47 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 40.6 tt0 -53.3 -39.29 63.89 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.839 -0.744 . . . . 4.2 109.549 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.09 -33.81 59.52 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.388 -0.597 . . . . 5.45 109.388 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -63.07 -36.94 85.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.468 -0.567 . . . . 3.92 109.468 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -104.81 -88.17 0.43 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.076 -0.966 . . . . 2.34 108.904 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 41.34 1.12 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.125 -1.512 . . . . 3.11 113.869 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 74' ' ' ASP . 44.0 pttt -120.76 58.0 6.29 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.073 -1.051 . . . . 6.17 109.194 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.1 38.8 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.251 3.301 . . . . 4.42 114.043 -106.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.92 38.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.073 -1.084 . . . . 5.56 108.073 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -104.33 154.02 20.34 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.737 -1.119 . . . . 5.92 110.971 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -125.29 -156.23 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.566 -1.197 . . . . 5.32 107.819 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.69 145.42 30.67 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.996 -0.742 . . . . 3.41 108.996 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 52.8 Cg_endo -88.89 145.68 22.0 Favored 'Cis proline' 0 C--N 1.316 -1.132 0 O-C-N 123.558 1.294 . . . . 1.96 112.36 16.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -102.51 144.12 31.35 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.445 -1.687 . . . . 3.86 106.445 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.58 140.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.843 -1.543 . . . . 1.5 112.988 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 24.9 m-85 -136.16 135.59 39.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 110.976 -2.829 . . . . 1.28 107.876 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.579 HG23 HG13 ' A' ' 69' ' ' ILE . 61.6 t -102.6 121.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 106.828 -1.545 . . . . 1.08 106.828 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.2 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.905 -1.043 . . . . 2.6 111.209 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 64' ' ' VAL . 58.2 mt-30 -135.06 3.31 3.15 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.26 -0.976 . . . . 4.92 111.666 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -105.39 155.41 19.15 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.843 0.354 . . . . 4.62 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 8.0 t-80 -92.78 149.18 21.46 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.409 -1.33 . . . . 1.77 107.409 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 64' ' ' VAL . 3.2 mm -118.01 -38.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 117.513 -1.675 . . . . 1.06 109.703 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.41 -26.59 3.06 Favored Glycine 0 N--CA 1.502 3.04 0 C-N-CA 118.937 -1.602 . . . . 2.39 112.435 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.37 -173.83 20.27 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 108.231 -1.947 . . . . 1.64 108.231 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -51.77 -59.33 4.43 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.89 -1.124 . . . . 2.0 111.611 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.69 -45.59 49.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 112.938 0.718 . . . . 2.07 112.938 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 1.4 m-20 -74.84 -51.71 13.25 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.793 -0.763 . . . . 2.56 110.205 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 79' ' ' VAL . 83.4 t80 -51.21 -43.33 61.37 Favored 'General case' 0 C--O 1.194 -1.84 0 N-CA-C 107.48 -1.304 . . . . 0.97 107.48 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.79 -60.63 2.94 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.018 -0.734 . . . . 0.9 109.018 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.96 -53.94 45.83 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.909 -0.716 . . . . 1.21 111.312 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -54.93 -53.12 59.65 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.416 -0.914 . . . . 1.43 110.126 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 80' ' ' LYS . 1.9 t -46.48 -62.52 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 124.48 1.112 . . . . 1.1 109.006 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.598 ' N ' HG12 ' A' ' 79' ' ' VAL . 15.8 tptp -34.63 -49.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.256 -1.793 . . . . 2.92 113.3 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.04 20.05 19.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.653 1.723 . . . . 6.42 115.653 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -132.14 -26.53 1.9 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.661 -1.615 . . . . 2.2 110.775 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 50.1 mt -100.95 45.56 0.97 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.426 -1.31 . . . . 2.75 107.804 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 121.933 0.873 . . . . 5.66 110.378 177.775 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 30' ' ' ASP . 77.5 mtm . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.211 -0.662 . . . . 2.72 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -109.43 102.16 11.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.727 -1.212 . . . . 4.5 107.727 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.3 m -91.66 139.43 30.7 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.599 -1.241 . . . . 0.78 109.27 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.52 139.03 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.045 -0.98 . . . . 0.91 109.988 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -118.34 109.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.156 1.535 . . . . 1.53 107.86 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG11 ' A' ' 36' ' ' VAL . 32.5 m-85 -91.74 90.74 7.66 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.174 -1.417 . . . . 1.28 107.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.85 -162.61 11.95 Favored Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.262 -0.971 . . . . 1.06 110.947 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.632 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -122.77 71.59 1.04 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.095 0.95 . . . . 6.25 111.532 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p 32.81 -77.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 116.393 1.997 . . . . 3.71 116.393 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -103.74 46.3 1.22 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 120.111 -1.042 . . . . 2.92 113.983 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.632 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 1.1 p -116.3 114.63 40.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 108.239 -1.023 . . . . 2.15 108.239 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.61 -54.89 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.187 1.925 . . . . 2.67 111.732 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.408 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 10.7 t80 -52.1 -40.43 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.279 -0.968 . . . . 2.54 109.913 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.42 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 28.4 m -62.24 -53.6 52.93 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.141 -1.024 . . . . 1.77 110.303 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -52.62 -42.14 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 114.669 -1.15 . . . . 1.42 111.663 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.526 HH12 ' CG ' ' A' ' 19' ' ' ASP . 10.0 mmm180 -42.5 -41.58 3.02 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 119.11 -1.036 . . . . 3.45 111.551 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.37 86.39 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.442 -0.903 . . . . 0.71 108.659 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.495 ' NZ ' ' HB2' ' A' ' 22' ' ' GLU . 4.1 tmtm? -62.6 -38.15 89.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.626 -0.879 . . . . 2.2 108.626 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CG ' HH12 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -61.46 -56.94 14.65 Favored 'General case' 0 C--O 1.192 -1.955 0 N-CA-C 106.666 -1.605 . . . . 3.53 106.666 177.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.1 tp -48.31 -56.93 6.8 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.145 -1.022 . . . . 1.08 108.655 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -50.53 9.84 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.71 108.425 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -57.41 -52.14 66.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.122 -0.631 . . . . 3.12 110.501 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 2.4 ttpp -52.68 -17.32 1.25 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.627 -1.17 . . . . 3.67 110.428 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.03 -53.37 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.506 -0.924 . . . . 1.48 108.506 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -43.9 -35.39 1.97 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.593 0.59 . . . . 1.53 112.593 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -105.62 22.3 15.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.086 1.143 . . . . 3.64 114.086 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 19.8 mt-10 -131.86 -27.6 1.86 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.575 -0.45 . . . . 3.27 110.242 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.59 -163.98 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.809 -0.756 . . . . 4.3 109.587 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.49 -179.98 4.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.14 -1.8 . . . . 4.69 106.14 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 t70 43.86 30.43 0.39 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 124.923 1.389 . . . . 3.6 112.059 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.87 85.88 2.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.243 -1.783 . . . . 1.01 113.068 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -102.71 141.82 34.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.178 -2.156 . . . . 3.42 105.178 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -133.1 153.62 51.34 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.627 -1.229 . . . . 1.07 109.567 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' HG23 ' A' ' 36' ' ' VAL . 1.7 tm0? -121.3 142.53 49.87 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.292 -1.373 . . . . 4.0 107.292 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.54 118.97 33.22 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.652 -1.219 . . . . 1.52 109.319 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 6' ' ' PHE . 26.3 t -109.43 136.07 46.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.027 -0.988 . . . . 1.01 109.152 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' A' ' 39' ' ' ARG . 17.1 t70 -118.58 44.86 2.17 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 114.842 -1.072 . . . . 1.99 108.743 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.1 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 114.364 -1.289 . . . . 2.0 114.199 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.616 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -59.14 -51.39 70.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.75 -0.659 . . . . 6.96 110.876 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' NH2' ' A' ' 39' ' ' ARG . . . -40.34 -51.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.381 -0.927 . . . . 1.27 110.24 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -74.93 -43.04 56.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.426 1.079 . . . . 3.17 110.478 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.4 30.81 1.23 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.161 -1.176 . . . . 2.2 110.161 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -98.44 152.35 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 2.32 108.171 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -124.4 -175.98 3.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.708 -0.678 . . . . 3.15 112.32 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -84.3 2.15 41.56 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.983 -0.687 . . . . 4.72 110.619 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.84 -45.91 5.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.037 -2.208 . . . . 5.05 105.037 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.5 -56.2 21.29 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.054 -0.975 . . . . 4.11 108.486 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -48.64 -40.25 27.13 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.713 -1.131 . . . . 2.06 111.5 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -44.23 -53.67 6.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.925 -1.11 . . . . 6.96 109.338 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -43.04 -49.92 6.06 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.493 -1.685 . . . . 6.89 113.297 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 5.4 mtpp -91.06 -28.02 18.22 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.516 -1.22 . . . . 5.48 114.162 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -73.61 -51.24 17.5 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.569 1.168 . . . . 1.95 112.899 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.98 -32.94 2.68 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.143 -1.983 . . . . 2.32 108.143 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 52' ' ' ALA . 26.0 mttt -86.38 -179.07 1.27 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 114.547 -0.827 . . . . 6.01 108.807 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.73 124.45 14.13 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.749 2.299 . . . . 4.81 111.76 155.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 56' ' ' VAL . 30.5 m -77.42 31.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.898 -0.592 . . . . 8.28 111.377 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.19 -7.85 12.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.41 -0.959 . . . . 5.64 108.41 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -85.04 54.09 2.97 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.243 -1.392 . . . . 6.46 107.243 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 19.2 m -89.68 169.57 12.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.161 -1.382 . . . . 3.41 111.799 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.671 ' C ' ' HA ' ' A' ' 59' ' ' VAL . 5.6 Cg_endo -46.16 137.67 1.8 Allowed 'Cis proline' 0 N--CA 1.489 1.219 0 C-N-CA 125.072 -0.803 . . . . 2.36 110.518 -13.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 61' ' ' GLN . 0.2 OUTLIER -94.53 116.63 29.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.091 -1.818 . . . . 3.29 106.091 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.6 mp -108.29 139.7 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 123.035 1.397 . . . . 1.12 111.416 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 3.8 m-85 -126.71 136.58 52.65 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 111.833 -2.44 . . . . 1.67 106.257 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.588 HG23 HG13 ' A' ' 69' ' ' ILE . 54.9 t -110.11 110.07 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 118.677 -1.209 . . . . 1.14 109.84 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 t70 75.38 -72.3 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 124.29 0.994 . . . . 2.69 112.216 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -134.03 -41.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.619 0.97 . . . . 4.5 113.619 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -94.26 160.75 14.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.552 0.945 . . . . 4.05 113.552 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.6 t-160 -77.09 144.47 38.5 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.772 -1.936 . . . . 1.51 105.772 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 64' ' ' VAL . 20.9 mm -103.66 -25.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 117.916 -1.514 . . . . 1.38 109.504 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.405 ' HA2' ' HD2' ' A' ' 54' ' ' LYS . . . 137.73 -34.05 2.2 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 118.522 -1.799 . . . . 2.77 113.294 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.78 -175.01 22.37 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.514 -1.434 . . . . 1.7 109.514 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 2.6 t80 -51.29 -44.44 61.88 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.375 -0.93 . . . . 2.01 111.625 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 p -66.81 -58.85 4.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.768 0.794 . . . . 1.45 110.548 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.73 -46.44 40.87 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.634 -1.166 . . . . 2.71 109.21 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 62' ' ' ILE . 48.7 t80 -60.88 -53.23 59.81 Favored 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 108.198 -1.038 . . . . 1.04 108.198 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.59 -53.39 11.55 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.71 -0.796 . . . . 0.79 112.655 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.48 13.58 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 118.999 -1.081 . . . . 0.91 110.126 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -44.41 -48.64 9.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.22 0.95 . . . . 1.32 108.828 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 t -47.67 -59.36 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 124.154 0.909 . . . . 1.02 108.865 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 7.6 tmtm? -57.33 -59.92 4.41 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.498 -1.281 . . . . 3.11 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -52.66 -36.27 56.61 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.24 1.57 . . . . 3.86 115.24 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -101.27 -28.67 12.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.811 -1.155 . . . . 1.73 113.563 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.07 -26.43 26.97 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 117.862 -1.535 . . . . 1.75 112.571 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 . . . . . 0 N--CA 1.5 2.073 0 C-N-CA 118.393 -1.323 . . . . 3.33 111.153 -179.114 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.459 ' N ' ' CG ' ' A' ' 30' ' ' ASP . 13.9 ptp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.162 -0.681 . . . . 2.91 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 19.6 pt20 -123.82 125.53 44.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.749 0.656 . . . . 3.66 110.721 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -94.25 132.03 39.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.488 -0.93 . . . . 1.12 108.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.87 117.94 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.59 -1.634 . . . . 0.91 106.59 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.8 mm -108.96 125.04 66.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.568 -1.253 . . . . 1.76 108.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.13 96.02 6.94 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.962 -0.755 . . . . 1.31 108.962 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.59 -173.67 18.09 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.559 -1.817 . . . . 0.93 108.559 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.11 170.84 3.69 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.813 -0.81 . . . . 8.79 108.813 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -90.51 53.7 2.52 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 105.864 -1.902 . . . . 6.05 105.864 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.83 -39.16 0.12 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.339 -1.904 . . . . 6.99 108.339 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -90.59 151.67 44.27 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 108.578 -0.897 . . . . 5.02 108.578 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.2 Cg_endo -91.28 178.91 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.58 2.187 . . . . 4.69 109.027 146.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER 76.6 -36.56 0.27 Allowed 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 120.454 -0.498 . . . . 3.37 111.714 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -31.77 11.32 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 120.28 -0.568 . . . . 1.78 111.936 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 59.4 t -59.84 -53.5 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.444 -0.902 . . . . 1.12 109.7 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -33.86 -53.15 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.295 -0.866 . . . . 4.2 113.323 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.9 84.16 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.451 -0.9 . . . . 0.81 109.733 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 2.5 tmtm? -53.33 -47.9 68.94 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.891 -1.049 . . . . 1.84 110.251 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.547 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 1.3 p-10 -68.03 -43.14 79.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.143 -1.423 . . . . 2.84 109.083 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.52 -58.57 6.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.273 -1.371 . . . . 0.91 109.953 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.94 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.542 -0.863 . . . . 0.89 110.725 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.623 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 24.1 tt0 -50.75 -57.8 7.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.885 -1.126 . . . . 2.67 109.265 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.61 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -49.14 -54.07 17.94 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.901 -1.045 . . . . 4.69 110.178 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -48.9 -44.15 39.87 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 114.107 1.151 . . . . 1.66 114.107 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.7 p -49.73 -19.94 0.73 Allowed 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 119.351 -0.939 . . . . 2.28 113.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 26' ' ' ASN . 1.2 m120 -99.53 -2.82 34.86 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.713 -0.395 . . . . 3.26 111.531 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.61 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 14.9 mt-10 -114.6 -32.8 5.75 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.577 0.703 . . . . 3.35 111.24 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 8.6 mmm-85 -95.67 -173.62 2.92 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.743 -1.183 . . . . 3.74 113.953 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 7.1 p-10 -96.55 -71.77 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 113.45 -1.705 . . . . 5.15 111.969 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.472 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 42.1 t0 -101.91 66.63 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.918 0.866 . . . . 4.02 108.861 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -124.04 102.47 7.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.774 -1.103 . . . . 1.34 110.163 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 45.7 mt-30 -119.07 163.33 17.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.363 -1.718 . . . . 3.28 106.363 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 35.3 p90 -158.83 164.07 36.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.291 -1.364 . . . . 1.31 110.135 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -136.14 137.62 41.17 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.679 -1.146 . . . . 3.46 108.789 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -96.78 137.21 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.164 -2.532 . . . . 1.28 104.164 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.6 139.12 52.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.447 -0.901 . . . . 0.7 111.672 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -115.79 124.5 50.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 104.807 -2.294 . . . . 1.79 104.807 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 pt -51.02 -35.79 15.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.116 -0.947 . . . . 1.9 111.918 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -81.75 4.02 23.53 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 113.237 0.828 . . . . 5.2 113.237 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.63 -46.27 3.06 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.987 -0.685 . . . . 1.96 109.925 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.451 -0.899 . . . . 3.74 109.355 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.64 48.66 1.77 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 120.035 -1.079 . . . . 3.08 110.752 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.38 147.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.407 -0.917 . . . . 2.57 110.471 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.1 p -117.71 170.46 8.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.712 -1.218 . . . . 3.71 107.712 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -53.89 48.69 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.071 -1.052 . . . . 6.11 108.978 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -35.08 -62.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.534 -1.212 . . . . 5.38 110.559 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -46.78 -59.11 3.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.253 -0.885 . . . . 4.41 111.976 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.1 mt -50.68 -44.87 57.92 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.834 -0.746 . . . . 2.39 111.372 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 5.3 tm0? -42.17 -55.15 3.37 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.597 -0.841 . . . . 6.53 110.143 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -49.23 -33.96 13.83 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.022 -0.99 . . . . 6.6 113.271 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.68 -26.37 19.61 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.981 -0.688 . . . . 3.39 111.835 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 -45.45 53.79 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.886 -0.726 . . . . 1.69 109.559 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.13 -52.48 0.63 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.176 -1.57 . . . . 3.61 109.176 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 2.4 ttpm? -95.27 161.92 26.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 6.52 108.026 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 87.5 Cg_exo -30.45 121.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 121.538 1.492 . . . . 5.56 109.137 147.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.6 47.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.617 -0.833 . . . . 7.77 111.812 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 1.8 mm-40 -83.48 53.3 2.47 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.951 1.358 . . . . 8.49 108.697 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -147.72 99.22 3.07 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 105.575 -2.009 . . . . 5.21 105.575 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -113.53 147.69 38.08 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.309 -0.997 . . . . 3.15 108.309 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 59' ' ' VAL . 11.1 Cg_endo -84.2 174.35 38.49 Favored 'Cis proline' 0 C--O 1.207 -1.043 0 C-N-CA 125.403 -0.666 . . . . 2.12 111.48 21.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.72 146.9 48.92 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.459 -0.896 . . . . 3.57 110.57 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.463 HG21 ' CG ' ' A' ' 75' ' ' PHE . 14.8 mm -120.09 134.93 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 124.011 0.82 . . . . 1.74 108.901 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HA ' HG12 ' A' ' 69' ' ' ILE . 15.5 m-85 -137.38 133.16 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.167 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 69' ' ' ILE . 84.6 t -100.11 122.32 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 106.25 -1.759 . . . . 1.3 106.25 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.53 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.783 0.677 . . . . 2.97 111.582 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' VAL . 74.1 mt-30 -138.35 10.07 2.73 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.601 -0.84 . . . . 5.03 112.239 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.77 152.66 24.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.488 -0.485 . . . . 4.24 110.12 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -85.14 145.1 27.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.588 -1.264 . . . . 1.57 107.588 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 HG23 ' A' ' 64' ' ' VAL . 14.0 mm -113.5 -34.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 C-N-CA 119.255 -0.978 . . . . 1.2 110.895 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.0 -128.94 4.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.323 -1.111 . . . . 1.77 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.73 -59.2 0.59 Allowed Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.868 -1.158 . . . . 2.32 112.073 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -163.63 -60.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.959 -1.096 . . . . 1.86 109.157 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 p -41.6 -48.06 3.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.973 -1.121 . . . . 1.84 107.973 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -68.75 0.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.756 -2.02 . . . . 2.96 110.353 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CG ' HG21 ' A' ' 62' ' ' ILE . 71.7 t80 -52.62 -39.23 61.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.305 -0.958 . . . . 1.04 110.762 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.499 -0.481 . . . . 0.94 111.174 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.09 -48.71 61.91 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.894 -1.151 . . . . 1.56 107.894 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.442 ' CZ3' ' CE1' ' A' ' 75' ' ' PHE . 60.8 t90 -41.6 -52.09 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.712 -1.131 . . . . 1.2 108.923 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 83' ' ' LEU . 3.0 t -41.81 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.619 -1.252 . . . . 1.16 107.619 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -47.78 -53.42 15.42 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.468 0.652 . . . . 3.25 111.235 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 1.1 mp0 -62.69 -17.99 61.63 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.081 1.141 . . . . 4.02 114.081 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -110.6 -32.24 6.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 118.826 -1.149 . . . . 1.78 113.385 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.539 HD12 HG13 ' A' ' 79' ' ' VAL . 19.2 mt -92.87 -19.7 21.42 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.363 -0.935 . . . . 1.74 111.697 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 . . . . . 0 N--CA 1.495 1.779 0 N-CA-C 108.398 -0.964 . . . . 3.45 108.398 179.839 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.898 0.38 . . . . 4.04 110.689 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.78 174.8 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.247 -1.02 . . . . 4.14 108.247 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 75' ' ' PHE . 57.5 m -114.88 141.18 48.27 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.741 -1.184 . . . . 0.75 113.695 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.7 t -119.63 128.27 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.14 -2.17 . . . . 0.64 105.14 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.46 120.56 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 124.474 1.109 . . . . 1.53 110.48 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CD2' HG11 ' A' ' 36' ' ' VAL . 91.0 m-85 -99.42 81.3 2.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.175 -1.417 . . . . 0.92 107.175 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.42 -174.15 13.6 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.929 -1.268 . . . . 1.87 109.929 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 9' ' ' SER . 7.5 mmm180 -102.91 -63.62 1.15 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.732 -0.787 . . . . 6.47 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 75.5 m 97.45 145.9 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 125.408 1.692 . . . . 5.95 107.78 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.18 -21.22 31.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 106.63 -2.588 . . . . 4.7 106.63 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -113.27 150.25 42.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.996 -1.102 . . . . 3.46 110.072 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.09 -56.48 2.53 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.702 1.601 . . . . 3.03 112.317 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.56 -44.09 79.09 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.597 -0.841 . . . . 3.09 112.114 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 20.1 p -54.9 -55.13 33.85 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 117.291 -1.764 . . . . 3.57 107.999 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 18' ' ' LYS . 97.7 t -52.97 -47.37 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 1.19 111.167 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -32.83 -50.01 0.25 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 113.555 0.946 . . . . 4.46 113.555 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.13 95.62 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.003 -1.079 . . . . 0.82 110.517 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -61.09 -47.49 86.08 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.251 -0.648 . . . . 1.92 109.251 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m-20 -56.86 -47.85 79.46 Favored 'General case' 0 C--O 1.199 -1.596 0 C-N-CA 118.81 -1.156 . . . . 3.47 109.244 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.62 -57.69 11.86 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.443 -1.303 . . . . 0.87 109.361 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.582 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -50.56 -53.51 29.79 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.145 -1.422 . . . . 0.74 110.071 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 20.2 tt0 -55.19 -49.54 71.66 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.585 0.707 . . . . 2.8 112.228 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.64 -51.14 71.08 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.032 -1.099 . . . . 7.08 108.032 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.81 -52.86 37.09 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.468 -0.787 . . . . 1.7 109.967 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 p -60.42 -14.58 19.81 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.107 -1.437 . . . . 1.72 112.358 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -117.71 17.57 14.33 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.178 0.513 . . . . 3.41 110.194 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.54 -45.52 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.203 1.001 . . . . 3.9 109.474 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 2.3 mmp_? -101.86 -36.68 8.57 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.193 -1.367 . . . . 4.04 111.392 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 31' ' ' PHE . 15.5 m-20 77.42 -40.74 0.35 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 124.636 1.21 . . . . 6.4 110.389 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -72.79 17.84 0.11 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.486 -0.886 . . . . 6.59 109.729 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 29' ' ' ASP . 47.2 t80 -125.49 120.81 31.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.11 -0.95 . . . . 1.91 109.694 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.302 -1.37 . . . . 4.73 107.302 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 18.3 p90 -144.68 176.12 9.66 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.63 -0.828 . . . . 1.45 112.755 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -136.14 141.64 44.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.623 -1.621 . . . . 2.89 106.623 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -99.16 141.52 31.83 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.944 -1.503 . . . . 1.36 108.053 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -131.32 148.18 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.989 -1.115 . . . . 0.75 107.989 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.79 123.65 50.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.922 -1.14 . . . . 1.99 107.922 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 pt -54.14 -25.32 12.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.098 -1.041 . . . . 1.92 110.105 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.67 11.25 18.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.368 1.042 . . . . 6.67 111.653 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.86 -51.01 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.392 -0.595 . . . . 1.79 109.392 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.79 -32.55 63.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.547 -1.206 . . . . 2.78 109.641 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.45 46.77 1.93 Allowed Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.82 -1.181 . . . . 1.95 111.263 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 mt -114.19 147.39 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 118.378 -1.329 . . . . 1.92 109.065 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.5 p -105.26 -99.59 0.33 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.096 -1.042 . . . . 3.51 110.161 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.547 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 42.6 tttp -141.03 -63.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 5.53 106.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -45.25 -40.03 7.04 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.73 -1.123 . . . . 5.86 109.291 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' LEU . 51.4 m-20 -56.9 -67.39 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.588 -0.893 . . . . 4.91 108.588 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 61' ' ' GLN . 61.5 mt -36.75 -51.45 0.88 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.238 -0.892 . . . . 1.86 109.931 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -52.92 -62.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.157 -1.383 . . . . 5.45 110.59 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -58.08 -45.32 87.34 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.964 -0.694 . . . . 6.78 111.154 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -61.61 -29.51 70.09 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.458 -0.792 . . . . 3.56 110.563 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -81.8 -55.37 4.66 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.822 -0.751 . . . . 2.07 110.574 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -16.76 11.96 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.959 -2.056 . . . . 2.54 107.959 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -114.05 84.34 8.82 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 108.678 -0.86 . . . . 5.37 108.678 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 34.8 Cg_exo -50.32 177.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.125 1.883 . . . . 4.74 111.504 168.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 23.9 t 71.34 70.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 CA-C-O 122.422 1.106 . . . . 5.63 108.953 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.547 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 4.8 pt-20 -171.06 166.56 7.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.37 -1.741 . . . . 6.08 109.661 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 70.3 m -139.86 178.72 7.05 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.719 -1.586 . . . . 5.03 106.719 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 58' ' ' THR . 7.1 m -84.39 154.32 62.68 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 123.687 0.617 . . . . 3.37 110.501 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.01 167.95 78.5 Favored 'Cis proline' 0 N--CA 1.495 1.607 0 O-C-N 122.533 0.754 . . . . 1.95 111.842 6.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HG3' HD13 ' A' ' 48' ' ' LEU . 15.5 mm-40 -122.69 145.25 48.55 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 120.231 -0.588 . . . . 2.94 109.58 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.593 HG21 ' CG ' ' A' ' 75' ' ' PHE . 10.8 mm -118.08 126.35 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 120.193 -0.603 . . . . 1.32 111.599 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 21.1 m-85 -124.81 132.31 53.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.682 -1.97 . . . . 1.17 105.682 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.668 HG11 ' CH2' ' A' ' 78' ' ' TRP . 45.6 t -119.22 145.39 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.86 -1.136 . . . . 1.42 108.686 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 54.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.424 1.077 . . . . 4.43 109.35 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' VAL . 18.7 pt20 -148.34 9.76 0.85 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.93 -0.577 . . . . 4.64 109.971 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -116.5 169.61 9.2 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.435 0.636 . . . . 5.53 111.354 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CG ' ' HB1' ' A' ' 52' ' ' ALA . 10.9 t-80 -94.64 135.42 36.13 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 64' ' ' VAL . 5.7 mm -110.86 -36.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 117.901 -1.52 . . . . 1.07 109.579 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.15 -144.74 12.29 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.239 -1.458 . . . . 1.78 111.354 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' CG1' ' A' ' 62' ' ' ILE . . . -103.77 -60.8 0.69 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-O 119.178 -0.79 . . . . 2.57 112.942 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -150.13 -68.43 0.2 Allowed 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 117.914 -1.515 . . . . 2.11 111.118 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 p -49.06 -51.46 31.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.078 -1.082 . . . . 1.96 108.078 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.94 -53.74 14.99 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.746 -1.57 . . . . 3.54 110.667 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 62' ' ' ILE . 40.8 t80 -59.13 -51.36 70.36 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.169 -0.678 . . . . 1.02 109.169 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.2 -53.13 18.0 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.914 -0.773 . . . . 1.59 108.914 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -63.35 1.21 Allowed 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 114.814 -1.084 . . . . 1.46 109.051 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.668 ' CH2' HG11 ' A' ' 64' ' ' VAL . 68.5 t90 -43.06 -53.96 4.59 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.773 -0.771 . . . . 1.55 109.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.0 t -44.87 -63.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.994 -1.113 . . . . 1.86 107.994 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -52.9 -48.03 67.52 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.996 -1.081 . . . . 3.52 110.3 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.57 20.81 0.21 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.536 0.569 . . . . 3.99 112.536 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -142.77 -38.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.328 -0.549 . . . . 2.27 111.37 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.6 mt -94.35 -14.41 25.37 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.039 -0.665 . . . . 2.03 112.01 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 . . . . . 0 N--CA 1.497 1.914 0 C-N-CA 119.62 -0.832 . . . . 3.94 110.557 179.801 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.43 -0.952 . . . . 2.58 108.43 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HG2' ' N ' ' A' ' 3' ' ' THR . 6.5 tt0 -116.47 157.61 24.9 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.114 -1.034 . . . . 4.44 111.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.589 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 75.8 m -145.08 127.65 16.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.261 -0.644 . . . . 0.9 109.261 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.62 136.69 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.899 -0.778 . . . . 0.96 108.899 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.4 mm -113.21 130.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 36' ' ' VAL . 16.0 m-85 -108.0 97.78 7.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.025 0.828 . . . . 1.23 109.916 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.32 -141.74 4.53 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 108.845 -1.702 . . . . 0.9 108.845 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.729 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -116.89 176.76 4.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.213 -0.662 . . . . 6.17 109.213 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -83.21 61.9 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.91 . . . . 3.56 110.55 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.5 68.72 0.61 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.243 -1.456 . . . . 3.3 110.724 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.36 113.04 35.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.548 -1.278 . . . . 2.52 107.548 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.19 -50.29 1.61 Allowed 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 122.291 1.994 . . . . 3.24 113.143 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -68.66 -47.75 65.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.299 -1.36 . . . . 2.68 111.408 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -58.23 -42.73 86.95 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 118.048 -1.461 . . . . 2.89 110.243 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.8 -26.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 115.018 -0.992 . . . . 1.35 110.791 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 4.2 tpp180 -74.02 -50.21 20.84 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.031 -1.067 . . . . 4.31 109.322 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.35 -41.53 65.89 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.492 -1.67 . . . . 0.8 106.492 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 11.9 tmtt? -55.56 -58.98 5.52 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 113.948 -1.478 . . . . 2.13 108.255 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.552 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 79.4 m-20 -54.3 -53.47 53.4 Favored 'General case' 0 C--O 1.191 -1.998 0 C-N-CA 118.984 -1.087 . . . . 3.7 110.098 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 tp -46.17 -60.76 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.026 -1.07 . . . . 0.91 110.353 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.13 34.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.877 -1.129 . . . . 0.94 111.032 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 35.2 tt0 -52.36 -56.49 14.56 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.386 -0.926 . . . . 2.8 110.948 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 66.0 tttp -45.59 -57.17 4.38 Favored 'General case' 0 C--O 1.2 -1.54 0 CA-C-N 114.238 -1.347 . . . . 4.52 108.32 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.32 -45.77 80.17 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.684 -1.206 . . . . 1.81 110.03 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -50.3 -49.44 53.58 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.637 -0.71 . . . . 2.22 111.015 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -81.15 -28.79 34.92 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.928 -0.709 . . . . 3.09 112.185 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 62.0 mt-10 -100.93 42.01 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.21 1.005 . . . . 6.46 112.692 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.626 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -149.34 -143.71 0.14 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.104 -1.039 . . . . 5.5 109.316 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -133.88 -48.94 0.81 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.645 -0.872 . . . . 4.12 108.645 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 31' ' ' PHE . 51.6 t0 -98.75 -81.69 0.44 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.812 -1.086 . . . . 3.31 110.382 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 30' ' ' ASP . 21.3 t80 1.56 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 124.349 1.03 . . . . 1.26 113.544 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 64.9 mt-30 -94.24 112.16 23.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.895 -1.522 . . . . 2.9 107.291 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.34 164.17 12.94 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.39 -1.324 . . . . 1.6 111.335 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.91 157.46 44.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.742 -1.947 . . . . 3.83 105.742 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -110.43 149.45 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.545 -1.262 . . . . 1.16 109.1 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.662 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.8 t -132.75 147.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.635 -0.711 . . . . 0.66 109.579 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -119.73 121.15 38.56 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.152 0.977 . . . . 2.04 110.323 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 pt -57.61 -30.44 36.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.087 -0.96 . . . . 1.29 111.783 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.77 9.16 14.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 117.652 -1.619 . . . . 5.62 111.826 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.46 -43.18 3.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.898 -1.519 . . . . 1.33 106.898 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -74.3 -36.52 63.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.355 -0.98 . . . . 3.86 108.355 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.68 46.18 1.23 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.184 -1.566 . . . . 1.83 109.184 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 90.2 mt -108.11 145.99 14.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.881 -0.659 . . . . 2.21 112.625 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.4 p -117.89 -94.1 0.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.215 -1.032 . . . . 3.48 108.215 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -135.47 -61.59 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.417 -0.956 . . . . 6.11 108.417 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -36.37 -52.82 0.84 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.589 -1.187 . . . . 3.27 111.467 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -58.82 -56.91 16.09 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.865 -1.134 . . . . 3.15 110.516 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 48.9 mt -49.37 -47.67 47.38 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.219 -0.992 . . . . 1.88 110.021 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -56.55 -53.73 54.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.707 -1.197 . . . . 4.18 108.481 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -52.08 -64.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.395 1.059 . . . . 4.68 111.284 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -58.28 -45.81 87.21 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.448 -0.796 . . . . 3.4 112.405 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -58.04 -38.79 76.91 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 123.958 0.786 . . . . 2.1 110.095 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.67 39.98 6.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.644 -1.783 . . . . 2.94 108.644 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -119.44 151.62 51.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.195 -1.002 . . . . 5.2 110.499 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.6 -25.33 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.863 1.709 . . . . 4.72 111.671 154.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.27 108.19 23.2 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 112.416 -2.175 . . . . 6.25 108.928 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 167.87 11.33 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.876 -1.056 . . . . 5.99 111.861 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.2 p -156.1 174.97 14.58 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.484 -2.043 . . . . 5.97 105.484 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.13 156.36 45.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 118.319 -1.352 . . . . 3.78 108.573 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.08 -172.6 9.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 124.386 -1.089 . . . . 2.12 111.291 -17.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -119.77 147.36 44.72 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 107.624 -1.25 . . . . 3.31 107.624 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 62' ' ' ILE . 5.0 mp -122.86 143.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 122.317 1.056 . . . . 1.28 112.53 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 39.6 m-85 -123.0 124.84 44.05 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 112.141 -2.3 . . . . 1.34 106.18 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.649 ' CG1' ' H ' ' A' ' 65' ' ' ASP . 41.7 t -97.52 -172.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.065 -1.454 . . . . 1.69 107.52 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.649 ' H ' ' CG1' ' A' ' 64' ' ' VAL . 32.7 t70 -48.47 -35.0 12.08 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 112.954 0.724 . . . . 2.72 112.954 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.434 ' H ' ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -94.2 -72.66 0.6 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.522 -1.271 . . . . 8.49 113.892 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -134.97 -167.02 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.274 0.842 . . . . 5.25 113.274 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.627 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 35.9 t-80 -70.14 140.6 52.65 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 104.79 -2.3 . . . . 1.9 104.79 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 ' CG2' ' A' ' 64' ' ' VAL . 16.0 mm -107.5 -34.85 2.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 119.081 -1.048 . . . . 1.12 110.552 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.42 -150.14 21.88 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.465 -1.35 . . . . 1.74 110.644 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.406 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -96.77 -169.1 33.83 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.035 -1.226 . . . . 1.64 110.035 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.36 -47.53 66.08 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.755 -1.178 . . . . 1.69 110.733 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -62.49 -61.64 2.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.409 -0.917 . . . . 1.24 109.952 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -42.98 -54.27 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.426 -1.261 . . . . 2.91 109.389 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.7 t80 -61.23 -57.23 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.811 -1.086 . . . . 1.11 109.423 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -42.32 -54.58 3.7 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.12 -0.632 . . . . 1.06 110.32 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -59.44 -57.64 12.08 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.035 -0.984 . . . . 1.3 108.488 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CH2' HG11 ' A' ' 64' ' ' VAL . 85.0 t90 -41.99 -47.14 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.079 -0.711 . . . . 1.57 109.079 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HD12 ' A' ' 83' ' ' LEU . 92.6 t -62.26 -36.92 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.833 -0.621 . . . . 1.13 109.513 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -94.52 22.24 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.147 -0.478 . . . . 4.13 112.106 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -134.79 -40.86 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.954 -0.566 . . . . 4.56 110.13 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -92.85 -23.32 18.85 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 116.057 -0.519 . . . . 2.55 112.309 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 79' ' ' VAL . 39.8 mt -100.93 13.12 36.17 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.277 -1.369 . . . . 2.31 110.894 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.514 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 5.2 m-20 . . . . . 0 N--CA 1.497 1.896 0 C-N-CA 119.921 -0.711 . . . . 4.62 110.847 -179.326 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 30' ' ' ASP . 29.0 ttm . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 106.52 -1.659 . . . . 2.93 106.52 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -122.79 85.33 2.4 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.906 -0.718 . . . . 3.6 109.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 64' ' ' VAL . 27.7 m -88.71 131.22 35.11 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.26 -1.015 . . . . 1.18 108.26 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.6 138.19 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.781 -0.822 . . . . 0.69 108.781 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -114.96 119.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 124.559 1.162 . . . . 1.99 109.326 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -92.25 85.98 5.6 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.801 -2.296 . . . . 2.23 104.801 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.15 -168.45 15.16 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.634 -1.746 . . . . 0.94 110.593 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.61 133.14 54.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.81 -0.811 . . . . 5.41 108.81 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.442 ' N ' HH22 ' A' ' 8' ' ' ARG . 2.8 p -67.57 94.16 0.4 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.36 -0.836 . . . . 3.67 110.017 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.01 22.87 8.04 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.721 -0.951 . . . . 2.94 110.721 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -104.03 115.61 62.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 120.132 -0.627 . . . . 2.4 110.734 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 -31.43 90.57 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.554 2.17 . . . . 2.94 111.593 -159.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -92.72 -37.56 12.3 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.727 -1.124 . . . . 2.69 110.9 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 63.8 m -51.83 -45.18 63.85 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.631 -1.228 . . . . 2.23 109.199 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -46.58 -41.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.656 -1.156 . . . . 1.35 111.417 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.587 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.6 -37.11 3.38 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 112.157 0.429 . . . . 6.61 112.157 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.88 98.46 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.699 -1.201 . . . . 0.98 108.205 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.5 tmtm? -73.28 -32.98 64.97 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.17 -1.012 . . . . 2.51 110.672 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.546 ' CG ' HH21 ' A' ' 16' ' ' ARG . 5.7 m-20 -51.31 -57.49 8.73 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.015 -1.474 . . . . 3.27 108.647 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -46.13 -61.2 1.87 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.171 0.804 . . . . 0.92 113.171 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 33' ' ' TYR . . . -39.17 -39.85 0.65 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.668 0.618 . . . . 1.11 112.668 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -50.57 69.99 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.076 -1.05 . . . . 3.11 110.051 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -45.13 -46.95 12.15 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.5 -1.227 . . . . 5.98 110.256 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.2 mt -72.34 -50.03 29.89 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.208 -1.36 . . . . 1.23 112.649 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -55.89 -26.66 48.33 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.804 -0.758 . . . . 1.5 110.803 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -93.09 24.03 3.98 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.003 -0.679 . . . . 2.68 110.393 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.32 -49.86 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.646 0.591 . . . . 3.59 110.971 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.2 mpt_? -108.35 124.25 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.256 -0.883 . . . . 4.68 111.579 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.53 60.52 0.88 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 124.562 1.163 . . . . 5.95 109.156 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t70 -165.04 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.869 -1.514 . . . . 3.12 109.841 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 33' ' ' TYR . 14.5 t80 -66.19 102.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.596 -0.729 . . . . 0.99 109.994 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 83.6 mt-30 -91.47 -54.69 3.8 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.287 -0.565 . . . . 3.74 111.347 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER 59.0 149.64 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 O-C-N 126.357 2.285 . . . . 1.31 113.507 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -139.65 144.65 37.74 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 115.19 -0.914 . . . . 3.31 110.86 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -98.8 138.19 36.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.53 144.52 35.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.219 -1.4 . . . . 0.6 107.219 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -115.31 118.33 32.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.302 1.001 . . . . 2.2 111.738 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.01 -19.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.839 -1.144 . . . . 1.22 111.042 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 1.2 tmm_? -87.14 -9.8 54.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 123.289 0.368 . . . . 5.41 111.001 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.39 -39.34 8.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.616 -1.253 . . . . 1.17 107.616 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -104.51 28.16 7.23 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.24 -1.346 . . . . 2.54 109.959 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 27.24 64.49 0.08 OUTLIER Glycine 0 N--CA 1.507 3.413 0 CA-C-N 114.648 -1.16 . . . . 1.64 113.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.56 147.97 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.579 -0.849 . . . . 1.82 109.783 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -130.85 173.37 11.02 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.654 -0.818 . . . . 2.78 109.217 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -50.48 -50.78 51.75 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.699 -0.8 . . . . 6.96 110.138 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -34.2 -69.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.119 0.887 . . . . 3.47 113.063 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.54 -46.25 80.73 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 119.981 -0.687 . . . . 3.31 112.853 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLN . 97.8 mt -58.12 -53.2 60.9 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.457 -1.297 . . . . 1.97 110.62 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HG3' ' HE2' ' A' ' 45' ' ' LYS . 37.9 mt-30 -42.67 -53.04 4.67 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.153 -1.019 . . . . 3.75 108.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -55.56 -44.86 77.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.966 1.416 . . . . 5.26 110.873 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -90.13 11.09 21.92 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.625 -0.83 . . . . 4.44 111.85 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -102.77 -66.1 0.95 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.819 0.674 . . . . 1.86 112.819 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.34 18.21 34.2 Favored Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.922 -1.133 . . . . 3.52 112.81 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 68' ' ' HIS . 50.8 mtpt -121.97 24.85 0.11 Allowed Pre-proline 0 N--CA 1.502 2.168 0 CA-C-N 117.714 0.757 . . . . 5.8 110.798 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.59 46.28 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.752 2.301 . . . . 5.13 113.437 -105.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.3 15.95 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.982 -1.118 . . . . 5.43 107.982 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -84.01 173.82 10.83 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.149 -1.387 . . . . 6.55 109.542 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 t -149.22 -156.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.886 -0.726 . . . . 4.66 109.31 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.39 131.07 56.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.04 -1.096 . . . . 2.79 108.04 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -99.11 151.76 5.76 Favored 'Cis proline' 0 N--CA 1.481 0.761 0 O-C-N 122.661 0.822 . . . . 1.95 111.64 12.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -122.62 139.34 54.04 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.231 -0.895 . . . . 2.94 109.037 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -118.2 149.66 20.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.669 -1.234 . . . . 1.45 107.669 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 68' ' ' HIS . 22.6 m-85 -134.02 116.65 15.76 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 125.401 1.688 . . . . 1.01 106.726 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.633 HG23 HG13 ' A' ' 69' ' ' ILE . 84.8 t -88.2 108.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 118.067 -1.453 . . . . 1.04 110.078 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 54.03 -79.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 123.748 0.655 . . . . 3.04 112.086 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.6 pt20 -128.38 1.9 5.68 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.041 -1.064 . . . . 4.83 111.654 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 66' ' ' GLN . 10.0 mp0 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.946 -0.391 . . . . 4.24 109.946 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.744 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-80 -106.66 132.75 52.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.733 -1.21 . . . . 1.52 107.733 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 64' ' ' VAL . 5.3 mm -111.09 -56.17 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 105.867 -1.901 . . . . 1.89 105.867 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' NE2' ' A' ' 68' ' ' HIS . . . 68.87 88.09 0.08 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 116.261 1.265 . . . . 2.44 116.261 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 131.18 3.78 Favored Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.282 -1.437 . . . . 1.49 114.632 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 74' ' ' ASP . 22.4 t80 -66.23 -58.09 6.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.553 -0.859 . . . . 1.25 109.124 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 14.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.619 0.6 . . . . 2.57 112.619 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 72' ' ' TYR . 7.9 t70 -119.37 -63.92 1.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' TRP . 67.0 t80 -56.41 -39.05 72.39 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.878 -1.51 . . . . 0.97 108.426 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.634 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.21 -53.43 43.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.023 -1.103 . . . . 1.4 108.023 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 89.8 t90 -41.39 -65.45 0.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.362 -1.29 . . . . 1.61 110.862 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.8 t -42.82 -52.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.505 -0.924 . . . . 1.04 108.505 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -46.81 -42.29 16.88 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.417 -1.72 . . . . 5.04 109.919 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -106.81 25.18 11.59 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 120.085 -0.646 . . . . 4.8 112.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -129.85 -43.02 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.379 -1.328 . . . . 1.94 113.817 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 26.4 mt -101.54 32.26 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.118 -2.178 . . . . 1.5 105.118 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 . . . . . 0 C--N 1.318 -0.782 0 CA-C-N 113.026 -1.897 . . . . 6.15 106.773 -178.147 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 33.4 tpp . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.629 -0.508 . . . . 2.6 109.629 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' H ' ' A' ' 32' ' ' GLN . 8.5 pt20 -94.42 173.17 7.76 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.623 -1.231 . . . . 3.32 108.515 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.44 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 86.6 m -130.2 145.35 51.72 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.074 -1.05 . . . . 1.28 111.812 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.29 118.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 105.737 -1.949 . . . . 0.86 105.737 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.451 HG23 ' CD1' ' A' ' 62' ' ' ILE . 30.7 mt -100.07 113.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.009 -1.108 . . . . 2.89 108.009 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CD2' HG11 ' A' ' 36' ' ' VAL . 45.6 m-85 -97.58 78.06 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 105.747 -1.946 . . . . 1.25 105.747 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.74 1.91 Allowed Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.781 -1.676 . . . . 1.03 112.04 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER 179.23 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.811 -1.181 . . . . 4.86 107.811 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 13.2 m 97.29 162.92 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 O-C-N 125.335 1.647 . . . . 5.04 110.4 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 15' ' ' VAL . . . 97.12 -12.37 65.44 Favored Glycine 0 N--CA 1.503 3.14 0 C-N-CA 120.194 -1.003 . . . . 3.52 110.637 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.58 143.63 30.94 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.91 -0.645 . . . . 2.55 110.724 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 -54.71 5.01 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.257 1.305 . . . . 3.77 111.675 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -67.94 -2.58 7.76 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 113.802 1.038 . . . . 3.15 113.802 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 9' ' ' SER . 29.4 p -111.66 -41.87 3.97 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.651 -1.22 . . . . 2.33 109.09 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 17' ' ' ALA . 49.0 t -73.04 -30.98 33.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 118.824 -1.15 . . . . 0.92 108.357 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 9.3 mmm180 -71.9 23.47 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 C-N-CA 119.919 -0.712 . . . . 3.65 110.976 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -121.49 -48.87 2.16 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.64 -1.245 . . . . 1.08 107.64 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.9 tmtm? -57.97 -29.15 65.0 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.873 -0.731 . . . . 2.56 110.169 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 20' ' ' LEU . 3.6 p-10 -81.06 -38.66 27.0 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.727 -0.789 . . . . 3.28 108.926 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 75' ' ' PHE . 34.2 tp -60.23 -49.06 79.11 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.686 -1.598 . . . . 0.76 106.686 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.65 71.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.2 tp10 -63.48 -56.98 11.75 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.559 -1.256 . . . . 3.36 108.496 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -55.11 -51.88 65.01 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 118.356 -1.338 . . . . 4.61 108.145 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.426 -1.31 . . . . 1.26 109.459 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.1 m -51.23 -43.47 61.47 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 118.72 -1.192 . . . . 1.32 108.718 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.98 42.46 1.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.874 -1.057 . . . . 3.69 108.994 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 14.9 mm-40 -144.8 -58.7 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.957 -1.02 . . . . 3.18 113.492 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HE ' ' HB3' ' A' ' 27' ' ' GLU . 3.5 mmt180 -101.45 -157.89 0.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.809 -1.087 . . . . 5.42 112.476 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -102.61 -75.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.177 -0.92 . . . . 4.9 113.411 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.62 53.57 2.73 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.627 -1.229 . . . . 3.42 112.418 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 1' ' ' MET . 39.9 t80 -117.92 140.11 50.19 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.963 -1.095 . . . . 1.62 109.87 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.47 ' H ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 mt-30 -156.64 179.95 8.77 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.12 -1.807 . . . . 3.09 106.12 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 3' ' ' THR . 19.7 p90 -171.58 159.26 5.4 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.073 -1.451 . . . . 1.19 111.369 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -133.09 151.36 52.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.772 -1.566 . . . . 3.57 106.772 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -103.67 144.9 30.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.464 -1.695 . . . . 1.09 109.678 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.4 t -132.71 148.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.453 -1.249 . . . . 0.57 108.925 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.07 113.37 20.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.627 -1.249 . . . . 2.21 107.627 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 30.9 pt -44.59 -31.03 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.391 0 CA-C-N 115.211 -0.904 . . . . 1.44 110.466 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 38' ' ' ILE . 43.6 ttp180 -71.72 -60.44 2.23 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.112 -1.035 . . . . 4.78 109.322 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.34 -43.25 1.15 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.573 0.546 . . . . 1.75 110.174 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.61 -48.37 26.89 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.283 0.989 . . . . 4.46 109.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.33 41.51 0.81 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.41 -0.9 . . . . 2.47 111.235 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 62.7 mt -103.74 164.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.637 -0.505 . . . . 2.29 109.637 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 43' ' ' ILE . 40.2 p -113.25 -104.86 0.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.612 -0.722 . . . . 3.96 112.87 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 57' ' ' GLU . 34.7 tttp -142.82 -25.77 0.61 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.061 0.934 . . . . 6.88 109.614 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -86.98 -53.37 4.92 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 4.1 108.311 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' LEU . 17.9 t70 -47.5 -61.87 1.71 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.704 -0.798 . . . . 3.5 111.397 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -34.36 -46.89 0.28 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.436 -0.802 . . . . 2.17 111.073 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 53' ' ' GLY . 74.4 mt-30 -54.99 -54.56 41.38 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.119 -1.032 . . . . 5.61 108.486 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 47' ' ' ASP . 2.0 mp0 -60.79 -36.86 80.07 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.711 -0.796 . . . . 7.44 109.93 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -64.26 -29.43 70.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.79 -1.096 . . . . 4.01 110.12 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.599 ' HB1' ' CD2' ' A' ' 68' ' ' HIS . . . -100.68 -74.81 0.6 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.68 -1.146 . . . . 2.06 109.595 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' GLN . . . 121.94 39.78 0.55 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.73 -1.224 . . . . 3.96 111.178 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.478 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 22.3 mmtp -138.05 152.01 71.12 Favored Pre-proline 0 N--CA 1.499 2.017 0 C-N-CA 119.454 -0.898 . . . . 6.68 110.072 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.63 49.54 3.21 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 122.391 2.061 . . . . 6.02 111.188 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.64 94.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 115.188 -0.914 . . . . 7.23 108.707 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.49 -0.67 11.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.853 -0.739 . . . . 8.45 111.554 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 59' ' ' VAL . 16.7 m -88.67 171.85 9.7 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.149 0.5 . . . . 5.37 110.434 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.499 ' N ' HG22 ' A' ' 58' ' ' THR . 13.2 p -101.05 160.32 26.98 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 115.847 -0.615 . . . . 3.51 110.678 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 73.2 Cg_endo -100.12 -163.77 0.54 Allowed 'Cis proline' 0 N--CA 1.484 0.967 0 CA-C-O 121.926 0.719 . . . . 1.93 111.344 -27.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -124.58 155.24 39.4 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.298 -1.319 . . . . 3.26 108.608 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' A' ' 5' ' ' ILE . 36.2 mm -121.97 146.05 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 123.984 0.803 . . . . 1.99 110.251 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 12.5 m-85 -123.22 130.67 53.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.727 -1.579 . . . . 1.2 107.257 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 69' ' ' ILE . 55.3 t -109.81 138.06 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 118.221 -1.391 . . . . 1.13 109.275 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.2 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.2 -1.818 . . . . 3.06 111.716 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -136.47 -2.64 2.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.601 0.563 . . . . 5.93 111.499 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CA ' HE21 ' A' ' 67' ' ' GLN . 0.0 OUTLIER -115.31 176.4 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.423 0.63 . . . . 4.94 111.699 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.599 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -96.49 147.0 24.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.176 -1.787 . . . . 2.29 106.176 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 64' ' ' VAL . 41.7 mm -116.14 -46.5 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.703 -1.199 . . . . 1.17 110.414 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.69 -153.09 25.07 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.438 -1.363 . . . . 1.76 111.173 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.47 -170.47 47.15 Favored Glycine 0 N--CA 1.504 3.226 0 C-N-CA 119.242 -1.456 . . . . 1.46 112.149 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.9 t80 -51.93 -45.09 64.17 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.069 -0.652 . . . . 2.11 109.836 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 p -64.34 -42.45 96.25 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.349 -0.94 . . . . 1.32 109.297 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.478 ' CG ' ' NZ ' ' A' ' 54' ' ' LYS . 21.0 m-20 -62.32 -48.79 78.3 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.198 -1.401 . . . . 2.68 110.018 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 20' ' ' LEU . 12.8 t80 -60.62 -51.81 67.81 Favored 'General case' 0 C--O 1.2 -1.5 0 C-N-CA 117.936 -1.506 . . . . 1.03 108.102 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.79 30.52 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.453 -0.899 . . . . 0.93 111.077 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.04 -55.3 13.07 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.696 -0.802 . . . . 1.16 109.538 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -41.41 -47.46 3.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.929 -1.137 . . . . 1.05 107.929 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 81' ' ' GLU . 40.9 t -61.14 -57.69 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 106.16 -1.793 . . . . 1.34 106.16 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 1.3 tmtm? -75.96 32.18 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.83 -0.748 . . . . 3.72 110.427 179.549 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 79' ' ' VAL . 28.2 tt0 -132.37 -56.55 0.96 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.511 0.672 . . . . 5.45 109.262 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -98.64 -11.54 21.97 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.857 -1.065 . . . . 2.15 111.155 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -108.23 -34.65 6.77 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.76 -1.176 . . . . 2.36 108.842 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 . . . . . 0 N--CA 1.497 1.897 0 C-N-CA 119.161 -1.016 . . . . 6.06 110.541 179.485 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 30' ' ' ASP . 69.0 mtm . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 107.988 -1.116 . . . . 2.42 107.988 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 20.1 mt-30 -128.04 157.43 40.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 123.633 0.583 . . . . 3.48 110.029 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -141.6 141.71 33.46 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.819 -0.752 . . . . 0.7 112.065 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.0 t -133.11 139.09 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 106.539 -1.652 . . . . 0.74 106.539 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 4.6 mp -123.66 128.17 74.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.354 -0.98 . . . . 1.99 108.354 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -97.37 61.12 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.386 -1.339 . . . . 1.07 107.386 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -104.96 -158.5 23.36 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.153 -1.979 . . . . 1.3 108.153 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 21.9 ttp-105 -127.73 169.29 13.99 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.507 -1.294 . . . . 5.37 107.507 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -52.72 -50.16 63.94 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.182 -1.044 . . . . 4.41 108.182 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' CYS . . . -149.06 166.87 29.44 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.803 -1.189 . . . . 3.2 111.366 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.4 p 167.84 42.51 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.366 0 CA-C-O 122.795 1.283 . . . . 3.7 108.407 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -20.94 -48.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.431 2.754 . . . . 3.05 112.765 -99.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -27.4 -40.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 124.772 1.295 . . . . 2.51 113.907 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 85.1 m -53.59 -45.16 69.91 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.948 -0.701 . . . . 1.86 112.322 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.34 -34.49 50.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.887 -0.597 . . . . 1.03 111.081 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -50.96 -51.35 53.41 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.882 -1.127 . . . . 4.0 112.043 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.2 -42.66 81.67 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.302 -0.959 . . . . 1.33 109.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 28.8 tttm -63.22 -52.99 59.98 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.214 -1.357 . . . . 2.7 114.007 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.4 p30 -53.82 -34.04 58.01 Favored 'General case' 0 C--O 1.198 -1.651 0 C-N-CA 118.282 -1.367 . . . . 3.38 111.083 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.85 -42.44 89.34 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.269 -1.372 . . . . 0.95 109.703 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.93 19.34 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 120.448 -0.501 . . . . 0.97 110.971 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 22.6 tt0 -59.29 -40.95 87.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.845 -1.169 . . . . 3.31 107.845 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 4.6 ttmp? -64.0 -55.85 19.37 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 106.826 -1.546 . . . . 6.15 106.826 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.686 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 28.9 mt -46.96 -47.31 21.85 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 119.915 -0.714 . . . . 1.16 110.445 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -57.87 -11.42 2.32 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 124.256 0.972 . . . . 1.71 112.541 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -114.83 -41.04 3.43 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.12 -0.491 . . . . 2.94 111.067 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.686 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 13.0 pt-20 -74.65 -37.78 62.66 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.254 -0.885 . . . . 3.8 111.708 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.456 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 3.3 ttp180 -114.22 -168.26 1.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.388 0.613 . . . . 5.95 111.081 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.453 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 9.0 p-10 -124.12 -168.33 1.78 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 105.521 -2.029 . . . . 3.98 105.521 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.4 t70 37.53 41.39 0.28 Allowed 'General case' 0 N--CA 1.508 2.474 0 O-C-N 123.677 0.611 . . . . 3.43 110.543 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.38 93.07 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.441 -0.903 . . . . 0.98 109.889 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 11.7 mm100 -105.49 117.73 34.77 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.592 -1.633 . . . . 4.07 106.592 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -119.12 155.55 31.37 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.984 -1.007 . . . . 2.14 112.157 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.84 150.0 50.52 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.515 -2.031 . . . . 3.46 105.515 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 18' ' ' LYS . 26.0 t80 -112.08 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.784 -1.566 . . . . 1.88 108.48 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 5' ' ' ILE . 2.1 t -124.66 155.28 32.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.351 -1.351 . . . . 1.26 107.351 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 39' ' ' ARG . 1.8 t70 -127.69 42.71 3.27 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.831 0.678 . . . . 2.66 112.831 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.83 -65.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 114.97 1.47 . . . . 1.76 114.97 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -56.21 -51.29 68.62 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 4.55 108.521 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -42.83 2.25 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.902 -1.044 . . . . 1.26 111.203 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.26 -47.85 17.01 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.995 -1.113 . . . . 4.42 107.995 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.52 46.4 0.92 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.417 -1.873 . . . . 1.6 108.417 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.417 HG21 ' HG ' ' A' ' 48' ' ' LEU . 11.8 mm -89.23 155.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 120.374 -0.53 . . . . 1.99 111.824 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' GLU . 34.2 p -126.47 95.29 4.31 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.864 -0.607 . . . . 3.12 111.615 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 tttm 6.12 -64.6 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 116.656 2.095 . . . . 4.49 116.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' THR . 6.6 mm-40 -47.86 -44.99 29.76 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.252 -0.979 . . . . 4.68 110.841 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.2 t70 -58.5 -37.65 76.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.315 -0.857 . . . . 3.23 110.5 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HA ' ' CG ' ' A' ' 51' ' ' LYS . 6.7 mt -65.2 -45.86 83.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.135 -1.061 . . . . 1.62 108.135 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 13.1 mt-30 -49.99 -41.69 47.49 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.517 -1.29 . . . . 4.87 107.517 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -66.8 -60.74 2.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.608 -0.723 . . . . 5.23 112.496 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.576 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -60.46 -37.68 81.74 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.434 -0.906 . . . . 4.7 113.295 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -86.55 -53.43 4.98 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.719 0.771 . . . . 1.85 110.481 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.18 -55.73 0.59 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.123 -1.591 . . . . 3.57 109.123 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.79 74.7 37.93 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 119.602 -0.839 . . . . 5.81 113.08 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 52' ' ' ALA . 11.9 Cg_endo -89.59 140.96 3.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.223 1.948 . . . . 8.38 107.615 126.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.91 -15.78 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.971 -0.692 . . . . 5.56 110.043 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.524 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -119.27 -105.21 0.39 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.845 -0.616 . . . . 6.66 111.295 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.426 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 98.2 m -140.43 -57.09 0.53 Allowed 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.782 -0.767 . . . . 6.42 109.542 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 42.1 t -112.63 151.63 44.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.662 -0.815 . . . . 4.43 109.018 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HG2' ' N ' ' A' ' 72' ' ' TYR . 12.9 Cg_endo -97.67 173.47 10.38 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 O-C-N 122.619 0.799 . . . . 3.06 111.592 -14.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 3.1 mp0 -130.97 119.97 22.84 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 5.56 109.237 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -127.39 146.71 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.511 -0.876 . . . . 1.2 111.309 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 16.2 m-85 -126.86 133.05 50.81 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.01 -1.904 . . . . 1.03 107.035 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.605 HG11 ' CH2' ' A' ' 78' ' ' TRP . 85.5 t -131.76 150.6 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 118.733 -1.187 . . . . 1.34 110.097 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 66' ' ' GLN . 8.9 t70 60.12 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.464 -1.698 . . . . 5.01 107.978 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG3' ' C ' ' A' ' 65' ' ' ASP . 36.5 mt-30 -139.27 -16.27 1.07 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 124.209 0.943 . . . . 5.53 112.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.2 171.99 7.13 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.756 -0.778 . . . . 3.59 113.085 -178.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.4 t-80 -81.0 153.55 27.37 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.858 -1.904 . . . . 1.23 105.858 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 64' ' ' VAL . 12.2 mm -116.2 -43.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.4 -1.32 . . . . 1.01 109.81 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 139.93 -131.33 5.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.466 -1.454 . . . . 1.75 109.466 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.441 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.88 -154.27 12.55 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.756 -0.937 . . . . 1.44 110.756 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.436 ' N ' ' HG2' ' A' ' 60' ' ' PRO . 26.9 t80 -57.67 -56.33 23.37 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.1 -1.04 . . . . 1.53 111.01 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -38.24 17.24 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.878 -0.729 . . . . 1.38 110.537 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -72.41 -59.42 2.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.051 -0.977 . . . . 2.48 110.259 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.75 -45.8 63.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.471 -0.937 . . . . 1.48 108.471 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -58.69 6.63 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.931 -1.031 . . . . 0.85 109.272 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.13 -54.97 41.0 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.097 -1.041 . . . . 1.45 110.549 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.605 ' CH2' HG11 ' A' ' 64' ' ' VAL . 75.2 t90 -45.81 -53.81 9.04 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.413 -0.915 . . . . 1.65 109.131 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 83' ' ' LEU . 25.0 t -47.25 -58.82 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 124.453 1.096 . . . . 0.9 108.213 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 2.1 tmtm? -56.29 -54.18 48.41 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.015 1.117 . . . . 3.43 114.015 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.3 -33.19 70.79 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.519 0.933 . . . . 4.76 113.519 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.78 -26.98 13.28 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.182 1.179 . . . . 1.57 114.182 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 79' ' ' VAL . 11.4 mt -93.24 -22.56 18.94 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.367 -1.333 . . . . 1.73 111.52 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 . . . . . 0 N--CA 1.495 1.776 0 C-N-CA 119.256 -0.977 . . . . 4.28 108.694 -179.92 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 34.9 tpp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 2.74 108.284 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.521 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 34.8 mt-30 -97.03 97.35 9.16 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.964 -0.694 . . . . 3.69 109.81 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 m -83.02 114.22 21.12 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.513 -0.875 . . . . 1.16 109.895 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.67 140.01 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.077 -1.083 . . . . 1.0 108.077 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 17.8 mt -120.1 105.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 124.452 1.095 . . . . 2.32 110.428 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 31.1 m-85 -84.53 93.86 8.44 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.28 -1.008 . . . . 1.01 108.28 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.635 ' CA ' ' SG ' ' A' ' 14' ' ' CYS . . . -106.76 -163.08 22.32 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.051 -1.22 . . . . 1.39 110.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.515 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 ttp-105 -141.43 46.68 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.284 -1.366 . . . . 5.94 111.902 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' ' OD2' ' A' ' 37' ' ' ASP . 14.4 m 69.61 -70.73 0.14 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.809 1.04 . . . . 3.79 113.809 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.14 66.89 0.23 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 119.946 -1.121 . . . . 3.77 112.724 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -134.81 113.68 11.81 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.327 -1.36 . . . . 2.4 107.327 178.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.01 -50.7 9.48 Favored 'Trans proline' 0 C--O 1.205 -1.171 0 N-CA-C 109.033 -1.18 . . . . 3.5 109.033 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . 3.7 m-85 -52.84 -36.13 58.31 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.051 -0.977 . . . . 2.76 111.993 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' CA ' ' A' ' 7' ' ' GLY . 71.0 m -66.36 -53.21 38.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.205 -0.998 . . . . 2.22 109.475 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.1 t -62.08 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.8 -1.091 . . . . 1.05 110.136 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.55 ' NH2' ' N ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -61.27 -47.48 85.83 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.815 -0.629 . . . . 3.83 110.484 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.53 -47.91 80.71 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 5.7 tmtm? -56.96 -43.69 81.86 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 118.512 -1.275 . . . . 2.07 109.715 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 2.0 t0 -51.98 -51.25 58.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.74 -1.208 . . . . 3.32 107.74 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' ' NH2' ' A' ' 16' ' ' ARG . 31.4 tp -56.6 -52.09 66.17 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.929 -1.108 . . . . 1.24 110.098 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -46.17 -51.89 13.29 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.781 -1.168 . . . . 1.02 109.937 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -44.3 -47.48 9.51 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.113 0.959 . . . . 3.04 110.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.43 ' NZ ' ' HG2' ' A' ' 27' ' ' GLU . 8.9 tmtm? -75.0 -45.95 38.45 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.385 -1.326 . . . . 4.64 111.865 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 83' ' ' LEU . 1.3 mt -49.56 -48.52 48.46 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 119.375 -0.93 . . . . 1.66 110.531 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 m -42.99 -32.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.297 -1.774 . . . . 1.57 109.579 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -109.92 45.43 1.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.856 -1.065 . . . . 2.66 109.863 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HG2' ' NZ ' ' A' ' 23' ' ' LYS . 29.6 mm-40 -137.22 -54.46 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.729 -1.123 . . . . 3.89 110.103 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.418 ' NE ' ' HB3' ' A' ' 83' ' ' LEU . 50.1 mmt-85 -101.78 175.47 5.54 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.875 -1.057 . . . . 4.84 109.658 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.41 -51.24 17.99 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.984 -1.462 . . . . 5.1 114.324 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 37.3 t70 -118.2 82.08 1.78 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.336 -0.946 . . . . 4.26 111.7 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.97 113.45 14.6 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.702 -0.799 . . . . 0.98 110.459 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.06 157.87 26.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.682 -1.97 . . . . 3.79 105.682 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.9 p90 -156.39 153.48 29.0 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 117.562 -1.655 . . . . 1.2 111.29 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.9 146.68 43.61 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.183 -0.917 . . . . 3.25 109.724 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -94.97 144.43 25.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.264 -1.384 . . . . 1.18 107.264 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.99 155.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 123.752 0.657 . . . . 0.87 109.685 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' NH1' ' A' ' 39' ' ' ARG . 10.0 t70 -132.62 137.7 47.11 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.474 0.654 . . . . 2.52 109.306 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.43 HD11 ' HG3' ' A' ' 8' ' ' ARG . 31.5 pt -53.7 -25.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.392 0.886 . . . . 1.66 113.392 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 29.8 mtm-85 -88.66 -14.05 38.33 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.53 -1.268 . . . . 4.88 110.951 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.47 -40.7 61.71 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.99 -1.485 . . . . 1.55 106.99 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.37 -41.45 12.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.489 -1.687 . . . . 3.44 109.402 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.76 59.04 0.51 Allowed Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.653 -1.261 . . . . 1.73 111.116 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.2 mt -120.33 154.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.827 -0.749 . . . . 1.99 110.386 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -111.07 -160.72 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.052 -1.833 . . . . 2.32 106.052 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -99.13 18.43 17.44 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 116.772 -1.971 . . . . 4.37 109.413 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -101.76 -62.94 1.19 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.724 -1.58 . . . . 4.01 110.993 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' GLN . 1.9 t70 -56.51 -42.92 79.22 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.129 -0.628 . . . . 4.0 109.999 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -43.68 -38.57 3.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.804 -1.159 . . . . 1.89 109.948 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 56' ' ' VAL . 39.1 mm-40 -53.12 -42.76 66.32 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.869 -1.132 . . . . 4.68 109.219 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' ASP . 73.3 mm-40 -78.05 -37.04 47.62 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.812 -1.085 . . . . 6.22 111.665 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -68.81 -37.42 79.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.595 -0.842 . . . . 4.38 111.372 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -88.58 -47.53 8.23 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 124.128 0.893 . . . . 2.0 111.301 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.8 15.17 56.98 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.54 -1.424 . . . . 2.86 109.54 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.85 140.01 27.99 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 107.136 -1.431 . . . . 5.92 107.136 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.49 142.62 11.82 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 120.914 1.076 . . . . 4.58 111.662 -165.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.549 ' N ' HE22 ' A' ' 49' ' ' GLN . 40.8 t 66.75 -66.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.629 1.344 . . . . 5.42 114.629 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.92 144.55 1.77 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.81 -0.756 . . . . 6.12 111.363 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 45' ' ' LYS . 21.8 m -120.87 -65.12 1.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.582 -0.735 . . . . 7.03 111.643 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.34 154.76 81.7 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 120.206 -0.598 . . . . 3.69 110.254 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 13' ' ' TYR . 9.5 Cg_endo -92.94 142.53 9.3 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 124.284 -1.132 . . . . 1.6 109.775 0.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -113.62 141.05 47.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.947 -1.101 . . . . 3.47 108.361 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.5 mp -111.08 139.07 36.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 124.019 0.825 . . . . 1.36 108.954 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -118.32 122.49 43.0 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 103.634 -2.728 . . . . 1.41 103.634 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 50.3 t -99.53 83.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 117.202 -1.799 . . . . 1.92 111.627 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 28.3 t0 72.85 -60.27 0.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.326 -1.307 . . . . 3.8 113.637 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 3.4 pt20 -106.36 -56.14 2.23 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 115.337 1.606 . . . . 6.82 115.337 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 15.2 pt20 -118.86 176.2 5.39 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.318 1.229 . . . . 4.19 114.318 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.566 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 12.3 t-80 -77.77 147.16 35.45 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.872 -1.529 . . . . 1.59 106.872 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.571 HG13 ' CG2' ' A' ' 64' ' ' VAL . 34.4 mm -117.57 -29.36 2.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.8 -0.76 . . . . 1.23 111.443 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.404 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 133.84 -156.32 22.25 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.085 -1.606 . . . . 2.14 109.085 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.86 -170.74 34.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.502 -1.439 . . . . 1.48 109.502 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -52.21 -36.38 51.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.641 -1.224 . . . . 1.41 110.446 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 p -64.08 -61.46 2.25 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.37 -1.332 . . . . 1.57 109.836 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.18 -50.15 67.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.635 -0.711 . . . . 2.49 110.313 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.19 -46.75 88.66 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 119.543 -0.863 . . . . 1.04 109.003 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.91 26.93 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.598 -0.841 . . . . 0.95 110.411 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.36 -58.7 6.24 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.186 -1.005 . . . . 1.2 108.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.42 ' O ' ' C ' ' A' ' 79' ' ' VAL . 61.8 t90 -40.66 -57.81 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.359 -0.837 . . . . 1.25 108.963 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 78' ' ' TRP . 2.4 t -40.7 -51.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.297 -1.372 . . . . 1.0 107.297 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.492 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -59.39 -60.96 3.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.451 -1.249 . . . . 2.83 110.406 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -76.81 31.21 0.13 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 113.454 0.909 . . . . 4.34 113.454 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -145.0 -40.0 0.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.972 -0.558 . . . . 1.77 110.704 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 24' ' ' LEU . 35.7 mt -96.05 -26.12 15.64 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.036 -1.066 . . . . 1.56 111.325 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.424 ' OD2' ' HA ' ' A' ' 80' ' ' LYS . 44.7 m-20 . . . . . 0 N--CA 1.504 2.27 0 N-CA-C 107.136 -1.431 . . . . 4.1 107.136 178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 83' ' ' LEU . 25.2 ttm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.851 -1.166 . . . . 3.17 107.851 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 54.9 mt-30 -133.33 150.22 51.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.35 -0.611 . . . . 3.86 109.35 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 22.6 m -140.4 137.77 34.25 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 118.636 -1.226 . . . . 0.72 112.761 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.29 133.43 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.432 -0.951 . . . . 0.58 108.432 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' HB1' ' A' ' 17' ' ' ALA . 22.0 mm -111.64 128.73 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 124.437 1.085 . . . . 1.54 108.265 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 36' ' ' VAL . 30.6 m-85 -109.94 73.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.931 -1.137 . . . . 1.07 107.931 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -133.71 -159.57 9.04 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 106.627 -2.589 . . . . 1.14 106.627 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.749 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.5 ptm180 -123.88 143.53 50.3 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.025 -1.47 . . . . 5.45 109.245 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -64.78 76.95 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.35 -1.75 . . . . 4.19 108.952 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 151.04 13.42 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.189 -1.005 . . . . 2.59 111.889 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.749 ' SG ' ' HG2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -119.98 124.91 27.61 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.585 -0.895 . . . . 2.38 108.585 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -41.32 -64.21 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.063 0 C-N-CA 122.422 2.081 . . . . 2.98 112.017 -170.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -47.01 -38.83 11.48 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.922 -0.711 . . . . 3.55 112.553 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 m -75.1 -57.94 3.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.609 0.718 . . . . 2.18 109.306 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.09 -41.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 114.038 -1.437 . . . . 1.03 108.819 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 115.543 -0.753 . . . . 5.28 109.423 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' ARG . . . -40.37 -43.26 1.73 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.454 -0.898 . . . . 0.97 108.896 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 12.6 tmtt? -60.2 -58.29 9.16 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.349 -1.352 . . . . 2.21 107.349 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -48.48 -51.22 28.19 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.843 -0.743 . . . . 3.62 109.648 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 ' CD2' ' A' ' 75' ' ' PHE . 44.2 tp -52.2 -54.02 36.16 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.002 -0.74 . . . . 0.84 109.002 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -57.0 13.62 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.295 -0.962 . . . . 0.77 109.509 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 13.7 tt0 -51.91 -40.28 60.48 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.156 -0.929 . . . . 3.06 110.966 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -60.48 -60.17 4.24 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.722 -1.214 . . . . 3.54 107.722 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.654 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 53.5 mt -47.0 -52.37 14.92 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.233 -0.987 . . . . 1.07 111.564 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -39.84 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 114.288 1.218 . . . . 1.43 114.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -118.8 -30.72 5.01 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.19 -0.604 . . . . 3.28 111.824 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.654 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -80.71 -19.74 44.41 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.922 -0.711 . . . . 3.77 111.149 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.531 HH12 ' CB ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -111.93 -154.78 0.55 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.674 -1.148 . . . . 5.06 108.423 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -115.81 -79.14 0.58 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 114.009 1.114 . . . . 4.01 114.009 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 9.4 p-10 -93.84 60.83 2.97 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.632 -0.827 . . . . 3.46 111.003 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -116.32 99.96 7.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.914 -1.114 . . . . 0.9 112.069 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 56.9 mm-40 -104.92 161.99 13.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.256 -1.387 . . . . 3.68 107.256 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.443 ' HA ' ' H ' ' A' ' 3' ' ' THR . 40.2 p90 -159.12 166.46 31.49 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.552 -1.259 . . . . 1.73 109.253 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.01 146.48 40.91 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.746 -1.575 . . . . 3.35 106.746 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.76 135.02 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.873 -1.531 . . . . 1.05 107.906 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.0 t -119.51 144.15 28.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 105.859 -1.904 . . . . 0.7 105.859 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 6.0 t70 -117.25 102.22 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.344 -0.942 . . . . 2.37 111.295 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -49.97 -23.91 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 114.858 -1.065 . . . . 2.26 111.17 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -87.8 -61.2 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.182 -1.407 . . . . 8.42 108.618 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.41 -43.15 23.42 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 123.789 0.681 . . . . 2.6 112.836 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.19 -34.8 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.89 -0.724 . . . . 2.39 112.025 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.51 50.49 1.2 Allowed Glycine 0 N--CA 1.505 3.257 0 C-N-CA 119.89 -1.148 . . . . 1.97 110.722 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 76.2 mt -109.71 143.24 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 120.161 -0.616 . . . . 1.52 111.325 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 p -110.96 -97.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.474 -0.936 . . . . 2.17 108.474 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 56' ' ' VAL . 29.3 tttm -134.31 -54.31 0.85 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.619 -0.882 . . . . 5.98 108.619 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.84 -52.81 4.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.371 -1.286 . . . . 4.66 110.97 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -54.01 -72.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 118.905 -1.118 . . . . 4.31 108.932 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 83.4 mt -35.12 -49.62 0.48 Allowed 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 112.541 0.571 . . . . 3.22 112.541 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -46.41 -50.84 16.14 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.828 -0.749 . . . . 5.35 109.545 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -43.34 -36.73 1.98 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.027 0.83 . . . . 6.15 111.568 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.5 ' NZ ' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -95.68 -11.45 27.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.984 1.105 . . . . 4.86 113.984 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.57 -47.25 2.22 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 119.325 -0.95 . . . . 2.67 112.925 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.0 49.05 2.74 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 106.437 -2.665 . . . . 3.15 106.437 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -123.14 78.43 52.01 Favored Pre-proline 0 N--CA 1.505 2.325 0 N-CA-C 112.182 0.438 . . . . 5.95 112.182 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.53 33.77 0.45 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.677 1.584 . . . . 7.25 111.732 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -132.27 -81.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.908 -0.775 . . . . 6.22 108.908 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 58' ' ' THR . 20.1 pm0 -96.79 -165.46 1.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.369 -1.715 . . . . 5.28 106.369 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 10.1 t 177.43 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.993 -1.083 . . . . 8.39 112.698 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 16.3 t -117.33 138.83 25.35 Favored Pre-proline 0 N--CA 1.502 2.138 0 C-N-CA 119.488 -0.885 . . . . 3.77 110.485 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 56.6 Cg_endo -86.86 166.78 46.51 Favored 'Cis proline' 0 N--CA 1.493 1.458 0 C-N-CA 125.105 -0.79 . . . . 2.85 110.126 -23.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -140.76 161.92 36.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.518 -0.873 . . . . 3.08 111.787 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -122.94 146.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.127 -1.397 . . . . 1.37 108.243 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 51' ' ' LYS . 9.6 m-85 -123.8 127.18 47.72 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.027 -1.897 . . . . 1.75 106.483 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' HG13 ' A' ' 69' ' ' ILE . 38.9 t -109.72 136.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 117.996 -1.481 . . . . 0.98 107.863 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.84 -89.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.314 1.009 . . . . 2.85 108.383 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.3 mm-40 -141.99 3.95 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.744 0.653 . . . . 5.39 111.151 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -107.7 152.82 23.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.087 0.47 . . . . 5.14 111.138 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.48 ' HA ' ' CD1' ' A' ' 63' ' ' PHE . 35.9 t-80 -77.77 141.29 39.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.415 -1.698 . . . . 1.79 106.415 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.513 HG13 ' CG2' ' A' ' 64' ' ' VAL . 42.2 mm -115.42 -45.97 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 C-N-CA 118.235 -1.386 . . . . 1.13 109.253 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.66 -137.0 8.39 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.466 -1.35 . . . . 1.76 110.275 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.29 -166.94 21.22 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.754 -0.736 . . . . 1.57 111.54 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -55.16 -66.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.994 -0.683 . . . . 2.11 112.424 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -51.37 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.096 0.776 . . . . 1.84 113.096 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.95 -52.87 10.1 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.174 -1.01 . . . . 2.92 111.178 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CD2' HD23 ' A' ' 20' ' ' LEU . 44.3 t80 -49.62 -38.29 31.35 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.817 -1.153 . . . . 0.88 108.899 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -58.74 -65.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.149 -1.387 . . . . 0.93 110.319 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -54.87 41.91 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.894 -1.122 . . . . 1.15 108.113 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.468 ' HH2' ' SD ' ' A' ' 1' ' ' MET . 57.2 t90 -41.15 -51.05 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.263 0.977 . . . . 1.49 109.93 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 80' ' ' LYS . 2.1 t -48.74 -61.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 114.803 -1.089 . . . . 1.02 108.464 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.503 ' NZ ' ' HB3' ' A' ' 84' ' ' ASP . 5.9 tmtm? -53.58 -46.63 70.38 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.967 -0.693 . . . . 2.86 112.673 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -56.44 -55.72 30.17 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.504 -1.225 . . . . 3.74 113.564 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -89.06 -27.09 21.03 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 114.739 1.385 . . . . 2.01 114.739 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 1' ' ' MET . 60.4 mt -89.38 -19.24 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.157 -1.417 . . . . 1.58 111.894 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.531 ' CB ' HH12 ' A' ' 28' ' ' ARG . 10.3 t70 . . . . . 0 N--CA 1.495 1.806 0 C-N-CA 118.487 -1.285 . . . . 4.32 110.637 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 71.2 mtm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.123 -0.695 . . . . 1.99 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 5.8 mt-30 -126.65 123.92 38.69 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 108.265 -1.013 . . . . 4.14 108.265 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.4 m -120.34 139.16 53.17 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.875 -1.13 . . . . 0.96 110.026 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.3 t -119.25 125.42 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.803 -0.759 . . . . 0.62 109.317 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -106.75 117.96 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 124.882 1.364 . . . . 2.07 107.928 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 15.4 m-85 -98.23 93.46 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.828 -1.175 . . . . 1.11 107.828 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.88 -170.67 16.02 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.771 -1.204 . . . . 0.93 110.897 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 22.0 mtp180 -126.81 27.28 6.05 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.086 -0.646 . . . . 6.35 109.292 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' ARG . 59.3 m 34.25 52.52 0.51 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 123.59 0.556 . . . . 3.6 111.111 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.1 52.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.799 -1.32 . . . . 3.58 109.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -151.71 72.38 8.1 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 107.623 -1.251 . . . . 3.3 107.623 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -29.2 -59.07 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 123.202 2.601 . . . . 2.72 113.796 -139.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -39.88 -38.97 0.75 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 120.603 -0.439 . . . . 4.79 112.0 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 92.2 m -51.05 -46.09 61.55 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.284 -0.871 . . . . 2.42 110.426 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -55.93 -48.2 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.651 -0.82 . . . . 1.16 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.497 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -42.98 -48.69 5.98 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.709 -0.796 . . . . 4.51 111.063 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.99 -44.86 15.38 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.591 -0.844 . . . . 0.9 110.571 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.2 tmtm? -63.77 -54.44 35.2 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 108.385 -0.969 . . . . 2.79 108.385 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.497 ' CG ' HH22 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -52.56 -43.09 65.0 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.799 -0.637 . . . . 3.13 111.699 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 39.2 tp -71.66 -49.41 40.1 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.028 -0.669 . . . . 0.97 109.831 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -57.29 -42.97 82.71 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.104 -1.443 . . . . 0.61 107.104 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.14 -57.86 10.04 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.586 -1.264 . . . . 2.82 107.586 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 22' ' ' GLU . 60.8 tttp -37.43 -61.77 0.57 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.32 -1.309 . . . . 3.78 108.911 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 mt -56.45 -56.92 15.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.776 -0.77 . . . . 1.72 112.564 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 -15.43 0.66 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 114.04 1.126 . . . . 1.55 114.04 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -107.41 -44.5 4.3 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 119.842 -0.743 . . . . 3.08 110.508 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.73 -19.43 48.81 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.898 -1.501 . . . . 3.66 112.782 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NH1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -118.69 -178.36 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.789 -0.641 . . . . 6.48 109.954 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.08 -59.62 1.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 113.048 0.759 . . . . 3.76 113.048 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.5 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.5 t70 -78.08 52.74 1.11 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.889 0.852 . . . . 3.29 111.786 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -145.71 92.53 2.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.287 -0.883 . . . . 0.96 111.521 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 17.7 mp0 -105.14 126.76 52.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.604 -2.369 . . . . 3.31 104.604 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.68 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.3 p90 -127.03 157.57 39.25 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.813 -1.155 . . . . 1.48 109.549 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -131.23 140.62 49.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.495 -0.928 . . . . 3.79 108.495 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -99.83 131.01 46.07 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.936 -1.106 . . . . 1.26 108.045 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.2 145.47 22.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 114.689 -1.141 . . . . 0.71 108.932 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -118.52 116.72 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.436 -1.69 . . . . 2.66 106.436 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' A' ' 8' ' ' ARG . 2.7 pt -51.32 -27.7 6.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.319 -1.352 . . . . 1.32 112.416 -178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.6 -8.65 58.14 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.067 -1.053 . . . . 6.22 113.071 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.21 -37.6 12.0 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.392 -0.923 . . . . 1.47 108.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -87.03 -37.48 17.44 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.978 -0.689 . . . . 2.56 110.826 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 52.07 0.59 Allowed Glycine 0 N--CA 1.505 3.253 0 N-CA-C 110.105 -1.198 . . . . 1.42 110.105 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.2 137.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.899 -0.65 . . . . 1.6 109.363 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -103.41 -101.31 0.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.145 -1.428 . . . . 2.67 107.145 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -138.97 -47.45 0.49 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.557 -2.016 . . . . 6.44 105.557 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -46.07 -52.35 12.14 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.018 -1.104 . . . . 3.52 108.018 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 24.4 m-20 -44.93 -57.28 3.9 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.735 -1.121 . . . . 4.35 111.611 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 77.1 mt -56.04 -53.66 54.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.003 -1.453 . . . . 1.86 110.334 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -51.24 -47.04 62.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.991 -1.083 . . . . 3.86 109.022 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -51.69 -45.13 63.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.819 -0.752 . . . . 6.03 108.998 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -68.37 0.81 3.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.863 -1.062 . . . . 4.03 113.472 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' PRO . . . -129.89 -44.76 1.18 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.942 -1.103 . . . . 2.83 112.272 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.44 -58.82 0.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.107 -1.197 . . . . 4.76 110.107 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.574 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 55.1 pttt -165.2 62.6 0.88 Allowed Pre-proline 0 N--CA 1.504 2.231 0 C-N-CA 119.201 -1.0 . . . . 11.28 112.844 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 10.1 Cg_endo -96.74 159.6 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.156 1.238 . . . . 6.44 112.041 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.75 -20.81 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 115.013 -0.994 . . . . 4.78 108.649 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.714 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -72.8 70.45 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.511 -1.222 . . . . 5.55 108.123 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.2 t -42.43 -45.66 4.46 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.389 -0.823 . . . . 6.6 110.465 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 60' ' ' PRO . 57.3 t -142.76 152.45 59.37 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.891 -0.781 . . . . 2.63 108.891 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 12.0 Cg_endo -84.26 166.8 60.23 Favored 'Cis proline' 0 N--CA 1.486 1.049 0 O-C-N 123.426 1.224 . . . . 1.98 109.885 -17.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 82.4 mt-30 -139.76 153.99 47.3 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.074 -1.05 . . . . 2.74 111.436 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.1 mt -134.07 150.97 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.703 1.24 . . . . 1.74 112.623 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.49 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 61.4 m-85 -135.87 126.35 26.85 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 112.62 -2.082 . . . . 1.18 108.852 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 69' ' ' ILE . 58.9 t -96.62 121.26 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 105.903 -1.888 . . . . 1.19 105.903 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.16 -87.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.902 0.751 . . . . 2.62 111.672 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.91 12.76 3.99 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.238 -0.985 . . . . 4.47 112.913 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -111.83 156.73 21.53 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.877 -0.729 . . . . 3.91 109.699 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.49 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.7 t-160 -90.92 138.34 31.67 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.025 -1.102 . . . . 1.54 108.025 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.586 HG13 HG23 ' A' ' 64' ' ' VAL . 9.7 mm -110.71 -31.73 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.523 -1.271 . . . . 0.9 110.547 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.96 -138.47 10.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.295 -1.431 . . . . 1.96 109.764 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . -94.29 -89.09 1.67 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.583 -1.294 . . . . 2.41 111.476 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.12 -55.32 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.849 -1.14 . . . . 1.72 109.49 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -43.04 -48.27 6.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.274 -1.01 . . . . 1.33 108.274 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -64.95 0.66 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.379 -1.737 . . . . 3.3 110.296 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -51.55 -46.15 63.29 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.246 -0.982 . . . . 1.11 109.25 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.77 -53.47 31.5 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.297 -1.001 . . . . 0.84 108.297 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' GLU . . . -55.47 -56.26 22.29 Favored 'General case' 0 C--O 1.198 -1.643 0 N-CA-C 107.933 -1.136 . . . . 0.98 107.933 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -50.16 -34.28 21.85 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 123.43 0.456 . . . . 1.3 110.631 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 t -71.49 -44.32 71.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.421 -0.955 . . . . 1.8 108.421 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.495 ' NZ ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -82.25 -65.8 0.97 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.443 -1.303 . . . . 3.07 111.602 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' ALA . 41.9 mt-10 -62.21 0.77 0.38 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 117.272 2.323 . . . . 4.71 117.272 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.48 -26.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.32 -0.952 . . . . 2.67 112.233 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.67 -21.98 28.1 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.281 -1.368 . . . . 1.95 112.713 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 80' ' ' LYS . 30.7 p30 . . . . . 0 N--CA 1.508 2.452 0 C-N-CA 117.108 -1.837 . . . . 4.59 112.325 -179.547 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 122.951 1.358 . . . . 2.82 109.16 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -121.02 126.5 50.06 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.829 -1.915 . . . . 5.97 105.829 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 64' ' ' VAL . 60.4 m -112.72 144.67 41.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.275 -1.37 . . . . 0.95 113.192 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.0 117.56 52.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.941 -1.874 . . . . 1.08 105.941 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 62' ' ' ILE . 16.2 mm -107.2 124.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.242 -1.392 . . . . 1.9 107.242 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.84 96.2 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.323 -1.732 . . . . 1.05 106.323 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -142.71 -152.6 5.71 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.639 -1.267 . . . . 0.9 111.631 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.04 6.58 3.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.996 -0.742 . . . . 6.74 108.996 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 t 45.24 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.569 1.176 . . . . 5.75 112.764 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.41 -66.51 3.63 Favored Glycine 0 N--CA 1.498 2.795 0 CA-C-N 114.781 -1.1 . . . . 4.65 111.443 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 137.93 89.28 Favored Pre-proline 0 N--CA 1.497 1.896 0 C-N-CA 119.886 -0.726 . . . . 2.75 111.143 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.38 -61.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.283 1.989 . . . . 3.16 111.021 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 10.3 t80 -48.89 -50.54 34.5 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.561 -0.855 . . . . 4.0 109.431 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -53.86 -53.51 51.5 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.675 0.75 . . . . 2.57 110.106 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -52.09 -43.21 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.513 -1.221 . . . . 0.96 111.182 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.526 HH22 ' N ' ' A' ' 20' ' ' LEU . 10.0 mmm180 -40.26 -50.96 2.76 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.714 -1.195 . . . . 3.84 112.188 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.75 -52.66 13.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.733 -1.187 . . . . 0.69 109.193 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.512 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -58.64 -45.97 88.14 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.987 -1.461 . . . . 1.93 110.482 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 66.0 t0 -62.11 -44.38 96.77 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.41 -0.916 . . . . 3.64 109.774 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.526 ' N ' HH22 ' A' ' 16' ' ' ARG . 11.0 tp -62.72 -58.87 5.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.617 -0.833 . . . . 0.91 109.077 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.69 -51.81 58.72 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.102 -1.039 . . . . 0.63 109.127 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.512 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.6 tt0 -46.33 -58.93 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.964 0.79 . . . . 3.24 109.796 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HZ2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -47.43 -60.6 2.41 Favored 'General case' 0 C--O 1.206 -1.195 0 O-C-N 125.644 1.84 . . . . 6.34 107.76 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 56.6 mt -51.08 -51.47 52.96 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.244 -1.383 . . . . 1.39 112.192 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 13.4 p -66.75 8.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.54 -1.264 . . . . 1.86 114.408 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.86 -39.71 2.1 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.693 -1.225 . . . . 4.04 107.693 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.94 -31.8 61.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.598 -1.183 . . . . 3.4 109.046 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.0 mtp-105 -110.76 -171.04 1.75 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.318 -1.31 . . . . 4.63 111.794 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -125.53 -48.9 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.176 -0.92 . . . . 3.69 111.748 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.68 -21.24 61.1 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.779 -1.168 . . . . 4.84 110.39 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 25' ' ' SER . 59.2 t80 -84.92 124.49 31.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.763 -1.175 . . . . 1.13 112.331 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 38.0 mt-30 -139.2 163.16 33.19 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.622 -1.626 . . . . 2.68 106.809 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 7.8 p90 -158.95 163.18 36.72 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.568 -1.253 . . . . 1.65 110.594 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . 0.491 HE21 HG23 ' A' ' 36' ' ' VAL . 18.6 pt20 -128.73 157.25 41.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.463 -1.31 . . . . 4.71 107.463 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -115.56 127.36 55.2 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.06 -1.456 . . . . 1.7 107.78 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 HE21 ' A' ' 34' ' ' GLN . 1.2 t -113.45 132.05 63.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.423 -1.695 . . . . 0.82 106.423 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.3 t70 -108.27 110.57 22.21 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.44 -0.948 . . . . 1.9 108.44 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -44.58 -25.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.676 0.991 . . . . 1.13 113.676 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.523 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 6.4 mmm180 -91.93 -48.81 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.067 -1.453 . . . . 7.95 109.584 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -52.44 -40.76 62.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.401 -0.963 . . . . 1.48 108.401 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' GLY . 71.3 mm-40 -86.57 26.39 1.1 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.26 -1.336 . . . . 3.64 110.61 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 25.04 59.43 0.06 OUTLIER Glycine 0 N--CA 1.504 3.211 0 O-C-N 123.406 0.441 . . . . 2.39 113.73 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 44' ' ' THR . 31.7 mt -104.13 161.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.584 -0.895 . . . . 2.18 108.584 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 43' ' ' ILE . 8.9 t -112.96 -168.07 1.27 Allowed 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.671 -1.233 . . . . 3.01 107.671 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -82.3 -46.12 14.05 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.702 -1.199 . . . . 5.6 109.887 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.726 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.5 mp0 -44.48 -51.82 8.45 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.901 0.858 . . . . 4.48 110.281 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.32 -61.68 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.39 -1.277 . . . . 3.63 111.452 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.24 -52.58 2.62 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.011 -0.995 . . . . 1.88 113.497 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -44.68 -46.39 10.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.332 -0.947 . . . . 4.81 111.243 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -51.27 69.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.772 0.67 . . . . 6.69 111.244 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.605 ' NZ ' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -46.48 -37.69 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.494 -1.23 . . . . 4.48 112.868 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.97 -30.06 11.85 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.224 0.952 . . . . 2.0 111.574 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.56 49.88 17.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.29 -1.124 . . . . 3.34 110.29 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 37.0 mttm -142.56 156.62 63.3 Favored Pre-proline 0 N--CA 1.501 2.114 0 C-N-CA 118.655 -1.218 . . . . 7.51 112.003 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 8.1 Cg_endo -81.33 39.34 0.85 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.318 2.012 . . . . 5.89 111.175 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 p -141.01 125.86 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.529 -2.026 . . . . 5.14 105.529 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 63.54 0.91 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.254 0.835 . . . . 8.74 113.254 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.5 p -105.08 166.62 10.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.181 -1.408 . . . . 5.2 112.558 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -113.81 152.37 45.53 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.672 -1.233 . . . . 3.2 107.672 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.93 177.04 22.42 Favored 'Cis proline' 0 N--CA 1.485 0.973 0 O-C-N 122.541 0.758 . . . . 2.0 110.848 -12.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -131.81 142.05 49.62 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.842 -0.743 . . . . 2.99 109.627 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.8 mp -119.65 143.18 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-O 121.822 0.82 . . . . 1.47 111.663 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CE2' ' NZ ' ' A' ' 51' ' ' LYS . 84.3 m-85 -128.87 136.66 50.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.412 -1.722 . . . . 1.22 108.745 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.691 HG11 ' CH2' ' A' ' 78' ' ' TRP . 75.5 t -122.76 137.3 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.489 -1.284 . . . . 1.25 109.293 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 56.4 m-20 54.42 -80.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.678 -1.601 . . . . 3.58 111.197 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' VAL . 40.3 tt0 -138.76 -19.66 1.03 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.294 -0.866 . . . . 4.68 112.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.65 163.82 12.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.948 1.092 . . . . 4.57 113.948 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.484 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 29.2 t-80 -80.25 137.97 36.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.954 -1.93 . . . . 1.56 106.532 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.525 HG13 HG23 ' A' ' 64' ' ' VAL . 34.3 mm -110.15 -50.34 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.343 -1.343 . . . . 0.97 109.718 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.1 -141.07 10.88 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.472 -1.347 . . . . 1.6 110.81 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.7 -168.08 32.35 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.636 -1.386 . . . . 1.49 109.636 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 12.9 t80 -56.77 -23.27 41.87 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.854 -1.138 . . . . 1.32 109.358 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -75.33 -65.76 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 1.43 111.003 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.92 -43.06 69.44 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.54 -0.911 . . . . 2.88 108.54 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 62' ' ' ILE . 22.7 t80 -59.71 -53.43 58.04 Favored 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 107.159 -1.423 . . . . 1.13 107.159 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.4 11.52 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.573 -0.851 . . . . 0.77 111.043 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.4 -60.3 4.03 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.238 -0.985 . . . . 0.96 109.997 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.691 ' CH2' HG11 ' A' ' 64' ' ' VAL . 46.2 t90 -41.62 -49.41 4.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 123.825 0.703 . . . . 1.25 109.584 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -49.49 -61.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.096 -0.956 . . . . 1.12 110.12 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.498 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -50.96 -50.63 57.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.672 -0.811 . . . . 3.11 111.503 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.54 -39.86 92.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.096 1.888 . . . . 3.94 116.096 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -105.48 -17.23 14.49 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.664 1.357 . . . . 1.65 114.664 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 31' ' ' PHE . 68.8 mt -97.55 -21.55 17.03 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.909 -1.516 . . . . 2.06 110.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.498 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 11.4 m-20 . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 118.096 -1.441 . . . . 4.68 111.373 -179.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.01 -1.107 . . . . 2.91 108.01 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 9.1 tt0 -105.98 157.89 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.122 -1.066 . . . . 3.82 108.122 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.43 ' HA ' ' H ' ' A' ' 65' ' ' ASP . 31.0 m -149.22 149.74 31.46 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.861 -1.149 . . . . 0.91 109.84 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.87 134.7 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 119.981 -0.688 . . . . 0.62 111.197 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 62' ' ' ILE . 25.3 mm -114.93 119.61 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.97 -1.493 . . . . 1.72 106.97 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.493 ' CD2' HG11 ' A' ' 36' ' ' VAL . 36.3 m-85 -103.0 103.71 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.46 -0.941 . . . . 0.87 108.46 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.15 -150.18 5.43 Favored Glycine 0 N--CA 1.502 3.042 0 C-N-CA 119.399 -1.381 . . . . 1.24 110.932 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 38' ' ' ILE . 18.1 mtt180 -121.85 -144.89 0.35 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.267 -0.642 . . . . 7.34 109.267 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m -118.06 77.8 1.19 Allowed 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.973 -0.691 . . . . 3.42 112.085 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.03 44.07 0.64 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.109 -1.52 . . . . 2.48 111.041 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -110.0 101.61 47.91 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.438 -1.319 . . . . 2.13 107.438 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -32.86 -34.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 123.081 2.521 . . . . 2.24 112.899 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 1.7 t80 -75.54 -55.27 5.83 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.398 -0.819 . . . . 4.62 109.855 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -54.16 -40.71 67.72 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.03 -1.47 . . . . 2.51 107.03 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.47 -54.64 32.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.168 -1.378 . . . . 1.01 107.705 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 7.3 tpm_? -46.36 -51.91 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 3.28 110.325 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -58.1 -43.67 87.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.115 -1.034 . . . . 0.7 108.591 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.9 -47.84 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.205 -1.406 . . . . 2.76 107.205 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.25 -50.81 64.03 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.901 -1.12 . . . . 2.93 108.852 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -53.98 -58.28 7.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.037 -1.065 . . . . 1.34 110.324 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.533 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.29 -52.43 52.95 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.948 -1.101 . . . . 0.69 109.752 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.69 -49.08 66.02 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.291 0.567 . . . . 2.91 110.094 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 28.0 ttpp -48.76 -60.65 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.277 -0.969 . . . . 5.07 108.855 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.603 HD22 ' HD2' ' A' ' 28' ' ' ARG . 64.9 mt -48.19 -58.37 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.772 -0.771 . . . . 1.42 111.515 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 m -41.25 -34.13 0.45 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.674 -0.81 . . . . 1.38 110.896 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -88.19 -36.01 17.05 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 120.396 -0.522 . . . . 3.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 6.4 pt-20 -99.74 23.48 9.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.535 0.683 . . . . 4.4 112.017 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HD2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -137.02 177.11 8.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.775 -0.824 . . . . 4.53 108.775 179.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.56 -38.78 3.67 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.536 -1.211 . . . . 4.18 108.606 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.7 p-10 -110.34 22.0 16.02 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.821 -1.536 . . . . 4.12 113.424 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -102.83 99.48 9.42 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 118.189 -1.404 . . . . 0.92 114.406 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 42.5 mt-30 -111.64 127.82 55.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.835 -1.543 . . . . 2.8 106.835 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 25.5 p90 -129.64 162.1 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.624 -0.83 . . . . 1.05 110.326 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -131.71 146.97 52.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.72 -0.844 . . . . 3.38 108.72 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -99.76 135.27 41.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.8 -1.556 . . . . 1.15 106.8 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.493 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -121.35 138.03 53.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.796 -0.816 . . . . 0.71 108.796 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -111.22 109.36 19.36 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.657 -1.156 . . . . 2.39 108.666 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CD1' HH21 ' A' ' 8' ' ' ARG . 27.0 pt -51.17 -25.81 4.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.915 -1.039 . . . . 1.26 109.392 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -79.33 -63.53 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.02 -1.072 . . . . 5.18 108.286 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.21 -42.3 0.67 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 123.66 0.6 . . . . 1.47 111.409 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.21 -46.81 14.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.85 -1.068 . . . . 2.4 111.028 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.67 51.79 0.83 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.821 -1.312 . . . . 1.76 109.821 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 44' ' ' THR . 24.4 mt -100.26 172.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.977 -0.611 . . . . 1.85 109.384 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.518 ' N ' HG22 ' A' ' 43' ' ' ILE . 51.5 p -103.67 -171.01 1.86 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.601 -0.888 . . . . 2.46 108.601 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 29.96 7.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.276 -1.379 . . . . 4.84 107.276 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -119.31 -55.6 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 110.341 -3.118 . . . . 3.53 104.084 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -47.96 27.65 Favored 'General case' 0 C--O 1.202 -1.396 0 CA-C-N 112.458 -2.155 . . . . 3.58 110.46 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 59' ' ' VAL . 59.2 mt -53.6 -37.97 63.51 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.897 -1.047 . . . . 1.98 111.819 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.67 -49.71 13.95 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.928 -1.109 . . . . 4.47 108.903 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.436 ' C ' ' CD ' ' A' ' 50' ' ' GLN . 11.2 tm0? -52.65 -43.94 65.81 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.749 -1.114 . . . . 4.73 110.062 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -16.33 35.1 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.924 -1.035 . . . . 4.95 111.681 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -89.75 -51.58 5.43 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.193 -1.781 . . . . 2.05 106.193 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.79 -25.19 2.56 Favored Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.371 -1.286 . . . . 2.98 110.558 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' VAL . 29.6 mtmm -109.43 155.78 40.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 109.008 -0.738 . . . . 9.97 109.008 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.5 74.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 123.053 2.502 . . . . 6.38 112.784 -149.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 54' ' ' LYS . 11.9 p -96.83 162.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.793 -0.817 . . . . 6.8 108.793 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.1 pt-20 -90.34 -99.22 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.908 -1.042 . . . . 6.68 110.552 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -131.03 -162.28 1.2 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.153 -0.619 . . . . 5.27 109.819 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 60' ' ' PRO . 73.0 t -84.14 140.25 39.63 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-N 115.007 -0.997 . . . . 4.05 109.639 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 59' ' ' VAL . 9.7 Cg_endo -91.31 164.93 28.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 O-C-N 123.069 1.036 . . . . 2.49 112.623 14.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -131.71 156.16 46.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.793 -1.094 . . . . 3.11 109.816 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 5' ' ' ILE . 68.2 mt -125.55 144.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.5 -0.773 . . . . 1.2 111.754 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 14.3 m-85 -129.03 122.65 30.46 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.624 -1.625 . . . . 1.1 108.942 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 69' ' ' ILE . 22.3 t -91.98 122.91 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 105.358 -2.09 . . . . 1.08 105.358 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.549 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 1.2 t70 64.05 -74.76 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 125.076 1.485 . . . . 2.91 109.099 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.549 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -147.92 -5.5 0.46 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.921 -0.581 . . . . 4.78 111.558 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -104.63 137.26 42.72 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.22 -0.592 . . . . 5.29 112.554 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 50.4 t-80 -68.92 129.92 41.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.765 -1.568 . . . . 1.6 106.765 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 64' ' ' VAL . 33.3 mm -106.73 -36.84 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.719 -1.193 . . . . 1.29 111.149 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.76 -132.33 4.36 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.692 -1.718 . . . . 1.63 110.843 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.62 -148.75 12.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.989 -0.844 . . . . 1.85 110.989 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 16' ' ' ARG . 72.9 t80 -78.79 -56.98 3.99 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.053 -0.573 . . . . 1.94 110.432 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.47 -64.99 0.64 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.141 0.793 . . . . 2.1 113.141 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -53.98 -60.19 3.65 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.211 -0.596 . . . . 2.73 109.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -43.93 -48.44 8.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.716 -0.476 . . . . 1.31 109.716 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.69 -59.26 5.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.01 -0.541 . . . . 1.42 109.91 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -53.25 -62.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.272 -1.01 . . . . 1.55 108.272 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -41.37 -60.21 1.34 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.194 -0.912 . . . . 1.6 109.657 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG1' HD21 ' A' ' 24' ' ' LEU . 3.2 t -40.61 -63.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.335 -1.357 . . . . 1.22 107.335 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -44.64 -54.9 5.69 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 125.018 1.449 . . . . 2.72 109.788 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' ALA . 18.0 mm-40 -80.17 26.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.199 0.815 . . . . 5.56 113.199 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.48 -43.5 0.32 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.13 -0.628 . . . . 1.73 111.504 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' HD3' ' A' ' 28' ' ' ARG . 14.6 mt -94.44 -4.19 48.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.385 -0.926 . . . . 1.77 111.794 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 . . . . . 0 N--CA 1.496 1.873 0 O-C-N 124.321 1.013 . . . . 3.6 108.592 179.182 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 83.3 mtp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 107.704 -1.221 . . . . 2.03 107.704 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -118.9 116.99 27.63 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.857 1.348 . . . . 5.0 107.541 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.0 m -99.74 131.91 45.42 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.5 -1.28 . . . . 0.67 108.41 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.64 128.93 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.849 -1.167 . . . . 0.54 107.849 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.77 109.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.633 -1.618 . . . . 1.66 106.633 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.581 ' CD2' HG11 ' A' ' 36' ' ' VAL . 26.8 m-85 -94.03 107.52 19.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.076 -1.453 . . . . 1.18 107.076 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.83 5.6 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.354 -0.927 . . . . 1.51 110.932 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.596 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 31.9 ptt-85 -130.06 -162.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.857 -1.164 . . . . 7.82 107.857 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 39' ' ' ARG . 33.3 p -132.49 140.09 48.22 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.178 -1.009 . . . . 3.96 110.961 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.4 -1.91 23.64 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.247 -0.977 . . . . 3.11 111.721 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 95.72 24.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 120.022 -0.671 . . . . 2.16 111.453 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . 0.408 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 83.3 Cg_exo -35.29 -38.63 0.2 Allowed 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 122.339 2.026 . . . . 4.02 112.14 168.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -67.04 -45.12 78.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.701 -1.6 . . . . 3.8 109.217 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' NH2' ' A' ' 8' ' ' ARG . 82.0 m -53.32 -41.91 66.18 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.717 -1.193 . . . . 2.03 107.902 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' PRO . 58.0 t -48.33 -38.89 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.458 -0.897 . . . . 1.02 111.14 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.8 mmp_? -50.25 -20.94 1.17 Allowed 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 112.835 0.68 . . . . 5.79 112.835 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -43.77 22.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.76 -1.57 . . . . 0.83 106.76 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.0 tmtt? -57.1 -46.6 82.46 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.598 -0.889 . . . . 2.69 108.598 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.611 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 31.8 m-20 -53.3 -43.9 67.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.794 -1.162 . . . . 3.01 111.033 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.16 -57.73 4.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.17 -1.012 . . . . 0.81 109.529 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -43.22 37.31 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.056 -1.058 . . . . 1.13 109.156 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 19.9 tt0 -65.84 -65.21 0.7 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.366 -0.934 . . . . 2.72 109.504 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -36.33 -50.74 0.77 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.145 0.903 . . . . 3.6 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.551 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 95.2 mt -49.72 -40.15 39.53 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.823 -1.08 . . . . 1.26 112.272 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.0 m -50.48 -12.59 0.1 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.576 0.548 . . . . 1.25 111.618 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 24' ' ' LEU . 44.5 m-80 -114.73 -41.8 3.34 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.853 -0.612 . . . . 2.49 111.045 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 5.9 pt-20 -81.79 -10.59 59.3 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.156 -1.018 . . . . 3.69 113.415 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.5 mpt_? -105.76 -177.4 3.35 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.281 -0.967 . . . . 5.2 110.914 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -63.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.486 -1.234 . . . . 6.04 112.024 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.4 t70 -118.91 -43.78 2.64 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 109.476 -0.564 . . . . 5.47 109.476 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 25' ' ' SER . 16.4 t80 8.61 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.41 -1.723 . . . . 0.76 115.113 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -112.72 158.82 19.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.689 -1.967 . . . . 3.27 105.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.657 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 10.8 p90 -151.28 164.69 36.06 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.16 -1.416 . . . . 1.02 110.695 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -144.27 154.86 43.51 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.374 -1.343 . . . . 4.0 107.374 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 36' ' ' VAL . 38.7 t80 -106.76 148.28 28.64 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.117 -1.433 . . . . 1.7 109.068 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -131.02 125.86 58.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 124.399 1.062 . . . . 1.13 108.62 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -109.02 122.76 47.94 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.558 -1.275 . . . . 1.94 107.558 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.1 pt -51.93 -31.35 13.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.614 -0.834 . . . . 1.48 111.811 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.8 OUTLIER -84.22 -5.9 59.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.652 0.612 . . . . 4.82 112.652 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.12 -39.32 6.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.798 -0.761 . . . . 1.3 110.194 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.76 -35.08 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.442 -0.903 . . . . 2.67 110.148 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.41 53.85 0.71 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.151 -1.58 . . . . 1.91 109.151 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.25 137.68 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.506 -0.924 . . . . 1.8 108.506 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -117.46 54.06 0.9 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.69 -1.204 . . . . 4.28 113.901 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.1 mttp 62.94 -65.01 0.1 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.365 1.246 . . . . 7.52 114.365 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -44.25 -51.74 8.04 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.022 0.749 . . . . 4.65 113.022 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.46 -38.23 58.86 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.758 -1.177 . . . . 4.04 109.999 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLN . 71.9 mt -71.92 -51.77 20.51 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.311 -0.956 . . . . 1.73 108.522 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -40.39 -45.21 2.14 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.178 -1.045 . . . . 5.49 108.178 178.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -68.75 -58.02 4.81 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 126.008 2.068 . . . . 5.79 110.455 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -43.55 -37.51 2.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.669 -0.696 . . . . 3.67 112.327 -179.21 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.6 -8.83 18.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.044 0.84 . . . . 1.96 111.316 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.29 49.63 55.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.102 -1.599 . . . . 2.4 109.102 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 26.2 mmtp -122.97 154.26 64.36 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 114.401 -0.9 . . . . 4.99 110.739 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.25 36.34 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.282 1.321 . . . . 4.76 110.815 152.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 54' ' ' LYS . 25.1 t 57.24 151.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.432 1.083 . . . . 6.07 112.742 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.551 ' CG ' ' H ' ' A' ' 58' ' ' THR . 6.6 pm0 -131.17 -106.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.556 -1.275 . . . . 6.26 107.556 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 67.4 m -119.23 175.56 5.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.321 -1.363 . . . . 6.36 107.321 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.534 HG21 HH12 ' A' ' 8' ' ' ARG . 3.2 m -112.6 164.56 15.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.64 -0.504 . . . . 4.13 109.64 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.29 -172.5 10.93 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 124.131 -1.195 . . . . 2.3 110.421 -11.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -103.03 131.97 49.63 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.641 -1.614 . . . . 3.55 106.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.594 HG21 ' CG ' ' A' ' 75' ' ' PHE . 8.7 mm -108.62 125.92 65.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.356 -0.937 . . . . 1.48 110.832 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.21 124.16 41.84 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.421 -1.326 . . . . 1.03 107.421 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.474 ' CG2' HG13 ' A' ' 69' ' ' ILE . 42.2 t -116.54 122.91 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.068 -1.053 . . . . 1.0 108.863 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 50.44 32.2 6.26 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.013 1.863 . . . . 2.53 108.803 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 82.52 -34.5 0.09 Allowed 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 110.016 -3.266 . . . . 6.99 109.757 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -47.1 112.66 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 4.91 108.719 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HA2' ' A' ' 70' ' ' GLY . 21.6 t-80 -57.85 131.57 50.77 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 117.825 -1.55 . . . . 1.81 106.876 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 ' CG2' ' A' ' 64' ' ' VAL . 51.0 mm -105.43 -42.97 7.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.198 -1.408 . . . . 1.13 107.198 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 131.54 -125.1 4.27 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.941 -1.599 . . . . 1.59 111.109 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.22 19.8 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.626 -1.273 . . . . 1.94 112.281 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -52.46 -44.88 65.83 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.119 -1.04 . . . . 1.67 111.921 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -63.31 -58.82 5.88 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.306 -0.958 . . . . 1.57 110.794 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.85 -56.47 8.64 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.096 -0.642 . . . . 4.59 109.429 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 62' ' ' ILE . 66.7 t80 -55.46 -45.46 76.91 Favored 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 115.184 -0.916 . . . . 0.8 109.455 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.68 -55.1 33.31 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.716 -0.794 . . . . 0.78 110.334 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.73 63.89 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.722 -1.214 . . . . 1.09 107.722 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.529 ' CE2' ' ND2' ' A' ' 82' ' ' ASN . 81.6 t90 -42.75 -58.8 2.19 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 115.556 -0.747 . . . . 1.59 110.003 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 51.3 t -46.1 -23.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.275 -0.875 . . . . 1.89 111.579 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.8 -67.96 0.9 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.531 0.52 . . . . 2.55 110.769 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.51 -22.16 19.92 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.83 1.048 . . . . 4.69 113.83 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . 0.529 ' ND2' ' CE2' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -112.5 -31.99 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 114.302 1.223 . . . . 3.11 114.302 -178.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 55.0 mt -96.87 -9.41 28.63 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 117.428 -1.709 . . . . 1.36 111.088 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 65.3 m-20 . . . . . 0 N--CA 1.499 2.007 0 N-CA-C 108.357 -0.979 . . . . 3.53 108.357 178.929 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 45.3 tpp . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.706 -1.22 . . . . 2.7 107.706 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.2 100.03 11.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.606 -1.257 . . . . 3.76 107.606 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -87.84 120.88 29.6 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.408 -0.917 . . . . 0.86 109.237 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 46.2 t -108.44 135.17 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-N 115.876 -0.602 . . . . 0.73 109.44 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mm -118.79 111.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.691 1.245 . . . . 1.55 109.375 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 36' ' ' VAL . 47.7 m-85 -93.9 98.14 10.85 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.508 -0.477 . . . . 1.29 110.443 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.85 -163.01 11.55 Favored Glycine 0 N--CA 1.512 3.738 0 C-N-CA 120.339 -0.934 . . . . 1.06 111.123 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.579 ' HG2' ' NH1' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -129.47 18.61 5.82 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 119.167 -1.013 . . . . 6.55 112.477 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.7 m 72.55 -58.04 0.61 Allowed 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 113.772 1.027 . . . . 3.05 113.772 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.51 35.88 3.42 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 119.106 -1.521 . . . . 2.84 110.944 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.9 88.96 45.17 Favored Pre-proline 0 N--CA 1.491 1.599 0 C-N-CA 120.453 -0.499 . . . . 2.63 110.046 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.36 -53.48 1.34 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.711 2.274 . . . . 2.6 112.417 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -55.83 -49.58 72.88 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.769 -1.172 . . . . 3.73 109.292 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 37.0 m -57.59 -39.27 76.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.226 -0.99 . . . . 2.5 109.538 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' ARG . 58.6 t -60.19 -53.92 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.931 -1.108 . . . . 1.26 110.463 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tpm_? -35.83 -51.35 0.69 Allowed 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.09 0.472 . . . . 4.43 110.716 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.89 -48.22 3.08 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.696 -0.684 . . . . 0.92 111.245 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.7 tmtt? -52.25 -41.25 62.66 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.543 -0.753 . . . . 3.02 111.949 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.546 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 17.1 m-20 -53.12 -49.8 65.78 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 118.948 -1.101 . . . . 2.63 110.087 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.29 -55.71 4.7 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.81 -1.541 . . . . 1.74 108.387 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -60.18 -49.43 77.67 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.177 -1.829 . . . . 0.91 109.836 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -45.74 -53.38 9.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.784 1.302 . . . . 4.22 109.791 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 8.5 mmmm -56.89 -64.21 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.597 -0.729 . . . . 3.56 109.783 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -44.38 -56.89 3.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.947 -1.024 . . . . 1.22 113.249 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 p -48.16 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.044 1.498 . . . . 2.01 115.044 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -123.36 -36.07 2.86 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.117 0.484 . . . . 3.03 110.432 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -74.19 -31.16 62.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.975 -1.011 . . . . 3.66 110.424 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.415 HH21 ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -109.52 -166.38 1.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.05 -0.66 . . . . 5.47 110.256 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.1 p30 -96.8 -77.59 0.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.593 2.071 . . . . 4.53 116.593 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' C ' ' A' ' 31' ' ' PHE . 8.7 t70 -74.12 -59.47 2.71 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.457 0.91 . . . . 4.13 113.457 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' A' ' 30' ' ' ASP . 57.3 t80 0.06 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.528 1.307 . . . . 0.93 114.528 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -106.07 159.43 16.08 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.607 -1.997 . . . . 3.92 105.607 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.512 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 40.7 p90 -160.67 154.13 22.06 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.509 -1.276 . . . . 1.66 110.828 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.2 133.61 28.29 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.039 -0.982 . . . . 3.01 109.85 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.65 136.57 32.89 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.834 -2.284 . . . . 1.58 104.834 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 6' ' ' PHE . 1.6 t -126.79 147.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.87 -1.159 . . . . 0.59 107.87 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.401 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 1.5 t70 -122.15 135.61 54.81 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.027 -0.669 . . . . 2.27 110.688 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.42 -23.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.508 -1.277 . . . . 1.94 110.819 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -88.95 -3.57 58.7 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.724 -0.671 . . . . 5.86 112.637 -178.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.53 -41.83 7.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.786 -1.19 . . . . 1.44 107.786 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -83.45 -39.45 20.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.151 -1.386 . . . . 2.83 108.859 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.14 49.48 1.14 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.452 -1.859 . . . . 1.49 108.452 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 47' ' ' ASP . 74.4 mt -112.43 157.01 13.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 120.262 -0.575 . . . . 1.41 111.07 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 46' ' ' GLU . 15.3 p -110.92 -179.17 3.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.273 -1.01 . . . . 2.17 108.273 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -85.87 46.67 1.34 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 106.462 -1.681 . . . . 5.46 106.462 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' THR . 53.2 mt-10 -122.17 -61.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.577 -1.647 . . . . 4.07 107.274 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 16.7 t70 -49.75 -46.04 50.1 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 114.851 -1.068 . . . . 3.82 109.534 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -52.79 -4.55 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.756 1.021 . . . . 2.76 113.756 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' ASP . 1.1 mp0 -108.39 -53.17 2.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.234 -1.395 . . . . 5.42 107.234 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -60.37 -33.13 72.01 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.031 0.92 . . . . 6.18 110.745 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.448 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 1.8 ttpp -92.11 14.49 15.85 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.389 -1.278 . . . . 3.84 109.344 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -123.24 -59.82 1.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.304 1.003 . . . . 1.56 111.988 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.85 -20.35 48.28 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.179 -1.01 . . . . 2.47 112.823 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -131.08 161.83 59.33 Favored Pre-proline 0 N--CA 1.506 2.342 0 C-N-CA 120.749 -0.38 . . . . 5.98 111.971 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 54' ' ' LYS . 55.4 Cg_exo -12.98 -147.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.109 1 C-N-CA 125.316 4.011 . . . . 6.11 116.675 -123.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.7 -51.23 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.459 -1.246 . . . . 6.23 110.896 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -39.01 31.49 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.626 0.602 . . . . 6.05 112.626 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -31.57 144.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 115.728 1.751 . . . . 6.08 115.728 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.83 159.49 31.54 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 106.887 -1.523 . . . . 2.82 106.887 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -79.56 -179.57 26.79 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.934 -1.277 . . . . 1.78 109.913 -17.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.519 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 13.5 mm-40 -104.98 125.42 50.94 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.029 -1.068 . . . . 3.22 108.29 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.503 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 13.7 mm -105.66 137.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.809 -1.552 . . . . 1.31 106.809 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 78.0 m-85 -122.15 124.33 43.63 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.879 -1.156 . . . . 1.11 107.879 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 29.3 t -98.38 111.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.641 -1.624 . . . . 1.15 108.339 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 59.04 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.395 1.059 . . . . 2.6 111.701 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.5 mm-40 -133.79 -8.84 2.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.906 0.706 . . . . 4.93 112.906 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -103.78 153.08 21.11 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.233 0.924 . . . . 5.24 111.251 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.731 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.9 t-80 -87.33 133.91 33.64 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.794 -1.187 . . . . 1.4 107.794 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -116.1 -29.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.163 -0.68 . . . . 1.52 109.163 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 29.34 108.18 0.0 OUTLIER Glycine 1 N--CA 1.518 4.107 0 N-CA-C 116.433 1.333 . . . . 2.59 116.433 178.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.52 121.63 2.8 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.347 -1.101 . . . . 1.77 110.347 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -59.46 -45.06 92.71 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.989 -1.084 . . . . 1.54 108.866 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -53.97 -54.28 41.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.293 -0.867 . . . . 1.21 110.149 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -57.97 -55.22 37.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.703 -1.135 . . . . 2.69 110.316 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.433 ' CG ' HG21 ' A' ' 62' ' ' ILE . 42.3 t80 -55.04 -45.82 75.27 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.263 -0.975 . . . . 0.81 108.725 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 -59.2 5.35 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.09 -0.644 . . . . 0.79 109.534 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -56.82 -61.52 2.38 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.698 -0.801 . . . . 0.88 109.212 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.419 ' CH2' HG11 ' A' ' 64' ' ' VAL . 62.1 t90 -39.82 -51.56 2.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.251 0.97 . . . . 1.54 109.814 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.415 HG13 HD12 ' A' ' 83' ' ' LEU . 4.0 t -54.74 -51.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.91 108.38 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.45 16.24 0.15 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.634 -1.166 . . . . 4.86 112.087 -178.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -127.98 -60.1 1.16 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.408 0.623 . . . . 3.82 110.57 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -83.76 -14.94 50.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.593 -1.185 . . . . 2.02 112.89 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.415 HD12 HG13 ' A' ' 79' ' ' VAL . 54.4 mt -99.21 4.87 46.84 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.325 -1.75 . . . . 1.39 108.695 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 . . . . . 0 N--CA 1.485 1.279 0 O-C-N 125.505 1.753 . . . . 3.5 107.574 178.768 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 25.6 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.161 -0.681 . . . . 2.7 109.161 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -112.19 97.87 6.94 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.508 -0.923 . . . . 5.3 108.508 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -82.13 135.27 35.32 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.503 -1.226 . . . . 0.78 109.741 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -126.38 130.18 71.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.044 -1.465 . . . . 0.75 107.044 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -104.85 128.59 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.982 -1.488 . . . . 1.51 106.982 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.75 94.25 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.355 -1.35 . . . . 1.3 107.355 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.75 -164.44 11.81 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.716 -2.154 . . . . 1.0 107.716 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 ptm180 -143.16 137.61 29.18 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 117.837 -1.545 . . . . 5.45 111.787 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.445 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 61.6 m -53.02 125.05 15.95 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.224 -1.391 . . . . 4.45 108.424 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 -35.97 2.99 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.031 -1.557 . . . . 3.87 110.549 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 1.5 p -71.19 161.37 78.66 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 117.845 -1.542 . . . . 3.66 108.563 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -98.95 -57.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.504 1.469 . . . . 2.71 112.441 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -45.86 -32.14 2.48 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.955 0.724 . . . . 3.55 112.955 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -53.53 -31.39 46.1 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 118.004 -1.478 . . . . 2.42 110.728 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 -47.58 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.033 -0.667 . . . . 1.08 109.263 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.549 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -37.62 -48.64 1.05 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 124.554 1.159 . . . . 4.09 112.994 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.62 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.306 -1.358 . . . . 0.73 109.349 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 12.8 tmtt? -62.51 -53.0 61.26 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.414 -0.812 . . . . 2.21 111.45 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.549 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.9 OUTLIER -52.18 -48.72 64.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 118.292 -1.363 . . . . 3.29 109.657 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 -62.23 1.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.199 0.937 . . . . 0.73 110.87 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.87 -46.04 71.18 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.711 -1.195 . . . . 0.84 110.417 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.54 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 39.7 tt0 -48.46 -65.02 0.64 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.545 -0.752 . . . . 2.8 110.45 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 44.2 tttm -38.91 -60.43 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.148 0.905 . . . . 3.78 112.638 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.3 mt -35.06 -45.12 0.26 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.913 1.449 . . . . 1.42 114.913 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.6 p -49.09 -38.85 25.88 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 124.118 0.887 . . . . 3.03 110.505 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.553 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -102.64 23.71 11.6 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.644 -0.422 . . . . 3.0 110.236 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -130.3 -44.04 1.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.685 -0.806 . . . . 3.29 112.174 -178.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.607 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -107.3 -24.33 11.91 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.41 -1.316 . . . . 5.62 112.089 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 35.7 t70 84.23 -27.34 0.1 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 123.932 0.77 . . . . 4.96 111.809 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 10.5 p-10 -100.86 17.08 23.09 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 120.15 -0.62 . . . . 4.73 111.038 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CG ' ' HB3' ' A' ' 24' ' ' LEU . 72.3 t80 -112.71 119.18 37.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.842 -1.143 . . . . 1.13 112.097 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.31 148.39 43.23 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.212 -1.403 . . . . 2.8 107.212 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 29.9 p90 -149.17 157.69 43.58 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.001 -1.08 . . . . 1.32 110.833 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -136.3 156.97 47.89 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.072 -1.455 . . . . 3.75 107.072 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -108.22 144.64 35.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.74 -1.584 . . . . 1.26 109.033 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.23 129.88 65.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.353 -0.98 . . . . 0.66 108.353 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -108.83 115.99 31.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.268 -1.753 . . . . 2.48 106.268 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.2 -7.1 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 118.372 -1.331 . . . . 1.73 111.91 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -91.81 -9.75 42.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.815 -0.809 . . . . 4.94 108.815 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.08 -44.16 6.4 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.012 -1.477 . . . . 1.21 107.012 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -74.22 -41.5 61.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.143 -1.428 . . . . 2.92 107.143 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.79 55.33 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.937 -1.665 . . . . 1.32 108.937 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.29 154.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 120.163 -0.615 . . . . 1.33 110.1 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.4 151.63 34.34 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.376 -0.829 . . . . 2.33 109.251 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 56' ' ' VAL . 19.0 mtpp -55.68 -50.56 69.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.159 -1.416 . . . . 5.55 108.226 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -39.94 -63.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.526 1.141 . . . . 4.1 110.403 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -55.74 8.68 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.62 0.724 . . . . 5.11 111.3 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.87 -40.57 56.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.157 -0.929 . . . . 2.26 110.919 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 54' ' ' LYS . 10.9 mm100 -40.87 -40.99 1.49 Allowed 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 119.782 -0.767 . . . . 5.31 109.963 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.008 -0.996 . . . . 4.89 112.436 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.54 -29.8 22.4 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.385 1.254 . . . . 3.99 114.385 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -98.73 -32.76 11.22 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.62 -0.832 . . . . 3.06 112.273 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.15 51.24 46.02 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 120.157 -1.021 . . . . 3.92 112.422 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.55 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.04 -179.78 0.71 Allowed Pre-proline 0 N--CA 1.507 2.385 0 C-N-CA 119.407 -0.917 . . . . 8.24 109.591 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.79 170.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.264 1.976 . . . . 6.97 111.11 148.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 57' ' ' GLU . 35.1 m -89.92 -60.58 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.179 -1.408 . . . . 7.13 110.589 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.57 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -39.53 -69.66 0.12 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 124.506 1.129 . . . . 7.3 109.205 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -15.47 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.386 1.679 . . . . 5.54 113.929 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -144.63 158.26 53.89 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 106.551 -1.648 . . . . 3.37 106.551 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.2 Cg_endo -84.34 -163.27 2.97 Favored 'Cis proline' 0 N--CA 1.483 0.868 0 N-CA-C 109.26 -1.092 . . . . 1.84 109.26 -10.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HA ' HE21 ' A' ' 61' ' ' GLN . 1.2 mm100 -133.75 151.9 51.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.877 -1.529 . . . . 3.61 109.914 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.7 mp -119.71 145.8 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.939 -1.134 . . . . 1.13 107.939 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -133.47 128.63 35.83 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.72 -1.582 . . . . 1.12 107.152 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 65' ' ' ASP . 50.5 t -106.91 -166.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.402 -1.703 . . . . 2.03 106.402 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.841 ' H ' HG12 ' A' ' 64' ' ' VAL . 2.9 m-20 -46.47 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 123.711 1.719 . . . . 3.81 112.916 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' VAL . 81.1 mt-30 51.82 35.65 16.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 110.242 -3.163 . . . . 4.95 113.368 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -137.53 136.44 37.65 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.0 -0.68 . . . . 4.86 111.555 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.661 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -79.64 141.54 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 105.377 -2.082 . . . . 1.36 105.377 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 64' ' ' VAL . 11.2 mm -107.76 -50.59 7.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 C-N-CA 119.109 -1.036 . . . . 1.36 110.32 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.14 -140.57 9.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.2 -1.56 . . . . 1.66 109.2 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 62' ' ' ILE . . . -101.76 -54.62 0.92 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 120.407 -0.902 . . . . 2.61 112.297 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 15.3 t80 -159.05 -62.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.037 -1.465 . . . . 1.7 109.573 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -44.82 -40.43 6.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.606 1.669 . . . . 1.37 107.306 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.08 -53.97 50.49 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 111.579 -2.555 . . . . 2.62 109.988 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' HG21 ' A' ' 69' ' ' ILE . 19.0 t80 -61.87 -38.55 88.72 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 117.615 -1.634 . . . . 1.01 108.353 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.12 -54.63 32.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.724 -1.213 . . . . 1.03 107.724 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.59 -51.37 70.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.468 -0.893 . . . . 1.42 109.51 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 71.0 t90 -46.55 -48.1 19.54 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.756 -0.831 . . . . 2.14 108.756 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.28 -51.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -82.14 33.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.316 -0.954 . . . . 3.03 110.547 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -133.29 -49.48 0.85 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.657 0.741 . . . . 7.19 109.337 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -102.73 -15.64 16.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.31 -1.313 . . . . 2.55 111.72 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 29.9 mt -107.45 1.96 23.92 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 117.824 -1.551 . . . . 1.56 112.483 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 10.3 p-10 . . . . . 0 N--CA 1.503 2.217 0 C-N-CA 117.692 -1.603 . . . . 5.24 107.487 177.622 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.071 -1.455 . . . . 2.13 107.071 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.522 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.3 mp0 -110.05 105.31 14.39 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.905 -1.118 . . . . 4.09 110.131 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 m -87.85 146.2 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.83 -1.148 . . . . 0.84 111.24 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.6 t -120.5 136.57 57.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 0.72 107.075 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -113.72 108.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.511 -0.922 . . . . 1.4 108.511 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 61' ' ' GLN . 48.7 m-85 -94.5 103.9 15.86 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.752 -0.833 . . . . 0.89 108.752 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.21 -161.54 10.87 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 107.893 -2.083 . . . . 1.25 107.893 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.718 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.82 31.2 5.53 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.164 -1.415 . . . . 4.97 112.869 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.613 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.1 m 67.55 174.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.13 -0.941 . . . . 3.52 109.948 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 13.47 51.78 0.01 OUTLIER Glycine 0 N--CA 1.511 3.648 0 N-CA-C 116.0 1.16 . . . . 2.75 116.0 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.718 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -130.7 101.85 16.81 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.682 -1.229 . . . . 2.16 107.682 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -41.4 -47.02 5.76 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.751 1.634 . . . . 3.4 110.644 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB ' ' A' ' 59' ' ' VAL . 6.1 t80 -57.12 -44.7 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.147 -1.021 . . . . 2.61 109.423 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.76 -51.19 69.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.735 -1.209 . . . . 1.8 107.735 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' LYS . 96.6 t -43.7 -48.81 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 114.516 -1.22 . . . . 1.03 111.122 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.423 ' C ' ' HE2' ' A' ' 72' ' ' TYR . 18.7 mtm180 -35.82 -39.23 0.15 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 120.057 -0.657 . . . . 7.42 112.042 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.22 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.917 -0.771 . . . . 0.89 108.917 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 8.5 tmtt? -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.675 -1.232 . . . . 2.74 107.675 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . 0.567 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 60.7 m-20 -58.13 -54.65 44.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.394 -0.922 . . . . 3.14 109.377 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.15 -59.25 4.9 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.604 -1.238 . . . . 0.77 110.31 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -53.26 -44.56 68.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.886 -0.726 . . . . 0.67 110.56 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.8 tt0 -55.7 -57.05 13.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.272 0.983 . . . . 2.94 109.666 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.93 -54.34 47.77 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.747 -0.66 . . . . 4.22 111.202 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 28' ' ' ARG . 79.7 mt -48.35 -57.27 6.27 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.584 -0.846 . . . . 1.61 111.678 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -35.0 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 114.039 1.125 . . . . 1.38 114.039 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 24' ' ' LEU . 9.2 t30 -104.1 -50.25 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.932 -0.766 . . . . 4.1 108.932 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.37 40.52 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.837 -1.074 . . . . 4.07 111.258 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.486 HH12 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -147.76 -150.43 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.944 -1.102 . . . . 5.03 112.196 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 4.1 m-20 -111.82 -127.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.008 -0.996 . . . . 6.78 110.188 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.4 67.21 5.08 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.662 -1.236 . . . . 3.85 107.662 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -112.59 114.56 27.26 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.918 -1.037 . . . . 0.9 111.565 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -120.22 158.83 26.17 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.773 -1.936 . . . . 3.39 105.773 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 16.3 p90 -160.58 152.79 20.35 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 117.804 -1.559 . . . . 1.2 112.932 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -131.07 164.06 26.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.459 -1.246 . . . . 4.09 108.347 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -113.14 143.2 44.77 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.767 -1.197 . . . . 1.18 107.767 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -132.83 143.85 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.381 -0.97 . . . . 0.66 108.381 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.95 129.66 55.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.258 0.551 . . . . 2.16 109.805 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -58.45 -24.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.192 -1.003 . . . . 1.33 110.933 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.611 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.23 -34.17 25.92 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.955 -1.098 . . . . 4.44 109.645 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.51 -45.18 88.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.824 -0.625 . . . . 1.19 110.193 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 43' ' ' ILE . 8.2 mm-40 -86.34 -43.66 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.091 -1.043 . . . . 2.93 110.075 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.76 54.66 0.72 Allowed Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.736 -1.745 . . . . 1.56 108.736 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 41' ' ' GLU . 6.5 mt -115.74 158.5 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.91 -0.645 . . . . 1.51 110.399 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.4 p -117.6 171.09 8.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.022 -0.733 . . . . 2.63 109.022 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 7.9 tmtm? -69.37 -43.08 74.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.885 -1.526 . . . . 7.01 108.699 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -56.15 -51.07 69.32 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.072 -0.714 . . . . 3.83 109.072 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.44 -51.56 62.25 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.92 -1.112 . . . . 3.05 109.098 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ALA . 55.7 mt -52.97 -51.67 60.72 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.44 -1.304 . . . . 1.59 107.682 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.1 tm0? -46.16 -48.14 17.49 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.935 0.772 . . . . 4.56 109.894 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -59.95 -40.6 89.56 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.641 0.734 . . . . 6.38 109.034 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.786 -1.097 . . . . 4.41 111.525 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.637 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -94.19 -50.17 5.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.504 0.557 . . . . 1.88 112.504 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.5 15.02 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.703 -1.237 . . . . 2.72 111.545 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.511 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 19.3 ptmt -110.8 74.35 0.93 Allowed Pre-proline 0 N--CA 1.5 2.07 0 C-N-CA 120.28 -0.568 . . . . 6.39 111.367 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.0 140.23 40.0 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.581 1.521 . . . . 4.15 111.616 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.8 t 76.18 60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.394 1.058 . . . . 5.6 110.202 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -110.22 -176.04 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.621 -1.172 . . . . 5.93 108.057 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.548 ' CG2' ' H ' ' A' ' 72' ' ' TYR . 12.2 t -100.93 -161.84 0.89 Allowed 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.283 -1.367 . . . . 7.97 108.357 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' A' ' 13' ' ' TYR . 74.3 t -105.9 162.82 18.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 121.506 0.669 . . . . 4.63 110.325 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.56 -166.47 5.16 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 124.336 -1.11 . . . . 3.19 109.293 -29.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.32 119.0 34.02 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.878 -1.527 . . . . 2.93 106.878 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.46 134.01 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.806 -1.158 . . . . 1.52 109.324 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 68' ' ' HIS . 2.8 m-85 -118.14 114.14 22.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 105.35 -2.093 . . . . 1.76 105.35 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.603 HG23 HG13 ' A' ' 69' ' ' ILE . 53.2 t -96.86 110.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 117.188 -1.805 . . . . 1.31 111.19 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t70 61.32 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.594 0.961 . . . . 2.51 113.594 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' VAL . 11.8 mm-40 -130.53 -18.56 3.15 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.117 1.155 . . . . 4.46 114.117 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.46 156.7 19.16 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.741 -1.184 . . . . 4.83 111.285 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.637 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 39.2 t-80 -87.53 141.36 28.68 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.803 -1.159 . . . . 1.76 109.71 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -114.18 -54.85 4.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.005 -1.48 . . . . 1.51 107.005 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' A' ' 68' ' ' HIS . . . 58.65 123.22 0.01 OUTLIER Glycine 0 N--CA 1.501 3.003 0 O-C-N 124.493 1.121 . . . . 2.4 113.6 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' A' ' 58' ' ' THR . . . 104.23 141.12 10.89 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.875 -1.155 . . . . 1.54 112.57 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.548 ' H ' ' CG2' ' A' ' 58' ' ' THR . 20.2 t80 -82.97 -54.5 5.02 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.458 -0.897 . . . . 1.89 109.211 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -67.65 1.82 2.22 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.162 -1.015 . . . . 1.8 108.939 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 72' ' ' TYR . 15.2 t70 -100.53 -63.6 1.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.927 -1.508 . . . . 3.1 106.927 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -55.58 -45.61 77.35 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.257 -0.883 . . . . 0.78 108.936 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.92 -38.61 10.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.109 -0.496 . . . . 0.88 110.39 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -81.05 -50.77 9.25 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.6 -1.259 . . . . 0.97 107.6 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . 0.602 ' CH2' HG11 ' A' ' 64' ' ' VAL . 76.6 t90 -38.62 -53.23 1.62 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.125 0.89 . . . . 1.35 108.712 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 83' ' ' LEU . 75.6 t -44.02 -46.42 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.324 -1.307 . . . . 1.13 110.505 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.417 ' HZ3' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -73.28 -58.57 3.22 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.914 -0.714 . . . . 3.61 111.707 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -57.4 -24.69 56.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.122 0.786 . . . . 3.74 113.122 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -101.02 -34.26 9.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.355 1.243 . . . . 1.95 114.355 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 79' ' ' VAL . 36.8 mt -96.04 -11.63 26.12 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.328 -1.349 . . . . 1.77 111.677 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . 0.486 ' CG ' HH12 ' A' ' 28' ' ' ARG . 36.3 m-20 . . . . . 0 N--CA 1.498 1.968 0 O-C-N 124.287 0.992 . . . . 3.74 109.967 179.108 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.9 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.929 -0.767 . . . . 2.95 108.929 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -110.11 98.18 7.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.723 -1.584 . . . . 3.94 106.723 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 33' ' ' TYR . 86.6 m -82.17 141.3 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.383 -0.927 . . . . 0.79 111.939 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -133.86 138.78 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.569 -0.741 . . . . 0.63 110.096 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.79 123.28 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 105.28 -2.119 . . . . 1.54 105.28 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PHE . . . . . 0.445 ' CD2' HG11 ' A' ' 36' ' ' VAL . 58.2 m-85 -104.07 78.45 1.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.048 -1.093 . . . . 1.17 108.048 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.6 -151.06 9.49 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.514 -1.327 . . . . 1.0 110.739 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ARG . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' SER . 2.7 tmm_? -119.47 -178.32 3.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.343 -0.984 . . . . 5.35 108.343 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.647 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.44 59.45 0.29 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.037 0.384 . . . . 3.6 112.037 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.3 71.26 0.84 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.159 -1.496 . . . . 2.89 112.197 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -129.21 149.82 73.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.925 -0.71 . . . . 2.14 109.687 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.48 -65.67 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.303 2.002 . . . . 3.89 113.206 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -78.01 15.86 0.83 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 119.104 -1.038 . . . . 3.69 112.897 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 36.1 m -107.16 -48.78 3.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.624 -1.621 . . . . 2.12 106.624 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 17' ' ' ALA . 50.1 t -73.96 -38.3 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.947 -1.479 . . . . 1.08 108.529 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -80.09 38.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.174 0.987 . . . . 3.77 109.391 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -142.21 -49.56 0.37 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.073 -1.825 . . . . 1.33 106.073 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' LYS . . . . . 0.697 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 50.9 tttm -57.59 -38.88 75.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.904 -1.498 . . . . 3.46 110.081 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -43.55 -47.42 7.34 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.376 0.608 . . . . 4.65 110.448 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.24 -42.85 96.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.409 -0.814 . . . . 1.51 110.156 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -63.65 -57.91 8.58 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.332 -0.947 . . . . 0.73 109.251 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.697 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 47.8 mt-10 -51.44 -51.56 53.86 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.805 0.812 . . . . 3.53 109.262 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -53.96 -59.21 4.93 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.937 -1.029 . . . . 4.24 109.928 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 24' ' ' LEU . 7.4 mt -51.79 -53.17 42.97 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.528 -1.269 . . . . 1.93 110.888 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -52.99 -32.12 44.63 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.061 -1.056 . . . . 1.61 111.76 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -83.37 -37.18 23.67 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.887 -0.725 . . . . 3.3 111.059 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -74.39 -40.06 62.31 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 122.071 0.939 . . . . 2.9 110.336 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.607 HH21 ' CG ' ' A' ' 30' ' ' ASP . 9.1 mmm180 -99.62 179.3 4.59 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.113 -1.403 . . . . 6.92 111.418 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' CZ ' ' A' ' 28' ' ' ARG . 2.0 p30 -122.3 -12.79 8.2 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.772 -1.104 . . . . 3.79 110.843 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' HH21 ' A' ' 28' ' ' ARG . 14.5 p30 -103.63 -46.14 4.62 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.7 1.0 . . . . 4.52 113.7 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -48.39 110.39 0.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 113.502 0.927 . . . . 0.83 113.502 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.587 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 2.3 tm0? -103.35 156.16 17.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.493 -0.929 . . . . 5.29 108.493 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.587 ' H ' ' NE2' ' A' ' 32' ' ' GLN . 1.6 p90 -164.09 156.74 17.44 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.489 -0.884 . . . . 1.24 111.218 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -139.23 152.44 47.32 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.606 -1.179 . . . . 3.12 108.772 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 53.3 t80 -107.47 138.6 43.38 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.145 -1.422 . . . . 1.05 107.593 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -124.59 143.52 37.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 124.204 0.94 . . . . 0.66 108.7 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -117.23 118.33 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.853 -1.536 . . . . 2.47 106.853 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -53.09 -19.27 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.654 -0.818 . . . . 1.28 110.985 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.77 -37.89 55.08 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.593 0.558 . . . . 5.65 111.445 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 -43.43 55.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.908 -0.717 . . . . 1.32 109.298 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.27 -43.22 52.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.169 -0.923 . . . . 3.36 109.33 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.06 60.29 1.13 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.305 -1.918 . . . . 1.41 108.305 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 44' ' ' THR . 30.3 mm -114.52 160.75 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 C-N-CA 119.458 -0.897 . . . . 2.83 112.346 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -121.33 151.29 40.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.63 -1.168 . . . . 2.51 109.772 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 46' ' ' GLU . 4.1 ttpt -56.69 -46.61 81.09 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.656 -1.218 . . . . 4.82 109.746 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . 0.548 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 23.8 mm-40 -45.06 -56.85 4.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.284 -0.566 . . . . 4.34 110.159 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.56 -56.34 22.57 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.825 0.821 . . . . 4.37 110.281 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.457 ' HB3' ' CD ' ' A' ' 61' ' ' GLN . 21.7 mt -46.97 -46.85 21.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.112 -0.949 . . . . 1.62 110.39 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 25.8 tt0 -52.56 -50.32 63.18 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.72 -1.127 . . . . 3.62 109.561 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -52.45 -32.17 38.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.878 0.847 . . . . 5.62 110.301 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' LYS . . . . . 0.771 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.98 19.46 17.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.294 -1.321 . . . . 4.03 111.139 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -113.15 -41.08 3.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.826 0.703 . . . . 1.83 110.569 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.02 -55.4 0.51 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.45 -1.86 . . . . 2.44 108.45 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 55' ' ' PRO . 31.3 tttm -92.03 151.98 42.38 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.574 -1.269 . . . . 7.37 107.574 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.442 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 30.3 Cg_exo -61.23 75.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.543 1.495 . . . . 4.65 110.684 158.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.38 82.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.032 0.92 . . . . 6.48 108.527 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -50.3 -31.66 14.96 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.082 -1.417 . . . . 5.5 111.57 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 59' ' ' VAL . 99.9 m -94.61 169.05 10.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.682 -0.69 . . . . 5.16 110.763 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -116.4 166.0 13.65 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.454 -1.313 . . . . 2.78 107.454 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 76.6 Cg_endo -92.86 -151.08 0.33 Allowed 'Cis proline' 0 C--N 1.312 -1.355 0 N-CA-C 109.592 -0.965 . . . . 2.61 109.592 -17.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.457 ' CD ' ' HB3' ' A' ' 48' ' ' LEU . 24.9 mt-30 -123.66 154.48 39.3 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.499 -0.926 . . . . 4.3 108.499 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ILE . . . . . 0.485 HD11 ' HB1' ' A' ' 17' ' ' ALA . 38.7 mt -128.04 142.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.269 -1.332 . . . . 1.2 107.926 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.2 122.58 21.82 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.377 -1.342 . . . . 0.97 107.377 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 3' ' ' THR . 60.4 t -106.71 97.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 117.77 -1.572 . . . . 1.71 109.424 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 1' ' ' MET . 17.5 t0 80.49 -64.82 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.869 -1.059 . . . . 2.51 113.011 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -140.92 -29.65 0.66 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.258 1.947 . . . . 5.78 116.258 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -100.01 -174.96 2.82 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.938 -1.105 . . . . 5.31 111.736 -178.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.9 t-160 -103.41 138.66 39.84 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.779 -1.193 . . . . 1.57 107.779 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ILE . . . . . 0.454 HG13 HG23 ' A' ' 64' ' ' VAL . 25.2 mm -122.85 -40.73 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 124.061 0.851 . . . . 2.1 109.872 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.02 -176.15 0.18 Allowed Glycine 0 N--CA 1.509 3.522 0 CA-C-O 122.085 0.825 . . . . 2.86 115.153 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.02 -160.39 0.01 OUTLIER Glycine 0 N--CA 1.508 3.437 0 CA-C-N 113.857 -1.172 . . . . 1.86 113.89 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 16' ' ' ARG . 33.4 t80 -121.51 -58.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.121 -1.066 . . . . 1.92 108.121 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 p -39.46 -47.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.246 1.022 . . . . 1.8 110.061 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -63.04 1.2 Allowed 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 112.535 -2.12 . . . . 3.25 108.67 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.3 -49.51 9.39 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 119.231 -0.988 . . . . 1.23 109.988 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.08 -65.76 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.68 -1.145 . . . . 1.2 111.813 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.95 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.875 -0.787 . . . . 1.3 108.875 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -44.95 -56.28 4.73 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.65 -1.159 . . . . 1.46 109.502 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 83' ' ' LEU . 3.1 t -47.93 -60.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.944 -1.132 . . . . 1.33 107.944 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -47.05 -46.75 22.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.3 1.0 . . . . 3.16 111.095 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.11 21.05 8.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.243 1.201 . . . . 5.21 114.243 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -130.33 -32.96 1.73 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.866 -0.733 . . . . 2.15 109.835 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 HG13 ' A' ' 79' ' ' VAL . 27.1 mt -96.21 32.62 1.91 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.349 -1.34 . . . . 2.01 111.786 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.499 1.987 0 N-CA-C 108.969 -0.752 . . . . 5.32 108.969 177.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.494 ' N ' ' O ' ' A' ' 30' ' ' ASP . 74.9 mtp . . . . . 0 N--CA 1.481 1.106 0 N-CA-C 107.961 -1.125 . . . . 2.17 107.961 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 42.7 tp60 -123.64 146.96 47.81 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 123.745 0.653 . . . . 4.88 110.365 -178.595 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 34.6 m -128.56 154.54 46.07 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 119.088 -1.045 . . . . 1.02 109.159 178.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.8 t -134.19 128.72 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 N-CA-C 107.648 -1.241 . . . . 0.74 107.648 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 21.2 mt -111.35 120.25 61.52 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.811 0 N-CA-C 108.107 -1.071 . . . . 2.73 108.107 179.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -101.91 74.26 1.46 Allowed 'General case' 0 N--CA 1.493 1.683 0 N-CA-C 107.882 -1.155 . . . . 0.96 107.882 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -147.03 -173.15 17.99 Favored Glycine 0 N--CA 1.492 2.374 0 C-N-CA 119.114 -1.517 . . . . 2.2 109.724 -179.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.484 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 18.4 mtp-105 -123.11 154.7 38.26 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 119.045 -1.062 . . . . 6.27 109.631 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 17.5 m -72.23 77.0 0.98 Allowed 'General case' 0 C--N 1.3 -1.55 0 C-N-CA 119.438 -0.905 . . . . 5.0 111.296 -179.157 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 144.35 21.5 0.17 Allowed Glycine 0 N--CA 1.502 3.045 0 C-N-CA 119.388 -1.387 . . . . 3.01 113.101 179.318 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.484 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -121.99 80.57 42.64 Favored Pre-proline 0 N--CA 1.495 1.806 0 N-CA-C 109.048 -0.723 . . . . 3.1 109.048 178.336 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -18.73 -69.39 0.02 OUTLIER 'Trans proline' 0 N--CA 1.486 1.08 0 C-N-CA 124.194 3.262 . . . . 3.18 114.285 -143.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.47 ' HB2' ' CD ' ' A' ' 60' ' ' PRO . 3.8 m-30 -34.2 -45.04 0.2 Allowed 'General case' 0 N--CA 1.507 2.381 0 O-C-N 123.363 0.414 . . . . 3.71 112.096 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.688 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 57.7 m -52.35 -55.94 18.24 Favored 'General case' 0 N--CA 1.491 1.599 0 CA-C-N 114.972 -1.013 . . . . 2.03 109.638 -179.373 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 49.3 t -58.25 -45.78 88.99 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.662 0 CA-C-N 114.109 -1.405 . . . . 1.1 108.101 -179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.65 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 1.7 mmp_? -55.84 -51.83 66.15 Favored 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 119.666 -0.814 . . . . 3.71 112.255 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.17 -50.07 65.36 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.089 -1.448 . . . . 0.82 107.089 178.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.575 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 3.0 tmtm? -53.88 -55.12 29.72 Favored 'General case' 0 C--O 1.199 -1.57 0 CA-C-N 114.981 -1.009 . . . . 1.92 109.315 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.575 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 40.9 m-20 -47.8 -56.86 6.48 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.18 0.514 . . . . 2.9 109.617 179.129 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.462 HD23 ' CD2' ' A' ' 75' ' ' PHE . 29.8 tp -55.35 -57.13 13.1 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 114.989 -1.005 . . . . 0.92 111.472 -179.303 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.58 -54.39 44.64 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.444 -0.903 . . . . 0.65 109.579 -179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.484 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 12.5 tt0 -47.59 -47.56 28.53 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 108.515 -0.92 . . . . 2.26 108.515 -179.48 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.401 ' HD2' ' C ' ' A' ' 23' ' ' LYS . 0.1 OUTLIER -53.3 -64.22 0.89 Allowed 'General case' 0 N--CA 1.489 1.48 0 O-C-N 124.179 0.925 . . . . 4.71 110.5 179.185 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.9 mt -38.55 -47.0 1.25 Allowed 'General case' 0 N--CA 1.506 2.348 0 O-C-N 123.92 0.763 . . . . 1.16 112.835 -179.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.3 m -39.06 -36.0 0.26 Allowed 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 113.335 0.865 . . . . 1.35 113.335 179.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 71.0 m-80 -97.66 12.6 33.11 Favored 'General case' 0 N--CA 1.505 2.305 0 N-CA-C 114.046 1.128 . . . . 2.42 114.046 -177.44 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.437 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 19.3 mt-10 -131.9 -30.83 1.56 Allowed 'General case' 0 C--N 1.297 -1.699 0 O-C-N 123.87 0.732 . . . . 3.22 110.942 179.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NH1' ' O ' ' A' ' 27' ' ' GLU . 1.0 OUTLIER -99.12 -24.15 14.99 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 112.954 0.724 . . . . 3.92 112.954 -178.518 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 19.9 m-20 70.04 -62.59 0.42 Allowed 'General case' 0 N--CA 1.509 2.492 0 O-C-N 124.071 0.857 . . . . 4.7 110.565 179.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.494 ' O ' ' N ' ' A' ' 1' ' ' MET . 10.6 t70 -82.45 55.85 3.07 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 106.814 -1.55 . . . . 3.43 106.814 178.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 85.4 t80 -140.83 91.94 2.46 Favored 'General case' 0 N--CA 1.487 1.423 0 CA-C-N 115.225 -0.898 . . . . 1.09 109.968 -179.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.507 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 13.6 mm-40 -110.02 128.24 55.29 Favored 'General case' 0 C--N 1.294 -1.818 0 N-CA-C 106.985 -1.487 . . . . 4.52 106.985 179.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -111.14 160.56 16.8 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.096 -1.041 . . . . 1.41 110.594 -179.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 50.3 tp60 -123.97 146.64 48.36 Favored 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 107.372 -1.344 . . . . 2.84 107.372 178.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.7 t80 -102.09 132.11 48.16 Favored 'General case' 0 C--N 1.3 -1.582 0 C-N-CA 118.993 -1.083 . . . . 2.3 108.378 -179.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -130.9 135.27 60.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 N-CA-C 107.335 -1.357 . . . . 0.65 107.335 179.067 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.473 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 34.3 t0 -110.44 111.39 22.62 Favored 'General case' 0 N--CA 1.507 2.419 0 CA-C-O 122.23 1.014 . . . . 1.73 109.905 -178.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.1 pt -48.7 -32.21 4.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 CA-C-N 114.25 -1.341 . . . . 2.04 114.035 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.473 ' NE ' ' HA ' ' A' ' 39' ' ' ARG . 2.7 mmp_? -101.46 19.32 18.09 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.699 -0.8 . . . . 9.02 111.714 -178.299 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.473 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -122.73 -43.68 2.25 Favored 'General case' 0 C--N 1.3 -1.577 0 N-CA-C 107.682 -1.229 . . . . 1.6 107.682 179.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -74.52 -45.32 46.54 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-N 113.375 -1.738 . . . . 2.87 110.429 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 116.59 63.49 0.34 Allowed Glycine 0 N--CA 1.501 2.967 0 C-N-CA 119.746 -1.216 . . . . 1.68 112.693 179.117 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.441 HG23 ' HB2' ' A' ' 47' ' ' ASP . 55.2 mt -111.6 145.6 17.58 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 C-N-CA 119.769 -0.772 . . . . 1.78 109.289 179.581 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.7 p -116.93 -97.56 0.46 Allowed 'General case' 0 N--CA 1.498 1.938 0 C-N-CA 119.939 -0.704 . . . . 2.46 110.203 179.862 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.572 ' HZ2' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -137.6 -50.76 0.62 Allowed 'General case' 0 N--CA 1.497 1.896 0 N-CA-C 105.78 -1.933 . . . . 7.8 105.78 178.435 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.572 ' CD ' ' HZ2' ' A' ' 45' ' ' LYS . 3.8 mp0 -51.29 -50.17 59.83 Favored 'General case' 0 N--CA 1.488 1.432 0 CA-C-N 113.679 -1.601 . . . . 4.81 108.894 179.223 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.441 ' HB2' HG23 ' A' ' 43' ' ' ILE . 23.8 m-20 -46.44 -64.34 0.78 Allowed 'General case' 0 N--CA 1.5 2.033 0 CA-C-O 122.102 0.953 . . . . 3.59 109.329 178.54 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CB ' ' HD2' ' A' ' 54' ' ' LYS . 81.1 mt -49.93 -50.94 44.65 Favored 'General case' 0 C--O 1.203 -1.359 0 CA-C-N 114.21 -1.359 . . . . 2.25 110.044 -179.607 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.9 mt-30 -56.15 -36.55 68.42 Favored 'General case' 0 N--CA 1.497 1.917 0 C-N-CA 118.168 -1.413 . . . . 4.66 110.749 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.5 tt0 -75.63 -39.43 57.83 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.278 0.561 . . . . 6.68 112.064 -179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.642 ' HE3' ' CZ ' ' A' ' 63' ' ' PHE . 1.7 ttpp -87.37 -28.79 21.98 Favored 'General case' 0 N--CA 1.504 2.256 0 N-CA-C 114.575 1.324 . . . . 4.77 114.575 -178.035 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -118.19 -35.7 3.76 Favored 'General case' 0 N--CA 1.498 1.949 0 O-C-N 123.838 0.711 . . . . 1.89 112.689 -178.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.9 -44.57 1.48 Allowed Glycine 0 N--CA 1.491 2.361 0 N-CA-C 106.075 -2.81 . . . . 3.87 106.075 -178.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.499 ' NZ ' ' HG3' ' A' ' 57' ' ' GLU . 9.1 tttp 53.21 102.77 0.03 OUTLIER Pre-proline 0 N--CA 1.495 1.814 0 CA-C-N 113.297 -1.451 . . . . 9.82 112.656 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_exo -51.07 179.47 0.03 OUTLIER 'Trans proline' 0 C--N 1.316 -1.168 0 C-N-CA 122.214 1.943 . . . . 5.22 110.327 143.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.6 t -87.95 59.32 0.22 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.739 0 C-N-CA 118.571 -1.252 . . . . 5.9 110.358 -178.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.499 ' HG3' ' NZ ' ' A' ' 54' ' ' LYS . 15.6 pt-20 -103.51 178.81 4.45 Favored 'General case' 0 N--CA 1.495 1.81 0 CA-C-N 113.654 -1.612 . . . . 5.66 107.549 179.424 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.5 m -116.42 -106.32 0.39 Allowed 'General case' 0 N--CA 1.496 1.827 0 C-N-CA 118.356 -1.338 . . . . 6.1 109.193 179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 27.4 m -135.29 154.64 78.84 Favored Pre-proline 0 N--CA 1.486 1.327 0 O-C-N 123.964 0.79 . . . . 3.66 109.83 179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.688 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 48.6 Cg_endo -96.74 -164.95 1.02 Allowed 'Cis proline' 0 C--N 1.314 -1.259 0 O-C-N 122.507 0.741 . . . . 2.0 110.452 -1.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 11.7 mt-30 -147.78 163.74 35.78 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 124.19 0.931 . . . . 2.65 108.64 178.666 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.591 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.1 mp -121.32 151.18 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.015 0 CA-C-O 122.302 1.048 . . . . 1.01 111.787 -179.453 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.642 ' CZ ' ' HE3' ' A' ' 51' ' ' LYS . 9.4 m-85 -133.31 130.94 39.56 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 112.764 -2.016 . . . . 1.24 108.726 178.619 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.505 HG23 HG13 ' A' ' 69' ' ' ILE . 66.8 t -121.62 129.77 75.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 N-CA-C 106.778 -1.564 . . . . 0.98 106.778 177.593 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.447 ' O ' ' HB2' ' A' ' 66' ' ' GLN . 5.1 m-20 51.47 25.32 2.61 Favored 'General case' 0 N--CA 1.503 2.207 0 CA-C-O 122.698 1.237 . . . . 2.77 112.276 -179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.447 ' HB2' ' O ' ' A' ' 65' ' ' ASP . 2.4 mm100 79.49 -6.36 1.83 Allowed 'General case' 0 N--CA 1.506 2.353 0 CA-C-N 112.216 -2.266 . . . . 7.24 114.559 178.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -83.84 154.96 23.19 Favored 'General case' 0 C--N 1.307 -1.261 0 N-CA-C 105.963 -1.865 . . . . 4.35 105.963 179.046 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 17.3 t-160 -83.16 147.52 28.01 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 117.469 -1.692 . . . . 1.26 109.492 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.505 HG13 HG23 ' A' ' 64' ' ' VAL . 16.8 mm -116.63 -35.7 1.93 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 O-C-N 124.294 0.996 . . . . 0.92 109.154 -179.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.16 -139.76 9.81 Favored Glycine 0 N--CA 1.493 2.441 0 C-N-CA 119.754 -1.212 . . . . 1.94 110.301 179.694 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -99.15 -65.75 0.85 Allowed Glycine 0 N--CA 1.492 2.418 0 N-CA-C 110.577 -1.009 . . . . 2.8 110.577 -178.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.599 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 66.5 t80 -157.75 -53.78 0.07 Allowed 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 118.26 -1.376 . . . . 1.81 110.677 179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 8.2 p -46.68 -47.62 20.27 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 107.356 -1.35 . . . . 1.55 107.356 178.621 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -53.44 -59.36 4.68 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 113.25 -1.795 . . . . 3.27 109.602 178.075 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.591 ' CD1' HG21 ' A' ' 62' ' ' ILE . 38.6 t80 -51.78 -47.64 64.1 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.442 -0.903 . . . . 0.85 109.224 179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.77 -59.37 4.38 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 119.315 -0.954 . . . . 1.04 109.915 179.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.82 -63.72 1.2 Allowed 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.31 -0.859 . . . . 1.04 109.564 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 90.8 t90 -40.49 -48.89 2.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 124.006 0.816 . . . . 1.14 110.13 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.402 ' O ' ' C ' ' A' ' 80' ' ' LYS . 9.9 t -60.5 -59.2 4.52 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.328 -0.99 . . . . 1.23 108.328 179.469 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.542 ' NZ ' ' O ' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -41.27 -49.65 3.67 Favored 'General case' 0 C--N 1.304 -1.407 0 CA-C-N 114.882 -1.054 . . . . 3.49 109.925 -179.528 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 32.6 mt-10 -70.96 -55.68 7.84 Favored 'General case' 0 C--N 1.299 -1.588 0 N-CA-C 116.41 2.004 . . . . 3.81 116.41 -177.805 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.4 m-80 -83.54 -20.11 34.46 Favored 'General case' 0 C--N 1.297 -1.691 0 N-CA-C 113.948 1.092 . . . . 1.75 113.948 -176.018 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 63.4 mt -109.69 -37.31 5.71 Favored 'General case' 0 C--N 1.299 -1.622 0 C-N-CA 117.997 -1.481 . . . . 2.28 113.24 -178.589 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.542 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 63.5 m-20 -118.96 20.31 12.79 Favored 'General case' 0 N--CA 1.498 1.968 0 C-N-CA 118.071 -1.452 . . . . 5.8 112.738 -177.566 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.504 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.507 2.418 0 CA-C-O 115.991 -1.957 . . . . 6.91 111.663 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.533 ' N ' ' O ' ' A' ' 30' ' ' ASP . 36.5 mtm . . . . . 0 N--CA 1.484 1.261 0 N-CA-C 107.0 -1.481 . . . . 2.42 107.0 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -124.57 143.37 50.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.733 -0.787 . . . . 4.65 110.008 -179.689 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.43 ' O ' ' HA ' ' A' ' 33' ' ' TYR . 61.4 m -125.19 145.11 50.12 Favored 'General case' 0 N--CA 1.5 2.035 0 C-N-CA 119.08 -1.048 . . . . 0.68 113.282 -178.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -120.8 136.79 56.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 107.949 -1.13 . . . . 0.58 107.949 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 65.6 mt -118.09 122.03 68.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.819 0 O-C-N 124.226 0.954 . . . . 2.29 109.727 179.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -93.66 87.21 5.41 Favored 'General case' 0 N--CA 1.497 1.898 0 N-CA-C 107.618 -1.253 . . . . 1.1 107.618 178.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.89 -164.29 14.51 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.529 -1.428 . . . . 0.97 109.529 -179.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.692 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.5 OUTLIER -128.11 -158.7 0.89 Allowed 'General case' 0 N--CA 1.506 2.348 0 CA-C-N 117.98 0.89 . . . . 5.63 109.655 179.749 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.496 ' H ' ' HG2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -101.91 61.46 0.88 Allowed 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 108.66 -0.867 . . . . 3.81 108.66 -179.549 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 106.67 92.32 2.26 Favored Glycine 0 N--CA 1.494 2.503 0 N-CA-C 108.048 -2.021 . . . . 2.82 108.048 -179.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.692 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -155.27 63.63 3.81 Favored Pre-proline 0 C--N 1.301 -1.518 0 C-N-CA 120.311 -0.556 . . . . 2.35 110.224 -179.245 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_exo -20.42 -55.06 0.04 OUTLIER 'Trans proline' 0 N--CA 1.489 1.256 0 C-N-CA 124.044 3.162 . . . . 2.35 114.001 -145.826 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.48 ' N ' ' O ' ' A' ' 11' ' ' CYS . 4.3 m-85 -42.69 -44.94 4.52 Favored 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.246 -0.582 . . . . 4.63 111.668 179.637 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 14.4 p -57.14 -46.12 82.97 Favored 'General case' 0 N--CA 1.493 1.677 0 C-N-CA 119.538 -0.865 . . . . 2.4 111.046 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 68.0 t -55.8 -43.17 73.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.829 0 CA-C-N 115.643 -0.708 . . . . 0.81 110.916 -179.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.682 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -47.27 -48.98 24.56 Favored 'General case' 0 N--CA 1.499 1.994 0 C-N-CA 118.645 -1.222 . . . . 3.67 112.583 -179.318 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.07 -45.91 68.35 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 119.128 -1.029 . . . . 0.67 108.864 179.276 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.444 ' NZ ' ' HA ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -58.5 -50.81 72.41 Favored 'General case' 0 C--O 1.2 -1.512 0 C-N-CA 119.277 -0.969 . . . . 2.46 108.404 179.521 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.444 ' HA ' ' NZ ' ' A' ' 18' ' ' LYS . 66.1 m-20 -49.67 -48.4 49.54 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 118.447 -1.301 . . . . 2.98 110.055 179.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 30.4 tp -60.14 -65.84 0.62 Allowed 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 118.396 -1.322 . . . . 0.8 110.119 179.569 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.8 -51.94 8.97 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 121.788 0.804 . . . . 0.81 110.713 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 22.0 tt0 -59.05 -52.48 65.58 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 114.588 -1.187 . . . . 2.31 107.906 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.493 ' HA ' ' OD1' ' A' ' 26' ' ' ASN . 6.2 tmtm? -43.7 -36.43 2.21 Favored 'General case' 0 N--CA 1.505 2.3 0 CA-C-N 115.531 -0.759 . . . . 3.79 110.515 179.651 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.534 HD11 ' CG1' ' A' ' 79' ' ' VAL . 11.4 mt -78.32 -44.82 24.24 Favored 'General case' 0 N--CA 1.494 1.74 0 CA-C-N 115.146 -0.934 . . . . 1.38 110.438 178.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.428 ' C ' ' H ' ' A' ' 27' ' ' GLU . 74.4 m -50.25 -42.31 51.78 Favored 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 118.938 -1.105 . . . . 1.37 109.387 178.432 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.493 ' OD1' ' HA ' ' A' ' 23' ' ' LYS . 3.2 p-10 -80.73 28.31 0.34 Allowed 'General case' 0 N--CA 1.498 1.97 0 C-N-CA 118.033 -1.467 . . . . 4.75 111.335 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.428 ' H ' ' C ' ' A' ' 25' ' ' SER . 1.6 mt-10 -127.68 -64.85 0.95 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.611 -1.177 . . . . 4.21 110.58 178.554 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.488 HH22 ' C ' ' A' ' 85' ' ' ALA . 14.7 mtt180 -119.21 150.29 40.32 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.54 -0.864 . . . . 4.15 109.655 -178.536 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -73.34 -25.81 60.77 Favored 'General case' 0 C--N 1.299 -1.6 0 N-CA-C 108.647 -0.872 . . . . 5.58 108.647 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.533 ' O ' ' N ' ' A' ' 1' ' ' MET . 38.5 t70 -74.54 -8.76 57.37 Favored 'General case' 0 C--O 1.202 -1.442 0 C-N-CA 119.065 -1.054 . . . . 3.31 111.711 -179.018 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 57.3 t80 -106.78 97.19 7.01 Favored 'General case' 0 N--CA 1.497 1.88 0 C-N-CA 116.76 -1.976 . . . . 1.14 111.151 179.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 3.1 mp0 -113.75 160.13 19.0 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.868 -1.16 . . . . 3.51 107.868 178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.43 ' HA ' ' O ' ' A' ' 3' ' ' THR . 21.5 p90 -147.92 165.18 31.47 Favored 'General case' 0 C--N 1.3 -1.546 0 C-N-CA 119.51 -0.876 . . . . 0.99 108.929 179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 43.0 tt0 -131.05 136.53 48.53 Favored 'General case' 0 C--N 1.296 -1.735 0 N-CA-C 107.225 -1.398 . . . . 3.59 107.225 179.019 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -89.29 140.76 29.16 Favored 'General case' 0 C--N 1.306 -1.316 0 C-N-CA 117.236 -1.786 . . . . 1.2 107.659 -179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.1 t -132.78 137.38 54.09 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.793 0 N-CA-C 108.528 -0.915 . . . . 0.63 108.528 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 14.7 t0 -111.77 121.71 45.82 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 107.493 -1.299 . . . . 2.41 107.493 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.8 pt -44.81 -31.18 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.648 0 N-CA-C 113.701 1.0 . . . . 1.53 113.701 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -96.41 17.77 15.36 Favored 'General case' 0 N--CA 1.51 2.531 0 C-N-CA 118.14 -1.424 . . . . 5.54 111.972 -179.246 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.86 -41.85 5.52 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 106.245 -1.761 . . . . 1.58 106.245 178.022 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -82.98 -39.66 21.05 Favored 'General case' 0 N--CA 1.493 1.699 0 CA-C-N 113.726 -1.579 . . . . 3.47 108.952 178.954 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 50.29 0.65 Allowed Glycine 0 N--CA 1.499 2.837 0 N-CA-C 109.295 -1.522 . . . . 1.46 109.295 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 84.2 mt -103.61 160.06 4.7 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 CA-C-N 114.676 -0.762 . . . . 1.9 111.129 -178.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 57.6 p -112.74 -158.14 0.64 Allowed 'General case' 0 N--CA 1.491 1.616 0 CA-C-N 114.606 -1.179 . . . . 3.01 110.844 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.42 ' O ' ' HG2' ' A' ' 45' ' ' LYS . 3.8 ttpp -114.15 12.8 17.9 Favored 'General case' 0 N--CA 1.494 1.734 0 N-CA-C 106.486 -1.672 . . . . 5.43 106.486 178.177 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.482 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -119.11 -50.08 2.38 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 114.645 -1.161 . . . . 4.78 109.625 -178.587 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.4 t0 -57.89 -45.4 86.47 Favored 'General case' 0 N--CA 1.496 1.84 0 N-CA-C 107.907 -1.146 . . . . 3.83 107.907 179.485 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.435 HD23 ' HA ' ' A' ' 48' ' ' LEU . 23.0 mt -42.23 -47.88 4.8 Favored 'General case' 0 N--CA 1.501 2.093 0 CA-C-N 115.207 -0.906 . . . . 2.8 110.468 178.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.452 ' HG2' ' HA ' ' A' ' 55' ' ' PRO . 1.3 tm0? -46.78 -49.17 20.26 Favored 'General case' 0 N--CA 1.495 1.819 0 N-CA-C 108.617 -0.882 . . . . 4.5 108.617 178.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 38.4 mm-40 -73.86 -40.54 63.18 Favored 'General case' 0 N--CA 1.498 1.971 0 CA-C-N 114.902 -1.044 . . . . 7.16 110.98 179.728 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.408 ' HG3' ' HA ' ' A' ' 48' ' ' LEU . 0.0 OUTLIER -53.92 -47.71 70.94 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 109.503 -0.555 . . . . 4.91 109.503 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -76.29 -49.68 16.34 Favored 'General case' 0 C--N 1.307 -1.255 0 CA-C-N 115.21 -0.905 . . . . 2.59 109.998 179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.41 16.33 55.53 Favored Glycine 0 N--CA 1.495 2.63 0 C-N-CA 119.238 -1.458 . . . . 3.0 109.671 179.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.415 ' NZ ' ' OE1' ' A' ' 57' ' ' GLU . 6.4 ttmt -120.26 77.42 25.45 Favored Pre-proline 0 C--N 1.3 -1.578 0 N-CA-C 108.602 -0.888 . . . . 6.04 108.602 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.452 ' HA ' ' HG2' ' A' ' 49' ' ' GLN . 20.5 Cg_endo -80.85 22.66 0.77 Allowed 'Trans proline' 0 C--N 1.309 -1.532 0 C-N-CA 121.632 1.555 . . . . 4.2 112.503 -127.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 13.2 p -128.24 -12.18 3.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.672 0 CA-C-N 114.56 -1.2 . . . . 5.96 111.767 -179.883 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.415 ' OE1' ' NZ ' ' A' ' 54' ' ' LYS . 11.6 pt-20 -86.77 174.85 8.55 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 118.748 -1.181 . . . . 6.13 112.691 -178.635 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 22.1 p -131.45 -80.07 0.52 Allowed 'General case' 0 N--CA 1.491 1.621 0 CA-C-N 115.072 -0.967 . . . . 4.93 110.698 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 22.4 t -119.82 151.82 52.86 Favored Pre-proline 0 N--CA 1.492 1.629 0 CA-C-N 115.721 -0.672 . . . . 3.5 109.451 -179.634 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.404 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 45.4 Cg_endo -87.64 168.53 40.48 Favored 'Cis proline' 0 C--N 1.319 -0.974 0 C-N-CA 124.814 -0.911 . . . . 2.46 111.04 -18.391 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.441 ' NE2' ' HB2' ' A' ' 52' ' ' ALA . 87.2 mt-30 -131.42 117.56 19.02 Favored 'General case' 0 C--N 1.29 -2.012 0 N-CA-C 105.478 -2.045 . . . . 2.77 105.478 178.125 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.643 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.0 mp -113.25 141.98 27.19 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.29 0 CA-C-N 114.916 -1.038 . . . . 1.09 108.894 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.509 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 4.4 m-85 -120.06 138.23 53.66 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-N 112.778 -2.01 . . . . 1.31 108.756 -178.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.443 ' CG2' HG13 ' A' ' 69' ' ' ILE . 74.8 t -116.79 130.07 72.27 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.372 0 C-N-CA 119.064 -1.054 . . . . 1.22 108.63 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 54.09 -69.2 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 CA-C-N 112.607 -2.088 . . . . 3.29 113.383 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 64' ' ' VAL . 72.7 mt-30 -131.22 -31.3 1.67 Allowed 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 115.164 1.542 . . . . 4.57 115.164 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.476 ' H ' ' NE2' ' A' ' 67' ' ' GLN . 1.4 pm0 -117.56 171.95 7.67 Favored 'General case' 0 N--CA 1.485 1.306 0 N-CA-C 114.003 1.112 . . . . 3.46 114.003 -177.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.3 t-80 -73.44 147.64 43.99 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 105.603 -1.999 . . . . 1.84 105.603 177.893 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.443 HG13 ' CG2' ' A' ' 64' ' ' VAL . 46.2 mm -122.29 -29.39 1.57 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.757 0 C-N-CA 118.649 -1.22 . . . . 1.52 108.852 179.668 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 157.44 -171.55 34.7 Favored Glycine 0 N--CA 1.493 2.472 0 C-N-CA 120.069 -1.062 . . . . 2.13 111.337 178.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.433 ' C ' ' H ' ' A' ' 73' ' ' THR . . . -105.12 -149.53 19.0 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 107.219 -2.353 . . . . 1.56 107.219 -179.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -79.53 42.79 0.53 Allowed 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 117.651 -1.62 . . . . 2.97 109.467 179.651 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 71' ' ' GLY . 11.7 p -144.62 -69.06 0.3 Allowed 'General case' 0 N--CA 1.493 1.678 0 CA-C-N 114.826 -1.079 . . . . 1.82 109.726 179.698 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -73.72 -54.09 8.88 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-N 114.873 -1.058 . . . . 2.99 108.403 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.522 ' CE2' HG21 ' A' ' 62' ' ' ILE . 22.5 t80 -52.87 -56.87 12.65 Favored 'General case' 0 N--CA 1.498 1.955 0 N-CA-C 104.959 -2.237 . . . . 1.67 104.959 177.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.446 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -38.65 -52.84 1.65 Allowed 'General case' 0 N--CA 1.5 2.039 0 CA-C-N 114.688 -1.142 . . . . 1.53 110.232 178.028 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.446 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -63.54 -58.37 7.2 Favored 'General case' 0 N--CA 1.497 1.898 0 C-N-CA 119.316 -0.954 . . . . 1.14 110.056 178.873 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.446 ' C ' ' O ' ' A' ' 77' ' ' ALA . 61.5 t90 -40.93 -51.01 3.27 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 119.243 -0.983 . . . . 1.47 109.145 179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.534 ' CG1' HD11 ' A' ' 24' ' ' LEU . 71.0 t -43.13 -58.7 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 N-CA-C 108.124 -1.065 . . . . 1.38 108.124 179.041 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.615 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -51.61 -60.9 2.63 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-N 114.876 -1.056 . . . . 2.76 111.655 -179.302 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.458 ' CD ' ' HZ1' ' A' ' 80' ' ' LYS . 8.5 mp0 -59.03 -33.1 70.37 Favored 'General case' 0 N--CA 1.504 2.255 0 N-CA-C 116.239 1.94 . . . . 3.88 116.239 -178.16 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 82' ' ' ASN . 0.8 OUTLIER -98.99 -23.38 15.32 Favored 'General case' 0 N--CA 1.509 2.485 0 C-N-CA 117.809 -1.556 . . . . 1.77 113.066 -179.275 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.537 ' O ' ' N ' ' A' ' 85' ' ' ALA . 15.3 mt -83.72 -53.59 5.53 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 105.023 -2.214 . . . . 1.35 105.023 178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.446 ' C ' ' O ' ' A' ' 83' ' ' LEU . 4.6 m-20 18.82 -76.67 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 O-C-N 124.858 1.349 . . . . 5.1 113.552 176.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.537 ' N ' ' O ' ' A' ' 83' ' ' LEU . . . . . . . . 0 N--CA 1.505 2.278 0 CA-C-N 111.337 -2.665 . . . . 8.6 112.106 -178.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 44.6 tpp . . . . . 0 N--CA 1.493 1.694 0 N-CA-C 107.434 -1.321 . . . . 2.37 107.434 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 1.3 mp0 -131.97 132.92 43.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 123.765 0.666 . . . . 4.29 110.317 -179.696 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 38.5 m -121.64 142.79 49.78 Favored 'General case' 0 N--CA 1.507 2.389 0 C-N-CA 119.623 -0.831 . . . . 0.74 110.939 178.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 89.6 t -119.47 127.35 75.86 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.362 0 N-CA-C 108.42 -0.956 . . . . 1.02 108.42 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.7 mm -117.32 109.44 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.452 0 O-C-N 124.84 1.337 . . . . 1.81 108.582 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.454 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 98.3 m-85 -87.87 100.05 12.58 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 108.111 -1.07 . . . . 1.35 108.111 179.47 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -118.8 -166.93 13.69 Favored Glycine 0 N--CA 1.501 3.015 0 N-CA-C 109.114 -1.594 . . . . 0.99 109.114 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.697 ' CG ' ' SG ' ' A' ' 11' ' ' CYS . 5.8 ptm180 -119.24 37.27 4.19 Favored 'General case' 0 N--CA 1.508 2.442 0 C-N-CA 118.257 -1.377 . . . . 5.61 112.088 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.413 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 50.5 m 83.47 51.71 0.01 OUTLIER 'General case' 0 N--CA 1.516 2.843 0 N-CA-C 116.094 1.887 . . . . 3.53 116.094 177.609 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 82.77 67.34 1.49 Allowed Glycine 0 N--CA 1.505 3.246 0 C-N-CA 119.069 -1.539 . . . . 3.78 114.1 177.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.697 ' SG ' ' CG ' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -111.42 159.07 34.41 Favored Pre-proline 0 N--CA 1.497 1.883 0 C-N-CA 119.339 -0.944 . . . . 2.38 109.886 179.453 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.412 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 81.2 Cg_exo -40.31 144.24 0.43 Allowed 'Trans proline' 0 C--N 1.321 -0.884 0 C-N-CA 121.438 1.426 . . . . 3.66 110.015 157.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.412 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.7 OUTLIER 77.11 -59.46 0.48 Allowed 'General case' 0 N--CA 1.506 2.337 0 N-CA-C 107.568 -1.271 . . . . 3.27 107.568 -178.803 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.416 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 33.4 m -53.78 -47.16 71.04 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.4 -0.818 . . . . 1.73 110.029 -179.846 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 11' ' ' CYS . 86.1 t -49.12 -41.26 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.843 0 C-N-CA 118.856 -1.138 . . . . 1.61 108.033 178.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 4.2 mmp_? -74.58 82.82 2.02 Favored 'General case' 0 N--CA 1.491 1.607 0 N-CA-C 107.657 -1.238 . . . . 4.41 107.657 179.865 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . 173.36 -52.24 0.01 OUTLIER 'General case' 0 C--N 1.287 -2.122 0 CA-C-N 112.291 -2.231 . . . . 1.01 105.471 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.503 ' NZ ' ' OH ' ' A' ' 33' ' ' TYR . 5.9 tmtm? -69.17 -47.18 65.63 Favored 'General case' 0 C--N 1.308 -1.224 0 N-CA-C 106.964 -1.495 . . . . 2.72 106.964 179.614 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -55.29 -37.39 67.27 Favored 'General case' 0 N--CA 1.493 1.679 0 N-CA-C 108.775 -0.824 . . . . 3.41 108.775 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 27.8 tp -70.02 -58.97 3.22 Favored 'General case' 0 N--CA 1.488 1.435 0 C-N-CA 118.301 -1.36 . . . . 1.18 108.563 178.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -40.14 -54.55 2.28 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.511 -0.876 . . . . 1.02 110.918 179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.416 ' CD ' ' HZ1' ' A' ' 18' ' ' LYS . 3.8 mm-40 -38.77 -41.86 0.76 Allowed 'General case' 0 N--CA 1.494 1.75 0 CA-C-O 121.852 0.834 . . . . 2.81 112.735 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.437 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -70.51 -54.63 11.42 Favored 'General case' 0 C--N 1.302 -1.497 0 CA-C-N 115.013 -0.994 . . . . 4.62 109.502 -178.564 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.555 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 49.3 mt -49.99 -46.25 52.47 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 114.54 -1.209 . . . . 1.36 108.15 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 33.0 m -58.02 -28.7 64.69 Favored 'General case' 0 N--CA 1.502 2.167 0 O-C-N 124.252 0.97 . . . . 1.35 112.667 179.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 16.6 t30 -102.2 -17.26 16.04 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 120.265 -0.574 . . . . 4.14 111.761 -178.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.402 ' HB2' ' HD2' ' A' ' 28' ' ' ARG . 34.1 mt-10 -87.93 -45.23 10.43 Favored 'General case' 0 N--CA 1.491 1.608 0 C-N-CA 120.253 -0.579 . . . . 3.13 110.537 -179.388 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.437 ' NE ' ' O ' ' A' ' 83' ' ' LEU . 2.0 mpt_? -104.69 -17.09 14.77 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 119.867 -0.733 . . . . 5.55 111.486 -178.64 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 69.59 -51.32 0.62 Allowed 'General case' 0 N--CA 1.512 2.65 0 O-C-N 124.394 1.059 . . . . 5.9 112.326 -179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -76.86 54.73 1.02 Allowed 'General case' 0 N--CA 1.498 1.927 0 CA-C-O 122.421 1.105 . . . . 3.43 108.642 179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.555 ' CD2' ' HB2' ' A' ' 24' ' ' LEU . 74.0 t80 -146.34 82.2 1.59 Allowed 'General case' 0 C--N 1.295 -1.763 0 CA-C-N 115.393 -0.821 . . . . 1.28 109.745 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 12.8 mp0 -89.71 142.11 27.99 Favored 'General case' 0 C--N 1.298 -1.663 0 N-CA-C 106.481 -1.674 . . . . 3.19 106.481 179.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.503 ' OH ' ' NZ ' ' A' ' 18' ' ' LYS . 38.0 p90 -129.78 150.27 51.16 Favored 'General case' 0 C--N 1.298 -1.654 0 C-N-CA 119.289 -0.964 . . . . 1.26 108.659 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 49.9 tt0 -116.74 136.29 53.08 Favored 'General case' 0 N--CA 1.494 1.745 0 N-CA-C 108.841 -0.8 . . . . 3.79 108.841 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 48.3 t80 -95.23 114.95 26.8 Favored 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 106.091 -1.818 . . . . 1.22 106.091 179.073 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 2.7 t -112.54 134.57 54.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.566 0 CA-C-N 114.776 -1.102 . . . . 0.6 109.362 -178.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 1.3 t70 -113.17 132.38 55.5 Favored 'General case' 0 C--N 1.3 -1.571 0 N-CA-C 108.504 -0.924 . . . . 2.17 108.504 179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 38.0 pt -60.87 -29.77 46.05 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 C-N-CA 118.686 -1.205 . . . . 1.35 111.825 -179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.552 ' HB2' ' CZ ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -77.15 -34.19 56.56 Favored 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.012 -1.475 . . . . 4.8 110.602 -179.773 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.23 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.663 -0.815 . . . . 1.1 111.262 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.0 mt-10 -85.08 -34.46 22.23 Favored 'General case' 0 N--CA 1.503 2.196 0 C-N-CA 119.322 -0.951 . . . . 2.53 111.225 -179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 100.89 52.85 1.07 Allowed Glycine 0 N--CA 1.505 3.261 0 N-CA-C 109.677 -1.369 . . . . 1.33 109.677 179.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 67.6 mt -104.74 155.89 6.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 CA-C-N 114.764 -0.718 . . . . 1.49 110.849 -177.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.0 p -118.62 161.58 19.83 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 115.167 -0.924 . . . . 2.32 110.648 -179.623 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.47 ' NZ ' ' OE1' ' A' ' 49' ' ' GLN . 19.0 ttpp -55.73 -42.59 75.57 Favored 'General case' 0 N--CA 1.498 1.929 0 N-CA-C 106.687 -1.597 . . . . 4.53 106.687 178.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.508 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 1.2 mp0 -51.55 -56.82 11.32 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 114.237 -1.347 . . . . 3.72 109.647 178.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -46.84 -51.47 16.52 Favored 'General case' 0 N--CA 1.502 2.146 0 C-N-CA 119.581 -0.848 . . . . 3.62 111.139 179.636 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -63.76 -52.1 61.88 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 115.311 -0.859 . . . . 1.76 110.457 -179.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.47 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 40.6 tt0 -53.3 -39.29 63.89 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 119.839 -0.744 . . . . 4.2 109.549 179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -76.09 -33.81 59.52 Favored 'General case' 0 N--CA 1.495 1.789 0 N-CA-C 109.388 -0.597 . . . . 5.45 109.388 178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.463 ' HG2' ' CZ ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -63.07 -36.94 85.26 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 109.468 -0.567 . . . . 3.92 109.468 179.44 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.538 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -104.81 -88.17 0.43 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-N 115.076 -0.966 . . . . 2.34 108.904 179.065 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 111.76 41.34 1.12 Allowed Glycine 0 N--CA 1.498 2.783 0 C-N-CA 119.125 -1.512 . . . . 3.11 113.869 177.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.405 ' NZ ' ' OD1' ' A' ' 74' ' ' ASP . 44.0 pttt -120.76 58.0 6.29 Favored Pre-proline 0 N--CA 1.495 1.776 0 C-N-CA 119.073 -1.051 . . . . 6.17 109.194 179.025 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_exo -74.1 38.8 0.49 Allowed 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 124.251 3.301 . . . . 4.42 114.043 -106.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 20.5 m -133.92 38.05 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 N-CA-C 108.073 -1.084 . . . . 5.56 108.073 179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 6.8 pm0 -104.33 154.02 20.34 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-N 114.737 -1.119 . . . . 5.92 110.971 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 10.2 t -125.29 -156.23 0.72 Allowed 'General case' 0 N--CA 1.493 1.717 0 CA-C-N 114.566 -1.197 . . . . 5.32 107.819 179.753 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -104.69 145.42 30.67 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 108.996 -0.742 . . . . 3.41 108.996 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.454 ' HA ' ' O ' ' A' ' 6' ' ' PHE . 52.8 Cg_endo -88.89 145.68 22.0 Favored 'Cis proline' 0 C--N 1.316 -1.132 0 O-C-N 123.558 1.294 . . . . 1.96 112.36 16.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.8 mm-40 -102.51 144.12 31.35 Favored 'General case' 0 N--CA 1.49 1.559 0 N-CA-C 106.445 -1.687 . . . . 3.86 106.445 178.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 29.9 mt -127.58 140.61 48.65 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 117.843 -1.543 . . . . 1.5 112.988 -177.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.542 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 24.9 m-85 -136.16 135.59 39.32 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-N 110.976 -2.829 . . . . 1.28 107.876 179.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.579 HG23 HG13 ' A' ' 69' ' ' ILE . 61.6 t -102.6 121.02 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.004 0 N-CA-C 106.828 -1.545 . . . . 1.08 106.828 178.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 53.2 -80.93 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 114.905 -1.043 . . . . 2.6 111.209 -178.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.429 ' N ' ' O ' ' A' ' 64' ' ' VAL . 58.2 mt-30 -135.06 3.31 3.15 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.26 -0.976 . . . . 4.92 111.666 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -105.39 155.41 19.15 Favored 'General case' 0 C--N 1.298 -1.657 0 CA-C-O 120.843 0.354 . . . . 4.62 110.399 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.542 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 8.0 t-80 -92.78 149.18 21.46 Favored 'General case' 0 N--CA 1.492 1.633 0 N-CA-C 107.409 -1.33 . . . . 1.77 107.409 179.613 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.579 HG13 HG23 ' A' ' 64' ' ' VAL . 3.2 mm -118.01 -38.7 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 C-N-CA 117.513 -1.675 . . . . 1.06 109.703 -179.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.41 -26.59 3.06 Favored Glycine 0 N--CA 1.502 3.04 0 C-N-CA 118.937 -1.602 . . . . 2.39 112.435 179.231 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 131.37 -173.83 20.27 Favored Glycine 0 N--CA 1.501 2.998 0 N-CA-C 108.231 -1.947 . . . . 1.64 108.231 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 29.3 t80 -51.77 -59.33 4.43 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 118.89 -1.124 . . . . 2.0 111.611 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -49.69 -45.59 49.07 Favored 'General case' 0 C--N 1.298 -1.637 0 N-CA-C 112.938 0.718 . . . . 2.07 112.938 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.405 ' OD1' ' NZ ' ' A' ' 54' ' ' LYS . 1.4 m-20 -74.84 -51.71 13.25 Favored 'General case' 0 N--CA 1.497 1.888 0 C-N-CA 119.793 -0.763 . . . . 2.56 110.205 -178.623 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.45 ' CE2' HG21 ' A' ' 79' ' ' VAL . 83.4 t80 -51.21 -43.33 61.37 Favored 'General case' 0 C--O 1.194 -1.84 0 N-CA-C 107.48 -1.304 . . . . 0.97 107.48 178.657 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -51.79 -60.63 2.94 Favored 'General case' 0 N--CA 1.487 1.421 0 N-CA-C 109.018 -0.734 . . . . 0.9 109.018 178.729 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -53.96 -53.94 45.83 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.909 -0.716 . . . . 1.21 111.312 179.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 81.1 t90 -54.93 -53.12 59.65 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.416 -0.914 . . . . 1.43 110.126 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.598 HG12 ' N ' ' A' ' 80' ' ' LYS . 1.9 t -46.48 -62.52 0.36 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.286 0 O-C-N 124.48 1.112 . . . . 1.1 109.006 179.44 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.598 ' N ' HG12 ' A' ' 79' ' ' VAL . 15.8 tptp -34.63 -49.32 0.41 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-N 113.256 -1.793 . . . . 2.92 113.3 -178.93 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.4 tp10 -105.04 20.05 19.53 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 115.653 1.723 . . . . 6.42 115.653 -177.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 31.3 m-80 -132.14 -26.53 1.9 Allowed 'General case' 0 C--N 1.291 -1.968 0 C-N-CA 117.661 -1.615 . . . . 2.2 110.775 178.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 50.1 mt -100.95 45.56 0.97 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 118.426 -1.31 . . . . 2.75 107.804 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 4.1 p-10 44.01 39.36 2.71 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.933 0.873 . . . . 5.66 110.378 177.775 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.416 ' HB3' ' HA ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.496 1.837 0 C-N-CA 118.224 -1.39 . . . . 9.04 110.142 -179.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.5 ' N ' ' O ' ' A' ' 30' ' ' ASP . 77.5 mtm . . . . . 0 N--CA 1.479 0.996 0 N-CA-C 109.211 -0.662 . . . . 2.72 109.211 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 4.7 mm100 -109.43 102.16 11.07 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.727 -1.212 . . . . 4.5 107.727 179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 54.3 m -91.66 139.43 30.7 Favored 'General case' 0 C--N 1.293 -1.855 0 C-N-CA 118.599 -1.241 . . . . 0.78 109.27 -178.891 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 21.9 t -121.52 139.03 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.83 0 CA-C-N 115.045 -0.98 . . . . 0.91 109.988 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 17.2 mm -118.34 109.87 28.52 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 125.156 1.535 . . . . 1.53 107.86 179.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.524 ' CD2' HG11 ' A' ' 36' ' ' VAL . 32.5 m-85 -91.74 90.74 7.66 Favored 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 107.174 -1.417 . . . . 1.28 107.174 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -119.85 -162.61 11.95 Favored Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.262 -0.971 . . . . 1.06 110.947 -178.593 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.632 ' CB ' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -122.77 71.59 1.04 Allowed 'General case' 0 N--CA 1.502 2.127 0 CA-C-O 122.095 0.95 . . . . 6.25 111.532 -179.613 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 4.9 p 32.81 -77.31 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.315 0 N-CA-C 116.393 1.997 . . . . 3.71 116.393 178.927 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.456 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . -103.74 46.3 1.22 Allowed Glycine 0 N--CA 1.494 2.564 0 C-N-CA 120.111 -1.042 . . . . 2.92 113.983 -177.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.632 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 1.1 p -116.3 114.63 40.65 Favored Pre-proline 0 N--CA 1.491 1.58 0 N-CA-C 108.239 -1.023 . . . . 2.15 108.239 177.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.1 Cg_endo -48.61 -54.89 4.68 Favored 'Trans proline' 0 N--CA 1.487 1.134 0 C-N-CA 122.187 1.925 . . . . 2.67 111.732 -169.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.408 ' CE2' ' HD2' ' A' ' 60' ' ' PRO . 10.7 t80 -52.1 -40.43 61.26 Favored 'General case' 0 N--CA 1.498 1.929 0 C-N-CA 119.279 -0.968 . . . . 2.54 109.913 179.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.42 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 28.4 m -62.24 -53.6 52.93 Favored 'General case' 0 N--CA 1.493 1.72 0 C-N-CA 119.141 -1.024 . . . . 1.77 110.303 -179.816 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -52.62 -42.14 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 CA-C-N 114.669 -1.15 . . . . 1.42 111.663 -179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.526 HH12 ' CG ' ' A' ' 19' ' ' ASP . 10.0 mmm180 -42.5 -41.58 3.02 Favored 'General case' 0 N--CA 1.509 2.476 0 C-N-CA 119.11 -1.036 . . . . 3.45 111.551 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -66.73 -42.37 86.39 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 119.442 -0.903 . . . . 0.71 108.659 179.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.495 ' NZ ' ' HB2' ' A' ' 22' ' ' GLU . 4.1 tmtm? -62.6 -38.15 89.03 Favored 'General case' 0 N--CA 1.488 1.468 0 N-CA-C 108.626 -0.879 . . . . 2.2 108.626 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.526 ' CG ' HH12 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -61.46 -56.94 14.65 Favored 'General case' 0 C--O 1.192 -1.955 0 N-CA-C 106.666 -1.605 . . . . 3.53 106.666 177.578 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 28.1 tp -48.31 -56.93 6.8 Favored 'General case' 0 C--N 1.308 -1.207 0 C-N-CA 119.145 -1.022 . . . . 1.08 108.655 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -44.67 -50.53 9.84 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 108.425 -0.954 . . . . 0.71 108.425 178.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.495 ' HB2' ' NZ ' ' A' ' 18' ' ' LYS . 0.9 OUTLIER -57.41 -52.14 66.57 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 120.122 -0.631 . . . . 3.12 110.501 179.652 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 2.4 ttpp -52.68 -17.32 1.25 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-N 114.627 -1.17 . . . . 3.67 110.428 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 93.5 mt -98.03 -53.37 3.4 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.506 -0.924 . . . . 1.48 108.506 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.1 m -43.9 -35.39 1.97 Allowed 'General case' 0 N--CA 1.499 2.014 0 N-CA-C 112.593 0.59 . . . . 1.53 112.593 179.445 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.4 m-80 -105.62 22.3 15.75 Favored 'General case' 0 N--CA 1.497 1.88 0 N-CA-C 114.086 1.143 . . . . 3.64 114.086 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 19.8 mt-10 -131.86 -27.6 1.86 Allowed 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 120.575 -0.45 . . . . 3.27 110.242 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -123.59 -163.98 1.18 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.809 -0.756 . . . . 4.3 109.587 179.576 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 45.8 t0 -120.49 -179.98 4.14 Favored 'General case' 0 C--N 1.317 -0.834 0 N-CA-C 106.14 -1.8 . . . . 4.69 106.14 179.921 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' O ' ' N ' ' A' ' 1' ' ' MET . 35.0 t70 43.86 30.43 0.39 Allowed 'General case' 0 N--CA 1.511 2.583 0 O-C-N 124.923 1.389 . . . . 3.6 112.059 -178.369 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -124.87 85.88 2.48 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.243 -1.783 . . . . 1.01 113.068 -179.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -102.71 141.82 34.89 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 105.178 -2.156 . . . . 3.42 105.178 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -133.1 153.62 51.34 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 118.627 -1.229 . . . . 1.07 109.567 179.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.463 ' OE1' HG23 ' A' ' 36' ' ' VAL . 1.7 tm0? -121.3 142.53 49.87 Favored 'General case' 0 N--CA 1.496 1.849 0 N-CA-C 107.292 -1.373 . . . . 4.0 107.292 178.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -95.54 118.97 33.22 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 118.652 -1.219 . . . . 1.52 109.319 -179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 6' ' ' PHE . 26.3 t -109.43 136.07 46.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.38 0 CA-C-N 115.027 -0.988 . . . . 1.01 109.152 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.616 ' O ' ' N ' ' A' ' 39' ' ' ARG . 17.1 t70 -118.58 44.86 2.17 Favored 'General case' 0 N--CA 1.504 2.241 0 CA-C-N 114.842 -1.072 . . . . 1.99 108.743 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.459 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.1 -74.75 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 CA-C-N 114.364 -1.289 . . . . 2.0 114.199 -179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.616 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -59.14 -51.39 70.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 115.75 -0.659 . . . . 6.96 110.876 -179.527 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.451 ' O ' ' NH2' ' A' ' 39' ' ' ARG . . . -40.34 -51.66 2.76 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 119.381 -0.927 . . . . 1.27 110.24 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 59.1 mt-10 -74.93 -43.04 56.38 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 124.426 1.079 . . . . 3.17 110.478 -179.408 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 121.4 30.81 1.23 Allowed Glycine 0 N--CA 1.493 2.439 0 N-CA-C 110.161 -1.176 . . . . 2.2 110.161 179.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 80.7 mt -98.44 152.35 4.3 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.456 0 N-CA-C 108.171 -1.048 . . . . 2.32 108.171 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 78.7 p -124.4 -175.98 3.4 Favored 'General case' 0 N--CA 1.496 1.848 0 CA-C-N 115.708 -0.678 . . . . 3.15 112.32 -178.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 9.0 mtmp? -84.3 2.15 41.56 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.983 -0.687 . . . . 4.72 110.619 -179.137 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.5 mp0 -101.84 -45.91 5.07 Favored 'General case' 0 C--N 1.301 -1.541 0 N-CA-C 105.037 -2.208 . . . . 5.05 105.037 178.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 68.1 t0 -54.5 -56.2 21.29 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-N 115.054 -0.975 . . . . 4.11 108.486 178.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 72.7 mt -48.64 -40.25 27.13 Favored 'General case' 0 N--CA 1.488 1.45 0 CA-C-N 114.713 -1.131 . . . . 2.06 111.5 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -44.23 -53.67 6.39 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.925 -1.11 . . . . 6.96 109.338 179.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 6.3 tt0 -43.04 -49.92 6.06 Favored 'General case' 0 N--CA 1.497 1.909 0 CA-C-N 113.493 -1.685 . . . . 6.89 113.297 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.424 ' O ' ' HB2' ' A' ' 68' ' ' HIS . 5.4 mtpp -91.06 -28.02 18.22 Favored 'General case' 0 N--CA 1.496 1.85 0 CA-C-N 114.516 -1.22 . . . . 5.48 114.162 -177.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.516 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -73.61 -51.24 17.5 Favored 'General case' 0 C--N 1.295 -1.78 0 O-C-N 124.569 1.168 . . . . 1.95 112.899 -178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 81.98 -32.94 2.68 Favored Glycine 0 N--CA 1.497 2.729 0 N-CA-C 108.143 -1.983 . . . . 2.32 108.143 -178.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.516 ' H ' ' C ' ' A' ' 52' ' ' ALA . 26.0 mttt -86.38 -179.07 1.27 Allowed Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 114.547 -0.827 . . . . 6.01 108.807 179.374 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_exo -62.73 124.45 14.13 Favored 'Trans proline' 0 N--CA 1.485 1.008 0 C-N-CA 122.749 2.299 . . . . 4.81 111.76 155.534 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' H ' HG22 ' A' ' 56' ' ' VAL . 30.5 m -77.42 31.11 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 CA-C-N 115.898 -0.592 . . . . 8.28 111.377 -179.128 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -114.19 -7.85 12.98 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 108.41 -0.959 . . . . 5.64 108.41 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 19.6 p -85.04 54.09 2.97 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 107.243 -1.392 . . . . 6.46 107.243 179.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.671 ' HA ' ' C ' ' A' ' 60' ' ' PRO . 19.2 m -89.68 169.57 12.35 Favored Pre-proline 0 N--CA 1.489 1.501 0 CA-C-N 114.161 -1.382 . . . . 3.41 111.799 -177.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.671 ' C ' ' HA ' ' A' ' 59' ' ' VAL . 5.6 Cg_endo -46.16 137.67 1.8 Allowed 'Cis proline' 0 N--CA 1.489 1.219 0 C-N-CA 125.072 -0.803 . . . . 2.36 110.518 -13.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.5 ' HA ' HE21 ' A' ' 61' ' ' GLN . 0.2 OUTLIER -94.53 116.63 29.01 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 106.091 -1.818 . . . . 3.29 106.091 -179.423 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.471 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.6 mp -108.29 139.7 29.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.259 0 CA-C-O 123.035 1.397 . . . . 1.12 111.416 -178.588 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.548 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 3.8 m-85 -126.71 136.58 52.65 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-N 111.833 -2.44 . . . . 1.67 106.257 179.452 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.588 HG23 HG13 ' A' ' 69' ' ' ILE . 54.9 t -110.11 110.07 30.76 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 C-N-CA 118.677 -1.209 . . . . 1.14 109.84 -179.222 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.0 t70 75.38 -72.3 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 124.29 0.994 . . . . 2.69 112.216 178.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -134.03 -41.13 0.83 Allowed 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 113.619 0.97 . . . . 4.5 113.619 -178.14 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -94.26 160.75 14.54 Favored 'General case' 0 C--N 1.31 -1.11 0 N-CA-C 113.552 0.945 . . . . 4.05 113.552 -176.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.548 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.6 t-160 -77.09 144.47 38.5 Favored 'General case' 0 C--N 1.304 -1.381 0 N-CA-C 105.772 -1.936 . . . . 1.51 105.772 178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.588 HG13 HG23 ' A' ' 64' ' ' VAL . 20.9 mm -103.66 -25.51 3.7 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.928 0 C-N-CA 117.916 -1.514 . . . . 1.38 109.504 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.405 ' HA2' ' HD2' ' A' ' 54' ' ' LYS . . . 137.73 -34.05 2.2 Favored Glycine 0 N--CA 1.497 2.723 0 C-N-CA 118.522 -1.799 . . . . 2.77 113.294 178.778 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 140.78 -175.01 22.37 Favored Glycine 0 N--CA 1.494 2.546 0 N-CA-C 109.514 -1.434 . . . . 1.7 109.514 -179.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.419 ' HB2' ' HG2' ' A' ' 60' ' ' PRO . 2.6 t80 -51.29 -44.44 61.88 Favored 'General case' 0 N--CA 1.501 2.098 0 C-N-CA 119.375 -0.93 . . . . 2.01 111.625 -178.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.1 p -66.81 -58.85 4.23 Favored 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.768 0.794 . . . . 1.45 110.548 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -48.73 -46.44 40.87 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 114.634 -1.166 . . . . 2.71 109.21 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.456 ' CG ' HG21 ' A' ' 62' ' ' ILE . 48.7 t80 -60.88 -53.23 59.81 Favored 'General case' 0 C--O 1.193 -1.886 0 N-CA-C 108.198 -1.038 . . . . 1.04 108.198 178.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.59 -53.39 11.55 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 119.71 -0.796 . . . . 0.79 112.655 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -73.42 -52.48 13.58 Favored 'General case' 0 N--CA 1.5 2.063 0 C-N-CA 118.999 -1.081 . . . . 0.91 110.126 -179.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 70.8 t90 -44.41 -48.64 9.9 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 124.22 0.95 . . . . 1.32 108.828 179.595 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 5.3 t -47.67 -59.36 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.279 0 O-C-N 124.154 0.909 . . . . 1.02 108.865 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.479 ' C ' ' HD3' ' A' ' 80' ' ' LYS . 7.6 tmtm? -57.33 -59.92 4.41 Favored 'General case' 0 C--N 1.295 -1.8 0 C-N-CA 118.498 -1.281 . . . . 3.11 111.653 -179.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 36.1 mt-10 -52.66 -36.27 56.61 Favored 'General case' 0 N--CA 1.493 1.724 0 N-CA-C 115.24 1.57 . . . . 3.86 115.24 -177.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.4 m-80 -101.27 -28.67 12.51 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 118.811 -1.155 . . . . 1.73 113.563 -178.263 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 14.3 mt -85.07 -26.43 26.97 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 117.862 -1.535 . . . . 1.75 112.571 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -102.44 40.64 1.33 Allowed 'General case' 0 N--CA 1.5 2.073 0 C-N-CA 118.393 -1.323 . . . . 3.33 111.153 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.3 -1.56 0 CA-C-O 116.465 -1.731 . . . . 6.59 108.856 179.128 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.459 ' N ' ' CG ' ' A' ' 30' ' ' ASP . 13.9 ptp . . . . . 0 N--CA 1.493 1.712 0 N-CA-C 109.162 -0.681 . . . . 2.91 109.162 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.452 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 19.6 pt20 -123.82 125.53 44.85 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 123.749 0.656 . . . . 3.66 110.721 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 87.6 m -94.25 132.03 39.24 Favored 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.488 -0.93 . . . . 1.12 108.488 179.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.7 t -112.87 117.94 56.65 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 106.59 -1.634 . . . . 0.91 106.59 -179.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 36.8 mm -108.96 125.04 66.04 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 C-N-CA 118.568 -1.253 . . . . 1.76 108.711 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 87.7 m-85 -101.13 96.02 6.94 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.962 -0.755 . . . . 1.31 108.962 -179.467 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -114.59 -173.67 18.09 Favored Glycine 0 N--CA 1.483 1.825 0 N-CA-C 108.559 -1.817 . . . . 0.93 108.559 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -174.11 170.84 3.69 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 108.813 -0.81 . . . . 8.79 108.813 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 83.6 p -90.51 53.7 2.52 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 105.864 -1.902 . . . . 6.05 105.864 179.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.83 -39.16 0.12 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.339 -1.904 . . . . 6.99 108.339 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 5.8 p -90.59 151.67 44.27 Favored Pre-proline 0 C--N 1.309 -1.185 0 N-CA-C 108.578 -0.897 . . . . 5.02 108.578 179.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.419 ' O ' ' CB ' ' A' ' 13' ' ' TYR . 4.2 Cg_endo -91.28 178.91 1.69 Allowed 'Trans proline' 0 C--N 1.306 -1.686 0 C-N-CA 122.58 2.187 . . . . 4.69 109.027 146.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CB ' ' O ' ' A' ' 12' ' ' PRO . 0.8 OUTLIER 76.6 -36.56 0.27 Allowed 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 120.454 -0.498 . . . . 3.37 111.714 178.961 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -49.59 -31.77 11.32 Favored 'General case' 0 N--CA 1.508 2.426 0 C-N-CA 120.28 -0.568 . . . . 1.78 111.936 -178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.404 ' O ' ' HB3' ' A' ' 18' ' ' LYS . 59.4 t -59.84 -53.5 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 119.444 -0.902 . . . . 1.12 109.7 179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.569 ' CB ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -33.86 -53.15 0.45 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 115.295 -0.866 . . . . 4.2 113.323 -179.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -61.11 -47.9 84.16 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 119.451 -0.9 . . . . 0.81 109.733 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.547 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 2.5 tmtm? -53.33 -47.9 68.94 Favored 'General case' 0 C--N 1.302 -1.457 0 CA-C-N 114.891 -1.049 . . . . 1.84 110.251 179.748 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.547 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 1.3 p-10 -68.03 -43.14 79.43 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 118.143 -1.423 . . . . 2.84 109.083 179.409 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 60.1 tp -53.52 -58.57 6.67 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 118.273 -1.371 . . . . 0.91 109.953 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.83 -50.94 70.25 Favored 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 119.542 -0.863 . . . . 0.89 110.725 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.623 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 24.1 tt0 -50.75 -57.8 7.46 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.885 -1.126 . . . . 2.67 109.265 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.61 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 0.2 OUTLIER -49.14 -54.07 17.94 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-N 114.901 -1.045 . . . . 4.69 110.178 -179.995 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 88.4 mt -48.9 -44.15 39.87 Favored 'General case' 0 N--CA 1.505 2.293 0 N-CA-C 114.107 1.151 . . . . 1.66 114.107 -179.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.7 p -49.73 -19.94 0.73 Allowed 'General case' 0 N--CA 1.514 2.727 0 C-N-CA 119.351 -0.939 . . . . 2.28 113.061 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.492 HD22 ' N ' ' A' ' 26' ' ' ASN . 1.2 m120 -99.53 -2.82 34.86 Favored 'General case' 0 N--CA 1.503 2.201 0 C-N-CA 120.713 -0.395 . . . . 3.26 111.531 -179.086 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.61 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 14.9 mt-10 -114.6 -32.8 5.75 Favored 'General case' 0 N--CA 1.499 2.019 0 CA-C-O 121.577 0.703 . . . . 3.35 111.24 -179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.508 ' HA ' ' HE ' ' A' ' 28' ' ' ARG . 8.6 mmm-85 -95.67 -173.62 2.92 Favored 'General case' 0 N--CA 1.489 1.524 0 C-N-CA 118.743 -1.183 . . . . 3.74 113.953 -178.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.472 ' CG ' ' H ' ' A' ' 30' ' ' ASP . 7.1 p-10 -96.55 -71.77 0.66 Allowed 'General case' 0 N--CA 1.489 1.485 0 CA-C-N 113.45 -1.705 . . . . 5.15 111.969 -178.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.472 ' H ' ' CG ' ' A' ' 29' ' ' ASP . 42.1 t0 -101.91 66.63 1.05 Allowed 'General case' 0 N--CA 1.495 1.823 0 CA-C-O 121.918 0.866 . . . . 4.02 108.861 -179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 18.7 t80 -124.04 102.47 7.77 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.774 -1.103 . . . . 1.34 110.163 -179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.452 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 45.7 mt-30 -119.07 163.33 17.16 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 106.363 -1.718 . . . . 3.28 106.363 179.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.623 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 35.3 p90 -158.83 164.07 36.09 Favored 'General case' 0 C--N 1.298 -1.648 0 C-N-CA 118.291 -1.364 . . . . 1.31 110.135 179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 47.8 tt0 -136.14 137.62 41.17 Favored 'General case' 0 C--N 1.298 -1.631 0 CA-C-N 114.679 -1.146 . . . . 3.46 108.789 179.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 53.4 t80 -96.78 137.21 36.2 Favored 'General case' 0 N--CA 1.485 1.291 0 N-CA-C 104.164 -2.532 . . . . 1.28 104.164 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.3 t -129.6 139.12 52.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 C-N-CA 119.447 -0.901 . . . . 0.7 111.672 -178.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 59.1 t0 -115.79 124.5 50.9 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 104.807 -2.294 . . . . 1.79 104.807 177.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 41.2 pt -51.02 -35.79 15.24 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.116 -0.947 . . . . 1.9 111.918 -179.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 19.2 mtm-85 -81.75 4.02 23.53 Favored 'General case' 0 N--CA 1.502 2.147 0 N-CA-C 113.237 0.828 . . . . 5.2 113.237 -177.859 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -113.63 -46.27 3.06 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 119.987 -0.685 . . . . 1.96 109.925 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -74.42 -33.43 62.97 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.451 -0.899 . . . . 3.74 109.355 -179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 98.64 48.66 1.77 Allowed Glycine 0 N--CA 1.502 3.041 0 C-N-CA 120.035 -1.079 . . . . 3.08 110.752 179.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 98.4 mt -117.38 147.77 20.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 C-N-CA 119.407 -0.917 . . . . 2.57 110.471 -178.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 75.1 p -117.71 170.46 8.76 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.712 -1.218 . . . . 3.71 107.712 178.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.61 -53.89 48.69 Favored 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.071 -1.052 . . . . 6.11 108.978 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.6 mp0 -35.08 -62.5 0.37 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 114.534 -1.212 . . . . 5.38 110.559 179.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 63.4 t0 -46.78 -59.11 3.27 Favored 'General case' 0 N--CA 1.501 2.094 0 CA-C-N 115.253 -0.885 . . . . 4.41 111.976 -179.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.406 ' O ' ' C ' ' A' ' 49' ' ' GLN . 85.1 mt -50.68 -44.87 57.92 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.834 -0.746 . . . . 2.39 111.372 -179.315 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.406 ' C ' ' O ' ' A' ' 48' ' ' LEU . 5.3 tm0? -42.17 -55.15 3.37 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.597 -0.841 . . . . 6.53 110.143 179.384 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 9.7 tt0 -49.23 -33.96 13.83 Favored 'General case' 0 N--CA 1.502 2.153 0 CA-C-N 115.022 -0.99 . . . . 6.6 113.271 -178.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 3.5 mtmm -90.68 -26.37 19.61 Favored 'General case' 0 N--CA 1.494 1.74 0 C-N-CA 119.981 -0.688 . . . . 3.39 111.835 -178.42 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -73.5 -45.45 53.79 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 119.886 -0.726 . . . . 1.69 109.559 179.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 110.13 -52.48 0.63 Allowed Glycine 0 N--CA 1.498 2.81 0 N-CA-C 109.176 -1.57 . . . . 3.61 109.176 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.48 ' NZ ' ' O ' ' A' ' 55' ' ' PRO . 2.4 ttpm? -95.27 161.92 26.44 Favored Pre-proline 0 N--CA 1.491 1.608 0 N-CA-C 108.026 -1.101 . . . . 6.52 108.026 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.48 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . 87.5 Cg_exo -30.45 121.2 0.07 OUTLIER 'Trans proline' 0 C--N 1.327 -0.591 0 C-N-CA 121.538 1.492 . . . . 5.56 109.137 147.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.6 47.58 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.484 1.255 0 C-N-CA 119.617 -0.833 . . . . 7.77 111.812 -177.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.422 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 1.8 mm-40 -83.48 53.3 2.47 Favored 'General case' 0 N--CA 1.498 1.939 0 CA-C-O 122.951 1.358 . . . . 8.49 108.697 178.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 27.3 m -147.72 99.22 3.07 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 105.575 -2.009 . . . . 5.21 105.575 179.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.584 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.5 OUTLIER -113.53 147.69 38.08 Favored Pre-proline 0 N--CA 1.498 1.944 0 N-CA-C 108.309 -0.997 . . . . 3.15 108.309 -179.093 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.584 ' HA ' HG22 ' A' ' 59' ' ' VAL . 11.1 Cg_endo -84.2 174.35 38.49 Favored 'Cis proline' 0 C--O 1.207 -1.043 0 C-N-CA 125.403 -0.666 . . . . 2.12 111.48 21.354 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.8 mt-30 -124.72 146.9 48.92 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.459 -0.896 . . . . 3.57 110.57 -179.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.463 HG21 ' CG ' ' A' ' 75' ' ' PHE . 14.8 mm -120.09 134.93 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.805 0 O-C-N 124.011 0.82 . . . . 1.74 108.901 179.388 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.43 ' HA ' HG12 ' A' ' 69' ' ' ILE . 15.5 m-85 -137.38 133.16 34.5 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-N 115.634 -0.712 . . . . 1.69 111.167 179.373 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.474 HG23 HG13 ' A' ' 69' ' ' ILE . 84.6 t -100.11 122.32 51.88 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.964 0 N-CA-C 106.25 -1.759 . . . . 1.3 106.25 177.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 52.53 -83.5 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 123.783 0.677 . . . . 2.97 111.582 -178.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.454 ' N ' ' O ' ' A' ' 64' ' ' VAL . 74.1 mt-30 -138.35 10.07 2.73 Favored 'General case' 0 C--N 1.302 -1.463 0 C-N-CA 119.601 -0.84 . . . . 5.03 112.239 -179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -108.77 152.66 24.55 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 120.488 -0.485 . . . . 4.24 110.12 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.9 t-160 -85.14 145.1 27.79 Favored 'General case' 0 N--CA 1.492 1.655 0 N-CA-C 107.588 -1.264 . . . . 1.57 107.588 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 HG23 ' A' ' 64' ' ' VAL . 14.0 mm -113.5 -34.1 2.14 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.875 0 C-N-CA 119.255 -0.978 . . . . 1.2 110.895 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 136.0 -128.94 4.76 Favored Glycine 0 N--CA 1.491 2.329 0 N-CA-C 110.323 -1.111 . . . . 1.77 110.323 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -106.73 -59.2 0.59 Allowed Glycine 0 N--CA 1.498 2.767 0 C-N-CA 119.868 -1.158 . . . . 2.32 112.073 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -163.63 -60.45 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.882 0 C-N-CA 118.959 -1.096 . . . . 1.86 109.157 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.6 p -41.6 -48.06 3.97 Favored 'General case' 0 N--CA 1.496 1.859 0 N-CA-C 107.973 -1.121 . . . . 1.84 107.973 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -50.71 -68.75 0.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-N 112.756 -2.02 . . . . 2.96 110.353 178.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.463 ' CG ' HG21 ' A' ' 62' ' ' ILE . 71.7 t80 -52.62 -39.23 61.48 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 119.305 -0.958 . . . . 1.04 110.762 -179.625 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -57.76 -57.74 11.42 Favored 'General case' 0 N--CA 1.5 2.061 0 C-N-CA 120.499 -0.481 . . . . 0.94 111.174 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -69.09 -48.71 61.91 Favored 'General case' 0 N--CA 1.5 2.053 0 N-CA-C 107.894 -1.151 . . . . 1.56 107.894 179.751 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.442 ' CZ3' ' CE1' ' A' ' 75' ' ' PHE . 60.8 t90 -41.6 -52.09 3.84 Favored 'General case' 0 N--CA 1.49 1.571 0 CA-C-N 114.712 -1.131 . . . . 1.2 108.923 178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.539 HG13 HD12 ' A' ' 83' ' ' LEU . 3.0 t -41.81 -65.59 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 N-CA-C 107.619 -1.252 . . . . 1.16 107.619 178.594 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.449 ' NZ ' ' HA ' ' A' ' 81' ' ' GLU . 0.0 OUTLIER -47.78 -53.42 15.42 Favored 'General case' 0 N--CA 1.498 1.932 0 CA-C-O 121.468 0.652 . . . . 3.25 111.235 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.449 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 1.1 mp0 -62.69 -17.99 61.63 Favored 'General case' 0 N--CA 1.505 2.3 0 N-CA-C 114.081 1.141 . . . . 4.02 114.081 -179.151 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.1 m-80 -110.6 -32.24 6.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 118.826 -1.149 . . . . 1.78 113.385 -178.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.539 HD12 HG13 ' A' ' 79' ' ' VAL . 19.2 mt -92.87 -19.7 21.42 Favored 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 119.363 -0.935 . . . . 1.74 111.697 -178.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.51 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 2.1 m-20 -113.19 -51.67 2.81 Favored 'General case' 0 N--CA 1.495 1.779 0 N-CA-C 108.398 -0.964 . . . . 3.45 108.398 179.839 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.51 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.505 2.305 0 O-C-N 126.449 2.343 . . . . 5.23 108.834 -179.825 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 21.1 ptm . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.898 0.38 . . . . 4.04 110.689 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 16.2 mt-30 -106.78 174.8 5.73 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.247 -1.02 . . . . 4.14 108.247 179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.424 HG21 ' CZ ' ' A' ' 75' ' ' PHE . 57.5 m -114.88 141.18 48.27 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 118.741 -1.184 . . . . 0.75 113.695 -178.354 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 88.7 t -119.63 128.27 75.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.742 0 N-CA-C 105.14 -2.17 . . . . 0.64 105.14 177.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.6 mm -112.46 120.56 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 124.474 1.109 . . . . 1.53 110.48 -179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.539 ' CD2' HG11 ' A' ' 36' ' ' VAL . 91.0 m-85 -99.42 81.3 2.51 Favored 'General case' 0 N--CA 1.494 1.764 0 N-CA-C 107.175 -1.417 . . . . 0.92 107.175 179.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -130.42 -174.15 13.6 Favored Glycine 0 N--CA 1.487 2.084 0 N-CA-C 109.929 -1.268 . . . . 1.87 109.929 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.5 ' O ' ' HB2' ' A' ' 9' ' ' SER . 7.5 mmm180 -102.91 -63.62 1.15 Allowed 'General case' 0 C--N 1.297 -1.695 0 C-N-CA 119.732 -0.787 . . . . 6.47 110.877 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.5 ' HB2' ' O ' ' A' ' 8' ' ' ARG . 75.5 m 97.45 145.9 0.02 OUTLIER 'General case' 0 N--CA 1.505 2.306 0 O-C-N 125.408 1.692 . . . . 5.95 107.78 -179.359 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 107.18 -21.22 31.68 Favored Glycine 0 N--CA 1.491 2.359 0 N-CA-C 106.63 -2.588 . . . . 4.7 106.63 -177.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.499 ' O ' ' SG ' ' A' ' 14' ' ' CYS . 0.6 OUTLIER -113.27 150.25 42.76 Favored Pre-proline 0 N--CA 1.493 1.696 0 CA-C-N 113.996 -1.102 . . . . 3.46 110.072 179.558 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -54.09 -56.48 2.53 Favored 'Trans proline' 0 C--N 1.317 -1.106 0 C-N-CA 121.702 1.601 . . . . 3.03 112.317 -172.345 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.7 t80 -67.56 -44.09 79.09 Favored 'General case' 0 N--CA 1.501 2.089 0 C-N-CA 119.597 -0.841 . . . . 3.09 112.114 -178.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.499 ' SG ' ' O ' ' A' ' 11' ' ' CYS . 20.1 p -54.9 -55.13 33.85 Favored 'General case' 0 N--CA 1.5 2.074 0 C-N-CA 117.291 -1.764 . . . . 3.57 107.999 179.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.405 HG13 ' HD2' ' A' ' 18' ' ' LYS . 97.7 t -52.97 -47.37 53.53 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.324 0 CA-C-N 114.899 -1.046 . . . . 1.19 111.167 179.927 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.506 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -32.83 -50.01 0.25 Allowed 'General case' 0 N--CA 1.511 2.609 0 N-CA-C 113.555 0.946 . . . . 4.46 113.555 179.761 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -64.32 -43.13 95.62 Favored 'General case' 0 N--CA 1.494 1.763 0 C-N-CA 119.003 -1.079 . . . . 0.82 110.517 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -61.09 -47.49 86.08 Favored 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 109.251 -0.648 . . . . 1.92 109.251 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.522 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 4.2 m-20 -56.86 -47.85 79.46 Favored 'General case' 0 C--O 1.199 -1.596 0 C-N-CA 118.81 -1.156 . . . . 3.47 109.244 179.392 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 20.4 tp -58.62 -57.69 11.86 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 118.443 -1.303 . . . . 0.87 109.361 179.811 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.582 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -50.56 -53.51 29.79 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 118.145 -1.422 . . . . 0.74 110.071 179.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.453 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 20.2 tt0 -55.19 -49.54 71.66 Favored 'General case' 0 N--CA 1.493 1.7 0 CA-C-O 121.585 0.707 . . . . 2.8 112.228 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -59.64 -51.14 71.08 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.032 -1.099 . . . . 7.08 108.032 -178.502 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 94.6 mt -50.81 -52.86 37.09 Favored 'General case' 0 N--CA 1.487 1.414 0 CA-C-N 115.468 -0.787 . . . . 1.7 109.967 179.713 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.9 p -60.42 -14.58 19.81 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 118.107 -1.437 . . . . 1.72 112.358 -179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.2 t30 -117.71 17.57 14.33 Favored 'General case' 0 N--CA 1.509 2.522 0 CA-C-O 121.178 0.513 . . . . 3.41 110.194 179.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -130.54 -45.52 1.08 Allowed 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 122.203 1.001 . . . . 3.9 109.474 179.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' O ' ' HB2' ' A' ' 29' ' ' ASP . 2.3 mmp_? -101.86 -36.68 8.57 Favored 'General case' 0 C--N 1.302 -1.484 0 CA-C-N 114.193 -1.367 . . . . 4.04 111.392 -178.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.565 ' C ' ' H ' ' A' ' 31' ' ' PHE . 15.5 m-20 77.42 -40.74 0.35 Allowed 'General case' 0 N--CA 1.509 2.509 0 O-C-N 124.636 1.21 . . . . 6.4 110.389 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 63.5 m-20 -72.79 17.84 0.11 Allowed 'General case' 0 N--CA 1.502 2.134 0 C-N-CA 119.486 -0.886 . . . . 6.59 109.729 179.29 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.565 ' H ' ' C ' ' A' ' 29' ' ' ASP . 47.2 t80 -125.49 120.81 31.96 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.11 -0.95 . . . . 1.91 109.694 179.876 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 98.2 mm-40 -127.78 144.2 51.1 Favored 'General case' 0 N--CA 1.493 1.713 0 N-CA-C 107.302 -1.37 . . . . 4.73 107.302 179.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.582 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 18.3 p90 -144.68 176.12 9.66 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 119.63 -0.828 . . . . 1.45 112.755 -177.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 52.0 tp60 -136.14 141.64 44.15 Favored 'General case' 0 N--CA 1.488 1.471 0 N-CA-C 106.623 -1.621 . . . . 2.89 106.623 177.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -99.16 141.52 31.83 Favored 'General case' 0 C--N 1.302 -1.486 0 C-N-CA 117.944 -1.503 . . . . 1.36 108.053 179.582 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.539 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -131.32 148.18 32.8 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.476 0 N-CA-C 107.989 -1.115 . . . . 0.75 107.989 179.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 68.3 t0 -112.79 123.65 50.8 Favored 'General case' 0 N--CA 1.496 1.869 0 N-CA-C 107.922 -1.14 . . . . 1.99 107.922 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.6 pt -54.14 -25.32 12.93 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 C-N-CA 119.098 -1.041 . . . . 1.92 110.105 179.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -88.67 11.25 18.02 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 124.368 1.042 . . . . 6.67 111.653 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -114.86 -51.01 2.75 Favored 'General case' 0 N--CA 1.501 2.085 0 N-CA-C 109.392 -0.595 . . . . 1.79 109.392 179.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -73.79 -32.55 63.82 Favored 'General case' 0 N--CA 1.494 1.734 0 CA-C-N 114.547 -1.206 . . . . 2.78 109.641 179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 99.45 46.77 1.93 Allowed Glycine 0 N--CA 1.497 2.726 0 C-N-CA 119.82 -1.181 . . . . 1.95 111.263 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 38.4 mt -114.19 147.39 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 118.378 -1.329 . . . . 1.92 109.065 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 74.5 p -105.26 -99.59 0.33 Allowed 'General case' 0 C--N 1.302 -1.491 0 C-N-CA 119.096 -1.042 . . . . 3.51 110.161 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.547 ' NZ ' ' O ' ' A' ' 57' ' ' GLU . 42.6 tttp -141.03 -63.01 0.47 Allowed 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 106.999 -1.482 . . . . 5.53 106.999 179.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.527 ' N ' ' CD ' ' A' ' 46' ' ' GLU . 0.0 OUTLIER -45.25 -40.03 7.04 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-N 114.73 -1.123 . . . . 5.86 109.291 179.077 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.419 ' O ' ' C ' ' A' ' 48' ' ' LEU . 51.4 m-20 -56.9 -67.39 0.32 Allowed 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.588 -0.893 . . . . 4.91 108.588 178.621 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.459 HD13 ' HG3' ' A' ' 61' ' ' GLN . 61.5 mt -36.75 -51.45 0.88 Allowed 'General case' 0 N--CA 1.501 2.122 0 CA-C-N 115.238 -0.892 . . . . 1.86 109.931 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 27.5 mt-30 -52.92 -62.12 1.86 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 114.157 -1.383 . . . . 5.45 110.59 179.481 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 40.1 mt-30 -58.08 -45.32 87.34 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 119.964 -0.694 . . . . 6.78 111.154 -179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 1.6 ttpp -61.61 -29.51 70.09 Favored 'General case' 0 C--N 1.299 -1.601 0 CA-C-N 115.458 -0.792 . . . . 3.56 110.563 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.576 ' HB1' ' CG ' ' A' ' 68' ' ' HIS . . . -81.8 -55.37 4.66 Favored 'General case' 0 C--N 1.296 -1.759 0 C-N-CA 119.822 -0.751 . . . . 2.07 110.574 179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 118.02 -16.76 11.96 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 107.959 -2.056 . . . . 2.54 107.959 -178.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.41 ' HD2' ' O ' ' A' ' 55' ' ' PRO . 0.0 OUTLIER -114.05 84.34 8.82 Favored Pre-proline 0 N--CA 1.481 1.114 0 N-CA-C 108.678 -0.86 . . . . 5.37 108.678 179.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.414 ' O ' ' HB ' ' A' ' 56' ' ' VAL . 34.8 Cg_exo -50.32 177.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.317 -1.101 0 C-N-CA 122.125 1.883 . . . . 4.74 111.504 168.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.414 ' HB ' ' O ' ' A' ' 55' ' ' PRO . 23.9 t 71.34 70.73 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 CA-C-O 122.422 1.106 . . . . 5.63 108.953 179.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.547 ' O ' ' NZ ' ' A' ' 45' ' ' LYS . 4.8 pt-20 -171.06 166.56 7.35 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 113.37 -1.741 . . . . 6.08 109.661 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 70.3 m -139.86 178.72 7.05 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 106.719 -1.586 . . . . 5.03 106.719 179.757 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 ' H ' HG22 ' A' ' 58' ' ' THR . 7.1 m -84.39 154.32 62.68 Favored Pre-proline 0 N--CA 1.5 2.056 0 O-C-N 123.687 0.617 . . . . 3.37 110.501 -179.529 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -77.01 167.95 78.5 Favored 'Cis proline' 0 N--CA 1.495 1.607 0 O-C-N 122.533 0.754 . . . . 1.95 111.842 6.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HG3' HD13 ' A' ' 48' ' ' LEU . 15.5 mm-40 -122.69 145.25 48.55 Favored 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 120.231 -0.588 . . . . 2.94 109.58 179.145 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.593 HG21 ' CG ' ' A' ' 75' ' ' PHE . 10.8 mm -118.08 126.35 74.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 C-N-CA 120.193 -0.603 . . . . 1.32 111.599 -179.199 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 21.1 m-85 -124.81 132.31 53.35 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 105.682 -1.97 . . . . 1.17 105.682 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.668 HG11 ' CH2' ' A' ' 78' ' ' TRP . 45.6 t -119.22 145.39 25.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 118.86 -1.136 . . . . 1.42 108.686 179.492 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 21.4 t70 54.64 -84.98 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.777 0 O-C-N 124.424 1.077 . . . . 4.43 109.35 -179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.438 ' N ' ' O ' ' A' ' 64' ' ' VAL . 18.7 pt20 -148.34 9.76 0.85 Allowed 'General case' 0 C--N 1.294 -1.814 0 CA-C-N 115.93 -0.577 . . . . 4.64 109.971 179.256 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 48.0 mm-40 -116.5 169.61 9.2 Favored 'General case' 0 C--N 1.305 -1.341 0 CA-C-O 121.435 0.636 . . . . 5.53 111.354 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.576 ' CG ' ' HB1' ' A' ' 52' ' ' ALA . 10.9 t-80 -94.64 135.42 36.13 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 104.642 -2.355 . . . . 1.4 104.642 178.513 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.424 HG13 HG23 ' A' ' 64' ' ' VAL . 5.7 mm -110.86 -36.71 2.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 C-N-CA 117.901 -1.52 . . . . 1.07 109.579 -178.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 150.15 -144.74 12.29 Favored Glycine 0 N--CA 1.492 2.433 0 C-N-CA 119.239 -1.458 . . . . 1.78 111.354 178.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.417 ' O ' ' CG1' ' A' ' 62' ' ' ILE . . . -103.77 -60.8 0.69 Allowed Glycine 0 N--CA 1.493 2.494 0 CA-C-O 119.178 -0.79 . . . . 2.57 112.942 -179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 13.4 t80 -150.13 -68.43 0.2 Allowed 'General case' 0 N--CA 1.504 2.226 0 C-N-CA 117.914 -1.515 . . . . 2.11 111.118 -179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 13.6 p -49.06 -51.46 31.28 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.078 -1.082 . . . . 1.96 108.078 179.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -47.94 -53.74 14.99 Favored 'General case' 0 N--CA 1.495 1.779 0 CA-C-N 113.746 -1.57 . . . . 3.54 110.667 178.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.593 ' CG ' HG21 ' A' ' 62' ' ' ILE . 40.8 t80 -59.13 -51.36 70.36 Favored 'General case' 0 C--N 1.297 -1.714 0 N-CA-C 109.169 -0.678 . . . . 1.02 109.169 179.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.2 -53.13 18.0 Favored 'General case' 0 N--CA 1.495 1.804 0 N-CA-C 108.914 -0.773 . . . . 1.59 108.914 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.12 -63.35 1.21 Allowed 'General case' 0 C--O 1.204 -1.336 0 CA-C-N 114.814 -1.084 . . . . 1.46 109.051 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.668 ' CH2' HG11 ' A' ' 64' ' ' VAL . 68.5 t90 -43.06 -53.96 4.59 Favored 'General case' 0 N--CA 1.504 2.24 0 C-N-CA 119.773 -0.771 . . . . 1.55 109.818 179.973 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 50.0 t -44.87 -63.69 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.453 0 N-CA-C 107.994 -1.113 . . . . 1.86 107.994 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -52.9 -48.03 67.52 Favored 'General case' 0 C--N 1.298 -1.64 0 C-N-CA 118.996 -1.081 . . . . 3.52 110.3 179.823 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -76.57 20.81 0.21 Allowed 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 112.536 0.569 . . . . 3.99 112.536 -178.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.9 m-80 -142.77 -38.31 0.36 Allowed 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 120.328 -0.549 . . . . 2.27 111.37 177.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 16.6 mt -94.35 -14.41 25.37 Favored 'General case' 0 N--CA 1.494 1.737 0 C-N-CA 120.039 -0.665 . . . . 2.03 112.01 -178.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -118.3 -49.22 2.49 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 119.62 -0.832 . . . . 3.94 110.557 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.936 0 CA-C-O 116.895 -1.526 . . . . 6.03 109.221 179.783 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 108.43 -0.952 . . . . 2.58 108.43 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.589 ' HG2' ' N ' ' A' ' 3' ' ' THR . 6.5 tt0 -116.47 157.61 24.9 Favored 'General case' 0 N--CA 1.491 1.579 0 C-N-CA 119.114 -1.034 . . . . 4.44 111.637 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.589 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 75.8 m -145.08 127.65 16.08 Favored 'General case' 0 N--CA 1.493 1.703 0 N-CA-C 109.261 -0.644 . . . . 0.9 109.261 177.299 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 30.9 t -123.62 136.69 59.3 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 N-CA-C 108.899 -0.778 . . . . 0.96 108.899 -179.267 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.4 mm -113.21 130.97 66.18 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 N-CA-C 108.263 -1.014 . . . . 1.72 108.263 179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.662 ' CD2' HG11 ' A' ' 36' ' ' VAL . 16.0 m-85 -108.0 97.78 7.44 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 124.025 0.828 . . . . 1.23 109.916 -179.589 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -134.32 -141.74 4.53 Favored Glycine 0 N--CA 1.501 2.986 0 N-CA-C 108.845 -1.702 . . . . 0.9 108.845 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.729 ' HB3' ' SG ' ' A' ' 11' ' ' CYS . 0.3 OUTLIER -116.89 176.76 4.98 Favored 'General case' 0 N--CA 1.495 1.79 0 N-CA-C 109.213 -0.662 . . . . 6.17 109.213 -179.864 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.557 ' N ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -83.21 61.9 6.35 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-N 115.198 -0.91 . . . . 3.56 110.55 179.703 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 109.5 68.72 0.61 Allowed Glycine 0 N--CA 1.495 2.629 0 C-N-CA 119.243 -1.456 . . . . 3.3 110.724 179.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -119.36 113.04 35.41 Favored Pre-proline 0 N--CA 1.491 1.587 0 N-CA-C 107.548 -1.278 . . . . 2.52 107.548 179.004 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_exo -37.19 -50.29 1.61 Allowed 'Trans proline' 0 N--CA 1.482 0.852 0 C-N-CA 122.291 1.994 . . . . 3.24 113.143 -172.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -68.66 -47.75 65.74 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 118.299 -1.36 . . . . 2.68 111.408 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 20.1 p -58.23 -42.73 86.95 Favored 'General case' 0 N--CA 1.499 2.006 0 C-N-CA 118.048 -1.461 . . . . 2.89 110.243 -178.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 75.4 t -43.8 -26.32 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 CA-C-N 115.018 -0.992 . . . . 1.35 110.791 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.501 ' HA ' ' CZ ' ' A' ' 16' ' ' ARG . 4.2 tpp180 -74.02 -50.21 20.84 Favored 'General case' 0 C--N 1.306 -1.29 0 C-N-CA 119.031 -1.067 . . . . 4.31 109.322 179.309 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -53.35 -41.53 65.89 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 106.492 -1.67 . . . . 0.8 106.492 177.863 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.552 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 11.9 tmtt? -55.56 -58.98 5.52 Favored 'General case' 0 C--O 1.202 -1.411 0 CA-C-N 113.948 -1.478 . . . . 2.13 108.255 179.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.552 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 79.4 m-20 -54.3 -53.47 53.4 Favored 'General case' 0 C--O 1.191 -1.998 0 C-N-CA 118.984 -1.087 . . . . 3.7 110.098 179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.9 tp -46.17 -60.76 2.1 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 119.026 -1.07 . . . . 0.91 110.353 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.42 -55.13 34.77 Favored 'General case' 0 N--CA 1.489 1.488 0 C-N-CA 118.877 -1.129 . . . . 0.94 111.032 -179.235 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.458 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 35.2 tt0 -52.36 -56.49 14.56 Favored 'General case' 0 N--CA 1.493 1.718 0 C-N-CA 119.386 -0.926 . . . . 2.8 110.948 -178.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.459 ' NZ ' ' OE2' ' A' ' 27' ' ' GLU . 66.0 tttp -45.59 -57.17 4.38 Favored 'General case' 0 C--O 1.2 -1.54 0 CA-C-N 114.238 -1.347 . . . . 4.52 108.32 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 95.4 mt -56.32 -45.77 80.17 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 118.684 -1.206 . . . . 1.81 110.03 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.454 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 1.0 OUTLIER -50.3 -49.44 53.58 Favored 'General case' 0 C--N 1.294 -1.818 0 CA-C-N 115.637 -0.71 . . . . 2.22 111.015 179.458 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -81.15 -28.79 34.92 Favored 'General case' 0 N--CA 1.5 2.051 0 C-N-CA 119.928 -0.709 . . . . 3.09 112.185 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.459 ' OE2' ' NZ ' ' A' ' 23' ' ' LYS . 62.0 mt-10 -100.93 42.01 1.15 Allowed 'General case' 0 N--CA 1.492 1.665 0 CA-C-O 122.21 1.005 . . . . 6.46 112.692 -178.125 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.626 ' NE ' ' HA ' ' A' ' 28' ' ' ARG . 0.8 OUTLIER -149.34 -143.71 0.14 Allowed 'General case' 0 C--N 1.297 -1.707 0 C-N-CA 119.104 -1.039 . . . . 5.5 109.316 178.671 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.506 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -133.88 -48.94 0.81 Allowed 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 108.645 -0.872 . . . . 4.12 108.645 -178.686 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.49 ' O ' ' C ' ' A' ' 31' ' ' PHE . 51.6 t0 -98.75 -81.69 0.44 Allowed 'General case' 0 N--CA 1.503 2.216 0 CA-C-N 114.812 -1.086 . . . . 3.31 110.382 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.49 ' C ' ' O ' ' A' ' 30' ' ' ASP . 21.3 t80 1.56 78.21 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.369 0 O-C-N 124.349 1.03 . . . . 1.26 113.544 -179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.449 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 64.9 mt-30 -94.24 112.16 23.94 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 117.895 -1.522 . . . . 2.9 107.291 179.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.458 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.1 OUTLIER -110.34 164.17 12.94 Favored 'General case' 0 C--N 1.286 -2.177 0 C-N-CA 118.39 -1.324 . . . . 1.6 111.335 -179.108 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.2 tp-100 -143.91 157.46 44.34 Favored 'General case' 0 C--N 1.295 -1.795 0 N-CA-C 105.742 -1.947 . . . . 3.83 105.742 177.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 55.4 t80 -110.43 149.45 30.27 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 118.545 -1.262 . . . . 1.16 109.1 179.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.662 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.8 t -132.75 147.02 31.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.521 0 CA-C-N 115.635 -0.711 . . . . 0.66 109.579 179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 51.7 t0 -119.73 121.15 38.56 Favored 'General case' 0 N--CA 1.496 1.874 0 CA-C-O 122.152 0.977 . . . . 2.04 110.323 -178.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 4.3 pt -57.61 -30.44 36.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.677 0 CA-C-N 115.087 -0.96 . . . . 1.29 111.783 -179.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -84.77 9.16 14.83 Favored 'General case' 0 N--CA 1.501 2.085 0 C-N-CA 117.652 -1.619 . . . . 5.62 111.826 -178.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -111.46 -43.18 3.72 Favored 'General case' 0 N--CA 1.493 1.694 0 N-CA-C 106.898 -1.519 . . . . 1.33 106.898 177.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 87.7 mt-10 -74.3 -36.52 63.75 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 108.355 -0.98 . . . . 3.86 108.355 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.68 46.18 1.23 Allowed Glycine 0 N--CA 1.502 3.086 0 N-CA-C 109.184 -1.566 . . . . 1.83 109.184 179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 90.2 mt -108.11 145.99 14.57 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.709 0 CA-C-N 114.881 -0.659 . . . . 2.21 112.625 -177.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 23.4 p -117.89 -94.1 0.5 Allowed 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 108.215 -1.032 . . . . 3.48 108.215 178.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 6.0 tptp -135.47 -61.59 0.73 Allowed 'General case' 0 N--CA 1.494 1.742 0 N-CA-C 108.417 -0.956 . . . . 6.11 108.417 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -36.37 -52.82 0.84 Allowed 'General case' 0 N--CA 1.497 1.88 0 CA-C-N 114.589 -1.187 . . . . 3.27 111.467 179.544 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -58.82 -56.91 16.09 Favored 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 118.865 -1.134 . . . . 3.15 110.516 -179.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.499 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 48.9 mt -49.37 -47.67 47.38 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.219 -0.992 . . . . 1.88 110.021 179.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 6.1 tm0? -56.55 -53.73 54.15 Favored 'General case' 0 C--N 1.298 -1.635 0 C-N-CA 118.707 -1.197 . . . . 4.18 108.481 178.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -52.08 -64.35 0.84 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 124.395 1.059 . . . . 4.68 111.284 179.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -58.28 -45.81 87.21 Favored 'General case' 0 N--CA 1.488 1.457 0 CA-C-N 115.448 -0.796 . . . . 3.4 112.405 -179.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.627 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -58.04 -38.79 76.91 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 123.958 0.786 . . . . 2.1 110.095 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 87.67 39.98 6.94 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 108.644 -1.783 . . . . 2.94 108.644 179.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 21.2 mmtp -119.44 151.62 51.7 Favored Pre-proline 0 N--CA 1.492 1.63 0 C-N-CA 119.195 -1.002 . . . . 5.2 110.499 -179.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -90.6 -25.33 0.41 Allowed 'Trans proline' 0 C--N 1.317 -1.091 0 C-N-CA 121.863 1.709 . . . . 4.72 111.671 154.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 2.7 m -119.27 108.19 23.2 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.72 0 CA-C-N 112.416 -2.175 . . . . 6.25 108.928 179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.95 167.87 11.33 Favored 'General case' 0 N--CA 1.495 1.813 0 CA-C-N 114.876 -1.056 . . . . 5.99 111.861 -178.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 33.2 p -156.1 174.97 14.58 Favored 'General case' 0 C--N 1.299 -1.626 0 N-CA-C 105.484 -2.043 . . . . 5.97 105.484 178.855 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 13.4 m -115.13 156.36 45.52 Favored Pre-proline 0 N--CA 1.492 1.635 0 C-N-CA 118.319 -1.352 . . . . 3.78 108.573 178.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -73.08 -172.6 9.9 Favored 'Cis proline' 0 C--N 1.309 -1.518 0 C-N-CA 124.386 -1.089 . . . . 2.12 111.291 -17.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 41.2 mm-40 -119.77 147.36 44.72 Favored 'General case' 0 N--CA 1.503 2.221 0 N-CA-C 107.624 -1.25 . . . . 3.31 107.624 178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.527 HD12 ' N ' ' A' ' 62' ' ' ILE . 5.0 mp -122.86 143.25 36.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 CA-C-O 122.317 1.056 . . . . 1.28 112.53 -178.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.566 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 39.6 m-85 -123.0 124.84 44.05 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 112.141 -2.3 . . . . 1.34 106.18 178.297 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.649 ' CG1' ' H ' ' A' ' 65' ' ' ASP . 41.7 t -97.52 -172.86 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 C-N-CA 118.065 -1.454 . . . . 1.69 107.52 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.649 ' H ' ' CG1' ' A' ' 64' ' ' VAL . 32.7 t70 -48.47 -35.0 12.08 Favored 'General case' 0 C--N 1.286 -2.181 0 N-CA-C 112.954 0.724 . . . . 2.72 112.954 -178.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.434 ' H ' ' NE2' ' A' ' 66' ' ' GLN . 0.0 OUTLIER -94.2 -72.66 0.6 Allowed 'General case' 0 C--N 1.292 -1.893 0 C-N-CA 118.522 -1.271 . . . . 8.49 113.892 -178.947 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -134.97 -167.02 1.92 Allowed 'General case' 0 N--CA 1.487 1.408 0 N-CA-C 113.274 0.842 . . . . 5.25 113.274 -177.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.627 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 35.9 t-80 -70.14 140.6 52.65 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 104.79 -2.3 . . . . 1.9 104.79 177.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.6 HG13 ' CG2' ' A' ' 64' ' ' VAL . 16.0 mm -107.5 -34.85 2.84 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.039 0 C-N-CA 119.081 -1.048 . . . . 1.12 110.552 -178.186 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 142.42 -150.14 21.88 Favored Glycine 0 N--CA 1.493 2.444 0 C-N-CA 119.465 -1.35 . . . . 1.74 110.644 179.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.406 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -96.77 -169.1 33.83 Favored Glycine 0 N--CA 1.496 2.681 0 N-CA-C 110.035 -1.226 . . . . 1.64 110.035 -179.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 76.7 t80 -52.36 -47.53 66.08 Favored 'General case' 0 N--CA 1.501 2.121 0 C-N-CA 118.755 -1.178 . . . . 1.69 110.733 -179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -62.49 -61.64 2.3 Favored 'General case' 0 N--CA 1.493 1.701 0 C-N-CA 119.409 -0.917 . . . . 1.24 109.952 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.406 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -42.98 -54.27 4.34 Favored 'General case' 0 N--CA 1.494 1.758 0 CA-C-N 114.426 -1.261 . . . . 2.91 109.389 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.453 ' CD1' HG21 ' A' ' 62' ' ' ILE . 41.7 t80 -61.23 -57.23 13.27 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-N 114.811 -1.086 . . . . 1.11 109.423 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -42.32 -54.58 3.7 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.12 -0.632 . . . . 1.06 110.32 179.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.483 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -59.44 -57.64 12.08 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-N 115.035 -0.984 . . . . 1.3 108.488 179.588 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.486 ' CH2' HG11 ' A' ' 64' ' ' VAL . 85.0 t90 -41.99 -47.14 4.35 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 109.079 -0.711 . . . . 1.57 109.079 179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.4 HG13 HD12 ' A' ' 83' ' ' LEU . 92.6 t -62.26 -36.92 77.08 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.899 0 CA-C-N 115.833 -0.621 . . . . 1.13 109.513 179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.515 ' HA ' ' NZ ' ' A' ' 80' ' ' LYS . 0.4 OUTLIER -94.52 22.24 6.38 Favored 'General case' 0 C--N 1.304 -1.38 0 CA-C-N 116.147 -0.478 . . . . 4.13 112.106 179.075 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 54.7 mt-10 -134.79 -40.86 0.77 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.954 -0.566 . . . . 4.56 110.13 178.504 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -92.85 -23.32 18.85 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-N 116.057 -0.519 . . . . 2.55 112.309 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.4 HD12 HG13 ' A' ' 79' ' ' VAL . 39.8 mt -100.93 13.12 36.17 Favored 'General case' 0 N--CA 1.505 2.299 0 C-N-CA 118.277 -1.369 . . . . 2.31 110.894 -179.098 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.514 ' CG ' ' HZ2' ' A' ' 80' ' ' LYS . 5.2 m-20 -115.17 -63.52 1.44 Allowed 'General case' 0 N--CA 1.497 1.896 0 C-N-CA 119.921 -0.711 . . . . 4.62 110.847 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 117.58 -1.2 . . . . 7.07 108.109 179.12 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.489 ' N ' ' O ' ' A' ' 30' ' ' ASP . 29.0 ttm . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 106.52 -1.659 . . . . 2.93 106.52 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 14.6 mt-30 -122.79 85.33 2.4 Favored 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 119.906 -0.718 . . . . 3.6 109.531 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.476 HG23 HG22 ' A' ' 64' ' ' VAL . 27.7 m -88.71 131.22 35.11 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 108.26 -1.015 . . . . 1.18 108.26 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 94.5 t -112.6 138.19 42.69 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.986 0 N-CA-C 108.781 -0.822 . . . . 0.69 108.781 -179.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 61.4 mt -114.96 119.92 63.12 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.412 0 O-C-N 124.559 1.162 . . . . 1.99 109.326 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 21.9 m-30 -92.25 85.98 5.6 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 104.801 -2.296 . . . . 2.23 104.801 178.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.15 -168.45 15.16 Favored Glycine 0 N--CA 1.492 2.423 0 C-N-CA 118.634 -1.746 . . . . 0.94 110.593 -178.197 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.587 ' HB2' ' SG ' ' A' ' 14' ' ' CYS . 0.0 OUTLIER -111.61 133.14 54.07 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.81 -0.811 . . . . 5.41 108.81 179.087 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.442 ' N ' HH22 ' A' ' 8' ' ' ARG . 2.8 p -67.57 94.16 0.4 Allowed 'General case' 0 N--CA 1.489 1.491 0 CA-C-N 115.36 -0.836 . . . . 3.67 110.017 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 105.01 22.87 8.04 Favored Glycine 0 N--CA 1.499 2.872 0 N-CA-C 110.721 -0.951 . . . . 2.94 110.721 179.348 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.534 ' CB ' ' HB2' ' A' ' 8' ' ' ARG . 0.1 OUTLIER -104.03 115.61 62.94 Favored Pre-proline 0 N--CA 1.492 1.672 0 C-N-CA 120.132 -0.627 . . . . 2.4 110.734 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -57.2 -31.43 90.57 Favored 'Trans proline' 0 N--CA 1.487 1.116 0 C-N-CA 122.554 2.17 . . . . 2.94 111.593 -159.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 40.8 t80 -92.72 -37.56 12.3 Favored 'General case' 0 N--CA 1.49 1.535 0 CA-C-N 114.727 -1.124 . . . . 2.69 110.9 -179.263 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.587 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 63.8 m -51.83 -45.18 63.85 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 118.631 -1.228 . . . . 2.23 109.199 -178.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 51.7 t -46.58 -41.41 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 CA-C-N 114.656 -1.156 . . . . 1.35 111.417 179.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.587 ' HE ' ' N ' ' A' ' 16' ' ' ARG . 0.0 OUTLIER -44.6 -37.11 3.38 Favored 'General case' 0 N--CA 1.515 2.779 0 N-CA-C 112.157 0.429 . . . . 6.61 112.157 -179.288 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -63.38 -40.88 98.46 Favored 'General case' 0 N--CA 1.493 1.722 0 C-N-CA 118.699 -1.201 . . . . 0.98 108.205 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.5 tmtm? -73.28 -32.98 64.97 Favored 'General case' 0 C--N 1.305 -1.365 0 C-N-CA 119.17 -1.012 . . . . 2.51 110.672 -179.441 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.546 ' CG ' HH21 ' A' ' 16' ' ' ARG . 5.7 m-20 -51.31 -57.49 8.73 Favored 'General case' 0 C--N 1.299 -1.606 0 C-N-CA 118.015 -1.474 . . . . 3.27 108.647 178.361 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 26.8 tp -46.13 -61.2 1.87 Allowed 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 113.171 0.804 . . . . 0.92 113.171 -179.791 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.419 ' HB1' ' CD2' ' A' ' 33' ' ' TYR . . . -39.17 -39.85 0.65 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 112.668 0.618 . . . . 1.11 112.668 -179.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -55.72 -50.57 69.99 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 119.076 -1.05 . . . . 3.11 110.051 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 5.2 tmtt? -45.13 -46.95 12.15 Favored 'General case' 0 N--CA 1.502 2.156 0 CA-C-N 114.5 -1.227 . . . . 5.98 110.256 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 22.2 mt -72.34 -50.03 29.89 Favored 'General case' 0 N--CA 1.502 2.172 0 CA-C-N 114.208 -1.36 . . . . 1.23 112.649 -178.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.0 m -55.89 -26.66 48.33 Favored 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 119.804 -0.758 . . . . 1.5 110.803 -179.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 42.5 m-80 -93.09 24.03 3.98 Favored 'General case' 0 N--CA 1.499 1.978 0 C-N-CA 120.003 -0.679 . . . . 2.68 110.393 179.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 52.5 mt-10 -136.32 -49.86 0.67 Allowed 'General case' 0 N--CA 1.489 1.504 0 O-C-N 123.646 0.591 . . . . 3.59 110.971 179.503 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.519 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.2 mpt_? -108.35 124.25 50.07 Favored 'General case' 0 N--CA 1.492 1.658 0 CA-C-N 115.256 -0.883 . . . . 4.68 111.579 -178.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -74.53 60.52 0.88 Allowed 'General case' 0 N--CA 1.502 2.142 0 O-C-N 124.562 1.163 . . . . 5.95 109.156 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.489 ' O ' ' N ' ' A' ' 1' ' ' MET . 1.1 t70 -165.04 -41.37 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.788 0 CA-C-N 113.869 -1.514 . . . . 3.12 109.841 -178.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.472 ' CE1' ' HB3' ' A' ' 33' ' ' TYR . 14.5 t80 -66.19 102.44 0.83 Allowed 'General case' 0 N--CA 1.49 1.537 0 CA-C-N 115.596 -0.729 . . . . 0.99 109.994 -179.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' O ' ' CD2' ' A' ' 33' ' ' TYR . 83.6 mt-30 -91.47 -54.69 3.8 Favored 'General case' 0 N--CA 1.499 2.0 0 C-N-CA 120.287 -0.565 . . . . 3.74 111.347 -179.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 31' ' ' PHE . 0.3 OUTLIER 59.0 149.64 0.01 OUTLIER 'General case' 0 N--CA 1.523 3.176 0 O-C-N 126.357 2.285 . . . . 1.31 113.507 -179.745 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 42.9 tp60 -139.65 144.65 37.74 Favored 'General case' 0 N--CA 1.503 2.225 0 CA-C-N 115.19 -0.914 . . . . 3.31 110.86 -179.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.0 t80 -98.8 138.19 36.29 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 107.534 -1.284 . . . . 1.0 107.534 179.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.4 t -125.53 144.52 35.33 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 N-CA-C 107.219 -1.4 . . . . 0.6 107.219 179.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -115.31 118.33 32.95 Favored 'General case' 0 N--CA 1.5 2.026 0 O-C-N 124.302 1.001 . . . . 2.2 111.738 -178.017 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 42.4 pt -58.01 -19.89 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 C-N-CA 118.839 -1.144 . . . . 1.22 111.042 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.535 ' HB2' ' NH1' ' A' ' 8' ' ' ARG . 1.2 tmm_? -87.14 -9.8 54.37 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 123.289 0.368 . . . . 5.41 111.001 -179.151 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.39 -39.34 8.43 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 107.616 -1.253 . . . . 1.17 107.616 179.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 40.1 mt-10 -104.51 28.16 7.23 Favored 'General case' 0 N--CA 1.496 1.869 0 CA-C-N 114.24 -1.346 . . . . 2.54 109.959 179.188 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 27.24 64.49 0.08 OUTLIER Glycine 0 N--CA 1.507 3.413 0 CA-C-N 114.648 -1.16 . . . . 1.64 113.565 179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 11.6 mt -111.56 147.97 15.12 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.266 0 C-N-CA 119.579 -0.849 . . . . 1.82 109.783 -179.646 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.1 p -130.85 173.37 11.02 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 119.654 -0.818 . . . . 2.78 109.217 178.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.474 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 0.1 OUTLIER -50.48 -50.78 51.75 Favored 'General case' 0 N--CA 1.495 1.81 0 C-N-CA 119.699 -0.8 . . . . 6.96 110.138 179.811 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -34.2 -69.16 0.1 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 124.119 0.887 . . . . 3.47 113.063 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -56.54 -46.25 80.73 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 119.981 -0.687 . . . . 3.31 112.853 -179.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.414 ' O ' ' C ' ' A' ' 49' ' ' GLN . 97.8 mt -58.12 -53.2 60.9 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 118.457 -1.297 . . . . 1.97 110.62 -179.381 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.444 ' HG3' ' HE2' ' A' ' 45' ' ' LYS . 37.9 mt-30 -42.67 -53.04 4.67 Favored 'General case' 0 N--CA 1.508 2.456 0 C-N-CA 119.153 -1.019 . . . . 3.75 108.867 179.759 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 63.9 mt-30 -55.56 -44.86 77.22 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 124.966 1.416 . . . . 5.26 110.873 179.842 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.42 ' NZ ' ' HB2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -90.13 11.09 21.92 Favored 'General case' 0 N--CA 1.506 2.345 0 C-N-CA 119.625 -0.83 . . . . 4.44 111.85 -179.517 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.744 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -102.77 -66.1 0.95 Allowed 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 112.819 0.674 . . . . 1.86 112.819 -177.418 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 95.34 18.21 34.2 Favored Glycine 0 N--CA 1.501 2.988 0 C-N-CA 119.922 -1.133 . . . . 3.52 112.81 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.403 ' HD3' ' CE1' ' A' ' 68' ' ' HIS . 50.8 mtpt -121.97 24.85 0.11 Allowed Pre-proline 0 N--CA 1.502 2.168 0 CA-C-N 117.714 0.757 . . . . 5.8 110.798 179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_endo -74.59 46.28 1.42 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 C-N-CA 122.752 2.301 . . . . 5.13 113.437 -105.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 9.9 p -131.3 15.95 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 107.982 -1.118 . . . . 5.43 107.982 178.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.473 ' CD ' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -84.01 173.82 10.83 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-N 114.149 -1.387 . . . . 6.55 109.542 179.639 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 12.7 t -149.22 -156.81 0.75 Allowed 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.886 -0.726 . . . . 4.66 109.31 -179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 38.5 t -82.39 131.07 56.76 Favored Pre-proline 0 N--CA 1.491 1.59 0 N-CA-C 108.04 -1.096 . . . . 2.79 108.04 -179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -99.11 151.76 5.76 Favored 'Cis proline' 0 N--CA 1.481 0.761 0 O-C-N 122.661 0.822 . . . . 1.95 111.64 12.388 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.4 mt-30 -122.62 139.34 54.04 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 115.231 -0.895 . . . . 2.94 109.037 179.69 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.606 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.5 mp -118.2 149.66 20.54 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.35 0 N-CA-C 107.669 -1.234 . . . . 1.45 107.669 -179.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.46 ' CZ ' ' CD2' ' A' ' 68' ' ' HIS . 22.6 m-85 -134.02 116.65 15.76 Favored 'General case' 0 C--N 1.284 -2.257 0 O-C-N 125.401 1.688 . . . . 1.01 106.726 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.633 HG23 HG13 ' A' ' 69' ' ' ILE . 84.8 t -88.2 108.95 19.2 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.259 0 C-N-CA 118.067 -1.453 . . . . 1.04 110.078 179.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.4 m-20 54.03 -79.41 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.966 0 O-C-N 123.748 0.655 . . . . 3.04 112.086 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.43 ' N ' ' O ' ' A' ' 64' ' ' VAL . 2.6 pt20 -128.38 1.9 5.68 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.041 -1.064 . . . . 4.83 111.654 179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.405 ' NE2' ' HG3' ' A' ' 66' ' ' GLN . 10.0 mp0 -101.81 160.14 14.73 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 109.946 -0.391 . . . . 4.24 109.946 179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.744 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 7.0 t-80 -106.66 132.75 52.29 Favored 'General case' 0 C--N 1.299 -1.603 0 N-CA-C 107.733 -1.21 . . . . 1.52 107.733 179.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.633 HG13 HG23 ' A' ' 64' ' ' VAL . 5.3 mm -111.09 -56.17 4.52 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.902 0 N-CA-C 105.867 -1.901 . . . . 1.89 105.867 179.02 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.417 ' HA3' ' NE2' ' A' ' 68' ' ' HIS . . . 68.87 88.09 0.08 OUTLIER Glycine 0 N--CA 1.501 3.012 0 N-CA-C 116.261 1.265 . . . . 2.44 116.261 177.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 122.88 131.18 3.78 Favored Glycine 0 N--CA 1.506 3.332 0 C-N-CA 119.282 -1.437 . . . . 1.49 114.632 178.433 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.524 ' C ' ' H ' ' A' ' 74' ' ' ASP . 22.4 t80 -66.23 -58.09 6.13 Favored 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 119.553 -0.859 . . . . 1.25 109.124 178.701 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -63.44 14.66 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.117 0 N-CA-C 112.619 0.6 . . . . 2.57 112.619 179.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.524 ' H ' ' C ' ' A' ' 72' ' ' TYR . 7.9 t70 -119.37 -63.92 1.33 Allowed 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 105.753 -1.943 . . . . 3.14 105.753 178.259 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.409 ' O ' ' HB3' ' A' ' 78' ' ' TRP . 67.0 t80 -56.41 -39.05 72.39 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.878 -1.51 . . . . 0.97 108.426 179.22 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.77 -65.49 0.57 Allowed 'General case' 0 N--CA 1.489 1.512 0 CA-C-N 115.302 -0.863 . . . . 1.03 109.634 179.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -52.21 -53.43 43.52 Favored 'General case' 0 N--CA 1.493 1.704 0 N-CA-C 108.023 -1.103 . . . . 1.4 108.023 179.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.409 ' HB3' ' O ' ' A' ' 75' ' ' PHE . 89.8 t90 -41.39 -65.45 0.44 Allowed 'General case' 0 C--N 1.297 -1.678 0 CA-C-N 114.362 -1.29 . . . . 1.61 110.862 179.546 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 42.8 t -42.82 -52.45 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.901 0 N-CA-C 108.505 -0.924 . . . . 1.04 108.505 179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.582 ' HB3' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -46.81 -42.29 16.88 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 113.417 -1.72 . . . . 5.04 109.919 179.908 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 20.1 mp0 -106.81 25.18 11.59 Favored 'General case' 0 N--CA 1.503 2.211 0 C-N-CA 120.085 -0.646 . . . . 4.8 112.495 179.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -129.85 -43.02 1.24 Allowed 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 118.379 -1.328 . . . . 1.94 113.817 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.519 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 26.4 mt -101.54 32.26 3.42 Favored 'General case' 0 C--N 1.287 -2.134 0 N-CA-C 105.118 -2.178 . . . . 1.5 105.118 179.374 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.545 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 5.3 m-20 55.3 30.69 15.21 Favored 'General case' 0 C--N 1.318 -0.782 0 CA-C-N 113.026 -1.897 . . . . 6.15 106.773 -178.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.545 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.531 3.59 0 O-C-N 125.706 1.879 . . . . 8.66 111.776 -179.52 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.434 ' O ' ' HA ' ' A' ' 31' ' ' PHE . 33.4 tpp . . . . . 0 N--CA 1.486 1.347 0 N-CA-C 109.629 -0.508 . . . . 2.6 109.629 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.47 ' HA ' ' H ' ' A' ' 32' ' ' GLN . 8.5 pt20 -94.42 173.17 7.76 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.623 -1.231 . . . . 3.32 108.515 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.44 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 86.6 m -130.2 145.35 51.72 Favored 'General case' 0 N--CA 1.501 2.079 0 C-N-CA 119.074 -1.05 . . . . 1.28 111.812 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 2.2 t -122.29 118.01 53.99 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 N-CA-C 105.737 -1.949 . . . . 0.86 105.737 178.497 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.451 HG23 ' CD1' ' A' ' 62' ' ' ILE . 30.7 mt -100.07 113.58 35.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.556 0 N-CA-C 108.009 -1.108 . . . . 2.89 108.009 179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.513 ' CD2' HG11 ' A' ' 36' ' ' VAL . 45.6 m-85 -97.58 78.06 2.62 Favored 'General case' 0 N--CA 1.488 1.444 0 N-CA-C 105.747 -1.946 . . . . 1.25 105.747 -179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.3 -112.74 1.91 Allowed Glycine 0 N--CA 1.485 1.961 0 C-N-CA 118.781 -1.676 . . . . 1.03 112.04 -178.069 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.465 ' HG3' ' N ' ' A' ' 9' ' ' SER . 0.2 OUTLIER 179.23 -45.24 0.01 OUTLIER 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 107.811 -1.181 . . . . 4.86 107.811 -178.079 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.465 ' N ' ' HG3' ' A' ' 8' ' ' ARG . 13.2 m 97.29 162.92 0.02 OUTLIER 'General case' 0 N--CA 1.511 2.621 0 O-C-N 125.335 1.647 . . . . 5.04 110.4 179.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.446 ' H ' ' CG2' ' A' ' 15' ' ' VAL . . . 97.12 -12.37 65.44 Favored Glycine 0 N--CA 1.503 3.14 0 C-N-CA 120.194 -1.003 . . . . 3.52 110.637 179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -115.58 143.63 30.94 Favored Pre-proline 0 N--CA 1.49 1.556 0 CA-C-N 114.91 -0.645 . . . . 2.55 110.724 -179.127 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 9.7 Cg_endo -50.43 -54.71 5.01 Favored 'Trans proline' 0 C--N 1.318 -1.055 0 C-N-CA 121.257 1.305 . . . . 3.77 111.675 179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -67.94 -2.58 7.76 Favored 'General case' 0 N--CA 1.505 2.295 0 N-CA-C 113.802 1.038 . . . . 3.15 113.802 -178.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.451 ' SG ' ' HA ' ' A' ' 9' ' ' SER . 29.4 p -111.66 -41.87 3.97 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 118.651 -1.22 . . . . 2.33 109.09 179.596 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.55 ' C ' ' H ' ' A' ' 17' ' ' ALA . 49.0 t -73.04 -30.98 33.49 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.352 0 C-N-CA 118.824 -1.15 . . . . 0.92 108.357 179.274 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.447 ' HB3' ' CZ ' ' A' ' 72' ' ' TYR . 9.3 mmm180 -71.9 23.47 0.05 OUTLIER 'General case' 0 N--CA 1.506 2.325 0 C-N-CA 119.919 -0.712 . . . . 3.65 110.976 179.286 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.55 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -121.49 -48.87 2.16 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 107.64 -1.245 . . . . 1.08 107.64 179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.486 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.9 tmtm? -57.97 -29.15 65.0 Favored 'General case' 0 C--N 1.312 -1.05 0 C-N-CA 119.873 -0.731 . . . . 2.56 110.169 -179.489 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.451 ' CG ' ' N ' ' A' ' 20' ' ' LEU . 3.6 p-10 -81.06 -38.66 27.0 Favored 'General case' 0 C--N 1.301 -1.542 0 C-N-CA 119.727 -0.789 . . . . 3.28 108.926 178.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.501 HD23 ' CD2' ' A' ' 75' ' ' PHE . 34.2 tp -60.23 -49.06 79.11 Favored 'General case' 0 N--CA 1.498 1.956 0 N-CA-C 106.686 -1.598 . . . . 0.76 106.686 179.555 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -61.38 -31.65 71.55 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 108.008 -1.108 . . . . 0.87 108.008 178.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.412 ' HB3' ' O ' ' A' ' 19' ' ' ASP . 3.2 tp10 -63.48 -56.98 11.75 Favored 'General case' 0 C--N 1.31 -1.129 0 C-N-CA 118.559 -1.256 . . . . 3.36 108.496 179.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.577 ' HG3' ' CG ' ' A' ' 27' ' ' GLU . 0.1 OUTLIER -55.11 -51.88 65.01 Favored 'General case' 0 C--O 1.201 -1.453 0 C-N-CA 118.356 -1.338 . . . . 4.61 108.145 179.992 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.51 ' HA ' ' HB2' ' A' ' 27' ' ' GLU . 71.8 mt -47.29 -53.86 12.44 Favored 'General case' 0 N--CA 1.498 1.928 0 C-N-CA 118.426 -1.31 . . . . 1.26 109.459 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 49.1 m -51.23 -43.47 61.47 Favored 'General case' 0 N--CA 1.502 2.142 0 C-N-CA 118.72 -1.192 . . . . 1.32 108.718 177.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -94.98 42.46 1.09 Allowed 'General case' 0 N--CA 1.497 1.899 0 CA-C-N 114.874 -1.057 . . . . 3.69 108.994 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.577 ' CG ' ' HG3' ' A' ' 23' ' ' LYS . 14.9 mm-40 -144.8 -58.7 0.36 Allowed 'General case' 0 N--CA 1.495 1.804 0 CA-C-N 114.957 -1.02 . . . . 3.18 113.492 -179.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.429 ' HE ' ' HB3' ' A' ' 27' ' ' GLU . 3.5 mmt180 -101.45 -157.89 0.64 Allowed 'General case' 0 N--CA 1.489 1.496 0 CA-C-N 114.809 -1.087 . . . . 5.42 112.476 -176.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -102.61 -75.59 0.6 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-N 115.177 -0.92 . . . . 4.9 113.411 -177.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -84.62 53.57 2.73 Favored 'General case' 0 N--CA 1.499 2.022 0 C-N-CA 118.627 -1.229 . . . . 3.42 112.418 -178.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.434 ' HA ' ' O ' ' A' ' 1' ' ' MET . 39.9 t80 -117.92 140.11 50.19 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 118.963 -1.095 . . . . 1.62 109.87 179.333 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.47 ' H ' ' HA ' ' A' ' 2' ' ' GLN . 43.7 mt-30 -156.64 179.95 8.77 Favored 'General case' 0 N--CA 1.497 1.892 0 N-CA-C 106.12 -1.807 . . . . 3.09 106.12 179.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.44 ' HA ' ' H ' ' A' ' 3' ' ' THR . 19.7 p90 -171.58 159.26 5.4 Favored 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 118.073 -1.451 . . . . 1.19 111.369 178.788 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -133.09 151.36 52.02 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 106.772 -1.566 . . . . 3.57 106.772 178.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.1 t80 -103.67 144.9 30.83 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 117.464 -1.695 . . . . 1.09 109.678 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.513 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.4 t -132.71 148.39 31.64 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.453 -1.249 . . . . 0.57 108.925 179.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.0 t0 -120.07 113.37 20.39 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.627 -1.249 . . . . 2.21 107.627 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 43' ' ' ILE . 30.9 pt -44.59 -31.03 0.71 Allowed 'Isoleucine or valine' 0 C--O 1.203 -1.391 0 CA-C-N 115.211 -0.904 . . . . 1.44 110.466 -178.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.403 ' N ' HG13 ' A' ' 38' ' ' ILE . 43.6 ttp180 -71.72 -60.44 2.23 Favored 'General case' 0 N--CA 1.496 1.848 0 C-N-CA 119.112 -1.035 . . . . 4.78 109.322 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -39.34 -43.25 1.15 Allowed 'General case' 0 N--CA 1.501 2.112 0 O-C-N 123.573 0.546 . . . . 1.75 110.174 178.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 92.8 mt-10 -74.61 -48.37 26.89 Favored 'General case' 0 N--CA 1.502 2.16 0 O-C-N 124.283 0.989 . . . . 4.46 109.361 179.135 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 115.33 41.51 0.81 Allowed Glycine 0 N--CA 1.503 3.116 0 C-N-CA 120.41 -0.9 . . . . 2.47 111.235 179.378 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.457 ' HB ' ' HB ' ' A' ' 38' ' ' ILE . 62.7 mt -103.74 164.57 3.52 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 N-CA-C 109.637 -0.505 . . . . 2.29 109.637 -179.216 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.437 ' N ' HG22 ' A' ' 43' ' ' ILE . 40.2 p -113.25 -104.86 0.4 Allowed 'General case' 0 N--CA 1.495 1.793 0 CA-C-N 115.612 -0.722 . . . . 3.96 112.87 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.465 ' HE3' ' HB2' ' A' ' 57' ' ' GLU . 34.7 tttp -142.82 -25.77 0.61 Allowed 'General case' 0 N--CA 1.501 2.089 0 CA-C-O 122.061 0.934 . . . . 6.88 109.614 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.608 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -86.98 -53.37 4.92 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.311 -0.996 . . . . 4.1 108.311 -179.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.424 ' O ' ' C ' ' A' ' 48' ' ' LEU . 17.9 t70 -47.5 -61.87 1.71 Allowed 'General case' 0 N--CA 1.499 1.979 0 C-N-CA 119.704 -0.798 . . . . 3.5 111.397 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' C ' ' O ' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -34.36 -46.89 0.28 Allowed 'General case' 0 N--CA 1.498 1.941 0 CA-C-N 115.436 -0.802 . . . . 2.17 111.073 -179.43 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 53' ' ' GLY . 74.4 mt-30 -54.99 -54.56 41.38 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 119.119 -1.032 . . . . 5.61 108.486 179.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.417 ' NE2' ' HA ' ' A' ' 47' ' ' ASP . 2.0 mp0 -60.79 -36.86 80.07 Favored 'General case' 0 N--CA 1.509 2.495 0 C-N-CA 119.711 -0.796 . . . . 7.44 109.93 178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 2.6 ttpp -64.26 -29.43 70.52 Favored 'General case' 0 N--CA 1.496 1.832 0 CA-C-N 114.79 -1.096 . . . . 4.01 110.12 179.887 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.599 ' HB1' ' CD2' ' A' ' 68' ' ' HIS . . . -100.68 -74.81 0.6 Allowed 'General case' 0 C--N 1.299 -1.588 0 CA-C-N 114.68 -1.146 . . . . 2.06 109.595 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 49' ' ' GLN . . . 121.94 39.78 0.55 Allowed Glycine 0 N--CA 1.495 2.606 0 C-N-CA 119.73 -1.224 . . . . 3.96 111.178 -179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.478 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 22.3 mmtp -138.05 152.01 71.12 Favored Pre-proline 0 N--CA 1.499 2.017 0 C-N-CA 119.454 -0.898 . . . . 6.68 110.072 179.42 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -81.63 49.54 3.21 Favored 'Trans proline' 0 N--CA 1.483 0.897 0 C-N-CA 122.391 2.061 . . . . 6.02 111.188 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.439 HG22 ' HB3' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -122.64 94.33 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 CA-C-N 115.188 -0.914 . . . . 7.23 108.707 179.647 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.465 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -71.49 -0.67 11.0 Favored 'General case' 0 N--CA 1.493 1.716 0 C-N-CA 119.853 -0.739 . . . . 8.45 111.554 -179.558 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.499 HG22 ' N ' ' A' ' 59' ' ' VAL . 16.7 m -88.67 171.85 9.7 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-O 121.149 0.5 . . . . 5.37 110.434 -179.44 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.499 ' N ' HG22 ' A' ' 58' ' ' THR . 13.2 p -101.05 160.32 26.98 Favored Pre-proline 0 N--CA 1.494 1.741 0 CA-C-N 115.847 -0.615 . . . . 3.51 110.678 -179.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 73.2 Cg_endo -100.12 -163.77 0.54 Allowed 'Cis proline' 0 N--CA 1.484 0.967 0 CA-C-O 121.926 0.719 . . . . 1.93 111.344 -27.18 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 20.7 mp0 -124.58 155.24 39.4 Favored 'General case' 0 N--CA 1.493 1.691 0 CA-C-N 114.298 -1.319 . . . . 3.26 108.608 178.552 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.451 ' CD1' HG23 ' A' ' 5' ' ' ILE . 36.2 mm -121.97 146.05 27.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 123.984 0.803 . . . . 1.99 110.251 -179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.577 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 12.5 m-85 -123.22 130.67 53.07 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-N 113.727 -1.579 . . . . 1.2 107.257 179.114 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.528 HG23 HG13 ' A' ' 69' ' ' ILE . 55.3 t -109.81 138.06 39.17 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 C-N-CA 118.221 -1.391 . . . . 1.13 109.275 179.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 53.2 -81.53 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-N 113.2 -1.818 . . . . 3.06 111.716 -179.647 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 31.2 mm-40 -136.47 -2.64 2.2 Favored 'General case' 0 C--N 1.301 -1.525 0 O-C-N 123.601 0.563 . . . . 5.93 111.499 -179.293 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.479 ' CA ' HE21 ' A' ' 67' ' ' GLN . 0.0 OUTLIER -115.31 176.4 5.09 Favored 'General case' 0 C--N 1.305 -1.349 0 CA-C-O 121.423 0.63 . . . . 4.94 111.699 -178.422 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.599 ' CD2' ' HB1' ' A' ' 52' ' ' ALA . 0.2 OUTLIER -96.49 147.0 24.3 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 106.176 -1.787 . . . . 2.29 106.176 179.229 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.528 HG13 HG23 ' A' ' 64' ' ' VAL . 41.7 mm -116.14 -46.5 4.16 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 C-N-CA 118.703 -1.199 . . . . 1.17 110.414 -179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.69 -153.09 25.07 Favored Glycine 0 N--CA 1.498 2.812 0 C-N-CA 119.438 -1.363 . . . . 1.76 111.173 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -85.47 -170.47 47.15 Favored Glycine 0 N--CA 1.504 3.226 0 C-N-CA 119.242 -1.456 . . . . 1.46 112.149 -178.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.447 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 5.9 t80 -51.93 -45.09 64.17 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 120.069 -0.652 . . . . 2.11 109.836 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.2 p -64.34 -42.45 96.25 Favored 'General case' 0 C--N 1.305 -1.344 0 C-N-CA 119.349 -0.94 . . . . 1.32 109.297 179.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.478 ' CG ' ' NZ ' ' A' ' 54' ' ' LYS . 21.0 m-20 -62.32 -48.79 78.3 Favored 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 118.198 -1.401 . . . . 2.68 110.018 179.7 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.501 ' CD2' HD23 ' A' ' 20' ' ' LEU . 12.8 t80 -60.62 -51.81 67.81 Favored 'General case' 0 C--O 1.2 -1.5 0 C-N-CA 117.936 -1.506 . . . . 1.03 108.102 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -49.92 -52.79 30.52 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.453 -0.899 . . . . 0.93 111.077 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -68.04 -55.3 13.07 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.696 -0.802 . . . . 1.16 109.538 -179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 91.3 t90 -41.41 -47.46 3.6 Favored 'General case' 0 N--CA 1.496 1.846 0 N-CA-C 107.929 -1.137 . . . . 1.05 107.929 178.823 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.451 ' C ' ' H ' ' A' ' 81' ' ' GLU . 40.9 t -61.14 -57.69 10.98 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.381 0 N-CA-C 106.16 -1.793 . . . . 1.34 106.16 177.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.522 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 1.3 tmtm? -75.96 32.18 0.12 Allowed 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 119.83 -0.748 . . . . 3.72 110.427 179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.451 ' H ' ' C ' ' A' ' 79' ' ' VAL . 28.2 tt0 -132.37 -56.55 0.96 Allowed 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.511 0.672 . . . . 5.45 109.262 179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 60.4 m-80 -98.64 -11.54 21.97 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 114.857 -1.065 . . . . 2.15 111.155 -179.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 33.8 mt -108.23 -34.65 6.77 Favored 'General case' 0 N--CA 1.501 2.094 0 C-N-CA 118.76 -1.176 . . . . 2.36 108.842 178.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 18.9 m-20 -139.59 60.27 1.57 Allowed 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 119.161 -1.016 . . . . 6.06 110.541 179.485 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.522 ' C ' ' NZ ' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.51 2.548 0 CA-C-O 115.569 -2.158 . . . . 7.53 114.583 179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' N ' ' O ' ' A' ' 30' ' ' ASP . 69.0 mtm . . . . . 0 N--CA 1.485 1.28 0 N-CA-C 107.988 -1.116 . . . . 2.42 107.988 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.513 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 20.1 mt-30 -128.04 157.43 40.7 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 123.633 0.583 . . . . 3.48 110.029 179.662 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 35.9 m -141.6 141.71 33.46 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.819 -0.752 . . . . 0.7 112.065 -179.668 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 17.0 t -133.11 139.09 50.19 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.116 0 N-CA-C 106.539 -1.652 . . . . 0.74 106.539 179.598 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.496 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 4.6 mp -123.66 128.17 74.33 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.679 0 N-CA-C 108.354 -0.98 . . . . 1.99 108.354 -179.672 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 63.4 m-85 -97.37 61.12 1.67 Allowed 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 107.386 -1.339 . . . . 1.07 107.386 -179.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.443 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -104.96 -158.5 23.36 Favored Glycine 0 N--CA 1.483 1.82 0 N-CA-C 108.153 -1.979 . . . . 1.3 108.153 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.512 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 21.9 ttp-105 -127.73 169.29 13.99 Favored 'General case' 0 C--N 1.295 -1.773 0 N-CA-C 107.507 -1.294 . . . . 5.37 107.507 179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.3 p -52.72 -50.16 63.94 Favored 'General case' 0 C--N 1.3 -1.563 0 N-CA-C 108.182 -1.044 . . . . 4.41 108.182 179.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 11' ' ' CYS . . . -149.06 166.87 29.44 Favored Glycine 0 N--CA 1.488 2.14 0 C-N-CA 119.803 -1.189 . . . . 3.2 111.366 178.742 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.514 ' SG ' ' N ' ' A' ' 14' ' ' CYS . 14.4 p 167.84 42.51 0.0 OUTLIER Pre-proline 0 N--CA 1.506 2.366 0 CA-C-O 122.795 1.283 . . . . 3.7 108.407 178.551 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -20.94 -48.54 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 123.431 2.754 . . . . 3.05 112.765 -99.525 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -27.4 -40.77 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.414 0 O-C-N 124.772 1.295 . . . . 2.51 113.907 -179.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.514 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 85.1 m -53.59 -45.16 69.91 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.948 -0.701 . . . . 1.86 112.322 -179.542 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 84.3 t -58.34 -34.49 50.41 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.714 0 CA-C-N 115.887 -0.597 . . . . 1.03 111.081 -179.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.518 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 0.6 OUTLIER -50.96 -51.35 53.41 Favored 'General case' 0 N--CA 1.497 1.883 0 C-N-CA 118.882 -1.127 . . . . 4.0 112.043 -179.211 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.2 -42.66 81.67 Favored 'General case' 0 N--CA 1.495 1.811 0 C-N-CA 119.302 -0.959 . . . . 1.33 109.774 179.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.469 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 28.8 tttm -63.22 -52.99 59.98 Favored 'General case' 0 C--N 1.304 -1.405 0 CA-C-N 114.214 -1.357 . . . . 2.7 114.007 -179.012 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.495 ' O ' ' HB2' ' A' ' 23' ' ' LYS . 2.4 p30 -53.82 -34.04 58.01 Favored 'General case' 0 C--O 1.198 -1.651 0 C-N-CA 118.282 -1.367 . . . . 3.38 111.083 -178.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.1 tp -58.85 -42.44 89.34 Favored 'General case' 0 N--CA 1.506 2.349 0 C-N-CA 118.269 -1.372 . . . . 0.95 109.703 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -77.01 -47.93 19.34 Favored 'General case' 0 N--CA 1.499 1.988 0 C-N-CA 120.448 -0.501 . . . . 0.97 110.971 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.475 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 22.6 tt0 -59.29 -40.95 87.76 Favored 'General case' 0 N--CA 1.497 1.889 0 N-CA-C 107.845 -1.169 . . . . 3.31 107.845 179.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.536 ' HB2' ' NZ ' ' A' ' 23' ' ' LYS . 4.6 ttmp? -64.0 -55.85 19.37 Favored 'General case' 0 C--O 1.198 -1.639 0 N-CA-C 106.826 -1.546 . . . . 6.15 106.826 178.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.686 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 28.9 mt -46.96 -47.31 21.85 Favored 'General case' 0 N--CA 1.504 2.243 0 C-N-CA 119.915 -0.714 . . . . 1.16 110.445 178.462 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 39.6 m -57.87 -11.42 2.32 Favored 'General case' 0 N--CA 1.513 2.686 0 O-C-N 124.256 0.972 . . . . 1.71 112.541 179.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 t30 -114.83 -41.04 3.43 Favored 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 116.12 -0.491 . . . . 2.94 111.067 -179.224 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.686 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 13.0 pt-20 -74.65 -37.78 62.66 Favored 'General case' 0 N--CA 1.502 2.143 0 CA-C-N 115.254 -0.885 . . . . 3.8 111.708 -179.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.456 ' N ' ' HG3' ' A' ' 27' ' ' GLU . 3.3 ttp180 -114.22 -168.26 1.33 Allowed 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.388 0.613 . . . . 5.95 111.081 -178.285 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.453 ' O ' ' NE ' ' A' ' 28' ' ' ARG . 9.0 p-10 -124.12 -168.33 1.78 Allowed 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 105.521 -2.029 . . . . 3.98 105.521 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.547 ' O ' ' N ' ' A' ' 1' ' ' MET . 19.4 t70 37.53 41.39 0.28 Allowed 'General case' 0 N--CA 1.508 2.474 0 O-C-N 123.677 0.611 . . . . 3.43 110.543 178.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 39.6 t80 -142.38 93.07 2.49 Favored 'General case' 0 N--CA 1.493 1.695 0 C-N-CA 119.441 -0.903 . . . . 0.98 109.889 -179.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.513 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 11.7 mm100 -105.49 117.73 34.77 Favored 'General case' 0 C--N 1.29 -2.0 0 N-CA-C 106.592 -1.633 . . . . 4.07 106.592 179.367 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.475 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 0.0 OUTLIER -119.12 155.55 31.37 Favored 'General case' 0 C--N 1.293 -1.871 0 CA-C-N 114.984 -1.007 . . . . 2.14 112.157 -177.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -128.84 150.0 50.52 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 105.515 -2.031 . . . . 3.46 105.515 178.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 18' ' ' LYS . 26.0 t80 -112.08 145.58 39.5 Favored 'General case' 0 N--CA 1.492 1.629 0 C-N-CA 117.784 -1.566 . . . . 1.88 108.48 179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.496 ' HB ' ' O ' ' A' ' 5' ' ' ILE . 2.1 t -124.66 155.28 32.7 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 107.351 -1.351 . . . . 1.26 107.351 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.615 ' O ' ' N ' ' A' ' 39' ' ' ARG . 1.8 t70 -127.69 42.71 3.27 Favored 'General case' 0 N--CA 1.508 2.443 0 N-CA-C 112.831 0.678 . . . . 2.66 112.831 -176.805 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.49 HG13 ' H ' ' A' ' 39' ' ' ARG . 1.2 pt 31.83 -65.22 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 N-CA-C 114.97 1.47 . . . . 1.76 114.97 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.615 ' N ' ' O ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -56.21 -51.29 68.62 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 108.521 -0.918 . . . . 4.55 108.521 179.087 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -41.27 -42.83 2.25 Favored 'General case' 0 N--CA 1.496 1.856 0 CA-C-N 114.902 -1.044 . . . . 1.26 111.203 179.242 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.0 mt-10 -78.26 -47.85 17.01 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 107.995 -1.113 . . . . 4.42 107.995 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.52 46.4 0.92 Allowed Glycine 0 N--CA 1.49 2.279 0 N-CA-C 108.417 -1.873 . . . . 1.6 108.417 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.417 HG21 ' HG ' ' A' ' 48' ' ' LEU . 11.8 mm -89.23 155.77 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.031 0 C-N-CA 120.374 -0.53 . . . . 1.99 111.824 -178.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.479 ' O ' ' N ' ' A' ' 46' ' ' GLU . 34.2 p -126.47 95.29 4.31 Favored 'General case' 0 N--CA 1.502 2.146 0 CA-C-N 115.864 -0.607 . . . . 3.12 111.615 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.3 tttm 6.12 -64.6 0.0 OUTLIER 'General case' 0 N--CA 1.523 3.18 0 N-CA-C 116.656 2.095 . . . . 4.49 116.656 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.479 ' N ' ' O ' ' A' ' 44' ' ' THR . 6.6 mm-40 -47.86 -44.99 29.76 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 119.252 -0.979 . . . . 4.68 110.841 -179.257 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.468 ' O ' ' HG2' ' A' ' 51' ' ' LYS . 1.2 t70 -58.5 -37.65 76.01 Favored 'General case' 0 C--N 1.297 -1.685 0 CA-C-N 115.315 -0.857 . . . . 3.23 110.5 179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.432 ' HA ' ' CG ' ' A' ' 51' ' ' LYS . 6.7 mt -65.2 -45.86 83.08 Favored 'General case' 0 N--CA 1.494 1.763 0 N-CA-C 108.135 -1.061 . . . . 1.62 108.135 179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.432 ' NE2' ' HA ' ' A' ' 46' ' ' GLU . 13.1 mt-30 -49.99 -41.69 47.49 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 107.517 -1.29 . . . . 4.87 107.517 177.417 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -66.8 -60.74 2.41 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.608 -0.723 . . . . 5.23 112.496 179.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.576 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.1 OUTLIER -60.46 -37.68 81.74 Favored 'General case' 0 N--CA 1.501 2.108 0 C-N-CA 119.434 -0.906 . . . . 4.7 113.295 -178.988 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.551 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -86.55 -53.43 4.98 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-O 121.719 0.771 . . . . 1.85 110.481 -179.053 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 104.18 -55.73 0.59 Allowed Glycine 0 N--CA 1.486 2.031 0 N-CA-C 109.123 -1.591 . . . . 3.57 109.123 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -138.79 74.7 37.93 Favored Pre-proline 0 N--CA 1.498 1.968 0 C-N-CA 119.602 -0.839 . . . . 5.81 113.08 -178.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.427 ' HD3' ' CB ' ' A' ' 52' ' ' ALA . 11.9 Cg_endo -89.59 140.96 3.78 Favored 'Trans proline' 0 C--N 1.303 -1.84 0 C-N-CA 122.223 1.948 . . . . 8.38 107.615 126.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.5 t -102.91 -15.78 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.033 0 C-N-CA 119.971 -0.692 . . . . 5.56 110.043 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.524 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 1.5 pm0 -119.27 -105.21 0.39 Allowed 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 115.845 -0.616 . . . . 6.66 111.295 -179.164 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.426 ' H ' ' HG2' ' A' ' 57' ' ' GLU . 98.2 m -140.43 -57.09 0.53 Allowed 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.782 -0.767 . . . . 6.42 109.542 -179.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 42.1 t -112.63 151.63 44.06 Favored Pre-proline 0 C--N 1.302 -1.489 0 C-N-CA 119.662 -0.815 . . . . 4.43 109.018 -179.654 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' HG2' ' N ' ' A' ' 72' ' ' TYR . 12.9 Cg_endo -97.67 173.47 10.38 Favored 'Cis proline' 0 N--CA 1.49 1.29 0 O-C-N 122.619 0.799 . . . . 3.06 111.592 -14.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.497 ' N ' ' OE1' ' A' ' 61' ' ' GLN . 3.1 mp0 -130.97 119.97 22.84 Favored 'General case' 0 N--CA 1.5 2.055 0 N-CA-C 109.237 -0.653 . . . . 5.56 109.237 179.377 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.59 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -127.39 146.71 32.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 C-N-CA 119.511 -0.876 . . . . 1.2 111.309 -179.565 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.489 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 16.2 m-85 -126.86 133.05 50.81 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 113.01 -1.904 . . . . 1.03 107.035 179.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.605 HG11 ' CH2' ' A' ' 78' ' ' TRP . 85.5 t -131.76 150.6 34.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 C-N-CA 118.733 -1.187 . . . . 1.34 110.097 179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.429 ' C ' ' HG3' ' A' ' 66' ' ' GLN . 8.9 t70 60.12 -88.79 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.464 -1.698 . . . . 5.01 107.978 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.429 ' HG3' ' C ' ' A' ' 65' ' ' ASP . 36.5 mt-30 -139.27 -16.27 1.07 Allowed 'General case' 0 C--N 1.295 -1.779 0 O-C-N 124.209 0.943 . . . . 5.53 112.067 -179.798 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.424 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.2 OUTLIER -110.2 171.99 7.13 Favored 'General case' 0 C--N 1.313 -1.019 0 C-N-CA 119.756 -0.778 . . . . 3.59 113.085 -178.041 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.551 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 9.4 t-80 -81.0 153.55 27.37 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 105.858 -1.904 . . . . 1.23 105.858 178.412 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.436 HG13 HG23 ' A' ' 64' ' ' VAL . 12.2 mm -116.2 -43.87 3.56 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 C-N-CA 118.4 -1.32 . . . . 1.01 109.81 -178.895 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.512 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 139.93 -131.33 5.06 Favored Glycine 0 N--CA 1.493 2.491 0 N-CA-C 109.466 -1.454 . . . . 1.75 109.466 -179.568 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.441 ' H ' ' CG ' ' A' ' 74' ' ' ASP . . . -111.88 -154.27 12.55 Favored Glycine 0 N--CA 1.497 2.725 0 N-CA-C 110.756 -0.937 . . . . 1.44 110.756 179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.436 ' N ' ' HG2' ' A' ' 60' ' ' PRO . 26.9 t80 -57.67 -56.33 23.37 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 119.1 -1.04 . . . . 1.53 111.01 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -48.11 -38.24 17.24 Favored 'General case' 0 C--N 1.297 -1.69 0 C-N-CA 119.878 -0.729 . . . . 1.38 110.537 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.441 ' CG ' ' H ' ' A' ' 71' ' ' GLY . 1.2 m-20 -72.41 -59.42 2.74 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 115.051 -0.977 . . . . 2.48 110.259 -179.118 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.6 t80 -51.75 -45.8 63.82 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 108.471 -0.937 . . . . 1.48 108.471 179.491 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.16 -58.69 6.63 Favored 'General case' 0 C--N 1.299 -1.627 0 CA-C-N 114.931 -1.031 . . . . 0.85 109.272 178.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -58.13 -54.97 41.0 Favored 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 119.097 -1.041 . . . . 1.45 110.549 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.605 ' CH2' HG11 ' A' ' 64' ' ' VAL . 75.2 t90 -45.81 -53.81 9.04 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 119.413 -0.915 . . . . 1.65 109.131 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.452 HG13 HD12 ' A' ' 83' ' ' LEU . 25.0 t -47.25 -58.82 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.38 0 O-C-N 124.453 1.096 . . . . 0.9 108.213 179.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.464 ' NZ ' ' C ' ' A' ' 85' ' ' ALA . 2.1 tmtm? -56.29 -54.18 48.41 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 114.015 1.117 . . . . 3.43 114.015 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -59.3 -33.19 70.79 Favored 'General case' 0 N--CA 1.497 1.916 0 N-CA-C 113.519 0.933 . . . . 4.76 113.519 -178.014 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -101.78 -26.98 13.28 Favored 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 114.182 1.179 . . . . 1.57 114.182 -178.283 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.452 HD12 HG13 ' A' ' 79' ' ' VAL . 11.4 mt -93.24 -22.56 18.94 Favored 'General case' 0 N--CA 1.494 1.769 0 C-N-CA 118.367 -1.333 . . . . 1.73 111.52 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.497 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 6.3 m-20 -110.98 -50.95 2.9 Favored 'General case' 0 N--CA 1.495 1.776 0 C-N-CA 119.256 -0.977 . . . . 4.28 108.694 -179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.497 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.161 0 O-C-N 126.377 2.298 . . . . 6.08 107.013 -179.383 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.631 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 34.9 tpp . . . . . 0 N--CA 1.492 1.659 0 N-CA-C 108.284 -1.006 . . . . 2.74 108.284 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.521 ' H ' ' CG ' ' A' ' 65' ' ' ASP . 34.8 mt-30 -97.03 97.35 9.16 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 119.964 -0.694 . . . . 3.69 109.81 -178.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 4.3 m -83.02 114.22 21.12 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 119.513 -0.875 . . . . 1.16 109.895 -179.399 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 40.4 t -105.67 140.01 25.08 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 N-CA-C 108.077 -1.083 . . . . 1.0 108.077 179.752 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.444 ' CD1' ' HA ' ' A' ' 18' ' ' LYS . 17.8 mt -120.1 105.32 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.948 0 O-C-N 124.452 1.095 . . . . 2.32 110.428 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.45 ' O ' ' HA ' ' A' ' 60' ' ' PRO . 31.1 m-85 -84.53 93.86 8.44 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 108.28 -1.008 . . . . 1.01 108.28 -179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.635 ' CA ' ' SG ' ' A' ' 14' ' ' CYS . . . -106.76 -163.08 22.32 Favored Glycine 0 N--CA 1.483 1.823 0 N-CA-C 110.051 -1.22 . . . . 1.39 110.051 179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.515 ' N ' ' SG ' ' A' ' 11' ' ' CYS . 7.1 ttp-105 -141.43 46.68 1.7 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.284 -1.366 . . . . 5.94 111.902 -179.06 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.408 ' N ' ' OD2' ' A' ' 37' ' ' ASP . 14.4 m 69.61 -70.73 0.14 Allowed 'General case' 0 N--CA 1.514 2.739 0 N-CA-C 113.809 1.04 . . . . 3.79 113.809 178.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -108.14 66.89 0.23 Allowed Glycine 0 N--CA 1.5 2.957 0 C-N-CA 119.946 -1.121 . . . . 3.77 112.724 -177.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.515 ' SG ' ' N ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -134.81 113.68 11.81 Favored Pre-proline 0 C--N 1.293 -1.851 0 N-CA-C 107.327 -1.36 . . . . 2.4 107.327 178.318 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -46.01 -50.7 9.48 Favored 'Trans proline' 0 C--O 1.205 -1.171 0 N-CA-C 109.033 -1.18 . . . . 3.5 109.033 -175.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.45 ' HB3' ' HG2' ' A' ' 60' ' ' PRO . 3.7 m-85 -52.84 -36.13 58.31 Favored 'General case' 0 N--CA 1.492 1.627 0 CA-C-N 115.051 -0.977 . . . . 2.76 111.993 179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.635 ' SG ' ' CA ' ' A' ' 7' ' ' GLY . 71.0 m -66.36 -53.21 38.76 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 119.205 -0.998 . . . . 2.22 109.475 -179.587 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 50.1 t -62.08 -45.41 98.79 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-N 114.8 -1.091 . . . . 1.05 110.136 -179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.55 ' NH2' ' N ' ' A' ' 20' ' ' LEU . 0.7 OUTLIER -61.27 -47.48 85.83 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 115.815 -0.629 . . . . 3.83 110.484 -179.962 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -57.53 -47.91 80.71 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 107.058 -1.46 . . . . 0.81 107.058 178.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.475 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 5.7 tmtm? -56.96 -43.69 81.86 Favored 'General case' 0 C--N 1.309 -1.175 0 C-N-CA 118.512 -1.275 . . . . 2.07 109.715 178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.475 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 2.0 t0 -51.98 -51.25 58.5 Favored 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 107.74 -1.208 . . . . 3.32 107.74 178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.55 ' N ' ' NH2' ' A' ' 16' ' ' ARG . 31.4 tp -56.6 -52.09 66.17 Favored 'General case' 0 N--CA 1.499 1.975 0 C-N-CA 118.929 -1.108 . . . . 1.24 110.098 -179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.508 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -46.17 -51.89 13.29 Favored 'General case' 0 N--CA 1.497 1.921 0 C-N-CA 118.781 -1.168 . . . . 1.02 109.937 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.5 tp10 -44.3 -47.48 9.51 Favored 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 122.113 0.959 . . . . 3.04 110.71 179.264 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.43 ' NZ ' ' HG2' ' A' ' 27' ' ' GLU . 8.9 tmtm? -75.0 -45.95 38.45 Favored 'General case' 0 N--CA 1.489 1.499 0 C-N-CA 118.385 -1.326 . . . . 4.64 111.865 -179.091 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.443 HD21 ' CD1' ' A' ' 83' ' ' LEU . 1.3 mt -49.56 -48.52 48.46 Favored 'General case' 0 N--CA 1.51 2.566 0 C-N-CA 119.375 -0.93 . . . . 1.66 110.531 179.79 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 18.3 m -42.99 -32.55 0.66 Allowed 'General case' 0 N--CA 1.497 1.916 0 CA-C-N 113.297 -1.774 . . . . 1.57 109.579 178.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 54.8 m-80 -109.92 45.43 1.1 Allowed 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 114.856 -1.065 . . . . 2.66 109.863 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.43 ' HG2' ' NZ ' ' A' ' 23' ' ' LYS . 29.6 mm-40 -137.22 -54.46 0.7 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.729 -1.123 . . . . 3.89 110.103 178.696 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.418 ' NE ' ' HB3' ' A' ' 83' ' ' LEU . 50.1 mmt-85 -101.78 175.47 5.54 Favored 'General case' 0 C--N 1.301 -1.508 0 CA-C-N 114.875 -1.057 . . . . 4.84 109.658 -179.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.41 -51.24 17.99 Favored 'General case' 0 C--N 1.287 -2.116 0 CA-C-N 113.984 -1.462 . . . . 5.1 114.324 -177.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.418 ' O ' ' HB3' ' A' ' 1' ' ' MET . 37.3 t70 -118.2 82.08 1.78 Allowed 'General case' 0 N--CA 1.499 2.021 0 C-N-CA 119.336 -0.946 . . . . 4.26 111.7 -178.565 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 41.6 t80 -129.97 113.45 14.6 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 119.702 -0.799 . . . . 0.98 110.459 178.384 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 4.2 mp0 -118.06 157.87 26.04 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 105.682 -1.97 . . . . 3.79 105.682 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.508 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.9 p90 -156.39 153.48 29.0 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 117.562 -1.655 . . . . 1.2 111.29 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 10.2 tt0 -137.9 146.68 43.61 Favored 'General case' 0 N--CA 1.498 1.955 0 CA-C-N 115.183 -0.917 . . . . 3.25 109.724 179.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 43.2 t80 -94.97 144.43 25.69 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 107.264 -1.384 . . . . 1.18 107.264 179.15 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 3.1 t -140.99 155.8 21.9 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 123.752 0.657 . . . . 0.87 109.685 -179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.426 ' OD1' ' NH1' ' A' ' 39' ' ' ARG . 10.0 t70 -132.62 137.7 47.11 Favored 'General case' 0 N--CA 1.499 2.017 0 CA-C-O 121.474 0.654 . . . . 2.52 109.306 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.43 HD11 ' HG3' ' A' ' 8' ' ' ARG . 31.5 pt -53.7 -25.66 12.08 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 N-CA-C 113.392 0.886 . . . . 1.66 113.392 -178.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' NH1' ' OD1' ' A' ' 37' ' ' ASP . 29.8 mtm-85 -88.66 -14.05 38.33 Favored 'General case' 0 N--CA 1.506 2.33 0 C-N-CA 118.53 -1.268 . . . . 4.88 110.951 -179.932 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.47 -40.7 61.71 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 106.99 -1.485 . . . . 1.55 106.99 179.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -89.37 -41.45 12.12 Favored 'General case' 0 N--CA 1.49 1.55 0 CA-C-N 113.489 -1.687 . . . . 3.44 109.402 179.122 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 109.76 59.04 0.51 Allowed Glycine 0 N--CA 1.504 3.233 0 C-N-CA 119.653 -1.261 . . . . 1.73 111.116 179.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 29.2 mt -120.33 154.23 23.45 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 C-N-CA 119.827 -0.749 . . . . 1.99 110.386 -179.083 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 69.3 p -111.07 -160.72 0.72 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 106.052 -1.833 . . . . 2.32 106.052 179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 58' ' ' THR . 0.0 OUTLIER -99.13 18.43 17.44 Favored 'General case' 0 N--CA 1.499 1.995 0 C-N-CA 116.772 -1.971 . . . . 4.37 109.413 179.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -101.76 -62.94 1.19 Allowed 'General case' 0 C--N 1.295 -1.791 0 CA-C-N 113.724 -1.58 . . . . 4.01 110.993 -179.237 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.408 ' O ' ' N ' ' A' ' 50' ' ' GLN . 1.9 t70 -56.51 -42.92 79.22 Favored 'General case' 0 N--CA 1.506 2.371 0 C-N-CA 120.129 -0.628 . . . . 4.0 109.999 -179.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 2.2 mt -43.68 -38.57 3.18 Favored 'General case' 0 N--CA 1.497 1.914 0 C-N-CA 118.804 -1.159 . . . . 1.89 109.948 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.549 HE22 ' N ' ' A' ' 56' ' ' VAL . 39.1 mm-40 -53.12 -42.76 66.32 Favored 'General case' 0 N--CA 1.5 2.04 0 C-N-CA 118.869 -1.132 . . . . 4.68 109.219 178.635 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.408 ' N ' ' O ' ' A' ' 47' ' ' ASP . 73.3 mm-40 -78.05 -37.04 47.62 Favored 'General case' 0 N--CA 1.491 1.613 0 CA-C-N 114.812 -1.085 . . . . 6.22 111.665 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 6.4 mtpp -68.81 -37.42 79.22 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 119.595 -0.842 . . . . 4.38 111.372 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.566 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -88.58 -47.53 8.23 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 124.128 0.893 . . . . 2.0 111.301 -179.011 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 90.8 15.17 56.98 Favored Glycine 0 N--CA 1.497 2.727 0 N-CA-C 109.54 -1.424 . . . . 2.86 109.54 -179.621 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 6.5 tttm -118.85 140.01 27.99 Favored Pre-proline 0 C--N 1.305 -1.338 0 N-CA-C 107.136 -1.431 . . . . 5.92 107.136 -179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -82.49 142.62 11.82 Favored 'Trans proline' 0 C--N 1.315 -1.21 0 C-N-CA 120.914 1.076 . . . . 4.58 111.662 -165.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.549 ' N ' HE22 ' A' ' 49' ' ' GLN . 40.8 t 66.75 -66.17 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.505 2.307 0 N-CA-C 114.629 1.344 . . . . 5.42 114.629 178.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -45.92 144.55 1.77 Allowed 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 119.81 -0.756 . . . . 6.12 111.363 -178.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 45' ' ' LYS . 21.8 m -120.87 -65.12 1.17 Allowed 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 115.582 -0.735 . . . . 7.03 111.643 -178.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -132.34 154.76 81.7 Favored Pre-proline 0 N--CA 1.49 1.528 0 C-N-CA 120.206 -0.598 . . . . 3.69 110.254 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.45 ' HG2' ' HB3' ' A' ' 13' ' ' TYR . 9.5 Cg_endo -92.94 142.53 9.3 Favored 'Cis proline' 0 C--N 1.313 -1.311 0 C-N-CA 124.284 -1.132 . . . . 1.6 109.775 0.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 50.4 mm-40 -113.62 141.05 47.67 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.947 -1.101 . . . . 3.47 108.361 179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.561 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.5 mp -111.08 139.07 36.65 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 124.019 0.825 . . . . 1.36 108.954 -179.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 17.3 m-85 -118.32 122.49 43.0 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 103.634 -2.728 . . . . 1.41 103.634 179.118 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.631 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 50.3 t -99.53 83.83 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.836 0 C-N-CA 117.202 -1.799 . . . . 1.92 111.627 -178.03 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.521 ' CG ' ' H ' ' A' ' 2' ' ' GLN . 28.3 t0 72.85 -60.27 0.54 Allowed 'General case' 0 N--CA 1.496 1.86 0 CA-C-N 114.326 -1.307 . . . . 3.8 113.637 177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.406 ' HG3' ' H ' ' A' ' 67' ' ' GLN . 3.4 pt20 -106.36 -56.14 2.23 Favored 'General case' 0 C--N 1.3 -1.575 0 N-CA-C 115.337 1.606 . . . . 6.82 115.337 -177.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 66' ' ' GLN . 15.2 pt20 -118.86 176.2 5.39 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.318 1.229 . . . . 4.19 114.318 -177.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.566 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 12.3 t-80 -77.77 147.16 35.45 Favored 'General case' 0 N--CA 1.485 1.32 0 N-CA-C 106.872 -1.529 . . . . 1.59 106.872 178.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.571 HG13 ' CG2' ' A' ' 64' ' ' VAL . 34.4 mm -117.57 -29.36 2.0 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 C-N-CA 119.8 -0.76 . . . . 1.23 111.443 -178.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.404 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 133.84 -156.32 22.25 Favored Glycine 0 N--CA 1.493 2.459 0 N-CA-C 109.085 -1.606 . . . . 2.14 109.085 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -96.86 -170.74 34.03 Favored Glycine 0 N--CA 1.489 2.232 0 N-CA-C 109.502 -1.439 . . . . 1.48 109.502 -179.275 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 24.3 t80 -52.21 -36.38 51.99 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.641 -1.224 . . . . 1.41 110.446 -179.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 3.0 p -64.08 -61.46 2.25 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 118.37 -1.332 . . . . 1.57 109.836 -179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -54.18 -50.15 67.72 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 115.635 -0.711 . . . . 2.49 110.313 -178.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 88.6 t80 -60.19 -46.75 88.66 Favored 'General case' 0 C--O 1.197 -1.664 0 C-N-CA 119.543 -0.863 . . . . 1.04 109.003 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -55.86 -55.91 26.93 Favored 'General case' 0 N--CA 1.494 1.768 0 C-N-CA 119.598 -0.841 . . . . 0.95 110.411 179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -63.36 -58.7 6.24 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.186 -1.005 . . . . 1.2 108.756 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.42 ' O ' ' C ' ' A' ' 79' ' ' VAL . 61.8 t90 -40.66 -57.81 1.79 Allowed 'General case' 0 N--CA 1.495 1.808 0 CA-C-N 115.359 -0.837 . . . . 1.25 108.963 178.887 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.42 ' C ' ' O ' ' A' ' 78' ' ' TRP . 2.4 t -40.7 -51.69 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 N-CA-C 107.297 -1.372 . . . . 1.0 107.297 178.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.492 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -59.39 -60.96 3.02 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-N 114.451 -1.249 . . . . 2.83 110.406 179.538 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 11.7 mp0 -76.81 31.21 0.13 Allowed 'General case' 0 N--CA 1.506 2.355 0 N-CA-C 113.454 0.909 . . . . 4.34 113.454 -178.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -145.0 -40.0 0.25 Allowed 'General case' 0 N--CA 1.499 2.008 0 CA-C-N 115.972 -0.558 . . . . 1.77 110.704 178.374 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.443 ' CD1' HD21 ' A' ' 24' ' ' LEU . 35.7 mt -96.05 -26.12 15.64 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.036 -1.066 . . . . 1.56 111.325 -178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.424 ' OD2' ' HA ' ' A' ' 80' ' ' LYS . 44.7 m-20 -94.26 -42.21 9.05 Favored 'General case' 0 N--CA 1.504 2.27 0 N-CA-C 107.136 -1.431 . . . . 4.1 107.136 178.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.302 -1.461 0 CA-C-O 116.472 -1.727 . . . . 5.44 106.931 178.549 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' SD ' HD21 ' A' ' 83' ' ' LEU . 25.2 ttm . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.851 -1.166 . . . . 3.17 107.851 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 54.9 mt-30 -133.33 150.22 51.86 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 109.35 -0.611 . . . . 3.86 109.35 179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.443 ' H ' ' HA ' ' A' ' 33' ' ' TYR . 22.6 m -140.4 137.77 34.25 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 118.636 -1.226 . . . . 0.72 112.761 179.08 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 41.3 t -122.29 133.43 68.58 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.349 0 N-CA-C 108.432 -0.951 . . . . 0.58 108.432 178.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' HB1' ' A' ' 17' ' ' ALA . 22.0 mm -111.64 128.73 67.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.718 0 O-C-N 124.437 1.085 . . . . 1.54 108.265 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.596 ' CD2' HG11 ' A' ' 36' ' ' VAL . 30.6 m-85 -109.94 73.27 0.83 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.931 -1.137 . . . . 1.07 107.931 179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -133.71 -159.57 9.04 Favored Glycine 0 N--CA 1.492 2.416 0 N-CA-C 106.627 -2.589 . . . . 1.14 106.627 179.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.749 ' HG2' ' SG ' ' A' ' 11' ' ' CYS . 2.5 ptm180 -123.88 143.53 50.3 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 118.025 -1.47 . . . . 5.45 109.245 178.148 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 19.6 m -64.78 76.95 0.04 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 CA-C-N 113.35 -1.75 . . . . 4.19 108.952 -179.751 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.402 ' N ' ' O ' ' A' ' 8' ' ' ARG . . . 151.04 13.42 0.08 OUTLIER Glycine 0 N--CA 1.492 2.373 0 C-N-CA 120.189 -1.005 . . . . 2.59 111.889 -179.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.749 ' SG ' ' HG2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -119.98 124.91 27.61 Favored Pre-proline 0 N--CA 1.499 1.979 0 N-CA-C 108.585 -0.895 . . . . 2.38 108.585 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_exo -41.32 -64.21 0.26 Allowed 'Trans proline' 0 C--O 1.207 -1.063 0 C-N-CA 122.422 2.081 . . . . 2.98 112.017 -170.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -47.01 -38.83 11.48 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 119.922 -0.711 . . . . 3.55 112.553 -179.895 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.3 m -75.1 -57.94 3.59 Favored 'General case' 0 N--CA 1.488 1.447 0 CA-C-O 121.609 0.718 . . . . 2.18 109.306 -178.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 98.1 t -47.09 -41.85 6.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.519 0 CA-C-N 114.038 -1.437 . . . . 1.03 108.819 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.436 ' O ' ' C ' ' A' ' 17' ' ' ALA . 0.0 OUTLIER -70.26 -61.42 1.78 Allowed 'General case' 0 C--O 1.196 -1.734 0 CA-C-N 115.543 -0.753 . . . . 5.28 109.423 179.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 16' ' ' ARG . . . -40.37 -43.26 1.73 Allowed 'General case' 0 N--CA 1.502 2.164 0 C-N-CA 119.454 -0.898 . . . . 0.97 108.896 179.156 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.433 ' NZ ' ' OE1' ' A' ' 22' ' ' GLU . 12.6 tmtt? -60.2 -58.29 9.16 Favored 'General case' 0 C--N 1.306 -1.307 0 N-CA-C 107.349 -1.352 . . . . 2.21 107.349 178.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.4 t70 -48.48 -51.22 28.19 Favored 'General case' 0 N--CA 1.498 1.925 0 C-N-CA 119.843 -0.743 . . . . 3.62 109.648 177.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.449 HD23 ' CD2' ' A' ' 75' ' ' PHE . 44.2 tp -52.2 -54.02 36.16 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 109.002 -0.74 . . . . 0.84 109.002 179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -55.3 -57.0 13.62 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 119.295 -0.962 . . . . 0.77 109.509 179.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.433 ' OE1' ' NZ ' ' A' ' 18' ' ' LYS . 13.7 tt0 -51.91 -40.28 60.48 Favored 'General case' 0 N--CA 1.492 1.67 0 CA-C-N 115.156 -0.929 . . . . 3.06 110.966 -179.575 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 24.1 tptp -60.48 -60.17 4.24 Favored 'General case' 0 C--N 1.299 -1.616 0 N-CA-C 107.722 -1.214 . . . . 3.54 107.722 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.654 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 53.5 mt -47.0 -52.37 14.92 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 119.233 -0.987 . . . . 1.07 111.564 -179.297 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 69.1 m -39.84 -24.64 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.973 0 N-CA-C 114.288 1.218 . . . . 1.43 114.288 179.705 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -118.8 -30.72 5.01 Favored 'General case' 0 C--N 1.3 -1.586 0 C-N-CA 120.19 -0.604 . . . . 3.28 111.824 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.654 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 0.5 OUTLIER -80.71 -19.74 44.41 Favored 'General case' 0 N--CA 1.498 1.948 0 C-N-CA 119.922 -0.711 . . . . 3.77 111.149 -179.959 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.531 HH12 ' CB ' ' A' ' 84' ' ' ASP . 0.4 OUTLIER -111.93 -154.78 0.55 Allowed 'General case' 0 C--N 1.303 -1.413 0 CA-C-N 114.674 -1.148 . . . . 5.06 108.423 -179.439 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -115.81 -79.14 0.58 Allowed 'General case' 0 N--CA 1.504 2.23 0 N-CA-C 114.009 1.114 . . . . 4.01 114.009 -177.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.444 ' O ' ' N ' ' A' ' 1' ' ' MET . 9.4 p-10 -93.84 60.83 2.97 Favored 'General case' 0 N--CA 1.499 1.98 0 C-N-CA 119.632 -0.827 . . . . 3.46 111.003 -177.786 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -116.32 99.96 7.56 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.914 -1.114 . . . . 0.9 112.069 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.465 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 56.9 mm-40 -104.92 161.99 13.72 Favored 'General case' 0 C--N 1.301 -1.536 0 N-CA-C 107.256 -1.387 . . . . 3.68 107.256 178.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.443 ' HA ' ' H ' ' A' ' 3' ' ' THR . 40.2 p90 -159.12 166.46 31.49 Favored 'General case' 0 C--N 1.294 -1.834 0 C-N-CA 118.552 -1.259 . . . . 1.73 109.253 179.327 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -139.01 146.48 40.91 Favored 'General case' 0 C--N 1.293 -1.87 0 N-CA-C 106.746 -1.575 . . . . 3.35 106.746 179.247 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.2 t80 -105.76 135.02 47.93 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 117.873 -1.531 . . . . 1.05 107.906 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.596 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.0 t -119.51 144.15 28.85 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.84 0 N-CA-C 105.859 -1.904 . . . . 0.7 105.859 179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.639 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 6.0 t70 -117.25 102.22 9.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.344 -0.942 . . . . 2.37 111.295 -178.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 30.4 pt -49.97 -23.91 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 CA-C-N 114.858 -1.065 . . . . 2.26 111.17 -179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 5.8 mmp_? -87.8 -61.2 1.77 Allowed 'General case' 0 N--CA 1.487 1.406 0 C-N-CA 118.182 -1.407 . . . . 8.42 108.618 179.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.639 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -47.41 -43.15 23.42 Favored 'General case' 0 N--CA 1.502 2.172 0 O-C-N 123.789 0.681 . . . . 2.6 112.836 -178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -75.19 -34.8 61.55 Favored 'General case' 0 N--CA 1.498 1.96 0 C-N-CA 119.89 -0.724 . . . . 2.39 112.025 -178.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.51 50.49 1.2 Allowed Glycine 0 N--CA 1.505 3.257 0 C-N-CA 119.89 -1.148 . . . . 1.97 110.722 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.436 ' CG2' ' HG ' ' A' ' 48' ' ' LEU . 76.2 mt -109.71 143.24 20.19 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 C-N-CA 120.161 -0.616 . . . . 1.52 111.325 -178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 20.0 p -110.96 -97.67 0.41 Allowed 'General case' 0 N--CA 1.494 1.749 0 N-CA-C 108.474 -0.936 . . . . 2.17 108.474 179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.403 ' CE ' ' O ' ' A' ' 56' ' ' VAL . 29.3 tttm -134.31 -54.31 0.85 Allowed 'General case' 0 N--CA 1.498 1.934 0 N-CA-C 108.619 -0.882 . . . . 5.98 108.619 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -42.84 -52.81 4.92 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.371 -1.286 . . . . 4.66 110.97 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -54.01 -72.77 0.05 Allowed 'General case' 0 N--CA 1.506 2.364 0 C-N-CA 118.905 -1.118 . . . . 4.31 108.932 179.533 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.436 ' HG ' ' CG2' ' A' ' 43' ' ' ILE . 83.4 mt -35.12 -49.62 0.48 Allowed 'General case' 0 N--CA 1.506 2.358 0 N-CA-C 112.541 0.571 . . . . 3.22 112.541 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 26.1 mt-30 -46.41 -50.84 16.14 Favored 'General case' 0 N--CA 1.501 2.111 0 C-N-CA 119.828 -0.749 . . . . 5.35 109.545 -179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 16.5 mm100 -43.34 -36.73 1.98 Allowed 'General case' 0 N--CA 1.5 2.059 0 O-C-N 124.027 0.83 . . . . 6.15 111.568 179.387 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.5 ' NZ ' ' CE1' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -95.68 -11.45 27.08 Favored 'General case' 0 N--CA 1.495 1.801 0 N-CA-C 113.984 1.105 . . . . 4.86 113.984 -178.295 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -121.57 -47.25 2.22 Favored 'General case' 0 N--CA 1.506 2.333 0 C-N-CA 119.325 -0.95 . . . . 2.67 112.925 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 93.0 49.05 2.74 Favored Glycine 0 N--CA 1.484 1.898 0 N-CA-C 106.437 -2.665 . . . . 3.15 106.437 -177.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 2.4 mmpt? -123.14 78.43 52.01 Favored Pre-proline 0 N--CA 1.505 2.325 0 N-CA-C 112.182 0.438 . . . . 5.95 112.182 -179.03 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -77.53 33.77 0.45 Allowed 'Trans proline' 0 C--N 1.314 -1.244 0 C-N-CA 121.677 1.584 . . . . 7.25 111.732 -176.729 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 ' O ' ' CE ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -132.27 -81.96 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.059 0 N-CA-C 108.908 -0.775 . . . . 6.22 108.908 179.868 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 58' ' ' THR . 20.1 pm0 -96.79 -165.46 1.27 Allowed 'General case' 0 N--CA 1.492 1.63 0 N-CA-C 106.369 -1.715 . . . . 5.28 106.369 178.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.527 ' HB ' ' O ' ' A' ' 57' ' ' GLU . 10.1 t 177.43 -24.26 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.993 -1.083 . . . . 8.39 112.698 -179.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.468 ' HA ' ' HA ' ' A' ' 60' ' ' PRO . 16.3 t -117.33 138.83 25.35 Favored Pre-proline 0 N--CA 1.502 2.138 0 C-N-CA 119.488 -0.885 . . . . 3.77 110.485 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.468 ' HA ' ' HA ' ' A' ' 59' ' ' VAL . 56.6 Cg_endo -86.86 166.78 46.51 Favored 'Cis proline' 0 N--CA 1.493 1.458 0 C-N-CA 125.105 -0.79 . . . . 2.85 110.126 -23.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 81.1 mt-30 -140.76 161.92 36.65 Favored 'General case' 0 N--CA 1.5 2.072 0 C-N-CA 119.518 -0.873 . . . . 3.08 111.787 179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.528 HD12 ' N ' ' A' ' 62' ' ' ILE . 4.9 mp -122.94 146.08 28.8 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-N 114.127 -1.397 . . . . 1.37 108.243 178.868 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.5 ' CE1' ' NZ ' ' A' ' 51' ' ' LYS . 9.6 m-85 -123.8 127.18 47.72 Favored 'General case' 0 C--N 1.29 -1.994 0 CA-C-N 113.027 -1.897 . . . . 1.75 106.483 179.076 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.513 ' CG2' HG13 ' A' ' 69' ' ' ILE . 38.9 t -109.72 136.02 46.92 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 C-N-CA 117.996 -1.481 . . . . 0.98 107.863 179.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 52.84 -89.22 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.638 0 O-C-N 124.314 1.009 . . . . 2.85 108.383 -178.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.436 ' N ' ' O ' ' A' ' 64' ' ' VAL . 8.3 mm-40 -141.99 3.95 1.63 Allowed 'General case' 0 N--CA 1.495 1.801 0 O-C-N 123.744 0.653 . . . . 5.39 111.151 179.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 37.8 tp60 -107.7 152.82 23.81 Favored 'General case' 0 C--N 1.303 -1.435 0 CA-C-O 121.087 0.47 . . . . 5.14 111.138 -178.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.48 ' HA ' ' CD1' ' A' ' 63' ' ' PHE . 35.9 t-80 -77.77 141.29 39.35 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 106.415 -1.698 . . . . 1.79 106.415 179.24 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.513 HG13 ' CG2' ' A' ' 64' ' ' VAL . 42.2 mm -115.42 -45.97 4.28 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.835 0 C-N-CA 118.235 -1.386 . . . . 1.13 109.253 -179.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 138.66 -137.0 8.39 Favored Glycine 0 N--CA 1.491 2.351 0 C-N-CA 119.466 -1.35 . . . . 1.76 110.275 179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -108.29 -166.94 21.22 Favored Glycine 0 N--CA 1.495 2.568 0 C-N-CA 120.754 -0.736 . . . . 1.57 111.54 -178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 21.4 t80 -55.16 -66.61 0.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 119.994 -0.683 . . . . 2.11 112.424 -178.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -37.05 -51.37 0.95 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 113.096 0.776 . . . . 1.84 113.096 -179.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.2 p-10 -74.95 -52.87 10.1 Favored 'General case' 0 N--CA 1.5 2.046 0 C-N-CA 119.174 -1.01 . . . . 2.92 111.178 -179.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.449 ' CD2' HD23 ' A' ' 20' ' ' LEU . 44.3 t80 -49.62 -38.29 31.35 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.817 -1.153 . . . . 0.88 108.899 179.202 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.4 ' O ' ' HB ' ' A' ' 79' ' ' VAL . . . -58.74 -65.61 0.63 Allowed 'General case' 0 N--CA 1.49 1.565 0 CA-C-N 114.149 -1.387 . . . . 0.93 110.319 179.255 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.38 -54.87 41.91 Favored 'General case' 0 N--CA 1.492 1.655 0 C-N-CA 118.894 -1.122 . . . . 1.15 108.113 179.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.468 ' HH2' ' SD ' ' A' ' 1' ' ' MET . 57.2 t90 -41.15 -51.05 3.5 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 124.263 0.977 . . . . 1.49 109.93 179.214 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.402 HG12 ' N ' ' A' ' 80' ' ' LYS . 2.1 t -48.74 -61.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 CA-C-N 114.803 -1.089 . . . . 1.02 108.464 178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.52 ' HZ3' ' HB3' ' A' ' 84' ' ' ASP . 5.9 tmtm? -53.58 -46.63 70.38 Favored 'General case' 0 N--CA 1.495 1.779 0 C-N-CA 119.967 -0.693 . . . . 2.86 112.673 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 84.4 mt-10 -56.44 -55.72 30.17 Favored 'General case' 0 C--N 1.298 -1.636 0 CA-C-N 114.504 -1.225 . . . . 3.74 113.564 -178.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.0 m-80 -89.06 -27.09 21.03 Favored 'General case' 0 C--N 1.296 -1.736 0 N-CA-C 114.739 1.385 . . . . 2.01 114.739 -176.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.538 HD21 ' SD ' ' A' ' 1' ' ' MET . 60.4 mt -89.38 -19.24 25.45 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 118.157 -1.417 . . . . 1.58 111.894 -179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.531 ' CB ' HH12 ' A' ' 28' ' ' ARG . 10.3 t70 -121.71 -47.47 2.2 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.487 -1.285 . . . . 4.32 110.637 -178.767 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.495 ' C ' ' HZ1' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.509 2.52 0 O-C-N 125.531 1.769 . . . . 6.17 108.453 179.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.427 ' N ' ' OD1' ' A' ' 30' ' ' ASP . 71.2 mtm . . . . . 0 N--CA 1.488 1.47 0 N-CA-C 109.123 -0.695 . . . . 1.99 109.123 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 5.8 mt-30 -126.65 123.92 38.69 Favored 'General case' 0 C--O 1.205 -1.27 0 N-CA-C 108.265 -1.013 . . . . 4.14 108.265 -179.212 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 86.4 m -120.34 139.16 53.17 Favored 'General case' 0 N--CA 1.508 2.439 0 C-N-CA 118.875 -1.13 . . . . 0.96 110.026 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.467 ' C ' HD12 ' A' ' 5' ' ' ILE . 17.3 t -119.25 125.42 74.43 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.287 0 C-N-CA 119.803 -0.759 . . . . 0.62 109.317 179.45 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.587 ' N ' HD12 ' A' ' 5' ' ' ILE . 1.6 mp -106.75 117.96 53.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 124.882 1.364 . . . . 2.07 107.928 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.405 ' CD1' ' N ' ' A' ' 6' ' ' PHE . 15.4 m-85 -98.23 93.46 6.25 Favored 'General case' 0 N--CA 1.495 1.791 0 N-CA-C 107.828 -1.175 . . . . 1.11 107.828 -179.813 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -115.88 -170.67 16.02 Favored Glycine 0 N--CA 1.505 3.243 0 C-N-CA 119.771 -1.204 . . . . 0.93 110.897 -179.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.529 ' HB2' ' SG ' ' A' ' 11' ' ' CYS . 22.0 mtp180 -126.81 27.28 6.05 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 120.086 -0.646 . . . . 6.35 109.292 179.407 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' ARG . 59.3 m 34.25 52.52 0.51 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 123.59 0.556 . . . . 3.6 111.111 -178.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 154.1 52.44 0.01 OUTLIER Glycine 0 N--CA 1.494 2.524 0 N-CA-C 109.799 -1.32 . . . . 3.58 109.799 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.529 ' SG ' ' HB2' ' A' ' 8' ' ' ARG . 0.8 OUTLIER -151.71 72.38 8.1 Favored Pre-proline 0 C--N 1.297 -1.717 0 N-CA-C 107.623 -1.251 . . . . 3.3 107.623 179.28 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.7 Cg_exo -29.2 -59.07 0.13 Allowed 'Trans proline' 0 N--CA 1.489 1.221 0 C-N-CA 123.202 2.601 . . . . 2.72 113.796 -139.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 49.8 m-85 -39.88 -38.97 0.75 Allowed 'General case' 0 N--CA 1.507 2.39 0 C-N-CA 120.603 -0.439 . . . . 4.79 112.0 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.404 ' SG ' ' HB3' ' A' ' 60' ' ' PRO . 92.2 m -51.05 -46.09 61.55 Favored 'General case' 0 N--CA 1.498 1.949 0 CA-C-N 115.284 -0.871 . . . . 2.42 110.426 179.806 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 59.8 t -55.93 -48.2 78.88 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.772 0 C-N-CA 119.651 -0.82 . . . . 1.16 110.848 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.497 HH22 ' CG ' ' A' ' 19' ' ' ASP . 0.0 OUTLIER -42.98 -48.69 5.98 Favored 'General case' 0 N--CA 1.503 2.182 0 C-N-CA 119.709 -0.796 . . . . 4.51 111.063 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -45.99 -44.86 15.38 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 119.591 -0.844 . . . . 0.9 110.571 179.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.5 ' HD3' ' C ' ' A' ' 18' ' ' LYS . 5.2 tmtm? -63.77 -54.44 35.2 Favored 'General case' 0 C--O 1.199 -1.603 0 N-CA-C 108.385 -0.969 . . . . 2.79 108.385 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.497 ' CG ' HH22 ' A' ' 16' ' ' ARG . 1.0 OUTLIER -52.56 -43.09 65.0 Favored 'General case' 0 N--CA 1.495 1.788 0 CA-C-N 115.799 -0.637 . . . . 3.13 111.699 179.758 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.414 ' O ' ' HB3' ' A' ' 23' ' ' LYS . 39.2 tp -71.66 -49.41 40.1 Favored 'General case' 0 C--N 1.299 -1.62 0 C-N-CA 120.028 -0.669 . . . . 0.97 109.831 -179.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.68 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -57.29 -42.97 82.71 Favored 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 107.104 -1.443 . . . . 0.61 107.104 179.099 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.451 ' O ' ' C ' ' A' ' 23' ' ' LYS . 0.6 OUTLIER -55.14 -57.86 10.04 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.586 -1.264 . . . . 2.82 107.586 178.756 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.451 ' C ' ' O ' ' A' ' 22' ' ' GLU . 60.8 tttp -37.43 -61.77 0.57 Allowed 'General case' 0 N--CA 1.484 1.259 0 CA-C-N 114.32 -1.309 . . . . 3.78 108.911 178.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 29.4 mt -56.45 -56.92 15.18 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 119.776 -0.77 . . . . 1.72 112.564 -179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 3.3 p -52.48 -15.43 0.66 Allowed 'General case' 0 N--CA 1.504 2.254 0 N-CA-C 114.04 1.126 . . . . 1.55 114.04 -179.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.1 t30 -107.41 -44.5 4.3 Favored 'General case' 0 N--CA 1.509 2.512 0 C-N-CA 119.842 -0.743 . . . . 3.08 110.508 179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -79.73 -19.43 48.81 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 113.898 -1.501 . . . . 3.66 112.782 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.5 ' NH1' ' HB3' ' A' ' 30' ' ' ASP . 0.0 OUTLIER -118.69 -178.36 3.52 Favored 'General case' 0 N--CA 1.495 1.789 0 CA-C-N 115.789 -0.641 . . . . 6.48 109.954 -179.747 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -116.08 -59.62 1.96 Allowed 'General case' 0 N--CA 1.507 2.39 0 N-CA-C 113.048 0.759 . . . . 3.76 113.048 -179.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.5 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.5 t70 -78.08 52.74 1.11 Allowed 'General case' 0 N--CA 1.501 2.105 0 CA-C-O 121.889 0.852 . . . . 3.29 111.786 -179.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 64.6 t80 -145.71 92.53 2.23 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.287 -0.883 . . . . 0.96 111.521 179.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.528 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 17.7 mp0 -105.14 126.76 52.44 Favored 'General case' 0 C--N 1.3 -1.558 0 N-CA-C 104.604 -2.369 . . . . 3.31 104.604 178.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.68 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 2.3 p90 -127.03 157.57 39.25 Favored 'General case' 0 C--N 1.289 -2.032 0 C-N-CA 118.813 -1.155 . . . . 1.48 109.549 -179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 5.3 tp-100 -131.23 140.62 49.89 Favored 'General case' 0 C--N 1.298 -1.645 0 N-CA-C 108.495 -0.928 . . . . 3.79 108.495 178.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 69.6 t80 -99.83 131.01 46.07 Favored 'General case' 0 C--N 1.301 -1.502 0 C-N-CA 118.936 -1.106 . . . . 1.26 108.045 -179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.9 t -117.2 145.47 22.95 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.695 0 CA-C-N 114.689 -1.141 . . . . 0.71 108.932 -179.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -118.52 116.72 27.24 Favored 'General case' 0 N--CA 1.491 1.595 0 N-CA-C 106.436 -1.69 . . . . 2.66 106.436 179.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.427 HG12 ' HG2' ' A' ' 8' ' ' ARG . 2.7 pt -51.32 -27.7 6.92 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.666 0 C-N-CA 118.319 -1.352 . . . . 1.32 112.416 -178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -85.6 -8.65 58.14 Favored 'General case' 0 N--CA 1.51 2.553 0 C-N-CA 119.067 -1.053 . . . . 6.22 113.071 -178.647 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -93.21 -37.6 12.0 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 119.392 -0.923 . . . . 1.47 108.89 179.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 91.7 mt-10 -87.03 -37.48 17.44 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.978 -0.689 . . . . 2.56 110.826 179.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 110.84 52.07 0.59 Allowed Glycine 0 N--CA 1.505 3.253 0 N-CA-C 110.105 -1.198 . . . . 1.42 110.105 179.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 69.3 mt -112.2 137.12 46.17 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.765 0 CA-C-N 114.899 -0.65 . . . . 1.6 109.363 -178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.3 p -103.41 -101.31 0.3 Allowed 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 107.145 -1.428 . . . . 2.67 107.145 179.46 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 18.3 pttp -138.97 -47.45 0.49 Allowed 'General case' 0 C--N 1.295 -1.788 0 N-CA-C 105.557 -2.016 . . . . 6.44 105.557 177.505 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 3.4 mp0 -46.07 -52.35 12.14 Favored 'General case' 0 N--CA 1.497 1.921 0 N-CA-C 108.018 -1.104 . . . . 3.52 108.018 177.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.444 ' O ' ' HB3' ' A' ' 50' ' ' GLN . 24.4 m-20 -44.93 -57.28 3.9 Favored 'General case' 0 N--CA 1.502 2.154 0 CA-C-N 114.735 -1.121 . . . . 4.35 111.611 179.402 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.4 ' HB3' ' OE1' ' A' ' 61' ' ' GLN . 77.1 mt -56.04 -53.66 54.31 Favored 'General case' 0 C--N 1.303 -1.414 0 CA-C-N 114.003 -1.453 . . . . 1.86 110.334 -179.195 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 66.5 mt-30 -51.24 -47.04 62.5 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 118.991 -1.083 . . . . 3.86 109.022 -179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB3' ' O ' ' A' ' 47' ' ' ASP . 0.2 OUTLIER -51.69 -45.13 63.37 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 119.819 -0.752 . . . . 6.03 108.998 178.229 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.472 ' O ' ' NZ ' ' A' ' 51' ' ' LYS . 0.2 OUTLIER -68.37 0.81 3.49 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-N 114.863 -1.062 . . . . 4.03 113.472 -179.917 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' CB ' ' HG3' ' A' ' 55' ' ' PRO . . . -129.89 -44.76 1.18 Allowed 'General case' 0 N--CA 1.5 2.058 0 C-N-CA 118.942 -1.103 . . . . 2.83 112.272 -178.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 129.44 -58.82 0.7 Allowed Glycine 0 N--CA 1.491 2.303 0 N-CA-C 110.107 -1.197 . . . . 4.76 110.107 -179.452 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.574 ' N ' ' HD3' ' A' ' 55' ' ' PRO . 55.1 pttt -165.2 62.6 0.88 Allowed Pre-proline 0 N--CA 1.504 2.231 0 C-N-CA 119.201 -1.0 . . . . 11.28 112.844 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.574 ' HD3' ' N ' ' A' ' 54' ' ' LYS . 10.1 Cg_endo -96.74 159.6 1.15 Allowed 'Trans proline' 0 C--N 1.317 -1.103 0 C-N-CA 121.156 1.238 . . . . 6.44 112.041 172.288 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 27.5 m -112.75 -20.81 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 CA-C-N 115.013 -0.994 . . . . 4.78 108.649 178.797 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.714 ' CD ' ' H ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -72.8 70.45 0.98 Allowed 'General case' 0 N--CA 1.49 1.559 0 CA-C-N 114.511 -1.222 . . . . 5.55 108.123 179.609 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 3.2 t -42.43 -45.66 4.46 Favored 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 115.389 -0.823 . . . . 6.6 110.465 179.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.404 HG13 ' HA ' ' A' ' 60' ' ' PRO . 57.3 t -142.76 152.45 59.37 Favored Pre-proline 0 N--CA 1.488 1.449 0 N-CA-C 108.891 -0.781 . . . . 2.63 108.891 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.444 ' O ' ' HA2' ' A' ' 71' ' ' GLY . 12.0 Cg_endo -84.26 166.8 60.23 Favored 'Cis proline' 0 N--CA 1.486 1.049 0 O-C-N 123.426 1.224 . . . . 1.98 109.885 -17.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.493 ' HA ' ' HA2' ' A' ' 71' ' ' GLY . 82.4 mt-30 -139.76 153.99 47.3 Favored 'General case' 0 N--CA 1.5 2.044 0 C-N-CA 119.074 -1.05 . . . . 2.74 111.436 179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 85.1 mt -134.07 150.97 31.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 CA-C-O 122.703 1.24 . . . . 1.74 112.623 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.49 ' CD2' ' HA ' ' A' ' 68' ' ' HIS . 61.4 m-85 -135.87 126.35 26.85 Favored 'General case' 0 C--N 1.3 -1.548 0 CA-C-N 112.62 -2.082 . . . . 1.18 108.852 178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.586 HG23 HG13 ' A' ' 69' ' ' ILE . 58.9 t -96.62 121.26 46.96 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 105.903 -1.888 . . . . 1.19 105.903 178.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 53.16 -87.65 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.461 0 O-C-N 123.902 0.751 . . . . 2.62 111.672 -178.739 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -133.91 12.76 3.99 Favored 'General case' 0 N--CA 1.494 1.736 0 C-N-CA 119.238 -0.985 . . . . 4.47 112.913 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -111.83 156.73 21.53 Favored 'General case' 0 C--N 1.308 -1.221 0 C-N-CA 119.877 -0.729 . . . . 3.91 109.699 179.791 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.49 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 11.7 t-160 -90.92 138.34 31.67 Favored 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.025 -1.102 . . . . 1.54 108.025 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.586 HG13 HG23 ' A' ' 64' ' ' VAL . 9.7 mm -110.71 -31.73 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 C-N-CA 118.523 -1.271 . . . . 0.9 110.547 -179.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 128.96 -138.47 10.29 Favored Glycine 0 N--CA 1.489 2.23 0 C-N-CA 119.295 -1.431 . . . . 1.96 109.764 -179.777 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.493 ' HA2' ' HA ' ' A' ' 61' ' ' GLN . . . -94.29 -89.09 1.67 Allowed Glycine 0 N--CA 1.488 2.137 0 C-N-CA 119.583 -1.294 . . . . 2.41 111.476 -178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 64.5 t80 -138.12 -55.32 0.65 Allowed 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 118.849 -1.14 . . . . 1.72 109.49 -179.793 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -43.04 -48.27 6.05 Favored 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.274 -1.01 . . . . 1.33 108.274 178.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -54.07 -64.95 0.66 Allowed 'General case' 0 C--N 1.296 -1.718 0 CA-C-N 113.379 -1.737 . . . . 3.3 110.296 178.777 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 45.1 t80 -51.55 -46.15 63.29 Favored 'General case' 0 N--CA 1.498 1.943 0 C-N-CA 119.246 -0.982 . . . . 1.11 109.25 179.675 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -50.77 -53.47 31.5 Favored 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 108.297 -1.001 . . . . 0.84 108.297 179.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.409 ' O ' ' N ' ' A' ' 81' ' ' GLU . . . -55.47 -56.26 22.29 Favored 'General case' 0 C--O 1.198 -1.643 0 N-CA-C 107.933 -1.136 . . . . 0.98 107.933 178.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 69.9 t90 -50.16 -34.28 21.85 Favored 'General case' 0 N--CA 1.512 2.651 0 O-C-N 123.43 0.456 . . . . 1.3 110.631 179.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 35.0 t -71.49 -44.32 71.18 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 N-CA-C 108.421 -0.955 . . . . 1.8 108.421 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.495 ' NZ ' ' OD1' ' A' ' 84' ' ' ASP . 0.2 OUTLIER -82.25 -65.8 0.97 Allowed 'General case' 0 C--N 1.294 -1.819 0 C-N-CA 118.443 -1.303 . . . . 3.07 111.602 -179.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.409 ' N ' ' O ' ' A' ' 77' ' ' ALA . 41.9 mt-10 -62.21 0.77 0.38 Allowed 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 117.272 2.323 . . . . 4.71 117.272 -177.463 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -134.48 -26.94 1.39 Allowed 'General case' 0 C--N 1.294 -1.845 0 C-N-CA 119.32 -0.952 . . . . 2.67 112.233 179.655 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 36.4 mt -85.67 -21.98 28.1 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 118.281 -1.368 . . . . 1.95 112.713 179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.495 ' OD1' ' NZ ' ' A' ' 80' ' ' LYS . 30.7 p30 -117.3 39.79 3.19 Favored 'General case' 0 N--CA 1.508 2.452 0 C-N-CA 117.108 -1.837 . . . . 4.59 112.325 -179.547 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.497 1.884 0 CA-C-O 116.172 -1.87 . . . . 5.52 110.05 179.601 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.634 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.667 0 CA-C-O 122.951 1.358 . . . . 2.82 109.16 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 6.7 mp0 -121.02 126.5 50.06 Favored 'General case' 0 C--N 1.299 -1.618 0 N-CA-C 105.829 -1.915 . . . . 5.97 105.829 -179.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.424 HG23 HG22 ' A' ' 64' ' ' VAL . 60.4 m -112.72 144.67 41.85 Favored 'General case' 0 N--CA 1.49 1.552 0 C-N-CA 118.275 -1.37 . . . . 0.95 113.192 -178.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 3.5 t -123.0 117.56 52.11 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.328 0 N-CA-C 105.941 -1.874 . . . . 1.08 105.941 178.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.406 HD13 HG23 ' A' ' 62' ' ' ILE . 16.2 mm -107.2 124.4 63.01 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.372 0 N-CA-C 107.242 -1.392 . . . . 1.9 107.242 179.737 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -104.84 96.2 6.4 Favored 'General case' 0 N--CA 1.493 1.706 0 N-CA-C 106.323 -1.732 . . . . 1.05 106.323 179.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.474 ' O ' ' HA ' ' A' ' 37' ' ' ASP . . . -142.71 -152.6 5.71 Favored Glycine 0 N--CA 1.502 3.061 0 C-N-CA 119.639 -1.267 . . . . 0.9 111.631 -179.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.455 ' HD3' ' O ' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -135.04 6.58 3.38 Favored 'General case' 0 N--CA 1.497 1.894 0 N-CA-C 108.996 -0.742 . . . . 6.74 108.996 179.444 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 16.4 t 45.24 -177.91 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.012 0 CA-C-O 122.569 1.176 . . . . 5.75 112.764 -178.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 86.41 -66.51 3.63 Favored Glycine 0 N--CA 1.498 2.795 0 CA-C-N 114.781 -1.1 . . . . 4.65 111.443 179.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -59.5 137.93 89.28 Favored Pre-proline 0 N--CA 1.497 1.896 0 C-N-CA 119.886 -0.726 . . . . 2.75 111.143 -179.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 12.0 Cg_endo -53.38 -61.33 0.47 Allowed 'Trans proline' 0 N--CA 1.49 1.29 0 C-N-CA 122.283 1.989 . . . . 3.16 111.021 -169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.454 ' CZ ' ' HB3' ' A' ' 72' ' ' TYR . 10.3 t80 -48.89 -50.54 34.5 Favored 'General case' 0 N--CA 1.497 1.9 0 C-N-CA 119.561 -0.855 . . . . 4.0 109.431 179.202 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 12.8 m -53.86 -53.51 51.5 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.675 0.75 . . . . 2.57 110.106 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 78.8 t -52.09 -43.21 37.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 CA-C-N 114.513 -1.221 . . . . 0.96 111.182 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.526 HH22 ' N ' ' A' ' 20' ' ' LEU . 10.0 mmm180 -40.26 -50.96 2.76 Favored 'General case' 0 N--CA 1.504 2.269 0 C-N-CA 118.714 -1.195 . . . . 3.84 112.188 179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -46.75 -52.66 13.53 Favored 'General case' 0 N--CA 1.5 2.075 0 C-N-CA 118.733 -1.187 . . . . 0.69 109.193 179.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.512 ' NZ ' ' CD ' ' A' ' 22' ' ' GLU . 1.4 tmtm? -58.64 -45.97 88.14 Favored 'General case' 0 C--N 1.304 -1.379 0 CA-C-N 113.987 -1.461 . . . . 1.93 110.482 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 66.0 t0 -62.11 -44.38 96.77 Favored 'General case' 0 N--CA 1.502 2.147 0 C-N-CA 119.41 -0.916 . . . . 3.64 109.774 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.526 ' N ' HH22 ' A' ' 16' ' ' ARG . 11.0 tp -62.72 -58.87 5.96 Favored 'General case' 0 N--CA 1.502 2.168 0 C-N-CA 119.617 -0.833 . . . . 0.91 109.077 179.277 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.482 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.69 -51.81 58.72 Favored 'General case' 0 N--CA 1.491 1.617 0 C-N-CA 119.102 -1.039 . . . . 0.63 109.127 -179.924 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.512 ' CD ' ' NZ ' ' A' ' 18' ' ' LYS . 36.6 tt0 -46.33 -58.93 3.26 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 123.964 0.79 . . . . 3.24 109.796 178.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.59 ' HZ2' ' N ' ' A' ' 23' ' ' LYS . 0.0 OUTLIER -47.43 -60.6 2.41 Favored 'General case' 0 C--O 1.206 -1.195 0 O-C-N 125.644 1.84 . . . . 6.34 107.76 -179.253 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.496 ' HB2' ' CD2' ' A' ' 31' ' ' PHE . 56.6 mt -51.08 -51.47 52.96 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 118.244 -1.383 . . . . 1.39 112.192 -179.401 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.503 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 13.4 p -66.75 8.78 0.23 Allowed 'General case' 0 N--CA 1.5 2.066 0 C-N-CA 118.54 -1.264 . . . . 1.86 114.408 -178.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -125.86 -39.71 2.1 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 107.693 -1.225 . . . . 4.04 107.693 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -74.94 -31.8 61.59 Favored 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.598 -1.183 . . . . 3.4 109.046 178.594 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HB3' ' NH1' ' A' ' 28' ' ' ARG . 4.0 mtp-105 -110.76 -171.04 1.75 Allowed 'General case' 0 N--CA 1.498 1.937 0 CA-C-N 114.318 -1.31 . . . . 4.63 111.794 -179.141 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 23.0 p-10 -125.53 -48.9 1.66 Allowed 'General case' 0 N--CA 1.497 1.876 0 CA-C-N 115.176 -0.92 . . . . 3.69 111.748 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -72.68 -21.24 61.1 Favored 'General case' 0 N--CA 1.494 1.767 0 C-N-CA 118.779 -1.168 . . . . 4.84 110.39 -179.252 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.503 ' O ' ' HA ' ' A' ' 25' ' ' SER . 59.2 t80 -84.92 124.49 31.71 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 118.763 -1.175 . . . . 1.13 112.331 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.408 ' HA ' ' HB3' ' A' ' 25' ' ' SER . 38.0 mt-30 -139.2 163.16 33.19 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-N 113.622 -1.626 . . . . 2.68 106.809 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.482 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 7.8 p90 -158.95 163.18 36.72 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.568 -1.253 . . . . 1.65 110.594 178.607 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . 0.491 HE21 HG23 ' A' ' 36' ' ' VAL . 18.6 pt20 -128.73 157.25 41.92 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.463 -1.31 . . . . 4.71 107.463 177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -115.56 127.36 55.2 Favored 'General case' 0 N--CA 1.488 1.471 0 C-N-CA 118.06 -1.456 . . . . 1.7 107.78 179.03 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.491 HG23 HE21 ' A' ' 34' ' ' GLN . 1.2 t -113.45 132.05 63.45 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 106.423 -1.695 . . . . 0.82 106.423 179.44 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.476 ' HB3' ' HB3' ' A' ' 40' ' ' ALA . 9.3 t70 -108.27 110.57 22.21 Favored 'General case' 0 N--CA 1.5 2.041 0 N-CA-C 108.44 -0.948 . . . . 1.9 108.44 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -44.58 -25.4 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 113.676 0.991 . . . . 1.13 113.676 -178.677 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.523 ' HA ' ' NH2' ' A' ' 39' ' ' ARG . 6.4 mmm180 -91.93 -48.81 6.57 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 118.067 -1.453 . . . . 7.95 109.584 -179.631 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . 0.476 ' HB3' ' HB3' ' A' ' 37' ' ' ASP . . . -52.44 -40.76 62.59 Favored 'General case' 0 N--CA 1.499 1.978 0 N-CA-C 108.401 -0.963 . . . . 1.48 108.401 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.416 ' O ' ' C ' ' A' ' 42' ' ' GLY . 71.3 mm-40 -86.57 26.39 1.1 Allowed 'General case' 0 N--CA 1.488 1.433 0 CA-C-N 114.26 -1.336 . . . . 3.64 110.61 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . 0.416 ' C ' ' O ' ' A' ' 41' ' ' GLU . . . 25.04 59.43 0.06 OUTLIER Glycine 0 N--CA 1.504 3.211 0 O-C-N 123.406 0.441 . . . . 2.39 113.73 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 44' ' ' THR . 31.7 mt -104.13 161.79 4.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.814 0 N-CA-C 108.584 -0.895 . . . . 2.18 108.584 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.445 ' N ' HG22 ' A' ' 43' ' ' ILE . 8.9 t -112.96 -168.07 1.27 Allowed 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 107.671 -1.233 . . . . 3.01 107.671 178.752 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 27.1 ttpt -82.3 -46.12 14.05 Favored 'General case' 0 N--CA 1.496 1.839 0 C-N-CA 118.702 -1.199 . . . . 5.6 109.887 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.726 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 7.5 mp0 -44.48 -51.82 8.45 Favored 'General case' 0 N--CA 1.504 2.236 0 CA-C-O 121.901 0.858 . . . . 4.48 110.281 -179.531 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -46.32 -61.68 1.68 Allowed 'General case' 0 N--CA 1.499 1.995 0 CA-C-N 114.39 -1.277 . . . . 3.63 111.452 179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 15.4 mt -40.24 -52.58 2.62 Favored 'General case' 0 N--CA 1.499 1.981 0 CA-C-N 115.011 -0.995 . . . . 1.88 113.497 -179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 52.8 mt-30 -44.68 -46.39 10.26 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.332 -0.947 . . . . 4.81 111.243 -179.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -56.58 -51.27 69.28 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 123.772 0.67 . . . . 6.69 111.244 -178.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.605 ' NZ ' ' CE2' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -46.48 -37.69 8.16 Favored 'General case' 0 N--CA 1.492 1.656 0 CA-C-N 114.494 -1.23 . . . . 4.48 112.868 -179.543 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -100.97 -30.06 11.85 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 124.224 0.952 . . . . 2.0 111.574 -179.206 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 72.56 49.88 17.34 Favored Glycine 0 N--CA 1.49 2.292 0 N-CA-C 110.29 -1.124 . . . . 3.34 110.29 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.43 ' HA ' ' HD3' ' A' ' 55' ' ' PRO . 37.0 mttm -142.56 156.62 63.3 Favored Pre-proline 0 N--CA 1.501 2.114 0 C-N-CA 118.655 -1.218 . . . . 7.51 112.003 -179.304 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.43 ' HD3' ' HA ' ' A' ' 54' ' ' LYS . 8.1 Cg_endo -81.33 39.34 0.85 Allowed 'Trans proline' 0 N--CA 1.487 1.129 0 C-N-CA 122.318 2.012 . . . . 5.89 111.175 179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 3.7 p -141.01 125.86 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 N-CA-C 105.529 -2.026 . . . . 5.14 105.529 179.145 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -121.63 63.54 0.91 Allowed 'General case' 0 N--CA 1.496 1.858 0 N-CA-C 113.254 0.835 . . . . 8.74 113.254 -177.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 82.5 p -105.08 166.62 10.26 Favored 'General case' 0 N--CA 1.495 1.808 0 C-N-CA 118.181 -1.408 . . . . 5.2 112.558 -179.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 94.5 t -113.81 152.37 45.53 Favored Pre-proline 0 N--CA 1.501 2.079 0 N-CA-C 107.672 -1.233 . . . . 3.2 107.672 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 9.8 Cg_endo -87.93 177.04 22.42 Favored 'Cis proline' 0 N--CA 1.485 0.973 0 O-C-N 122.541 0.758 . . . . 2.0 110.848 -12.489 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 74.8 mm-40 -131.81 142.05 49.62 Favored 'General case' 0 N--CA 1.5 2.043 0 C-N-CA 119.842 -0.743 . . . . 2.99 109.627 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.455 HG21 ' CD1' ' A' ' 75' ' ' PHE . 3.8 mp -119.65 143.18 31.92 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.165 0 CA-C-O 121.822 0.82 . . . . 1.47 111.663 179.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.605 ' CE2' ' NZ ' ' A' ' 51' ' ' LYS . 84.3 m-85 -128.87 136.66 50.74 Favored 'General case' 0 C--N 1.299 -1.589 0 CA-C-N 113.412 -1.722 . . . . 1.22 108.745 178.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.691 HG11 ' CH2' ' A' ' 78' ' ' TRP . 75.5 t -122.76 137.3 56.7 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.852 0 C-N-CA 118.489 -1.284 . . . . 1.25 109.293 178.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' H2 ' ' A' ' 1' ' ' MET . 56.4 m-20 54.42 -80.41 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 CA-C-N 113.678 -1.601 . . . . 3.58 111.197 -179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' VAL . 40.3 tt0 -138.76 -19.66 1.03 Allowed 'General case' 0 C--N 1.291 -1.946 0 CA-C-N 115.294 -0.866 . . . . 4.68 112.1 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 3.2 pt20 -101.65 163.82 12.06 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 113.948 1.092 . . . . 4.57 113.948 -176.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.484 ' HA ' ' CD2' ' A' ' 63' ' ' PHE . 29.2 t-80 -80.25 137.97 36.72 Favored 'General case' 0 C--N 1.308 -1.201 0 CA-C-N 112.954 -1.93 . . . . 1.56 106.532 178.811 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.525 HG13 HG23 ' A' ' 64' ' ' VAL . 34.3 mm -110.15 -50.34 6.65 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.738 0 C-N-CA 118.343 -1.343 . . . . 0.97 109.718 -178.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 141.1 -141.07 10.88 Favored Glycine 0 N--CA 1.499 2.869 0 C-N-CA 119.472 -1.347 . . . . 1.6 110.81 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -97.7 -168.08 32.35 Favored Glycine 0 N--CA 1.498 2.805 0 N-CA-C 109.636 -1.386 . . . . 1.49 109.636 -179.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 12.9 t80 -56.77 -23.27 41.87 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 118.854 -1.138 . . . . 1.32 109.358 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -75.33 -65.76 0.85 Allowed 'General case' 0 C--N 1.3 -1.556 0 CA-C-N 116.016 -0.538 . . . . 1.43 111.003 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -53.92 -43.06 69.44 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.54 -0.911 . . . . 2.88 108.54 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.455 ' CD1' HG21 ' A' ' 62' ' ' ILE . 22.7 t80 -59.71 -53.43 58.04 Favored 'General case' 0 C--O 1.201 -1.46 0 N-CA-C 107.159 -1.423 . . . . 1.13 107.159 178.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -48.71 -55.4 11.52 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.573 -0.851 . . . . 0.77 111.043 179.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -60.4 -60.3 4.03 Favored 'General case' 0 N--CA 1.499 1.99 0 C-N-CA 119.238 -0.985 . . . . 0.96 109.997 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.691 ' CH2' HG11 ' A' ' 64' ' ' VAL . 46.2 t90 -41.62 -49.41 4.15 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 123.825 0.703 . . . . 1.25 109.584 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 4.9 t -49.49 -61.34 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 CA-C-N 115.096 -0.956 . . . . 1.12 110.12 179.361 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.509 ' HZ2' ' C ' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -50.96 -50.63 57.72 Favored 'General case' 0 N--CA 1.491 1.581 0 C-N-CA 119.672 -0.811 . . . . 3.11 111.503 -178.879 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -65.54 -39.86 92.22 Favored 'General case' 0 N--CA 1.498 1.959 0 N-CA-C 116.096 1.888 . . . . 3.94 116.096 -176.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 21.8 m-80 -105.48 -17.23 14.49 Favored 'General case' 0 N--CA 1.498 1.967 0 N-CA-C 114.664 1.357 . . . . 1.65 114.664 -177.823 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.455 HD13 ' CD1' ' A' ' 31' ' ' PHE . 68.8 mt -97.55 -21.55 17.03 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.909 -1.516 . . . . 2.06 110.62 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.498 ' O ' ' NZ ' ' A' ' 80' ' ' LYS . 11.4 m-20 -139.16 32.07 2.15 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 118.096 -1.441 . . . . 4.68 111.373 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.509 ' C ' ' HZ2' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.504 2.25 0 CA-C-O 117.835 -1.079 . . . . 5.34 110.808 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' SD ' ' N ' ' A' ' 1' ' ' MET . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 108.01 -1.107 . . . . 2.91 108.01 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.475 ' HA ' ' O ' ' A' ' 32' ' ' GLN . 9.1 tt0 -105.98 157.89 17.18 Favored 'General case' 0 N--CA 1.49 1.542 0 N-CA-C 108.122 -1.066 . . . . 3.82 108.122 179.737 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.43 ' HA ' ' H ' ' A' ' 65' ' ' ASP . 31.0 m -149.22 149.74 31.46 Favored 'General case' 0 N--CA 1.504 2.246 0 O-C-N 120.861 -1.149 . . . . 0.91 109.84 179.138 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.0 t -131.87 134.7 59.75 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.268 0 C-N-CA 119.981 -0.688 . . . . 0.62 111.197 -178.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.411 HD13 HG23 ' A' ' 62' ' ' ILE . 25.3 mm -114.93 119.61 62.2 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 N-CA-C 106.97 -1.493 . . . . 1.72 106.97 178.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.493 ' CD2' HG11 ' A' ' 36' ' ' VAL . 36.3 m-85 -103.0 103.71 13.84 Favored 'General case' 0 N--CA 1.491 1.617 0 N-CA-C 108.46 -0.941 . . . . 0.87 108.46 -179.261 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -140.15 -150.18 5.43 Favored Glycine 0 N--CA 1.502 3.042 0 C-N-CA 119.399 -1.381 . . . . 1.24 110.932 179.769 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.538 HH21 ' CD1' ' A' ' 38' ' ' ILE . 18.1 mtt180 -121.85 -144.89 0.35 Allowed 'General case' 0 N--CA 1.502 2.144 0 N-CA-C 109.267 -0.642 . . . . 7.34 109.267 -179.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.5 m -118.06 77.8 1.19 Allowed 'General case' 0 N--CA 1.504 2.252 0 C-N-CA 119.973 -0.691 . . . . 3.42 112.085 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 116.03 44.07 0.64 Allowed Glycine 0 N--CA 1.494 2.553 0 C-N-CA 119.109 -1.52 . . . . 2.48 111.041 179.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.417 ' O ' ' N ' ' A' ' 13' ' ' TYR . 0.2 OUTLIER -110.0 101.61 47.91 Favored Pre-proline 0 C--N 1.302 -1.494 0 N-CA-C 107.438 -1.319 . . . . 2.13 107.438 178.845 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_exo -32.86 -34.87 0.06 OUTLIER 'Trans proline' 0 N--CA 1.492 1.383 0 C-N-CA 123.081 2.521 . . . . 2.24 112.899 -176.414 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HG2' ' A' ' 60' ' ' PRO . 1.7 t80 -75.54 -55.27 5.83 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.398 -0.819 . . . . 4.62 109.855 179.807 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 29.2 p -54.16 -40.71 67.72 Favored 'General case' 0 N--CA 1.497 1.922 0 N-CA-C 107.03 -1.47 . . . . 2.51 107.03 179.538 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 97.2 t -60.47 -54.64 32.31 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 CA-C-N 114.168 -1.378 . . . . 1.01 107.705 178.13 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.482 ' NE ' ' HA ' ' A' ' 16' ' ' ARG . 7.3 tpm_? -46.36 -51.91 13.91 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.227 0.537 . . . . 3.28 110.325 179.201 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.406 ' HB1' HD12 ' A' ' 5' ' ' ILE . . . -58.1 -43.67 87.24 Favored 'General case' 0 N--CA 1.493 1.691 0 C-N-CA 119.115 -1.034 . . . . 0.7 108.591 179.284 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -52.9 -47.84 67.64 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 107.205 -1.406 . . . . 2.76 107.205 178.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 36.1 m-20 -53.25 -50.81 64.03 Favored 'General case' 0 C--O 1.202 -1.401 0 C-N-CA 118.901 -1.12 . . . . 2.93 108.852 178.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 8.7 tp -53.98 -58.28 7.87 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.037 -1.065 . . . . 1.34 110.324 179.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.533 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -52.29 -52.43 52.95 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 118.948 -1.101 . . . . 0.69 109.752 -179.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -52.69 -49.08 66.02 Favored 'General case' 0 N--CA 1.484 1.265 0 CA-C-O 121.291 0.567 . . . . 2.91 110.094 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.453 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 28.0 ttpp -48.76 -60.65 2.55 Favored 'General case' 0 N--CA 1.492 1.637 0 C-N-CA 119.277 -0.969 . . . . 5.07 108.855 179.342 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.603 HD22 ' HD2' ' A' ' 28' ' ' ARG . 64.9 mt -48.19 -58.37 4.63 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.772 -0.771 . . . . 1.42 111.515 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 62.5 m -41.25 -34.13 0.45 Allowed 'General case' 0 N--CA 1.492 1.666 0 C-N-CA 119.674 -0.81 . . . . 1.38 110.896 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.4 m-80 -88.19 -36.01 17.05 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 120.396 -0.522 . . . . 3.0 110.513 179.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.589 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 6.4 pt-20 -99.74 23.48 9.56 Favored 'General case' 0 N--CA 1.495 1.809 0 CA-C-O 121.535 0.683 . . . . 4.4 112.017 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.603 ' HD2' HD22 ' A' ' 24' ' ' LEU . 0.0 OUTLIER -137.02 177.11 8.11 Favored 'General case' 0 C--N 1.287 -2.142 0 N-CA-C 108.775 -0.824 . . . . 4.53 108.775 179.003 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -115.56 -38.78 3.67 Favored 'General case' 0 C--N 1.29 -1.983 0 CA-C-N 114.536 -1.211 . . . . 4.18 108.606 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.45 ' O ' ' N ' ' A' ' 1' ' ' MET . 8.7 p-10 -110.34 22.0 16.02 Favored 'General case' 0 C--N 1.302 -1.479 0 CA-C-N 113.821 -1.536 . . . . 4.12 113.424 -178.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -102.83 99.48 9.42 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 118.189 -1.404 . . . . 0.92 114.406 -177.424 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.475 ' O ' ' HA ' ' A' ' 2' ' ' GLN . 42.5 mt-30 -111.64 127.82 55.87 Favored 'General case' 0 N--CA 1.491 1.609 0 N-CA-C 106.835 -1.543 . . . . 2.8 106.835 179.227 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.533 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 25.5 p90 -129.64 162.1 29.06 Favored 'General case' 0 N--CA 1.492 1.633 0 C-N-CA 119.624 -0.83 . . . . 1.05 110.326 -178.884 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.5 tt0 -131.71 146.97 52.45 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.72 -0.844 . . . . 3.38 108.72 178.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 26.3 t80 -99.76 135.27 41.43 Favored 'General case' 0 C--N 1.305 -1.339 0 N-CA-C 106.8 -1.556 . . . . 1.15 106.8 178.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.493 HG11 ' CD2' ' A' ' 6' ' ' PHE . 1.7 t -121.35 138.03 53.06 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.796 -0.816 . . . . 0.71 108.796 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -111.22 109.36 19.36 Favored 'General case' 0 N--CA 1.493 1.725 0 CA-C-N 114.657 -1.156 . . . . 2.39 108.666 -179.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.538 ' CD1' HH21 ' A' ' 8' ' ' ARG . 27.0 pt -51.17 -25.81 4.36 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.611 0 CA-C-N 114.915 -1.039 . . . . 1.26 109.392 -179.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 36.1 ttp180 -79.33 -63.53 1.4 Allowed 'General case' 0 N--CA 1.489 1.519 0 C-N-CA 119.02 -1.072 . . . . 5.18 108.286 179.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -38.21 -42.3 0.67 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 123.66 0.6 . . . . 1.47 111.409 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -81.21 -46.81 14.28 Favored 'General case' 0 N--CA 1.491 1.601 0 CA-C-N 114.85 -1.068 . . . . 2.4 111.028 179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.67 51.79 0.83 Allowed Glycine 0 N--CA 1.498 2.832 0 N-CA-C 109.821 -1.312 . . . . 1.76 109.821 179.507 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 44' ' ' THR . 24.4 mt -100.26 172.26 1.24 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.597 0 CA-C-N 114.977 -0.611 . . . . 1.85 109.384 -179.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.518 ' N ' HG22 ' A' ' 43' ' ' ILE . 51.5 p -103.67 -171.01 1.86 Allowed 'General case' 0 N--CA 1.496 1.848 0 N-CA-C 108.601 -0.888 . . . . 2.46 108.601 179.672 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -118.33 29.96 7.49 Favored 'General case' 0 N--CA 1.497 1.915 0 N-CA-C 107.276 -1.379 . . . . 4.84 107.276 177.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.4 mp0 -119.31 -55.6 2.13 Favored 'General case' 0 N--CA 1.494 1.765 0 CA-C-N 110.341 -3.118 . . . . 3.53 104.084 178.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -47.52 -47.96 27.65 Favored 'General case' 0 C--O 1.202 -1.396 0 CA-C-N 112.458 -2.155 . . . . 3.58 110.46 178.875 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.429 HD13 HG22 ' A' ' 59' ' ' VAL . 59.2 mt -53.6 -37.97 63.51 Favored 'General case' 0 C--N 1.295 -1.793 0 CA-C-N 114.897 -1.047 . . . . 1.98 111.819 -179.113 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . . . . . . . . . 35.3 tt0 -77.67 -49.71 13.95 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 118.928 -1.109 . . . . 4.47 108.903 179.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.436 ' C ' ' CD ' ' A' ' 50' ' ' GLN . 11.2 tm0? -52.65 -43.94 65.81 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.749 -1.114 . . . . 4.73 110.062 179.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.43 -16.33 35.1 Favored 'General case' 0 N--CA 1.493 1.715 0 CA-C-N 114.924 -1.035 . . . . 4.95 111.681 -179.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' C ' ' H ' ' A' ' 54' ' ' LYS . . . -89.75 -51.58 5.43 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 106.193 -1.781 . . . . 2.05 106.193 178.624 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 78.79 -25.19 2.56 Favored Glycine 0 N--CA 1.491 2.326 0 CA-C-N 114.371 -1.286 . . . . 2.98 110.558 179.123 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.448 ' O ' ' N ' ' A' ' 56' ' ' VAL . 29.6 mtmm -109.43 155.78 40.63 Favored Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 109.008 -0.738 . . . . 9.97 109.008 -179.543 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_exo -60.5 74.86 0.07 OUTLIER 'Trans proline' 0 N--CA 1.491 1.337 0 C-N-CA 123.053 2.502 . . . . 6.38 112.784 -149.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.448 ' N ' ' O ' ' A' ' 54' ' ' LYS . 11.9 p -96.83 162.67 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.337 0 N-CA-C 108.793 -0.817 . . . . 6.8 108.793 179.633 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.414 ' N ' HG22 ' A' ' 56' ' ' VAL . 1.1 pt-20 -90.34 -99.22 0.1 Allowed 'General case' 0 C--N 1.299 -1.603 0 CA-C-N 114.908 -1.042 . . . . 6.68 110.552 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 13.0 t -131.03 -162.28 1.2 Allowed 'General case' 0 N--CA 1.486 1.37 0 C-N-CA 120.153 -0.619 . . . . 5.27 109.819 -179.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.646 HG13 ' HA ' ' A' ' 60' ' ' PRO . 73.0 t -84.14 140.25 39.63 Favored Pre-proline 0 N--CA 1.496 1.83 0 CA-C-N 115.007 -0.997 . . . . 4.05 109.639 -179.368 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.646 ' HA ' HG13 ' A' ' 59' ' ' VAL . 9.7 Cg_endo -91.31 164.93 28.89 Favored 'Cis proline' 0 N--CA 1.484 0.941 0 O-C-N 123.069 1.036 . . . . 2.49 112.623 14.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 22.1 mt-30 -131.71 156.16 46.4 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-N 114.793 -1.094 . . . . 3.11 109.816 -179.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.411 HG23 HD13 ' A' ' 5' ' ' ILE . 68.2 mt -125.55 144.16 36.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 CA-C-N 115.5 -0.773 . . . . 1.2 111.754 -178.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.42 ' CE2' ' HB2' ' A' ' 68' ' ' HIS . 14.3 m-85 -129.03 122.65 30.46 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 113.624 -1.625 . . . . 1.1 108.942 179.746 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.453 ' CG2' HG13 ' A' ' 69' ' ' ILE . 22.3 t -91.98 122.91 43.85 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.428 0 N-CA-C 105.358 -2.09 . . . . 1.08 105.358 178.242 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.549 ' HB3' ' NE2' ' A' ' 66' ' ' GLN . 1.2 t70 64.05 -74.76 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.383 0 O-C-N 125.076 1.485 . . . . 2.91 109.099 -179.166 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.549 ' NE2' ' HB3' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -147.92 -5.5 0.46 Allowed 'General case' 0 C--N 1.298 -1.635 0 CA-C-N 115.921 -0.581 . . . . 4.78 111.558 178.897 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 -104.63 137.26 42.72 Favored 'General case' 0 C--N 1.306 -1.31 0 C-N-CA 120.22 -0.592 . . . . 5.29 112.554 -177.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' HB2' ' CE2' ' A' ' 63' ' ' PHE . 50.4 t-80 -68.92 129.92 41.3 Favored 'General case' 0 N--CA 1.49 1.548 0 N-CA-C 106.765 -1.568 . . . . 1.6 106.765 179.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.453 HG13 ' CG2' ' A' ' 64' ' ' VAL . 33.3 mm -106.73 -36.84 3.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 C-N-CA 118.719 -1.193 . . . . 1.29 111.149 -178.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 146.76 -132.33 4.36 Favored Glycine 0 N--CA 1.492 2.412 0 C-N-CA 118.692 -1.718 . . . . 1.63 110.843 -179.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -109.62 -148.75 12.55 Favored Glycine 0 N--CA 1.489 2.18 0 N-CA-C 110.989 -0.844 . . . . 1.85 110.989 -178.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.465 ' CZ ' ' HD3' ' A' ' 16' ' ' ARG . 72.9 t80 -78.79 -56.98 3.99 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-N 115.053 -0.573 . . . . 1.94 110.432 -179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -47.47 -64.99 0.64 Allowed 'General case' 0 N--CA 1.496 1.839 0 N-CA-C 113.141 0.793 . . . . 2.1 113.141 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -53.98 -60.19 3.65 Favored 'General case' 0 N--CA 1.492 1.669 0 C-N-CA 120.211 -0.596 . . . . 2.73 109.76 179.826 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -43.93 -48.44 8.54 Favored 'General case' 0 N--CA 1.493 1.695 0 N-CA-C 109.716 -0.476 . . . . 1.31 109.716 178.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.69 -59.26 5.27 Favored 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 116.01 -0.541 . . . . 1.42 109.91 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.403 ' O ' ' HG2' ' A' ' 81' ' ' GLU . . . -53.25 -62.71 1.48 Allowed 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 108.272 -1.01 . . . . 1.55 108.272 179.088 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 66.6 t90 -41.37 -60.21 1.34 Allowed 'General case' 0 N--CA 1.496 1.875 0 CA-C-N 115.194 -0.912 . . . . 1.6 109.657 179.164 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.446 ' CG1' HD21 ' A' ' 24' ' ' LEU . 3.2 t -40.61 -63.62 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 N-CA-C 107.335 -1.357 . . . . 1.22 107.335 178.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.408 ' HZ2' ' C ' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -44.64 -54.9 5.69 Favored 'General case' 0 N--CA 1.486 1.337 0 O-C-N 125.018 1.449 . . . . 2.72 109.788 179.648 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.403 ' HG2' ' O ' ' A' ' 77' ' ' ALA . 18.0 mm-40 -80.17 26.9 0.34 Allowed 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 113.199 0.815 . . . . 5.56 113.199 -178.021 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -142.48 -43.5 0.32 Allowed 'General case' 0 N--CA 1.501 2.086 0 C-N-CA 120.13 -0.628 . . . . 1.73 111.504 178.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.427 HD13 ' HD3' ' A' ' 28' ' ' ARG . 14.6 mt -94.44 -4.19 48.72 Favored 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 119.385 -0.926 . . . . 1.77 111.794 -177.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 13.4 m-20 -117.85 -48.94 2.54 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 124.321 1.013 . . . . 3.6 108.592 179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.75 0 CA-C-O 116.727 -1.606 . . . . 5.72 108.713 179.201 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.424 ' N ' ' OD2' ' A' ' 30' ' ' ASP . 83.3 mtp . . . . . 0 N--CA 1.484 1.252 0 N-CA-C 107.704 -1.221 . . . . 2.03 107.704 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -118.9 116.99 27.63 Favored 'General case' 0 C--N 1.311 -1.09 0 O-C-N 124.857 1.348 . . . . 5.0 107.541 179.694 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 93.0 m -99.74 131.91 45.42 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 118.5 -1.28 . . . . 0.67 108.41 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 6.6 t -118.64 128.93 75.51 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.44 0 N-CA-C 107.849 -1.167 . . . . 0.54 107.849 179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -109.77 109.48 28.55 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.676 0 N-CA-C 106.633 -1.618 . . . . 1.66 106.633 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.581 ' CD2' HG11 ' A' ' 36' ' ' VAL . 26.8 m-85 -94.03 107.52 19.43 Favored 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 107.076 -1.453 . . . . 1.18 107.076 -179.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -142.08 -151.83 5.6 Favored Glycine 0 N--CA 1.491 2.318 0 C-N-CA 120.354 -0.927 . . . . 1.51 110.932 -179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.596 ' NH2' ' SG ' ' A' ' 14' ' ' CYS . 31.9 ptt-85 -130.06 -162.78 1.24 Allowed 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 107.857 -1.164 . . . . 7.82 107.857 179.614 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.517 ' OG ' ' NH1' ' A' ' 39' ' ' ARG . 33.3 p -132.49 140.09 48.22 Favored 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 119.178 -1.009 . . . . 3.96 110.961 -179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 114.4 -1.91 23.64 Favored Glycine 0 N--CA 1.499 2.898 0 C-N-CA 120.247 -0.977 . . . . 3.11 111.721 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 95.72 24.95 Favored Pre-proline 0 N--CA 1.493 1.697 0 C-N-CA 120.022 -0.671 . . . . 2.16 111.453 -179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . 0.408 ' O ' ' HB ' ' A' ' 15' ' ' VAL . 83.3 Cg_exo -35.29 -38.63 0.2 Allowed 'Trans proline' 0 N--CA 1.485 0.978 0 C-N-CA 122.339 2.026 . . . . 4.02 112.14 168.834 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 9.1 t80 -67.04 -45.12 78.38 Favored 'General case' 0 N--CA 1.492 1.632 0 C-N-CA 117.701 -1.6 . . . . 3.8 109.217 179.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.596 ' SG ' ' NH2' ' A' ' 8' ' ' ARG . 82.0 m -53.32 -41.91 66.18 Favored 'General case' 0 N--CA 1.497 1.897 0 C-N-CA 118.717 -1.193 . . . . 2.03 107.902 179.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 12' ' ' PRO . 58.0 t -48.33 -38.89 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 C-N-CA 119.458 -0.897 . . . . 1.02 111.14 178.904 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.614 ' HA ' ' HE ' ' A' ' 16' ' ' ARG . 1.8 mmp_? -50.25 -20.94 1.17 Allowed 'General case' 0 N--CA 1.514 2.75 0 N-CA-C 112.835 0.68 . . . . 5.79 112.835 -179.646 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -79.56 -43.77 22.38 Favored 'General case' 0 C--N 1.301 -1.504 0 N-CA-C 106.76 -1.57 . . . . 0.83 106.76 178.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.611 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.0 tmtt? -57.1 -46.6 82.46 Favored 'General case' 0 C--O 1.202 -1.418 0 N-CA-C 108.598 -0.889 . . . . 2.69 108.598 179.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.611 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 31.8 m-20 -53.3 -43.9 67.9 Favored 'General case' 0 C--N 1.297 -1.706 0 C-N-CA 118.794 -1.162 . . . . 3.01 111.033 -179.205 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 45.5 tp -72.16 -57.73 4.01 Favored 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 119.17 -1.012 . . . . 0.81 109.529 -179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -48.73 -43.22 37.31 Favored 'General case' 0 N--CA 1.503 2.184 0 C-N-CA 119.056 -1.058 . . . . 1.13 109.156 179.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.657 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 19.9 tt0 -65.84 -65.21 0.7 Allowed 'General case' 0 C--N 1.305 -1.341 0 C-N-CA 119.366 -0.934 . . . . 2.72 109.504 179.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 19.0 tptm -36.33 -50.74 0.77 Allowed 'General case' 0 N--CA 1.496 1.859 0 O-C-N 124.145 0.903 . . . . 3.6 111.618 -179.556 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.551 ' HA ' ' CG ' ' A' ' 27' ' ' GLU . 95.2 mt -49.72 -40.15 39.53 Favored 'General case' 0 C--N 1.293 -1.885 0 CA-C-N 114.823 -1.08 . . . . 1.26 112.272 -179.253 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.423 ' HA ' ' O ' ' A' ' 31' ' ' PHE . 20.0 m -50.48 -12.59 0.1 Allowed 'General case' 0 N--CA 1.5 2.056 0 O-C-N 123.576 0.548 . . . . 1.25 111.618 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.402 ' H ' ' C ' ' A' ' 24' ' ' LEU . 44.5 m-80 -114.73 -41.8 3.34 Favored 'General case' 0 N--CA 1.487 1.42 0 CA-C-N 115.853 -0.612 . . . . 2.49 111.045 179.152 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.551 ' CG ' ' HA ' ' A' ' 24' ' ' LEU . 5.9 pt-20 -81.79 -10.59 59.3 Favored 'General case' 0 N--CA 1.498 1.939 0 C-N-CA 119.156 -1.018 . . . . 3.69 113.415 -178.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.4 ' NH1' ' O ' ' A' ' 83' ' ' LEU . 1.5 mpt_? -105.76 -177.4 3.35 Favored 'General case' 0 C--N 1.299 -1.601 0 C-N-CA 119.281 -0.967 . . . . 5.2 110.914 179.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -72.46 -63.24 1.19 Allowed 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 114.486 -1.234 . . . . 6.04 112.024 -178.415 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.424 ' OD2' ' N ' ' A' ' 1' ' ' MET . 1.4 t70 -118.91 -43.78 2.64 Favored 'General case' 0 N--CA 1.509 2.503 0 N-CA-C 109.476 -0.564 . . . . 5.47 109.476 179.031 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.423 ' O ' ' HA ' ' A' ' 25' ' ' SER . 16.4 t80 8.61 96.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 CA-C-N 113.41 -1.723 . . . . 0.76 115.113 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 75.4 mt-30 -112.72 158.82 19.6 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 105.689 -1.967 . . . . 3.27 105.689 177.806 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.657 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 10.8 p90 -151.28 164.69 36.06 Favored 'General case' 0 C--N 1.295 -1.776 0 C-N-CA 118.16 -1.416 . . . . 1.02 110.695 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 7.0 tp-100 -144.27 154.86 43.51 Favored 'General case' 0 C--N 1.298 -1.659 0 N-CA-C 107.374 -1.343 . . . . 4.0 107.374 177.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.411 ' CD1' ' N ' ' A' ' 36' ' ' VAL . 38.7 t80 -106.76 148.28 28.64 Favored 'General case' 0 N--CA 1.495 1.806 0 C-N-CA 118.117 -1.433 . . . . 1.7 109.068 -179.863 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.581 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -131.02 125.86 58.54 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 O-C-N 124.399 1.062 . . . . 1.13 108.62 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 46.8 t0 -109.02 122.76 47.94 Favored 'General case' 0 N--CA 1.501 2.076 0 N-CA-C 107.558 -1.275 . . . . 1.94 107.558 -179.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.1 pt -51.93 -31.35 13.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 C-N-CA 119.614 -0.834 . . . . 1.48 111.811 -179.371 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.542 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.8 OUTLIER -84.22 -5.9 59.32 Favored 'General case' 0 N--CA 1.493 1.716 0 N-CA-C 112.652 0.612 . . . . 4.82 112.652 -178.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -104.12 -39.32 6.58 Favored 'General case' 0 N--CA 1.494 1.747 0 C-N-CA 119.798 -0.761 . . . . 1.3 110.194 -179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -82.76 -35.08 26.89 Favored 'General case' 0 N--CA 1.495 1.803 0 C-N-CA 119.442 -0.903 . . . . 2.67 110.148 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.41 53.85 0.71 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 109.151 -1.58 . . . . 1.91 109.151 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 6.1 mt -105.25 137.68 33.69 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.818 0 N-CA-C 108.506 -0.924 . . . . 1.8 108.506 -179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.9 p -117.46 54.06 0.9 Allowed 'General case' 0 N--CA 1.505 2.276 0 C-N-CA 118.69 -1.204 . . . . 4.28 113.901 -178.074 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 53.1 mttp 62.94 -65.01 0.1 Allowed 'General case' 0 N--CA 1.504 2.264 0 N-CA-C 114.365 1.246 . . . . 7.52 114.365 178.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 -44.25 -51.74 8.04 Favored 'General case' 0 N--CA 1.501 2.08 0 N-CA-C 113.022 0.749 . . . . 4.65 113.022 -179.606 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -52.46 -38.23 58.86 Favored 'General case' 0 N--CA 1.497 1.913 0 C-N-CA 118.758 -1.177 . . . . 4.04 109.999 179.781 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 49' ' ' GLN . 71.9 mt -71.92 -51.77 20.51 Favored 'General case' 0 N--CA 1.492 1.67 0 C-N-CA 119.311 -0.956 . . . . 1.73 108.522 179.645 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.421 HE21 ' HB3' ' A' ' 49' ' ' GLN . 0.1 OUTLIER -40.39 -45.21 2.14 Favored 'General case' 0 N--CA 1.496 1.853 0 N-CA-C 108.178 -1.045 . . . . 5.49 108.178 178.242 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.501 ' OE1' ' NZ ' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -68.75 -58.02 4.81 Favored 'General case' 0 N--CA 1.484 1.261 0 O-C-N 126.008 2.068 . . . . 5.79 110.455 178.929 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.501 ' NZ ' ' OE1' ' A' ' 50' ' ' GLN . 0.1 OUTLIER -43.55 -37.51 2.52 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 115.669 -0.696 . . . . 3.67 112.327 -179.21 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -104.6 -8.83 18.69 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 124.044 0.84 . . . . 1.96 111.316 179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 53.29 49.63 55.66 Favored Glycine 0 N--CA 1.502 3.051 0 N-CA-C 109.102 -1.599 . . . . 2.4 109.102 -179.272 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.451 ' NZ ' ' OE2' ' A' ' 57' ' ' GLU . 26.2 mmtp -122.97 154.26 64.36 Favored Pre-proline 0 N--CA 1.499 2.008 0 CA-C-N 114.401 -0.9 . . . . 4.99 110.739 -179.113 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 7.3 Cg_exo -78.25 36.34 0.57 Allowed 'Trans proline' 0 C--N 1.314 -1.248 0 C-N-CA 121.282 1.321 . . . . 4.76 110.815 152.04 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.418 ' H ' ' C ' ' A' ' 54' ' ' LYS . 25.1 t 57.24 151.91 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.204 0 O-C-N 124.432 1.083 . . . . 6.07 112.742 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.551 ' CG ' ' H ' ' A' ' 58' ' ' THR . 6.6 pm0 -131.17 -106.0 0.27 Allowed 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 107.556 -1.275 . . . . 6.26 107.556 178.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.551 ' H ' ' CG ' ' A' ' 57' ' ' GLU . 67.4 m -119.23 175.56 5.74 Favored 'General case' 0 C--N 1.3 -1.553 0 N-CA-C 107.321 -1.363 . . . . 6.36 107.321 178.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.534 HG21 HH12 ' A' ' 8' ' ' ARG . 3.2 m -112.6 164.56 15.07 Favored Pre-proline 0 N--CA 1.493 1.695 0 N-CA-C 109.64 -0.504 . . . . 4.13 109.64 179.653 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -75.29 -172.5 10.93 Favored 'Cis proline' 0 C--N 1.314 -1.262 0 C-N-CA 124.131 -1.195 . . . . 2.3 110.421 -11.207 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 mt-30 -103.03 131.97 49.63 Favored 'General case' 0 C--N 1.296 -1.737 0 N-CA-C 106.641 -1.614 . . . . 3.55 106.641 179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.594 HG21 ' CG ' ' A' ' 75' ' ' PHE . 8.7 mm -108.62 125.92 65.48 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.356 -0.937 . . . . 1.48 110.832 -178.404 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -124.21 124.16 41.84 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 107.421 -1.326 . . . . 1.03 107.421 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.474 ' CG2' HG13 ' A' ' 69' ' ' ILE . 42.2 t -116.54 122.91 70.89 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.068 -1.053 . . . . 1.0 108.863 179.855 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 50.44 32.2 6.26 Favored 'General case' 0 N--CA 1.5 2.059 0 CA-C-O 124.013 1.863 . . . . 2.53 108.803 179.893 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 82.52 -34.5 0.09 Allowed 'General case' 0 C--N 1.278 -2.539 0 CA-C-N 110.016 -3.266 . . . . 6.99 109.757 -179.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 57.8 mm-40 -47.1 112.66 0.55 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 108.719 -0.845 . . . . 4.91 108.719 -179.655 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' HA2' ' A' ' 70' ' ' GLY . 21.6 t-80 -57.85 131.57 50.77 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 117.825 -1.55 . . . . 1.81 106.876 178.499 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.474 HG13 ' CG2' ' A' ' 64' ' ' VAL . 51.0 mm -105.43 -42.97 7.34 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.856 0 N-CA-C 107.198 -1.408 . . . . 1.13 107.198 179.691 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.407 ' HA2' ' CE1' ' A' ' 68' ' ' HIS . . . 131.54 -125.1 4.27 Favored Glycine 0 N--CA 1.49 2.248 0 C-N-CA 118.941 -1.599 . . . . 1.59 111.109 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . -112.0 -175.22 19.8 Favored Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.626 -1.273 . . . . 1.94 112.281 -178.734 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 11.6 t80 -52.46 -44.88 65.83 Favored 'General case' 0 N--CA 1.495 1.785 0 CA-C-N 114.119 -1.04 . . . . 1.67 111.921 -179.22 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 40.3 p -63.31 -58.82 5.88 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 119.306 -0.958 . . . . 1.57 110.794 -179.436 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -48.85 -56.47 8.64 Favored 'General case' 0 N--CA 1.498 1.959 0 C-N-CA 120.096 -0.642 . . . . 4.59 109.429 179.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.594 ' CG ' HG21 ' A' ' 62' ' ' ILE . 66.7 t80 -55.46 -45.46 76.91 Favored 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 115.184 -0.916 . . . . 0.8 109.455 179.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -54.68 -55.1 33.31 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.716 -0.794 . . . . 0.78 110.334 179.505 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -56.77 -52.73 63.89 Favored 'General case' 0 N--CA 1.498 1.96 0 N-CA-C 107.722 -1.214 . . . . 1.09 107.722 179.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.529 ' CE2' ' ND2' ' A' ' 82' ' ' ASN . 81.6 t90 -42.75 -58.8 2.19 Favored 'General case' 0 N--CA 1.501 2.104 0 CA-C-N 115.556 -0.747 . . . . 1.59 110.003 178.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.437 ' O ' ' HB2' ' A' ' 83' ' ' LEU . 51.3 t -46.1 -23.38 0.37 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 CA-C-N 115.275 -0.875 . . . . 1.89 111.579 179.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.467 ' C ' ' HZ3' ' A' ' 80' ' ' LYS . 0.0 OUTLIER -105.8 -67.96 0.9 Allowed 'General case' 0 C--N 1.304 -1.378 0 O-C-N 123.531 0.52 . . . . 2.55 110.769 -179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -55.51 -22.16 19.92 Favored 'General case' 0 N--CA 1.5 2.045 0 N-CA-C 113.83 1.048 . . . . 4.69 113.83 -178.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . 0.529 ' ND2' ' CE2' ' A' ' 78' ' ' TRP . 0.1 OUTLIER -112.5 -31.99 6.62 Favored 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 114.302 1.223 . . . . 3.11 114.302 -178.239 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 79' ' ' VAL . 55.0 mt -96.87 -9.41 28.63 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 117.428 -1.709 . . . . 1.36 111.088 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.456 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 65.3 m-20 -120.76 -55.55 2.0 Allowed 'General case' 0 N--CA 1.499 2.007 0 N-CA-C 108.357 -0.979 . . . . 3.53 108.357 178.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' CB ' ' O ' ' A' ' 84' ' ' ASP . . . . . . . . 0 N--CA 1.495 1.805 0 CA-C-N 111.359 -2.655 . . . . 6.03 106.158 -178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.627 ' SD ' ' CG1' ' A' ' 64' ' ' VAL . 45.3 tpp . . . . . 0 N--CA 1.478 0.961 0 N-CA-C 107.706 -1.22 . . . . 2.7 107.706 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -95.2 100.03 11.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.606 -1.257 . . . . 3.76 107.606 -179.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.1 m -87.84 120.88 29.6 Favored 'General case' 0 C--N 1.294 -1.825 0 C-N-CA 119.408 -0.917 . . . . 0.86 109.237 -178.659 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . 0.401 ' HB ' ' HB2' ' A' ' 63' ' ' PHE . 46.2 t -108.44 135.17 48.06 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.12 0 CA-C-N 115.876 -0.602 . . . . 0.73 109.44 -178.712 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 10.4 mm -118.79 111.1 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 124.691 1.245 . . . . 1.55 109.375 -179.217 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.51 ' CE2' HG11 ' A' ' 36' ' ' VAL . 47.7 m-85 -93.9 98.14 10.85 Favored 'General case' 0 N--CA 1.504 2.232 0 C-N-CA 120.508 -0.477 . . . . 1.29 110.443 179.807 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -124.85 -163.01 11.55 Favored Glycine 0 N--CA 1.512 3.738 0 C-N-CA 120.339 -0.934 . . . . 1.06 111.123 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.579 ' HG2' ' NH1' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -129.47 18.61 5.82 Favored 'General case' 0 N--CA 1.508 2.458 0 C-N-CA 119.167 -1.013 . . . . 6.55 112.477 179.96 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 69.7 m 72.55 -58.04 0.61 Allowed 'General case' 0 N--CA 1.511 2.602 0 N-CA-C 113.772 1.027 . . . . 3.05 113.772 179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -87.51 35.88 3.42 Favored Glycine 0 N--CA 1.499 2.864 0 C-N-CA 119.106 -1.521 . . . . 2.84 110.944 -178.671 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . . . . . . . . . 4.7 t -120.9 88.96 45.17 Favored Pre-proline 0 N--CA 1.491 1.599 0 C-N-CA 120.453 -0.499 . . . . 2.63 110.046 -179.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -37.36 -53.48 1.34 Allowed 'Trans proline' 0 N--CA 1.486 1.052 0 C-N-CA 122.711 2.274 . . . . 2.6 112.417 179.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 11.7 t80 -55.83 -49.58 72.88 Favored 'General case' 0 N--CA 1.5 2.045 0 C-N-CA 118.769 -1.172 . . . . 3.73 109.292 179.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.479 ' HA ' ' HG3' ' A' ' 60' ' ' PRO . 37.0 m -57.59 -39.27 76.43 Favored 'General case' 0 N--CA 1.497 1.885 0 C-N-CA 119.226 -0.99 . . . . 2.5 109.538 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.427 ' O ' ' C ' ' A' ' 16' ' ' ARG . 58.6 t -60.19 -53.92 42.02 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 118.931 -1.108 . . . . 1.26 110.463 179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 15' ' ' VAL . 1.3 tpm_? -35.83 -51.35 0.69 Allowed 'General case' 0 N--CA 1.513 2.689 0 CA-C-O 121.09 0.472 . . . . 4.43 110.716 179.892 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -40.89 -48.22 3.08 Favored 'General case' 0 N--CA 1.505 2.299 0 CA-C-N 115.696 -0.684 . . . . 0.92 111.245 179.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.546 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 7.7 tmtt? -52.25 -41.25 62.66 Favored 'General case' 0 N--CA 1.49 1.526 0 CA-C-N 115.543 -0.753 . . . . 3.02 111.949 -178.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.546 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 17.1 m-20 -53.12 -49.8 65.78 Favored 'General case' 0 N--CA 1.501 2.076 0 C-N-CA 118.948 -1.101 . . . . 2.63 110.087 -179.451 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -44.29 -55.71 4.7 Favored 'General case' 0 N--CA 1.496 1.828 0 CA-C-N 113.81 -1.541 . . . . 1.74 108.387 -179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.512 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -60.18 -49.43 77.67 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-N 113.177 -1.829 . . . . 0.91 109.836 -179.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -45.74 -53.38 9.56 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 124.784 1.302 . . . . 4.22 109.791 179.095 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.521 ' HB3' ' HZ3' ' A' ' 23' ' ' LYS . 8.5 mmmm -56.89 -64.21 0.95 Allowed 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.597 -0.729 . . . . 3.56 109.783 179.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . . . . . . . . . 79.1 mt -44.38 -56.89 3.87 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-N 114.947 -1.024 . . . . 1.22 113.249 -179.083 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 6.4 p -48.16 -12.1 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.279 0 N-CA-C 115.044 1.498 . . . . 2.01 115.044 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -123.36 -36.07 2.86 Favored 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.117 0.484 . . . . 3.03 110.432 -179.599 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 80.8 mt-10 -74.19 -31.16 62.55 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-N 114.975 -1.011 . . . . 3.66 110.424 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.415 HH21 ' CG ' ' A' ' 29' ' ' ASP . 0.1 OUTLIER -109.52 -166.38 1.1 Allowed 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 120.05 -0.66 . . . . 5.47 110.256 179.674 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.415 ' CG ' HH21 ' A' ' 28' ' ' ARG . 13.1 p30 -96.8 -77.59 0.49 Allowed 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 116.593 2.071 . . . . 4.53 116.593 -176.781 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.501 ' O ' ' C ' ' A' ' 31' ' ' PHE . 8.7 t70 -74.12 -59.47 2.71 Favored 'General case' 0 N--CA 1.5 2.074 0 N-CA-C 113.457 0.91 . . . . 4.13 113.457 -177.584 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.501 ' C ' ' O ' ' A' ' 30' ' ' ASP . 57.3 t80 0.06 97.09 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.267 0 N-CA-C 114.528 1.307 . . . . 0.93 114.528 -178.721 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 69.6 mt-30 -106.07 159.43 16.08 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 105.607 -1.997 . . . . 3.92 105.607 178.588 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.512 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 40.7 p90 -160.67 154.13 22.06 Favored 'General case' 0 C--N 1.301 -1.505 0 C-N-CA 118.509 -1.276 . . . . 1.66 110.828 178.999 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -141.2 133.61 28.29 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-N 115.039 -0.982 . . . . 3.01 109.85 178.257 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 56.8 t80 -87.65 136.57 32.89 Favored 'General case' 0 N--CA 1.485 1.323 0 N-CA-C 104.834 -2.284 . . . . 1.58 104.834 178.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.51 HG11 ' CE2' ' A' ' 6' ' ' PHE . 1.6 t -126.79 147.21 31.7 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.828 0 N-CA-C 107.87 -1.159 . . . . 0.59 107.87 -179.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.401 ' CG ' ' NH1' ' A' ' 39' ' ' ARG . 1.5 t70 -122.15 135.61 54.81 Favored 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 120.027 -0.669 . . . . 2.27 110.688 -178.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 pt -57.42 -23.91 20.55 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 C-N-CA 118.508 -1.277 . . . . 1.94 110.819 -179.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.401 ' NH1' ' CG ' ' A' ' 37' ' ' ASP . 0.0 OUTLIER -88.95 -3.57 58.7 Favored 'General case' 0 N--CA 1.503 2.196 0 CA-C-N 115.724 -0.671 . . . . 5.86 112.637 -178.656 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -98.53 -41.83 7.58 Favored 'General case' 0 N--CA 1.494 1.74 0 N-CA-C 107.786 -1.19 . . . . 1.44 107.786 179.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -83.45 -39.45 20.54 Favored 'General case' 0 N--CA 1.488 1.448 0 CA-C-N 114.151 -1.386 . . . . 2.83 108.859 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 103.14 49.48 1.14 Allowed Glycine 0 N--CA 1.496 2.665 0 N-CA-C 108.452 -1.859 . . . . 1.49 108.452 -179.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 47' ' ' ASP . 74.4 mt -112.43 157.01 13.32 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 C-N-CA 120.262 -0.575 . . . . 1.41 111.07 -178.499 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.441 ' C ' ' H ' ' A' ' 46' ' ' GLU . 15.3 p -110.92 -179.17 3.66 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 108.273 -1.01 . . . . 2.17 108.273 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 1.6 tmtt? -85.87 46.67 1.34 Allowed 'General case' 0 N--CA 1.504 2.233 0 N-CA-C 106.462 -1.681 . . . . 5.46 106.462 179.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.441 ' H ' ' C ' ' A' ' 44' ' ' THR . 53.2 mt-10 -122.17 -61.56 1.47 Allowed 'General case' 0 N--CA 1.496 1.838 0 CA-C-N 113.577 -1.647 . . . . 4.07 107.274 179.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.499 ' HB3' ' CG2' ' A' ' 43' ' ' ILE . 16.7 t70 -49.75 -46.04 50.1 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 114.851 -1.068 . . . . 3.82 109.534 178.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 91.2 mt -52.79 -4.55 0.03 OUTLIER 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 113.756 1.021 . . . . 2.76 113.756 -178.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.42 ' N ' ' O ' ' A' ' 47' ' ' ASP . 1.1 mp0 -108.39 -53.17 2.67 Favored 'General case' 0 N--CA 1.497 1.924 0 N-CA-C 107.234 -1.395 . . . . 5.42 107.234 176.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 69.5 mm-40 -60.37 -33.13 72.01 Favored 'General case' 0 N--CA 1.5 2.044 0 CA-C-O 122.031 0.92 . . . . 6.18 110.745 -179.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.448 ' NZ ' ' CZ ' ' A' ' 63' ' ' PHE . 1.8 ttpp -92.11 14.49 15.85 Favored 'General case' 0 C--N 1.295 -1.779 0 CA-C-N 114.389 -1.278 . . . . 3.84 109.344 -179.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.731 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -123.24 -59.82 1.54 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 124.304 1.003 . . . . 1.56 111.988 -178.867 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 100.85 -20.35 48.28 Favored Glycine 0 N--CA 1.501 3.022 0 C-N-CA 120.179 -1.01 . . . . 2.47 112.823 179.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.536 ' NZ ' ' O ' ' A' ' 70' ' ' GLY . 0.3 OUTLIER -131.08 161.83 59.33 Favored Pre-proline 0 N--CA 1.506 2.342 0 C-N-CA 120.749 -0.38 . . . . 5.98 111.971 -178.529 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.449 ' CD ' ' HB2' ' A' ' 54' ' ' LYS . 55.4 Cg_exo -12.98 -147.17 0.0 OUTLIER 'Trans proline' 0 N--CA 1.487 1.109 1 C-N-CA 125.316 4.011 . . . . 6.11 116.675 -123.914 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 45.1 t -124.7 -51.23 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 CA-C-N 114.459 -1.246 . . . . 6.23 110.896 -178.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.87 -39.01 31.49 Favored 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 112.626 0.602 . . . . 6.05 112.626 -179.142 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 5.7 t -31.57 144.03 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.405 0 N-CA-C 115.728 1.751 . . . . 6.08 115.728 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 t -155.83 159.49 31.54 Favored Pre-proline 0 N--CA 1.493 1.686 0 N-CA-C 106.887 -1.523 . . . . 2.82 106.887 178.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.479 ' HG3' ' HA ' ' A' ' 14' ' ' CYS . 73.1 Cg_endo -79.56 -179.57 26.79 Favored 'Cis proline' 0 C--N 1.314 -1.25 0 C-N-CA 123.934 -1.277 . . . . 1.78 109.913 -17.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.519 ' HA ' ' HA2' ' A' ' 70' ' ' GLY . 13.5 mm-40 -104.98 125.42 50.94 Favored 'General case' 0 C--N 1.297 -1.684 0 C-N-CA 119.029 -1.068 . . . . 3.22 108.29 179.65 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.503 ' H ' ' HA2' ' A' ' 70' ' ' GLY . 13.7 mm -105.66 137.11 37.04 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 N-CA-C 106.809 -1.552 . . . . 1.31 106.809 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.448 ' CZ ' ' NZ ' ' A' ' 51' ' ' LYS . 78.0 m-85 -122.15 124.33 43.63 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 107.879 -1.156 . . . . 1.11 107.879 179.177 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.627 ' CG1' ' SD ' ' A' ' 1' ' ' MET . 29.3 t -98.38 111.76 28.86 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.632 0 C-N-CA 117.641 -1.624 . . . . 1.15 108.339 179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.5 t70 59.04 -76.89 0.02 OUTLIER 'General case' 0 C--N 1.303 -1.428 0 O-C-N 124.395 1.059 . . . . 2.6 111.701 179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' VAL . 42.5 mm-40 -133.79 -8.84 2.76 Favored 'General case' 0 N--CA 1.493 1.675 0 N-CA-C 112.906 0.706 . . . . 4.93 112.906 -179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 38.7 tp60 -103.78 153.08 21.11 Favored 'General case' 0 N--CA 1.484 1.247 0 CA-C-N 119.233 0.924 . . . . 5.24 111.251 -178.707 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.731 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 14.9 t-80 -87.33 133.91 33.64 Favored 'General case' 0 N--CA 1.493 1.705 0 N-CA-C 107.794 -1.187 . . . . 1.4 107.794 179.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.549 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -116.1 -29.56 2.09 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 N-CA-C 109.163 -0.68 . . . . 1.52 109.163 -179.101 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.536 ' O ' ' NZ ' ' A' ' 54' ' ' LYS . . . 29.34 108.18 0.0 OUTLIER Glycine 1 N--CA 1.518 4.107 0 N-CA-C 116.433 1.333 . . . . 2.59 116.433 178.413 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 121.52 121.63 2.8 Favored Glycine 0 N--CA 1.499 2.883 0 N-CA-C 110.347 -1.101 . . . . 1.77 110.347 -179.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.6 t80 -59.46 -45.06 92.71 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 118.989 -1.084 . . . . 1.54 108.866 179.857 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 1.2 p -53.97 -54.28 41.21 Favored 'General case' 0 C--N 1.3 -1.582 0 CA-C-N 115.293 -0.867 . . . . 1.21 110.149 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.413 ' N ' ' OD1' ' A' ' 74' ' ' ASP . 0.7 OUTLIER -57.97 -55.22 37.75 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-N 114.703 -1.135 . . . . 2.69 110.316 -179.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.433 ' CG ' HG21 ' A' ' 62' ' ' ILE . 42.3 t80 -55.04 -45.82 75.27 Favored 'General case' 0 N--CA 1.492 1.671 0 C-N-CA 119.263 -0.975 . . . . 0.81 108.725 179.662 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.62 -59.2 5.35 Favored 'General case' 0 C--N 1.297 -1.686 0 C-N-CA 120.09 -0.644 . . . . 0.79 109.534 179.278 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.413 ' O ' ' N ' ' A' ' 80' ' ' LYS . . . -56.82 -61.52 2.38 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 119.698 -0.801 . . . . 0.88 109.212 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.419 ' CH2' HG11 ' A' ' 64' ' ' VAL . 62.1 t90 -39.82 -51.56 2.4 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 124.251 0.97 . . . . 1.54 109.814 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.415 HG13 HD12 ' A' ' 83' ' ' LEU . 4.0 t -54.74 -51.18 54.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 N-CA-C 108.38 -0.97 . . . . 0.91 108.38 179.057 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.413 ' N ' ' O ' ' A' ' 77' ' ' ALA . 0.0 OUTLIER -72.45 16.24 0.15 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 114.634 -1.166 . . . . 4.86 112.087 -178.933 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 86.0 mt-10 -127.98 -60.1 1.16 Allowed 'General case' 0 N--CA 1.495 1.816 0 CA-C-O 121.408 0.623 . . . . 3.82 110.57 179.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 34.2 m-80 -83.76 -14.94 50.28 Favored 'General case' 0 N--CA 1.492 1.672 0 CA-C-N 114.593 -1.185 . . . . 2.02 112.89 -176.664 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.415 HD12 HG13 ' A' ' 79' ' ' VAL . 54.4 mt -99.21 4.87 46.84 Favored 'General case' 0 N--CA 1.497 1.899 0 C-N-CA 117.325 -1.75 . . . . 1.39 108.695 179.087 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -112.47 -54.36 2.63 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 125.505 1.753 . . . . 3.5 107.574 178.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.595 0 CA-C-O 116.079 -1.915 . . . . 6.55 108.017 178.672 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.455 ' N ' ' OD2' ' A' ' 65' ' ' ASP . 25.6 mmm . . . . . 0 N--CA 1.488 1.428 0 N-CA-C 109.161 -0.681 . . . . 2.7 109.161 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 47.2 tp60 -112.19 97.87 6.94 Favored 'General case' 0 C--N 1.311 -1.094 0 N-CA-C 108.508 -0.923 . . . . 5.3 108.508 -179.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 97.4 m -82.13 135.27 35.32 Favored 'General case' 0 C--N 1.296 -1.734 0 CA-C-N 114.503 -1.226 . . . . 0.78 109.741 -179.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 12.2 t -126.38 130.18 71.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.482 0 N-CA-C 107.044 -1.465 . . . . 0.75 107.044 178.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.7 mm -104.85 128.59 58.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 106.982 -1.488 . . . . 1.51 106.982 179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 -105.75 94.25 5.09 Favored 'General case' 0 N--CA 1.489 1.502 0 N-CA-C 107.355 -1.35 . . . . 1.3 107.355 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -125.75 -164.44 11.81 Favored Glycine 0 N--CA 1.496 2.646 0 N-CA-C 107.716 -2.154 . . . . 1.0 107.716 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.551 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 3.6 ptm180 -143.16 137.61 29.18 Favored 'General case' 0 N--CA 1.491 1.609 0 C-N-CA 117.837 -1.545 . . . . 5.45 111.787 178.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.445 ' O ' ' NH1' ' A' ' 8' ' ' ARG . 61.6 m -53.02 125.05 15.95 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 118.224 -1.391 . . . . 4.45 108.424 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 124.83 -35.97 2.99 Favored Glycine 0 N--CA 1.49 2.239 0 C-N-CA 119.031 -1.557 . . . . 3.87 110.549 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.551 ' SG ' ' O ' ' A' ' 8' ' ' ARG . 1.5 p -71.19 161.37 78.66 Favored Pre-proline 0 N--CA 1.488 1.474 0 C-N-CA 117.845 -1.542 . . . . 3.66 108.563 179.846 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -98.95 -57.63 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 C-N-CA 121.504 1.469 . . . . 2.71 112.441 164.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -45.86 -32.14 2.48 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 112.955 0.724 . . . . 3.55 112.955 -178.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.6 p -53.53 -31.39 46.1 Favored 'General case' 0 N--CA 1.502 2.161 0 C-N-CA 118.004 -1.478 . . . . 2.42 110.728 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . . . . . . . . . 87.8 t -56.01 -47.58 80.0 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 C-N-CA 120.033 -0.667 . . . . 1.08 109.263 178.68 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.549 HH21 ' CG ' ' A' ' 19' ' ' ASP . 0.3 OUTLIER -37.62 -48.64 1.05 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 124.554 1.159 . . . . 4.09 112.994 -179.628 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -70.02 -38.62 75.94 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 118.306 -1.358 . . . . 0.73 109.349 179.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.487 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 12.8 tmtt? -62.51 -53.0 61.26 Favored 'General case' 0 N--CA 1.486 1.371 0 CA-C-N 115.414 -0.812 . . . . 2.21 111.45 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.549 ' CG ' HH21 ' A' ' 16' ' ' ARG . 0.9 OUTLIER -52.18 -48.72 64.84 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 118.292 -1.363 . . . . 3.29 109.657 -179.169 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 17.5 tp -54.57 -62.23 1.79 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 124.199 0.937 . . . . 0.73 110.87 178.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . . . . . . . . . . . -53.87 -46.04 71.18 Favored 'General case' 0 N--CA 1.499 2.008 0 C-N-CA 118.711 -1.195 . . . . 0.84 110.417 -179.646 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.54 ' HA ' ' CE1' ' A' ' 33' ' ' TYR . 39.7 tt0 -48.46 -65.02 0.64 Allowed 'General case' 0 C--N 1.3 -1.562 0 CA-C-N 115.545 -0.752 . . . . 2.8 110.45 179.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . 0.516 ' NZ ' ' CD ' ' A' ' 27' ' ' GLU . 44.2 tttm -38.91 -60.43 0.85 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 124.148 0.905 . . . . 3.78 112.638 -179.175 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.424 ' HB3' ' CG ' ' A' ' 31' ' ' PHE . 17.3 mt -35.06 -45.12 0.26 Allowed 'General case' 0 N--CA 1.505 2.303 0 N-CA-C 114.913 1.449 . . . . 1.42 114.913 -179.208 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.6 p -49.09 -38.85 25.88 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 124.118 0.887 . . . . 3.03 110.505 -179.538 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.553 HD22 ' N ' ' A' ' 26' ' ' ASN . 0.8 OUTLIER -102.64 23.71 11.6 Favored 'General case' 0 N--CA 1.504 2.251 0 C-N-CA 120.644 -0.422 . . . . 3.0 110.236 -179.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . 0.516 ' CD ' ' NZ ' ' A' ' 23' ' ' LYS . 0.3 OUTLIER -130.3 -44.04 1.15 Allowed 'General case' 0 C--N 1.301 -1.536 0 C-N-CA 119.685 -0.806 . . . . 3.29 112.174 -178.895 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.607 ' HE ' ' CG ' ' A' ' 30' ' ' ASP . 0.6 OUTLIER -107.3 -24.33 11.91 Favored 'General case' 0 N--CA 1.496 1.861 0 C-N-CA 118.41 -1.316 . . . . 5.62 112.089 -178.836 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.431 ' HB3' ' O ' ' A' ' 28' ' ' ARG . 35.7 t70 84.23 -27.34 0.1 Allowed 'General case' 0 N--CA 1.51 2.529 0 O-C-N 123.932 0.77 . . . . 4.96 111.809 178.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' ' HE ' ' A' ' 28' ' ' ARG . 10.5 p-10 -100.86 17.08 23.09 Favored 'General case' 0 N--CA 1.512 2.655 0 C-N-CA 120.15 -0.62 . . . . 4.73 111.038 -179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . 0.424 ' CG ' ' HB3' ' A' ' 24' ' ' LEU . 72.3 t80 -112.71 119.18 37.19 Favored 'General case' 0 C--N 1.3 -1.575 0 C-N-CA 118.842 -1.143 . . . . 1.13 112.097 -178.189 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -119.31 148.39 43.23 Favored 'General case' 0 N--CA 1.487 1.392 0 N-CA-C 107.212 -1.403 . . . . 2.8 107.212 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.54 ' CE1' ' HA ' ' A' ' 22' ' ' GLU . 29.9 p90 -149.17 157.69 43.58 Favored 'General case' 0 C--N 1.302 -1.5 0 C-N-CA 119.001 -1.08 . . . . 1.32 110.833 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 6.2 tp-100 -136.3 156.97 47.89 Favored 'General case' 0 C--N 1.294 -1.812 0 N-CA-C 107.072 -1.455 . . . . 3.75 107.072 178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 34.2 t80 -108.22 144.64 35.41 Favored 'General case' 0 N--CA 1.497 1.875 0 C-N-CA 117.74 -1.584 . . . . 1.26 109.033 179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 1.6 t -130.23 129.88 65.37 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 108.353 -0.98 . . . . 0.66 108.353 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . 0.422 ' OD1' ' HA ' ' A' ' 8' ' ' ARG . 0.7 OUTLIER -108.83 115.99 31.14 Favored 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 106.268 -1.753 . . . . 2.48 106.268 179.666 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 36.4 pt -62.2 -7.1 1.91 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.829 0 C-N-CA 118.372 -1.331 . . . . 1.73 111.91 -178.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 24.8 ttp180 -91.81 -9.75 42.34 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.815 -0.809 . . . . 4.94 108.815 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -99.08 -44.16 6.4 Favored 'General case' 0 N--CA 1.49 1.563 0 N-CA-C 107.012 -1.477 . . . . 1.21 107.012 179.315 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 mm-40 -74.22 -41.5 61.28 Favored 'General case' 0 N--CA 1.491 1.601 0 N-CA-C 107.143 -1.428 . . . . 2.92 107.143 178.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 97.79 55.33 1.15 Allowed Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.937 -1.665 . . . . 1.32 108.937 179.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 51.1 mt -114.29 154.31 15.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 C-N-CA 120.163 -0.615 . . . . 1.33 110.1 -179.09 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -115.4 151.63 34.34 Favored 'General case' 0 N--CA 1.487 1.392 0 CA-C-N 115.376 -0.829 . . . . 2.33 109.251 -179.837 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.522 ' NZ ' ' O ' ' A' ' 56' ' ' VAL . 19.0 mtpp -55.68 -50.56 69.95 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.159 -1.416 . . . . 5.55 108.226 179.52 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -39.94 -63.91 0.55 Allowed 'General case' 0 N--CA 1.492 1.637 0 O-C-N 124.526 1.141 . . . . 4.1 110.403 179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -47.61 -55.74 8.68 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.62 0.724 . . . . 5.11 111.3 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.4 mt -50.87 -40.57 56.65 Favored 'General case' 0 N--CA 1.49 1.557 0 CA-C-N 115.157 -0.929 . . . . 2.26 110.919 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.487 ' NE2' ' HD3' ' A' ' 54' ' ' LYS . 10.9 mm100 -40.87 -40.99 1.49 Allowed 'General case' 0 N--CA 1.506 2.356 0 C-N-CA 119.782 -0.767 . . . . 5.31 109.963 179.303 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -63.35 -38.46 91.23 Favored 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 115.008 -0.996 . . . . 4.89 112.436 -179.32 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 19.2 mtpp -86.54 -29.8 22.4 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 114.385 1.254 . . . . 3.99 114.385 -177.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.661 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -98.73 -32.76 11.22 Favored 'General case' 0 N--CA 1.497 1.908 0 C-N-CA 119.62 -0.832 . . . . 3.06 112.273 -179.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 66.15 51.24 46.02 Favored Glycine 0 N--CA 1.498 2.782 0 C-N-CA 120.157 -1.021 . . . . 3.92 112.422 179.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.55 ' CD ' ' H ' ' A' ' 54' ' ' LYS . 0.0 OUTLIER -110.04 -179.78 0.71 Allowed Pre-proline 0 N--CA 1.507 2.385 0 C-N-CA 119.407 -0.917 . . . . 8.24 109.591 179.16 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_exo -43.79 170.7 0.02 OUTLIER 'Trans proline' 0 N--CA 1.484 0.913 0 C-N-CA 122.264 1.976 . . . . 6.97 111.11 148.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.57 HG23 ' H ' ' A' ' 57' ' ' GLU . 35.1 m -89.92 -60.58 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 118.179 -1.408 . . . . 7.13 110.589 -178.685 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.57 ' H ' HG23 ' A' ' 56' ' ' VAL . 0.0 OUTLIER -39.53 -69.66 0.12 Allowed 'General case' 0 N--CA 1.501 2.12 0 O-C-N 124.506 1.129 . . . . 7.3 109.205 179.9 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 64.0 m -15.47 107.95 0.02 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 125.386 1.679 . . . . 5.54 113.929 179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.549 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.4 OUTLIER -144.63 158.26 53.89 Favored Pre-proline 0 N--CA 1.497 1.924 0 N-CA-C 106.551 -1.648 . . . . 3.37 106.551 179.457 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.549 ' HA ' HG22 ' A' ' 59' ' ' VAL . 10.2 Cg_endo -84.34 -163.27 2.97 Favored 'Cis proline' 0 N--CA 1.483 0.868 0 N-CA-C 109.26 -1.092 . . . . 1.84 109.26 -10.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.481 ' HA ' HE21 ' A' ' 61' ' ' GLN . 1.2 mm100 -133.75 151.9 51.73 Favored 'General case' 0 N--CA 1.495 1.785 0 C-N-CA 117.877 -1.529 . . . . 3.61 109.914 179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.519 HD12 ' N ' ' A' ' 62' ' ' ILE . 3.7 mp -119.71 145.8 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.8 0 N-CA-C 107.939 -1.134 . . . . 1.13 107.939 179.408 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 15.5 m-85 -133.47 128.63 35.83 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.72 -1.582 . . . . 1.12 107.152 178.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 65' ' ' ASP . 50.5 t -106.91 -166.83 0.23 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.202 0 N-CA-C 106.402 -1.703 . . . . 2.03 106.402 177.594 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.841 ' H ' HG12 ' A' ' 64' ' ' VAL . 2.9 m-20 -46.47 91.64 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 123.711 1.719 . . . . 3.81 112.916 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.491 ' N ' ' O ' ' A' ' 64' ' ' VAL . 81.1 mt-30 51.82 35.65 16.0 Favored 'General case' 0 C--N 1.278 -2.528 0 CA-C-N 110.242 -3.163 . . . . 4.95 113.368 179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 6.3 pt20 -137.53 136.44 37.65 Favored 'General case' 0 C--N 1.301 -1.52 0 C-N-CA 120.0 -0.68 . . . . 4.86 111.555 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.661 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 10.0 t-160 -79.64 141.54 36.4 Favored 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 105.377 -2.082 . . . . 1.36 105.377 178.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.577 HG13 HG23 ' A' ' 64' ' ' VAL . 11.2 mm -107.76 -50.59 7.55 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.006 0 C-N-CA 119.109 -1.036 . . . . 1.36 110.32 -179.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 145.14 -140.57 9.19 Favored Glycine 0 N--CA 1.491 2.347 0 N-CA-C 109.2 -1.56 . . . . 1.66 109.2 -179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.473 ' O ' ' CD1' ' A' ' 62' ' ' ILE . . . -101.76 -54.62 0.92 Allowed Glycine 0 N--CA 1.498 2.833 0 C-N-CA 120.407 -0.902 . . . . 2.61 112.297 -178.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.506 ' CZ ' ' HB3' ' A' ' 16' ' ' ARG . 15.3 t80 -159.05 -62.31 0.08 Allowed 'General case' 0 N--CA 1.504 2.266 0 C-N-CA 118.037 -1.465 . . . . 1.7 109.573 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 2.3 p -44.82 -40.43 6.15 Favored 'General case' 0 N--CA 1.492 1.634 0 CA-C-O 123.606 1.669 . . . . 1.37 107.306 178.262 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -61.08 -53.97 50.49 Favored 'General case' 0 C--N 1.294 -1.813 0 CA-C-N 111.579 -2.555 . . . . 2.62 109.988 179.315 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . 0.444 ' HA ' HG21 ' A' ' 69' ' ' ILE . 19.0 t80 -61.87 -38.55 88.72 Favored 'General case' 0 N--CA 1.494 1.752 0 C-N-CA 117.615 -1.634 . . . . 1.01 108.353 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -53.12 -54.63 32.78 Favored 'General case' 0 N--CA 1.493 1.686 0 N-CA-C 107.724 -1.213 . . . . 1.03 107.724 178.003 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -59.59 -51.37 70.13 Favored 'General case' 0 N--CA 1.491 1.61 0 C-N-CA 119.468 -0.893 . . . . 1.42 109.51 179.356 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.559 ' CZ2' HG11 ' A' ' 64' ' ' VAL . 71.0 t90 -46.55 -48.1 19.54 Favored 'General case' 0 N--CA 1.503 2.175 0 N-CA-C 108.756 -0.831 . . . . 2.14 108.756 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . . . . . . . . . 43.1 t -56.28 -51.37 64.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.306 0 N-CA-C 106.653 -1.61 . . . . 1.0 106.653 178.405 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.451 ' NZ ' ' OD2' ' A' ' 84' ' ' ASP . 0.5 OUTLIER -82.14 33.06 0.39 Allowed 'General case' 0 N--CA 1.491 1.589 0 C-N-CA 119.316 -0.954 . . . . 3.03 110.547 179.61 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 25.1 tt0 -133.29 -49.48 0.85 Allowed 'General case' 0 C--N 1.301 -1.52 0 CA-C-O 121.657 0.741 . . . . 7.19 109.337 179.718 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 39.9 m-80 -102.73 -15.64 16.23 Favored 'General case' 0 N--CA 1.491 1.586 0 CA-C-N 114.31 -1.313 . . . . 2.55 111.72 -179.527 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.468 ' O ' ' NH1' ' A' ' 28' ' ' ARG . 29.9 mt -107.45 1.96 23.92 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 117.824 -1.551 . . . . 1.56 112.483 -179.239 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.451 ' OD2' ' NZ ' ' A' ' 80' ' ' LYS . 10.3 p-10 -103.63 14.48 31.05 Favored 'General case' 0 N--CA 1.503 2.217 0 C-N-CA 117.692 -1.603 . . . . 5.24 107.487 177.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.462 0 CA-C-N 113.174 -1.83 . . . . 7.53 108.571 179.196 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.2 mtp . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 107.071 -1.455 . . . . 2.13 107.071 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.522 ' CD ' ' N ' ' A' ' 2' ' ' GLN . 2.3 mp0 -110.05 105.31 14.39 Favored 'General case' 0 N--CA 1.497 1.879 0 C-N-CA 118.905 -1.118 . . . . 4.09 110.131 -178.546 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 46.0 m -87.85 146.2 25.71 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 118.83 -1.148 . . . . 0.84 111.24 -179.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 56.6 t -120.5 136.57 57.1 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.54 0 N-CA-C 107.075 -1.454 . . . . 0.72 107.075 179.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 8.4 mm -113.72 108.4 25.41 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 N-CA-C 108.511 -0.922 . . . . 1.4 108.511 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.483 ' HB2' ' HB2' ' A' ' 61' ' ' GLN . 48.7 m-85 -94.5 103.9 15.86 Favored 'General case' 0 N--CA 1.498 1.935 0 N-CA-C 108.752 -0.833 . . . . 0.89 108.752 179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -127.21 -161.54 10.87 Favored Glycine 0 N--CA 1.5 2.954 0 N-CA-C 107.893 -2.083 . . . . 1.25 107.893 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.718 ' HG3' ' SG ' ' A' ' 11' ' ' CYS . 0.0 OUTLIER -125.82 31.2 5.53 Favored 'General case' 0 N--CA 1.505 2.301 0 C-N-CA 118.164 -1.415 . . . . 4.97 112.869 -179.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.613 ' O ' ' SG ' ' A' ' 11' ' ' CYS . 9.1 m 67.55 174.76 0.26 Allowed 'General case' 0 N--CA 1.498 1.969 0 CA-C-N 115.13 -0.941 . . . . 3.52 109.948 179.599 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 13.47 51.78 0.01 OUTLIER Glycine 0 N--CA 1.511 3.648 0 N-CA-C 116.0 1.16 . . . . 2.75 116.0 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.718 ' SG ' ' HG3' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -130.7 101.85 16.81 Favored Pre-proline 0 N--CA 1.496 1.849 0 N-CA-C 107.682 -1.229 . . . . 2.16 107.682 178.138 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -41.4 -47.02 5.76 Favored 'Trans proline' 0 C--N 1.32 -0.955 0 C-N-CA 121.751 1.634 . . . . 3.4 110.644 -178.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . 0.419 ' CD1' ' HB ' ' A' ' 59' ' ' VAL . 6.1 t80 -57.12 -44.7 83.56 Favored 'General case' 0 N--CA 1.497 1.922 0 C-N-CA 119.147 -1.021 . . . . 2.61 109.423 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 57.3 m -61.76 -51.19 69.33 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 107.735 -1.209 . . . . 1.8 107.735 179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.42 ' O ' ' N ' ' A' ' 18' ' ' LYS . 96.6 t -43.7 -48.81 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.931 0 CA-C-N 114.516 -1.22 . . . . 1.03 111.122 -179.694 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.423 ' C ' ' HE2' ' A' ' 72' ' ' TYR . 18.7 mtm180 -35.82 -39.23 0.15 Allowed 'General case' 0 N--CA 1.512 2.646 0 C-N-CA 120.057 -0.657 . . . . 7.42 112.042 179.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -67.34 -46.17 74.22 Favored 'General case' 0 N--CA 1.5 2.072 0 N-CA-C 108.917 -0.771 . . . . 0.89 108.917 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.567 ' HD3' ' N ' ' A' ' 19' ' ' ASP . 8.5 tmtt? -53.88 -44.74 70.68 Favored 'General case' 0 C--N 1.305 -1.337 0 N-CA-C 107.675 -1.232 . . . . 2.74 107.675 179.507 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.567 ' N ' ' HD3' ' A' ' 18' ' ' LYS . 60.7 m-20 -58.13 -54.65 44.54 Favored 'General case' 0 C--N 1.302 -1.489 0 C-N-CA 119.394 -0.922 . . . . 3.14 109.377 179.68 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 24.5 tp -54.15 -59.25 4.9 Favored 'General case' 0 C--N 1.302 -1.468 0 C-N-CA 118.604 -1.238 . . . . 0.77 110.31 179.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.425 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -53.26 -44.56 68.28 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 119.886 -0.726 . . . . 0.67 110.56 -179.615 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.421 ' CD ' ' HZ3' ' A' ' 18' ' ' LYS . 40.8 tt0 -55.7 -57.05 13.59 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 124.272 0.983 . . . . 2.94 109.666 179.211 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 57.1 tttp -56.93 -54.34 47.77 Favored 'General case' 0 N--CA 1.496 1.849 0 CA-C-N 115.747 -0.66 . . . . 4.22 111.202 -179.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.477 HD22 ' HD2' ' A' ' 28' ' ' ARG . 79.7 mt -48.35 -57.27 6.27 Favored 'General case' 0 N--CA 1.498 1.946 0 C-N-CA 119.584 -0.846 . . . . 1.61 111.678 -179.197 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 53.9 m -35.0 -26.29 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.497 0 N-CA-C 114.039 1.125 . . . . 1.38 114.039 179.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.458 ' N ' ' O ' ' A' ' 24' ' ' LEU . 9.2 t30 -104.1 -50.25 3.41 Favored 'General case' 0 N--CA 1.494 1.726 0 N-CA-C 108.932 -0.766 . . . . 4.1 108.932 179.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -87.37 40.52 0.93 Allowed 'General case' 0 N--CA 1.496 1.831 0 CA-C-N 114.837 -1.074 . . . . 4.07 111.258 -178.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.486 HH12 ' CG ' ' A' ' 84' ' ' ASP . 0.3 OUTLIER -147.76 -150.43 0.34 Allowed 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.944 -1.102 . . . . 5.03 112.196 -179.621 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.457 ' H ' ' HG3' ' A' ' 28' ' ' ARG . 4.1 m-20 -111.82 -127.31 0.28 Allowed 'General case' 0 N--CA 1.489 1.524 0 CA-C-N 115.008 -0.996 . . . . 6.78 110.188 -178.301 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -79.4 67.21 5.08 Favored 'General case' 0 N--CA 1.503 2.181 0 N-CA-C 107.662 -1.236 . . . . 3.85 107.662 179.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -112.59 114.56 27.26 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 114.918 -1.037 . . . . 0.9 111.565 -179.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 62.7 mt-30 -120.22 158.83 26.17 Favored 'General case' 0 N--CA 1.491 1.603 0 N-CA-C 105.773 -1.936 . . . . 3.39 105.773 178.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.425 ' CG ' ' HB1' ' A' ' 21' ' ' ALA . 16.3 p90 -160.58 152.79 20.35 Favored 'General case' 0 N--CA 1.498 1.972 0 C-N-CA 117.804 -1.559 . . . . 1.2 112.932 179.717 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 20.3 pt20 -131.07 164.06 26.26 Favored 'General case' 0 C--N 1.305 -1.362 0 CA-C-N 114.459 -1.246 . . . . 4.09 108.347 178.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 28.3 t80 -113.14 143.2 44.77 Favored 'General case' 0 N--CA 1.491 1.594 0 N-CA-C 107.767 -1.197 . . . . 1.18 107.767 179.058 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.427 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -132.83 143.85 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 N-CA-C 108.381 -0.97 . . . . 0.66 108.381 179.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -118.95 129.66 55.29 Favored 'General case' 0 N--CA 1.501 2.087 0 CA-C-O 121.258 0.551 . . . . 2.16 109.805 -179.1 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 43.6 pt -58.45 -24.01 24.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 C-N-CA 119.192 -1.003 . . . . 1.33 110.933 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.611 ' HB3' ' NH1' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -83.23 -34.17 25.92 Favored 'General case' 0 N--CA 1.495 1.821 0 C-N-CA 118.955 -1.098 . . . . 4.44 109.645 179.696 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -64.51 -45.18 88.34 Favored 'General case' 0 C--N 1.3 -1.578 0 CA-C-N 115.824 -0.625 . . . . 1.19 110.193 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . 0.404 ' HB2' HG13 ' A' ' 43' ' ' ILE . 8.2 mm-40 -86.34 -43.66 12.7 Favored 'General case' 0 N--CA 1.491 1.592 0 C-N-CA 119.091 -1.043 . . . . 2.93 110.075 179.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 105.76 54.66 0.72 Allowed Glycine 0 N--CA 1.506 3.302 0 N-CA-C 108.736 -1.745 . . . . 1.56 108.736 -179.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.404 HG13 ' HB2' ' A' ' 41' ' ' GLU . 6.5 mt -115.74 158.5 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 CA-C-N 114.91 -0.645 . . . . 1.51 110.399 -177.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 58.4 p -117.6 171.09 8.25 Favored 'General case' 0 N--CA 1.492 1.643 0 N-CA-C 109.022 -0.733 . . . . 2.63 109.022 179.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.488 ' NZ ' ' OE1' ' A' ' 61' ' ' GLN . 7.9 tmtm? -69.37 -43.08 74.28 Favored 'General case' 0 N--CA 1.496 1.835 0 C-N-CA 117.885 -1.526 . . . . 7.01 108.699 -179.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.648 ' CD ' ' H ' ' A' ' 46' ' ' GLU . 2.1 mp0 -56.15 -51.07 69.32 Favored 'General case' 0 N--CA 1.498 1.974 0 N-CA-C 109.072 -0.714 . . . . 3.83 109.072 179.549 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -53.44 -51.56 62.25 Favored 'General case' 0 N--CA 1.498 1.973 0 C-N-CA 118.92 -1.112 . . . . 3.05 109.098 179.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.515 ' O ' ' N ' ' A' ' 52' ' ' ALA . 55.7 mt -52.97 -51.67 60.72 Favored 'General case' 0 C--O 1.205 -1.279 0 C-N-CA 118.44 -1.304 . . . . 1.59 107.682 178.237 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.456 ' HB3' ' O ' ' A' ' 46' ' ' GLU . 1.1 tm0? -46.16 -48.14 17.49 Favored 'General case' 0 C--N 1.305 -1.347 0 O-C-N 123.935 0.772 . . . . 4.56 109.894 179.058 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 42.6 mm-40 -59.95 -40.6 89.56 Favored 'General case' 0 N--CA 1.502 2.167 0 CA-C-O 121.641 0.734 . . . . 6.38 109.034 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.42 -8.4 58.98 Favored 'General case' 0 N--CA 1.493 1.706 0 CA-C-N 114.786 -1.097 . . . . 4.41 111.525 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.637 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -94.19 -50.17 5.4 Favored 'General case' 0 N--CA 1.497 1.912 0 N-CA-C 112.504 0.557 . . . . 1.88 112.504 -177.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 99.12 -28.5 15.02 Favored Glycine 0 N--CA 1.492 2.415 0 C-N-CA 119.703 -1.237 . . . . 2.72 111.545 179.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.511 ' NZ ' ' CG ' ' A' ' 74' ' ' ASP . 19.3 ptmt -110.8 74.35 0.93 Allowed Pre-proline 0 N--CA 1.5 2.07 0 C-N-CA 120.28 -0.568 . . . . 6.39 111.367 -179.293 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.9 Cg_endo -51.0 140.23 40.0 Favored 'Trans proline' 0 C--N 1.319 -1.022 0 C-N-CA 121.581 1.521 . . . . 4.15 111.616 178.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 16.8 t 76.18 60.02 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 124.394 1.058 . . . . 5.6 110.202 178.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -110.22 -176.04 2.89 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-N 114.621 -1.172 . . . . 5.93 108.057 179.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.548 ' CG2' ' H ' ' A' ' 72' ' ' TYR . 12.2 t -100.93 -161.84 0.89 Allowed 'General case' 0 N--CA 1.507 2.41 0 C-N-CA 118.283 -1.367 . . . . 7.97 108.357 179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.419 ' HB ' ' CD1' ' A' ' 13' ' ' TYR . 74.3 t -105.9 162.82 18.52 Favored Pre-proline 0 N--CA 1.497 1.875 0 CA-C-O 121.506 0.669 . . . . 4.63 110.325 -178.819 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -76.56 -166.47 5.16 Favored 'Cis proline' 0 C--N 1.31 -1.461 0 C-N-CA 124.336 -1.11 . . . . 3.19 109.293 -29.576 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.488 ' OE1' ' NZ ' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -96.32 119.0 34.02 Favored 'General case' 0 C--N 1.297 -1.694 0 N-CA-C 106.878 -1.527 . . . . 2.93 106.878 -179.956 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . . . . . . . . . 10.1 mm -103.46 134.01 45.78 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 C-N-CA 118.806 -1.158 . . . . 1.52 109.324 -178.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.456 ' CE1' ' HB2' ' A' ' 68' ' ' HIS . 2.8 m-85 -118.14 114.14 22.62 Favored 'General case' 0 C--N 1.291 -1.946 0 N-CA-C 105.35 -2.093 . . . . 1.76 105.35 178.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.603 HG23 HG13 ' A' ' 69' ' ' ILE . 53.2 t -96.86 110.77 25.51 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 C-N-CA 117.188 -1.805 . . . . 1.31 111.19 -179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 29.5 t70 61.32 -77.05 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 113.594 0.961 . . . . 2.51 113.594 177.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . 0.401 ' N ' ' O ' ' A' ' 64' ' ' VAL . 11.8 mm-40 -130.53 -18.56 3.15 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 114.117 1.155 . . . . 4.46 114.117 -178.765 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -108.46 156.7 19.16 Favored 'General case' 0 N--CA 1.492 1.648 0 C-N-CA 118.741 -1.184 . . . . 4.83 111.285 -178.699 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.637 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 39.2 t-80 -87.53 141.36 28.68 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 118.803 -1.159 . . . . 1.76 109.71 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.603 HG13 HG23 ' A' ' 64' ' ' VAL . 8.7 mm -114.18 -54.85 4.6 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.993 0 N-CA-C 107.005 -1.48 . . . . 1.51 107.005 179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . 0.528 ' HA3' ' CE1' ' A' ' 68' ' ' HIS . . . 58.65 123.22 0.01 OUTLIER Glycine 0 N--CA 1.501 3.003 0 O-C-N 124.493 1.121 . . . . 2.4 113.6 179.304 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . 0.447 ' HA2' HG22 ' A' ' 58' ' ' THR . . . 104.23 141.12 10.89 Favored Glycine 0 N--CA 1.491 2.35 0 C-N-CA 119.875 -1.155 . . . . 1.54 112.57 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' H ' ' CG2' ' A' ' 58' ' ' THR . 20.2 t80 -82.97 -54.5 5.02 Favored 'General case' 0 N--CA 1.49 1.546 0 C-N-CA 119.458 -0.897 . . . . 1.89 109.211 179.682 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 16.5 p -67.65 1.82 2.22 Favored 'General case' 0 N--CA 1.497 1.906 0 C-N-CA 119.162 -1.015 . . . . 1.8 108.939 179.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . 0.521 ' H ' ' C ' ' A' ' 72' ' ' TYR . 15.2 t70 -100.53 -63.6 1.12 Allowed 'General case' 0 C--N 1.305 -1.34 0 N-CA-C 106.927 -1.508 . . . . 3.1 106.927 179.029 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -55.58 -45.61 77.35 Favored 'General case' 0 N--CA 1.489 1.48 0 CA-C-N 115.257 -0.883 . . . . 0.78 108.936 179.291 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -46.92 -38.61 10.8 Favored 'General case' 0 N--CA 1.493 1.703 0 CA-C-N 116.109 -0.496 . . . . 0.88 110.39 179.586 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.435 ' O ' ' C ' ' A' ' 78' ' ' TRP . . . -81.05 -50.77 9.25 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 107.6 -1.259 . . . . 0.97 107.6 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . 0.602 ' CH2' HG11 ' A' ' 64' ' ' VAL . 76.6 t90 -38.62 -53.23 1.62 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 124.125 0.89 . . . . 1.35 108.712 179.143 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 83' ' ' LEU . 75.6 t -44.02 -46.42 2.12 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 CA-C-N 114.324 -1.307 . . . . 1.13 110.505 179.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.544 ' HZ1' ' C ' ' A' ' 85' ' ' ALA . 0.0 OUTLIER -73.28 -58.57 3.22 Favored 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 119.914 -0.714 . . . . 3.61 111.707 -178.83 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 5.0 mp0 -57.4 -24.69 56.96 Favored 'General case' 0 N--CA 1.501 2.108 0 N-CA-C 113.122 0.786 . . . . 3.74 113.122 -178.859 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -101.02 -34.26 9.82 Favored 'General case' 0 N--CA 1.501 2.113 0 N-CA-C 114.355 1.243 . . . . 1.95 114.355 -178.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.464 HD12 HG13 ' A' ' 79' ' ' VAL . 36.8 mt -96.04 -11.63 26.12 Favored 'General case' 0 N--CA 1.503 2.216 0 C-N-CA 118.328 -1.349 . . . . 1.77 111.677 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . 0.492 ' O ' ' CB ' ' A' ' 85' ' ' ALA . 36.3 m-20 -122.48 -50.5 1.99 Allowed 'General case' 0 N--CA 1.498 1.968 0 O-C-N 124.287 0.992 . . . . 3.74 109.967 179.108 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.544 ' C ' ' HZ1' ' A' ' 80' ' ' LYS . . . . . . . . 0 N--CA 1.502 2.144 0 O-C-N 126.159 2.162 . . . . 6.15 107.099 -178.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.405 ' N ' ' OD1' ' A' ' 65' ' ' ASP . 4.9 mtp . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 108.929 -0.767 . . . . 2.95 108.929 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -110.11 98.18 7.51 Favored 'General case' 0 C--N 1.304 -1.374 0 N-CA-C 106.723 -1.584 . . . . 3.94 106.723 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.545 ' HB ' ' HB2' ' A' ' 33' ' ' TYR . 86.6 m -82.17 141.3 33.17 Favored 'General case' 0 C--N 1.298 -1.638 0 C-N-CA 119.383 -0.927 . . . . 0.79 111.939 -178.339 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' VAL . . . . . . . . . . . . . 10.2 t -133.86 138.78 49.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-N 115.569 -0.741 . . . . 0.63 110.096 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 12.1 mm -118.79 123.28 71.26 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 N-CA-C 105.28 -2.119 . . . . 1.54 105.28 178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PHE . . . . . 0.445 ' CD2' HG11 ' A' ' 36' ' ' VAL . 58.2 m-85 -104.07 78.45 1.52 Allowed 'General case' 0 N--CA 1.494 1.758 0 N-CA-C 108.048 -1.093 . . . . 1.17 108.048 -179.559 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -116.6 -151.06 9.49 Favored Glycine 0 N--CA 1.499 2.863 0 C-N-CA 119.514 -1.327 . . . . 1.0 110.739 -178.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ARG . . . . . 0.647 ' HD2' ' H ' ' A' ' 9' ' ' SER . 2.7 tmm_? -119.47 -178.32 3.58 Favored 'General case' 0 N--CA 1.495 1.782 0 N-CA-C 108.343 -0.984 . . . . 5.35 108.343 179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.647 ' H ' ' HD2' ' A' ' 8' ' ' ARG . 0.0 OUTLIER -71.44 59.45 0.29 Allowed 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 112.037 0.384 . . . . 3.6 112.037 179.64 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . 104.3 71.26 0.84 Allowed Glycine 0 N--CA 1.501 2.975 0 C-N-CA 119.159 -1.496 . . . . 2.89 112.197 179.14 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' CYS . . . . . 0.465 ' SG ' ' CB ' ' A' ' 8' ' ' ARG . 0.5 OUTLIER -129.21 149.82 73.73 Favored Pre-proline 0 N--CA 1.495 1.804 0 C-N-CA 119.925 -0.71 . . . . 2.14 109.687 178.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -46.48 -65.67 0.18 Allowed 'Trans proline' 0 C--N 1.32 -0.939 0 C-N-CA 122.303 2.002 . . . . 3.89 113.206 -169.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' TYR . . . . . . . . . . . . . 67.2 m-85 -78.01 15.86 0.83 Allowed 'General case' 0 N--CA 1.505 2.303 0 C-N-CA 119.104 -1.038 . . . . 3.69 112.897 -178.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . 0.458 ' SG ' ' HG3' ' A' ' 60' ' ' PRO . 36.1 m -107.16 -48.78 3.4 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 106.624 -1.621 . . . . 2.12 106.624 178.781 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' VAL . . . . . 0.488 ' C ' ' H ' ' A' ' 17' ' ' ALA . 50.1 t -73.96 -38.3 49.39 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 CA-C-N 113.947 -1.479 . . . . 1.08 108.529 179.303 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.427 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -80.09 38.88 0.42 Allowed 'General case' 0 N--CA 1.494 1.755 0 CA-C-O 122.174 0.987 . . . . 3.77 109.391 179.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . 0.488 ' H ' ' C ' ' A' ' 15' ' ' VAL . . . -142.21 -49.56 0.37 Allowed 'General case' 0 C--N 1.29 -1.981 0 N-CA-C 106.073 -1.825 . . . . 1.33 106.073 178.851 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LYS . . . . . 0.697 ' HZ2' ' CD ' ' A' ' 22' ' ' GLU . 50.9 tttm -57.59 -38.88 75.61 Favored 'General case' 0 C--N 1.311 -1.087 0 CA-C-N 113.904 -1.498 . . . . 3.46 110.081 178.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -43.55 -47.42 7.34 Favored 'General case' 0 N--CA 1.492 1.675 0 CA-C-O 121.376 0.608 . . . . 4.65 110.448 179.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.9 tp -60.24 -42.85 96.15 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-N 115.409 -0.814 . . . . 1.51 110.156 -179.714 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ALA . . . . . 0.502 ' HB1' ' CG ' ' A' ' 33' ' ' TYR . . . -63.65 -57.91 8.58 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 119.332 -0.947 . . . . 0.73 109.251 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.697 ' CD ' ' HZ2' ' A' ' 18' ' ' LYS . 47.8 mt-10 -51.44 -51.56 53.86 Favored 'General case' 0 N--CA 1.483 1.223 0 CA-C-O 121.805 0.812 . . . . 3.53 109.262 179.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' LYS . . . . . . . . . . . . . 22.1 ttpp -53.96 -59.21 4.93 Favored 'General case' 0 C--N 1.302 -1.482 0 CA-C-N 114.937 -1.029 . . . . 4.24 109.928 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 24' ' ' LEU . 7.4 mt -51.79 -53.17 42.97 Favored 'General case' 0 N--CA 1.494 1.749 0 C-N-CA 118.528 -1.269 . . . . 1.93 110.888 -179.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 73.6 m -52.99 -32.12 44.63 Favored 'General case' 0 N--CA 1.501 2.118 0 C-N-CA 119.061 -1.056 . . . . 1.61 111.76 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.2 t30 -83.37 -37.18 23.67 Favored 'General case' 0 N--CA 1.506 2.35 0 C-N-CA 119.887 -0.725 . . . . 3.3 111.059 -179.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 54.2 mt-10 -74.39 -40.06 62.31 Favored 'General case' 0 N--CA 1.508 2.45 0 CA-C-O 122.071 0.939 . . . . 2.9 110.336 179.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.607 HH21 ' CG ' ' A' ' 30' ' ' ASP . 9.1 mmm180 -99.62 179.3 4.59 Favored 'General case' 0 C--N 1.296 -1.72 0 CA-C-N 114.113 -1.403 . . . . 6.92 111.418 -178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ASP . . . . . 0.408 ' H ' ' CZ ' ' A' ' 28' ' ' ARG . 2.0 p30 -122.3 -12.79 8.2 Favored 'General case' 0 N--CA 1.502 2.137 0 CA-C-N 114.772 -1.104 . . . . 3.79 110.843 179.632 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ASP . . . . . 0.607 ' CG ' HH21 ' A' ' 28' ' ' ARG . 14.5 p30 -103.63 -46.14 4.62 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 113.7 1.0 . . . . 4.52 113.7 -177.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -48.39 110.39 0.33 Allowed 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 113.502 0.927 . . . . 0.83 113.502 -179.219 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.587 ' NE2' ' H ' ' A' ' 33' ' ' TYR . 2.3 tm0? -103.35 156.16 17.94 Favored 'General case' 0 N--CA 1.489 1.512 0 N-CA-C 108.493 -0.929 . . . . 5.29 108.493 179.114 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.587 ' H ' ' NE2' ' A' ' 32' ' ' GLN . 1.6 p90 -164.09 156.74 17.44 Favored 'General case' 0 N--CA 1.49 1.537 0 C-N-CA 119.489 -0.884 . . . . 1.24 111.218 179.44 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -139.23 152.44 47.32 Favored 'General case' 0 C--N 1.3 -1.553 0 CA-C-N 114.606 -1.179 . . . . 3.12 108.772 178.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.4 ' CD2' ' HD2' ' A' ' 18' ' ' LYS . 53.3 t80 -107.47 138.6 43.38 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 118.145 -1.422 . . . . 1.05 107.593 179.485 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.445 HG11 ' CD2' ' A' ' 6' ' ' PHE . 2.1 t -124.59 143.52 37.75 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.661 0 O-C-N 124.204 0.94 . . . . 0.66 108.7 -178.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -117.23 118.33 32.02 Favored 'General case' 0 N--CA 1.496 1.833 0 N-CA-C 106.853 -1.536 . . . . 2.47 106.853 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 35.3 pt -53.09 -19.27 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 C-N-CA 119.654 -0.818 . . . . 1.28 110.985 -178.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.53 ' CZ ' ' CB ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -76.77 -37.89 55.08 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 123.593 0.558 . . . . 5.65 111.445 179.353 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ALA . . . . . . . . . . . . . . . -74.5 -43.43 55.96 Favored 'General case' 0 N--CA 1.493 1.704 0 C-N-CA 119.908 -0.717 . . . . 1.32 109.298 -179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -75.27 -43.22 52.54 Favored 'General case' 0 N--CA 1.489 1.518 0 CA-C-N 115.169 -0.923 . . . . 3.36 109.33 178.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 94.06 60.29 1.13 Allowed Glycine 0 N--CA 1.496 2.654 0 N-CA-C 108.305 -1.918 . . . . 1.41 108.305 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.499 HG22 ' N ' ' A' ' 44' ' ' THR . 30.3 mm -114.52 160.75 13.76 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.223 0 C-N-CA 119.458 -0.897 . . . . 2.83 112.346 -178.177 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . 0.499 ' N ' HG22 ' A' ' 43' ' ' ILE . 0.9 OUTLIER -121.33 151.29 40.27 Favored 'General case' 0 N--CA 1.489 1.5 0 CA-C-N 114.63 -1.168 . . . . 2.51 109.772 179.772 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.548 ' HE2' ' N ' ' A' ' 46' ' ' GLU . 4.1 ttpt -56.69 -46.61 81.09 Favored 'General case' 0 N--CA 1.497 1.909 0 C-N-CA 118.656 -1.218 . . . . 4.82 109.746 179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . 0.548 ' N ' ' HE2' ' A' ' 45' ' ' LYS . 23.8 mm-40 -45.06 -56.85 4.29 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.284 -0.566 . . . . 4.34 110.159 -179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -56.56 -56.34 22.57 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.825 0.821 . . . . 4.37 110.281 178.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.457 ' HB3' ' CD ' ' A' ' 61' ' ' GLN . 21.7 mt -46.97 -46.85 21.84 Favored 'General case' 0 N--CA 1.498 1.975 0 CA-C-N 115.112 -0.949 . . . . 1.62 110.39 -179.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLN . . . . . 0.474 ' HB2' ' HE3' ' A' ' 45' ' ' LYS . 25.8 tt0 -52.56 -50.32 63.18 Favored 'General case' 0 C--N 1.296 -1.733 0 CA-C-N 114.72 -1.127 . . . . 3.62 109.561 179.302 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 52.8 tp60 -52.45 -32.17 38.19 Favored 'General case' 0 N--CA 1.492 1.657 0 CA-C-O 121.878 0.847 . . . . 5.62 110.301 179.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' LYS . . . . . 0.771 ' HB3' ' HZ2' ' A' ' 51' ' ' LYS . 0.0 OUTLIER -100.98 19.46 17.33 Favored 'General case' 0 N--CA 1.497 1.907 0 CA-C-N 114.294 -1.321 . . . . 4.03 111.139 179.84 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.597 ' HB1' ' CE1' ' A' ' 68' ' ' HIS . . . -113.15 -41.08 3.77 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 123.826 0.703 . . . . 1.83 110.569 -179.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 112.02 -55.4 0.51 Allowed Glycine 0 N--CA 1.495 2.596 0 N-CA-C 108.45 -1.86 . . . . 2.44 108.45 179.628 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.442 ' HG2' ' N ' ' A' ' 55' ' ' PRO . 31.3 tttm -92.03 151.98 42.38 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 107.574 -1.269 . . . . 7.37 107.574 179.172 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.442 ' N ' ' HG2' ' A' ' 54' ' ' LYS . 30.3 Cg_exo -61.23 75.38 0.08 OUTLIER 'Trans proline' 0 C--N 1.314 -1.267 0 C-N-CA 121.543 1.495 . . . . 4.65 110.684 158.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.403 HG22 ' H ' ' A' ' 56' ' ' VAL . 0.1 OUTLIER -70.38 82.42 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 CA-C-O 122.032 0.92 . . . . 6.48 108.527 178.852 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLU . . . . . 0.437 ' N ' ' CD ' ' A' ' 57' ' ' GLU . 0.2 OUTLIER -50.3 -31.66 14.96 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-N 114.082 -1.417 . . . . 5.5 111.57 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 59' ' ' VAL . 99.9 m -94.61 169.05 10.46 Favored 'General case' 0 N--CA 1.492 1.663 0 CA-C-N 115.682 -0.69 . . . . 5.16 110.763 -179.363 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.437 HG22 ' HA ' ' A' ' 60' ' ' PRO . 0.9 OUTLIER -116.4 166.0 13.65 Favored Pre-proline 0 N--CA 1.493 1.681 0 N-CA-C 107.454 -1.313 . . . . 2.78 107.454 179.691 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.458 ' HG3' ' SG ' ' A' ' 14' ' ' CYS . 76.6 Cg_endo -92.86 -151.08 0.33 Allowed 'Cis proline' 0 C--N 1.312 -1.355 0 N-CA-C 109.592 -0.965 . . . . 2.61 109.592 -17.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.457 ' CD ' ' HB3' ' A' ' 48' ' ' LEU . 24.9 mt-30 -123.66 154.48 39.3 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 108.499 -0.926 . . . . 4.3 108.499 178.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ILE . . . . . 0.485 HD11 ' HB1' ' A' ' 17' ' ' ALA . 38.7 mt -128.04 142.43 43.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.639 0 CA-C-N 114.269 -1.332 . . . . 1.2 107.926 -179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -135.2 122.58 21.82 Favored 'General case' 0 C--N 1.286 -2.156 0 N-CA-C 107.377 -1.342 . . . . 0.97 107.377 -179.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . 0.478 HG22 HG23 ' A' ' 3' ' ' THR . 60.4 t -106.71 97.18 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 C-N-CA 117.77 -1.572 . . . . 1.71 109.424 179.636 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' OD1' ' N ' ' A' ' 1' ' ' MET . 17.5 t0 80.49 -64.82 0.17 Allowed 'General case' 0 N--CA 1.492 1.626 0 CA-C-N 114.869 -1.059 . . . . 2.51 113.011 177.735 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -140.92 -29.65 0.66 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 116.258 1.947 . . . . 5.78 116.258 -177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLN . . . . . 0.473 ' CD ' ' H ' ' A' ' 67' ' ' GLN . 0.0 OUTLIER -100.01 -174.96 2.82 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 118.938 -1.105 . . . . 5.31 111.736 -178.728 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.597 ' CE1' ' HB1' ' A' ' 52' ' ' ALA . 11.9 t-160 -103.41 138.66 39.84 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 107.779 -1.193 . . . . 1.57 107.779 179.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ILE . . . . . 0.454 HG13 HG23 ' A' ' 64' ' ' VAL . 25.2 mm -122.85 -40.73 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 124.061 0.851 . . . . 2.1 109.872 -179.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLY . . . . . . . . . . . . . . . 53.02 -176.15 0.18 Allowed Glycine 0 N--CA 1.509 3.522 0 CA-C-O 122.085 0.825 . . . . 2.86 115.153 179.199 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLY . . . . . . . . . . . . . . . 37.02 -160.39 0.01 OUTLIER Glycine 0 N--CA 1.508 3.437 0 CA-C-N 113.857 -1.172 . . . . 1.86 113.89 179.348 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.427 ' CD1' ' O ' ' A' ' 16' ' ' ARG . 33.4 t80 -121.51 -58.67 1.75 Allowed 'General case' 0 N--CA 1.494 1.748 0 N-CA-C 108.121 -1.066 . . . . 1.92 108.121 179.057 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 6.8 p -39.46 -47.22 1.8 Allowed 'General case' 0 N--CA 1.494 1.758 0 CA-C-O 122.246 1.022 . . . . 1.8 110.061 178.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -65.06 -63.04 1.2 Allowed 'General case' 0 C--O 1.193 -1.908 0 CA-C-N 112.535 -2.12 . . . . 3.25 108.67 -179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' PHE . . . . . . . . . . . . . 1.7 t80 -44.3 -49.51 9.39 Favored 'General case' 0 N--CA 1.504 2.257 0 C-N-CA 119.231 -0.988 . . . . 1.23 109.988 178.74 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -56.08 -65.76 0.55 Allowed 'General case' 0 N--CA 1.493 1.687 0 CA-C-N 114.68 -1.145 . . . . 1.2 111.813 179.878 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -57.55 -52.95 63.33 Favored 'General case' 0 N--CA 1.493 1.682 0 N-CA-C 108.875 -0.787 . . . . 1.3 108.875 -179.775 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -44.95 -56.28 4.73 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-N 114.65 -1.159 . . . . 1.46 109.502 179.224 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' VAL . . . . . 0.434 HG13 HD12 ' A' ' 83' ' ' LEU . 3.1 t -47.93 -60.76 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 107.944 -1.132 . . . . 1.33 107.944 179.096 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . 0.465 ' NZ ' ' O ' ' A' ' 80' ' ' LYS . 0.2 OUTLIER -47.05 -46.75 22.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 124.3 1.0 . . . . 3.16 111.095 -179.949 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 8.6 mm-40 -95.11 21.05 8.24 Favored 'General case' 0 N--CA 1.497 1.904 0 N-CA-C 114.243 1.201 . . . . 5.21 114.243 -178.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -130.33 -32.96 1.73 Allowed 'General case' 0 N--CA 1.496 1.859 0 C-N-CA 119.866 -0.733 . . . . 2.15 109.835 178.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.434 HD12 HG13 ' A' ' 79' ' ' VAL . 27.1 mt -96.21 32.62 1.91 Allowed 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 118.349 -1.34 . . . . 2.01 111.786 -179.078 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -108.63 -60.8 1.69 Allowed 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.969 -0.752 . . . . 5.32 108.969 177.729 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.865 0 CA-C-O 116.584 -1.674 . . . . 8.59 110.064 179.974 . . . . . . . . 0 0 . 1 stop_ save_